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ABSTRACT 
 
With nearly a quarter of the global population consuming fecally contaminated water, 
waterborne pathogens can have a significant impact on public health.  Human adenovirus 
(HAdV), is found globally in water sources and can cause a variety of illnesses including 
gastroenteritis, respiratory disease, and conjunctivitis. HAdV is of particular concern in drinking 
water because of its resistance to common disinfectants such as low-pressure ultraviolet light and 
monochloramine. The reason HAdV is so resistant to monochloramine yet so susceptible to free 
chlorine remains unknown.   
 
The main goal of this research was to gain a better understanding of the mechanisms of HAdV 
serotype 2 (HAdV-2) inactivation by drinking water disinfectants.  This research achieved the 
following objectives:  (1) Characterized bacteriophage PR772 inactivation kinetics over a range 
of environmental conditions for a variety of drinking water disinfectants, with an emphasis on 
chlorine, to determine if PR772 is a good surrogate for HAdV-2; (2) developed methods to 
quantitatively analyze stages of the HAdV-2 and PR772 replication cycles that are able to 
distinguish between untreated viruses, partially inactivated (~90%) viruses, and inactivated up to 
99.99%; (3) determined what stages of the HAdV-2 and PR772 replication cycles became 
inhibited after free chlorine or monochloramine disinfection.   
 
This research elucidated that HAdV-2 inactivated up to 99.99% by free chlorine could still attach 
to host cell monolayers, but genome synthesis as well as late hexon mRNA and early E1A 
mRNA transcription were inhibited.  When exposed to free chlorine, PR772 had remarkably 
similar inactivation kinetics compared to HAdV-2.  Like HAdV-2, free chlorine inactivated 
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PR772 could still bind to host cells but genome replication and mRNA transcription were 
inhibited.  Similar results were obtained for viruses inactivated by monochloramine, but the 
kinetics of inactivation for the two viruses were orders of magnitude different.  Overall, exposure 
to chlorine-based disinfectants interfered with HAdV-2 and PR772 replication cycle events that 
occurred post-binding but prior to early viral protein synthesis.  Additional work toward a more 
fundamental understanding of how viruses become inactivated is key for the development of new 
disinfection technologies and novel sensors to detect infectious viruses in drinking water. 
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CHAPTER 1:  INTRODUCTION 
1.1 Waterborne Viruses:  A Barrier to Safe Drinking Water* 
1.1.1 Global Status of Access to Safe, Pathogen-Free Drinking Water 
Nearly 25% of the global population (1.8 billion people in 2012) is consuming fecally-
contaminated water.1 This water can contain bacteria, protozoa, and viruses that can cause a 
variety of diseases in humans, most notably gastroenteritis. The impact on public health is 
staggering. Unsafe water, inadequate sanitation, and poor hygiene are responsible for about 90% 
of diarrheal deaths worldwide.2 Not surprisingly, diarrhea is the second leading cause of death 
for children under the age of five globally (1.2 million deaths in 2012).2 In addition to the human 
cost, the World Bank estimates that lack of access to safe water and sanitation results in a global 
economic loss of US$260 billion annually.3 
 
The lack of access to improved water disproportionally affects those living in poverty in rural, 
developing regions; however, even populations living in countries with state-of-the-art water and 
waste treatment facilities are prone to waterborne disease outbreaks. For example, there were at 
least 33 outbreaks associated with drinking water reported in the United States of America 
during 2009-2010.4 Regardless of the socioeconomic status of a country, illnesses due to 
contaminated drinking water are considered significantly underreported because people do not 
seek medical attention for self-limiting infections and because of the current limitations on 
clinical detection of virus infections.4  
 
1.1.2 Waterborne Viruses are a Particular Concern 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  *Adapted from Gall, A. M.; Mariñas, B. J.; Lu, Y.; Shisler, J. L. Waterborne Viruses: A Barrier 
to Safe Drinking Water. PLoS Pathog. 2015, 11 (6), e1004867.	  
	   2 
It is well known that bacteria are major causes of diarrhea transmitted through unsafe drinking 
water. What is less appreciated are viruses in these same drinking water sources and their impact 
on human health. Water-transmitted viral pathogens that are classified as having a moderate to 
high health significance by the World Health Organization (WHO) include adenovirus, 
astrovirus, hepatitis A and E viruses, rotavirus, norovirus and other caliciviruses, and 
enteroviruses, including coxsackieviruses and polioviruses.5  Also, viruses that are excreted 
through urine like polyomaviruses5 and cytomegalovirus6 can potentially be spread through 
water.  Other viruses, such as influenza and coronaviruses, have been suggested as organisms 
that can be transmitted through drinking water, but evidence is inconclusive.5  
 
Most of the above viruses are most commonly associated with gastroenteritis, which can cause 
diarrhea as well as other symptoms including abdominal cramping, vomiting, and fever.  It 
should be noted that some of these same viruses could also cause more severe illnesses including 
encephalitis, meningitis, myocarditis (enteroviruses), cancer (polyomavirus), and hepatitis 
(hepatitis A and E viruses).5 Hepatitis E virus can also cause a mortality rate of up to 25% in 
pregnant women.5 Viral infections are usually self-limiting in healthy individuals. They can 
cause greater morbidity in children under the age of five, the elderly, immunocompromised 
people, and pregnant women. Waterborne virus-based diseases may be higher in developing 
regions, where there is widespread malnutrition and large populations of HIV-positive people. 
Regardless, there are few broad spectrum anti-viral drugs to treat these diseases.  
 
Certainly, there is good cause for controlling these waterborne viruses.  Rotavirus, for example, 
is the leading cause of severe acute diarrhea in children under the age of five globally, resulting 
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in over half a million deaths annually.7 The worldwide use of new rotavirus vaccines may make 
the removal of this virus from water supplies less of an issue in the future.  Similarly, better 
coverage with vaccinations against hepatitis A and poliovirus would also greatly decrease the 
health risks of these viruses in drinking water. 
 
Waterborne viruses differ in terms of their genome content and capsid proteins, but these viruses 
share several properties that make them of particular concern regarding the risk of disease 
outbreak associated with drinking water contamination. Several of these viruses have extremely 
low infectious doses; the probability of infection from exposure to one rotavirus particle is 31%.8 
Viruses are shed in feces in very high numbers even asymptomatically. For example, up to 1011 
norovirus particles can be present per gram of stool.9 In addition, non-enveloped viruses can 
persist in water for long periods of time.10 When considering these characteristics, inadequate 
disinfection of fecally contaminated drinking water could easily lead to outbreaks of viral 
gastroenteritis from ingestion. Notably, drinking water can also transmit viruses via inhalation 
(e.g., showering) or contact with skin and eyes (e.g., swimming) causing respiratory and ocular 
infections.    
 
1.1.3 State-of-the-Art for Control of Viruses in Water 
Water treatment utilities routinely assay for the presence of fecal coliforms in water supplies, but 
they do not assay for the presence of infectious viruses because it is either impossible or not 
feasible to detect or propagate infectious virus particles in a cost-efficient and timely manner. 
Despite these barriers, the United States Environmental Protection Agency (USEPA) is 
evaluating adenovirus, caliciviruses, enteroviruses, and hepatitis A virus for potential regulatory 
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action.11 The current US regulations require the removal or inactivation of 99.99% of enteric 
viruses by approved treatment techniques, but specific virus families are not individually 
regulated. These approved treatment techniques are based on bench scale studies where a 
specific virus is exposed to a disinfectant at various environmental conditions until reaching 
99.99% inactivation.  By studying a range of enteric viruses, regulations are decided for each 
disinfectant based on an appropriate dose to adequately inactivate the most resistant enteric virus 
studied.  Utilities must apply an appropriate disinfectant dose to meet enteric virus regulations.   
 
Common water treatment techniques worldwide include physically removing pathogens through 
conventional treatment and inactivating pathogens by applying ultraviolet light or chemical 
oxidants such as chlorine, chloramines, ozone, and chlorine dioxide.  Since viruses are so small, 
conventional treatment, including filtration, is ineffective at physically removing viruses.  The 
application of disinfectants highly depends on water chemistry and local regulations.  Free 
chlorine (i.e., sum of hypochlorous acid and hypochlorite ion formed by dissolution and 
hydrolysis of chlorine gas in water) is the most commonly used disinfectant worldwide and has 
been used to disinfect water since the early 1900s.12 Most viruses are inactivated by this strong 
oxidant. However, free chlorine treatment may produce regulated toxic disinfection by-products 
(DBPs), and it is ineffective to control Cryptosporidium, a protozoan that is transmitted in water 
and causes diarrhea.13, 14 Thus, some drinking water utilities are moving towards using 
monochloramine (i.e., formed by mixing chlorine and ammonia with the latter in slight excess) 
to control the formation of regulated toxic DBPs, and either monochromatic (~254 nm) or 
polychromatic (200-300 nm) ultraviolet (UV) light for controlling both DBP formation and 
Cryptosporidium contamination. Unfortunately, these changes in disinfection practice come at a 
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cost to virus control. For example, while adenovirus is susceptible to inactivation by free 
chlorine, it is highly resistant to inactivation by both monochloramine and UV light.15 Chlorine 
dioxide and ozone, also strong oxidants, are both effective at controlling viruses, but they have 
operational challenges, such as the need for on-site generation, and the production of DBPs, 
including chlorite from chlorine dioxide and bromate from ozone.12    
 
Regardless of the disinfectant applied at a drinking water utility, as the treated water travels from 
the treatment plant to the tap, cross-contamination can occur throughout the miles of water 
distribution infrastructure due to cavitation and accidental depressurization; therefore, the use of 
secondary disinfectants in distribution systems is required. Unfortunately, the only two 
disinfectants capable of maintaining a residual in the distribution system are free chlorine and 
monochloramine. Although free chlorine is a stronger disinfectant with respect to pathogen 
inactivation, monochloramine provides a more stable residual in distribution systems, and so 
both are utilized.   
 
1.1.4  Barriers Towards Disinfecting Viruses in Drinking Water 
There are several barriers that prevent viruses in drinking water from being detected. From a 
technological standpoint, as compared to detecting fecal coliforms, virus propagation requires 
the use of tissue culture, a system that requires increased time, labor, expertise, and expensive 
equipment.8 Furthermore, several of these viruses cannot be grown easily (adenovirus serotypes 
40 and 41) or at all (human norovirus, hepatitis A virus) in cell culture. Consequently, traditional 
viral growth assays (plaque assays) are either unavailable or too lengthy in time to be practical 
for water treatment facilities. For example, a 10-day incubation period is required to detect 
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replicating adenoviruses via plaque assays. While ELISA or qPCR-based technologies can be 
used to rapidly detect viral proteins or genomes, respectively, they do not distinguish infectious 
versus non-infectious viral particles. Integrated cell culture-PCR (ICC-PCR) reduces time 
requirements of traditional plaque assays and allows for infectious viruses to replicate in host 
cells, but it still employs the use of cell culture that is impractical at water treatment utilities.8 
Although there have been advances in concentrating viruses from large volumes of water,16 there 
has yet to be a rapid way to detect viable viruses.       
 
In addition to these detection technology limitations, there is not one “silver bullet” water 
treatment that will inactivate all virus types independently of water quality. For example, human 
adenovirus is nearly five times more resistant to monochromatic (254 nm) UV inactivation 
compared to other enteric viruses.17 While bacteriophages are often used as models to study 
enteric eukaryotic viruses, no bacteriophage studied to date accurately represents enteric virus 
behavior for all disinfectants. The scientific community does not yet understand why viruses 
have different profiles of resistance to different disinfectants.  Regardless, from a regulatory 
standpoint, a major barrier is that not one disinfection method is effective against all viruses that 
can be applied to all water quality conditions. 
 
Waterborne viruses have a range of genome types (e.g., DNA, RNA, linear, segmented) and 
capsid protein structures that contribute to their resistance or susceptibility to specific 
disinfectants. Many studies have determined reaction rates of disinfectants with amino acids and 
nucleotides, and this information can be useful in analyzing the mechanism of virus inactivation.  
However, these data are not always predictive due to the complex nature of viral capsid 
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structures and secondary reactions.18  It was initially thought that UV treatment of viruses would 
damage the viral genome as the mechanism for disinfection, whereas chemical oxidants like free 
chlorine would damage viral capsid proteins as a means for disinfection. UV light is known to be 
more reactive with nucleotides than amino acids; however, UV light can also damage viral 
proteins,19 suggesting that UV light has multiple mechanisms to disinfect viruses. For example, 
UV irradiation inactivates bacteriophage MS2 by both site-specific backbone cleavage of the 
major capsid protein resulting in genome injection inhibition and by damaging the RNA genome 
leading to genomic replication inhibition.19  Whether this is true for other viruses is unknown.  
Chemical oxidants like free chlorine typically have higher reaction rates with amino acids, but 
have been shown to damage both viral proteins and genomes.19-21  Regardless, determining 
precisely how a disinfectant damages and neutralizes specific viruses is necessary to fully 
understand the mechanisms of virus inactivation.   
 
1.1.5 The Future of Waterborne Virus Research 
How does the scientific community overcome the technological and knowledge barriers? First, 
we must increase our fundamental understanding of how individual viruses become inactivated 
by disinfectants on a molecular level. This will require detailed studies of the individual 
components of a viral particle as well as the virion as a whole (Figure 1.1). The state-of-the-art 
technique is to correlate virus disinfection with a block in the virus replication cycle as a means 
to pinpoint what alteration of the protein capsid and/or the viral genome by the disinfectant 
results in loss of infectivity.19, 22 Technologies including mass spectrometry will afford the 
opportunity to understand, on an amino acid level, how a disinfectant modifies viral capsid 
proteins, and how this may result in a non-infectious virus particle.18  Labeling techniques can 
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also be utilized to determine if viral capsid proteins have undergone specific modifications, such 
as using a biotin hydrazide that forms covalent bonds with carbonyl groups,23 one of many 
oxidative products formed on amino acids. The scientific field is now beginning to capitalize on 
the sensitivity of qPCR or RT-qPCR to detect specific regions of a viral genome that are 
damaged by a disinfectant. Disinfectant-induced genomic damage can block viral DNA/RNA 
replication in host cells or viral genome amplification in PCR reactions.24 However, PCR cannot 
elucidate what type of genome modification is caused by a disinfectant (e.g., pyrimidine dimers, 
crosslinking to proteins, chlorine-carbon bonds) or if the host cell is able to repair the lesions.17, 
24 A variety of techniques will need to be used and developed to determine on a molecular level 
how a disinfectant neutralizes a virus and what stage of the replication cycle is blocked.  This 
will likely vary for different viruses and for each disinfectant.      
 
A grand challenge remains to design technology to rapidly distinguish infectious from damaged 
or portions of viral particles.  Recently developed methods combine the antibody-based capture 
of viral capsids and subsequent qPCR amplification of genomes as a strategy to quantify 
structurally intact viruses in environmental samples.25  This immunocapture-qPCR (IC-qPCR) 
technique is promising to detect infectious viral particles rather than fragments of viral nucleic 
acid and proteins using ELISA- or qPCR-based techniques alone.  Another recent technique 
employs dyes (ethidium monoazide and propidium monoazide) that can penetrate damaged viral 
capsids and intercalate into viral nucleic acids inhibiting PCR amplification.26  This method, like 
IC-qPCR, requires an intact viral capsid to detect an infectious virus. Unlike IC-qPCR, these 
dye-based assays rely on the mechanism of inactivation to be a leaky capsid structure.  Results 
from these assays must be interpreted carefully because it is possible that a disinfectant modifies 
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a capsid protein responsible for a key replication cycle event like attachment, but does not affect 
the capsid structure or genome.  Another new, promising technology to meet this grand challenge 
relies on the use of aptamers to selectively detect infectious virus particles.  For this to occur, 
there is an in vitro selection from a large library of nucleic acids of aptamers that will selectively 
bind surface receptors of infectious viruses, but not those from non-infectious viral particles.27 
This technology has already been used in sensors to detect toxins and metals, and many aptamers 
have been selected for viral proteins and whole viruses for use in antiviral agents.28  Indeed, an 
aptamer-based sensor can already distinguish between viable and heat-inactivated vaccinia virus, 
showing the promise of this technology for detecting other viruses.29  Because aptamers are 
much more stable and cheaper than antibodies used in ELISA, such a technology would allow 
rapid detection of infectious viruses more cost-effectively and selectively.  
 
Once we understand how disinfectants inactivate viruses, we can develop effective treatment 
protocols for water utilities and the next generations of sensors that rapidly detect and quantify 
infectious viruses in finished drinking water. Populations most vulnerable to unsafe drinking 
water live in rural and periurban areas of developing countries. Thus, scientists and engineers 
must design protocols and sensors to be cost-effective, rugged, and easy to use for these 
populations. Ultimately, the fundamental knowledge of how viruses become inactivated will 
ensure better control of viruses in drinking water, increasing access to safer drinking water 
globally.   
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1.2 Objectives  
The overall objective of this research was to gain a better understanding of the mechanisms of 
adenovirus inactivation by drinking water disinfectants.  Human adenovirus type 2 (HAdV-2) 
was selected as the waterborne virus of interest because HAdV is prevalent in drinking water 
sources globally and causes a variety of human health effects including gastroenteritis.  HAdV is 
known to be resistant to specific water disinfectants and is included on the USEPA Contaminant 
Candidate List for potential future regulation in drinking water.30  HAdV-2 structure and 
replication cycle are well characterized because of its use in viral vaccine vectors and gene 
therapy.  To gain a better understanding of HAdV-2, bacteriophage PR772 was also used in this 
comparative study.  PR772 is hypothesized to be evolutionarily related to HAdV due to their 
similar morphologies.31  Utilizing a potential bacteriophage surrogate increases efficiency and 
can aid in our understanding of HAdV inactivation.            
 
Drinking water disinfectants can cause many modifications to viral capsid proteins and regions 
of the viral genome. The molecular modification that results in inactivation could be determined 
by knowing what stage in the virus replication cycle becomes disrupted.  Therefore, to elucidate 
the mechanism of HAdV-2 inactivation by drinking water disinfectants a detailed study of the 
virus replication cycle is needed.  A graphical representation of HAdV-2 and PR772 replication 
cycles is presented in Figure 1.2 and will be further discussed in Chapter 2. 
 
The objectives of this research were: 
	   11 
1.  Determine if bacteriophage PR772 is a good surrogate for HAdV-2 inactivation through the 
characterization of inactivation kinetics over a range of pH and temperatures representative of 
drinking water conditions for a variety of disinfectants.  
2.  Develop methods to quantitatively analyze stages of the HAdV-2 and PR772 replication 
cycles that are able to distinguish between untreated viruses, partially inactivated (~90%) 
viruses, and viruses inactivated up to 99.99%. 
3.  In a comparative study with both viruses, determine stages of the viral replication cycles that 
become inhibited after free chlorine or monochloramine disinfection. 
 
1.3 Scope  
To achieve these research objectives, this PhD dissertation is organized into several chapters.    
A detailed description of HAdV-2 and PR772 structures and replication cycles is presented in 
Chapter 2 along with a comparison of the two viruses highlighting their similarities.  The bulk of 
this research is organized in the form of four manuscripts in Chapter 3 through Chapter 6 with 
their abstracts presented below.  Supplementary information for each manuscript as well as raw 
data is located in the appendixes.  Lastly, Chapter 7 summarizes this dissertation with an 
overview of the main conclusions and recommendations for future research.     
 
1.3.1 Analysis of the Viral Replication Cycle of Adenovirus Serotype 2 after Inactivation by 
Free Chlorine (Chapter 3)† 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  †Abstract from Gall, A. M.; Shisler, J. L.; Mariñas, B. J. Analysis of the Viral Replication Cycle 
of Adenovirus Serotype 2 after Inactivation by Free Chlorine. Environ. Sci. Technol. 2015, 49 
(7), 4584-4590.	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Free chlorine is effective at inactivating a wide range of waterborne viral pathogens including 
human adenovirus (HAdV), but the mechanisms by which free chlorine inactivates HAdV and 
other human viruses remain to be elucidated.  Such advances in fundamental knowledge are key 
for development of new disinfection technologies and novel sensors to detect infectious viruses 
in drinking water.  We developed and tested a quantitative assay to analyze several steps in the 
HAdV replication cycle upon increasing free chlorine exposure.  We used quantitative 
polymerase chain reaction (qPCR) to detect HAdV genomic DNA as a means to quantify 
attachment and genome replication of untreated and treated virions.  Also, we used quantitative 
reverse-transcription PCR (RT-qPCR) to quantify the transcription of E1A (first early protein) 
and hexon mRNA.  We compared these replication cycle events to virus inactivation kinetics to 
determine what stage of the virus replication cycle was inhibited as a function of free chlorine 
exposure.  We observed that adenovirus inactivated at levels up to 99.99% by free chlorine still 
attached to host cells; however, viral DNA synthesis, and early E1A and late hexon gene 
transcription were inhibited.  We conclude that free chlorine exposure interferes with a 
replication cycle event occurring postbinding but prior to early viral protein synthesis. 
 
1.3.2  Characterizing Bacteriophage PR772 as a Potential Surrogate for Adenovirus in 
Water Disinfection:  A Comparative Analysis of Inactivation Kinetics and Replication 
Cycle Inhibition by Free Chlorine (Chapter 4)‡ 
Elucidating mechanisms by which pathogenic waterborne viruses become inactivated by 
drinking water disinfectants would facilitate the development of sensors to detect infectious 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ‡Abstract from Gall, A. M.; Shisler, J. L.; Mariñas, B. J. Characterizing Bacteriophage PR772 as 
a Potential Surrogate for Adenovirus in Water Disinfection: A Comparative Analysis of 
Inactivation Kinetics and Replication Cycle Inhibition by Free Chlorine.  Environ. Sci. Technol. 
2016, 50 (5), 2522-2529. 
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viruses and novel disinfection strategies to provide safe water.  Using bacteriophages as 
surrogates for human pathogenic viruses could assist in elucidating these mechanisms; however, 
an appropriate viral surrogate for human adenovirus (HAdV), a medium-sized virus with a 
double-stranded DNA genome, needs to be identified.  Here, we characterized the inactivation 
kinetics of bacteriophage PR772, a member of the Tectiviridae family with many similarities in 
structure and replication to HAdV.  The inactivation of PR772 and HAdV by free chlorine had 
similar kinetics that could be represented with a model previously developed for HAdV type 2 
(HAdV-2).  We developed and tested a quantitative assay to analyze several steps in the PR772 
replication cycle to determine if both viruses being inactivated at similar rates resulted from 
similar replication cycle events being inhibited.  Like HAdV-2, we observed that PR772 
inactivated by free chlorine still attached to host cells, and viral DNA synthesis and early and 
late gene transcriptions were inhibited.  Consequently, free chlorine exposure inhibited a 
replication cycle event that was post-binding but took place prior to early gene synthesis for both 
PR772 and HAdV-2. 
 
1.3.3  Inactivation Kinetics and Replication Cycle Inhibition of Adenovirus by 
Monochloramine (Chapter 5)§ 
Monochloramine is commonly used as a secondary disinfectant to maintain a residual in drinking 
water distribution systems in the U.S.  The mechanism by which waterborne viruses become 
inactivated by monochloramine remains widely unknown.  A more fundamental understanding 
of how viruses become inactivated is necessary for better detection and control of viruses in 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  §Abstract from Gall, A. M.; Shisler, J. L.; Mariñas, B. J. Inactivation Kinetics and Replication 
Cycle Inhibition of Adenovirus by Monochloramine.  Environ. Sci. Technol. Letters 2016, 3 (4), 
185-189. 
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drinking water.  Human adenovirus (HAdV) is known to be the most resistant waterborne virus 
to monochloramine disinfection, and this study presents inactivation kinetics over a range of 
environmental conditions.  Several steps in the HAdV replication cycle were investigated to 
determine which steps become inhibited by monochloramine disinfection.  Interestingly, 
monochloramine-inactivated HAdV could bind to host cells but genome replication and early 
and late mRNA transcription were inhibited.  We conclude that monochloramine exposure 
inhibited a replication cycle event after binding but prior to early viral protein synthesis.   
 
1.3.4  Inactivation Kinetics and Replication Cycle Inhibition of Bacteriophage PR772 by 
Monochloramine:  A Comparative Analysis to Human Adenovirus (Chapter 6)** 
A more fundamental understanding of how viruses become inactivated by drinking water 
disinfectants is necessary for better control and detection of viruses in water.  Bacteriophage 
PR772 has similar morphology and replication strategies to human adenovirus (HAdV), and can 
give valuable insight into elucidating the mechanism of HAdV inactivation by monochloramine.  
Characterization of the inactivation kinetics of PR772 by monochloramine revealed that lower 
exposure was required to achieve 99.99% inactivation compared to those previously reported for 
HAdV-2.  The replication cycle of PR772 was investigated to determine what steps became 
inhibited due to monochloramine exposure as a means to identify the molecular target resulting 
in loss of infectivity.  Similar to HAdV-2, monochloramine-treated PR772 still bound to host 
cells; however, genome replication and early and late mRNA synthesis were inhibited.  Thus, 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  **Abstract from Gall, A. M.; McClary, J. S.; Shisler, J. L.; Mariñas, B. J. Inactivation Kinetics 
and Replication Cycle Inhibition of Bacteriophage PR772 by Monochloramine:  A Comparative 
Analysis to Human Adenovirus. (to be submitted) 2016. 
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monochloramine disinfection inactivated both viruses by inhibiting a replication cycle step that 
occurred post-binding and at or prior to early mRNA transcription. 
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Figure 1.1.  Future of waterborne virus research to provide safe drinking water globally.  
Gaining a better understanding of how viruses become inactivated by disinfectants requires 
detailed studies of many virus types and disinfectants to determine what stage of the virus 
replication cycle becomes blocked, and what modifications to the viral protein and/or genome 
lead to inactivation. The development of sensors to detect infectious viruses in drinking water 
will benefit from these studies and is also necessary to ensure safe drinking water.	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CHAPTER 2:  BACKGROUND 
2.1 Adenovirus  
2.1.1 Human Adenovirus 
Human adenovirus (HAdV) is a member of the Adenoviridae family in the genera 
Mastadenovirus.  There are over 60 serotypes of HAdV classified into seven species A-G based 
on serology, hemagglutination, oncogenicity in hamsters, pathology in humans, and genome 
sequencing (Table 2.1).1-3  HAdV most commonly causes respiratory disease, conjunctivitis, and 
gastroenteritis based on serotype.  HAdV can infect and replicate in the respiratory tract, eye, and 
gastrointestinal tract, and less commonly infect the urinary bladder and liver along with more 
rare occasions in other organs.  All HAdV serotypes replicate in the intestine with HAdV-40 and 
-41 being primarily responsible for gastrointestinal disease.  Most infections in children occur 
through the fecal-oral route as HAdV can be shed in stool for months even if the child is 
asymptomatic.  Initial spread may also include respiratory transmission.  Globally, an estimated 
8% of clinically relevant viral disease is caused by HAdV.  HAdV-1, -2, and -5 are the most 
common types, and neutralizing antibodies are present in 40-60% of children.  HAdV is highly 
studied because of their use as vectors for gene therapy, vaccinations, and cancer treatment.3 
 
HAdV is known for high stability and long-term viability in environmental waters, even in warm 
temperatures.4  The occurrence of HAdV has been found globally in river and coastal waters, 
swimming pools, sewage, and finished drinking water.5, 6  Contaminated water can be a source of 
exposure for any type of adenovirus through ingestion, inhalation, or direct contact with eyes.  
Enteric adenoviruses are second only to rotaviruses as the leading cause of gastroenteritis in 
children worldwide.6   
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2.1.2 Structure 
HAdV is nonenveloped with a 90 nm in diameter icosahedral capsid with pseudo T-25 
symmetry.2  The mass of one viral particle is 150 × 106 Da containing DNA (13% of mass), 
protein (87% of mass), and no membrane or lipid.  The virus consists of 12 structural proteins 
numbered II-IX, IIIa, IVa2, µ, and terminal protein as well as the p23 viral protease.  The 
icosahedral capsid consists of 240 hexon trimers, pentameric pentons at each of the 12 vertices, 
and 12 trimeric fibers extending from the pentons (Figure 2.1).7 Most HAdVs contain only one 
type of fiber; however, types 40, 41, and 52 encode two types where one or the other is present at 
each vertex.2  Minor capsid proteins IIIa, VIII, and IX stabilize the major capsid protein 
interactions.  Polypeptides VII, V, and µ contact the viral DNA within the core. Protein VI binds 
with a cavity in hexon trimmers and with protein V, binds the viral DNA-protein core to the 
icosahedral capsid.  Part of the penton and protein IIIa may also associate with the core.  Protein 
IVa2 is present only at one vertex in a few copies and binds at the left end of the genome at the 
packaging sequence.  One copy of the terminal protein is covalently bonded to each of the 5’ 
ends of the viral genome.  Lastly, the core contains approximately 10 molecules of p23 viral 
protease that cleaves proteins to disassemble during the infection process and additionally 
cleaves precursors of viral proteins during assembly.2  
 
The HAdV genome consists of linear double-stranded DNA, and HAdV-2 has 35,937 base pairs 
(bp).2  All HAdV types have inverted terminal repeat sequences from 36 to over 200 bp and a 
terminal protein used in DNA replication.  HAdV genomes have a series of transcription units 
that are all transcribed by the eukaryotic RNA polymerase II.  There are five early transcription 
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units (E1A, E1B, E2, E3, and E4) that produce proteins that mediate viral gene transcription and 
DNA replication, inhibit apoptosis, and act against cellular antiviral defenses.  The first early 
gene, E1A, encodes two proteins that are responsible for activating transcription and inducing 
the host cell to enter S phase.  At the same time as viral DNA replication, four intermediate 
transcription units are transcribed (IX, IVa2, L4 intermediate, and E2 late).  Lastly, one late 
transcription unit called ‘major late’ is transcribed to generate five groups of late mRNAs (L1-
L5) encoding many structural proteins.  Both strands of the viral DNA are transcribed.  A 
majority of the adenovirus genes produce multiple mRNAs that are differentiated by alternative 
splicing.2 
    
2.1.3 Replication Cycle 
The first step of the HAdV replication cycle begins with attachment of the virus to the host cell 
receptor.  HAdV species A, C, D, E, and F bind with high-affinity to the extracellular domain 
(D1) of the host cell coxsackie-adenovirus receptor (CAR) protein with the HAdV fiber knob.  
The CAR protein is found in epithelial tight junctions.  Some other receptors used by specific 
HAdV types include CD46 and sialic acid.  The longer fiber in HAdV-40 and -41 binds to CAR, 
but the receptor for the second shorter fiber remains unknown.2 
 
To enter the host cell, next the arg-gly-asp (RGD) loop domains of the penton base bind with 
ανβ3 and ανβ5 integrins on the host cell surface.  The fiber shaft must be flexible to make 
contact.  Receptor mediated endocytosis is triggered by integrin clustering, and HAdV-2 enters 
via clathrin-coated pits.  During this process, uncoating begins and fibers become detached from 
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the virion at the cell surface.2  It should be noted that unlike other HAdVs, HAdV-40 and -41 do 
not have RGD motifs and do not use ανβ3 and ανβ5 integrins for receptor mediated endocytosis.8 
 
About 15 minutes after binding to the host cell, HAdV-2 escapes from the endosome into the 
cytosol after further uncoating.2  The endosome becomes acidified, and proteins including penton 
base, peripentonal hexons, IIIa, VI, and VIII are released from the subvirion.  The p23 viral 
protease also becomes active and cleaves protein VI, which lyses the endosome.  The particles 
are then transported to the nucleus on microtubules and then associate with the nuclear pore 
complex by hexon trimers approximately 60 minutes post infection.  Further uncoating occurs at 
the nuclear pore complex, and the protein VII-viral DNA complex enters the nucleus by 2 hours 
post infection.  Most protein IX and hexons remain associated with the nuclear pore complex, 
and protein V remains in the cytosol.  During the entry process, the virion needs to disassemble 
properly in order to import the viral DNA into the nucleus of the host cell.2 
 
The early phase of mRNA transcription and translation lasts until about 6 hours post infection 
when viral DNA is first detected.  There are about 20 genes expressed in the early stage of 
infection.3  HAdV DNA replication requires only three proteins: the terminal protein used as a 
protein primer for DNA synthesis, the viral DNA polymerase called AdPol, and the single-
stranded DNA binding protein, DBP.  The inverted terminal repeats of the genome act as the 
replication origin.  At the same time as DNA replication, about 15 late genes are also transcribed 
in the nucleus and translated into proteins in the cytoplasm.2, 3  
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Progeny virion assembly begins with hexon and penton capsomers formed in the cytoplasm. 
Next, the capsomers are imported into the nucleus where assembly of the entire virion occurs.  
Viral DNA is packaged into the empty capsids by several proteins including IVa2.  Precursors of 
proteins VI, VII, VIII, µ, and the terminal protein are then cleaved by the viral protease and this 
maturation process renders the virus infectious.  The adenovirus death protein accumulates 
during the late stages of infection and causes cell lysis releasing 105 progeny virions.  The 
infection cycle is typically complete around 36 hours post infection.2    
 
2.2 Bacteriophage PR772 
2.2.1 Tectiviruses  
The family Tectiviridae consists of tailless bacteriophages that have internal lipid membranes 
such as phage Bam35 that infects Gram-positive bacteria and PRD1 that infects Gram-negative 
bacteria.9  Within the Tectivirus genus, there are six PRD1-like isolates named PRD1, PR772, 
PR3, PR4, PR5, and L17 that have nearly identical genomes.  These isolates infect hosts only 
with IncP-, IncN-, or IncW- multiple drug resistance conjugative plasmids.  PRD1 is the type 
virus for Tectiviridae and therefore has been studied in greater detail than other isolates.10  
PR772 is 97.2% similar to PRD1 at the genomic level.11  PR772 and PRD1 have been used as 
surrogates for enteric viruses in a few disinfection studies and PR772 is often utilized in filter 
performance testing.11  
 
2.2.2 Structure 
The structure of the PRD1 virion consists of a viral protein capsid, an internal lipid membrane 
derived from the host cell, and a linear double-stranded DNA genome.9  PRD1 is about 66 MDa 
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consisting of approximately 70% protein, 15% lipid, and 15% DNA.12 The icosahedral capsid is 
arranged in a pseudo T-25 lattice.9 The capsid consists of 240 trimers of major capsid protein P3, 
and located at each of the 12 vertices is the pentameric protein P31 (Figure 2.1).13  Extending 
from each of the vertices are elongated molecules of the trimeric protein P5, as well as the 
receptor binding protein P2.9  The PRD1 virion contains a total of 18 different structural proteins 
in the capsid and membrane.12 Unlike other dsDNA bacteriophages, tectiviruses do not have a 
tail.9  Similar to PRD1, PR772 is 60 nm in size and the genome contains 14,942 bp.10, 14 
 
2.2.3 Replication Cycle 
The first step of the PRD1 replication cycle is binding to the host cell receptor.  The spike-
complex proteins (P31, P5, and P2) are necessary for adsorption to the host cell. Protein P2 binds 
to the receptor and this leads to irreversible binding.9  There are approximately 25 and 60 
receptors throughout the cell surface of E. coli and Salmonella enterica, respectively, that 
contain an IncP, -N, or -W plasmid.  The receptor complex is the mating pair formation (Mpf) 
used in bacterial conjugation.9 After binding, PRD1 undergoes ‘partial rolling/tumbling’ to 
correctly orient the unique vertex.13  Solvent movement or binding of proteins P2 or P5 to 
secondary receptors may facilitate this positioning.  To deliver its dsDNA genome into the 
cytoplasm, PRD1 forms a tubular structure from its internal protein-rich lipid membrane.  The 
tube exits the capsid from the same distinct vertex used for DNA packaging and requires 
peripentonal P3 proteins, penton protein P31, and membrane protein P16 to disassemble from 
that vertex.  Capsid-membrane interactions are lost as other vertices become de-capped, implying 
a loss of P3, P31, vertex associated proteins P2 and P5, and membrane protein P16.  This 
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destabilizes the vesicle allowing the tail tube to form and pierce the cell.  The dsDNA genome 
then translocates into the cytoplasm through the 4.5 nm tube.13  
 
PRD1 utilizes a similar very early (P1, P8, and P12), medium early (P15 and P19), and late 
protein synthesis strategy as HAdV.15  Early proteins are synthesized within 5 minutes post 
infection, and late membrane and structural proteins are produced around 15 minutes.15, 16 
Genomic DNA replication occurs between 10 and 20 minutes post infection.17  PRD1 replicates 
its genomic DNA similarly to HAdV utilizing a protein-primed replication mechanism and 
encodes a phage DNA polymerase, P1.  PRD1 has a covalently bound protein at both 5’ ends of 
the genome and 110 bp terminal repeat sequences.9 
 
Around 15 minutes post infection, the major capsid protein P3 and the spike-complex proteins 
P31, P5, and P2 are found in the host cell cytosol and membrane proteins encoded by PRD1 are 
located on the host cell cytoplasmic membrane.  During assembly, a prohead is formed with 
capsid proteins enclosing the host lipid membrane containing phage proteins.  Genomic DNA is 
then packaged into the prohead by proteins P9, P20, and P22.  The progeny virions are released 
by host cell lysis about 60 minutes post infection.9, 15  PRD1 is a lytic phage, and there are two 
phage genes responsible for lysing the host cell using a holin-endolysin system.9 One infection 
cycle is complete with the release of 200-500 progeny virions.9, 16  
 
2.2.4 Similarities to Adenovirus 
Tectiviruses are similar to HAdV in capsid architecture, protein structure, some replication cycle 
events, and genome replication strategies, and these similarities suggest that the viruses are 
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evolutionarily related.18, 19 Tectiviruses and adenoviruses are the only viruses that have a pseudo 
T-25 lattice structure with 240 copies of the trimeric major capsid protein (P3 and hexon) and 12 
copies of a pentameric protein (P31 and penton) at the vertices.  TEM images are shown for both 
viruses in Figure 2.2.  Both viruses have proteins (P2 and fiber) projecting from the vertex used 
to attach to host cell receptors.  Both viruses release their genome through a vertex, adenovirus 
into the eukaryotic nucleus and tectiviruses into the bacterial cytosol.  Their linear dsDNA 
genomes both contain inverted terminal repeats and terminal 5’ proteins used in priming DNA 
replication.  Lastly, the major capsid protein monomers share the same structure consisting of 
two eight-stranded beta barrel jelly-rolls with nearly identical folds.20, 21  The elongated loop 
structure emerging from the jelly-rolls begins at the same positions between strands for both 
viruses.  Since HAdV is larger than PRD1, the proteins are also larger with additional residues 
within the loops.  Similarly, HAdV penton base and P31 in PRD1 each have one beta barrel 
jelly-roll with the same topology as hexon and P3.20 With such striking similarities, tectiviruses 
could be an excellent surrogate for HAdV.     
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2.3 Figures and Tables 
 
 Table 2.1.  Classification of HAdVs (adapted from2, 3). 
Species Hemagglutination Groups Serotype 
Oncogenic potential 
Major site of 
infection Tumors in 
animals 
Transform-
ation in cell 
culture 
HAdV-A IV (little or none) 12, 18, 31 High + Respiratory, urinary, gastrointestinal 
HAdV-B I (complete for monkey erythrocytes) 
3, 7, 11, 14, 16, 21, 34, 









HAdV-D III (complete for rat erythrocytes) 
8-10, 13, 15, 17, 19, 20, 
22-30, 32, 33, 36-39, 
42-49, 51, 53, 54, 56 
Low or 
none + Eye, gastrointestinal 
HAdV-E III 4 Low or none + Eye, respiratory 
HAdV-F III 40, 41 Unknown - Gastrointestinal 








Figure 2.1. Graphical representation of HAdV and PR772 structures (adapted from7, 13). 
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CHAPTER 3:  ANALYSIS OF THE VIRAL REPLICATION CYCLE OF ADENOVIRUS 
SEROTYPE 2 AFTER INACTIVATION BY FREE CHLORINE†† 
3.1 Introduction 
Waterborne pathogens significantly impact public health by causing morbidity and mortality, and 
the detection and control of waterborne pathogens in drinking water supplies remains a challenge 
globally.  Viral pathogens are particularly difficult to monitor and control in water treatment.  
There is currently no method to rapidly detect infectious viruses in water; current state-of-the-art 
methods using genome detection cannot distinguish between infectious viruses and fragments of 
virus nucleic acids.1  Human adenovirus (HAdV) is present globally in drinking water sources 
and is known for its high stability and long-term viability in environmental surface and ground 
waters.1-3  HAdV is second only to rotavirus as the leading cause of acute gastroenteritis in 
children worldwide.2  There are over 60 serotypes of HAdV classified into seven species (A to 
G) that cause a variety of diseases including gastroenteritis, respiratory disease, and 
conjunctivitis.1, 4  All adenovirus serotypes can remain in the gastrointestinal tract and be shed in 
feces for an extended period of time, even asymptomatically.2  Contaminated water can be a 
source of exposure for any type of adenovirus through ingestion, inhalation, or direct contact 
with eyes.2  HAdV type 2 (HAdV-2) is one of the most commonly isolated adenovirus serotypes 
in water sources.3  Because of the adverse health effects and prevalence of HAdV, the U.S. 
Environmental Protection Agency (EPA) has included HAdV, along with other enteric viruses 
like caliciviruses and enteroviruses, on the Contaminant Candidate List 3 used for potential 
future development of regulations in drinking water.5  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ††	  Adapted from Gall, A. M.; Shisler, J. L.; Mariñas, B. J., Analysis of the Viral Replication 
Cycle of Adenovirus Serotype 2 after Inactivation by Free Chlorine. Environ. Sci. Technol. 2015, 
49 (7), 4584-4590.	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Free chlorine is the most widely used disinfectant6 and has been shown to be highly effective at 
controlling HAdV-2 for a wide range of water quality conditions.7  HAdV-2 has similar 
inactivation kinetics when exposed to free chlorine as the enteric adenovirus serotypes 40 and 41 
that are analytically more fastidious.7-10  With recent federal regulation changes in the United 
States for better control of disinfection by-products and Cryptosporidium parvum oocysts,6, 11 
monochloramine (i.e., formed by reacting free chlorine with ammonia with the latter in excess) 
and ultraviolet light (UV) are becoming more common disinfectants.12  HAdV is considered a re-
emerging pathogen because it is highly resistant to low-pressure UV (LPUV) light (i.e., 
monochromatic light at a wavelength of ~254 nm) and monochloramine disinfection.13 
Identifying the molecular targets of various disinfectants would improve our understanding of 
why HAdV is so resistant to LPUV and monochloramine, yet so susceptible to free chlorine.  In 
turn, this new knowledge will facilitate the development of novel sensors that selectively detect 
the untransformed molecular targets and new technologies to control infectious HAdV in water.    
 
The structure and replication cycle of HAdV species C are well understood because of their use 
in gene therapy and viral vaccine development.  HAdV-2, belonging to the HAdV species C, has 
a 35,937-base pair double-stranded DNA (dsDNA) genome encapsulated by an icosahedral T-25 
lattice capsid.14  The capsid is comprised of 240 copies of hexon protein trimers forming the 20 
faces of the icosahedron, five copies of penton protein at each of 12 vertices, and fiber protein 
trimers protruding from each penton protein pentamer.  The virus first attaches to the host cell by 
connecting a fiber protein knob to a host cell receptor such as the Coxsackie-Adenovirus 
Receptor (CAR).  Next, the attached fiber bends, and the RGD-motif of the penton base interacts 
	  	   34 
with integrins to trigger receptor-mediated endocytosis.  Inside the endosome, the virus partially 
uncoats and releases protein VI to lyse the endosome.  The virus is then transported via 
microtubules to the nuclear pore complex, and further uncoating occurs upon docking.  The 
genome is injected into the nucleus together with protein VII.  At 1-2 h post infection (p.i.), the 
first early protein, E1A, is synthesized, and within 5-8 h p.i., genome replication begins and 
mRNA is transcribed to produce late proteins such as the hexon.  At 48 h p.i., host cells lyse and 
progeny virions are released to infect surrounding cells. 
 
To elucidate the mechanisms of adenovirus inactivation by free chlorine, we developed and 
tested a quantitative assay to analyze various stages of the HAdV-2 replication cycle.  In a recent 
study comparing HAdV-2 that were untreated to those after undergoing 1-log inactivation by 
free chlorine, we found that these viruses are still able to attach to host cell monolayers and 
recombinant CAR, but the E1A protein is not synthesized at the same level of abundance as that 
observed for the untreated viruses.15  U.S. regulations require 4-log (99.99%) 
removal/inactivation of enteric viruses, and therefore our goal was to determine if there were 
differences in the stages of replication cycle inhibition between virus populations that have 
undergone relatively low inactivation (e.g., 1-log) compared to those more highly inactivated 
(e.g., 4-log).  We used quantitative polymerase chain reaction (qPCR) to detect HAdV-2 DNA to 
quantify attachment and genome replication.  Also, we used quantitative reverse-transcription 
PCR (RT-qPCR) to quantify mRNA production at various times post infection.  Several studies 
have utilized PCR, qPCR, and RT-qPCR to identify the presence of adenovirus in water,16-19 
estimate viral infectivity,20, 21 or to quantify viral DNA damage after disinfection by UV light.22-
24  However, our study is the first to utilize qPCR and RT-qPCR to track HAdV genomic DNA 
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and mRNA production to monitor progression of the virus replication cycle with increasing free 
chlorine exposure.  We compare these replication cycle events to virus inactivation kinetics to 
determine what stage of the virus replication cycle is inhibited as a function of free chlorine 
exposure.  Because a lack of a rapid detection method for infectious viruses in drinking water 
makes it difficult to control the virus infection process in real-time, revealing the mechanism of 
HAdV inactivation would be beneficial for the development of sensors capable of detecting 
infectious HAdV, as well as for the design and optimization of more robust treatment 
technologies for virus control in drinking water globally. 
 
3.2 Materials and Methods 
3.2.1 Adenovirus Propagation and Viability Assessment  
HAdV-2 (VR-846) was propagated using human lung A549 carcinoma cells (CCL-185) obtained 
from the American Type Culture Collection (Manassas, VA).  Detailed methods for HAdV-2  
propagation and viability assessment as well as cell culture growth were described previously.13  
Details are provided in Text A.1 of Appendix A.      
 
3.2.2 Free Chlorine Disinfection Experiments 
Free chlorine disinfection experiments were performed using two batch reactors as described 
previously7 with slight modifications (see Text A.2 of Appendix A).  The concentration of free 
chlorine was determined using the N,N-diethyl-p-phenylenediamine colorimetric method25 and 
the CT values were calculated based on a first-order decay model of free chlorine measured 
throughout the experiments.7  Initial virus concentration ranged from 3.9×105 to 2.0×106 plaque 
forming units (PFU) per ml (see Figure A.2 and Table A.1).  Untreated and treated virus samples 
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were analyzed in parallel for viability and for assessing the effect of free chlorine on the 
adenovirus replication cycle using qPCR and RT-qPCR.  
 
3.2.3 Primers for PCR, qPCR, and RT-qPCR Assays 
Primers were designed to amplify the E1A and hexon genes of the HAdV-2 genome and the β-
actin gene of the host cell (Table 3.1).  The HAdV-2 E1A region was chosen for study because it 
is located at the left-hand end of the genome.  It is also the first viral gene transcribed during 
virus infection, and its transcription occurs before DNA replication.14  In contrast, the HAdV-2 
hexon gene is located toward the center of the genome,  and it is a late gene, a gene transcribed at 
high levels during viral genome replication.14  Because the HAdV-2 genome is DNA, these same 
primer sets can amplify either genomic DNA (using PCR or qPCR) or cDNA reverse transcribed 
from viral mRNA (using RT-qPCR).  
 
3.2.4 HAdV-2 Genomic Damage of Amplicon Region 
To determine if genomic regions used for quantifying genome copies were damaged during free 
chlorine treatment, viral DNA was extracted from treated and untreated virus samples.  Using a 
modified DNA extraction protocol from the DNeasy Blood & Tissue Kit (Qiagen, Valencia, 
CA), 20 µL of 10×PBS was added to 200 µL of virus sample before proteinase K digestion.  The 
remaining steps were according to the manufacturer’s procedures.  Extracted DNA was 
quantified using qPCR to determine if the genomic regions could still be amplified. 
 
3.2.5 Synchronization of HAdV-2 Infection 
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For all subsequent assays, confluent T-25 flasks of A549 cells were placed in a 4°C cold room 
for 1 h in culture media lacking fetal bovine serum (FBS).  Flasks were inoculated with ice-cold 
untreated or treated virus samples and incubated at 4 °C for 80 min with constant rocking.  
Supernatants were aspirated, and cellular monolayers were washed twice with ice-cold phosphate 
buffer to remove unbound viruses.  The cells with bound viruses were then used to measure: (i) 
viability by adding cell culture media without FBS and incubating at 37 °C for 80 min to allow 
virus entry, and then performing a plaque assay described previously; (ii) attachment by 
immediately harvesting the cells with bound viruses; or (iii) viral genomic replication and 
mRNA transcription at 4, 12, 24, and 36 h incubation at 37 °C after synchronized entry. 
 
3.2.6 HAdV-2 Attachment to A549 Cells 
To determine if inactivated virions were still able to attach to host cells, DNA from host cells 
with bound untreated or treated virions was extracted.  Cells were dislodged from T-25 flasks 
using 10 mM EDTA, collected in a microcentrifuge tube, and centrifuged at 300×g for 5 min.  
After supernatant removal, cells were lysed and total DNA was extracted using the DNeasy 
Blood & Tissue Kit (Qiagen, Valencia, CA) according to the manufacturer’s procedure.  
Extracted DNA samples were stored at -20 °C.  Total DNA was quantified using the NanoDrop 
spectrophotometer, and the number of attached viruses was analyzed using qPCR described in a 
following section.   
 
3.2.7 HAdV-2 Genomic DNA Replication and mRNA Transcription  
To quantify the amount of viral genome DNA present before and after genome replication 
begins, total DNA was extracted at 4, 12, 24, and 36 h post synchronized infection.  Cells were 
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first washed with phosphate buffer then dislodged using 0.25% trypsin (Sigma) and quenched 
using media with FBS. Detached cells were centrifuged at 300×g for 5 min, and the supernatants 
were discarded.  The DNA was extracted from the samples using the method described 
previously, and the number of adenovirus genomic copies was determined by qPCR using both 
E1A and hexon primer sets.  
 
Total RNA was also extracted from another set of virus infected cells at 4, 12, 24, and 36 h p.i. 
according to the procedure above to harvest cells and then using the RNeasy Mini Kit (Qiagen, 
Valencia, CA).  The cellular pellet was disrupted using lysis buffer supplemented with β-
mercaptoethanol, and homogenized in QIAshredder spin columns (Qiagen, Valencia, CA).  RNA 
was extracted into 50 µL of RNase-free water.  To remove genomic DNA contamination, 20 µL 
of extracted RNA was digested with 2.5 µL of RNase-free DNase I stock solution (Qiagen, 
Valencia, CA) for 15 min at room temperature.  Residual DNase was removed by purifying 
samples using the RNA cleanup protocol with RNeasy spin columns.  Extracted RNA samples 
were immediately stored at -80 °C until processed into cDNA.  Purified RNA was quantified by 
reading the absorbance at 260 nm on a NanoDrop spectrophotometer (Thermo Scientific, 
Wilmington, DE).  Total RNA was then converted by reverse transcriptase to cDNA.  To allow 
melting of RNA secondary structure and primer annealing to the RNA, 0.5 µg of total RNA from 
each sample was added to 0.5 µg oligo dT primer (IDT, Coralville, IA) in a 10 µL reaction and 
incubated at 70 °C for 5 min followed by 4 °C for 5 min.  cDNA was synthesized using Moloney 
Murine Leukemia Virus (M-MuLV) Reverse Transcriptase (New England BioLabs, Ipswich, 
MA), according to manufacturer’s instructions with a recombinant RNasin ribonuclease inhibitor 
(Promega, Madison, WI).  Samples were loaded into an Eppendorf Mastercycler and run for 5 
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min at 25 °C, 1 h at 42 °C, and 15 min at 70 °C to terminate the reaction.  A second reaction was 
prepared for each sample without the reverse transcriptase to verify that genomic DNA was 
adequately removed in subsequent qPCR controls.  cDNA samples were kept at 4 °C until 
processed by qPCR prior to storage at -20 °C.  
 
3.2.8 Quantitative PCR (qPCR) and Two-Step Reverse Transcriptase qPCR (RT-qPCR)  
Primers were designed to target two regions of the HAdV-2 genome (NCBI accession 
AC_000007.1) that also code specifically for two genes of interest, E1A and hexon.  The E1A 
primer set includes the 13S and 12S splice variants, but not the 9S variant that occurs later in the 
replication cycle.26  Additionally, a primer was designed for a housekeeping gene, β-actin, 
present in A549 cells to serve as a normalizer (NCBI accession NC_000007.14, Homo sapiens 
chromosome 7, GRCh38 Primary Assembly).  Primers were designed using IDT Primerquest 
Design Tool and analyzed using the OligoAnalyzer 3.1, and are represented in Table 3.1.  
Sequences were analyzed on Primer-BLAST (NCBI, Bethesda, MD) to ensure specificity of the 
primer to the gene of interest and to eliminate primers that had sequence homology in both 
systems.  To verify amplification of target regions, PCR products from each of the three primer 
sets were visualized using 2% agarose gel electrophoresis with ethidium bromide staining (data 
not shown).   
 
To analyze the amount of E1A, hexon, or β-actin mRNA, two-step RT-qPCR was performed.  
The resulting cDNA from the RT reaction was diluted 1:5 in DNase- and RNase-free water and 
processed by qPCR.  All qPCR reactions contained of 1 µL of genomic DNA or synthesized 
cDNA template and a final concentration of 300 nM forward and reverse primers and 1× SsoFast 
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EvaGreen supermix (BioRad Laboratories, Inc., Hercules, CA) in a 10 µL total reaction volume.  
All amplification reactions were performed in triplicate in a 96-well plate (Eppendorf) and heat-
sealed with film.  Plates were centrifuged at 300 rpm for 10 min and loaded into a Mastercycler 
ep realplex (Eppendorf, Hauppauge, NY).  The qPCR cycles for genomic DNA consisted of 
enzyme activation for 2 min at 98 °C, then 40 cycles of denaturing at 98 °C for 5 s, annealing 
and extension at 55 °C for 10 s, and finally a melting curve ramping from 65 to 95 °C.  The 
cycling conditions for cDNA were identical except for enzyme activation and denaturing steps 
were performed at 95 °C.  Standard curves were run on every plate for E1A and hexon using 10-
fold dilutions of an untreated virus sample.  To confirm that DNase digestion adequately 
removed genomic DNA from mRNA samples, no-RT controls were run for every sample for all 
three primer sets and all quantification cycle (Cq) values were outside the acceptable signal 
range.  
 
To calibrate the qPCR standard curves generated from experimental samples, DNA positive 
standards were created by conventional PCR amplifying regions of the HAdV-2 and A549 cell 
genomes using the same primer sets described previously.  The GoTaq system (Promega, 
Madison, WI) was used to PCR amplify the viral and cellular genomic regions with 30 cycles 
consisting of denaturing at 95 °C for 45 s, annealing at 57 °C for 30 s, and extension at 72 °C for 
12 s.  The products were purified using the QIAquick PCR Purification Kit (Qiagen, Valencia, 
CA) and the integrity of the product was verified by agarose gel electrophoresis (data not 
shown).  The concentration of the purified products was measured using a Qubit Fluorometer 
with a Qubit dsDNA HS Assay Kit (Life Technologies, Carlsbad, CA), from which the molar 
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concentration was then determined and the number of copies was calculated using Avogadro’s 
number.  
 
3.2.9 qPCR Data Analysis  
The data obtained from the qPCR and RT-qPCR reactions was analyzed as described in Text A.3 
of Appendix A to obtain relative and absolute quantification of the number of copies for the 
E1A, hexon and β-actin genes.  
 
3.3 Results and Discussion 
3.3.1 Effect of Free Chlorine on Genomic DNA Amplification 
To determine if free chlorine damaged the HAdV-2 genome, viral DNA isolated from untreated 
and treated virus samples was probed by qPCR.  Absolute copy numbers of viral genome 
amplicons were determined using the generated standard curve (Figure A.1 in Appendix A).  
PCR amplification of a viral DNA region occurs only when the genome region is not damaged 
because it is known that a single lesion is sufficient to block qPCR amplification of adenovirus 
DNA.21  
 
The ratio of E1A or hexon DNA copies from free chlorine-treated versus untreated virions 
(E1A/E1A0 or Hexon/Hexon0) are compared in Figure 3.1 to the survival ratio (N/N0) of each 
virus sample determined by plaque assay.  As the free chlorine exposure, quantified with CT 
values, increased and the survival ratio of the viruses decreased, the normalized copy numbers 
for E1A and hexon genes remained similar to those obtained for untreated HAdV-2.  These data 
suggest that these two regions of the HAdV-2 genome were not damaged by free chlorine 
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treatment.  This finding is consistent with that in a previous study that also did not detect a decay 
in genomic E1A DNA levels after free chlorine disinfection to 1-log inactivation.15 One caveat is 
that the viral DNA amplified here only consist of 0.6% of the total HAdV-2 genome, and thus 
we could not predict whether amplification of larger portions of the HAdV-2 genome would 
yield similar results.21  Nevertheless, with no loss of amplification observed for these regions, we 
feel confident that our subsequent analyses are not affected by damage to these genome regions.  
 
3.3.2 Effect of Free Chlorine on Adenovirus Attachment 
The effect of chlorination on adenovirus attachment to its host cell was examined next.  For these 
experiments, cells were incubated with untreated or treated viruses at 4 ºC to allow virus binding 
but prevent viral entry.  After unbound virions were removed, cells were collected and total 
DNA was extracted to quantify viral attachment using qPCR.  The relative quantities of E1A and 
hexon DNA (E1A/E1A0 or Hexon/Hexon0) were determined (see Text A.3 in Appendix A) using 
β-actin as a housekeeping gene and the untreated virus sample as the calibrator.  As shown by the 
data sets in Figure 3.2 at 0 h p.i., the relative quantity of E1A and hexon DNA were the same 
regardless of the presence of chlorine, suggesting that HAdV-2 attachment to host cells was not 
impeded by free chlorine exposures resulting in inactivation efficiencies of up to 99.99%.  This 
is in agreement with a previous study showing that a 1-log inactivation of HAdV-2 by free 
chlorine does not prevent virus from binding to either recombinant CAR or CAR-expressing host 
cell monolayers.15  The previous study also determined that approximately 5% of HAdV-2 
inactivated by free chlorine binds nonspecifically to cells that lack CAR proteins, suggesting that 
only a minority of the qPCR signal is due to random virus-host cell interactions.   
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3.3.3 Effect of Free Chlorine on Genome Replication 
To assess if free chlorine treatment compromised HAdV-2 genome replication, we inoculated 
cells with untreated and treated viruses, and extracted total DNA from infected cells at times 
when viral genome replication is known to occur.  The absolute copy numbers of viral genome 
equivalents per 100 β-actin copies were quantified for virus samples from two independent 
representative experiments by averaging the E1A and hexon copy numbers for each 
corresponding N/N0 shown (Figure 3.3).  In cells inoculated with untreated HAdV-2, the viral 
genome equivalents were relatively low at 4 h p.i. and then increased steadily from 12 to 36 h p.i.  
Indeed, there was a nearly 103-fold increase in genome copies from 4 to 24 h p.i. These results 
were expected because HAdV-2 genome replication begins between 5 and 8 h p.i. and thus the 
DNA copies at 4 h p.i. would correspond to viruses that attached to the host cells.  Different 
trends were observed when cells were infected with viruses exposed to free chlorine. The 
absolute number of genome equivalents were similar to untreated viruses at 4 h p.i., an 
observation that consistent with the data in Figure 3.2 at 0 h p.i. confirms that the attachment step 
was not inhibited by exposure to free chlorine.  In contrast, for all other times postinfection, the 
absolute number of genome equivalents detected was lower than those for untreated viruses.  
Figure 3.2 compares relative quantity of genomic DNA detected (E1A/E1A0 or Hexon/Hexon0) at 
4, 12, 24, and 36 h p.i. to those at 0 h p.i. and to the results (N/N0) from plaque assays.  Notably, 
there is good correlation between the decrease in viral titers found by plaque assay and a 
decrease in viral genome amplification at 24 and 36 h p.i.  This observation indicates that free 
chlorine inactivation of HAdV-2 prevents genome replication or earlier steps in the replication 
cycle for the fraction of viruses not producing plaques.  Notice that the absolute quantity of 
genome equivalents at 12 h p.i. would not be significantly different from those at 4 h p.i. because 
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exposure to free chlorine would reduce the number of viruses capable of completing DNA 
replication to below a detectable level above the baseline E1A and hexon DNA corresponding to 
attached viruses.  Accordingly, longer postinfection time would be required to observe 
measurable increases in genome copies.   
 
3.3.4 Effect of Free Chlorine on Late Gene mRNA Synthesis 
An expected outcome of a decrease in viral genome replication is a subsequent decrease of late 
gene transcription.  To test this hypothesis, we studied the effect of free chlorine on the 
transcription of the hexon gene in virus-infected cells, which occurs at a similar time as DNA 
replication.  The transcription of the hexon gene was evaluated by using RT-qPCR, in which the 
cDNA obtained from reverse transcription of hexon mRNA was quantified using qPCR.  Using 
the same virus samples inactivated by free chlorine shown in Figure 3.3, the lower plot in Figure 
3.4 shows the absolute copy number of hexon mRNA per 0.5 µg of total RNA.  When using cells 
inoculated with viruses unexposed to free chlorine (N/N0=1), transcription of the hexon gene was 
detected at 12 h p.i. and the levels of hexon transcripts increased as infections proceeded as 
expected.  When evaluating the effect of free chlorine treatment of HAdV-2, a similar pattern 
emerged at the two lowest inactivation levels investigated (corresponding to survival ratios N/N0 
= 0.27 and 0.084) except that the number of hexon mRNA copies at 12 h p.i. decreased 
consistently with the decrease in the virus survival ratios.  At higher free chlorine exposures 
(resulting in survival ratio N/N0 ≤ 0.0078) the number of hexon mRNA copies at 12 h p.i. was 
below the detection level of 11 copies.  For the same samples, the hexon mRNA copies detected 
at 24 and 36 h p.i. decreased generally consistently with the decrease in survival ratios within 
each postinfection data set.  Figure 3.5 compares the relative hexon mRNA expression 
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(Hexon/Hexon0) at 12, 24, and 36 h p.i. to survival ratios measured by plaque assay at increasing 
free chlorine dosages.  Notably, there is a correlation between the decrease in viral titers and a 
decrease in viral mRNA synthesis at all postinfection times.  This observation indicates that 
consistent with findings for DNA replication, free chlorine also inhibited late mRNA 
transcription and resulted in levels of hexon mRNA that correlated well with virus inactivation 
levels measured by plaque assay. 
 
3.3.5 Effect of Free Chlorine on Early Gene mRNA Synthesis 
Early E1A gene transcription occurs before viral DNA replication, about 1-2 h p.i.14  Similar to 
hexon mRNA production, the absolute E1A mRNA copy numbers were determined per 0.5 µg of 
total RNA at various times post infection (upper plot in Figure 3.4). When cells were inoculated 
with untreated HAdV-2, there was approximately 1,000 copies of E1A mRNA detected per 0.5 
µg of total RNA at 4 h p.i.  In contrast, viruses inactivated by free chlorine by 1-log produced 
about 1-log less E1A mRNA.  Consistent with observations for hexon mRNA production, E1A 
mRNA was below the detection level of approximately 13 copies when viruses were inactivated 
by more than 2-log at this time.  However, by 12 h p.i., all virus samples undergoing inactivation 
of up to nearly 3-logs have produced E1A mRNA, showing that increasing free chlorine 
treatment correlated with decreasing E1A mRNA.  As shown in Figure 3.5, the relative E1A 
mRNA expression (E1A/E1A0) was comparable to virus inactivation kinetics.  This observation 
reveals that HAdV-2 inactivation by free chlorine causes a decrease in early mRNA production 
thus supporting that the replication cycle is inhibited by free chlorine at an earlier step.  
 
3.3.6 Mechanistic Considerations of Adenovirus Inactivation by Free Chlorine 
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The results shown here indicate that free chlorine exposure up to 99.99% inactivation does not 
prevent HAdV-2 attachment to host cells.  In contrast, exposure to free chlorine resulting in 
inactivation levels of up to approximately 99.99% inhibited HAdV-2 replication cycle events 
including viral early gene transcription, viral genome replication, and late gene transcription.  
The conclusions drawn from these results are that free chlorine exposure interferes with a step 
that occurs post virus binding but prior to viral early protein synthesis. 
 
The inhibition of early viral gene transcription could be due to several factors.  The E1A region 
of the genome could be damaged preventing transcription of this early gene; however, Figure 3.1 
shows that the E1A region of chlorine-treated virions can still be amplified.  Additionally, 
reaction rates of free chlorine with specific amino acids are up to 3 orders of magnitude higher 
than the reaction rates with DNA.27  Thus, we argue that it is more likely that free chlorine 
induces protein damage rather than DNA damage as the reason for virus inactivation.  HAdV-2 
consists of a protein capsid and genomic DNA.  As the virus enters the host cell, it must uncoat 
and many proteins detach enabling the DNA to transverse to the nucleus.  The current model is 
that free chlorine damage does not alter viral proteins involved in host cell binding, but rather 
targets viral proteins necessary for virus entry, uncoating, endosomal lysis, or nuclear delivery. It 
is likely that the delay in mRNA transcription observed in this study is due to a delay of genomic 
DNA entering the nucleus.  A new method to track single molecules of adenoviral genomes 
during infection has recently shown that large quantities of capsid-free viral DNA accumulates in 
the cytosol indicating that import of viral DNA into the nucleus is a limiting step of infection.28  
This bottleneck might be even more difficult to overcome for free chlorine-damaged 
adenoviruses, leading to a delay in nuclear entry (providing an additional explanation to the 12 h 
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p.i. curve in Figure 3.2 deviating from those obtained at higher p.i. times) and mRNA 
production.  Determining target proteins that are damaged by free chlorine, and if the disinfectant 
acts on important amino acid residues for entry, endosomal lysis, or nuclear entry remains to be 
elucidated and should be the focus of future studies. 
 
3.3.7 Practical Implications 
The results of this study have practical implications for adenovirus detection and control.  Our 
results show that the dominant mechanism of HAdV-2 inactivation by free chlorine is most 
likely due to viral protein damage and not genome damage.  Targeted disinfection practices 
leading to protein damage are therefore a viable option for control of viruses in drinking water.  
There remains a need to determine if other common chemical disinfectants such as 
monochloramine are less effective in causing protein damage in HAdV-2.  The rates of chlorine 
transfer reactions of monochloramine with specific amino acids are approximately 5 orders of 
magnitude lower than those for the corresponding reactions with hypochlorous acid.27  If both 
disinfectants lead to a loss of viability through protein damage, this may explain why HAdV is 
so much more resistant to monochloramine than to free chlorine.  The qPCR and RT-qPCR 
techniques developed in this study to quantitatively measure HAdV-2 replication cycle events 
after inactivation by free chlorine is a promising technique to study the inactivation of the virus 
by other disinfectants.  This technique is highly sensitive and can reliably detect as low as 11-13 
copies of adenovirus DNA or mRNA present in one microliter of extracted nucleic acid, 
allowing us to study replication cycle events for the first time with HAdV-2 samples that have 
undergone up to approximately 4-log of inactivation.  Assessing replication cycle steps between 
HAdV-2 attachment and nuclear entry using this qPCR assay or by developing new related 
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techniques would help determine the exact replication cycle step that is inhibited by free chlorine 
and other chemical disinfectants and therefore narrow down which proteins are most likely the 
target for loss of infectivity.  If future studies can determine what protein regions are the most 
susceptible leading to inactivation, molecular sensors targeting these regions could also be 
developed to monitor infectious adenovirus in drinking water, allowing for the virus to be 
regulated. 
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3.4 Figures and Tables 
Table 3.1. Primers designed for qPCR and RT-qPCR. 











Forward 19 5'-GAACCACCTACCCTTCACG-3' 57.9% 55.2 673-778 106 E1A 
Reverse 20 5'-CCGCCAACATTACAGACTCG-3' 55.0% 56.0 
Hexon 
Forward 19 5'-AAAGCGGGCTACAAATAGG-3' 47.4% 52.6 19400-
19510 111 Hexon 
Reverse 20 5'-CTTCGTTCCACTGAGATTCG-3' 50.0% 53.1 
β-actin 
Forward 19 5'-ATGAGGCTGGTGTAAAGCG-3' 52.6% 55.3 5528803-
5528905 103 β-actin 
Reverse 19 5'-AGAACACGGCTAAGTGTGC-3' 52.6% 55.4 
a Tm, melting temperature, based on 50 mM NaCl. 
b Genomic position based on human adenovirus type 2 genome (NCBI accession 
AC_000007.1) for E1A and hexon, and homo sapien chromosome 7 (NCBI accession 
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Figure 3.1.  Relative copy numbers of the E1A and hexon amplicons (E1A/E1A0, Hexon/Hexon0, 
see Text A.3 in Appendix A) of the HAdV-2 genome extracted from virus samples subjected to 
increasing free chlorine inactivation compared to the survival ratio (N/N0) obtained by plaque 
assay.  Values for each sample are normalized to the untreated control at CT=0.     
CT (mgCl2×min/L)
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Figure 3.2.  Comparison of inactivation kinetics of adenovirus (expressed as survival ratios N/N0 
obtained by plaque assay) to the relative quantity of E1A and hexon DNA (E1A/E1A0, 
Hexon/Hexon0, see Text A.3 in Appendix A) at postinfection times of 0 h (corresponding to the 
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Figure 3.3.  Absolute quantification of adenovirus genome equivalents measured by the quantity 
of E1A and hexon DNA determined by a standard curve (see Text A.3 in Appendix A) after 4, 
12, 24, and 36 h p.i. (hpi) with untreated viruses (survival ratio N/N0 = 1) and virus samples 
exposed to increasing levels of free chlorine (survival ratios N/N0 = 0.27-0.0018).   
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Figure 3.4.  Absolute quantification of hexon mRNA (lower plot) and E1A mRNA (upper plot) 
copies per 0.5 µg of total RNA determined by a standard curve (see Text A.3 in Appendix A) 
measured after 4, 12, 24, and 36 h p.i. with untreated viruses (survival ratio N/N0 = 1) and virus 
samples subjected to increasing free chlorine exposure (corresponding to survival ratios N/N0 = 
0.27-0.0018).   
Time post infection (h)
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Figure 3.5.  Comparison of inactivation kinetics of adenovirus (expressed as survival ratios N/N0 
obtained by plaque assay) to the relative expression level of E1A and hexon mRNA (E1A/E1A0, 
Hexon/Hexon0, see Text A.3 in Appendix A) measured after 4, 12, 24, and 36 h p.i. with 
untreated viruses (survival ratio N/N0 = 1) and virus samples subjected to increasing free chlorine 
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Figure 3.6.  HAdV-2 replication cycle inhibition after free chlorine exposure.  
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CHAPTER 4:  CHARACTERIZING BACTERIOPHAGE PR772 AS A POTENTIAL 
SURROGATE FOR ADENOVIRUS IN WATER DISINFECTION: A COMPARATIVE 
ANALYSIS OF INACTIVATION KINETICS AND REPLICATION CYCLE 
INHIBITION BY FREE CHLORINE‡‡ 
4.1 Introduction 
Waterborne viruses are difficult to monitor in drinking water systems globally and without 
adequate disinfection they can negatively impact public health.  One such pathogenic waterborne 
virus, human adenovirus (HAdV), has been included on the United States Environmental 
Protection Agency (USEPA) contaminant candidate list four (CCL4) for potential future 
regulation.1 HAdV is known to be resistant to low-pressure ultraviolet light (LPUV) and 
monochloramine disinfection yet readily inactivated by free chlorine, but the mechanisms for the 
different susceptibilities remain widely unknown.2, 3  Elucidating the mechanism of HAdV 
inactivation by disinfectants would be instrumental for developing new disinfection technologies 
and real-time sensors to detect infectious viruses in drinking water, thereby enabling future 
regulation.  Knowing the viral modification that leads to inactivation would allow for the 
development of sensors that would specifically target the unmodified molecular region.4 
 
Bacteriophages have been widely utilized as models for pathogenic human viruses.5  Studying 
bacteriophages may help elucidate why some enteric viruses are more resistant to specific 
drinking water disinfectants than others.  Using bacteriophages as model organisms has many 
benefits, including the fact that phages and their hosts can be biosafety level 1 organisms and 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ‡‡	  Adapted from Gall, A. M.; Shisler, J. L.; Mariñas, B. J., Characterizing Bacteriophage PR772 
as a Potential Surrogate for Adenovirus in Water Disinfection: A Comparative Analysis of 
Inactivation Kinetics and Replication Cycle Inhibition by Free Chlorine.  Environ. Sci. Technol.  
2016, 50 (5), 2522-2529.	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plaque assays with bacterial hosts are less time consuming than those with eukaryotic cells.  
Members of Leviviridae, such as bacteriophage MS2, are widely studied as viral surrogates for 
some enteric viruses such as caliciviruses and enteroviruses because of their similar size, tail-
lacking structure, and single-stranded RNA genome.  Conversely, MS2 is not a good substitute 
for HAdV because HAdV is larger, has protruding attachment fibers absent in MS2, and contains 
a double-stranded DNA genome.6  Additionally, the kinetics of inactivation of MS2 are different 
from that of HAdV for common disinfectants, most likely because of their differences in size, 
structure, and genome type.  There is therefore a need to identify appropriate surrogates for 
human pathogenic HAdV.   
 
Another bacteriophage family, Tectiviridae, is proposed to be evolutionarily related to 
adenovirus and may be a more appropriate surrogate for HAdV disinfection studies.7, 8  Both 
viruses have similar morphologies consisting of icosahedral capsid structures with a pseudo T = 
25 lattice.  The major coat and vertex proteins have related structures consisting of a double beta-
barrel.  Both virus families have fiber projections at each of the 12 vertices that both use for 
binding to their host cell receptor.  Upon host infection, the linear double-stranded DNA of the 
viruses is released through a vertex: at the bacterial cell wall for tectiviruses, and at the 
eukaryotic cell nucleus for adenoviruses.  The genomes contain inverted terminal repeat 
sequences, and both use a protein-primed mechanism for genome replication utilizing a 5’ 
terminal protein.  A main structural difference between the two viruses is that tectiviruses 
contain an internal lipid membrane derived from the bacterial host membrane. 
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PRD1 is the most widely studied tectivirus, but it commonly uses Salmonella enterica subspecies 
enterica serovar Typhimurium as a host, which requires biosafety level 2 practices.  However, 
tectivirus PR772 has a genome that is 97.2% similar to PRD1, has a similar size of 60 nm,9, 10 
and propagates effectively using a biosafety level one bacterium, E. coli K12 with a R15 
plasmid.11  Similar to HAdV, PR772 utilizes an early and late gene synthesis strategy.  Upon 
host cell infection, tectiviruses transcribe early mRNAs within 5 min, late mRNAs by 15 min, 
and begin genome replication within 10-20 min.12-15  PRD1 and PR772 are both lytic phages and 
cause host cell lysis at 60 min post-infection releasing 200-500 progeny virions per cell.12, 13, 15  
Because of these structural, genomic, and replicative similarities, tectiviruses could also 
potentially exhibit inactivation kinetics similar to that of HAdV when exposed to drinking water 
disinfectants.    
 
The aims of this research are to (1) determine the inactivation kinetics of PR772 with free 
chlorine, (2) investigate if PR772 is a proper surrogate for HAdV serotype 2 (HAdV-2) in 
disinfection studies with the common water disinfectant free chlorine, and (3) analyze the 
replication cycle events of treated and untreated PR772 and compare the results with those 
obtained from our previous HAdV-2 replication cycle assessments.16  We developed and tested a 
quantitative assay capable of detecting virus attachment as well as PR772 DNA replication and 
mRNA transcription at various times post-infection for phages untreated and treated at increasing 
free chlorine exposure levels.  We used quantitative polymerase chain reaction (qPCR) to detect 
PR772 DNA for quantifying attachment and genome replication and reverse transcription qPCR 
(RT-qPCR) to detect PR772 mRNA production throughout the virus replication cycle.  By 
selecting an early gene, P12, and late gene for the major capsid protein, P3, as the targets for 
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qPCR and RT-qPCR, this method can be directly compared to our previous study with HAdV-2 
early E1A and late hexon genes, respectively.16  A more fundamental understanding of how 
viruses become inactivated will be beneficial toward developing novel disinfection technologies 
and sensors that detect PR772 and HAdV-2 in drinking water.   
 
4.2 Materials and Methods 
4.2.1 PR772 Propagation and Viability Assessment 
Bacteriophage PR772 (BAA-769-B1) was propagated using bacterial host Escherichia coli K12 
J53-1 R15 (BAA-769) obtained from the American Type Culture Collection (Manassas, VA).  
Freeze-dried E. coli was rehydrated with 3 % tryptic soy broth (TSB) and grown overnight at 37 
°C.  The overnight culture was injected into 500 mL of TSB and incubated at 37 °C until 
reaching exponential growth and inoculated with PR772.  After 20 h, the virus-host suspension 
was centrifuged at 5000 rpm for 10 min to separate the cellular debris, and virus-containing 
supernatants were removed and passed through 0.22 µm microfilter (Millipore, Billerica, MA).  
A polyethersulfone ultrafiltration membrane (Millipore) with 300 kDa cutoff mounted in an 
Amicon stirred cell was used to wash and concentrate the virus suspension with 200 mL of 1 
mM carbonate buffer solution (CBS) to remove small molecules and proteins.  Virus stocks were 
aliquoted into glass jars and stored at 4 °C in 1 mM CBS at pH 8.3.    The resulting virus titer 
ranged from 1.1×109 to 6.5×1010 plaque-forming units (PFU)/mL.  Bacteria streak plates, slants, 
and suspension cultures were stored at 4 °C.   
 
PR772 viability was assessed using the double agar layer plaque technique.17  Virus samples 
were serially diluted with TSB and mixed with freshly grown E. coli.  The plates were incubated 
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at 37 °C, and plaques were enumerated after 18-24 h.  Virus titers were calculated by counting 
the number of plaques on plates containing 30-300 PFU. 
 
4.2.2 Free Chlorine Disinfection Experiments 
Free chlorine disinfection experiments were performed using two batch reactors described 
previously (see Text B.1).2, 16  Experiments were performed at various pH conditions from 8.7 to 
10.0 and temperatures of 1, 14, and 30 °C (see Table B.1).  The concentration of free chlorine 
and its decay were monitored throughout the experiment using the N,N-diethyl-p-
phenylenediamine colorimetric method.18  Untreated and treated virus samples were analyzed for 
viability to develop the kinetic model and for assessing the effect of free chlorine on the PR772 
replication cycle in subsequent methods.  All replication cycle assays were performed in 
triplicate. 
 
4.2.3 Replication Cycle Analysis 
Primers for PCR-Based Assays and DNA Positive Standards 
Primers were designed to study the quantity of PR772 genome copies and viral mRNAs 
throughout various stages of the virus replication cycle.  Primers were designed to amplify the 
P12 and P3 genes of the PR772 genome (NCBI accession AY848688.1) and the rpoD gene of 
the E. coli K12 host cell genome (NCBI accession U00096.3) to serve as a housekeeping gene 
(Table 4.1 and Text B.2).  The P12 region is located at the right end of the genome and is one of 
the first viral genes transcribed during virus infection before genome replication.12, 19  The P3 
gene is located in the center of the genome and is a late gene that is transcribed during or after 
genome replication.12, 19  The same primer sets were used to amplify either genomic DNA (using 
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PCR or qPCR) or cDNA reverse transcribed from viral mRNA (using RT-qPCR).  Primers were 
designed using IDT Primerquest Design Tool and analyzed using OligoAnalyzer 3.1 and Primer-
BLAST (NCBI, Bethesda, MD).         	  
 
DNA was extracted from virus and bacteria samples using the DNeasy Blood and Tissue Kit 
(Qiagen, Valencia, CA) utilizing the Pretreatment for Gram-Negative Bacteria protocol with the 
incubation period at 56 °C for 20 min to ensure complete lysis.  The GoTaq system (Promega, 
Madison, WI) was used to amplify by conventional PCR the viral and cellular genomic regions 
with 30 cycles consisting of denaturing at 95 °C for 45 s, annealing at 55 °C for 30 s, and 
extension at 72 °C for 12 s.  To verify amplification of target regions, we visualized PCR 
products from the primer sets with 2% agarose gel electrophoresis with ethidium bromide 
staining (data not shown).  Additionally, DNA positive standards were created by conventional 
PCR amplifying regions of the PR772 and E. coli genomes using the primer sets (see Text B.2) 
as previously described for HAdV-2.16  
 
PR772 Genomic Damage of Amplicon Region 
Viral DNA was extracted from untreated and free chlorine-treated virus samples to determine if 
the P12 and P3 genomic regions were damaged during free chlorine treatment.  A 100 µl sample 
of untreated or treated viruses was added directly to the tissue lysis buffer with proteinase K, and 
the remaining steps were according to the manufacturer’s procedures from the DNeasy Blood 
and Tissue Kit.  
 
PR772 Attachment to E. coli 
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To determine if chlorine-treated PR772 was still able to attach to E. coli host cells, we extracted 
total DNA from virus-bound bacteria.  A suspension of exponentially growing E. coli was treated 
with 20 µg/mL chloramphenicol (Sigma-Aldrich, St. Louis, MO) for 20 min to inhibit protein 
synthesis.  Chloramphenicol inhibits bacteriophage genome replication indirectly by binding to 
the bacterial ribosome preventing the translation of PR772 DNA polymerase proteins necessary 
for viral DNA replication.20, 21 Aliquots (1 mL) of bacteria were inserted in 1.5 mL centrifuge 
tubes for each virus sample, and 100 µl of untreated or free chlorine-treated virus sample was 
added.  Virus-bacteria suspensions were incubated at 37 °C at 200 rpm for 1 h to facilitate 
attachment under normal conditions.  The whole sample was pelleted at 8000×g for 10 min at 4 
°C.  The supernatant was discarded, and the pellet was resuspended and washed twice with ice-
cold TSB with chloramphenicol to remove unbound viruses.  The final pellet was snap-frozen in 
liquid nitrogen.  Total DNA was extracted according to the procedure described previously.   
 
PR772 Genomic DNA Replication 
To determine if treated virions are able to replicate their genome, we extracted DNA from virus-
host suspensions at 0, 1, 2, and 3 h post-infection.  Upon reaching early exponential growth, a 10 
mL aliquot of E. coli was used for each sample.  A virus sample (1 mL) was then added to the 
bacteria, and the virus-host suspensions were incubated at 37 °C and 200 rpm.  Samples (100 
µL) were taken at each target post-infection time and placed immediately in liquid nitrogen to 
stop the infection cycle.  Total DNA was extracted according to the procedure described 
previously.       
       
PR772 mRNA Transcription 
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Total RNA was also extracted from the same virus-bacteria suspension used for DNA replication 
analysis.  Samples (250 µL) were removed from each suspension at 20, 40, 60, and 80 min post-
infection times and mixed with two volumes of RNAprotect bacteria reagent (Qiagen) to 
stabilize the RNA in vivo.  Following procedures specified by the manufacturer for Enzymatic 
Lysis and Proteinase K Digestion of Bacteria, the bacteria were lysed in TE buffer with 10 
mg/mL lysozyme (Sigma-Aldrich) and 20 µL proteinase K (Qiagen) and subsequently with lysis 
buffer supplemented with β-mercaptoethanol.  Total RNA was purified using the RNeasy Mini 
Kit (Qiagen) following manufacturer’s procedures and extracted into 50 µL.  To remove 
genomic DNA contamination, we digested 20 µL of extracted RNA with 3 µL of RNase-free 
DNase I stock solution (Qiagen) for 30 min at room temperature.  Residual DNase was removed 
by purifying samples using the RNA cleanup protocol with RNeasy spin columns.  Extracted 
RNA samples were immediately stored at -80 °C until processed into cDNA.  Total RNA (0.5 
µg) was then converted by reverse transcriptase to cDNA as described previously.16  Controls 
were prepared without the reverse transcriptase to verify that genomic DNA was adequately 
removed during DNase I digestion.      
 
Quantitative PCR and Two-Step Reverse Transcriptase qPCR  
To analyze the amount of P12, P3, or rpoD copies of DNA or mRNA present, we utilized 
quantitative PCR (qPCR) and two-step RT-qPCR as previously described using SsoFast 
EvaGreen supermix (BioRad Laboratories, Inc., Hercules, CA).16  The cycling conditions were 
identical to the method descried for HAdV-2 except the annealing and extension was run at 56 
°C (see Text B.2).   
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qPCR Data Analysis 
The quantification cycles (Cq) obtained for each sample were analyzed using relative 
quantification by utilizing the untreated virus control as the calibrator and rpoD as the 
housekeeping gene.  Using the standard curves generated by the DNA positive controls, the Cq 
values were also used to determine the absolute quantification of the P12 and P3 copy numbers 
(see Text B.2).  Relative quantification was used to directly compare with viral inactivation 
(N/N0), and absolute quantification was used to determine the amount of genomic DNA 
replicated and mRNA transcribed for each sample at increasing times post-infection. 
 
4.3 Results and Discussion 
4.3.1 Inactivation Kinetics of PR772 
PR772 was inactivated by free chlorine over a range of temperature and pH conditions (see 
Table B.1) to determine if it had similar inactivation kinetics to that of HAdV-2.  The pH effect 
was characterized from 8.7 to 10 using a batch reactor setup; below pH 8.7, the inactivation 
kinetics were too rapid to obtain full kinetic curves.  The pH effect was observed at three 
experimental temperatures at 30, 14, and 1°C (Figure 4.1) to directly compare with inactivation 
of previously reported HAdV-2 disinfection.2  PR772 inactivation curves were generally 
characterized by a lag phase, followed by a relatively rapid phase of inactivation dependent on 
both pH and temperature, and finally a slower phase of inactivation more pronounced (i.e., 
higher N2/N0) at low temperature and high pH but at a rate independent of pH and temperature.  
This trend in inactivation kinetics for PR772 was similar to that reported for HAdV-2 
inactivation with free chlorine,2 with the difference that after the initial fast kinetics, two 
subsequent slower phases of inactivation were observed for HAdV-2 inactivation, in contrast to 
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the single phase observed in the present study for PR772.  However, although each of the second 
and third phases for HAdV-2 had rates independent of pH and temperature as in the case of the 
second phase for PR772, they were both more pronounced than that for PR772 at the same 
temperature and pH.  Accordingly, the three-phase expression developed to represent the kinetics 
of HAdV-2 inactivation with free chlorine2 was simplified to the following two-phase expression 
for PR772:   
 !!! = !!!! 𝑒! !!!!!!! !" + !!!! 𝑒!!!!"                     (4.1) 
in which N1/N0 is the extrapolated intercept at zero exposure to free chlorine or CT = 0 
independent from pH and temperature, k1 and k2 are first- and second-phase inactivation rate 
constants,  𝛼! = 10-pH/ (10-pH + 10-pKa) the fraction of free chlorine present as HOCl, pKa is the 
deprotonation constant of HOCl dependent on temperature,22 and N2/N0 is the fraction of viruses 
that would remain infectious after the first phase of inactivation is completed if there were no 
second phase of inactivation.  During the lag phase, the survival ratio in equation 4.1 was 
assumed to be unity for CT values less than the CTlag solved in the following equality: 1 = !!!! 𝑒! !!!!!!! !"!"# + !!!! 𝑒!!!!"!"#     (4.2) 
The Arrhenius expression was used to describe the temperature dependence for the first-phase 
inactivation rate constant, k1: 𝑘! = 𝐴!𝑒!!!,!!"                        (4.3) 
Similarly, N2/N0 was found to be dependent on both pH and temperature and was represented by 
the same equation used in the HAdV-2 model that includes the Arrhenius expression with an 
additional dependence on pH:  
!!!! = 𝐴!  𝑒!!pH𝑒!!,!!"                      (4.4) 
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in which Ea,1 (J/mol), Ea,2 (J/mol), A1 (L/(mg×min)), A2 (dimensionless) and B2 (dimensionless) 
are fitting parameters, R is the ideal gas constant, and T is absolute temperature. 
 
Simultaneous fitting of all data sets in Figure 4.1 to Equation 4.1 resulted in N1/N0 = 3.74±1.38, 
Ea,1 = 33,510±2,280 J/mol, k2 = 5.98±0.46 L/(mg×min), Ea,2 = 133,000±12,300 J/mol, A1 = 
10(9.29±0.44) L/(mg×min), A2 = 10(-61.3±2.3) and B2 = 8.38±0.05.  The rate of the second phase of 
inactivation for PR772 matched within 0.4% that of the third phase of inactivation for HAdV-2, 
or k2,PR772 ≈ k3,HAdV-2 = 6 L/(mg×min).  Furthermore, the pH dependence of N2/N0 for PR772 also 
was within 1% of that of N3/N0 for HAdV-2 (B2,PR772 ≈ B3,HAdV-2 = 8.3) compared to 2.5 times 
that of N2/N0 for HAdV-2 (B2,HAdV-2 = 3.3).  In contrast, the temperature dependence of N2/N0 for 
PR772 was between those for N2/N0 (Ea,2,HAdV-2 = 101,400 J/mol) and N3/N0 (Ea,3,HAdV-2 = 
265,900 J/mol) for HAdV-2.  The deviations between data and model in Figure 4.1 were likely 
the result, at least partially, of errors associated with variability in pH measurements (±0.15 pH 
units) as supported by the data for experiments performed with most replicates (pH 9.6 and pH 
10 at 30 oC).   
 
A comparison of the kinetics of PR772 inactivation with free chlorine with those reported for 
HAdV-2 at the same pH and temperature2 are shown in Figure B.1 of Appendix B.  As depicted 
in the two plots, the kinetics of HAdV-2 inactivation with free chlorine (dotted lines) were more 
greatly dominated by the third phase of inactivation at pH 10 (1 and 14 oC) and pH 9.2 (1 oC), or 
a combination of phases 2 and 3 at pH 9.2 (14 oC) and pH 8.7 (1 oC) (i.e., N2/N0 or N3/N0 values 
either ≈ 1 or >1).  In contrast, the kinetics of PR772 inactivation with free chlorine (continuous 
lines) was dominated by the second phase of inactivation at pH 10 (1 oC) (i.e., N2/N0 > 1), or a 
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combination of the first and second phase of inactivation at all other conditions (i.e., N2/N0 < 1).  
Because of the more pronounced dominance of phases 2 and 3 in the case of HAdV-2 (i.e., N2/N0 
and N3/N0 values for HAdV-2 are generally higher than N2/N0 for PR772 at a given temperature 
and pH), the first phase could not be discerned under the conditions shown in Figure B.1. 
 
Although the experimental conditions were not identical to other previous studies, the chlorine 
doses applied to PR772 were similar in magnitude to those applied to HAdV-2, -5, -40, and -41 
to achieve 99.99% or 4-log inactivation.2, 23-25  Because PR772 had such similar inactivation 
kinetics to HAdV-2, we hypothesized that PR772 and HAdV-2 have similar mechanisms of 
inactivation with free chlorine due to their similar structure and replication cycle events.  To 
investigate what step in the PR772 replication cycle is inhibited after free chlorine exposure, we 
developed a qPCR-based assay similar to our previous assay developed for HAdV-2.16  
 
4.3.2 Effect of Free Chlorine on Genomic DNA Amplification 
To assess if free chlorine damaged the encapsidated PR772 genome, we extracted viral DNA 
from untreated and treated viruses with increasing free chlorine exposures and then quantified by 
qPCR.  Primers were designed to target the P12 and P3 regions of the PR772 genome (Table 
4.1).  P12 and P3 genes were selected on the basis of their location at the very right end and 
center of the genome, respectively, and because P12 is an early protein similar to HAdV-2 first 
early 1A protein (E1A) and P3 is the major capsid protein similar in structure and function to 
HAdV-2 hexon.19 The relative quantity of each gene (P12/P120 and P3/P30) was determined for 
each inactivated virus sample (CT  > 0) using the untreated virus sample (CT = 0) as the 
calibrator in the ΔΔCq expression (details in Text B.2).  The relative quantities were compared in 
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the top plot of Figure 4.2 to the survival ratio (N/N0) determined by plaque assay.  As the 
survival ratio decreased with increasing free chlorine exposure, the relative copy numbers of 
each gene remained similar to untreated PR772.  This suggests that the P12 and P3 regions of the 
PR772 genome were not damaged by free chlorine treatment because one lesion is capable of 
blocking qPCR amplification of DNA.26 The viral DNA amplified here consists of only 1.41% of 
the total 14,942 bp genome of PR772.19   Thus, this assay could not determine if other regions of 
the viral genome were damaged by free chlorine as longer amplicons would be necessary.27  
Because free chlorine exposure did not result in a loss of amplification of P12 and P3, our 
subsequent analyses were not affected because of damage to these regions. 
 
4.3.3 Effect of Free Chlorine on PR772 Attachment 
The effect of free chlorine on PR772 attachment to E. coli host cells was determined.  The E. coli 
K12 J53-1(R15) strain used contains an incompatibility group N plasmid R15 responsible for 
encoding the conjugative DNA-transfer complex that PR772 uses as a host cell receptor.13, 28 
Untreated and treated viruses were incubated with chloramphenicol-treated E. coli and allowed 
to bind for 1 h.  Unbound viruses were removed, and total genomic DNA was extracted from the 
viral-bound bacterial pellet.  The relative quantities P12/P120 and P3/P30 were determined to 
quantify the amount of bound viruses by qPCR using rpoD as the housekeeping bacterial gene 
for normalization (see Text B.2) and the untreated control at CT = 0 as the calibrator.  The 
relative copy numbers of each gene are shown in the bottom plot of Figure 4.2 compared with 
the survival ratio for virus samples with increasing free chlorine exposure.  As the survival ratio 
decreased, the relative quantity of attached viruses decreased only slightly (~0.5 log), suggesting 
that free chlorine-treated viruses were still capable of attaching to host cells. 
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4.3.4 Effect of Free Chlorine on Genome Replication 
To determine if viruses were capable of replicating their genomes after increasing levels of 
exposure to free chlorine, we incubated untreated and treated virus samples with exponentially 
growing bacteria suspension culture, and the total DNA was extracted at 0, 1, 2, and 3 h p.i.  
Genome replication begins within 10-20 min p.i., and progeny virions are released after 
approximately 60 min p.i., allowing for multiple rounds of infection throughout the time course.  
The relative quantity of PR772 genomic DNA for genes P12 and P3 expressed as P12/P120 and 
P3/P30 was compared to the survival ratio, N/N0, in Figure 4.2 (bottom plot).  As expected at 0 h 
p.i., the same relative quantity of viral DNA was present for all samples, which can also be 
visualized in Figure 4.3 in terms of absolute copy numbers at 0 h p.i.  Because there is only one 
copy of the P12 gene and one copy of the P3 gene per PR772 genome, the absolute copy number 
of PR772 DNA genome equivalents was represented by the average of P12 and P3 copies for 
each corresponding N/N0 quantified by qPCR determined from the generated standard curve 
(Text B.2, Figure B.2).  Untreated viruses (N/N0 = 1) steadily increased the amount of PR772 
DNA copies by 100-fold from 0 to 3 h p.i. Most samples treated with free chlorine (N/N0 < 1) 
also generated more genomic copies but less than the untreated samples.  On the basis of a one-
tailed t test with unequal variances, we determined that there was no statistical increase in DNA 
copies for N/N0 ≤ 0.0030 observed from 0 to 3 h p.i.  These samples with P > 0.1 have been 
marked with ∨  in Figure 4.3.  Genome replication went undetected in these samples because the 
remaining infectious viruses were not capable of replicating their genome at a measureable level 
above the baseline genome copies present at 0 h p.i.  In every replication cycle, PR772 will 
produce a few hundred progeny virions, whereas HAdV produces about 100,000 progeny 
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virions.6  The smaller number of progeny virions placed a limit on the range of this assay to 2-
log, whereas our previous study could quantify differences of up to 4-log HAdV-2 DNA 
replication.16  Figure 4.2 (bottom plot) shows good correlation (Pearson product moment 
correlation coefficient r ≥ 0.943 (P < 0.05), and a parallel line analysis determined the linear 
regression slopes and intercepts were not significantly different (P > 0.05)) between the 
inactivation of PR772 determined by plaque assay and the relative quantities of P12 and P3 DNA 
at 1, 2, and 3 h p.i.  These results reveal that similar to the finding for HAdV-2 in our previous 
study,16 free chlorine inactivated PR772 by blocking genome replication or a step earlier in the 
viral replication cycle.           
 
4.3.5 Effect of Free Chlorine on Early and Late Gene mRNA Synthesis 
PR772 mRNA transcription occurs before and during genome replication.  To assess if free 
chlorine inactivated PR772 was able to produce early and late mRNAs, we incubated untreated 
and treated viruses with E. coli throughout one viral replication cycle.  The absolute copy 
numbers of P12 and P3 mRNA per 0.5 µg of total RNA quantified by a standard curve (Figure 
B.2) were evaluated at 20, 40, 60, and 80 min p.i. (Figure 4.4).  Late mRNA transcription occurs 
by 15 min p.i. and only the untreated virus sample showed a detectable amount of P3 mRNA, the 
major capsid protein, by 20 min p.i. (bottom plot) and steadily increased over 103-fold.  P3 
mRNA was detected in the treated viruses (N/N0 = 0.66-0.0030) by 40 min p.i. and the amount of 
P3 mRNA generally increased at 60 and 80 min p.i. but remained lower than that for the 
untreated viruses.  As a quality-assurance check, the absolute quantification of the housekeeping 
gene rpoD for each sample was quantified and found to remain constant (Figure B.3).  
Comparing the relative quantity of P3 mRNA to the inactivation of PR772 determined by plaque 
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assay, Figure 4.5 shows good correlation (Pearson product moment correlation coefficient r ≥ 
0.912 (P < 0.05) and a parallel line analysis determined that the linear regression slopes and 
intercepts were not significantly different (P > 0.05)) between infectious viruses (N/N0) and the 
amount of P3 mRNA (P3/P30) for increasing free chlorine exposures (CT) at 40, 60, and 80 min 
p.i.  
 
Similar trends were observed for P12 mRNA transcription (Figures 4.4 and 4.5).  By 20 min p.i., 
the infections with untreated virus produced 101.5-fold more P12 than P3, which was expected 
because P12 is transcribed less than 5 min p.i.12  Free chlorine-treated virus samples (N/N0 = 
0.66-0.022) also demonstrated a lower amount of P12 mRNA at 20 min p.i. versus the untreated 
viruses; however, there was no detectable P12 mRNA synthesis when highly inactivated viruses 
(N/N0 ≤ 0.0030) were used.  The production of P12 mRNA peaked by 104-fold and then leveled 
off by 40 min p.i. untreated viruses for infection were used.  In general, infection with the free 
chlorine-treated viruses produced a majority of the P12 mRNA by 40 min p.i., and the amount 
transcribed slightly increased from 40 to 80 min p.i.  Notably, a comparison of the infectious 
virus titer obtained by plaque assay to the relative quantity of P12 mRNA (P12/P120) with 
increasing free chlorine exposure showed a good correlation (Pearson product moment 
correlation coefficient r ≥ 0.865 (P < 0.05) and a parallel line analysis determined the linear 
regression slopes and intercepts were not significantly different (P > 0.05)) throughout the 
replication cycle (Figure 4.5).  These data suggest that, similar to what was observed for HAdV-
2 in our previous study,16 free chlorine inactivated PR772 by inhibiting a replication cycle event 
at or before early mRNA transcription.           
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4.3.6 Comparative Analysis of PR772 and HAdV-2 Inactivation by Free Chlorine 
We observed that the free chlorine inactivation kinetics of PR772 were similar to that of HAdV-
2.  This study also demonstrated that PR772 inactivation by free chlorine did not inhibit virus 
binding to host cells; however, viral DNA synthesis as well as early and late mRNA transcription 
were inhibited.  This is consistent with our previous study with HAdV-2, which concludes that 
HAdV-2 inactivated by up to 99.99% is still able to attach to A549 host cells, but viral genomic 
DNA synthesis and mRNA transcription of early and late genes is inhibited.16  With such similar 
morphologies, replication cycle events, free chlorine inactivation kinetics, and replication cycle 
inhibition by free chlorine, the mechanism of PR772 inactivation by free chlorine could help 
elucidate the mechanism of HAdV-2 inactivation.   
 
Free chlorine may inactivate both viruses by damaging key capsid proteins required for host cell 
entry or by damaging the DNA genome.  With differences in bacterial and eukaryotic host cells, 
the entry process for PR772 is different than that of HAdV-2, but both require partial capsid 
protein disassembly and the release of genomic material through a vertex.  For both viruses, free 
chlorine may modify the viral capsid proteins, leading to a block in these similar replication 
cycle events.  After binding to the host cell, PR772 must reorient to position a unique vertex 
toward the host cell envelope, which may require secondary binding.29, 30  This vertex, along 
with others, becomes decapped, and fiber-like proteins P2 and P5, penton protein P31, and 
peripentonal P3 proteins are lost.29  Similarly, HAdV-2 undergoes secondary binding and then 
begins disassembly by the loss of fibers before endocytosis.6  Also, to escape from the 
endosome, the penton and peripentonal hexons along with other proteins are released from 
HAdV-2.6  During the PR772 replication cycle, a tubular structure is then formed from its 
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internal protein-rich lipid membrane that exists through a unique vertex, and the dsDNA genome 
translocates through the tube into the cytoplasm.29  The dsDNA genome of HAdV-2 similarly is 
released through a vertex in the subvirion and enters the eukaryotic nucleus through the nuclear 
pore complex.6  Determining what part of the replication cycle is blocked and what capsid 
protein or genome modifications led to the inhibition for each virus should be investigated next.   
 
Free chlorine modifications to the PR772 genome may inhibit cytoplasmic entry of the genome 
or early mRNA transcription.  Hypochlorous acid is known to damage DNA by chlorine 
bonding, dissociation of the DNA double helix, strand breaks, and the formation of DNA-protein 
cross-links potentially through secondary chloramine reactions.31  The reaction rates of free 
chlorine with DNA are up to 3 orders of magnitude lower than reaction rates with amino acids;32 
however, viruses have complex structures and spatial interactions will play a role in protein 
versus genomic susceptibility to modification.  Genomic damage could lead to the inhibition of 
early mRNA transcription observed for the P12 gene in PR772 and E1A in HAdV-2.  In both 
studies, the amplicon region of P12 and E1A could still be amplified by qPCR, but other regions 
of the gene could have been damaged, causing the inhibition of mRNA transcription.  Like E1A, 
P12 is an important very early gene in the PR772 replication cycle, and the P12 protein binds to 
ssDNA and dsDNA suggesting involvement in the shut-off of early protein synthesis and phage 
DNA replication.12, 33, 34  The inhibition of early mRNA transcription for free chlorine inactivated 
viruses could be due to genomic damage or may be because the genomic DNA does not enter the 
bacterial host cell or eukaryotic nucleus for PR772 and HAdV-2, respectively. 
 
4.3.7 Practical Implications 
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The results of this study show that PR772 is a promising surrogate to help understand HAdV-2 
inactivation by free chlorine.  Using the qPCR-based technique developed in this study will also 
be useful in studying PR772 inactivation by other disinfectants comparatively with HAdV-2.  
Using appropriate free chlorine dosages to understand how a virus population becomes 
inactivated on a scale of 1-log, 4-log etc. on a molecular level will greatly aid in the development 
of sensors to detect infectious viruses in drinking water.  Performing mechanistic studies with 
relatively high free chlorine dosages beyond what is required for 4-log inactivation will most 
likely not yield results useful for understanding the true mechanism of inactivation, and therefore 
a good understanding of inactivation kinetics is necessary.  Overall, a better understanding of 
how viruses such as PR772 and HAdV-2 become inactivated by disinfectants on a molecular 
level will be necessary for better detection and control of waterborne viruses in drinking water.  
With this knowledge, the development of sensors to detect infectious viruses would enable CCL4 
viruses to become regulated and monitored in drinking water supplies globally.               	    
	  	   77 
4.4 Figures and Tables 
 
Figure 4.1.  Effect of pH on the inactivation kinetics of bacteriophage PR772 by free chlorine at 
30 °C (top), 14 °C (middle), and 1 °C (bottom) characterized in batch reactors in 1 mM 
carbonate buffer over a CT range of 0-3.0 mgCl2×min/L.  Replicate experiments are indicated 
with different symbols.   
CT (mgCl2×min/L)
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Table 4.1. Primers designed for qPCR and RT-qPCR. 
Primer Bases        (bp) Sequence 










Forward 20 5'-AATCCACCTTTGGCGACTTC-3' 50.0% 55.5 14472-
14579 108 P12 
Reverse 22 5'-CCAGTACCTTTGGCAGAATCAG-3' 50.0% 55.6 
P3 
Forward 24 5'-CCCATTAAGTACGGCGATGTTATG-3' 45.8% 55.7 9007-
9108 102 P3 
Reverse 19 5'-GGCAAGCGGAACCCAATAG-3' 57.9% 56.5 
rpoD 
Forward 20 5'-GCCGTGCGAAGAAAGAGATG-3' 55.0% 56.5 3214164-
3214278 115 rpoD 
Reverse 21 5'-CCGATGTTGCCTTCCTGAATC-3' 52.4% 56.1 
a Tm, melting temperature, based on 50 mM NaCl. 
b Genomic position based on enterobacteria phage PR772 complete genome (NCBI accession 
AY848688.1) for P12 and P3, and Escherichia coli str. K-12 substr. MG1655 complete genome 
(NCBI accession U00096.3) for rpoD.	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Figure 4.2.  (Top) Relative copy numbers of the P12 and P3 amplicons (P12/P120 and P3/P30, 
see Text B.2) of the PR772 DNA genome extracted from virus samples subjected to increasing 
free chlorine exposure compared to the survival ratio (N/N0) obtained by plaque assay.  Values 
for each samples are normalized to the untreated control at CT=0. (Bottom) Comparison of the 
inactivation kinetics of PR772 by free chlorine expressed as the survival ratio (N/N0) obtained by 
plaque assay to the relative quantity of P12 and P3 genomic DNA  (P12/P120 and P3/P30, see 
Text B.2) to investigate viral attachment to host cells and genomic DNA replication at 0-3 h 
post-infection (p.i.).  Values for each treated virus sample are relative to the untreated control at 
CT=0.  Lines shown are linear regressions shown for clarity only.  	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Figure 4.3.  Absolute quantification of PR772 genome equivalents measured by the average of 
P12 and P3 DNA copies determined by a standard curve (see Text B.2) after 0-3 h p.i. with 
untreated viruses (N/N0=1) and viruses subjected to increasing free chlorine exposure 
(N/N0=0.66-0.00042).  Samples were compared to 0 h using a one-tailed t test with unequal 
variances.  Resulting P > 0.1 were indicated with v for samples that were not statistically 
different than the original copies at 0 h and therefore did not increase the viral genomic copies 
above the baseline.   	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Figure 4.4.  Absolute quantification of PR772 P12 mRNA (top) and P3 mRNA (bottom) copies 
per 0.5 µg of total RNA determined by a standard curve (see Text B.2) measured after 20, 40, 60, 
and 80 min p.i. with untreated viruses (N/N0=1) and viruses subjected to increasing free chlorine 
exposure (N/N0=0.66-0.00042).   
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Figure 4.5.  Comparison of the inactivation kinetics of PR772 by free chlorine expressed as the 
survival ratio (N/N0) obtained by plaque assay to the relative quantity of P12 and P3 mRNA  
(P12/P120 and P3/P30, see Text B.2) measured at 20, 40, 60, and 80 min p.i. Values for each 
treated virus sample are normalized to the untreated control at CT=0. 	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Figure 4.6.  PR772 replication cycle inhibition after free chlorine exposure. 
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CHAPTER 5.  INACTIVATION KINETICS AND REPLICATION CYCLE INHIBITION 
OF ADENOVIRUS BY MONOCHLORAMINE§§ 
5.1 Introduction 
Disinfection is an important drinking water treatment process for providing safe drinking water 
through inactivation of waterborne pathogens, including viruses.  Free chlorine is currently the 
most widely used drinking water disinfectant throughout the world and in the United States.  
Although enteric viruses are adequately controlled with free chlorine disinfection, many utilities 
have changed to alternative disinfection schemes (e.g., monochloramine or low-pressure 
ultraviolet light disinfection) to meet recent national U.S. primary drinking water regulations 
targeting disinfection byproducts (DBPs).1, 2  Disinfection with monochloramine, formed from 
the reaction of ammonia with aqueous chlorine, provides a residual in distribution systems while 
reducing the formation of regulated DBPs.3  Monochloramine is, however, a weaker disinfectant, 
requiring exposures higher than those of free chlorine to inactivate many types of waterborne 
pathogens, including enteric viruses. 
 
Few studies have investigated the efficacy of monochloramine disinfection on enteric viruses, 
and within those studies very few examine multiple pH and temperature conditions.4-15 Recent 
studies have focused on viruses listed on the U.S. Environmental Protection Agency (EPA) 
Contaminant Candidate List (CCL) that are known to be present in drinking water and may be 
regulated in the future.16 Current regulations require 99.99% (4-log) inactivation or removal of 
enteric viruses.17 Out of the four viral pathogens listed on CCL, including human adenovirus 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  §§	  Adapted from Gall, A. M.; Shisler, J. L.; Mariñas, B. J. Inactivation Kinetics and Replication 
Cycle Inhibition of Adenovirus by Monochloramine.  Environ. Sci. Technol. Letters 2016, 3 (4), 
185-189.	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(HAdV), caliciviruses, enterovirus, and hepatitis A virus, HAdV is the most resistant to 
monochloramine disinfection and is also one of the least resistant to free chlorine.10, 11, 16 The 
mechanism by which HAdV is so resistant to monochloramine inactivation remains unknown. 
Our previous study comparing untreated HAdV to monochloramine-treated viruses elucidated 
that viruses inactivated by less than 1-log were unable to synthesize the first early protein 
measured by immunoblotting at 12 h post infection (p.i.) in A549 cells, and treated viruses were 
unable to replicate their genomic DNA at 24 h p.i. measured by slot blotting to the same 
abundance as untreated viruses.13 The aims of this research were to produce a highly 
comprehensive set of inactivation kinetics over the range of environmental pH and temperature 
conditions encountered in water treatment to achieve 4-log inactivation of HAdV-2 by 
monochloramine and quantitatively analyze what steps in the viral replication cycle become 
inhibited over the range of viral inactivation (i.e. 0- to 4-log) by monochloramine using 
quantitative polymerase chain reaction (qPCR) to analyze HAdV-2 attachment, genome 
replication, and mRNA transcription several times p.i.  HAdV is listed on the CCL because it 
causes a variety of diseases, including gastroenteritis, respiratory disease, and conjunctivitis, and 
HAdV can be spread in contaminated water through ingestion, inhalation, or direct contact with 
eyes.18-20  Viruses on the CCL could be regulated in the future if methods that can rapidly detect 
infectious viruses while differentiating them from inactivated viral particles, empty capsids, and 
free-floating nucleic acids are developed.21  A more fundamental understanding of how viruses 
like HAdV become inactivated by disinfectants like monochloramine is needed for better 
detection and control of viruses in drinking water.  
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5.2 Materials and Methods 
5.2.1 HAdV-2 Viability and Monochloramine Disinfection 
HAdV-2 (VR-846) was propagated using A549 human lung carcinoma cells (CCL-185) obtained 
from the American Type Culture Collection (Manassas, VA).  HAdV-2 purification, A549 host 
cell culture growth, and viability using plaque assays have been described previously.12, 22  The 
methods used and range of conditions investigated for monochloramine disinfection experiments 
are described in Appendix C (see Text C.1 and Table C.1).   
 
5.2.2 Analysis of the HAdV-2 Replication Cycle  
The analysis of  the HAdV-2 replication cycle has been described previously (see Text C.2 and 
Figure C.3).22  HAdV-2 was untreated or treated with monochloramine (pH 8 and 15 °C) up to 
99.99% (4-log) inactivation corresponding to a survival ratio (N/N0) of 1 to 0.0001.  Genomic 
damage to target amplicon regions (E1A and hexon genes) was determined by extracting DNA 
from untreated and monochloramine-treated viruses.  Subsequent assays were performed by first 
synchronizing the HAdV-2 infection in A549 cells.  Total viral and cellular DNA and RNA were 
extracted at 0, 4, 12, 24, and 36 h p.i. to quantify HAdV-2 attachment and viral genomic DNA 
(E1A and hexon genes) replication by qPCR, and viral early (E1A) and late (hexon) mRNA 
transcription by reverse transcriptase qPCR (RT-qPCR) (see Text C.3). 
 
5.3 Results and Discussion 
5.3.1 Inactivation Kinetics and Kinetic Model  
The kinetics of HAdV-2 inactivation with monochloramine at pH 6-10 at temperatures of 5-30 
°C are shown in Figure 5.1.  These results were generally consistent with previously reported 
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data.5, 10-12  The inactivation data were represented with a two-population model similar in form 
to that proposed for the inactivation of HAdV-2 with free chlorine:23  
!!! = !!!! 𝑒!!!!" + !!!! 𝑒!!!!"      (5.1) 
where k1 and k2 are inactivation rate constants and N1/N0 and N2/N0 are the fractions of viruses in 
populations 1 and 2, respectively.  Kinetic curves were characterized by an initial relatively rapid 
phase of inactivation, followed by a slower second phase of inactivation.  N2/N0 was found to be 
independent of pH and temperature, and N1/N0 = (1-N2/N0).  In contrast, k1 and k2 were found to 
be dependent on both pH and temperature according to the expressions: 
𝑘! = 𝐴!𝑒!!!,!!" 𝑒!!!pH     (5.2) 
and 
𝑘! = 𝐴!𝑒!!!,!!" 𝑒!!!pH    (5.3) 
where R is the ideal gas constant, T is absolute temperature, and A1, A2, B1, B2, Ea,1 and Ea,2 are 
fitting parameters.  Simultaneous fitting of all data sets to equation 5.1 resulted in the following 
values:  N2/N0=exp(-3.505±0.393), A1 = exp(31.13±2.56) L/(mg×min), Ea,1 = 71,130±6,090 
J/mol, B1 = 0.834±0.057, A2 = exp(28.87±0.69) L/(mg×min), Ea,2 = 68,240±1,690 J/mol, and B2 
= 0.799±0.015.  Notice that the model represented the data generally well (see Figure 5.1 and 
Figure C.1) except for deviations observed for data sets at the two highest pH values investigated 
at 30 oC, which were excluded when the final fitting was performed.  This model was similar to 
our previous kinetic model developed for HAdV-2 inactivation by monochloramine with an 
additional term for the secondary slower inactivation phase that was not previously observed 
with limited kinetic data.12  Additionally, a lag phase was not observed in our current model 
potentially due to HAdV-2 stock preparations that resulted in fewer impurities and caused no 
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measurable decay of monochloramine; our previous model solved fitting parameters for each pH 
condition separately, whereas our current model allowed for simultaneous fitting of all data sets.  
 
5.3.2 Effect of Monochloramine on Genomic DNA Amplification 
Viral DNA extracted from untreated and monochloramine-treated viruses was probed by qPCR, 
using primers specific for the E1A or hexon genes to determine if monochloramine damaged 
these selected regions of the HAdV-2 genome.  The relative expression of each gene (E1A/E1A0 
and Hexon/Hexon0) was determined for each virus sample subjected to increasing 
monochloramine exposure (CT > 0), and the untreated virus sample (CT = 0) was used as the 
calibrator.  The relative copy numbers compared with the survival ratio (N/N0) are represented in 
the top plot of Figure 5.2.  As monochloramine exposure increased and survival ratio decreased, 
the relative quantity of both genes remained constant.  Even as HAdV-2 approached 4-log 
inactivation, the targeted genes were amplified with the same abundance as the untreated control, 
revealing that the E1A and hexon amplicon regions of the viral genomes were not damaged by 
monochloramine treatment.  However, the regions amplified consisted of <2% of the entire 
HAdV-2 genome; therefore, we were unable to conclude if other regions of the viral genome 
were damaged by monochloramine.  Because there was no loss of amplification of our target 
genes, our subsequent analyses were not affected by genomic damage of these regions due to 
monochloramine treatment. 
 
5.3.3 Effect of Monochloramine on Virus Attachment 
To assess if monochloramine exposure inhibited attachment to host cells, untreated and 
monochloramine-treated viruses were incubated on A549 cell monolayers at 4 °C, a temperature 
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that allowed virus attachment but prevented entry.  Unbound viruses were removed, and total 
DNA was extracted from cells and bound viruses and quantified by qPCR.  The relative 
quantities of E1A/E1A0 and Hexon/Hexon0 at 0 h p.i. are shown in the middle plot of Figure 5.2 
compared to the survival ratio of HAdV-2 (N/N0).  As the survival ratio decreased with 
increasing monochloramine exposure, the relative quantity of HAdV-2 genes remained constant. 
This revealed that monochloramine-treated HAdV-2 up to 99.95% inactivation was still able to 
bind to host cells. 
 
5.3.4 Effect of Monochloramine on Genome Replication 
The effect of monochloramine on HAdV-2 genome replication was assessed throughout the 
duration of one infectious cycle at 4, 12, 24, and 36 h post-synchronized infection.  At 4 h p.i., 
the middle plot of Figure 5.2 shows that the same quantity of HAdV-2 DNA was present for 
treated and untreated viruses, consistent with the HAdV-2 genome replication not beginning 
until approximately 5-8 h p.i.20  Genome replication is presented in terms of absolute copy 
numbers in the top plot of Figure 5.3.  The untreated control (N/N0 = 1) increased the amount of 
DNA copies by nearly 104-fold from 4 to 36 h. p.i.  Monochloramine-inactivated HAdV-2 
produced genomic DNA copies but fewer than the untreated control.  For example, HAdV-2 
inactivated by nearly 2-log (N/N0 = 0.021-0.012) by monochloramine produced nearly 2-log 
fewer copies than the untreated control at 36 h p.i.  By 24 and 36 h p.i., the relative quantity of 
HAdV-2 DNA replicated correlated with the survival curve (N/N0) of HAdV-2 (significant 
correlation; r  ≥ 0.83, P < 0.05) shown in the middle plot of Figure 5.2.  This suggested that 
monochloramine inactivated HAdV-2 by inhibiting a replication cycle event at or before genome 
replication.    
	  	   92 
      
5.3.5 Effect of Monochloramine on mRNA Synthesis 
Transcription of HAdV-2 early mRNAs (e.g., E1A) occurs before viral DNA replication, while 
late genes (e.g., hexon) are transcribed during genome replication.  To determine if 
monochloramine treatment also inhibited late mRNA production, the levels of hexon mRNA in 
cells infected with treated or untreated viruses were quantified throughout one infection cycle.  
The absolute number of hexon mRNA copies per 0.5 µg of total RNA was quantified at 4, 12, 
24, and 36 h p.i. in Figure 5.3 (bottom plot) (see Text C.3).  Late mRNA transcription in HAdV-
2 begins around 5-8 h p.i., and as expected, no detectable hexon mRNA was present 4 h p.i.  By 
12 h p.i., untreated and monochloramine-treated viruses to less than 1.7-log inactivation (N/N0 ≥ 
0.021) produced detectable levels of hexon mRNA.  The number of hexon mRNA copies 
increased gradually up to 107 copies at 36 h p.i.  The number of hexon mRNA copies also 
increased from 12 to 36 h p.i. for monochloramine-treated HAdV-2 but overall produced fewer 
copies compared to the untreated control.   
 
The transcription of an early gene (E1A) was also evaluated for HAdV-2 at the same times 
postinfection.  E1A is the first viral gene transcribed after infection, detected by 1-2 h p.i.20  
Accordingly, as shown in Figure 5.3 (middle plot), E1A mRNAs were transcribed for the 
untreated control at 4 h p.i., and the number increased to 105 copies by 12 h p.i.  The number of 
E1A mRNA copies for monochloramine-treated samples was smaller than the number for the 
untreated control, and the quantity of E1A mRNA decreased with an increasing level of 
inactivation at all times postinfection.  By 24 and 36 h p.i., the amount of E1A mRNA had 
leveled off because the viral infection had undergone the transition to the late stage, and no 
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additional E1A was needed.  Housekeeping gene β-actin mRNA transcription remained at 
constant levels throughout the infection for untreated and treated HAdV-2 (see Figure C.4), 
which verified β-actin as an effective normalizer gene.    
 
The relative quantities of early and late mRNAs produced by HAdV-2 subjected to increasing 
monochloramine exposure that were calibrated to the untreated control (N0) are shown in Figure 
5.2 (middle and bottom plots).  The relative quantity at 12, 24, and 36 h p.i. of early mRNA E1A 
(E1A/E1A0) and late hexon mRNA (Hexon/Hexon0) correlated to the survival ratio of HAdV-2 
(N/N0) measured by plaque assay (significant correlation; for E1A r ≥ 0.91; for Hexon r ≥ 0.85; 
P < 0.05).  This indicated that monochloramine exposure resulted in blocking a step in the viral 
replication cycle at or before early mRNA transcription. 
 
5.3.6 Mechanistic Considerations of Monochloramine Disinfection 
The results of this study revealed that HAdV-2 inactivated by monochloramine by >99.95% 
could bind to host cells.  However, downstream replication cycle events were inhibited, 
including early gene transcription, genome replication, and late gene transcription.  The results 
indicated that monochloramine inactivation of HAdV-2 inhibited a replication cycle event 
postbinding but at or before early mRNA synthesis. Our results of HAdV-2 inactivated up to 
99.95% by monochloramine were consistent with our previous study of HAdV-2 inactivated up 
to 80% (less than 1-log) that found decreased levels of E1A protein synthesis measured by 
immunoblotting at 12 h p.i. in A549 cells and inhibited viral genome replication at 24 h p.i. 
measured by slot blotting.13  
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Our recent study of HAdV-2 inactivation by free chlorine showed similar results; free chlorine-
treated HAdV-2 was able to bind to host cells, but viral gene transcription and genome 
replication were inhibited.22  It was interesting to find that the HAdV-2 replication cycle is 
impeded postbinding but prior to early gene synthesis for both disinfectants despite the fact that 
there was a difference of more than 4 orders of magnitude in treatment efficiency between the 
two disinfectants.  For example, a CT of approximately 0.5 mgCl2×min/L was required to 
achieve 4-log inactivation of HAdV-2 by free chlorine at pH 10 and 5 oC;23 in contrast, the CT 
required for the same level of inactivation with monochloramine at the same pH and temperature 
was approximately 25,000 mgCl2×min/L.  One possible explanation for the differences in 
HAdV-2 inactivation rates by free chlorine compared to that with monochloramine is that the 
reaction rate constants for specific amino acids are up to 5 orders of magnitude higher for 
chlorination than for chloramination.24  If the same key capsid proteins were modified by free 
chlorine and monochloramine disinfection leading to the same block in the HAdV-2 replication 
cycle, the reaction rate constants for the chlorination and chloramination of specific amino acids 
could explain the resistance of HAdV-2 to monochloramine disinfection.  Additionally, chlorine 
transfer reaction rate constants from chloramine to amino acids have been shown to increase with 
a decrease in pH in the range of 6-10, further supporting the idea that monochloramine may 
cause protein modifications that lead to inactivation of HAdV-2, and as observed in Figure 5.1, 
inactivation occurred more rapidly under low-pH conditions.25  Monochloramine and free 
chlorine most likely cause many modifications of the viral capsids and genome, and determining 
which modification results in inactivation will require further viral replication cycle studies.  
Studying if chlorine- and chloramine-treated HAdV-2 can successfully bind to its secondary 
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receptor, escape from the endosome, traverse to the nucleus, and uncoat leading to nuclear entry 
will help pinpoint what region may be the target of inactivation. 
 
5.3.7 Practical Implications 
The results of this study have several practical implications for the control and detection of 
HAdV in drinking water.  HAdV is known to be the most resistant CCL virus to 
monochloramine disinfection, and this study has characterized its inactivation over a range of 
environmental pH and temperature conditions.  Monochloramine is usually applied as a 
secondary disinfectant for maintaining a residual in the distribution system. If infiltration or 
depressurization events occur in drinking water distribution systems leading to contamination, 
monochloramine would typically not be adequate to inactivate HAdV.  Previous studies have 
also noted that the CT values recommended by the EPA for chloramines are insufficient for 
HAdV inactivation.10, 11 The CT values recommended for 4-log inactivation are 1988 
mgCl2×min/L at 5 °C and 994 mgCl2×min/L at 15 °C for pH values of 6-9.17, 26  In contrast, our 
data showed that at pH 9 the exposures required are nearly 13,000 mgCl2×min/L at 5 °C and 
>5,000 mgCl2×min/L at 15 °C.   
 
This study also contributes to the identification of potential molecular targets by demonstrating 
that the small amplicon regions of E1A and hexon genes are not the targets monochloramine 
disinfection, and that capsid protein or genomic DNA modifications inhibit a replication cycle 
event that occurs after binding but prior to viral mRNA transcription.  Determining the specific 
protein or genome modification that leads to the inhibition of the viral replication cycle and thus 
the inactivation of HAdV would be very beneficial for the detection of infectious HAdV in 
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drinking water.  The modification that leads to inactivation may be unique for each disinfectant.  
An understanding of these modifications would allow the development of methods for 
distinguishing between infectious and noninfectious HAdV in drinking water by detecting these 
specific molecular modifications.  The development of methods for rapidly detecting infectious 
viruses in drinking water would then allow CCL viruses like HAdV to become regulated in the 
future. 
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Figure 5.1.  Effect of pH 6-10 on the inactivation kinetics of HAdV-2 by monochloramine at 5 
°C (left), 15 °C (center), and 30 °C (right).  Replicate experiments are indicated with different 
symbols.  This figure is reproduced in Figure C.1 with the horizontal axis expanded for ease of 
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Figure 5.2. Relative quantification (see Text C.4) of E1A and hexon (E1A/E1A0 and 
Hexon/Hexon0) DNA or mRNA from virus samples subjected to increasing monochloramine 
exposure compared to the survival ratio (N/N0) obtained by plaque assay.  Values for each 
sample are relative to the untreated control at CT = 0.  Linear regressions are shown for the sake 
of clarity only. (Top) Relative quantity of HAdV-2 genomic DNA amplicons extracted from 
virus samples to determine amplicon integrity.  (Middle) Relative quantity of E1A and hexon 
genomic DNA to investigate the attachment to A549 monolayers at 0 h p.i. and genomic DNA 
replication at 4-36 h p.i. (Bottom) Relative quantity of early and late mRNA E1A/E1A0 and 
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E1A/E1A0, Hexon/Hexon0 at 12 h p.i.
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Figure 5.3.  Absolute quantification (see Text C.4) of HAdV-2 DNA or mRNA at 4-36 h p.i. for 
untreated viruses (N/N0 = 1) and viruses subjected to increasing monochloramine exposure (N/N0 
= 0.82-0.00044).  (Top) HAdV-2 DNA copies per 100 β-actin DNA copies.  Genome equivalents 
were measured by the average of E1A and hexon copies, and the error bars represent the 
standard deviation.  Samples not statically greater than the baseline DNA copies at 4 h p.i. are 
indicated by ν (P>0.1).  (Middle) Absolute quantification of HAdV-2 E1A mRNA copies per 0.5 
µg of total RNA.  (Bottom) Absolute quantification of HAdV-2 hexon mRNA copies per 0.5 µg 
of total RNA.  
  
Time post infection (h)












































































































































































Figure 5.4.  Comparison of free chlorine and monochloramine exposure required to achieve 4-
log inactivation of HAdV-2 in drinking water. 
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CHAPTER 6.  INACTIVATION KINETICS AND REPLICATION CYCLE INHIBITION 
OF BACTERIOPHAGE PR772 BY MONOCHLORAMINE:  A COMPARATIVE 
ANALYSIS TO HUMAN ADENOVIRUS*** 
6.1  Introduction 
Waterborne viruses can have a significant impact on public health without adequate control in 
drinking water systems.  Current U.S. regulations require 99.99% (4-log) inactivation or removal 
for enteric viruses, and four viral pathogens are listed on the U.S. EPA contaminant candidate list 
(CCL) for potential future regulation based on prevalence and health impact.1, 2  One of these 
viruses is human adenovirus (HAdV), a non-enveloped medium-size (~90 nm) virion with a 
protein capsid encasing a 35.9 kbp double-stranded DNA (dsDNA) genome.3  Present in 
drinking water sources globally, HAdV is the most susceptible to free chlorine disinfection 
among CCL viruses and has the highest resistance to monochloramine disinfection.4-6  
Monochloramine, formed from reacting aqueous chlorine and ammonia, is known for its longer 
stability but weaker disinfection potency compared to free chlorine.7  The specific mechanisms 
of HAdV inactivation by both monochloramine and free chlorine remain unidentified, but recent 
work points to transformation of capsid proteins as likely targets for both forms of chlorine 
disinfectants.8, 9  
 
A novel approach that could provide additional insights into HAdV mechanisms of inactivation 
by disinfectants is to perform comparative replication cycle studies with bacteriophages similar 
to HAdV.  Few studies have focused on virus inactivation by monochloramine, and 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ***	  Adapted from Gall, A. M.; McClary, J. S.; Shisler, J. L.; Mariñas, B. J. Inactivation Kinetics 
and Replication Cycle Inhibition of Bacteriophage PR772 by Monochloramine:  A Comparative 
Analysis to Human Adenovirus. (to be submitted) 2016.	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investigations including bacteriophages have been even more limited and only included small 
phages with single-stranded genomes, MS2 and ΦX174, which are not good analogs for 
HAdV.10-12    In contrast, tectiviruses, such as bacteriophage PR772, have similar morphology 
and replication cycle events as HAdV.  PR772 is a medium-sized virus (60 nm) with a dsDNA 
genome (14.9 kbp).13, 14  Both HAdV-2 and PR772 have an icosahedral capsid structure with 
fiber-like proteins projecting from the vertices that bind to host cell receptors to initiate 
infection.3, 15  The major capsid proteins have similar base structures consisting of a double beta-
barrel with HAdV proteins having more complex loop structures.16  Both viruses release their 
genome through a vertex and use a protein-primed mechanism for genome replication.  Upon 
host cell infection, HAdV-2 and PR772 undergo similar replication strategies with early mRNAs 
transcribed first, followed by late mRNA transcription simultaneously with genomic 
replication.3, 15  In a recent previous comparative study, we found that PR772 and HAdV-2 had 
similar inactivation kinetics and replication cycle inhibition after exposure to free chlorine.17  
Examining PR772 inactivation by monochloramine may therefore give additional insights into 
HAdV disinfection mechanisms. 	  
6.2  Materials and Methods 
6.2.1  PR772 Propagation and Viability 
PR772 propagation and purification, bacterial host cell growth, and viability using plaque assays 
have been described previously.17  Bacteriophage PR772 (BAA-769-B1) was propagated in 
Escherichia coli K12 J53-1 R15 (BAA-769) obtained from the American Type Culture 
Collection (Manassas, VA).  PR772 viability was assessed using the double agar layer plaque 
technique.17, 18    
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6.2.2  Monochloramine Disinfection 
Methods used for virus disinfection by monochloramine have been described previously.9  
Briefly, monochloramine was preformed in 1 mM carbonate buffered solution (CBS) or 1 mM 
phosphate buffer solution (PBS) by slow addition of sodium hypochlorite solution to ammonium 
chloride. Experiments were performed in 100 mL batch reactors in a temperature controlled 
water bath.  The N,N-diethyl-p-phenylenediamine colorimetric method19 was used to measure 
the initial monochloramine concentration (C0) before virus addition and was continuously 
monitored throughout the experiment.  There was no observable decay in concentration, and 
therefore the Caverage was used to calculate CT (Table 6.1).  A range of initial monochloramine 
concentrations were used (C0 = 1.24 to 10.58 mg/L as Cl2) as well as initial virus concentrations 
(N0 = 9.50E+03 to 1.15E+07 PFU/mL) at pH 8 and 15 °C.  Experimental conditions are shown in 
Table 6.1. 
 
6.2.3  Analysis of PR772 Replication Cycle 
PR772 replication cycle analysis methods using quantitative polymerase chain reaction (qPCR) 
have been described previously.17  Untreated and monochloramine-treated PR772 at pH 8 and 15 
°C were used to assess the impact of monochloramine disinfection on the ability of PR772 to 
complete replication cycle steps.  All assays were performed in triplicate.  Briefly, DNA and 
RNA were extracted at several times post-infection (p.i.) to assess viral genome damage, 
attachment, genome replication, and mRNA transcription.17  Genomic damage to the P12 and P3 
amplicon regions was determined by quantifying DNA from treated and untreated virus samples.  
To determine if monochloramine inactivated PR772 could still attach to host cells, total DNA 
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was extracted from viruses bound to E. coli treated with 20 µg/mL chloramphenicol (Sigma-
Aldrich, St. Louis, MO) after unbound viruses were removed.  Untreated and monochloramine-
treated PR772 were incubated with E. coli host cells, and at 0, 1, 2, and 3 h p.i., total DNA was 
extracted from virus-host suspensions to assess if treated PR772 could still replicate the viral 
genome.  The infection cycle was stopped by snap-freezing samples in liquid nitrogen prior to 
DNA extraction using the DNeasy Blood and Tissue Kit (Qiagen, Valencia, CA).  To determine 
if PR772 could transcribe early and late mRNAs, total RNA was extracted from the same virus-
host suspension at 20, 40, 60, and 80 minutes post infection.  RNAprotect Bacteria Reagent 
(Qiagen) was used to stabilize RNA in vivo before extracting RNA using the RNeasy Mini Kit 
(Qiagen).  Genomic DNA contamination was removed by digesting extracted RNA with DNase I 
stock solution (Qiagen) and was purified using RNeasy spin columns.  The bacterial gene rpoD 
was used as the housekeeping gene for DNA and RNA analyses.  Viral and bacterial DNA and 
mRNA were quantified using qPCR and reverse transcriptase qPCR (RT-qPCR), respectively, 
using primers designed previously for P12 and P3 viral genes and the bacterial gene rpoD (Table 
D.1).17  qPCR cycling conditions were previously described utilizing Ssofast EvaGreen supermix 
(Biorad Laboratiries, Inc. Hercules, CA).8, 17    
 
Data from qPCR and RT-qPCR was analyzed as described previously based on the quantification 
cycle (Cq) for each sample.17  Relative quantification was calculated using the ΔΔCq equation 
and represented as P12/P120 and P3/P30 for ease of comparison with the survival ratio, N/N0, in 
Figures 6.2 and 6.5.  The untreated virus sample was used as the calibrator, and rpoD was used 
as the normalizer gene.  Absolute quantification was used to determine the absolute copy number 
of each gene in a sample using the equations in Table D.1 previously developed using a standard 
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curve.17  The bacterial housekeeping gene, rpoD, was transcribed at a constant level throughout 
the infection for untreated and treated PR772 (Figure D.1) verifying its use as an effective 
normalizer gene.  
 
Statistical analysis were performed as previously described.17  To determine if genomic DNA 
copies at 1 to 3 h p.i. were statistically greater than the baseline copies detected at 0 h p.i., a one-
tailed t test was used.  Samples that were not statistically larger (P > 0.1) are indicated by ν in 
Figure 6.3 and omitted from the relative expression analysis in Figure 6.2.  SigmaPlot V12 
(Systat Software, Inc., San Jose, CA) was used to determine correlations between relative 
quantification (P12/P120 and P3/P30) and the survival ratio (N/N0).  The Pearson product moment 
correlation coefficient (r) was calculated with P < 0.05 as significant correlation.  A parallel line 
analysis was then performed to determine if the linear regression slopes were statistically similar.  
All significant correlations had statistically similar slopes for the parallel line analysis (P > 0.05) 
between the slope of N/N0 and the relative gene quantity (P12/P120 and P3/P30) with increasing 
monochloramine exposure.     	  
6.3  Results and Discussion 
6.3.1 Inactivation Kinetics and Kinetic Model  
The kinetics of PR772 inactivation with monochloramine at pH 6-10 and temperatures of 5-30 
°C are shown in Figure 6.1.  The inactivation data were represented with the two-population 
model proposed for the inactivation of HAdV-2 with monochloramine:9  
!!! = !!!! 𝑒!!!!" + !!!! 𝑒!!!!"     (6.1) 
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in which k1 and k2 are inactivation rate constants, and N1/N0 and N2/N0 are the fractions of viruses 
in populations 1 and 2.  Kinetic curves were characterized by an initial relatively rapid phase of 
inactivation, followed by a slower second phase of inactivation.  N2/N0 was found to be 
independent of pH and temperature and N1/N0 = (1-N2/N0).  In contrast, k1 and k2 were found to 
be dependent on both pH and temperature according to the expressions: 
𝑘! = 𝐴!𝑒!!!,!!" 𝑒!!!pH    (6.2) 
and 
𝑘! = 𝐴!𝑒!!!,!!" 𝑒!!!pH   (6.3) 
in which R is the ideal gas constant, T is absolute temperature, and A1, A2, B1, B2, Ea,1 and Ea,2 are 
fitting parameters.  Simultaneous fitting of all data sets to Equation (6.1) resulted in N2/N0 = 
exp(-6.901±2.593), A1 = exp(22.66±1.89) L/(mg×min), Ea,1 = 27,930±4,420 J/mol, B1 = 
1.48±0.04, A2 = exp(25.36±2.38) L/(mg×min), Ea,2 = 38,360±5,690 J/mol, and B2 = 1.48±0.07.  
Notice that the model represented the data generally well except for deviations at high pH values 
at 30 °C.  Intriguingly, similar deviations between data and model were also observed for HAdV-
2 inactivation with monochloramine at high pH and 30 °C.9 	  
In contrast to similar kinetics observed for the inactivation of PR772 and HAdV-2 with free 
chlorine, the inactivation kinetics of PR772 by monochloramine were significantly faster than 
HAdV-2 at all pH and temperature conditions investigated with the largest discrepancy occurring 
at the lowest pH and lowest temperature investigated; e.g., monochloramine CT required to 
achieve 99.99% inactivation at pH 6 and 5oC for HAdV-2 (~1,200 mg×min/L) was 
approximately 400 times higher compared to that for PR772 (~3 mg×min/L).9  To gain greater 
insight into disinfection phenomena, we utilized qPCR-based assays previously developed for 
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PR772 to investigate if there were similarities in inhibition for both viral replication cycles after 
monochloramine disinfection.17 
 
6.3.2  Effect of Monochloramine on Genomic DNA Amplification 
To determine if monochloramine damaged the P12 and P3 genes in the PR772 genome, viral 
DNA was extracted from untreated and monochloramine-treated viruses and quantified by 
qPCR.  P12, like the analogous E1A gene in HAdV-2, is located at the end of the dsDNA 
genome, and P3, like the analogous hexon gene in HAdV-2, is located in the center.3, 14  The 
relative copy numbers of each gene (P12/P120, and P3/P30) were determined by quantifying the 
copy number of each gene for each virus sample with increasing monochloramine exposure (CT 
≥ 0) and calibrating to the untreated control (CT = 0).  The relative copy numbers of each gene 
compared to the survival ratio (N/N0) are shown in Figure 6.2 (top).  As viruses became 
increasingly inactivated, the relative quantity of P12 and P3 remained constant.  This indicated 
that these two small amplicon regions of the PR772 genome were not damaged by 
monochloramine exposure.	  	  
6.3.3  Effect of Monochloramine on Virus Attachment 
Untreated and monochloramine-treated PR772 were incubated in a suspension of E. coli treated 
with chloramphenicol for one hour to determine if monochloramine had an effect on virus 
binding.  Unbound viruses were removed, and total viral and cellular DNA was extracted.  The 
relative quantity of each gene (P12/P120 and P3/P30) was quantified using the untreated control 
(CT = 0) as the calibrator and rpoD as the normalizer gene.  The relative quantity of each gene 
compared to the survival ratio (N/N0) is shown in Figure 6.2 (bottom).  As the survival ratio 
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(N/N0) decreased with increasing monochloramine exposure, the relative quantities of P12/P120 
and P3/P30 remained constant.  This confirmed that monochloramine-inactivated PR772 could 
still bind to E. coli. 	  
6.3.4  Effect of Monochloramine on Genome Replication	  	  
PR772 genome replication was assessed over multiple infection cycles in liquid culture at 0, 1, 2, 
and 3 h p.i. by extracting total DNA from virus-host suspensions.  The complete replication cycle 
of PR772 lasts 60 min and genome replication begins 10-20 min p.i.20, 21  Figure 6.2 (bottom) 
shows that the relative quantity of PR772 DNA (P12/P120 and P3/P30) present at 0 h p.i. was the 
same for all virus samples, verifying the same amount of virus was added to each bacterial 
culture.  The absolute quantity of genome equivalents is presented in Figure 6.3.  Untreated 
PR772 (N/N0 = 1) steadily increased the amount of genomic DNA by nearly 102-fold by 3 h p.i.  
Monochloramine-treated viruses also increased the amount of genomic DNA but to a lesser 
extent than untreated PR772.  For highly inactivated PR772 (N/N0 ≤ 0.00036), there was no 
detectable increase in DNA copies from 0-3 h p.i.  Genome replication may have been occurring 
but it remained undetected until exceeding the baseline DNA copies at 0 h p.i.  The samples that 
were not significantly greater than the baseline at 0 h p.i. based on a one-tailed t test (P > 0.1) 
have been indicated with ∨ in Figure 6.3.  From 2-3 h p.i., the relative quantity of genomic DNA 
produced by viruses subjected to increasing monochloramine exposure significantly correlated (r 
≥ 0.93, P < 0.05) with the inactivation of PR772 determined by plaque assay (N/N0) in Figure 6.2 
(bottom).  Monochloramine therefore inactivated PR772 by inhibiting a replication cycle event at 
or before genome replication.   
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6.3.5  Effect of Monochloramine on Early and Late Gene mRNA Synthesis 
To determine if monochloramine effects PR772 mRNA transcription, total RNA was extracted 
from virus-host suspensions at 20, 40, 60, and 80 min p.i.  PR772 mRNA transcription occurs 
before DNA replication in the early stage and during DNA replication in the late stage.    
Absolute quantities of mRNA are shown in Figure 6.4.  Upon host cell infection, late genes like 
P3 are transcribed after 15 min.22  For the untreated control, P3 mRNAs were detected at 20 min 
p.i., and steadily increased nearly 104-fold by 80 min p.i. in Figure 6.4 (bottom).  Most of the 
monochloramine treated viruses produced a detectable amount of P3 mRNA by 40 min p.i. and 
continued increasing the amount of P3 mRNA until 80 min p.i.  Viruses that had only been 
slightly inactivated compared to those that had been more significantly inactivated by 
monochloramine produced larger quantities of P3 mRNA, but less than the untreated control.    
 
Early genes like P12 are transcribed in less than 5 min p.i.22  Untreated PR772 increased the 
quantity of P12 mRNA by nearly 103.5 copies by 40 min p.i. (Figure 6.4, top).  A leveling off of 
P12 mRNA occurred by 40 min p.i.  Monochloramine-treated viruses also increased the quantity 
of P12 mRNA by 40 min p.i. but produced less than the untreated control.  At 20 min p.i., 
viruses inactivated by monochloramine by approximately 2-log or greater (N/N0 ≤ 0.0143) did 
not produce a detectable amount of P12.  The highly inactivated virus sample (N/N0 = 0.00036) 
was unable to produce a detectable amount of P12 or P3 mRNA by 80 min p.i.  
 
The relative quantities of the early P12 mRNA (P12/P120) and late P3 mRNA (P3/P30) are 
shown in Figure 6.5 compared to the survival ratio (N/N0).  The relative quantities of P12/P120 
and P3/P30 mRNA significantly correlated (r ≥ 0.91, P < 0.05) to the inactivation kinetics of 
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PR772 (N/N0) for all times post-infection.  This suggested that monochloramine inactivated 
PR772 by inhibiting a replication cycle event at or before early P12 mRNA transcription.      
 
6.3.6  Mechanistic Considerations  
Data here show that monochloramine inactivated PR772 by inhibiting a replication cycle event 
that occurs post binding but before or at early P12 mRNA transcription.  Similarly, our previous 
study with HAdV-2 showed that viruses inactivated by monochloramine up to 99.95% could 
bind to A549 host cells but were unable to transcribe the first early E1A mRNA.9  Interestingly, 
we previously obtained the same replication cycle inhibition with free chlorine-inactivated 
PR772 and HAdV-2.8, 17  The disinfectant exposure required for 99.99% inactivation is however 
very different between free chlorine and monochloramine-inactivated HAdV-2 and PR772.  The 
inactivation kinetic behavior and CT requirements were similar for both viruses exposed to free 
chlorine with a necessary exposure in the range of 100 mg×min/L.17, 23  The CT requirements for 
monochloramine were orders of magnitude larger.  For low temperatures (5°C) and high pH (10), 
PR772 required nearly 103 mg×min/L of monochloramine exposure to achieve 4-log 
inactivation, and HAdV-2 required 2.5×104 mg×min/L.9  Despite the differences in exposures 
necessary for 4-log inactivation, similarities in inactivation kinetic profiles and replication cycle 
inhibition hinted that the mechanism of inactivation may be the same for both HAdV-2 and 
PR772 after exposure to free chlorine and monochloramine. 
 
Disinfectants can inactivate viruses by structurally or chemically modifying the capsid or 
genome leading to inhibition of a replication cycle event.  The two replication cycle events in 
common for HAdV-2 and PR772 that could be investigated next are the uncoating process and 
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the release of genomic dsDNA through a capsid vertex.  If these entry process events can be 
quantitatively analyzed, specific regions can be investigated to pinpoint what modification leads 
to the loss of infectivity.  For example, both viruses must release fibers, pentons, and 
peripentonal pentons, and modifications to these proteins may disrupt the uncoating process 
necessary for entry.3, 24  The PR772 genome is released into the bacterial cytoplasm through a 
tubular structure formed at a vertex from its internal protein-rich lipid membrane, and HAdV 
genome is released into the eukaryotic nucleus at the cellular nuclear pore complex.3, 24  During 
the complex entry process for HAdV, DNA entering the nucleus is known to cause a bottleneck 
during infection.25  Damage from disinfectants to capsid proteins or the genome could prevent 
the dsDNA from being released into the bacterial cytoplasm or eukaryotic nucleus.  A detailed 
study on the modifications of HAdV and PR772 major capsid proteins after exposure to chlorine 
and chloramines would be beneficial to understanding disinfection mechanisms.  The major 
capsid proteins are crucial during entry processes for both viruses.  These major capsid protein 
structural similarities may be the reason why HAdV-2 and PR772 are inactivated at nearly the 
same rate by free chlorine, and yet HAdV-2 resistance to monochloramine disinfection may be 
due to the eukaryotic virus having a more complex protein structure than PR772.  Investigating 
the complex viral entry process and determining the structural or chemical modification that 
leads to inactivation is necessary to fundamentally understand virus inactivation by disinfectants.  
 
6.3.7  Practical Implications 
This study has practical implications for detection and control of viruses in drinking water.  In 
comparison to HAdV-2, PR772 is less complex.  Thus, identifying disinfection mechanisms for a 
simpler virus can be informative when tackling the molecular disinfection of HAdV-2.  To gain 
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valuable information from bacteriophages, it is optimal to use a bacteriophage with highly 
similar morphology and replication cycle events to the enteric virus of interest to draw parallels 
in mechanistic studies.  Since PR772 and HAdV have many similarities, furthering the 
comparative mechanistic studies of PR772 and HAdV-2 could help elucidate the molecular 
target of HAdV inactivation by disinfectants.  Overall, a more fundamental understanding of 
virus inactivation will have benefits for developing robust treatment techniques and methods for 
rapid detection of infectious viruses in water ensuring safe drinking water globally.  	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6.4  Figures and Tables  
Table 6.1.  Experimental conditions for monochloramine disinfection of bacteriophage PR772. 
pH Temp (°C) Reactor 
C0 
(mg/L as Cl2) 
Caverage  





6 5 1 mM CBS 1.31 1.26 4.54E+06 7.8 
6 5 1 mM PBS 1.36 1.31 3.12E+06 22.7 
7 5 1 mM CBS 2.97 2.89 5.19E+05 3.5 
7 5 1 mM CBS 1.29 1.25 4.54E+06 8.0 
7 5 1 mM PBS 1.28 1.27 3.76E+06 24.1 
7 5 1 mM PBS 1.49 1.43 3.98E+06 20.7 
8 5 1 mM CBS 3.06 3.02 2.60E+06 3.4 
8 5 1 mM CBS 3.23 3.14 6.63E+06 3.2 
9 5 1 mM CBS 9.83 9.47 3.75E+06 3.1 
9 5 1 mM CBS 10.58 10.56 3.68E+06 2.9 
10 5 1 mM CBS 9.80 9.67 2.38E+06 3.1 
10 5 1 mM CBS 9.69 9.52 4.25E+06 3.2 
10 5 1 mM CBS 10.37 10.18 4.29E+06 3.0 
6 15 1 mM CBS 2.99 2.95 9.06E+05 3.4 
6 15 1 mM CBS 1.30 1.25 5.75E+06 7.9 
7 15 1 mM CBS 3.09 3.02 1.68E+06 3.3 
7 15 1 mM CBS 1.24 1.23 5.75E+06 8.3 
8 15 1 mM CBS 2.68 2.69 7.75E+05 3.8 
8 15 1 mM CBS 2.33 2.25 1.34E+06 4.4 
8 15 1 mM CBS 1.31 1.30 1.16E+06 7.8 
8 15 1 mM CBS 9.79 9.56 7.38E+05 3.2 
8 15 1 mM CBS 3.06 3.08 8.63E+04 3.4 
8 15 1 mM CBS 2.97 3.06 9.50E+03 3.5 
*8 15 1 mM CBS 3.11 3.02 9.75E+06 3.3 
*8 15 1 mM CBS 3.14 3.05 1.10E+07 3.3 
*8 15 1 mM CBS 2.99 3.01 1.15E+07 3.4 
9 15 1 mM CBS 3.25 3.37 1.53E+06 3.2 
9 15 1 mM CBS 2.85 2.49 1.65E+06 3.6 
10 15 1 mM CBS 2.97 2.90 1.66E+06 3.5 
10 15 1 mM CBS 2.68 2.68 1.41E+06 3.8 
6 30 1 mM CBS 1.25 1.20 3.88E+06 8.2 
6 30 1 mM CBS 1.25 1.19 3.88E+06 8.2 
7 30 1 mM CBS 1.27 1.24 1.45E+06 8.1 
7 30 1 mM CBS 1.24 1.21 7.00E+06 8.3 
8 30 1 mM CBS 2.80 2.78 7.81E+05 3.7 
8 30 1 mM CBS 2.95 2.82 1.19E+06 3.5 
9 30 1 mM CBS 2.68 2.60 1.05E+06 3.8 
9 30 1 mM CBS 2.90 2.89 1.21E+06 3.5 
9 30 1 mM CBS 3.04 2.93 9.00E+06 3.4 
10 30 1 mM CBS 2.87 2.87 1.53E+06 3.6 
10 30 1 mM CBS 2.78 2.67 1.26E+06 3.7 
*Indicates experiments used for qPCR based studies. 
 




Figure 6.1.  Effect of pH from 6-10 on the inactivation kinetics of PR772 by monochloramine at 
5 °C (left), 15 °C (center), and 30 °C (right).  Replicate experiments are indicated with different 
symbols.  (Top) Inactivation kinetics from pH 6-10 and (bottom) horizontal axis expanded for 
ease of comparing model and data at pH 6-8.    	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Figure 6.2.  Comparison of the survival ratio obtained by plaque assay (N/N0) for PR772 
subjected to increasing monochloramine exposure (0-12 mgCl2×min/L) to the relative quantity of 
P12 and P3 genes (P12/P120 and P3/P30) to investigate genomic DNA amplicon integrity (top) 
and attachment to E. coli and genomic DNA replication from 0-3 h p.i. (bottom).  Relative 
quantities for each virus sample are calibrated to the untreated control at CT = 0 and linear 
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Figure 6.3.  Absolute quantification of PR772 genomic DNA from 0-3 h p.i for untreated viruses 
(N/N0 = 1) and viruses subjected to increasing monochloramine exposure (N/N0 = 0.47-0.00036). 
Genome equivalents were calculated by averaging P12 and P3 DNA copies, and the error bars 
represent the standard deviation.  indicates samples where DNA copies did not statistically 
increase above the baseline copies at 0 h.  
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Figure 6.4.  Absolute quantification of PR772 P12 mRNA (top) and P3 mRNA (bottom) per 0.5 
µg of total RNA measured after 20, 40, 60, and 80 min p.i. for untreated viruses (N/N0 = 1) and 
viruses subjected to increasing monochloramine exposure (N/N0 = 0.47-0.00036).   
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Figure 6.5.  Comparison of the survival ratio obtained by plaque assay (N/N0) for PR772 
subjected to increasing monochloramine exposure (0-12 mgCl2×min/L) to the relative quantity of 
early P12 and late P3 mRNA transcription from 20-80 min p.i.  Relative quantities for each virus 
sample are calibrated to the untreated control at CT = 0 and linear regressions are shown for 
clarity only.        
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CHAPTER 7. CONCLUSIONS AND FUTURE WORK 
7.1 Summary of Research  
The overall research objective was to gain a better understanding of the mechanisms of HAdV-2 
inactivation by drinking water disinfectants.  This was achieved by developing quantitative 
methods to study the HAdV-2 replication cycle as well as a highly similar bacteriophage, PR772.  
Prior to this research, mechanistic studies of HAdV-2 inactivation by free chlorine or 
monochloramine could only analyze virus inactivation up to 90% and studied one post-infection 
time.1, 2  The methods developed in this research allowed the HAdV-2 and PR772 replication 
cycles to be analyzed for viruses inactivated up to 99.99% and at various times throughout the 
replication cycle.  Overall this research elucidated that exposure to chlorine-based disinfectants 
resulting in up to 99.99% inactivation interferes with HAdV-2 and PR772 replication cycle 
events that occur post-binding but prior to early viral protein synthesis.  This suggests that 
chlorine-based disinfectants caused capsid protein modifications that lead to the inhibition of 
viral entry.   
 
The major findings of this research were:  
1.  The inactivation kinetics of bacteriophage PR772 after free chlorine treatment were 
characterized over a range of pH 8.7 to 10.0 and temperatures at 1, 14, and 30 °C.  The 
inactivation kinetic curve trends were very similar to HAdV-2 as well as the exposure required to 
achieve 4-log inactivation.  Like HAdV-2, PR772 is highly susceptible to free chlorine 
disinfection, and under all conditions studied a CT of less than 2 mgCl2×min/L could achieve 4-
log inactivation of PR772.  The three-phase kinetic model developed for HAdV-2 inactivation by 
free chlorine was simplified to a two-phase expression for PR772 and was found to be a good fit 
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for the experimental results.  PR772 was a good surrogate for HAdV-2 inactivation by free 
chlorine and the mechanism of inactivation by free chlorine may be the same for these highly 
similar viruses.  
 
2.  In a comparative study, the inactivation kinetics of HAdV-2 and PR772 by preformed 
monochloramine were characterized from pH 6-10 and temperatures of 5, 15, and 30 °C.  
Surprisingly, both viruses underwent similar trends of inactivation characterized by a relatively 
rapid phase of inactivation followed by a slower phase of inactivation.  Their similar inactivation 
behavior led to the development of the same two-population kinetic model for both viruses with 
different fitting parameter values.  HAdV-2 was found to be much more resistant to inactivation 
by monochloramine than PR772 for all conditions studied, typically by at least an order of 
magnitude.  The exposure of monochloramine necessary to achieve 4-log inactivation for both 
viruses was orders of magnitude larger than the exposure required for free chlorine.     
 
3.  A quantitative assay was developed and tested to analyze several steps in the HAdV-2 
replication cycle in A549 host cells after increasing disinfectant exposure.  Primers were 
designed to target two genes in the HAdV-2 genome as well as a housekeeping gene in A549 
cells.  The integrity of these genomic amplicon regions before and after disinfection was verified 
using quantitative polymerase chain reaction (qPCR).  The HAdV-2 infection was synchronized 
and total DNA and mRNA were extracted at various times post infection.  qPCR was used to 
detect HAdV-2 genomic DNA as a means to quantify viral attachment to host cells as well as 
genome replication of untreated and treated virions.  Reverse transcription qPCR (RT-qPCR) 
was used to quantify transcription of the first early gene (E1A) and late hexon genes.  The 
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quantitative method developed could detect differences throughout the range of HAdV-2 
inactivation from no treatment, to relatively low inactivation (e.g., 1-log), and up to high 
inactivation (e.g., 4-log).      
 
4. A parallel quantitative assay was developed and tested to analyze several steps in the PR772 
replication cycle in E. coli.  Primers were designed to amplify two regions of the PR772 genome 
to quantify the number of PR772 genome copies and viral mRNAs throughout the replication 
cycle as well as a housekeeping gene in E. coli.  The genomic regions selected were for an early 
gene, P12, similar in location and function to the HAdV-2 E1A gene, and a late gene, P3, similar 
in location and function to the major capsid protein hexon in HAdV-2.  Attachment to E. coli 
was quantified by extracting total DNA from virus-bound bacteria that were treated with 
chloramphenicol.  qPCR and RT-qPCR were used to quantify viral DNA replication and mRNA 
transcription throughout the PR772 replication cycle.  This assay developed could distinguish a 
range of PR772 exposure to disinfectants from untreated to highly inactivated.             
 
5.  Free chlorine and monochloramine did not damage the regions of the HAdV-2 and PR772 
genome studied.†††  Both free chlorine and monochloramine inactivation by up to 99.99% did not 
affect amplification of the E1A and hexon regions of the HAdV-2 genome or the P12 and P3 
regions of the PR772 genome.  The viral DNA amplified consisted of only 0.6% of the HAdV-2 
genome and 1.41% of the PR772 genome.  
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
†††Analysis of the viral replication cycles of HAdV-2 and PR772 were conducted after 
inactivation by free chlorine at pH 9.2, 14°C or monochloramine at pH 8.0, 15°C.   
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6.  Viruses inactivated by free chlorine or monochloramine up to 99.99% were still able to bind 
to host cells.  Untreated and treated HAdV-2 could attach to A549 cell monolayers, and PR772 
could bind to chloramphenicol treated E. coli.   
 
7.  Inactivation by chlorine-based disinfectants was found to inhibit viral genome replication.  
Untreated HAdV-2 increased the amount of viral DNA copies by nearly 104-fold from 4 to 36 h 
post-infection (p.i.).  Free chlorine or monochloramine-treated HAdV-2 did produce DNA copies 
but less than the untreated control.  There was statistical correlation between the decrease in viral 
titers measured by plaque assay and a decrease in relative genomic DNA copies at 24 and 36 h 
p.i.  Similar trends were observed for PR772 genome replication.  The relative quantity of viral 
DNA produced after one infection cycle at 1 h p.i. by PR772 subjected to increasing disinfectant 
exposure statistically correlated with the inactivation of PR772 determined by plaque assay.        
 
8.  Transcription of the late mRNA responsible for the major capsid protein for HAdV-2 and 
PR772 was inhibited by free chlorine and monochloramine disinfection.   Untreated HAdV-2 
increased the amount of hexon mRNA by over 107-fold by 36 h p.i.  Free chlorine or 
monochloramine treated viruses steadily increased the amount of hexon mRNA transcribed but 
produced fewer copies than the untreated control.  A correlation was observed between the 
decrease in viral titers and a decrease in mRNA synthesis at 24 and 36 h p.i.  Similar trends were 
observed for free chlorine and monochloramine treated PR772. Untreated PR772 increased the 
amount of P3 mRNA by over 103-fold at 60 min p.i., but treated PR772 produced less P3 
mRNA.  By 40 min p.i., PR772 inactivation measured by plaque assay correlated with the 
relative quantity of P3 mRNA transcribed after inactivation by free chlorine or monochloramine.     
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9.  Transcription of the first early gene (E1A) in HAdV-2 and early P12 gene in PR772 was 
inhibited by free chlorine and monochloramine disinfection.  Untreated HAdV-2 transcribed 105 
copies of E1A mRNA per 0.5 µg of total RNA by 12 h p.i., and E1A mRNA production leveled 
off at this point as the virus was transitioning into the late stage of infection.  Similarly, P12 
mRNA transcription for PR772 also leveled off by 40 min p.i. with nearly 103.5 copies produced.  
Inactivation by free chlorine or monochloramine caused a decrease in early mRNA production, 
and fewer copies of early mRNAs were observed at all times post infection.  The relative 
quantity of early E1A or P12 mRNA correlated to the survival ratio of HAdV-2 or PR772, 
respectively, measured by plaque assay.    
 
10.  Free chlorine or monochloramine inactivated both HAdV-2 and PR772 by inhibiting a 
replication cycle event that occurs post-binding but before or at early mRNA transcription.   
 
7.2 Practical Implications 
7.2.1 Adenovirus Control 
Monochloramine is known to be a weaker disinfectant than free chlorine, and this research 
detailed HAdV-2 resistance at many environmental pH and temperature conditions.  HAdV is the 
most resistant virus to monochloramine disinfection, and free chlorine is recommended over 
monochloramine to achieve 99.99% inactivation of HAdV-2.  The CT values recommended by 
the USEPA for chloramines are insufficient for HAdV inactivation.  For example, the CT values 
recommended for 4-log inactivation are 1988 mgCl2×min/L at 5 °C and 994 mgCl2×min/L at 15 
°C for pH values of 6 to 9.3, 4  This research determined at pH 9 a dosage of nearly 13,000 
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mgCl2×min/L was needed at 5°C and over 5000 mgCl2×min/L at 15 °C to achieve 4-log 
inactivation of HAdV-2.  Overall, this study included a comprehensive set of inactivation 
kinetics of HAdV-2 by monochloramine that can be useful for control of HAdV-2 in drinking 
water.           
 
7.2.2 Appropriate Surrogates 
This research identified PR772 as an appropriate surrogate for HAdV-2 inactivation by free 
chlorine.  Additionally, PR772 can be useful in elucidating the mechanisms of HAdV-2 
inactivation by monochloramine because of their similar inactivation kinetic behavior.  All of the 
viruses present on the USEPA contaminant candidate list are small (~30 nm) with positive sense 
single-stranded RNA genomes (~8 kbp) except HAdV.5, 6  Using bacteriophage MS2 as a 
surrogate for these viruses is logical because of its similar size and small single-stranded RNA 
genome.  HAdV, however, is very different because of its larger size and double-stranded DNA 
genome, perhaps causing HAdV to be the most resistant CCL virus to monochloramine 
disinfection and the least resistant to free chlorine.  PR772 was chosen as a potential surrogate 
because of its similarities in size, morphology, and replication strategies compared to HAdV, and 
both the phage and host are biosafety level one organisms.  Studying PR772 in parallel with 
HAdV-2 has given further insights into dsDNA virus inactivation by chlorine disinfectants.          
 
7.2.3 Virus Detection 
The results of this study have practical implications for virus detection.  Most likely HAdV-2 
inactivation by chlorine disinfectants is due to a modification on the protein capsid leading to 
inhibition in the entry process.  An understanding of the modification leading to inactivation will 
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enable the development of novel molecular sensors to detect infectious HAdV in drinking water.7 
This research has included beginning the selection process for an aptamer that binds with high 
specificity and selectivity to infectious adenoviruses, and the experimental methods developed 
included working with the entire complex viral structure.  If the molecular target were known, 
the aptamer selection process could be much simpler by selecting only against the protein and 
modification of interest.  Once an apatmer is identified, it can be complexed into a sensor to 
detect infectious HAdV-2 in water.  The development of sensors would then allow for HAdV to 
become regulated in the future.       
 
7.3 Future Work Recommendations 
The results of this work have identified that HAdV-2 and PR772 inactivation by free chlorine or 
monochloramine inhibited a step in the replication cycle that occurs post-binding but prior to 
early protein synthesis.  In order to determine the molecular target of inactivation, further 
replication cycle analyses are necessary, as well as detailed molecular studies of HAdV protein 
and genome damage.  Lastly, the methods developed in this work can be used to identify what 
stage of the HAdV-2 and PR772 replication cycles are inhibited by other disinfectants like 
ultraviolet light or ozone.   
 
7.3.1 HAdV-2 Replication Cycle Analysis 
Molecular assays could be developed to target specific replication cycle events that occur post-
binding but prior to early mRNA production to better understand what stage of the HAdV-2 
entry process becomes inhibited after chlorine exposure.  This research has determined that the 
virus was still able to attach to cell monolayers, but perhaps free chlorine inhibited the virus 
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entering the host cell.  Assays could be developed to assess adenovirus secondary attachment and 
entry, such as determining the affinity of the RGD loop of the penton base binding to an integrin 
to trigger receptor-mediated endocytosis.  Lower binding affinity would signify damage to the 
adenovirus capsid and a potential delay or inhibition of entering.  Binding affinity between the 
HAdV-2 penton base and cellular integrins could be measured using surface plasmon resonance.  
As part of this research, recombinant HAdV-2 penton base, fiber, and hexon proteins have been 
produced.  After the penton base binds with an integrin, fiber proteins detach from the viral 
capsid.  Being able to quantitatively measure extracellular fiber that is not bound to virions could 
determine if adenovirus is able to enter.  Lastly, radiolabeled adenovirus could be used with 
liquid scintillation counting to determine if adenovirus has not attached, has attached to host 
cells, or has entered the host cell before and after disinfection.  This is a typical method used to 
study virus replication cycle events; however, it is preferable to continue using unaltered 
adenoviruses for studying replication cycle events. 
   
If an inactivated adenovirus population is still able to enter the host cell at the same rate as 
infectious adenoviruses, the viruses may be getting trapped in the endosome.  Protein integrity is 
crucial during this step where several adenovirus capsid proteins must detach and allow protein 
VI to escape from the virion.  As the endosome becomes acidified, a conformational change is 
triggered in the capsid proteins causing the peripentonal hexons, penton base, protein IIIa, and 
protein VI to be removed from the capsid structure with the help of the p23 viral protease.  
Protein VI is responsible for endosomal lysis allowing the partially disassembled particles to be 
released into the cytoplasm.  One possible way to quantitatively determine if HAdV-2 is able to 
escape the endosome is by using the ribosomal toxin saporin.8 Saporin could be first added to a 
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cell monolayer, and as the virus undergoes endocytosis part of the surrounding fluids also enter 
the endosome.  If HAdV-2 can escape the endosome, saporin will also enter into the host cell and 
ultimately cause cell death.  If the virus is unable to escape the endosome, the host cell will 
survive, which can be measured using a colorimetric MTT assay.  Developing a method to 
quantitatively measure disassembly of pentons, protein IIIa, and especially protein VI would also 
help in elucidating the mechanism of inactivation. 
 
The last major entry event to determine if inactivated HAdV-2 is able to complete its replication 
cycle is nuclear import.  Viral DNA import into the nucleus is known to be a limiting step of 
HAdV infection.9 After escape from the endosome, HAdV-2 must traverse on microtubules and 
dock on the nuclear pore complex.  The dsDNA genome must unravel to allow genome injection 
with protein VII into the nucleus.  These are complex life cycle events that would currently be 
difficult to measure quantitatively. Subcellular fractionation can separate the cytoplasm from the 
nucleus of A549 cells.  Using this method, western blotting could be used to determine if protein 
VII enters the nucleus.  Additionally, the qPCR based-assay developed in this research could be 
used to track nuclear entry of the genome utilizing a time course if attached virions that are 
unable to enter can be removed from the cell membrane.  Preliminary research during this work 
has been unsuccessful in removing bound viruses using proteases including subtilisin, pronase, 
and trypsin.  Both protein modifications, especially to the hexon and protein VII, as well as 
genome damage could prevent the genome from entering into the nucleus.     
 
7.3.2 HAdV-2 Protein or Genome Modifications 
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Determining what stage in the entry process becomes inhibited would provide a greater 
understanding of the target of inactivation by disinfectants.  Table 7.1 shows examples of protein 
modifications that could cause inhibition of specific HAdV replication cycle events.  For 
example, if the virion is unable to enter to the host cell, perhaps the RGD motif on the penton 
base has been modified and therefore unable to interact with the secondary receptor integrins.  
As the virus is exposed to increasing doses of chlorine, most likely many protein residues 
become increasingly damaged.  Determining which modification results in the virus becoming 
inactivated by chlorine is needed.  Hypochlorous acid can cause chlorination of amino acids and 
peptides or oxidation of amines, α-amino groups, and lysine.10 Reactions can result in formation 
of secondary products like organic monochloramines and dichloramines, carbonyl products, and 
aldehydes that can also undergo subsequent reactions and lead to viral damage.  The rates of 
chlorine transfer reactions to specific amino acids by monochloramine are roughly five orders of 
magnitude lower than those by hypochlorous acid.10 The established rate constants and reaction 
products could predict HAdV damage based on the abundance of specific amino acids and their 
location with respect to key residues involved in adenovirus life cycle steps; however, protein 
secondary and tertiary structure also play a role in determining if these sites are accessible to 
disinfectants and their secondary reactions. 
 
HAdV has a complex protein structure.  Analyzing the structure in its entirety is very challenging 
because some proteins are quite abundant, like hexon, but only a few copies are present for 
others, making it difficult to analyze all proteins with the same resolution by mass spectrometry 
techniques.  Conversely, studying changes to a purified recombinant protein after chlorine 
disinfection may give misleading results as only some residues may be accessible to the 
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disinfectant in the actual viral particle, protein-protein interactions may result in secondary 
reactions damaging the protein of interest, and conformational changes relative to the entire viral 
particle may be quite different than ones observed in purified proteins. This research has also 
resulted in producing recombinant HAdV-2 hexon, penton base, and fiber expressed in E. coli.  
These proteins were exposed to free chlorine and modifications were observed by mass 
spectrometry.  Plasmids could be designed in the future to produce additional proteins of interest 
using the same Novagen pET expression system in E. coli.  The gene of interest could be 
synthesized and cloned into a pet-29b+ plasmid.  This plasmid conveys kanamycin resistance 
and adds a His-tag for protein purification.  Highly concentrated and purified proteins could be 
subjected to chlorine disinfectants and then analyzed for protein integrity.  Using high-
performance liquid chromatography tandem mass spectrometry (HPLC-MS/MS) chemical 
changes in amino acids such as oxidation and chlorination can be determined after disinfectant 
exposure.  Additionally, HPLC-MS/MS can elucidate protein cleavage sites.  If specific residues 
were modified that correlate to a key replication cycle step inhibited, this could result in the loss 
of function of the protein.  Methods could be developed to analyze the two-dimensional and 
three-dimensional conformational changes of individual proteins and the entire virus structure.  
Recent advances in cryo-electron microscopy have enabled adenovirus to be studied at very high 
resolution.11 Solving the crystal structure of adenovirus after chlorine inactivation would be a 
very challenging but exciting endeavor.  Highly sensitive technologies like cryo-EM will be 
necessary to determine protein chemical and structural damage after exposure to disinfectants.         
 
If the HAdV genome can still enter the nucleus or if entry at the nuclear pore complex was 
inhibited, HAdV genome damage would need to be comprehensively assessed.  Hypochlorous 
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acid is known to damage DNA by two main processes with nucleobases being the major 
targets.12 HOCl reacts rapidly with heterocyclic NH-groups on guanine and thymine, and also 
HOCl slowly reacts with amino groups of adenine, guanine, and cytosine.  This results in the 
generation of a nitrogen-chlorine bond as the hydrogen atom is substituted by chlorine.  Second, 
stable chlorinated products are formed by carbon-chlorine bonding in the aromatic ring.  These 
reactions are much slower, however, compared to reactions with amino acids.  Because of these 
reactions, HOCl can cause dissociation of the DNA double helix due to loss of hydrogen bonding 
between bases.  An ethidium bromide binding assay could be developed for HAdV to investigate 
if free chlorine has caused denaturation to the adenovirus genome.13 Ethidium bromide 
intercalates into DNA and the fluorescence can be quantified.  A loss of signal after free chlorine 
exposure would convey DNA denaturation.  Denaturation could lead to issues in nuclear delivery 
and subsequent replication cycle steps.     
 
Determining if the viral genome has been damaged and the location of the damage is very 
difficult for viruses with more than a few thousand bases.  A typical qPCR amplicon is less than 
150 bp or less than 0.5% of the entire HAdV genome.  There have been few previous studies 
looking at damage to long stretches of the HAdV genome,14 but to date there has been no method 
developed to analyze damage to the genome in its entirety.  A qPCR based approach would be 
the most quantitative to determine the specific location of genome damage.  Genome damage 
could prevent transcription of mRNAs, DNA replication, and potentially disrupt nuclear import 
of the genome.   
 
7.3.3 Other Disinfectants and Viruses 
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Methods developed in this research can be used to identify what stage of the HAdV-2 and PR772 
replication cycles are inhibited by other drinking water disinfectants.  Additionally, a similar 
qPCR-based assay could be developed for other CCL viruses of interest.  The long-term goals of 
this area of research are to comprehensively understand how viruses of different families become 
inactivated by drinking water disinfectants.  The mechanisms of inactivation will most likely be 
different for each virus family and different for each disinfectant.  Within the same family, virus 
serotypes can have varying resistance to a disinfectant, and perhaps their mechanism of 
inactivation could be unique.  An understanding of how viruses become inactivated would enable 
the development of sensitive assays and methodologies to work with viruses that currently are 
impossible or difficult to culture, like human norovirus and HAdV-40 and -41. Methods are 
needed to determine what dosages of disinfectants are necessary to render uncultureable viruses 
noninfectious.  Additionally, if specific protein residues or nucleotides that are targets for a 
disinfectant are elucidated, sensors could be developed to detect infectious viruses in drinking 
water.  Identifying these targets is extremely important for development of reliable sensors, and 
rapid, easy-to-use sensors would facilitate the regulation of specific viruses.  Overall, a greater 
understanding of virus disinfection is necessary for better detection and control of viruses in 
drinking water globally.   
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Table 7.1. Examples of HAdV-2 replication cycle events that could be inhibited due to damage 
to specific proteins. 
 
Life cycle step 




Fiber knob Loss of attachment affinity to CAR 
Fiber shaft Conformational changes do not allow bending, no binding of penton base with integrins 
Penton base RGD loop Unable to bind to integrins, cannot undergo endocytosis 
Fiber Unable to detach, entry/endosomal escape inhibited 
Endosomal escape 
Penton, peripentonal hexons, IIIa Damage to viral capid does not allow disassembly, VI trapped 
VI Unable to lyse endosome 
Nuclear import 
Hexons, reminaing protein 
structure Inability to traverse on micotubules, unable to dock on nuclear pore complex 
VII Unable to import genome 
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APPENDIX A.  SUPPORTING INFORMATION FOR CHAPTER 3‡‡‡  
A.1  Adenovirus Propagation and Viability Assessment  
HAdV-2 (VR-846) was propagated using human lung A549 carcinoma cells (CCL-185) obtained 
from the American Type Culture Collection (Manassas, VA). Detailed methods for adenovirus 
propagation and viability assessment as well as cell culture growth were described previously.1 
Briefly, A549 cellular monolayers were propagated in flasks in a nutrient media containing a 
modified Ham’s F12K growth media supplemented with 10 % fetal bovine serum (FBS), 0.25 
µg/mL amphotericin B, 100 units/mL penicillin, and 10 µg/mL streptomycin (Sigma-Aldrich, St. 
Louis, MO), and placed in a 5% CO2 incubator at 37 °C. Viruses were propagated by inoculating 
stock adenovirus solutions onto cellular monolayers, incubating the flasks until cytopathic effects 
were observed, and were released by three freeze-thaw cycles.  Cellular lysates were centrifuged 
at 2000 rpm for 15 min and virus-containing supernatants were removed and passed through a 
0.22 µm microfilter to remove large debris (Millipore, Billerica, MA). The virus suspension was 
washed several times with 200 mL 1 mM carbonate buffer solution (CBS) using a 300 kDa 
ultrafiltration membrane (Millipore) in an Amicon stirred cell to remove small molecules and 
proteins.  Virus stocks were aliquoted and stored at -80 °C in 1 mM CBS at pH 8.3. Virus 
infectivity was measured using a plaque assay in which virus was inoculated onto A549 cellular 
monolayers with a nutrient mixture and soft agar overlay. Plates were incubated at 37 °C, and 
plaques were quantified at 7 and 10 days post-infection.      
 
A.2  Free Chlorine Disinfection Experiments 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ‡‡‡	  Supporting information from Gall, A. M.; Shisler, J. L.; Mariñas, B. J., Analysis of the Viral 
Replication Cycle of Adenovirus Serotype 2 after Inactivation by Free Chlorine. Environ. Sci. 
Technol. 2015, 49 (7), 4584-4590.	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Free chlorine disinfection experiments were performed using two batch reactors as described 
previously2 with slight modifications.  Batch reactors used for free chlorine disinfection 
experiments contained a 100 mL volume of 1 mM CBS continuously stirred by magnetic mixing 
in a temperature controlled water bath at 14 °C.  The pH was adjusted using 0.1 M sodium 
hydroxide to 9.2, and the temperature and pH of the reactor was measured before and after each 
experiment to verify stability.  The initial dose of chlorine was determined using a control reactor 
containing only buffer and the addition of sodium hypochlorite.  In the second reactor, HAdV-2 
was added and allowed time to acclimate to the pH and temperature of the reactor.  A control 
HAdV-2 sample (N0) was taken before the addition of sodium hypochlorite to quantify the initial 
virus concentration.  A volume of sodium hypochlorite solution same as the control reactor was 
then added to the second reactor.  Virus samples were taken from the reactor, and the chlorine in 
the sample was quenched using 0.1% sodium thiosulfate. The time of quenching was recorded as 
the sample time. Additional samples were measured throughout the experiment to monitor the 
decay of free chlorine.   
 
A.3  PCR Data Analysis  
A.3.1 Relative Quantification 
For analysis of data generated from qPCR and RT-qPCR assays, relative and absolute 
quantification was used based on values obtained for the quantification cycle, Cq. The relative 
expression level, R, was determined using the ΔΔCq method using the following expression:  𝑅 = 2!∆∆!! = 2!(∆!!,sample!∆!!,calibrator) 
where the values ΔCq are obtained as ΔCq = (Cq,sample - Cq,β-actin). 
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For each analysis, the calibrator was the untreated virus sample (N0). The relative expression 
level, R, is represented as E1A/E1A0 for the relative quantity of E1A DNA or mRNA and 
Hexon/Hexon0 for the relative quantity of hexon DNA or mRNA in Figures 3.2 and 3.5 for ease 
of comparison with the survival ratio, N/N0.    
 
A.3.2 Absolute Quantification 
For absolute quantification, a standard curve was generated using dilutions of purified PCR 
amplicons generated from each primer set to correlate Cq values to log-copies as seen in Figure 
A.1. Linear regressions were used to determine the following expressions to calculate the 
absolute copy number for each primer set: 
E1A: Cq = -3.485×log10(number of gene copies)+36.43 (r2=0.99801)  
Hexon: Cq = -3.678×log10(number of gene copies)+37.99 (r2=0.99723)  
β-actin: Cq = -3.704×log10(number of gene copies)+38.38 (r2=0.99899)  
A sensitivity analysis showed that this qPCR and RT-qPCR assay reliability detected as low as 





Figure A.1.  Standard curve generated from purified PCR amplicons. 
 
A.4  Inactivation Kinetics 
Figure A.2 shows HAdV-2 inactivation kinetics for all disinfection experiments performed here.  
The free chlorine exposure (CT) and resulting survival ratio (N/N0, where N is the number of 
infectious viruses after treatment, and N0 is the initial HAdV-2 concentration) are shown for pH 
9.2 at a temperature of 14 °C.  This experimental condition was chosen because it represents a 
mid-range temperature encountered in source waters, and gives conditions to obtain kinetics 
throughout 4-log inactivation using a batch reactor. CT values were calculated using a first-order 
decay model described previously.2 The kinetics were consistent with a previous study at this pH 
and temperature condition,2 where 2-log inactivation occurs at a CT of 3 mg×min/L and 4-log 
inactivation is achieved by 0.7 mg×min/L. In subsequent figures, the relative qPCR data is 
shown for at least three independent experiments with only the corresponding inactivation 
Number of gene copies










A549 cell -Actin gene
	  	   142 
kinetics.  The initial concentrations of free chlorine (C0) and HAdV-2 (N0), and the decay rate 
constants (kd) for free chlorine are summarized in Table A.1. 
 
Figure A.2.  Inactivation kinetics of HAdV-2 by free chlorine at pH 9.2, 14°C.  Each experiment 
is represented by a different symbol.   
 
Table A.1.  Experimental conditions for disinfection experiments. 
Experiment Virus dose,  N0 (PFU/ml) 
Chlorine concentration 
(mg/l as Cl2) kd (min-1) r2 
Dose C0 
1 7.50E+05 0.549 0.507 0.109 0.997 
2 2.01E+06 0.494 0.451 0.122 0.988 
3 5.13E+05 0.504 0.449 0.169 0.974 
4 6.88E+05 0.538 0.514 0.151 0.942 
5 3.86E+05 0.532 0.559 0.168 0.948 
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APPENDIX B:  SUPPORTING INFORMATION FOR CHAPTER 4§§§  
B.1 Free Chlorine Disinfection Experiments 
Free chlorine disinfection experiments were performed as described previously using 1mM 
carbonate buffer in batch reactors.1, 2 Experimental conditions over a range of temperature and 
pH are shown in Table B.1.  Temperature and pH were monitored at the beginning and end of 
each experiment, and temperature variance was within ± 0.5 °C.  All experiments began within ± 
0.05 pH units of the target pH.  Data was discarded from the model if pH shifted greater ± 0.17 
pH units from the target pH.  Nine virus stocks were used (A-I) throughout the kinetic study 
along with a range of initial virus dose (N0 = 2.71E+05 to 8.50E+07 PFU/mL) and a range of 
initial doses of free chlorine (0.307-0.934 mg/L as Cl2).  The chlorine concentration was 
continuously monitored throughout the duration of the experiment using the N,N-diethyl-p-
phenylenediamine colorimetric method.3 For most experiments, CT values were calculated using 
a first order decay model (equation B.1) as described previously,2 and the decay rate constants 
C0, kd, and r2 are shown in Table B.1.  For some experiments the r2 was low for equation B.1, 
and the free chlorine concentration was better modeled by taking the arithmetic average of the 
measured chlorine concentration (Caverage in Table B.1) shown in equation B.2.   𝐶𝑇 = 𝐶  𝑑𝑡!!! = 𝐶! 𝑒!!!!!𝑑𝑡′!! = !!!! (1− 𝑒!!!!)   (B.1) 𝐶𝑇 = !! 𝐶!!!!! 𝑡 =   𝐶!"#$!%#×𝑡    (B.2) 
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C0 is the initial free chlorine concentration, kd is the first-order decay constant of free chlorine, t 
is the time of exposure to free chlorine, and n is the number of chlorine concentration samples 
taken. 
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Table B.1. Experimental conditions for free chlorine disinfection experiments and free chlorine 
decay.  All experiments were performed in batch reactors with 1mM carbonate buffer.   





Virus           
stock 
Chlorine concentration              
(mg/l as Cl2) 
    




10.00 1 4.63E+05 A 0.377  0.356 0.021 0.556 10.00 1 8.13E+05 A 0.415  0.408 0.023 0.997 10.00 1 8.50E+05 A 0.390  0.391 0.020 0.604 10.00 1 3.61E+07 H 0.466  0.470 0.009 0.777 9.80 1 5.25E+05 A 0.377 0.342     9.80 1 1.13E+06 A 0.350  0.344 0.029 0.516 9.80 1 2.60E+07 H 0.383  0.352 0.013 0.965 9.60 1 4.28E+06 A 0.640  0.472 0.032 0.851 9.60 1 3.72E+06 A 0.640  0.446 0.067 0.940 9.60 1 7.00E+05 A 0.420 0.376     9.20 1 1.15E+06 A 0.461  0.311 0.124 0.852 9.20 1 1.06E+06 A 0.423 0.401     9.20 1 1.28E+06 A 0.415 0.373     9.20 1 6.38E+07 H 0.413  0.392 0.015 0.992 9.00 1 9.50E+05 A 0.610 0.595     9.00 1 1.45E+06 A 0.478 0.449     9.00 1 1.56E+07 A 0.668  0.348 0.779 0.877 8.70 1 5.75E+05 A 0.307  0.305 0.112 0.666 8.70 1 4.88E+07 H 0.383  0.334 0.015 0.868 10.00 14 5.63E+05 B 0.428  0.370 0.027 0.998 10.00 14 1.28E+06 B 0.442  0.362 0.025 0.890 10.00 14 9.88E+05 B 0.452  0.333 0.052 0.794 10.00 14 2.71E+05 C 0.675  0.474 0.055 0.712 10.00 14 4.63E+07 H 0.385  0.354 0.009 0.594 9.80 14 7.75E+05 B 0.452  0.340 0.059 0.824 9.80 14 1.46E+06 B 0.464  0.371 0.033 0.966 9.60 14 9.63E+05 A 0.404  0.398 0.032 0.744 9.60 14 1.51E+06 A 0.448 0.411     9.60 14 3.56E+05 C 0.675 0.422     9.20 14 1.70E+06 A 0.448 0.410     9.20 14 1.33E+06 A 0.415 0.416     9.20 14 8.13E+05 B 0.428  0.360 0.009 0.989 9.20 14 7.63E+07 H 0.385  0.351 0.019 0.969 *9.20 14 8.88E+06 I 0.459  0.375 0.049 0.902 *9.20 14 7.38E+06 I 0.399  0.315 0.047 0.936 *9.20 14 8.75E+06 I 0.391  0.298 0.038 0.952 *9.20 14 4.88E+06 I 0.394  0.308 0.028 0.935 *Indicates experiments used for qPCR based studies 
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Table B.1. (continued)  Experimental conditions for free chlorine disinfection experiments and 
free chlorine decay.  All experiments were performed in batch reactors with 1mM carbonate 
buffer.   





Virus           
stock 
Chlorine concentration              
(mg/l as Cl2) 
    




8.70 14 6.88E+05 B 0.412  0.348 0.056 0.907 8.70 14 1.20E+06 B 0.442 0.330     8.70 14 8.50E+07 H 0.393  0.375 0.009 0.874 10.00 30 1.41E+06 B 0.433  0.328 0.034 0.918 10.00 30 2.04E+06 C 0.451  0.390 0.039 1.000 10.00 30 6.38E+06 C 0.619  0.407 0.065 0.992 10.00 30 6.00E+05 C 0.656  0.372 0.097 0.921 10.00 30 3.20E+07 H 0.375  0.349 0.014 0.960 10.00 30 8.00E+07 H 0.418  0.345 0.020 0.951 9.60 30 4.00E+05 A 0.318  0.281 0.062 0.823 9.60 30 1.14E+06 B 0.407  0.314 0.027 0.958 9.60 30 1.00E+06 B 0.433  0.329 0.061 0.925 9.60 30 8.88E+06 C 0.619  0.383 0.065 0.944 9.60 30 1.86E+07 F 0.516  0.358 0.031 0.937 9.60 30 1.70E+07 G 0.481 0.404     9.60 30 3.01E+07 H 0.375  0.342 0.017 0.914 9.60 30 4.13E+07 H 0.418  0.357 0.013 0.913 9.20 30 1.31E+06 B 0.412  0.334 0.064 0.812 9.20 30 8.88E+05 B 0.405 0.274     9.20 30 1.16E+07 D 0.934  0.427 0.174 0.937 9.20 30 1.11E+06 E 0.383  0.344 0.019 0.899 9.20 30 1.64E+07 F 0.516  0.361 0.033 0.975 9.20 30 1.46E+07 G 0.481  0.430 0.009 0.916 9.20 30 1.81E+07 G 0.567 0.392       
*Indicates experiments used for qPCR based studies. 
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Figure B.1. Comparative inactivation kinetics of PR772 with free chlorine obtained in this study 
to that reported for HAdV-22 at the same pH and temperature.    
CT (mgCl2×min/L)
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B.2 qPCR and RT-qPCR Data Analysis 
B.2.1  Quantitative PCR (qPCR) and Two-Step Reverse Transcriptase qPCR (RT-qPCR) 
To analyze the amount of P12, P3, or rpoD copies of DNA or mRNA present, qPCR and two-
step RT-qPCR was utilized.  All qPCR reactions contained 1 µL of template, a final 
concentration of 300 nM forward and reverse primers, and 1×SsoFast EvaGreen supermix 
(BioRad Laboratories, Inc., Hercules, CA) in a 10 µL total reaction volume.  For mRNA 
analysis, the resulting cDNA from the RT reaction was diluted 1:5 in DNase- and RNase-free 
water.  Reactions were performed in triplicate in a 96-well plate (Eppendorf) and loaded into a 
Mastercycler ep realplex (Eppendorf, Hauppauge, NY).  The qPCR cycles for genomic DNA 
consisted of enzyme activation for two minutes at 98 °C, then 40 cycles of denaturing at 98 °C 
for 5 s, annealing and extension at 56 °C for 10 s, and finally a melting curve ramping from 65 to 
95 °C.  The cycling conditions for cDNA were identical except for enzyme activation and 
denaturing steps were performed at 95 °C.  
 
B.2.2  Relative Quantification 
Data obtained from qPCR and RT-qPCR assays was analyzed for relative and absolute 
quantification using the quantification cycle, Cq, obtained for each gene in the sample.  The 
ΔΔCq equation was used to determine the relative expression level, R:  𝑅 = 2!∆∆!! = 2! ∆!!,sample!∆!!,calibrator   
where the values ΔCq are obtained as ΔCq,sample = (Cq,sample - Cq,rpoD), and the as ΔCq,calibrator = 
(Cq,N0 - Cq,rpoD for N0).  As noted, the housekeeping gene was rpoD and the calibrator was the 
untreated virus sample (N0).  The relative expression level, R, is represented for each PR772 gene 
as P12/P120 for the relative quantity of P12 DNA or mRNA and P3/P30 for the relative quantity 
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of P3 DNA or mRNA. The relative quantity of each gene is shown in Figures 4.2 (top and 
bottom plots) and 4.5 to compare directly with the survival ratio, N/N0.    
 
B.2.3  Absolute Quantification 
To determine the copy number of the gene in the sample, absolute quantification was used.  A 
standard curve was produced from serial dilutions of a known quantity of PCR purified 
amplicons for each primer set.  DNA positive standards were produced by conventional PCR 
amplifying regions of the PR772 and E. coli genomes using the primer sets for P12, P3, and 
rpoD.  The products were purified using the QIAquick PCR Purification Kit (Qiagen, Valencia, 
CA) and the integrity of the product was verified by agarose gel electrophoresis (data not 
shown).  The concentration of the purified products was measured using a Qubit Fluorometer 
with a Qubit dsDNA HS Assay Kit (Life Technologies, Carlsbad, CA), from which the molar 
concentration was then determined and the number of copies was calculated using Avogardo’s 
number.  
 
The serial dilutions of DNA positive standards were run on qPCR and the Cq was plotted with 
the known number of gene copies to produce Figure B.2.  Linear regressions were fit for each 
gene and the following equations were used to determine the number of gene copies in each 
sample:     
P12: Cq = -3.534×log10(number of gene copies)+36.01 (r2=0.998)  
P3: Cq = -3.370×log10(number of gene copies)+34.24 (r2=0.999)  
rpoD: Cq = -3.483 ×log10(number of gene copies)+34.11 (r2=0.997)  
	  	   151 
The efficiencies calculated for each gene were 91.9% for P12, 98.0% for P3, and 93.7% for 
rpoD. The qPCR and RT-qPCR assay can reliability detect as low as 2 copies of P12, P3, and 
rpoD DNA and cDNA determined by a sensitivity analysis. The rpoD gene was used as a 
housekeeping gene for all relative quantification analyses, and as a control, the absolute 
quantification of rpoD mRNA is shown to remain constant through all times post infection in 





Figure B.2.  Standard curve generated from PCR purified amplicons.  
Number of gene copies
















Figure B.3.  Absolute quantification of E. coli housekeeping gene rpoD mRNA copies per 0.5 
µg of total RNA determined by a standard curve (see Text B.2) measured after 20, 40, 60, and 80 
min p.i. in suspension with with untreated viruses (N/N0 = 1) and viruses subjected to increasing 
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APPENDIX C:  SUPPORTING INFORMATION FOR CHAPTER 5****  
C.1  Monochloramine Disinfection Experiments 
Monochloramine disinfection experiments were performed in 100 mL batch reactors using 
reagent grade chemicals in 1 mM carbonate buffered solution (CBS), 1 mM phosphate buffer 
solution (PBS), or 10 mM borate buffer solution (BBS) (see Table C.1).  These buffers were 
used for long-term pH stability, and HAdV-2 inactivation kinetics were comparable to 
experiments performed with CBS.  Monochloramine was preformed immediately before use by 
slow addition of 50 mL of sodium hypochlorite solution to 50 mL of ammonium chloride 
solution with vigorous stirring. Prior to virus addition, the initial monochloramine concentration 
(C0) was measured using the N,N-diethyl-p-phenylenediamine colorimetric method,1 and the 
absence of dichloramines and trichloramines was confirmed by UV-Vis spectroscopy.  Batch 
reactors were continuously stirred by magnetic mixing in a temperature controlled water bath, 
and temperature and pH were measured before and after each experiment to confirm stability.  
Immediately after virus addition, a virus sample was taken to determine the initial untreated virus 
concentration (N0).  Monochloramine was quenched in virus samples taken from the reactor 
using 0.1% sodium thiosulfate, and the time of quenching was recorded as the sample time.  A 
second reactor containing only buffered water and viruses was used to determine N0 for rapid 
inactivation kinetics.  The monochloramine concentration was continuously monitored 
throughout and no measureable decay was observed.  The average monochloramine 
concentration (see Table C.1) was used to calculate the CT.  The role of initial virus 
concentration (N0 = 2.39×104 to 1.39×106 PFU/mL) was investigated at pH 8 and 15 °C.  Initial 
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monochloramine concentration ranged from 2.71-13.4 mg/L as Cl2.  All experiments to 
characterize the inactivation kinetics with monochloramine were performed with the same virus 
stock of HAdV-2.  For the mechanistic study, a new stock of HAdV-2 was used after confirming 
that the kinetics of inactivation matched that of the previous stock.  Previous research found that 
HAdV-2 kinetics were independent of the ammonia nitrogen-to-chlorine molar ratio as long as 
ammonia is in excess to form monochloramine, and the present study typically used a midrange 
NH3-N/Cl2 molar ratio compared to previous work.2  Figure C.2 shows the effect of pH on the 
inactivation rate constants (k1 and k2) in equations 5.2 and 5.3 solved by simultaneous fitting of 
all data sets to equation 5.1 compared to the inactivation rate constants (k) previously reported by 
Sirikanchana et al. 2008 solved independently for each pH.   
 
C.2 Analysis of HAdV-2 Replication Cycle 
The analysis of HAdV-2 replication cycle has been described previously and key steps in the 
HAdV-2 replication cycle are shown in Figure C.3.3  First, virus samples were obtained by 
treating HAdV-2 from 0-99.99% inactivation by monochloramine at pH 8 and 15 °C.  All 
replication cycle analyses were performed in triplicate. Genomic damage to the amplicon regions 
was determined by extracting DNA from untreated and treated viruses. Subsequent assays were 
performed by first synchronizing the HAdV-2 infection in A549 cells.  Untreated and 
monochloramine treated HAdV-2 were inoculated on cell monolayers and allowed to attach at 4 
°C for 80 min.  Unbound viruses were removed and flasks were incubated at 37 °C to 
synchronize the entry process.  Total viral and cellular DNA and RNA were extracted at 0, 4, 12, 
24, and 36 h post infection (p.i.) to quantify HAdV-2 attachment, viral genomic DNA 
replication, and viral early and late mRNA transcription.  DNA and RNA were extracted using 
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the DNeasy Blood & Tissue Kit and the RNeasy Mini Kit, respectively (Qiagen, Valencia, CA) 
as described previously.3 All RNA samples were digested with RNase-free DNase I (Qiagen, 
Valencia, CA) and purified to remove genomic DNA contamination.   
 
C.3 Quantitative PCR (qPCR) and Two-Step Reverse Transcriptase qPCR (RT-qPCR) 
Primer sets were previously designed for E1A and hexon genes in HAdV-2 as well as a cellular 
gene, β-actin, used as the housekeeping gene (Table C.2).3  Quantitative PCR was used to 
analyze the amount of E1A, hexon, and β-actin DNA or cDNA using SsoFast EvaGreen 
supermix (BioRad Laboratories, Inc., Hercules, CA) in methods we previously developed.3 To 
analyze the quantity of mRNA present, first 0.5 µg of total RNA was converted by reverse 
transcriptase to cDNA, then analyzed by qPCR.3   
 
C.4 qPCR Data Analysis 
Data obtained from qPCR and RT-qPCR assays was analyzed using the obtained quantification 
cycle, Cq, for each gene in a sample as previously described.3  After running qPCR or RT-qPCR 
with each primer set for a given sample, the relative quantification and absolute quantification 
were determined.  The relative expression level, R, of DNA or mRNA was calculated using the 
ΔΔCq equation:   𝑅 = 2!∆∆!! = 2! ∆!!,sample!∆!!,calibrator   
where the values ΔCq are obtained as ΔCq,sample = (Cq,sample - Cq,housekeeping_gene), and the as 
ΔCq,calibrator = (Cq,N0 - Cq,housekeeping_gene for N0).  The housekeeping gene was β-actin, and the 
calibrator was the untreated virus sample (N0).  The relative expression level, R, is represented in 
the main text by the name of the gene for a particular sample divided by the untreated sample, 
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Gene/Gene0, for ease of comparison with the survival ratio, N/N0.  For example, the relative 
quantity of E1A DNA or mRNA at any time post infection for a monochloramine treated sample 
is represented by E1A/E1A0, and for an untreated sample the value would be equal to one.   
Similarly, the Cq values obtained were also used to determine the absolute copy number of the 
gene in a sample.  Standard curves were previously established and the resulting equations for 
each gene are shown in Table C.2 with efficiencies of 93.6% for E1A, 87.0% for hexon, and 
86.2% for β-actin.3  The absolute quantification equations were used for solving the number of 
gene copies of DNA or mRNA in a sample.  The housekeeping gene β-actin was used in all 
relative quantification analyses, and the absolute quantification of β-actin mRNA remained 
constant throughout all times post infection as shown in Figure C.4.   
 
Absolute quantification samples of genome replication were analyzed using a one-tailed t test to 
determine if genomic equivalents detected at 12, 24, and 36 h p.i. were statistically greater than 
the original baseline copies present at 4 h p.i.  Resulting P > 0.1 were determined to be statically 
similar and are indicated by ν in the top plot of Figure 5.3.  These samples had not replicated 
enough genomic DNA to be detected above the baseline and are therefore omitted in the relative 
expression analysis in Figure 5.2 (middle plot).     
 
To determine correlations between relative quantification and the survival ratio, statistical 
analyses were performed using SigmaPlot V12 (Systat Software, Inc., San Jose, CA).  The 
Pearson product moment correlation coefficient (r) was calculated between N/N0 and each 
relative gene quantity at each time p.i. with P  < 0.05 representing a significant correlation.  A 
	  	   157 
parallel line analysis then determined if the linear regression slopes were statistically similar (P 
> 0.05) between the slope of N/N0 and the relative gene quantity.      
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Table C.1.  Experimental conditions for monochloramine disinfection of HAdV-2. 
pH Temp (°C) Reactor C0  (mg/L as Cl2) 
Caverage 





6 5 1 mM CBS 10.40 10.30 7.63E+05 3.0 
6 5 1 mM PBS 9.37 9.05 9.50E+05 3.3 
6 5 1 mM PBS 11.02 10.52 1.33E+06 2.8 
6 5 1 mM PBS 10.40 10.13 2.31E+06 3.0 
7 5 1 mM PBS 12.11 12.04 1.06E+06 2.5 
7 5 1 mM PBS 12.21 11.79 1.04E+06 2.5 
8 5 1 mM CBS 9.66 9.54 1.03E+06 3.2 
8 5 1 mM CBS 13.35 13.12 9.13E+05 2.3 
9 5 10 mM BBS 10.83 10.59 1.81E+06 2.8 
9 5 10 mM BBS 12.61 12.30 1.48E+06 2.4 
10 5 10 mM BBS 10.31 10.22 1.31E+06 3.0 
10 5 10 mM BBS 11.90 12.23 1.59E+06 2.6 
6 15 1 mM CBS 4.82 4.77 8.13E+05 3.2 
6 15 1 mM PBS 9.16 8.93 5.13E+05 6.7 
6 15 1 mM PBS 8.98 8.73 1.50E+06 3.4 
6 15 1 mM PBS 10.12 9.83 2.81E+06 3.0 
7 15 1 mM PBS 9.37 9.27 8.75E+05 3.3 
7 15 1 mM PBS 9.90 9.69 2.31E+06 3.1 
7 15 1 mM PBS 9.30 9.18 1.34E+06 3.3 
8 15 1 mM CBS 3.14 3.08 5.50E+05 3.3 
8 15 1 mM CBS 8.61 8.61 6.38E+05 3.6 
8 15 1 mM CBS 10.40 10.13 1.06E+06 3.0 
8 15 1 mM CBS 10.01 9.91 1.39E+06 3.1 
8 15 1 mM CBS 11.78 11.80 1.70E+05 2.6 
8 15 1 mM CBS 12.07 11.77 2.39E+04 2.6 
8 15 1 mM CBS 5.11 5.00 1.38E+06 2.0 
*8 15 1 mM CBS 10.74 10.49 1.03E+06 2.9 
*8 15 1 mM CBS 10.55 10.40 9.88E+05 2.9 
*8 15 1 mM CBS 10.36 10.21 7.63E+05 3.0 
9 15 1 mM CBS 8.86 9.29 9.63E+05 3.5 
9 15 1 mM CBS 10.33 10.13 1.18E+06 3.0 
9 15 10 mM BBS 12.40 12.26 1.00E+06 2.5 
10 15 1 mM CBS 9.87 9.87 7.88E+05 3.1 
10 15 10 mM BBS 12.19 12.16 9.00E+05 2.5 
10 15 10 mM BBS 12.83 12.52 1.31E+06 2.4 
10 15 10 mM BBS 8.88 8.71 1.41E+06 3.5 
6 30 1 mM CBS 2.71 2.55 5.69E+05 3.8 
6 30 1 mM CBS 3.16 3.10 8.88E+05 3.3 
6 30 1 mM CBS 9.83 9.77 1.13E+06 3.1 
6 30 1 mM PBS 3.33 3.24 3.58E+06 3.1 
6 30 1 mM PBS 3.09 2.97 1.81E+06 3.3 
7 30 1 mM CBS 2.71 2.61 8.25E+05 3.8 
7 30 1 mM CBS 9.87 9.52 1.63E+06 3.1 
8 30 1 mM CBS 2.92 2.81 1.04E+06 3.5 
8 30 1 mM CBS 3.06 2.97 7.75E+05 3.4 
8 30 1 mM CBS 4.96 4.77 7.88E+05 3.1 
8 30 1 mM CBS 9.41 9.14 1.18E+06 3.3 
9 30 1 mM CBS 2.71 2.61 1.13E+06 3.8 
9 30 1 mM CBS 4.77 4.56 9.88E+05 3.2 
10 30 1 mM CBS 3.09 2.85 5.38E+05 3.3 
10 30 1 mM CBS 5.23 4.95 1.01E+06 3.0 
*Indicates experiments used for qPCR based studies. 
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Figure C.1.  Effect of pH 6-10 on the inactivation kinetics of HAdV-2 by monochloramine at 5 
°C, 15 °C, and 30 °C.  Replicate experiments are indicated with different symbols.  This figure is 
a reproduction of Figure 5.1 with the horizontal axis expanded for ease of comparing model and 






Figure C.2. The effect of pH on the inactivation rate constants (k1 and k2) in eq. 5.2 and 5.3 

















































k1   T=5°C
k1   T=15°C
k1   T=30°C
k2   T=5°C
k2   T=15°C
k2   T=30°C
k   T=10°C
k   T=20°C
k   T=30°C
This study
Sirikanchana et al. 2008
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Table C.2.  Primer sequences and absolute quantification equations for each gene (after Gall et 
al. 2015). 















Forward  5'-GAACCACCTACCCTTCACG-3' 
673- 
778 106 
Cq = -3.485 × 
log10(E1A copies)  
+ 36.43  
0.998 
Reverse  5'-CCGCCAACATTACAGACTCG-3' 
Hexon 
Forward  5'-AAAGCGGGCTACAAATAGG-3' 
19400- 
19510 111 
Cq = -3.678 × 
log10(Hexon copies) 
+ 37.99  
0.997 
Reverse  5'-CTTCGTTCCACTGAGATTCG-3' 






Forward  5'-ATGAGGCTGGTGTAAAGCG-3' 
5528803- 
5528905 103 
Cq = -3.704 × 
log10(β-actin copies) 
+ 38.38  
0.999 





Figure C.3.  Key steps of the HAdV-2 replication cycle (after 3). 
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Figure C.4.  Absolute quantification of housekeeping genes β-actin mRNA copies per 0.5 µg of 
total RNA determined by a standard curve (see Text C.4) for untreated viruses (N/N0 = 1) and 
viruses subjected to increasing monochloramine exposure.  Total mRNA was extracted for 
HAdV-2 infected A549 cells at 4, 12, 24, and 36 h p.i. 
C.5 References
1. American Public Health Association (APHA); American Water Works Association;
Water Environmental Federation. Standard Methods for the Examination of Water and
Wastewater. 21st ed.; APHA: Washington, D.C., 2005.
2. Sirikanchana, K.; Shisler, J. L.; Mariñas, B. J. Inactivation Kinetics of Adenovirus
Serotype 2 with Monochloramine. Water Res. 2008, 42 (6-7), 1467-1474.
3. Gall, A. M.; Shisler, J. L.; Mariñas, B. J. Analysis of the Viral Replication Cycle of
Adenovirus Serotype 2 after Inactivation by Free Chlorine. Environ. Sci. Technol. 2015, 49 (7),
4584-4590.
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APPENDIX D.  SUPPORTING INFORMATION FOR CHAPTER 6†††† 
D.1  Figures and Tables 
Table D.1.  Primer sequences and absolute quantification equations for each gene (after 1).  


















Cq = -3.534 × 
log10(P12 copies)  
+ 36.01  
0.998 
Reverse  5'-CCAGTACCTTTGGCAGAATCAG-3' 
P3 




Cq = -3.370 × 
log10(P3 copies)  
+ 34.24 
0.999 
Reverse  5'-GGCAAGCGGAACCCAATAG-3' 
E. coli  









Cq = -3.483 × 
log10(rpoD copies)  
+ 34.11 
0.997 




Figure D.1.  Absolute quantification of housekeeping gene rpoD mRNA copies per 0.5 µg of 
total RNA for bacteria infected with untreated viruses (N/N0 = 1) and viruses subjected to 
increasing monochloramine exposure (N/N0 = 0.47-0.00036) from 20-80 min p.i. 
                                                        
†††† Supporting information from Gall, A. M.; McClary, J. S.; Shisler, J. L.; Mariñas, B. J. 
Inactivation Kinetics and Replication Cycle Inhibition of Bacteriophage PR772 by 
Monochloramine:  A Comparative Analysis to Human Adenovirus. (to be submitted) 2016. 
Time post infection (min)
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0.450 1 0.117 0.556
1.500 1 0.115 0.546








0.750 1 0.099 0.470
Co$(mg/L$as$
Cl₂) 0.5073
1.017 1 0.095 0.451 kd$(minW¹) 0.109
2.400 1 0.082 0.390 R² 0.99721












1 0.00 TNTC 60 2 750000 1 0.000 0
2 0.25 TNTC 139 15 173750 0.23166667 0.125 0.10570071


























































0.217 1 0.105 0.499
1.300 1 0.103 0.489








0.400 1 0.092 0.437
Co$(mg/L$as$
Cl₂) 0.4507
0.983 1 0.083 0.394 kd$(minV¹) 0.122
2.433 1 0.069 0.328 R² 0.98772












1 0.00 TNTC 161 22 2012500 1 0.000 0
2 0.22 TNTC TNTC 61 762500 0.37888199 0.096 0.07874109


























































0.400 1 0.107 0.508
1.400 1 0.106 0.504








0.183 1 0.095 0.451
Co$(mg/L$as$
Cl₂) 0.4494
0.650 1 0.081 0.385 kd$(minW¹) 0.169
2.267 1 0.065 0.309 R² 0.97444












1 0.00 TNTC 41 2 512500 1 0.000 0
2 0.43 87 12 1 10875 0.02121951 0.188 0.15490895































































0.217 1 0.115 0.546
1.683 1 0.113 0.537








0.167 1 0.112 0.532
Co$(mg/L$as$
Cl₂) 0.5137
0.617 1 0.092 0.437 kd$(minW¹) 0.151
2.617 1 0.072 0.342 R² 0.94186












1 0.00 TNTC 55 5 687500 1 0.000 0
2 0.40 TNTC TNTC 80 100000 0.14545455 0.199 0.16389549
3 0.92 TNTC 45 4 562.5 0.00081818 0.440 0.37559382


































































0.183 1 0.113 0.537
1.317 1 0.112 0.532








0.167 1 0.120 0.570
Co$(mg/L$as$
Cl₂) 0.5594
1.467 1 0.085 0.404 kd$(minW¹) 0.168
2.767 1 0.074 0.352 R² 0.94772












1 0.00 347 27 5 385625 1 0.000 0
2 0.42 TNTC TNTC 82 102500 0.26580227 0.225 0.17220903
3 0.85 TNTC 198 17 2475 0.00641815 0.443 0.35130641


































































0.183 1 0.114 0.542
1.317 1 0.112 0.532








0.183 1 0.106 0.504
Co$(mg/L$as$
Cl₂) 0.5015
1.383 1 0.083 0.394 kd$(minW¹) 0.14
2.700 1 0.072 0.342 R² 0.97182












1 0.00 TNTC 58 5 725000 1 0.000 0
2 0.42 TNTC TNTC 49 61250 0.08448276 0.203 0.16231196
3 0.78 TNTC TNTC 45 5625 0.00775862 0.372 0.30514648
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4.113 DNA1 
 
Pos Name Ct SYBR Ct Mean SYBR Ct Dev. SYBR Expr. Level SYBR Range SYBR
A1 1A DNA:100 E1A 26.77 26.55 0.31
A2 1A DNA:100 E1A 26.68 26.55 0.31
A3 1A DNA:100 E1A 26.19 26.55 0.31
A4 2A DNA:100 E1A 26.63 26.56 0.10
A5 2A DNA:100 E1A 26.49 26.56 0.10
A6 2A DNA:100 E1A
A7 3A DNA:100 E1A 26.97 27.06 0.10
A8 3A DNA:100 E1A 27.16 27.06 0.10
A9 3A DNA:100 E1A 27.04 27.06 0.10
B1 1A DNA:100 Hex 27.39 27.02 0.34
B2 1A DNA:100 Hex 26.96 27.02 0.34
B3 1A DNA:100 Hex 26.71 27.02 0.34
B4 2A DNA:100 Hex 27.32 27.06 0.22 0.480 0.398 - 0.580
B5 2A DNA:100 Hex 26.96 27.06 0.22 0.480 0.398 - 0.580
B6 2A DNA:100 Hex 26.91 27.06 0.22 0.480 0.398 - 0.580
B7 3A DNA:100 Hex 27.68 27.73 0.07 0.374 0.349 - 0.400
B8 3A DNA:100 Hex 27.81 27.73 0.07 0.374 0.349 - 0.400
B9 3A DNA:100 Hex 27.70 27.73 0.07 0.374 0.349 - 0.400
C1 1A DNA:100 Actin2 28.24 27.44 0.70
C2 1A DNA:100 Actin2 27.14 27.44 0.70
C3 1A DNA:100 Actin2 26.93 27.44 0.70
C4 2A DNA:100 Actin2 26.59 26.42 0.15
C5 2A DNA:100 Actin2 26.29 26.42 0.15
C6 2A DNA:100 Actin2 26.39 26.42 0.15
C7 3A DNA:100 Actin2 26.67 26.73 0.07
C8 3A DNA:100 Actin2 26.70 26.73 0.07
C9 3A DNA:100 Actin2 26.81 26.73 0.07
D1 1As DNA E1A 21.98 21.52 0.41
D2 1As DNA E1A 21.39 21.52 0.41
D3 1As DNA E1A 21.19 21.52 0.41
D4 2As DNA E1A 21.12 20.95 0.18
D5 2As DNA E1A 20.76 20.95 0.18
D6 2As DNA E1A 20.98 20.95 0.18
D7 3As DNA E1A 21.36 20.99 0.48
D8 3As DNA E1A 21.16 20.99 0.48
D9 3As DNA E1A 20.46 20.99 0.48
E1 1As DNA Hex 22.69 22.13 0.51 177 119 - 263
E2 1As DNA Hex 21.70 22.13 0.51 177 119 - 263
E3 1As DNA Hex 21.99 22.13 0.51 177 119 - 263
E4 2As DNA Hex 22.33 22.00 0.33 97.9 75.7 - 127
E5 2As DNA Hex 22.00 22.00 0.33 97.9 75.7 - 127
E6 2As DNA Hex 21.66 22.00 0.33 97.9 75.7 - 127
E7 3As DNA Hex 22.31 21.49 0.76 223 130 - 383
E8 3As DNA Hex 20.81 21.49 0.76 223 130 - 383
E9 3As DNA Hex 21.35 21.49 0.76 223 130 - 383
F1 1As DNA Actin2 29.93 30.01 0.26
F2 1As DNA Actin2 29.81 30.01 0.26
F3 1As DNA Actin2 30.30 30.01 0.26
F4 2As DNA Actin2 29.08 29.03 0.17
F5 2As DNA Actin2 29.16 29.03 0.17
F6 2As DNA Actin2 28.84 29.03 0.17
F7 3As DNA Actin2 29.62 29.71 0.16
F8 3As DNA Actin2 29.62 29.71 0.16
F9 3As DNA Actin2 29.90 29.71 0.16
G1 1G DNA E1A 17.81 17.48 0.30
G2 1G DNA E1A 17.36 17.48 0.30
G3 1G DNA E1A 17.25 17.48 0.30
G4 2G DNA E1A 17.98 16.82 1.09
G5 2G DNA E1A 16.66 16.82 1.09
G6 2G DNA E1A 15.82 16.82 1.09
G7 3G DNA E1A 17.55 17.41 0.15
G8 3G DNA E1A 17.44 17.41 0.15
G9 3G DNA E1A 17.25 17.41 0.15
H1 1G DNA Hex 18.73 18.47 0.28
H2 1G DNA Hex 18.52 18.47 0.28
H3 1G DNA Hex 18.17 18.47 0.28
H4 2G DNA Hex 17.59 18.20 0.53
H5 2G DNA Hex 18.54 18.20 0.53
H6 2G DNA Hex 18.47 18.20 0.53
H7 3G DNA Hex 18.25 18.45 0.18
H8 3G DNA Hex 18.51 18.45 0.18
H9 3G DNA Hex 18.59 18.45 0.18
Subassay Subassay A1-F9 Analysis Parameters






Baseline range (from cycle no. ... to)n/a
Drift Correction OFF
Subassay Subassay G1-H9 Analysis Parameters






Baseline range (from cycle no. ... to)n/a
Drift Correction OFF
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4.113 DNA2 
 
Pos Name Ct SYBR Ct Mean SYBR Ct Dev. SYBR Expr. Level SYBR Range SYBR
F10 1D DNA:100 Actin2 27.67 27.85 0.26
F11 1D DNA:100 Actin2 27.72 27.85 0.26
F12 1D DNA:100 Actin2 28.15 27.85 0.26
G1 1D DNA:100 E1A 15.74 15.46 0.25
G2 1D DNA:100 E1A 15.37 15.46 0.25
G3 1D DNA:100 E1A 15.27 15.46 0.25
G4 2D DNA:100 E1A 22.55 22.54 0.01
G5 2D DNA:100 E1A 22.54 22.54 0.01
G6 2D DNA:100 E1A 22.54 22.54 0.01
G7 3D DNA:100 E1A 26.70 26.50 0.18
G8 3D DNA:100 E1A 26.35 26.50 0.18
G9 3D DNA:100 E1A 26.44 26.50 0.18
G10 2D DNA:100 Actin2 29.20 29.38 0.46
G11 2D DNA:100 Actin2 29.05 29.38 0.46
G12 2D DNA:100 Actin2 29.90 29.38 0.46
H1 1D DNA:100 Hex 17.52 16.89 0.55
H2 1D DNA:100 Hex 16.69 16.89 0.55
H3 1D DNA:100 Hex 16.48 16.89 0.55
H4 2D DNA:100 Hex 24.06 23.92 0.19 2.230E-2X 1.58E-02 - 3.15E-02
H5 2D DNA:100 Hex 24.00 23.92 0.19 2.230E-2X 1.58E-02 - 3.15E-02
H6 2D DNA:100 Hex 23.69 23.92 0.19 2.230E-2X 1.58E-02 - 3.15E-02
H7 3D DNA:100 Hex 27.61 27.92 0.27 1.590E-3X 1.24E-03 - 2.05E-03
H8 3D DNA:100 Hex 28.09 27.92 0.27 1.590E-3X 1.24E-03 - 2.05E-03
H9 3D DNA:100 Hex 28.06 27.92 0.27 1.590E-3X 1.24E-03 - 2.05E-03
H10 3D DNA:100 Actin2 29.66 29.58 0.24
H11 3D DNA:100 Actin2 29.30 29.58 0.24
H12 3D DNA:100 Actin2 29.77 29.58 0.24
A1 1B DNA:100 E1A 28.39 28.22 0.22
A2 1B DNA:100 E1A 28.29 28.22 0.22
A3 1B DNA:100 E1A 27.97 28.22 0.22
A4 2B DNA:100 E1A 29.81 29.58 0.46
A5 2B DNA:100 E1A 29.88 29.58 0.46
A6 2B DNA:100 E1A 29.05 29.58 0.46
A7 3B DNA:100 E1A 28.43 28.61 0.16
A8 3B DNA:100 E1A 28.70 28.61 0.16
A9 3B DNA:100 E1A 28.70 28.61 0.16
B1 1B DNA:100 Hex 29.65 29.18 0.46
B2 1B DNA:100 Hex 29.15 29.18 0.46
B3 1B DNA:100 Hex 28.73 29.18 0.46
B4 2B DNA:100 Hex 30.10 30.14 0.23 0.694 0.578 - 0.832
B5 2B DNA:100 Hex 30.39 30.14 0.23 0.694 0.578 - 0.832
B6 2B DNA:100 Hex 29.93 30.14 0.23 0.694 0.578 - 0.832
B7 3B DNA:100 Hex 29.76 29.46 0.34 0.546 0.428 - 0.697
B8 3B DNA:100 Hex 29.54 29.46 0.34 0.546 0.428 - 0.697
B9 3B DNA:100 Hex 29.09 29.46 0.34 0.546 0.428 - 0.697
C1 1B DNA:100 Actin2 28.83 27.89 0.82
C2 1B DNA:100 Actin2 27.54 27.89 0.82
C3 1B DNA:100 Actin2 27.31 27.89 0.82
C4 2B DNA:100 Actin2 28.45 28.33 0.13
C5 2B DNA:100 Actin2 28.33 28.33 0.13
C6 2B DNA:100 Actin2 28.20 28.33 0.13
C7 3B DNA:100 Actin2 27.39 27.30 0.08
C8 3B DNA:100 Actin2 27.23 27.30 0.08
C9 3B DNA:100 Actin2 27.29 27.30 0.08
D1 1C DNA:100 E1A 24.15 23.69 0.45
D2 1C DNA:100 E1A 23.24 23.69 0.45
D3 1C DNA:100 E1A 23.67 23.69 0.45
D4 2C DNA:100 E1A 30.93 30.36 0.51
D5 2C DNA:100 E1A 29.93 30.36 0.51
D6 2C DNA:100 E1A 30.22 30.36 0.51
D7 3C DNA:100 E1A 31.14 31.18 0.35
D8 3C DNA:100 E1A 30.85 31.18 0.35
D9 3C DNA:100 E1A 31.55 31.18 0.35
E1 1C DNA:100 Hex 25.24 24.72 0.46
E2 1C DNA:100 Hex 24.48 24.72 0.46
E3 1C DNA:100 Hex 24.42 24.72 0.46
E4 2C DNA:100 Hex 31.14 31.03 0.15 6.370E-3X 5.30E-03 - 7.66E-03
E5 2C DNA:100 Hex 31.09 31.03 0.15 6.370E-3X 5.30E-03 - 7.66E-03
E6 2C DNA:100 Hex 30.86 31.03 0.15 6.370E-3X 5.30E-03 - 7.66E-03
E7 3C DNA:100 Hex 32.30 32.37 0.53 1.250E-3X 8.62E-04 - 1.82E-03
E8 3C DNA:100 Hex 31.89 32.37 0.53 1.250E-3X 8.62E-04 - 1.82E-03
E9 3C DNA:100 Hex 32.93 32.37 0.53 1.250E-3X 8.62E-04 - 1.82E-03
F1 1C DNA:100 Actin2 30.57 29.80 0.70
F2 1C DNA:100 Actin2 29.60 29.80 0.70
F3 1C DNA:100 Actin2 29.21 29.80 0.70
F4 2C DNA:100 Actin2 28.69 28.82 0.22
F5 2C DNA:100 Actin2 28.69 28.82 0.22
F6 2C DNA:100 Actin2 29.07 28.82 0.22
F7 3C DNA:100 Actin2 27.83 27.81 0.12
F8 3C DNA:100 Actin2 27.91 27.81 0.12
F9 3C DNA:100 Actin2 27.69 27.81 0.12
Main Assay Analysis Parameters






Baseline range (from cycle no. ... to) n/a
Drift Correction OFF
Subassay Subassay A1-C9 Analysis Parameters






Baseline range (from cycle no. ... to) n/a
Drift Correction OFF
Subassay Subassay D1-F9 Analysis Parameters






Baseline range (from cycle no. ... to) n/a
Drift Correction OFF
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4.121 DNA1 
 
Pos Name Ct SYBR Ct Mean SYBR Ct Dev. SYBR Expr. Level SYBR Range SYBR
A1 1A DNA:100 E1A 26.62 26.35 0.24
A2 1A DNA:100 E1A 26.28 26.35 0.24
A3 1A DNA:100 E1A 26.15 26.35 0.24
A4 2A DNA:100 E1A 26.42 26.29 0.20
A5 2A DNA:100 E1A 26.38 26.29 0.20
A6 2A DNA:100 E1A 26.06 26.29 0.20
A7 3A DNA:100 E1A 26.48 26.30 0.35
A8 3A DNA:100 E1A 26.53 26.30 0.35
A9 3A DNA:100 E1A 25.90 26.30 0.35
A10 4A DNA:100 E1A 24.58 24.65 0.09
A11 4A DNA:100 E1A 24.75 24.65 0.09
A12 4A DNA:100 E1A 24.63 24.65 0.09
B1 1A DNA:100 Hex 28.04 27.49 0.58
B2 1A DNA:100 Hex 27.53 27.49 0.58
B3 1A DNA:100 Hex 26.89 27.49 0.58
B4 2A DNA:100 Hex 27.73 27.59 0.17 0.773 0.546 - 1.10
B5 2A DNA:100 Hex 27.62 27.59 0.17 0.773 0.546 - 1.10
B6 2A DNA:100 Hex 27.41 27.59 0.17 0.773 0.546 - 1.10
B7 3A DNA:100 Hex 27.70 27.78 0.12 0.791 0.690 - 0.907
B8 3A DNA:100 Hex 27.91 27.78 0.12 0.791 0.690 - 0.907
B9 3A DNA:100 Hex 27.72 27.78 0.12 0.791 0.690 - 0.907
B10 4A DNA:100 Hex 26.20 26.14 0.32 1.10 0.837 - 1.45
B11 4A DNA:100 Hex 25.79 26.14 0.32 1.10 0.837 - 1.45
B12 4A DNA:100 Hex 26.42 26.14 0.32 1.10 0.837 - 1.45
C1 1A DNA:100 Actin2 29.74 28.76 0.86
C2 1A DNA:100 Actin2 28.42 28.76 0.86
C3 1A DNA:100 Actin2 28.12 28.76 0.86
C4 2A DNA:100 Actin2 28.92 28.49 0.47
C5 2A DNA:100 Actin2 27.98 28.49 0.47
C6 2A DNA:100 Actin2 28.58 28.49 0.47
C7 3A DNA:100 Actin2 28.87 28.71 0.16
C8 3A DNA:100 Actin2 28.73 28.71 0.16
C9 3A DNA:100 Actin2 28.55 28.71 0.16
C10 4A DNA:100 Actin2 27.65 27.55 0.23
C11 4A DNA:100 Actin2 27.29 27.55 0.23
C12 4A DNA:100 Actin2 27.72 27.55 0.23
D1 1As DNA:100 E1A 24.07 23.78 0.27
D2 1As DNA:100 E1A 23.74 23.78 0.27
D3 1As DNA:100 E1A 23.54 23.78 0.27
D4 2As DNA:100 E1A 23.53 23.62 0.11
D5 2As DNA:100 E1A 23.74 23.62 0.11
D6 2As DNA:100 E1A 23.60 23.62 0.11
D7 3As DNA:100 E1A 23.17 23.27 0.32
D8 3As DNA:100 E1A 23.02 23.27 0.32
D9 3As DNA:100 E1A 23.63 23.27 0.32
D10 4As DNA:100 E1A 22.83 22.74 0.18
D11 4As DNA:100 E1A 22.86 22.74 0.18
D12 4As DNA:100 E1A 22.53 22.74 0.18
E1 1As DNA:100 Hex 24.81 24.87 0.07
E2 1As DNA:100 Hex 24.95 24.87 0.07
E3 1As DNA:100 Hex 24.86 24.87 0.07
E4 2As DNA:100 Hex 24.55 24.02 0.55
E5 2As DNA:100 Hex 24.04 24.02 0.55
E6 2As DNA:100 Hex 23.45 24.02 0.55
E7 3As DNA:100 Hex 24.05 24.41 0.31
E8 3As DNA:100 Hex 24.54 24.41 0.31
E9 3As DNA:100 Hex 24.64 24.41 0.31
E10 4As DNA:100 Hex 23.79 23.20 0.91
E11 4As DNA:100 Hex 23.66 23.20 0.91
E12 4As DNA:100 Hex 22.15 23.20 0.91
F1 1As DNA:100 Actin2 30.74 30.28 0.45
F2 1As DNA:100 Actin2 29.83 30.28 0.45
F3 1As DNA:100 Actin2 30.27 30.28 0.45
F4 2As DNA:100 Actin2 30.20 30.02 0.21
F5 2As DNA:100 Actin2 29.79 30.02 0.21
F6 2As DNA:100 Actin2 30.06 30.02 0.21
F7 3As DNA:100 Actin2 29.69 29.46 0.35
F8 3As DNA:100 Actin2 29.64 29.46 0.35
F9 3As DNA:100 Actin2 29.06 29.46 0.35
F10 4As DNA:100 Actin2 28.87 28.97 0.16
F11 4As DNA:100 Actin2 28.89 28.97 0.16
F12 4As DNA:100 Actin2 29.15 28.97 0.16
G1 1G DNA:1 E1A 17.77 17.56 0.41
G2 1G DNA:1 E1A 17.82 17.56 0.41
G3 1G DNA:1 E1A 17.09 17.56 0.41
G4 1G DNA:10 E1A 21.23 21.18 0.04
G5 1G DNA:10 E1A 21.15 21.18 0.04
G6 1G DNA:10 E1A 21.17 21.18 0.04
G7 1G DNA:100 E1A 24.05 24.04 0.05
G8 1G DNA:100 E1A 24.09 24.04 0.05
G9 1G DNA:100 E1A 23.99 24.04 0.05
G10 1G DNA:1000 E1A 27.73 27.49 0.21
G11 1G DNA:1000 E1A 27.37 27.49 0.21
G12 1G DNA:1000 E1A 27.37 27.49 0.21
H1 1G DNA:1 Hex 19.26 18.53 0.64
H2 1G DNA:1 Hex 18.28 18.53 0.64
H3 1G DNA:1 Hex 18.05 18.53 0.64
H4 1G DNA:10 Hex 22.83 22.62 0.20
H5 1G DNA:10 Hex 22.61 22.62 0.20
H6 1G DNA:10 Hex 22.42 22.62 0.20
H7 1G DNA:100 Hex 25.79 25.84 0.07
H8 1G DNA:100 Hex 25.80 25.84 0.07
H9 1G DNA:100 Hex 25.92 25.84 0.07
H10 1G DNA:1000 Hex 29.15 29.08 0.28
H11 1G DNA:1000 Hex 29.32 29.08 0.28
H12 1G DNA:1000 Hex 28.78 29.08 0.28
Analysis Parameters






Baseline range (from cycle no. ... to) n/a
Drift Correction OFF
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4.121 DNA2 
 
Pos Name Ct SYBR Ct Mean SYBR Ct Dev. SYBR Expr. Level SYBR Range SYBR
G1 1G DNA:1 E1A 17.86 17.29 0.60
G2 1G DNA:1 E1A 17.34 17.29 0.60
G3 1G DNA:1 E1A 16.67 17.29 0.60
G4 1G DNA:10 E1A 20.80 20.89 0.08
G5 1G DNA:10 E1A 20.93 20.89 0.08
G6 1G DNA:10 E1A 20.95 20.89 0.08
G7 1G DNA:100 E1A 24.48 24.25 0.22
G8 1G DNA:100 E1A 24.23 24.25 0.22
G9 1G DNA:100 E1A 24.05 24.25 0.22
G10 1G DNA:1000 E1A 27.33 27.63 0.27
G11 1G DNA:1000 E1A 27.86 27.63 0.27
G12 1G DNA:1000 E1A 27.69 27.63 0.27
H1 1G DNA:1 Hex 18.18 17.74 0.44
H2 1G DNA:1 Hex 17.74 17.74 0.44
H3 1G DNA:1 Hex 17.30 17.74 0.44
H4 1G DNA:10 Hex 21.84 21.74 0.18
H5 1G DNA:10 Hex 21.86 21.74 0.18
H6 1G DNA:10 Hex 21.53 21.74 0.18
H7 1G DNA:100 Hex 25.00 25.00 0.02
H8 1G DNA:100 Hex 25.02 25.00 0.02
H9 1G DNA:100 Hex 24.98 25.00 0.02
H10 1G DNA:1000 Hex 28.95 28.43 0.46
H11 1G DNA:1000 Hex 28.23 28.43 0.46
H12 1G DNA:1000 Hex 28.11 28.43 0.46
A1 1B DNA:100 E1A 27.79 27.73 0.07
A2 1B DNA:100 E1A 27.76 27.73 0.07
A3 1B DNA:100 E1A 27.65 27.73 0.07
A4 2B DNA:100 E1A 29.43 29.18 0.22
A5 2B DNA:100 E1A 29.00 29.18 0.22
A6 2B DNA:100 E1A 29.12 29.18 0.22
A7 3B DNA:100 E1A 28.23 28.56 0.39
A8 3B DNA:100 E1A 28.99 28.56 0.39
A9 3B DNA:100 E1A 28.47 28.56 0.39
A10 4B DNA:100 E1A 28.59 28.71 0.27
A11 4B DNA:100 E1A 29.03 28.71 0.27
A12 4B DNA:100 E1A 28.52 28.71 0.27
B1 1B DNA:100 Hex 28.39 28.05 0.31
B2 1B DNA:100 Hex 27.96 28.05 0.31
B3 1B DNA:100 Hex 27.80 28.05 0.31
B4 2B DNA:100 Hex 30.64 30.18 0.50 0.396 0.258 - 0.606
B5 2B DNA:100 Hex 30.25 30.18 0.50 0.396 0.258 - 0.606
B6 2B DNA:100 Hex 29.65 30.18 0.50 0.396 0.258 - 0.606
B7 3B DNA:100 Hex 29.58 29.51 0.19 0.664 0.566 - 0.778
B8 3B DNA:100 Hex 29.64 29.51 0.19 0.664 0.566 - 0.778
B9 3B DNA:100 Hex 29.30 29.51 0.19 0.664 0.566 - 0.778
B10 4B DNA:100 Hex 29.27 29.33 0.48 0.917 0.611 - 1.38
B11 4B DNA:100 Hex 29.84 29.33 0.48 0.917 0.611 - 1.38
B12 4B DNA:100 Hex 28.89 29.33 0.48 0.917 0.611 - 1.38
C1 1B DNA:100 Actin2 27.71 27.06 0.57
C2 1B DNA:100 Actin2 26.79 27.06 0.57
C3 1B DNA:100 Actin2 26.67 27.06 0.57
C4 2B DNA:100 Actin2 28.20 27.85 0.36
C5 2B DNA:100 Actin2 27.85 27.85 0.36
C6 2B DNA:100 Actin2 27.49 27.85 0.36
C7 3B DNA:100 Actin2 28.05 27.92 0.14
C8 3B DNA:100 Actin2 27.93 27.92 0.14
C9 3B DNA:100 Actin2 27.78 27.92 0.14
C10 4B DNA:100 Actin2 28.55 28.21 0.34
C11 4B DNA:100 Actin2 28.22 28.21 0.34
C12 4B DNA:100 Actin2 27.87 28.21 0.34
D1 1C DNA:100 E1A 27.91 27.24 0.58
D2 1C DNA:100 E1A 26.93 27.24 0.58
D3 1C DNA:100 E1A 26.89 27.24 0.58
D4 2C DNA:100 E1A 27.94 28.00 0.07
D5 2C DNA:100 E1A 27.97 28.00 0.07
D6 2C DNA:100 E1A 28.08 28.00 0.07
D7 3C DNA:100 E1A 29.41 29.39 0.26
D8 3C DNA:100 E1A 29.12 29.39 0.26
D9 3C DNA:100 E1A 29.63 29.39 0.26
D10 4C DNA:100 E1A 29.82 29.77 0.05
D11 4C DNA:100 E1A 29.72 29.77 0.05
D12 4C DNA:100 E1A 29.78 29.77 0.05
E1 1C DNA:100 Hex 27.79 27.68 0.18
E2 1C DNA:100 Hex 27.47 27.68 0.18
E3 1C DNA:100 Hex 27.77 27.68 0.18
E4 2C DNA:100 Hex 28.98 28.46 0.46 0.500 0.351 - 0.710
E5 2C DNA:100 Hex 28.10 28.46 0.46 0.500 0.351 - 0.710
E6 2C DNA:100 Hex 28.30 28.46 0.46 0.500 0.351 - 0.710
E7 3C DNA:100 Hex 29.57 29.72 0.20 0.163 0.139 - 0.190
E8 3C DNA:100 Hex 29.65 29.72 0.20 0.163 0.139 - 0.190
E9 3C DNA:100 Hex 29.95 29.72 0.20 0.163 0.139 - 0.190
E10 4C DNA:100 Hex 30.00 30.25 0.22 0.178 0.150 - 0.213
E11 4C DNA:100 Hex 30.40 30.25 0.22 0.178 0.150 - 0.213
E12 4C DNA:100 Hex 30.34 30.25 0.22 0.178 0.150 - 0.213
F1 1C DNA:100 Actin2 28.05 27.47 0.51
F2 1C DNA:100 Actin2 27.13 27.47 0.51
F3 1C DNA:100 Actin2 27.22 27.47 0.51
F4 2C DNA:100 Actin2 27.42 27.25 0.22
F5 2C DNA:100 Actin2 27.32 27.25 0.22
F6 2C DNA:100 Actin2 27.00 27.25 0.22
F7 3C DNA:100 Actin2 26.99 26.89 0.10
F8 3C DNA:100 Actin2 26.90 26.89 0.10
F9 3C DNA:100 Actin2 26.79 26.89 0.10
F10 4C DNA:100 Actin2 27.44 27.55 0.13
F11 4C DNA:100 Actin2 27.52 27.55 0.13
F12 4C DNA:100 Actin2 27.70 27.55 0.13
Main Assay Analysis Parameters






Baseline range (from cycle no. ... to) n/a
Drift Correction OFF
Subassay Subassay A1-C12 Analysis Parameters






Baseline range (from cycle no. ... to) n/a
Drift Correction OFF
Subassay Subassay D1-F12 Analysis Parameters






Baseline range (from cycle no. ... to) n/a
Drift Correction OFF
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Pos Name Ct SYBR Ct Mean SYBR Ct Dev. SYBR Expr. Level SYBR Range SYBR
A1 1D DNA:100 E1A 19.38 19.07 0.27
A2 1D DNA:100 E1A 18.93 19.07 0.27
A3 1D DNA:100 E1A 18.90 19.07 0.27
A4 2D DNA:100 E1A 23.06 22.88 0.15
A5 2D DNA:100 E1A 22.81 22.88 0.15
A6 2D DNA:100 E1A 22.78 22.88 0.15
A7 3D DNA:100 E1A 29.62 29.99 0.56
A8 3D DNA:100 E1A 29.71 29.99 0.56
A9 3D DNA:100 E1A 30.63 29.99 0.56
A10 4D DNA:100 E1A 31.10 31.17 0.33
A11 4D DNA:100 E1A 31.53 31.17 0.33
A12 4D DNA:100 E1A 30.88 31.17 0.33
B1 1D DNA:100 Hex 19.57 19.00 0.58
B2 1D DNA:100 Hex 19.00 19.00 0.58
B3 1D DNA:100 Hex 18.42 19.00 0.58
B4 2D DNA:100 Hex 23.18 23.06 0.15 4.580E-2X 3.46E-02 - 6.05E-02
B5 2D DNA:100 Hex 23.11 23.06 0.15 4.580E-2X 3.46E-02 - 6.05E-02
B6 2D DNA:100 Hex 22.88 23.06 0.15 4.580E-2X 3.46E-02 - 6.05E-02
B7 3D DNA:100 Hex 30.24 30.24 0.35 3.380E-4X 2.61E-04 - 4.38E-04
B8 3D DNA:100 Hex 29.88 30.24 0.35 3.380E-4X 2.61E-04 - 4.38E-04
B9 3D DNA:100 Hex 30.59 30.24 0.35 3.380E-4X 2.61E-04 - 4.38E-04
B10 4D DNA:100 Hex 31.65 31.05 0.65 2.300E-4X 1.39E-04 - 3.80E-04
B11 4D DNA:100 Hex 31.14 31.05 0.65 2.300E-4X 1.39E-04 - 3.80E-04
B12 4D DNA:100 Hex 30.36 31.05 0.65 2.300E-4X 1.39E-04 - 3.80E-04
C1 1D DNA:100 Actin2 28.90 28.05 0.75
C2 1D DNA:100 Actin2 27.75 28.05 0.75
C3 1D DNA:100 Actin2 27.51 28.05 0.75
C4 2D DNA:100 Actin2 28.09 27.66 0.37
C5 2D DNA:100 Actin2 27.39 27.66 0.37
C6 2D DNA:100 Actin2 27.51 27.66 0.37
C7 3D DNA:100 Actin2 27.72 27.76 0.11
C8 3D DNA:100 Actin2 27.89 27.76 0.11
C9 3D DNA:100 Actin2 27.67 27.76 0.11
C10 4D DNA:100 Actin2 27.88 28.02 0.33
C11 4D DNA:100 Actin2 27.78 28.02 0.33
C12 4D DNA:100 Actin2 28.39 28.02 0.33
D1 1G DNA:1 E1A 17.83 17.48 0.32
D2 1G DNA:1 E1A 17.40 17.48 0.32
D3 1G DNA:1 E1A 17.20 17.48 0.32
D4 2G DNA:1 E1A 17.51 17.47 0.27
D5 2G DNA:1 E1A 17.72 17.47 0.27
D6 2G DNA:1 E1A 17.19 17.47 0.27
D7 3G DNA:1 E1A 16.94 17.30 0.41
D8 3G DNA:1 E1A 17.21 17.30 0.41
D9 3G DNA:1 E1A 17.75 17.30 0.41
D10 4G DNA:1 E1A 17.24 17.24 0.18
D11 4G DNA:1 E1A 17.06 17.24 0.18
D12 4G DNA:1 E1A 17.42 17.24 0.18
E1 1G DNA:1 Hex 18.13 17.69 0.41
E2 1G DNA:1 Hex 17.64 17.69 0.41
E3 1G DNA:1 Hex 17.32 17.69 0.41
E4 2G DNA:1 Hex 17.80 17.73 0.21
E5 2G DNA:1 Hex 17.49 17.73 0.21
E6 2G DNA:1 Hex 17.89 17.73 0.21
E7 3G DNA:1 Hex 17.68 20.76 5.32
E8 3G DNA:1 Hex 17.70 20.76 5.32
E9 3G DNA:1 Hex 26.90 20.76 5.32
E10 4G DNA:1 Hex 18.14 17.96 0.16
E11 4G DNA:1 Hex 17.82 17.96 0.16
E12 4G DNA:1 Hex 17.91 17.96 0.16
F1 1G DNA:1 Actin2 35.40 35.09 0.27
F2 1G DNA:1 Actin2 34.91 35.09 0.27
F3 1G DNA:1 Actin2 34.96 35.09 0.27
F4 2G DNA:1 Actin2
F5 2G DNA:1 Actin2 33.96
F6 2G DNA:1 Actin2
F7 3G DNA:1 Actin2 35.99 35.22 0.77
F8 3G DNA:1 Actin2 34.45 35.22 0.77
F9 3G DNA:1 Actin2 35.21 35.22 0.77
F10 4G DNA:1 Actin2
F11 4G DNA:1 Actin2 34.89
F12 4G DNA:1 Actin2
G1 1G DNA:1 E1A 17.56 17.28 0.27
G2 1G DNA:1 E1A 17.25 17.28 0.27
G3 1G DNA:1 E1A 17.02 17.28 0.27
G4 1G DNA:10 E1A 21.16 21.10 0.06
G5 1G DNA:10 E1A 21.07 21.10 0.06
G6 1G DNA:10 E1A 21.06 21.10 0.06
G7 1G DNA:100 E1A 24.56 24.60 0.03
G8 1G DNA:100 E1A 24.59 24.60 0.03
G9 1G DNA:100 E1A 24.63 24.60 0.03
G10 1G DNA:1000 E1A 27.62 27.68 0.08
G11 1G DNA:1000 E1A 27.65 27.68 0.08
G12 1G DNA:1000 E1A 27.76 27.68 0.08
H1 1G DNA:1 Hex 18.00 18.18 0.18
H2 1G DNA:1 Hex 18.36 18.18 0.18
H3 1G DNA:1 Hex 18.19 18.18 0.18
H4 1G DNA:10 Hex 21.92 21.85 0.12
H5 1G DNA:10 Hex 21.92 21.85 0.12
H6 1G DNA:10 Hex 21.71 21.85 0.12
H7 1G DNA:100 Hex 25.36 25.29 0.21
H8 1G DNA:100 Hex 25.46 25.29 0.21
H9 1G DNA:100 Hex 25.06 25.29 0.21
H10 1G DNA:1000 Hex 28.99 28.73 0.30
H11 1G DNA:1000 Hex 28.39 28.73 0.30
H12 1G DNA:1000 Hex 28.80 28.73 0.30
Analysis Parameters






Baseline range (from cycle no. ... to) n/a
Drift Correction OFF
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Pos Name Ct SYBR Ct Mean SYBR Ct Dev. SYBR Expr. Level SYBR Range SYBR
A1 1A DNA:100 E1A 27.49 26.82 0.69
A2 1A DNA:100 E1A 26.87 26.82 0.69
A3 1A DNA:100 E1A 26.11 26.82 0.69
A4 2A DNA:100 E1A 26.05 25.84 0.23
A5 2A DNA:100 E1A 25.87 25.84 0.23
A6 2A DNA:100 E1A 25.60 25.84 0.23
A7 3A DNA:100 E1A 26.92 26.87 0.05
A8 3A DNA:100 E1A 26.83 26.87 0.05
A9 3A DNA:100 E1A 26.86 26.87 0.05
A10 4A DNA:100 E1A 26.82 26.60 0.19
A11 4A DNA:100 E1A 26.49 26.60 0.19
A12 4A DNA:100 E1A 26.50 26.60 0.19
B1 1A DNA:100 Hex 26.85 26.61 0.37
B2 1A DNA:100 Hex 26.80 26.61 0.37
B3 1A DNA:100 Hex 26.18 26.61 0.37
B4 2A DNA:100 Hex 26.17 25.98 0.22 0.886 0.687 - 1.14
B5 2A DNA:100 Hex 26.03 25.98 0.22 0.886 0.687 - 1.14
B6 2A DNA:100 Hex 25.74 25.98 0.22 0.886 0.687 - 1.14
B7 3A DNA:100 Hex 26.97 26.89 0.09 0.784 0.598 - 1.03
B8 3A DNA:100 Hex 26.90 26.89 0.09 0.784 0.598 - 1.03
B9 3A DNA:100 Hex 26.79 26.89 0.09 0.784 0.598 - 1.03
B10 4A DNA:100 Hex 26.98 26.95 0.05 0.910 0.757 - 1.09
B11 4A DNA:100 Hex 26.89 26.95 0.05 0.910 0.757 - 1.09
B12 4A DNA:100 Hex 26.98 26.95 0.05 0.910 0.757 - 1.09
C1 1A DNA:100 Actin2 28.30 27.93 0.34
C2 1A DNA:100 Actin2 27.84 27.93 0.34
C3 1A DNA:100 Actin2 27.64 27.93 0.34
C4 2A DNA:100 Actin2 27.27 27.12 0.29
C5 2A DNA:100 Actin2 26.78 27.12 0.29
C6 2A DNA:100 Actin2 27.31 27.12 0.29
C7 3A DNA:100 Actin2 28.09 27.85 0.38
C8 3A DNA:100 Actin2 28.06 27.85 0.38
C9 3A DNA:100 Actin2 27.42 27.85 0.38
C10 4A DNA:100 Actin2 27.83 28.13 0.26
C11 4A DNA:100 Actin2 28.25 28.13 0.26
C12 4A DNA:100 Actin2 28.31 28.13 0.26
D1 1As DNA E1A 24.96 24.31 0.65
D2 1As DNA E1A 24.30 24.31 0.65
D3 1As DNA E1A 23.66 24.31 0.65
D4 2As DNA E1A 23.58 23.45 0.20
D5 2As DNA E1A 23.22 23.45 0.20
D6 2As DNA E1A 23.54 23.45 0.20
D7 3As DNA E1A 23.24 23.15 0.48
D8 3As DNA E1A 23.58 23.15 0.48
D9 3As DNA E1A 22.63 23.15 0.48
D10 4As DNA E1A 23.74 23.45 0.38
D11 4As DNA E1A 23.61 23.45 0.38
D12 4As DNA E1A 23.02 23.45 0.38
E1 1As DNA Hex 24.50 24.40 0.22
E2 1As DNA Hex 24.14 24.40 0.22
E3 1As DNA Hex 24.55 24.40 0.22
E4 2As DNA Hex 24.36 23.83 0.60
E5 2As DNA Hex 23.95 23.83 0.60
E6 2As DNA Hex 23.18 23.83 0.60
E7 3As DNA Hex 23.63 23.89 0.26
E8 3As DNA Hex 24.14 23.89 0.26
E9 3As DNA Hex 23.91 23.89 0.26
E10 4As DNA Hex 23.62 23.37 0.47
E11 4As DNA Hex 22.84 23.37 0.47
E12 4As DNA Hex 23.66 23.37 0.47
F1 1As DNA Actin2 30.36 30.26 0.24
F2 1As DNA Actin2 30.44 30.26 0.24
F3 1As DNA Actin2 29.99 30.26 0.24
F4 2As DNA Actin2 28.79 28.04 0.66
F5 2As DNA Actin2 27.77 28.04 0.66
F6 2As DNA Actin2 27.55 28.04 0.66
F7 3As DNA Actin2 28.67 28.22 0.68
F8 3As DNA Actin2 27.44 28.22 0.68
F9 3As DNA Actin2 28.56 28.22 0.68
F10 4As DNA Actin2 28.17 28.78 0.55
F11 4As DNA Actin2 28.96 28.78 0.55
F12 4As DNA Actin2 29.22 28.78 0.55
G1 1G DNA:1 E1A 17.96 17.52 0.38
G2 1G DNA:1 E1A 17.37 17.52 0.38
G3 1G DNA:1 E1A 17.24 17.52 0.38
G4 1G DNA:10 E1A 21.07 20.88 0.16
G5 1G DNA:10 E1A 20.81 20.88 0.16
G6 1G DNA:10 E1A 20.76 20.88 0.16
G7 1G DNA:100 E1A 24.15 24.05 0.21
G8 1G DNA:100 E1A 24.20 24.05 0.21
G9 1G DNA:100 E1A 23.81 24.05 0.21
G10 1G DNA:1000 E1A 27.48 27.44 0.27
G11 1G DNA:1000 E1A 27.69 27.44 0.27
G12 1G DNA:1000 E1A 27.16 27.44 0.27
H1 1G DNA:1 Hex 17.92 18.09 0.55
H2 1G DNA:1 Hex 18.71 18.09 0.55
H3 1G DNA:1 Hex 17.65 18.09 0.55
H4 1G DNA:10 Hex 21.75 21.57 0.19
H5 1G DNA:10 Hex 21.59 21.57 0.19
H6 1G DNA:10 Hex 21.38 21.57 0.19
H7 1G DNA:100 Hex 24.65 24.76 0.12
H8 1G DNA:100 Hex 24.75 24.76 0.12
H9 1G DNA:100 Hex 24.89 24.76 0.12
H10 1G DNA:1000 Hex 27.98 27.90 0.16
H11 1G DNA:1000 Hex 28.00 27.90 0.16
H12 1G DNA:1000 Hex 27.71 27.90 0.16
Analysis Parameters






Baseline range (from cycle no. ... to) n/a
Drift Correction OFF
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4.123 DNA2 
 
Pos Name Ct SYBR Ct Mean SYBR Ct Dev. SYBR Expr. Level SYBR Range SYBR
A1 1B DNA:100 E1A 28.76 28.55 0.30
A2 1B DNA:100 E1A 28.68 28.55 0.30
A3 1B DNA:100 E1A 28.21 28.55 0.30
A4 2B DNA:100 E1A 29.78 29.41 0.34
A5 2B DNA:100 E1A 29.36 29.41 0.34
A6 2B DNA:100 E1A 29.11 29.41 0.34
A7 3B DNA:100 E1A 28.34 28.61 0.24
A8 3B DNA:100 E1A 28.80 28.61 0.24
A9 3B DNA:100 E1A 28.70 28.61 0.24
A10 4B DNA:100 E1A 29.41 29.28 0.30
A11 4B DNA:100 E1A 28.93 29.28 0.30
A12 4B DNA:100 E1A 29.50 29.28 0.30
B1 1B DNA:100 Hex 29.05 28.50 0.58
B2 1B DNA:100 Hex 28.56 28.50 0.58
B3 1B DNA:100 Hex 27.90 28.50 0.58
B4 2B DNA:100 Hex 29.57 29.61 0.19 0.486 0.419 - 0.564
B5 2B DNA:100 Hex 29.82 29.61 0.19 0.486 0.419 - 0.564
B6 2B DNA:100 Hex 29.46 29.61 0.19 0.486 0.419 - 0.564
B7 3B DNA:100 Hex 29.25 28.97 0.27 0.385 0.312 - 0.476
B8 3B DNA:100 Hex 28.92 28.97 0.27 0.385 0.312 - 0.476
B9 3B DNA:100 Hex 28.72 28.97 0.27 0.385 0.312 - 0.476
B10 4B DNA:100 Hex 29.31 29.14 0.15 0.557 0.443 - 0.700
B11 4B DNA:100 Hex 29.03 29.14 0.15 0.557 0.443 - 0.700
B12 4B DNA:100 Hex 29.09 29.14 0.15 0.557 0.443 - 0.700
C1 1B DNA:100 Actin2 29.62 28.39 1.07
C2 1B DNA:100 Actin2 27.86 28.39 1.07
C3 1B DNA:100 Actin2 27.69 28.39 1.07
C4 2B DNA:100 Actin2 28.57 28.46 0.11
C5 2B DNA:100 Actin2 28.37 28.46 0.11
C6 2B DNA:100 Actin2 28.43 28.46 0.11
C7 3B DNA:100 Actin2 27.55 27.47 0.14
C8 3B DNA:100 Actin2 27.56 27.47 0.14
C9 3B DNA:100 Actin2 27.31 27.47 0.14
C10 4B DNA:100 Actin2 27.99 28.18 0.29
C11 4B DNA:100 Actin2 28.04 28.18 0.29
C12 4B DNA:100 Actin2 28.52 28.18 0.29
D1 1C DNA:100 E1A 26.02 25.65 0.32
D2 1C DNA:100 E1A 25.46 25.65 0.32
D3 1C DNA:100 E1A 25.46 25.65 0.32
D4 2C DNA:100 E1A 28.72 28.98 0.50
D5 2C DNA:100 E1A 29.55 28.98 0.50
D6 2C DNA:100 E1A 28.66 28.98 0.50
D7 3C DNA:100 E1A 31.01 30.76 0.56
D8 3C DNA:100 E1A 30.11 30.76 0.56
D9 3C DNA:100 E1A 31.15 30.76 0.56
D10 4C DNA:100 E1A 30.37 30.07 0.27
D11 4C DNA:100 E1A 30.02 30.07 0.27
D12 4C DNA:100 E1A 29.84 30.07 0.27
E1 1C DNA:100 Hex 26.43 25.85 0.51 3.34 1.84 - 6.05
E2 1C DNA:100 Hex 25.46 25.85 0.51 3.34 1.84 - 6.05
E3 1C DNA:100 Hex 25.66 25.85 0.51 3.34 1.84 - 6.05
E4 2C DNA:100 Hex 28.99 28.68 0.34 0.440 0.325 - 0.595
E5 2C DNA:100 Hex 28.32 28.68 0.34 0.440 0.325 - 0.595
E6 2C DNA:100 Hex 28.73 28.68 0.34 0.440 0.325 - 0.595
E7 3C DNA:100 Hex 30.86 30.84 0.23 0.195 0.147 - 0.257
E8 3C DNA:100 Hex 30.60 30.84 0.23 0.195 0.147 - 0.257
E9 3C DNA:100 Hex 31.06 30.84 0.23 0.195 0.147 - 0.257
E10 4C DNA:100 Hex 29.87 30.13 0.30 0.149 0.110 - 0.202
E11 4C DNA:100 Hex 30.06 30.13 0.30 0.149 0.110 - 0.202
E12 4C DNA:100 Hex 30.46 30.13 0.30 0.149 0.110 - 0.202
F1 1C DNA:100 Actin2 28.26 27.48 0.69
F2 1C DNA:100 Actin2 27.21 27.48 0.69
F3 1C DNA:100 Actin2 26.96 27.48 0.69
F4 2C DNA:100 Actin2 27.61 27.38 0.27
F5 2C DNA:100 Actin2 27.08 27.38 0.27
F6 2C DNA:100 Actin2 27.45 27.38 0.27
F7 3C DNA:100 Actin2 28.74 28.36 0.33
F8 3C DNA:100 Actin2 28.25 28.36 0.33
F9 3C DNA:100 Actin2 28.11 28.36 0.33
F10 4C DNA:100 Actin2 27.18 27.27 0.32
F11 4C DNA:100 Actin2 27.00 27.27 0.32
F12 4C DNA:100 Actin2 27.63 27.27 0.32
G1 1G DNA:1 E1A 17.91 17.39 0.55
G2 1G DNA:1 E1A 17.45 17.39 0.55
G3 1G DNA:1 E1A 16.81 17.39 0.55
G4 1G DNA:10 E1A 20.73 20.53 0.20
G5 1G DNA:10 E1A 20.34 20.53 0.20
G6 1G DNA:10 E1A 20.51 20.53 0.20
G7 1G DNA:100 E1A 24.26 24.00 0.23
G8 1G DNA:100 E1A 23.89 24.00 0.23
G9 1G DNA:100 E1A 23.85 24.00 0.23
G10 1G DNA:1000 E1A 27.18 27.13 0.12
G11 1G DNA:1000 E1A 26.99 27.13 0.12
G12 1G DNA:1000 E1A 27.22 27.13 0.12
H1 1G DNA:1 Hex 17.48 17.74 0.23
H2 1G DNA:1 Hex 17.92 17.74 0.23
H3 1G DNA:1 Hex 17.84 17.74 0.23
H4 1G DNA:10 Hex 21.54 21.47 0.12
H5 1G DNA:10 Hex 21.54 21.47 0.12
H6 1G DNA:10 Hex 21.34 21.47 0.12
H7 1G DNA:100 Hex 24.71 24.75 0.10
H8 1G DNA:100 Hex 24.68 24.75 0.10
H9 1G DNA:100 Hex 24.87 24.75 0.10
H10 1G DNA:1000 Hex 28.11 27.91 0.23
H11 1G DNA:1000 Hex 27.97 27.91 0.23
H12 1G DNA:1000 Hex 27.66 27.91 0.23
Analysis Parameters






Baseline range (from cycle no. ... to) n/a
Drift Correction OFF
	  	   177 
4.123 DNA3 
 
Pos Name Ct SYBR Ct Mean SYBR Ct Dev. SYBR Expr. Level SYBR Range SYBR
A1 1D DNA:100 E1A 19.45 19.26 0.17
A2 1D DNA:100 E1A 19.22 19.26 0.17
A3 1D DNA:100 E1A 19.11 19.26 0.17
A4 2D DNA:100 E1A 21.74 21.59 0.15
A5 2D DNA:100 E1A 21.59 21.59 0.15
A6 2D DNA:100 E1A 21.43 21.59 0.15
A7 3D DNA:100 E1A 26.21 26.33 0.13
A8 3D DNA:100 E1A 26.46 26.33 0.13
A9 3D DNA:100 E1A 26.34 26.33 0.13
A10 4D DNA:100 E1A 26.97 27.23 0.39
A11 4D DNA:100 E1A 27.04 27.23 0.39
A12 4D DNA:100 E1A 27.68 27.23 0.39
B1 1D DNA:100 Hex 19.87 19.36 0.50
B2 1D DNA:100 Hex 19.35 19.36 0.50
B3 1D DNA:100 Hex 18.86 19.36 0.50
B4 2D DNA:100 Hex 22.27 22.30 0.21 4.220E-2X 3.09E-02 - 5.77E-02
B5 2D DNA:100 Hex 22.52 22.30 0.21 4.220E-2X 3.09E-02 - 5.77E-02
B6 2D DNA:100 Hex 22.11 22.30 0.21 4.220E-2X 3.09E-02 - 5.77E-02
B7 3D DNA:100 Hex 26.57 26.38 0.16 9.140E-4X 7.89E-04 - 1.06E-03
B8 3D DNA:100 Hex 26.26 26.38 0.16 9.140E-4X 7.89E-04 - 1.06E-03
B9 3D DNA:100 Hex 26.32 26.38 0.16 9.140E-4X 7.89E-04 - 1.06E-03
B10 4D DNA:100 Hex 27.42 27.40 0.10 7.810E-4X 5.96E-04 - 1.02E-03
B11 4D DNA:100 Hex 27.28 27.40 0.10 7.810E-4X 5.96E-04 - 1.02E-03
B12 4D DNA:100 Hex 27.49 27.40 0.10 7.810E-4X 5.96E-04 - 1.02E-03
C1 1D DNA:100 Actin2 30.21 29.43 0.73
C2 1D DNA:100 Actin2 29.31 29.43 0.73
C3 1D DNA:100 Actin2 28.76 29.43 0.73
C4 2D DNA:100 Actin2 27.91 27.80 0.40
C5 2D DNA:100 Actin2 27.36 27.80 0.40
C6 2D DNA:100 Actin2 28.13 27.80 0.40
C7 3D DNA:100 Actin2 26.51 26.35 0.14
C8 3D DNA:100 Actin2 26.26 26.35 0.14
C9 3D DNA:100 Actin2 26.29 26.35 0.14
C10 4D DNA:100 Actin2 26.88 27.14 0.37
C11 4D DNA:100 Actin2 26.97 27.14 0.37
C12 4D DNA:100 Actin2 27.57 27.14 0.37
D1 1E DNA:100 E1A 16.17 15.92 0.27
D2 1E DNA:100 E1A 15.95 15.92 0.27
D3 1E DNA:100 E1A 15.64 15.92 0.27
D4 2E DNA:100 E1A 19.74 19.53 0.19
D5 2E DNA:100 E1A 19.40 19.53 0.19
D6 2E DNA:100 E1A 19.44 19.53 0.19
D7 3E DNA:100 E1A 24.71 24.70 0.06
D8 3E DNA:100 E1A 24.75 24.70 0.06
D9 3E DNA:100 E1A 24.64 24.70 0.06
D10 4E DNA:100 E1A 26.51 26.62 0.14
D11 4E DNA:100 E1A 26.78 26.62 0.14
D12 4E DNA:100 E1A 26.58 26.62 0.14
E1 1E DNA:100 Hex 16.76 16.29 0.41 7.36 4.94 - 11.0
E2 1E DNA:100 Hex 16.13 16.29 0.41 7.36 4.94 - 11.0
E3 1E DNA:100 Hex 15.99 16.29 0.41 7.36 4.94 - 11.0
E4 2E DNA:100 Hex 20.41 20.17 0.20 0.413 0.263 - 0.649
E5 2E DNA:100 Hex 20.10 20.17 0.20 0.413 0.263 - 0.649
E6 2E DNA:100 Hex 20.02 20.17 0.20 0.413 0.263 - 0.649
E7 3E DNA:100 Hex 25.23 25.33 0.23 8.600E-3X 7.21E-03 - 1.03E-02
E8 3E DNA:100 Hex 25.16 25.33 0.23 8.600E-3X 7.21E-03 - 1.03E-02
E9 3E DNA:100 Hex 25.59 25.33 0.23 8.600E-3X 7.21E-03 - 1.03E-02
E10 4E DNA:100 Hex 27.02 26.89 0.11 2.440E-3X 1.94E-03 - 3.06E-03
E11 4E DNA:100 Hex 26.79 26.89 0.11 2.440E-3X 1.94E-03 - 3.06E-03
E12 4E DNA:100 Hex 26.86 26.89 0.11 2.440E-3X 1.94E-03 - 3.06E-03
F1 1E DNA:100 Actin2 29.67 29.24 0.41
F2 1E DNA:100 Actin2 28.86 29.24 0.41
F3 1E DNA:100 Actin2 29.19 29.24 0.41
F4 2E DNA:100 Actin2 28.46 28.97 0.62
F5 2E DNA:100 Actin2 28.78 28.97 0.62
F6 2E DNA:100 Actin2 29.66 28.97 0.62
F7 3E DNA:100 Actin2 28.62 28.53 0.11
F8 3E DNA:100 Actin2 28.41 28.53 0.11
F9 3E DNA:100 Actin2 28.57 28.53 0.11
F10 4E DNA:100 Actin2 27.92 28.28 0.31
F11 4E DNA:100 Actin2 28.43 28.28 0.31
F12 4E DNA:100 Actin2 28.47 28.28 0.31
G1 1G DNA:1 E1A 16.80 17.35 0.48
G2 1G DNA:1 E1A 17.62 17.35 0.48
G3 1G DNA:1 E1A 17.64 17.35 0.48
G4 1G DNA:10 E1A 20.86 20.79 0.09
G5 1G DNA:10 E1A 20.82 20.79 0.09
G6 1G DNA:10 E1A 20.69 20.79 0.09
G7 1G DNA:100 E1A 23.97 23.95 0.14
G8 1G DNA:100 E1A 24.08 23.95 0.14
G9 1G DNA:100 E1A 23.80 23.95 0.14
G10 1G DNA:1000 E1A 27.38 27.52 0.18
G11 1G DNA:1000 E1A 27.47 27.52 0.18
G12 1G DNA:1000 E1A 27.72 27.52 0.18
H1 1G DNA:1 Hex 18.98 18.32 0.60
H2 1G DNA:1 Hex 17.79 18.32 0.60
H3 1G DNA:1 Hex 18.19 18.32 0.60
H4 1G DNA:10 Hex 22.12 22.02 0.11
H5 1G DNA:10 Hex 22.04 22.02 0.11
H6 1G DNA:10 Hex 21.91 22.02 0.11
H7 1G DNA:100 Hex 25.01 25.21 0.18
H8 1G DNA:100 Hex 25.28 25.21 0.18
H9 1G DNA:100 Hex 25.34 25.21 0.18
H10 1G DNA:1000 Hex 28.62 31.04 3.43
H11 1G DNA:1000 Hex
H12 1G DNA:1000 Hex 33.47 31.04 3.43
Analysis Parameters






Baseline range (from cycle no. ... to) n/a
Drift Correction OFF
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4.123 and 4.125 DNA4 
 
Pos Name Ct SYBR Ct Mean SYBR Ct Dev. SYBR Amount SYBR Target SYBR
A1 1G DNA:1 E1A 18.67 18.40 0.69 -
A2 1G DNA:1 E1A 18.92 18.40 0.69 -
A3 1G DNA:1 E1A 17.62 18.40 0.69 -
A4 2G DNA:1 E1A 17.93 17.73 0.17 -
A5 2G DNA:1 E1A 17.62 17.73 0.17 -
A6 2G DNA:1 E1A 17.65 17.73 0.17 -
A7 3G DNA:1 E1A 17.29 17.48 0.29 -
A8 3G DNA:1 E1A 17.81 17.48 0.29 -
A9 3G DNA:1 E1A 17.32 17.48 0.29 -
A10 4G DNA:1 E1A 17.22 17.27 0.17 -
A11 4G DNA:1 E1A 17.46 17.27 0.17 -
A12 4G DNA:1 E1A 17.12 17.27 0.17 -
B1 1G DNA:1 Hex 18.40 18.34 0.07 -
B2 1G DNA:1 Hex 18.27 18.34 0.07 -
B3 1G DNA:1 Hex 18.36 18.34 0.07 -
B4 2G DNA:1 Hex 18.88 18.43 0.41 -
B5 2G DNA:1 Hex 18.10 18.43 0.41 -
B6 2G DNA:1 Hex 18.30 18.43 0.41 -
B7 3G DNA:1 Hex 18.29 18.31 0.02 -
B8 3G DNA:1 Hex 18.33 18.31 0.02 -
B9 3G DNA:1 Hex 18.30 18.31 0.02 -
B10 4G DNA:1 Hex 18.07 17.93 0.12 -
B11 4G DNA:1 Hex 17.84 17.93 0.12 -
B12 4G DNA:1 Hex 17.88 17.93 0.12 -
C1 1G DNA:1 E1A 18.15 17.61 0.54 -
C2 1G DNA:1 E1A 17.62 17.61 0.54 -
C3 1G DNA:1 E1A 17.07 17.61 0.54 -
C4 1G DNA:10 E1A 21.40 21.17 0.20 -
C5 1G DNA:10 E1A 21.11 21.17 0.20 -
C6 1G DNA:10 E1A 21.02 21.17 0.20 -
C7 1G DNA:100 E1A 24.57 24.37 0.18 -
C8 1G DNA:100 E1A 24.33 24.37 0.18 -
C9 1G DNA:100 E1A 24.22 24.37 0.18 -
C10 1G DNA:1000 E1A 27.94 27.71 0.26 -
C11 1G DNA:1000 E1A 27.76 27.71 0.26 -
C12 1G DNA:1000 E1A 27.42 27.71 0.26 -
D1 1G DNA:1 Hex 18.69 17.98 0.63 -
D2 1G DNA:1 Hex 17.51 17.98 0.63 -
D3 1G DNA:1 Hex 17.74 17.98 0.63 -
D4 1G DNA:10 Hex 21.99 21.88 0.10 -
D5 1G DNA:10 Hex 21.86 21.88 0.10 -
D6 1G DNA:10 Hex 21.81 21.88 0.10 -
D7 1G DNA:100 Hex 24.98 25.04 0.19 -
D8 1G DNA:100 Hex 24.88 25.04 0.19 -
D9 1G DNA:100 Hex 25.25 25.04 0.19 -
D10 1G DNA:1000 Hex 28.78 28.67 0.40 -
D11 1G DNA:1000 Hex 28.22 28.67 0.40 -
D12 1G DNA:1000 Hex 28.99 28.67 0.40 -
E1 1G 5_6 DNA:1 E1A 17.72 17.38 0.34 -
E2 1G 5_6 DNA:1 E1A 17.40 17.38 0.34 -
E3 1G 5_6 DNA:1 E1A 17.03 17.38 0.34 -
E4 2G 5_6 DNA:1 E1A 17.48 17.50 0.33 -
E5 2G 5_6 DNA:1 E1A 17.18 17.50 0.33 -
E6 2G 5_6 DNA:1 E1A 17.84 17.50 0.33 -
E7 3G 5_6 DNA:1 E1A 18.63 18.54 0.09 -
E8 3G 5_6 DNA:1 E1A 18.44 18.54 0.09 -
E9 3G 5_6 DNA:1 E1A 18.56 18.54 0.09 -
E10 4G 5_6 DNA:1 E1A 19.22 19.45 0.34 -
E11 4G 5_6 DNA:1 E1A 19.84 19.45 0.34 -
E12 4G 5_6 DNA:1 E1A 19.28 19.45 0.34 -
F1 1G 5_6 DNA:1 Hex 18.41 17.97 0.44 -
F2 1G 5_6 DNA:1 Hex 17.53 17.97 0.44 -
F3 1G 5_6 DNA:1 Hex 17.97 17.97 0.44 -
F4 2G 5_6 DNA:1 Hex 18.39 18.08 0.27 -
F5 2G 5_6 DNA:1 Hex 17.89 18.08 0.27 -
F6 2G 5_6 DNA:1 Hex 17.96 18.08 0.27 -
F7 3G 5_6 DNA:1 Hex 19.54 19.40 0.54 -
F8 3G 5_6 DNA:1 Hex 19.86 19.40 0.54 -
F9 3G 5_6 DNA:1 Hex 18.80 19.40 0.54 -
F10 4G 5_6 DNA:1 Hex 20.72 20.46 0.24 -
F11 4G 5_6 DNA:1 Hex 20.24 20.46 0.24 -
F12 4G 5_6 DNA:1 Hex 20.41 20.46 0.24 -
G1 1G 5_6 DNA:10 E1A 20.84 20.75 0.09 -
G2 1G 5_6 DNA:10 E1A 20.75 20.75 0.09 -
G3 1G 5_6 DNA:10 E1A 20.65 20.75 0.09 -
G4 1G 5_6 DNA:100 E1A 24.18 23.96 0.19 -
G5 1G 5_6 DNA:100 E1A 23.88 23.96 0.19 -
G6 1G 5_6 DNA:100 E1A 23.83 23.96 0.19 -
G7 1G 5_6 DNA:1000 E1A 27.49 27.32 0.15 -
G8 1G 5_6 DNA:1000 E1A 27.20 27.32 0.15 -
G9 1G 5_6 DNA:1000 E1A 27.27 27.32 0.15 -
G10 1G 5_6 DNA:10000 E1A 30.75 30.92 0.15 -
G11 1G 5_6 DNA:10000 E1A 31.03 30.92 0.15 -
G12 1G 5_6 DNA:10000 E1A 30.99 30.92 0.15 -
H1 1G 5_6 DNA:10 Hex 22.02 21.95 0.24 -
H2 1G 5_6 DNA:10 Hex 22.14 21.95 0.24 -
H3 1G 5_6 DNA:10 Hex 21.68 21.95 0.24 -
H4 1G 5_6 DNA:100 Hex 25.34 25.15 0.17 -
H5 1G 5_6 DNA:100 Hex 25.13 25.15 0.17 -
H6 1G 5_6 DNA:100 Hex 24.99 25.15 0.17 -
H7 1G 5_6 DNA:1000 Hex 28.41 28.44 0.03 -
H8 1G 5_6 DNA:1000 Hex 28.44 28.44 0.03 -
H9 1G 5_6 DNA:1000 Hex 28.47 28.44 0.03 -
H10 1G 5_6 DNA:10000 Hex 31.48 31.24 0.67 -
H11 1G 5_6 DNA:10000 Hex 31.77 31.24 0.67 -
H12 1G 5_6 DNA:10000 Hex 30.48 31.24 0.67 -
Subassay Subassay A1-D12 Analysis Parameters






Baseline range (from cycle no. ... to) n/a
Drift Correction OFF
Subassay Subassay E1-H12 Analysis Parameters






Baseline range (from cycle no. ... to) n/a
Drift Correction OFF
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4.125 DNA1 
 
Pos Name Ct SYBR Ct Mean SYBR Ct Dev. SYBR Amount SYBR Target SYBR
A1 1A DNA:100 E1A 27.30 27.00 0.30 -
A2 1A DNA:100 E1A 27.01 27.00 0.30 -
A3 1A DNA:100 E1A 26.70 27.00 0.30 -
A4 2A DNA:100 E1A 27.03 26.85 0.25 -
A5 2A DNA:100 E1A 26.96 26.85 0.25 -
A6 2A DNA:100 E1A 26.57 26.85 0.25 -
A7 3A DNA:100 E1A 26.74 26.60 0.12 -
A8 3A DNA:100 E1A 26.50 26.60 0.12 -
A9 3A DNA:100 E1A 26.57 26.60 0.12 -
A10 4A DNA:100 E1A 26.92 26.84 0.20 -
A11 4A DNA:100 E1A 26.62 26.84 0.20 -
A12 4A DNA:100 E1A 26.99 26.84 0.20 -
B1 1A DNA:100 Hex 28.19 27.57 0.63 -
B2 1A DNA:100 Hex 27.60 27.57 0.63 -
B3 1A DNA:100 Hex 26.93 27.57 0.63 -
B4 2A DNA:100 Hex 27.49 27.41 0.14 -
B5 2A DNA:100 Hex 27.25 27.41 0.14 -
B6 2A DNA:100 Hex 27.48 27.41 0.14 -
B7 3A DNA:100 Hex 27.65 27.37 0.24 -
B8 3A DNA:100 Hex 27.24 27.37 0.24 -
B9 3A DNA:100 Hex 27.22 27.37 0.24 -
B10 4A DNA:100 Hex 27.20 27.40 0.26 -
B11 4A DNA:100 Hex 27.30 27.40 0.26 -
B12 4A DNA:100 Hex 27.69 27.40 0.26 -
C1 1A DNA:100 Actin2 29.83 28.86 0.84 -
C2 1A DNA:100 Actin2 28.36 28.86 0.84 -
C3 1A DNA:100 Actin2 28.39 28.86 0.84 -
C4 2A DNA:100 Actin2 28.90 28.61 0.27 -
C5 2A DNA:100 Actin2 28.57 28.61 0.27 -
C6 2A DNA:100 Actin2 28.37 28.61 0.27 -
C7 3A DNA:100 Actin2 28.56 28.65 0.11 -
C8 3A DNA:100 Actin2 28.77 28.65 0.11 -
C9 3A DNA:100 Actin2 28.64 28.65 0.11 -
C10 4A DNA:100 Actin2 28.86 29.09 0.41 -
C11 4A DNA:100 Actin2 28.84 29.09 0.41 -
C12 4A DNA:100 Actin2 29.57 29.09 0.41 -
D1 1As DNA:1 E1A 24.72 24.32 0.38 -
D2 1As DNA:1 E1A 24.27 24.32 0.38 -
D3 1As DNA:1 E1A 23.96 24.32 0.38 -
D4 2As DNA:1 E1A 24.13 23.86 0.27 -
D5 2As DNA:1 E1A 23.60 23.86 0.27 -
D6 2As DNA:1 E1A 23.86 23.86 0.27 -
D7 3As DNA:1 E1A 23.82 23.90 0.16 -
D8 3As DNA:1 E1A 24.09 23.90 0.16 -
D9 3As DNA:1 E1A 23.79 23.90 0.16 -
D10 4As DNA:1 E1A 24.12 23.61 0.50 -
D11 4As DNA:1 E1A 23.56 23.61 0.50 -
D12 4As DNA:1 E1A 23.14 23.61 0.50 -
E1 1As DNA:1 Hex 25.32 24.97 0.30 -
E2 1As DNA:1 Hex 24.77 24.97 0.30 -
E3 1As DNA:1 Hex 24.83 24.97 0.30 -
E4 2As DNA:1 Hex 23.93 24.04 0.33 -
E5 2As DNA:1 Hex 23.78 24.04 0.33 -
E6 2As DNA:1 Hex 24.41 24.04 0.33 -
E7 3As DNA:1 Hex 24.31 24.48 0.44 -
E8 3As DNA:1 Hex 24.15 24.48 0.44 -
E9 3As DNA:1 Hex 24.98 24.48 0.44 -
E10 4As DNA:1 Hex 24.42 24.75 0.33 -
E11 4As DNA:1 Hex 24.76 24.75 0.33 -
E12 4As DNA:1 Hex 25.07 24.75 0.33 -
F1 1As DNA:1 Actin2 30.74 30.22 0.49 -
F2 1As DNA:1 Actin2 29.76 30.22 0.49 -
F3 1As DNA:1 Actin2 30.16 30.22 0.49 -
F4 2As DNA:1 Actin2 28.97 29.10 0.44 -
F5 2As DNA:1 Actin2 29.60 29.10 0.44 -
F6 2As DNA:1 Actin2 28.74 29.10 0.44 -
F7 3As DNA:1 Actin2 30.97 30.66 0.32 -
F8 3As DNA:1 Actin2 30.34 30.66 0.32 -
F9 3As DNA:1 Actin2 30.66 30.66 0.32 -
F10 4As DNA:1 Actin2 30.99 31.90 1.16 -
F11 4As DNA:1 Actin2 31.50 31.90 1.16 -
F12 4As DNA:1 Actin2 33.20 31.90 1.16 -
G1 1G DNA:10 E1A 21.03 20.92 0.10 -
G2 1G DNA:10 E1A 20.90 20.92 0.10 -
G3 1G DNA:10 E1A 20.83 20.92 0.10 -
G4 1G DNA:100 E1A 23.98 23.92 0.06 -
G5 1G DNA:100 E1A 23.89 23.92 0.06 -
G6 1G DNA:100 E1A 23.89 23.92 0.06 -
G7 1G DNA:1000 E1A 27.53 27.46 0.07 -
G8 1G DNA:1000 E1A 27.46 27.46 0.07 -
G9 1G DNA:1000 E1A 27.38 27.46 0.07 -
G10 1G DNA:10000 E1A 30.92 30.77 0.27 -
G11 1G DNA:10000 E1A 30.45 30.77 0.27 -
G12 1G DNA:10000 E1A 30.93 30.77 0.27 -
H1 1G DNA:10 Hex 22.02 21.86 0.16 -
H2 1G DNA:10 Hex 21.87 21.86 0.16 -
H3 1G DNA:10 Hex 21.70 21.86 0.16 -
H4 1G DNA:100 Hex 25.43 25.10 0.29 -
H5 1G DNA:100 Hex 25.01 25.10 0.29 -
H6 1G DNA:100 Hex 24.87 25.10 0.29 -
H7 1G DNA:1000 Hex 28.38 28.54 0.17 -
H8 1G DNA:1000 Hex 28.71 28.54 0.17 -
H9 1G DNA:1000 Hex 28.53 28.54 0.17 -
H10 1G DNA:10000 Hex 31.70 31.77 0.34 -
H11 1G DNA:10000 Hex 32.14 31.77 0.34 -
H12 1G DNA:10000 Hex 31.46 31.77 0.34 -
Analysis Parameters






Baseline range (from cycle no. ... to) n/a
Drift Correction OFF
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4.125 DNA2 
 
Pos Name Ct SYBR Ct Mean SYBR Ct Dev. SYBR Expr. Level SYBR Range SYBR
A1 1B DNA:100 E1A 29.63 29.82 0.18
A2 1B DNA:100 E1A 30.00 29.82 0.18
A3 1B DNA:100 E1A 29.82 29.82 0.18
A4 2B DNA:100 E1A 30.09 29.69 0.36
A5 2B DNA:100 E1A 29.40 29.69 0.36
A6 2B DNA:100 E1A 29.57 29.69 0.36
A7 3B DNA:100 E1A 30.43 30.33 0.28
A8 3B DNA:100 E1A 30.54 30.33 0.28
A9 3B DNA:100 E1A 30.01 30.33 0.28
A10 4B DNA:100 E1A 29.95 29.64 0.49
A11 4B DNA:100 E1A 29.08 29.64 0.49
A12 4B DNA:100 E1A 29.90 29.64 0.49
B1 1B DNA:100 Hex 30.45 30.19 0.53
B2 1B DNA:100 Hex 30.53 30.19 0.53
B3 1B DNA:100 Hex 29.58 30.19 0.53
B4 2B DNA:100 Hex 29.87 29.94 0.05 0.181 0.149 - 0.219
B5 2B DNA:100 Hex 29.97 29.94 0.05 0.181 0.149 - 0.219
B6 2B DNA:100 Hex 29.96 29.94 0.05 0.181 0.149 - 0.219
B7 3B DNA:100 Hex 30.93 30.92 0.08 0.213 0.168 - 0.271
B8 3B DNA:100 Hex 30.83 30.92 0.08 0.213 0.168 - 0.271
B9 3B DNA:100 Hex 30.99 30.92 0.08 0.213 0.168 - 0.271
B10 4B DNA:100 Hex 30.24 30.12 0.28 0.138 9.61E-02 - 0.199
B11 4B DNA:100 Hex 29.80 30.12 0.28 0.138 9.61E-02 - 0.199
B12 4B DNA:100 Hex 30.32 30.12 0.28 0.138 9.61E-02 - 0.199
C1 1B DNA:100 Actin2 32.15 31.20 0.86
C2 1B DNA:100 Actin2 30.95 31.20 0.86
C3 1B DNA:100 Actin2 30.50 31.20 0.86
C4 2B DNA:100 Actin2 28.77 28.48 0.27
C5 2B DNA:100 Actin2 28.22 28.48 0.27
C6 2B DNA:100 Actin2 28.45 28.48 0.27
C7 3B DNA:100 Actin2 29.86 29.70 0.34
C8 3B DNA:100 Actin2 29.93 29.70 0.34
C9 3B DNA:100 Actin2 29.31 29.70 0.34
C10 4B DNA:100 Actin2 28.09 28.28 0.45
C11 4B DNA:100 Actin2 27.96 28.28 0.45
C12 4B DNA:100 Actin2 28.79 28.28 0.45
D1 1C DNA:100 E1A 27.51 26.73 0.67
D2 1C DNA:100 E1A 26.39 26.73 0.67
D3 1C DNA:100 E1A 26.30 26.73 0.67
D4 2C DNA:100 E1A 30.58 30.72 0.32
D5 2C DNA:100 E1A 30.49 30.72 0.32
D6 2C DNA:100 E1A 31.09 30.72 0.32
D7 3C DNA:100 E1A 31.27 30.94 0.28
D8 3C DNA:100 E1A 30.80 30.94 0.28
D9 3C DNA:100 E1A 30.76 30.94 0.28
D10 4C DNA:100 E1A 30.71 29.90 0.78
D11 4C DNA:100 E1A 29.15 29.90 0.78
D12 4C DNA:100 E1A 29.84 29.90 0.78
E1 1C DNA:100 Hex 27.48 26.96 0.45 2.48 1.54 - 3.99
E2 1C DNA:100 Hex 26.67 26.96 0.45 2.48 1.54 - 3.99
E3 1C DNA:100 Hex 26.73 26.96 0.45 2.48 1.54 - 3.99
E4 2C DNA:100 Hex 30.89 30.66 0.34 0.118 8.71E-02 - 0.159
E5 2C DNA:100 Hex 30.27 30.66 0.34 0.118 8.71E-02 - 0.159
E6 2C DNA:100 Hex 30.82 30.66 0.34 0.118 8.71E-02 - 0.159
E7 3C DNA:100 Hex 31.21 30.71 0.48 6.830E-2X 4.86E-02 - 9.61E-02
E8 3C DNA:100 Hex 30.25 30.71 0.48 6.830E-2X 4.86E-02 - 9.61E-02
E9 3C DNA:100 Hex 30.67 30.71 0.48 6.830E-2X 4.86E-02 - 9.61E-02
E10 4C DNA:100 Hex 29.70 30.06 0.37 0.137 9.74E-02 - 0.193
E11 4C DNA:100 Hex 30.04 30.06 0.37 0.137 9.74E-02 - 0.193
E12 4C DNA:100 Hex 30.45 30.06 0.37 0.137 9.74E-02 - 0.193
F1 1C DNA:100 Actin2 29.86 29.28 0.51
F2 1C DNA:100 Actin2 29.10 29.28 0.51
F3 1C DNA:100 Actin2 28.88 29.28 0.51
F4 2C DNA:100 Actin2 28.84 28.59 0.27
F5 2C DNA:100 Actin2 28.30 28.59 0.27
F6 2C DNA:100 Actin2 28.63 28.59 0.27
F7 3C DNA:100 Actin2 27.98 27.86 0.11
F8 3C DNA:100 Actin2 27.83 27.86 0.11
F9 3C DNA:100 Actin2 27.76 27.86 0.11
F10 4C DNA:100 Actin2 28.16 28.21 0.32
F11 4C DNA:100 Actin2 27.92 28.21 0.32
F12 4C DNA:100 Actin2 28.55 28.21 0.32
G1 1G DNA:10 E1A 21.03 20.92 0.15
G2 1G DNA:10 E1A 20.99 20.92 0.15
G3 1G DNA:10 E1A 20.75 20.92 0.15
G4 1G DNA:100 E1A 24.46 24.21 0.22
G5 1G DNA:100 E1A 24.09 24.21 0.22
G6 1G DNA:100 E1A 24.06 24.21 0.22
G7 1G DNA:1000 E1A 28.10 27.78 0.32
G8 1G DNA:1000 E1A 27.80 27.78 0.32
G9 1G DNA:1000 E1A 27.46 27.78 0.32
G10 1G DNA:10000 E1A 30.87 31.47 0.73
G11 1G DNA:10000 E1A 31.27 31.47 0.73
G12 1G DNA:10000 E1A 32.28 31.47 0.73
H1 1G DNA:10 Hex 22.19 21.87 0.35
H2 1G DNA:10 Hex 21.93 21.87 0.35
H3 1G DNA:10 Hex 21.50 21.87 0.35
H4 1G DNA:100 Hex 24.97 25.04 0.36
H5 1G DNA:100 Hex 25.43 25.04 0.36
H6 1G DNA:100 Hex 24.73 25.04 0.36
H7 1G DNA:1000 Hex 27.90 28.43 0.47
H8 1G DNA:1000 Hex 28.82 28.43 0.47
H9 1G DNA:1000 Hex 28.57 28.43 0.47
H10 1G DNA:10000 Hex 30.94 31.51 0.75
H11 1G DNA:10000 Hex 31.23 31.51 0.75
H12 1G DNA:10000 Hex 32.36 31.51 0.75
Analysis Parameters






Baseline range (from cycle no. ... to) n/a
Drift Correction OFF
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4.125 DNA3 
  
Pos Name Ct SYBR Ct Mean SYBR Ct Dev. SYBR Expr. Level SYBR Range SYBR
A1 1D DNA:100 E1A 19.06 18.86 0.27
A2 1D DNA:100 E1A 18.96 18.86 0.27
A3 1D DNA:100 E1A 18.54 18.86 0.27
A4 2D DNA:100 E1A 22.91 22.45 0.42
A5 2D DNA:100 E1A 22.35 22.45 0.42
A6 2D DNA:100 E1A 22.08 22.45 0.42
A7 3D DNA:100 E1A 27.70 27.44 0.23
A8 3D DNA:100 E1A 27.26 27.44 0.23
A9 3D DNA:100 E1A 27.36 27.44 0.23
A10 4D DNA:100 E1A 28.40 28.57 0.23
A11 4D DNA:100 E1A 28.48 28.57 0.23
A12 4D DNA:100 E1A 28.83 28.57 0.23
B1 1D DNA:100 Hex 19.70 19.30 0.39
B2 1D DNA:100 Hex 19.29 19.30 0.39
B3 1D DNA:100 Hex 18.92 19.30 0.39
B4 2D DNA:100 Hex 23.06 22.86 0.18 3.070E-2X 2.68E-02 - 3.53E-02
B5 2D DNA:100 Hex 22.69 22.86 0.18 3.070E-2X 2.68E-02 - 3.53E-02
B6 2D DNA:100 Hex 22.84 22.86 0.18 3.070E-2X 2.68E-02 - 3.53E-02
B7 3D DNA:100 Hex 28.07 28.20 0.16 6.150E-4X 4.95E-04 - 7.65E-04
B8 3D DNA:100 Hex 28.38 28.20 0.16 6.150E-4X 4.95E-04 - 7.65E-04
B9 3D DNA:100 Hex 28.17 28.20 0.16 6.150E-4X 4.95E-04 - 7.65E-04
B10 4D DNA:100 Hex 28.99 29.09 0.09 8.270E-4X 6.76E-04 - 1.01E-03
B11 4D DNA:100 Hex 29.11 29.09 0.09 8.270E-4X 6.76E-04 - 1.01E-03
B12 4D DNA:100 Hex 29.18 29.09 0.09 8.270E-4X 6.76E-04 - 1.01E-03
C1 1D DNA:100 Actin2 29.81 29.11 0.61
C2 1D DNA:100 Actin2 28.69 29.11 0.61
C3 1D DNA:100 Actin2 28.83 29.11 0.61
C4 2D DNA:100 Actin2 27.72 27.64 0.08
C5 2D DNA:100 Actin2 27.56 27.64 0.08
C6 2D DNA:100 Actin2 27.64 27.64 0.08
C7 3D DNA:100 Actin2 27.54 27.34 0.27
C8 3D DNA:100 Actin2 27.45 27.34 0.27
C9 3D DNA:100 Actin2 27.04 27.34 0.27
C10 4D DNA:100 Actin2 28.71 28.66 0.28
C11 4D DNA:100 Actin2 28.36 28.66 0.28
C12 4D DNA:100 Actin2 28.90 28.66 0.28
D1 1E DNA:100 E1A 15.85 15.35 0.45
D2 1E DNA:100 E1A 15.24 15.35 0.45
D3 1E DNA:100 E1A 14.97 15.35 0.45
D4 2E DNA:100 E1A 19.79 19.68 0.10
D5 2E DNA:100 E1A 19.62 19.68 0.10
D6 2E DNA:100 E1A 19.64 19.68 0.10
D7 3E DNA:100 E1A 23.97 24.08 0.10
D8 3E DNA:100 E1A 24.08 24.08 0.10
D9 3E DNA:100 E1A 24.18 24.08 0.10
D10 4E DNA:100 E1A 24.83 24.67 0.15
D11 4E DNA:100 E1A 24.65 24.67 0.15
D12 4E DNA:100 E1A 24.54 24.67 0.15
E1 1E DNA:100 Hex 16.02 15.61 0.36 9.51 6.26 - 14.4
E2 1E DNA:100 Hex 15.48 15.61 0.36 9.51 6.26 - 14.4
E3 1E DNA:100 Hex 15.32 15.61 0.36 9.51 6.26 - 14.4
E4 2E DNA:100 Hex 20.07 19.90 0.15 0.469 0.415 - 0.531
E5 2E DNA:100 Hex 19.82 19.90 0.15 0.469 0.415 - 0.531
E6 2E DNA:100 Hex 19.80 19.90 0.15 0.469 0.415 - 0.531
E7 3E DNA:100 Hex 24.68 24.82 0.12 2.060E-2X 1.71E-02 - 2.48E-02
E8 3E DNA:100 Hex 24.88 24.82 0.12 2.060E-2X 1.71E-02 - 2.48E-02
E9 3E DNA:100 Hex 24.89 24.82 0.12 2.060E-2X 1.71E-02 - 2.48E-02
E10 4E DNA:100 Hex 24.95 24.98 0.11 1.540E-2X 1.39E-02 - 1.71E-02
E11 4E DNA:100 Hex 25.11 24.98 0.11 1.540E-2X 1.39E-02 - 1.71E-02
E12 4E DNA:100 Hex 24.89 24.98 0.11 1.540E-2X 1.39E-02 - 1.71E-02
F1 1E DNA:100 Actin2 29.15 28.66 0.48
F2 1E DNA:100 Actin2 28.64 28.66 0.48
F3 1E DNA:100 Actin2 28.19 28.66 0.48
F4 2E DNA:100 Actin2 28.51 28.61 0.10
F5 2E DNA:100 Actin2 28.62 28.61 0.10
F6 2E DNA:100 Actin2 28.70 28.61 0.10
F7 3E DNA:100 Actin2 29.28 29.02 0.24
F8 3E DNA:100 Actin2 28.96 29.02 0.24
F9 3E DNA:100 Actin2 28.81 29.02 0.24
F10 4E DNA:100 Actin2 28.71 28.76 0.10
F11 4E DNA:100 Actin2 28.70 28.76 0.10
F12 4E DNA:100 Actin2 28.88 28.76 0.10
G1 1G DNA:1 E1A 17.76 17.69 0.28
G2 1G DNA:1 E1A 17.92 17.69 0.28
G3 1G DNA:1 E1A 17.38 17.69 0.28
G4 1G DNA:10 E1A 20.86 20.82 0.08
G5 1G DNA:10 E1A 20.86 20.82 0.08
G6 1G DNA:10 E1A 20.73 20.82 0.08
G7 1G DNA:100 E1A 24.34 24.13 0.19
G8 1G DNA:100 E1A 23.97 24.13 0.19
G9 1G DNA:100 E1A 24.07 24.13 0.19
G10 1G DNA:1000 E1A 27.02 27.36 0.31
G11 1G DNA:1000 E1A 27.63 27.36 0.31
G12 1G DNA:1000 E1A 27.42 27.36 0.31
H1 1G DNA:1 Hex 18.73 18.49 0.50
H2 1G DNA:1 Hex 17.92 18.49 0.50
H3 1G DNA:1 Hex 18.82 18.49 0.50
H4 1G DNA:10 Hex 22.28 22.10 0.16
H5 1G DNA:10 Hex 22.03 22.10 0.16
H6 1G DNA:10 Hex 21.99 22.10 0.16
H7 1G DNA:100 Hex 25.09 25.12 0.05
H8 1G DNA:100 Hex 25.09 25.12 0.05
H9 1G DNA:100 Hex 25.18 25.12 0.05
H10 1G DNA:1000 Hex 28.51 28.58 0.07
H11 1G DNA:1000 Hex 28.66 28.58 0.07
H12 1G DNA:1000 Hex 28.57 28.58 0.07
Analysis Parameters






Baseline range (from cycle no. ... to) n/a
Drift Correction OFF
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All DNA qPCR results 
 
  











1B 100 27.73 28.05 27.06 1 1 3.14E+04 50509.3056 113689.5463 1 0
2B 100 29.18 30.18 27.85 0.6328783 0.39502066 1.20E+04 13312.2759 69574.34266 0.14545455 0.19939758
3B 100 28.56 29.51 27.92 1.02101213 0.65975396 1.81E+04 20249.6038 66611.8728 0.00081818 0.43975506
4B 100 28.71 29.33 28.21 1.12505848 0.91383145 1.64E+04 22665.0234 55623.98956 2.5455E-05 0.65516935
1B 100 28.55 28.5 27.775 1 1 1.83E+04 38108.5386 72894.77481 1 0
2B 100 29.41 29.61 28.46 0.88576752 0.74483873 1.03E+04 19020.7589 47618.00307 0.26580227 0.22511248
3B 100 28.61 28.97 27.47 0.77646888 0.58438862 1.75E+04 28394.5803 88112.06211 0.00641815 0.44309995
4B 100 29.28 29.14 28.18 0.79829839 0.849685 1.13E+04 25527.876 56671.02264 0.00181524 0.60031006
1B 100 29.82 30.19 30.725 1 1 7.89E+03 13229.1957 11649.38814 1 0
2B 100 29.69 29.94 28.48 0.23084558 0.25086794 8.59E+03 15470.5291 47029.66684 0.08448276 0.20298051
3B 100 30.33 30.92 29.7 0.34507934 0.29627319 5.63E+03 8376.37301 22030.07805 0.00775862 0.37206716
4B 100 29.64 30.12 28.28 0.20804968 0.19277635 8.88E+03 13821.8293 53255.5246 0.00362069 0.50409828
1B 100 28.22 29.18 27.89 1 1 2.27E+04 24896.5521 67865.73529 1 0
2B 100 29.58 30.14 28.33 0.52850902 0.69737183 9.24E+03 13649.8471 51625.76211 0.02121951 0.1877802
3B 100 28.61 29.46 27.3 0.50697974 0.54714685 1.75E+04 20893.4845 97933.03539 0.00139024 0.41347751









1C 100 27.24 27.68 27.47 1 1 4.34E+04 63675.0872 88112.06211 1 0
2C 100 28 28.46 27.25 0.50697974 0.5 2.63E+04 39074.8906 101024.6621 0.14545455 0.19939758
3C 100 29.39 29.72 26.89 0.15072598 0.16266773 1.05E+04 17754.9839 126361.3868 0.00081818 0.43975506
4C 100 29.77 30.25 27.55 0.18301071 0.17800627 8.15E+03 12741.4903 83837.4884 2.5455E-05 0.65516935
1C 100 25.65 25.85 27.48 1 1 1.24E+05 200226.966 87566.04342 1 0
2C 100 28.98 28.68 27.38 0.09278272 0.13121459 1.37E+04 34047.2981 93182.01756 0.26580227 0.22511248
3C 100 30.76 30.84 28.36 0.05328968 0.05791175 4.24E+03 8806.57342 50671.94343 0.00641815 0.44309995
4C 100 30.07 30.13 27.27 0.04038603 0.04450157 6.69E+03 13735.569 99776.46892 0.00181524 0.60031006
1C 100 26.73 26.96 29.28 1 1 6.08E+04 99937.4153 28602.29241 1 0
2C 100 30.72 30.66 28.59 0.03901033 0.0476956 4.35E+03 9857.04187 43921.37033 0.08448276 0.20298051
3C 100 30.94 30.71 27.86 0.02019301 0.02777633 3.76E+03 9553.2745 69143.19975 0.00775862 0.37206716
4C 100 29.9 30.06 28.21 0.05292158 0.05555267 7.48E+03 14350.8868 55623.98956 0.00362069 0.50409828









1D 100 19.07 19 28.05 1 1 9.59E+06 14586389.2 61440.72714 1 0
2D 100 22.88 23.06 27.66 0.05440941 0.04575268 7.74E+05 1148383.66 78296.48014 0.14545455 0.19939758
3D 100 29.99 30.24 27.76 0.00042214 0.00033816 7.05E+03 12821.5077 73577.64039 0.00081818 0.43975506
4D 100 31.17 31.05 28.02 0.0002231 0.00023097 3.23E+03 7721.66067 62597.25104 2.5455E-05 0.65516935
1D 100 19.26 19.36 29.43 1 1 8.46E+06 11643097 26055.91139 1 0
2D 100 21.59 22.3 27.8 0.06425711 0.04210105 1.81E+06 1848081.18 71770.72 0.26580227 0.22511248
3D 100 26.33 26.38 26.35 0.00088013 0.00091117 7.92E+04 143688.666 176764.4186 0.00641815 0.44309995
4D 100 27.23 27.4 27.14 0.00081552 0.00077689 4.37E+04 75874.8559 108174.1341 0.00181524 0.60031006
1D 100 18.86 19.3 29.11 1 1 1.10E+07 12088759.3 31790.30485 1 0
2D 100 22.45 22.86 27.64 0.029977 0.03060688 1.03E+06 1301560.57 79275.96094 0.08448276 0.20298051
3D 100 27.44 28.2 27.34 0.0007662 0.00061378 3.80E+04 45982.0536 95527.99498 0.00775862 0.37206716
4D 100 28.57 29.09 28.66 0.00087405 0.0008269 1.80E+04 26339.591 42051.20194 0.00362069 0.50409828









1E 100 15.92 16.29 29.24 1 1 7.69E+07 79572184.9 29322.39199 1 0
2E 100 19.53 20.17 28.97 0.06792093 0.05632815 7.08E+06 7011971.31 34680.8416 0.26580227 0.22511248
3E 100 24.7 25.33 28.53 0.00139067 0.00116134 2.32E+05 277270.555 45590.43236 0.00641815 0.44309995
4E 100 26.62 26.89 28.28 0.00030902 0.0003312 6.53E+04 104414.352 53255.5246 0.00181524 0.60031006
1E 100 15.35 15.61 28.66 1 1 1.12E+08 121799182 42051.20194 1 0
2E 100 19.68 19.9 28.61 0.04802735 0.04937758 6.41E+06 8303278.26 43378.70722 0.08448276 0.20298051
3E 100 24.08 24.82 29.02 0.00302259 0.00216713 3.50E+05 381562.836 33619.51444 0.00775862 0.37206716
4E 100 24.67 24.98 28.76 0.00167689 0.00161976 2.37E+05 345194.737 39516.82386 0.00362069 0.50409828
1D 100 15.46 16.89 27.85 1 1 1.04E+08 54654905.3 69574.34266 1 0
2D 100 22.54 23.92 29.38 0.02134438 0.02209709 9.69E+05 670292.367 26878.4648 0.02121951 0.1877802
3D 100 26.5 27.92 29.58 0.00157547 0.00158643 7.07E+04 54791.942 23736.22745 0.00139024 0.41347751
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4.113 RNA1 
 
Pos Name Ct SYBR Ct Mean SYBR Ct Dev. SYBR Amount SYBR Target SYBR
A1 1B cDNA:5 E1A 28.15 28.34 0.18 -
A2 1B cDNA:5 E1A 28.51 28.34 0.18 -
A3 1B cDNA:5 E1A 28.37 28.34 0.18 -
A4 2B cDNA:5 E1A 33.80 33.53 0.33 -
A5 2B cDNA:5 E1A 33.16 33.53 0.33 -
A6 2B cDNA:5 E1A 33.63 33.53 0.33 -
A7 3B cDNA:5 E1A -
A8 3B cDNA:5 E1A 35.83 -
A9 3B cDNA:5 E1A -
A10 1B -RT E1A -
A11 2B -RT E1A -
A12 3B -RT E1A -
B1 1B cDNA:5 Hex -
B2 1B cDNA:5 Hex -
B3 1B cDNA:5 Hex 35.80 -
B4 2B cDNA:5 Hex -
B5 2B cDNA:5 Hex -
B6 2B cDNA:5 Hex -
B7 3B cDNA:5 Hex -
B8 3B cDNA:5 Hex -
B9 3B cDNA:5 Hex -
B10 1B -RT Hex -
B11 2B -RT Hex -
B12 3B -RT Hex -
C1 1B cDNA:5 Actin2 27.36 27.04 0.38 -
C2 1B cDNA:5 Actin2 27.15 27.04 0.38 -
C3 1B cDNA:5 Actin2 26.62 27.04 0.38 -
C4 2B cDNA:5 Actin2 27.31 27.18 0.12 -
C5 2B cDNA:5 Actin2 27.09 27.18 0.12 -
C6 2B cDNA:5 Actin2 27.13 27.18 0.12 -
C7 3B cDNA:5 Actin2 27.32 27.20 0.10 -
C8 3B cDNA:5 Actin2 27.15 27.20 0.10 -
C9 3B cDNA:5 Actin2 27.13 27.20 0.10 -
C10 1B -RT Actin2 -
C11 2B -RT Actin2 -
C12 3B -RT Actin2 -
D1 1D cDNA:5 E1A 21.00 20.44 0.53 -
D2 1D cDNA:5 E1A 20.35 20.44 0.53 -
D3 1D cDNA:5 E1A 19.96 20.44 0.53 -
D4 2D cDNA:5 E1A 25.77 25.80 0.07 -
D5 2D cDNA:5 E1A 25.74 25.80 0.07 -
D6 2D cDNA:5 E1A 25.87 25.80 0.07 -
D7 3D cDNA:5 E1A 32.45 31.63 0.71 -
D8 3D cDNA:5 E1A 31.14 31.63 0.71 -
D9 3D cDNA:5 E1A 31.31 31.63 0.71 -
D10 1D -RT E1A -
D11 2D -RT E1A -
D12 3D -RT E1A -
E1 1D cDNA:5 Hex 14.78 14.39 0.36 -
E2 1D cDNA:5 Hex 14.08 14.39 0.36 -
E3 1D cDNA:5 Hex 14.29 14.39 0.36 -
E4 2D cDNA:5 Hex 20.16 20.08 0.13 -
E5 2D cDNA:5 Hex 19.93 20.08 0.13 -
E6 2D cDNA:5 Hex 20.16 20.08 0.13 -
E7 3D cDNA:5 Hex 25.93 26.10 0.19 -
E8 3D cDNA:5 Hex 26.05 26.10 0.19 -
E9 3D cDNA:5 Hex 26.31 26.10 0.19 -
E10 1D -RT Hex -
E11 2D -RT Hex -
E12 3D -RT Hex -
F1 1D cDNA:5 Actin2 26.88 26.46 0.37 -
F2 1D cDNA:5 Actin2 26.19 26.46 0.37 -
F3 1D cDNA:5 Actin2 26.31 26.46 0.37 -
F4 2D cDNA:5 Actin2 25.85 25.67 0.16 -
F5 2D cDNA:5 Actin2 25.61 25.67 0.16 -
F6 2D cDNA:5 Actin2 25.55 25.67 0.16 -
F7 3D cDNA:5 Actin2 26.16 26.26 0.16 -
F8 3D cDNA:5 Actin2 26.19 26.26 0.16 -
F9 3D cDNA:5 Actin2 26.44 26.26 0.16 -
F10 1D -RT Actin2 -
F11 2D -RT Actin2 -
F12 3D -RT Actin2 -
G1 1D cDNA:5 DF1 E1A 21.06 20.69 0.32 -
G2 1D cDNA:5 DF1 E1A 20.49 20.69 0.32 -
G3 1D cDNA:5 DF1 E1A 20.53 20.69 0.32 -
G4 1D cDNA:5 DF10 E1A 23.44 23.88 0.92 -
G5 1D cDNA:5 DF10 E1A 23.26 23.88 0.92 -
G6 1D cDNA:5 DF10 E1A 24.94 23.88 0.92 -
G7 1D cDNA:5 DF100 E1A 27.19 26.87 0.46 -
G8 1D cDNA:5 DF100 E1A 27.09 26.87 0.46 -
G9 1D cDNA:5 DF100 E1A 26.34 26.87 0.46 -
G10 1D cDNA:5 DF1000 E1A 30.19 29.98 0.20 -
G11 1D cDNA:5 DF1000 E1A 29.78 29.98 0.20 -
G12 1D cDNA:5 DF1000 E1A 29.97 29.98 0.20 -
H1 1D cDNA:5 DF1 Hex 14.75 14.67 0.08 -
H2 1D cDNA:5 DF1 Hex 14.68 14.67 0.08 -
H3 1D cDNA:5 DF1 Hex 14.58 14.67 0.08 -
H4 1D cDNA:5 DF10 Hex 17.66 17.43 0.20 -
H5 1D cDNA:5 DF10 Hex 17.37 17.43 0.20 -
H6 1D cDNA:5 DF10 Hex 17.27 17.43 0.20 -
H7 1D cDNA:5 DF100 Hex 20.78 20.79 0.03 -
H8 1D cDNA:5 DF100 Hex 20.78 20.79 0.03 -
H9 1D cDNA:5 DF100 Hex 20.82 20.79 0.03 -
H10 1D cDNA:5 DF1000 Hex 24.15 24.09 0.20 -
H11 1D cDNA:5 DF1000 Hex 24.25 24.09 0.20 -
H12 1D cDNA:5 DF1000 Hex 23.86 24.09 0.20 -
Analysis Parameters






Baseline range (from cycle no. ... to) n/a
Drift Correction OFF
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4.121 RNA1 
 
Pos Name Ct SYBR Ct Mean SYBR Ct Dev. SYBR Expr. Level SYBR Range SYBR
A1 1D cDNA:5 E1A 21.03 21.14 0.13
A2 1D cDNA:5 E1A 21.28 21.14 0.13
A3 1D cDNA:5 E1A 21.12 21.14 0.13
A4 2D cDNA:5 E1A 24.73 24.50 0.21
A5 2D cDNA:5 E1A 24.46 24.50 0.21
A6 2D cDNA:5 E1A 24.31 24.50 0.21
A7 3D cDNA:5 E1A 31.99 31.98 0.36
A8 3D cDNA:5 E1A 31.62 31.98 0.36
A9 3D cDNA:5 E1A 32.34 31.98 0.36
A10 4D cDNA:5 E1A 33.42 33.24 0.25
A11 4D cDNA:5 E1A 33.07 33.24 0.25
A12 4D cDNA:5 E1A
B1 1D cDNA:5 Hex 17.23 16.97 0.28
B2 1D cDNA:5 Hex 17.02 16.97 0.28
B3 1D cDNA:5 Hex 16.67 16.97 0.28
B4 2D cDNA:5 Hex 20.98 21.02 0.09 5.240E-2X 4.71E-02 - 5.83E-02
B5 2D cDNA:5 Hex 21.13 21.02 0.09 5.240E-2X 4.71E-02 - 5.83E-02
B6 2D cDNA:5 Hex 20.96 21.02 0.09 5.240E-2X 4.71E-02 - 5.83E-02
B7 3D cDNA:5 Hex 28.55 28.37 0.19 2.530E-4X 2.21E-04 - 2.89E-04
B8 3D cDNA:5 Hex 28.18 28.37 0.19 2.530E-4X 2.21E-04 - 2.89E-04
B9 3D cDNA:5 Hex 28.40 28.37 0.19 2.530E-4X 2.21E-04 - 2.89E-04
B10 4D cDNA:5 Hex 31.15 31.30 0.15 4.080E-5X 3.52E-05 - 4.72E-05
B11 4D cDNA:5 Hex 31.46 31.30 0.15 4.080E-5X 3.52E-05 - 4.72E-05
B12 4D cDNA:5 Hex 31.29 31.30 0.15 4.080E-5X 3.52E-05 - 4.72E-05
C1 1D cDNA:5 Actin2 27.38 27.21 0.15
C2 1D cDNA:5 Actin2 27.16 27.21 0.15
C3 1D cDNA:5 Actin2 27.10 27.21 0.15
C4 2D cDNA:5 Actin2 27.08 27.01 0.12
C5 2D cDNA:5 Actin2 26.87 27.01 0.12
C6 2D cDNA:5 Actin2 27.08 27.01 0.12
C7 3D cDNA:5 Actin2 26.71 26.67 0.04
C8 3D cDNA:5 Actin2 26.63 26.67 0.04
C9 3D cDNA:5 Actin2 26.66 26.67 0.04
C10 4D cDNA:5 Actin2 27.10 26.96 0.15
C11 4D cDNA:5 Actin2 26.81 26.96 0.15
C12 4D cDNA:5 Actin2 26.96 26.96 0.15
D1 1D cDNA:5 DF1 E1A 20.94 20.36 0.53
D2 1D cDNA:5 DF1 E1A 20.26 20.36 0.53
D3 1D cDNA:5 DF1 E1A 19.89 20.36 0.53
D4 1D cDNA:5 DF10 E1A 22.87 22.94 0.10
D5 1D cDNA:5 DF10 E1A 22.90 22.94 0.10
D6 1D cDNA:5 DF10 E1A 23.05 22.94 0.10
D7 1D cDNA:5 DF100 E1A 26.35 26.32 0.05
D8 1D cDNA:5 DF100 E1A 26.33 26.32 0.05
D9 1D cDNA:5 DF100 E1A 26.26 26.32 0.05
D10 1D cDNA:5 DF1000 E1A 30.16 29.95 0.18
D11 1D cDNA:5 DF1000 E1A 29.81 29.95 0.18
D12 1D cDNA:5 DF1000 E1A 29.88 29.95 0.18
E1 1D cDNA:5 DF1 Hex 16.91 16.64 0.26
E2 1D cDNA:5 DF1 Hex 16.40 16.64 0.26
E3 1D cDNA:5 DF1 Hex 16.60 16.64 0.26
E4 1D cDNA:5 DF10 Hex 19.53 19.48 0.10
E5 1D cDNA:5 DF10 Hex 19.36 19.48 0.10
E6 1D cDNA:5 DF10 Hex 19.55 19.48 0.10
E7 1D cDNA:5 DF100 Hex 22.68 22.82 0.24
E8 1D cDNA:5 DF100 Hex 22.68 22.82 0.24
E9 1D cDNA:5 DF100 Hex 23.10 22.82 0.24
E10 1D cDNA:5 DF1000 Hex 26.38 26.38 0.13
E11 1D cDNA:5 DF1000 Hex 26.24 26.38 0.13
E12 1D cDNA:5 DF1000 Hex 26.50 26.38 0.13
F1 1B -RT E1A
F2 2B -RT E1A
F3 3B -RT E1A
F4 4B -RT E1A
F5 1C -RT E1A
F6 2C -RT E1A
F7 3C -RT E1A
F8 4C -RT E1A
F9 1D -RT E1A 35.20
F10 2D -RT E1A
F11 3D -RT E1A
F12 4D -RT E1A
G1 1B -RT Hex
G2 2B -RT Hex
G3 3B -RT Hex
G4 4B -RT Hex
G5 1C -RT Hex
G6 2C -RT Hex
G7 3C -RT Hex
G8 4C -RT Hex
G9 1D -RT Hex 34.73
G10 2D -RT Hex
G11 3D -RT Hex
G12 4D -RT Hex
H1 1B -RT Actin2
H2 2B -RT Actin2
H3 3B -RT Actin2
H4 4B -RT Actin2
H5 1C -RT Actin2
H6 2C -RT Actin2
H7 3C -RT Actin2
H8 4C -RT Actin2
H9 1D -RT Actin2
H10 2D -RT Actin2
H11 3D -RT Actin2
H12 4D -RT Actin2
Analysis Parameters






Baseline range (from cycle no. ... to) n/a
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Pos Name Ct SYBR Ct Mean SYBR Ct Dev. SYBR Expr. Level SYBR Range SYBR
A1 1B cDNA:5 E1A 36.18 30.54 4.89
A2 1B cDNA:5 E1A 27.96 30.54 4.89
A3 1B cDNA:5 E1A 27.50 30.54 4.89
A4 2B cDNA:5 E1A 30.96 30.87 0.11 0.117 9.53E-02 - 0.144
A5 2B cDNA:5 E1A 30.75 30.87 0.11 0.117 9.53E-02 - 0.144
A6 2B cDNA:5 E1A 30.89 30.87 0.11 0.117 9.53E-02 - 0.144
A7 3B cDNA:5 E1A 1.390E-4X 1.20E-04 - 1.60E-04
A8 3B cDNA:5 E1A 1.390E-4X 1.20E-04 - 1.60E-04
A9 3B cDNA:5 E1A 39.77 1.390E-4X 1.20E-04 - 1.60E-04
A10 4B cDNA:5 E1A <not calculated>
A11 4B cDNA:5 E1A <not calculated>
A12 4B cDNA:5 E1A <not calculated>
B1 1B cDNA:5 Hex
B2 1B cDNA:5 Hex
B3 1B cDNA:5 Hex
B4 2B cDNA:5 Hex
B5 2B cDNA:5 Hex
B6 2B cDNA:5 Hex
B7 3B cDNA:5 Hex
B8 3B cDNA:5 Hex 36.04
B9 3B cDNA:5 Hex
B10 4B cDNA:5 Hex
B11 4B cDNA:5 Hex
B12 4B cDNA:5 Hex
C1 1B cDNA:5 Actin2 27.96 30.19 4.59
C2 1B cDNA:5 Actin2 35.47 30.19 4.59
C3 1B cDNA:5 Actin2 27.14 30.19 4.59
C4 2B cDNA:5 Actin2 27.73 27.42 0.28
C5 2B cDNA:5 Actin2 27.19 27.42 0.28
C6 2B cDNA:5 Actin2 27.35 27.42 0.28
C7 3B cDNA:5 Actin2 26.38 26.60 0.21
C8 3B cDNA:5 Actin2 26.63 26.60 0.21
C9 3B cDNA:5 Actin2 26.79 26.60 0.21
C10 4B cDNA:5 Actin2 26.82 26.89 0.06
C11 4B cDNA:5 Actin2 26.92 26.89 0.06
C12 4B cDNA:5 Actin2 26.93 26.89 0.06
D1 1C cDNA:5 E1A 22.98 22.65 0.31 37.6 27.6 - 51.2
D2 1C cDNA:5 E1A 22.59 22.65 0.31 37.6 27.6 - 51.2
D3 1C cDNA:5 E1A 22.36 22.65 0.31 37.6 27.6 - 51.2
D4 2C cDNA:5 E1A 26.77 26.65 0.19 1.51 1.29 - 1.77
D5 2C cDNA:5 E1A 26.74 26.65 0.19 1.51 1.29 - 1.77
D6 2C cDNA:5 E1A 26.43 26.65 0.19 1.51 1.29 - 1.77
D7 3C cDNA:5 E1A 32.84 32.34 0.47 3.520E-2X 2.54E-02 - 4.89E-02
D8 3C cDNA:5 E1A 31.92 32.34 0.47 3.520E-2X 2.54E-02 - 4.89E-02
D9 3C cDNA:5 E1A 32.26 32.34 0.47 3.520E-2X 2.54E-02 - 4.89E-02
D10 4C cDNA:5 E1A 34.91 34.78 0.18 5.750E-3X 4.75E-03 - 6.96E-03
D11 4C cDNA:5 E1A 5.750E-3X 4.75E-03 - 6.96E-03
D12 4C cDNA:5 E1A 34.66 34.78 0.18 5.750E-3X 4.75E-03 - 6.96E-03
E1 1C cDNA:5 Hex 28.96 28.78 0.18
E2 1C cDNA:5 Hex 28.61 28.78 0.18
E3 1C cDNA:5 Hex 28.77 28.78 0.18
E4 2C cDNA:5 Hex 34.97 34.21 0.66
E5 2C cDNA:5 Hex 33.91 34.21 0.66
E6 2C cDNA:5 Hex 33.76 34.21 0.66
E7 3C cDNA:5 Hex
E8 3C cDNA:5 Hex
E9 3C cDNA:5 Hex
E10 4C cDNA:5 Hex
E11 4C cDNA:5 Hex
E12 4C cDNA:5 Hex
F1 1C cDNA:5 Actin2 27.87 27.53 0.32
F2 1C cDNA:5 Actin2 27.45 27.53 0.32
F3 1C cDNA:5 Actin2 27.25 27.53 0.32
F4 2C cDNA:5 Actin2 27.02 26.89 0.12
F5 2C cDNA:5 Actin2 26.87 26.89 0.12
F6 2C cDNA:5 Actin2 26.77 26.89 0.12
F7 3C cDNA:5 Actin2 27.13 27.16 0.07
F8 3C cDNA:5 Actin2 27.11 27.16 0.07
F9 3C cDNA:5 Actin2 27.24 27.16 0.07
F10 4C cDNA:5 Actin2 26.80 26.99 0.21
F11 4C cDNA:5 Actin2 27.21 26.99 0.21
F12 4C cDNA:5 Actin2 26.95 26.99 0.21
G1 1D cDNA:5 DF1 E1A 20.80 20.48 0.28
G2 1D cDNA:5 DF1 E1A 20.35 20.48 0.28
G3 1D cDNA:5 DF1 E1A 20.29 20.48 0.28
G4 1D cDNA:5 DF10 E1A 23.67 23.58 0.29
G5 1D cDNA:5 DF10 E1A 23.81 23.58 0.29
G6 1D cDNA:5 DF10 E1A 23.25 23.58 0.29
G7 1D cDNA:5 DF100 E1A 26.79 26.55 0.21
G8 1D cDNA:5 DF100 E1A 26.40 26.55 0.21
G9 1D cDNA:5 DF100 E1A 26.47 26.55 0.21
G10 1D cDNA:5 DF1000 E1A 30.10 30.16 0.25
G11 1D cDNA:5 DF1000 E1A 30.44 30.16 0.25
G12 1D cDNA:5 DF1000 E1A 29.95 30.16 0.25
H1 1D cDNA:5 DF1 Hex 16.70 16.74 0.05
H2 1D cDNA:5 DF1 Hex 16.80 16.74 0.05
H3 1D cDNA:5 DF1 Hex 16.73 16.74 0.05
H4 1D cDNA:5 DF10 Hex 19.72 19.67 0.07
H5 1D cDNA:5 DF10 Hex 19.70 19.67 0.07
H6 1D cDNA:5 DF10 Hex 19.58 19.67 0.07
H7 1D cDNA:5 DF100 Hex 23.22 23.05 0.15
H8 1D cDNA:5 DF100 Hex 23.02 23.05 0.15
H9 1D cDNA:5 DF100 Hex 22.92 23.05 0.15
H10 1D cDNA:5 DF1000 Hex 26.36 26.33 0.03
H11 1D cDNA:5 DF1000 Hex 26.31 26.33 0.03
H12 1D cDNA:5 DF1000 Hex 26.32 26.33 0.03
Analysis Parameters
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Pos Name Ct SYBR Ct Mean SYBR Ct Dev. SYBR Amount SYBR Target SYBR
A1 1E -RT E1A 36.18 -
A2 1E -RT E1A -
A3 2E -RT E1A -
A4 2E -RT E1A -
A5 3E -RT E1A -
A6 3E -RT E1A -
A7 4E -RT E1A -
A8 4E -RT E1A -
A9 1D -RT E1A 35.27 -
A10 1D -RT E1A -
A11 2D -RT E1A -
A12 2D -RT E1A -
B1 1E -RT Hex 37.68 -
B2 1E -RT Hex -
B3 2E -RT Hex 37.74 -
B4 2E -RT Hex -
B5 3E -RT Hex -
B6 3E -RT Hex -
B7 4E -RT Hex -
B8 4E -RT Hex -
B9 1D -RT Hex -
B10 1D -RT Hex -
B11 2D -RT Hex -
B12 2D -RT Hex -
C1 1E -RT Actin2 -
C2 1E -RT Actin2 -
C3 2E -RT Actin2 -
C4 2E -RT Actin2 -
C5 3E -RT Actin2 -
C6 3E -RT Actin2 -
C7 4E -RT Actin2 -
C8 4E -RT Actin2 -
C9 1D -RT Actin2 -
C10 1D -RT Actin2 -
C11 2D -RT Actin2 -
C12 2D -RT Actin2 -
D1 3D -RT E1A -
D2 3D -RT E1A -
D3 4D -RT E1A -
D4 4D -RT E1A -
D5 1C -RT E1A -
D6 1C -RT E1A -
D7 2C -RT E1A -
D8 2C -RT E1A -
D9 3C -RT E1A -
D10 3C -RT E1A -
D11 4C -RT E1A -
D12 4C -RT E1A -
E1 3D -RT Hex -
E2 3D -RT Hex 36.77 -
E3 4D -RT Hex -
E4 4D -RT Hex -
E5 1C -RT Hex -
E6 1C -RT Hex -
E7 2C -RT Hex -
E8 2C -RT Hex -
E9 3C -RT Hex -
E10 3C -RT Hex -
E11 4C -RT Hex -
E12 4C -RT Hex -
F1 3D -RT Actin2 35.74 -
F2 3D -RT Actin2 -
F3 4D -RT Actin2 -
F4 4D -RT Actin2 -
F5 1C -RT Actin2 -
F6 1C -RT Actin2 -
F7 2C -RT Actin2 -
F8 2C -RT Actin2 -
F9 3C -RT Actin2 -
F10 3C -RT Actin2 -
F11 4C -RT Actin2 -
F12 4C -RT Actin2 -
G1 1B -RT E1A -
G2 1B -RT E1A -
G3 2B -RT E1A -
G4 2B -RT E1A -
G5 3B -RT E1A -
G6 3B -RT E1A -
G7 4B -RT E1A -
G8 4B -RT E1A -
G9 1B -RT Actin2 -
G10 2B -RT Actin2 -
G11 3B -RT Actin2 -
G12 4B -RT Actin2 -
H1 1B -RT Hex -
H2 1B -RT Hex -
H3 2B -RT Hex -
H4 2B -RT Hex -
H5 3B -RT Hex -
H6 3B -RT Hex -
H7 4B -RT Hex -
H8 4B -RT Hex -
H9 1B -RT Actin2 -
H10 2B -RT Actin2 -
H11 3B -RT Actin2 -
H12 4B -RT Actin2 -
Analysis Parameters
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Pos Name Ct SYBR Ct Mean SYBR Ct Dev. SYBR Expr. Level SYBR Range SYBR
A1 1B cDNA:5 E1A 27.83 27.77 0.25
A2 1B cDNA:5 E1A 27.99 27.77 0.25
A3 1B cDNA:5 E1A 27.49 27.77 0.25
A4 2B cDNA:5 E1A 30.09 30.17 0.14 0.142 0.121 - 0.167
A5 2B cDNA:5 E1A 30.33 30.17 0.14 0.142 0.121 - 0.167
A6 2B cDNA:5 E1A 30.07 30.17 0.14 0.142 0.121 - 0.167
A7 3B cDNA:5 E1A 7.600E-3X 7.03E-03 - 8.22E-03
A8 3B cDNA:5 E1A 7.600E-3X 7.03E-03 - 8.22E-03
A9 3B cDNA:5 E1A 35.05 7.600E-3X 7.03E-03 - 8.22E-03
A10 4B cDNA:5 E1A 35.29 35.31 0.04 4.120E-2X 3.46E-03 - 0.490
A11 4B cDNA:5 E1A 35.34 35.31 0.04 4.120E-2X 3.46E-03 - 0.490
A12 4B cDNA:5 E1A 4.120E-2X 3.46E-03 - 0.490
B1 1B cDNA:5 Hex
B2 1B cDNA:5 Hex
B3 1B cDNA:5 Hex
B4 2B cDNA:5 Hex
B5 2B cDNA:5 Hex
B6 2B cDNA:5 Hex
B7 3B cDNA:5 Hex
B8 3B cDNA:5 Hex
B9 3B cDNA:5 Hex
B10 4B cDNA:5 Hex
B11 4B cDNA:5 Hex
B12 4B cDNA:5 Hex
C1 1B cDNA:5 Actin2 28.00 27.69 0.27
C2 1B cDNA:5 Actin2 27.61 27.69 0.27
C3 1B cDNA:5 Actin2 27.47 27.69 0.27
C4 2B cDNA:5 Actin2 27.46 27.27 0.19
C5 2B cDNA:5 Actin2 27.09 27.27 0.19
C6 2B cDNA:5 Actin2 27.28 27.27 0.19
C7 3B cDNA:5 Actin2 27.99 27.93 0.11
C8 3B cDNA:5 Actin2 27.80 27.93 0.11
C9 3B cDNA:5 Actin2 28.01 27.93 0.11
C10 4B cDNA:5 Actin2 34.76 30.63 3.57
C11 4B cDNA:5 Actin2 28.66 30.63 3.57
C12 4B cDNA:5 Actin2 28.49 30.63 3.57
D1 1C cDNA:5 E1A 22.84 22.20 0.55 44.1 29.3 - 66.3
D2 1C cDNA:5 E1A 21.93 22.20 0.55 44.1 29.3 - 66.3
D3 1C cDNA:5 E1A 21.84 22.20 0.55 44.1 29.3 - 66.3
D4 2C cDNA:5 E1A 25.81 25.47 0.34 3.46 2.65 - 4.50
D5 2C cDNA:5 E1A 25.14 25.47 0.34 3.46 2.65 - 4.50
D6 2C cDNA:5 E1A 25.47 25.47 0.34 3.46 2.65 - 4.50
D7 3C cDNA:5 E1A 31.49 30.90 0.68 6.660E-2X 4.15E-02 - 0.107
D8 3C cDNA:5 E1A 30.16 30.90 0.68 6.660E-2X 4.15E-02 - 0.107
D9 3C cDNA:5 E1A 31.06 30.90 0.68 6.660E-2X 4.15E-02 - 0.107
D10 4C cDNA:5 E1A 32.42 32.50 0.12 3.290E-2X 2.91E-02 - 3.72E-02
D11 4C cDNA:5 E1A 32.64 32.50 0.12 3.290E-2X 2.91E-02 - 3.72E-02
D12 4C cDNA:5 E1A 32.45 32.50 0.12 3.290E-2X 2.91E-02 - 3.72E-02
E1 1C cDNA:5 Hex 28.91 28.31 0.52
E2 1C cDNA:5 Hex 28.03 28.31 0.52
E3 1C cDNA:5 Hex 27.98 28.31 0.52
E4 2C cDNA:5 Hex 32.10 31.96 0.16
E5 2C cDNA:5 Hex 32.00 31.96 0.16
E6 2C cDNA:5 Hex 31.79 31.96 0.16
E7 3C cDNA:5 Hex
E8 3C cDNA:5 Hex
E9 3C cDNA:5 Hex
E10 4C cDNA:5 Hex
E11 4C cDNA:5 Hex
E12 4C cDNA:5 Hex 35.50
F1 1C cDNA:5 Actin2 27.82 27.59 0.20
F2 1C cDNA:5 Actin2 27.46 27.59 0.20
F3 1C cDNA:5 Actin2 27.48 27.59 0.20
F4 2C cDNA:5 Actin2 27.39 27.19 0.18
F5 2C cDNA:5 Actin2 27.04 27.19 0.18
F6 2C cDNA:5 Actin2 27.12 27.19 0.18
F7 3C cDNA:5 Actin2 26.91 26.92 0.03
F8 3C cDNA:5 Actin2 26.95 26.92 0.03
F9 3C cDNA:5 Actin2 26.90 26.92 0.03
F10 4C cDNA:5 Actin2 27.63 27.50 0.13
F11 4C cDNA:5 Actin2 27.49 27.50 0.13
F12 4C cDNA:5 Actin2 27.38 27.50 0.13
G1 1E cDNA:5 DF1 E1A 21.30 20.96 0.32
G2 1E cDNA:5 DF1 E1A 20.91 20.96 0.32
G3 1E cDNA:5 DF1 E1A 20.65 20.96 0.32
G4 1E cDNA:5 DF10 E1A 24.41 24.10 0.27
G5 1E cDNA:5 DF10 E1A 23.91 24.10 0.27
G6 1E cDNA:5 DF10 E1A 23.98 24.10 0.27
G7 1E cDNA:5 DF100 E1A 27.26 27.13 0.20
G8 1E cDNA:5 DF100 E1A 27.22 27.13 0.20
G9 1E cDNA:5 DF100 E1A 26.90 27.13 0.20
G10 1E cDNA:5 DF1000 E1A 30.47 30.44 0.03
G11 1E cDNA:5 DF1000 E1A 30.41 30.44 0.03
G12 1E cDNA:5 DF1000 E1A 30.45 30.44 0.03
H1 1E cDNA:5 DF1 Hex 14.71 14.63 0.09
H2 1E cDNA:5 DF1 Hex 14.65 14.63 0.09
H3 1E cDNA:5 DF1 Hex 14.54 14.63 0.09
H4 1E cDNA:5 DF10 Hex 17.89 17.65 0.23
H5 1E cDNA:5 DF10 Hex 17.61 17.65 0.23
H6 1E cDNA:5 DF10 Hex 17.44 17.65 0.23
H7 1E cDNA:5 DF100 Hex 20.75 20.74 0.02
H8 1E cDNA:5 DF100 Hex 20.73 20.74 0.02
H9 1E cDNA:5 DF100 Hex 20.76 20.74 0.02
H10 1E cDNA:5 DF1000 Hex 24.39 24.03 0.31
H11 1E cDNA:5 DF1000 Hex 23.85 24.03 0.31
H12 1E cDNA:5 DF1000 Hex 23.84 24.03 0.31
Analysis Parameters
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Pos Name Ct SYBR Ct Mean SYBR Ct Dev. SYBR Amount SYBR Target SYBR
A1 1D cDNA:5 E1A 21.00 21.00 0.20 -
A2 1D cDNA:5 E1A 21.20 21.00 0.20 -
A3 1D cDNA:5 E1A 20.79 21.00 0.20 -
A4 2D cDNA:5 E1A 24.46 24.12 0.32 -
A5 2D cDNA:5 E1A 24.08 24.12 0.32 -
A6 2D cDNA:5 E1A 23.82 24.12 0.32 -
A7 3D cDNA:5 E1A 29.55 29.73 0.28 -
A8 3D cDNA:5 E1A 29.59 29.73 0.28 -
A9 3D cDNA:5 E1A 30.05 29.73 0.28 -
A10 4D cDNA:5 E1A 30.30 29.92 0.35 -
A11 4D cDNA:5 E1A 29.62 29.92 0.35 -
A12 4D cDNA:5 E1A 29.86 29.92 0.35 -
B1 1D cDNA:5 Hex 16.60 16.40 0.22 -
B2 1D cDNA:5 Hex 16.43 16.40 0.22 -
B3 1D cDNA:5 Hex 16.16 16.40 0.22 -
B4 2D cDNA:5 Hex 19.01 19.01 0.02 -
B5 2D cDNA:5 Hex 18.99 19.01 0.02 -
B6 2D cDNA:5 Hex 19.03 19.01 0.02 -
B7 3D cDNA:5 Hex 25.85 25.75 0.09 -
B8 3D cDNA:5 Hex 25.72 25.75 0.09 -
B9 3D cDNA:5 Hex 25.68 25.75 0.09 -
B10 4D cDNA:5 Hex 26.06 26.15 0.09 -
B11 4D cDNA:5 Hex 26.17 26.15 0.09 -
B12 4D cDNA:5 Hex 26.23 26.15 0.09 -
C1 1D cDNA:5 Actin2 29.01 28.65 0.47 -
C2 1D cDNA:5 Actin2 28.81 28.65 0.47 -
C3 1D cDNA:5 Actin2 28.12 28.65 0.47 -
C4 2D cDNA:5 Actin2 27.48 27.35 0.12 -
C5 2D cDNA:5 Actin2 27.30 27.35 0.12 -
C6 2D cDNA:5 Actin2 27.25 27.35 0.12 -
C7 3D cDNA:5 Actin2 27.67 27.72 0.10 -
C8 3D cDNA:5 Actin2 27.83 27.72 0.10 -
C9 3D cDNA:5 Actin2 27.64 27.72 0.10 -
C10 4D cDNA:5 Actin2 27.08 27.04 0.14 -
C11 4D cDNA:5 Actin2 26.88 27.04 0.14 -
C12 4D cDNA:5 Actin2 27.16 27.04 0.14 -
D1 1E cDNA:5 E1A 21.30 20.72 0.54 -
D2 1E cDNA:5 E1A 20.63 20.72 0.54 -
D3 1E cDNA:5 E1A 20.23 20.72 0.54 -
D4 2E cDNA:5 E1A 23.41 23.38 0.04 -
D5 2E cDNA:5 E1A 23.33 23.38 0.04 -
D6 2E cDNA:5 E1A 23.40 23.38 0.04 -
D7 3E cDNA:5 E1A 28.40 28.40 0.13 -
D8 3E cDNA:5 E1A 28.52 28.40 0.13 -
D9 3E cDNA:5 E1A 28.26 28.40 0.13 -
D10 4E cDNA:5 E1A 30.29 30.22 0.07 -
D11 4E cDNA:5 E1A 30.20 30.22 0.07 -
D12 4E cDNA:5 E1A 30.15 30.22 0.07 -
E1 1E cDNA:5 Hex 14.80 14.40 0.35 -
E2 1E cDNA:5 Hex 14.27 14.40 0.35 -
E3 1E cDNA:5 Hex 14.15 14.40 0.35 -
E4 2E cDNA:5 Hex 17.43 17.32 0.23 -
E5 2E cDNA:5 Hex 17.05 17.32 0.23 -
E6 2E cDNA:5 Hex 17.46 17.32 0.23 -
E7 3E cDNA:5 Hex 22.18 22.24 0.08 -
E8 3E cDNA:5 Hex 22.22 22.24 0.08 -
E9 3E cDNA:5 Hex 22.33 22.24 0.08 -
E10 4E cDNA:5 Hex 24.43 24.29 0.23 -
E11 4E cDNA:5 Hex 24.02 24.29 0.23 -
E12 4E cDNA:5 Hex 24.42 24.29 0.23 -
F1 1E cDNA:5 Actin2 28.21 27.83 0.34 -
F2 1E cDNA:5 Actin2 27.56 27.83 0.34 -
F3 1E cDNA:5 Actin2 27.73 27.83 0.34 -
F4 2E cDNA:5 Actin2 28.15 27.97 0.18 -
F5 2E cDNA:5 Actin2 27.81 27.97 0.18 -
F6 2E cDNA:5 Actin2 27.95 27.97 0.18 -
F7 3E cDNA:5 Actin2 26.65 26.53 0.11 -
F8 3E cDNA:5 Actin2 26.44 26.53 0.11 -
F9 3E cDNA:5 Actin2 26.50 26.53 0.11 -
F10 4E cDNA:5 Actin2 26.41 26.54 0.14 -
F11 4E cDNA:5 Actin2 26.51 26.54 0.14 -
F12 4E cDNA:5 Actin2 26.69 26.54 0.14 -
G1 1E cDNA:5 DF1 E1A 21.29 21.06 0.20 -
G2 1E cDNA:5 DF1 E1A 20.98 21.06 0.20 -
G3 1E cDNA:5 DF1 E1A 20.91 21.06 0.20 -
G4 1E cDNA:5 DF10 E1A 24.59 24.16 0.38 -
G5 1E cDNA:5 DF10 E1A 24.00 24.16 0.38 -
G6 1E cDNA:5 DF10 E1A 23.90 24.16 0.38 -
G7 1E cDNA:5 DF100 E1A 27.49 27.22 0.29 -
G8 1E cDNA:5 DF100 E1A 27.27 27.22 0.29 -
G9 1E cDNA:5 DF100 E1A 26.91 27.22 0.29 -
G10 1E cDNA:5 DF1000 E1A 30.49 30.34 0.14 -
G11 1E cDNA:5 DF1000 E1A 30.31 30.34 0.14 -
G12 1E cDNA:5 DF1000 E1A 30.21 30.34 0.14 -
H1 1E cDNA:5 DF1 Hex 14.81 14.70 0.16 -
H2 1E cDNA:5 DF1 Hex 14.78 14.70 0.16 -
H3 1E cDNA:5 DF1 Hex 14.51 14.70 0.16 -
H4 1E cDNA:5 DF10 Hex 17.68 20.37 4.76 -
H5 1E cDNA:5 DF10 Hex 17.55 20.37 4.76 -
H6 1E cDNA:5 DF10 Hex 25.87 20.37 4.76 -
H7 1E cDNA:5 DF100 Hex 20.86 20.83 0.03 -
H8 1E cDNA:5 DF100 Hex 20.81 20.83 0.03 -
H9 1E cDNA:5 DF100 Hex 20.82 20.83 0.03 -
H10 1E cDNA:5 DF1000 Hex 24.54 24.15 0.36 -
H11 1E cDNA:5 DF1000 Hex 24.09 24.15 0.36 -
H12 1E cDNA:5 DF1000 Hex 23.82 24.15 0.36 -
Analysis Parameters
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Pos Name Ct SYBR Ct Mean SYBR Ct Dev. SYBR Amount SYBR Target SYBR
A1 1E -RT E1A 36.02 -
A2 1E -RT E1A -
A3 2E -RT E1A -
A4 2E -RT E1A -
A5 3E -RT E1A -
A6 3E -RT E1A -
A7 4E -RT E1A -
A8 4E -RT E1A -
A9 1D -RT E1A -
A10 1D -RT E1A -
A11 2D -RT E1A -
A12 2D -RT E1A -
B1 1E -RT Hex 35.78 35.89 0.14 -
B2 1E -RT Hex 35.99 35.89 0.14 -
B3 2E -RT Hex -
B4 2E -RT Hex -
B5 3E -RT Hex -
B6 3E -RT Hex -
B7 4E -RT Hex -
B8 4E -RT Hex -
B9 1D -RT Hex -
B10 1D -RT Hex -
B11 2D -RT Hex -
B12 2D -RT Hex -
C1 1E -RT Actin2 -
C2 1E -RT Actin2 -
C3 2E -RT Actin2 -
C4 2E -RT Actin2 -
C5 3E -RT Actin2 -
C6 3E -RT Actin2 -
C7 4E -RT Actin2 -
C8 4E -RT Actin2 -
C9 1D -RT Actin2 -
C10 1D -RT Actin2 -
C11 2D -RT Actin2 -
C12 2D -RT Actin2 -
D1 3D -RT E1A -
D2 3D -RT E1A -
D3 4D -RT E1A -
D4 4D -RT E1A -
D5 1C -RT E1A -
D6 1C -RT E1A -
D7 2C -RT E1A -
D8 2C -RT E1A -
D9 3C -RT E1A -
D10 3C -RT E1A -
D11 4C -RT E1A -
D12 4C -RT E1A -
E1 3D -RT Hex -
E2 3D -RT Hex -
E3 4D -RT Hex -
E4 4D -RT Hex -
E5 1C -RT Hex -
E6 1C -RT Hex -
E7 2C -RT Hex -
E8 2C -RT Hex -
E9 3C -RT Hex -
E10 3C -RT Hex -
E11 4C -RT Hex -
E12 4C -RT Hex -
F1 3D -RT Actin2 -
F2 3D -RT Actin2 -
F3 4D -RT Actin2 -
F4 4D -RT Actin2 -
F5 1C -RT Actin2 -
F6 1C -RT Actin2 -
F7 2C -RT Actin2 -
F8 2C -RT Actin2 -
F9 3C -RT Actin2 -
F10 3C -RT Actin2 -
F11 4C -RT Actin2 -
F12 4C -RT Actin2 -
G1 1B -RT E1A -
G2 1B -RT E1A -
G3 2B -RT E1A -
G4 2B -RT E1A -
G5 3B -RT E1A -
G6 3B -RT E1A -
G7 4B -RT E1A -
G8 4B -RT E1A -
G9 1B -RT Actin2 -
G10 2B -RT Actin2 -
G11 3B -RT Actin2 -
G12 4B -RT Actin2 -
H1 1B -RT Hex -
H2 1B -RT Hex -
H3 2B -RT Hex -
H4 2B -RT Hex -
H5 3B -RT Hex -
H6 3B -RT Hex -
H7 4B -RT Hex -
H8 4B -RT Hex -
H9 1B -RT Actin2 -
H10 2B -RT Actin2 -
H11 3B -RT Actin2 -
H12 4B -RT Actin2 -
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Pos Name Ct SYBR Ct Mean SYBR Ct Dev. SYBR Expr. Level SYBR Range SYBR
A1 1B cDNA:5 E1A 28.91 28.75 0.32
A2 1B cDNA:5 E1A 28.95 28.75 0.32
A3 1B cDNA:5 E1A 28.38 28.75 0.32
A4 2B cDNA:5 E1A 32.97 32.21 0.66 6.290E-2X 3.55E-02 - 0.111
A5 2B cDNA:5 E1A 31.94 32.21 0.66 6.290E-2X 3.55E-02 - 0.111
A6 2B cDNA:5 E1A 31.73 32.21 0.66 6.290E-2X 3.55E-02 - 0.111
A7 3B cDNA:5 E1A 37.64 37.09 1.97 1.490E-3X 3.82E-04 - 5.86E-03
A8 3B cDNA:5 E1A 34.91 37.09 1.97 1.490E-3X 3.82E-04 - 5.86E-03
A9 3B cDNA:5 E1A 38.73 37.09 1.97 1.490E-3X 3.82E-04 - 5.86E-03
A10 4B cDNA:5 E1A 36.11 36.28 0.24 3.750E-3X 3.10E-03 - 4.54E-03
A11 4B cDNA:5 E1A 36.44 36.28 0.24 3.750E-3X 3.10E-03 - 4.54E-03
A12 4B cDNA:5 E1A 3.750E-3X 3.10E-03 - 4.54E-03
B1 1B cDNA:5 Hex
B2 1B cDNA:5 Hex
B3 1B cDNA:5 Hex
B4 2B cDNA:5 Hex
B5 2B cDNA:5 Hex
B6 2B cDNA:5 Hex
B7 3B cDNA:5 Hex
B8 3B cDNA:5 Hex
B9 3B cDNA:5 Hex
B10 4B cDNA:5 Hex
B11 4B cDNA:5 Hex
B12 4B cDNA:5 Hex
C1 1B cDNA:5 Actin2 27.82 27.67 0.21
C2 1B cDNA:5 Actin2 27.52 27.67 0.21
C3 1B cDNA:5 Actin2
C4 2B cDNA:5 Actin2 27.69 27.14 0.49
C5 2B cDNA:5 Actin2 26.76 27.14 0.49
C6 2B cDNA:5 Actin2 26.97 27.14 0.49
C7 3B cDNA:5 Actin2 26.75 26.62 0.11
C8 3B cDNA:5 Actin2 26.59 26.62 0.11
C9 3B cDNA:5 Actin2 26.54 26.62 0.11
C10 4B cDNA:5 Actin2 27.11 27.14 0.14
C11 4B cDNA:5 Actin2 27.01 27.14 0.14
C12 4B cDNA:5 Actin2 27.29 27.14 0.14
D1 1C cDNA:5 E1A 22.79 22.38 0.36 176 40.0 - 777
D2 1C cDNA:5 E1A 22.21 22.38 0.36 176 40.0 - 777
D3 1C cDNA:5 E1A 22.13 22.38 0.36 176 40.0 - 777
D4 2C cDNA:5 E1A 26.56 26.39 0.16 3.83 3.07 - 4.77
D5 2C cDNA:5 E1A 26.26 26.39 0.16 3.83 3.07 - 4.77
D6 2C cDNA:5 E1A 26.36 26.39 0.16 3.83 3.07 - 4.77
D7 3C cDNA:5 E1A 29.83 30.10 0.61 0.212 0.134 - 0.336
D8 3C cDNA:5 E1A 29.67 30.10 0.61 0.212 0.134 - 0.336
D9 3C cDNA:5 E1A 30.81 30.10 0.61 0.212 0.134 - 0.336
D10 4C cDNA:5 E1A 31.96 31.05 0.81 8.510E-2X 4.83E-02 - 0.150
D11 4C cDNA:5 E1A 30.39 31.05 0.81 8.510E-2X 4.83E-02 - 0.150
D12 4C cDNA:5 E1A 30.79 31.05 0.81 8.510E-2X 4.83E-02 - 0.150
E1 1C cDNA:5 Hex 26.18 25.95 0.28
E2 1C cDNA:5 Hex 25.64 25.95 0.28
E3 1C cDNA:5 Hex 26.03 25.95 0.28
E4 2C cDNA:5 Hex 33.72 32.82 0.99
E5 2C cDNA:5 Hex 32.96 32.82 0.99
E6 2C cDNA:5 Hex 31.76 32.82 0.99
E7 3C cDNA:5 Hex
E8 3C cDNA:5 Hex
E9 3C cDNA:5 Hex
E10 4C cDNA:5 Hex
E11 4C cDNA:5 Hex 34.10
E12 4C cDNA:5 Hex
F1 1C cDNA:5 Actin2 27.69 28.76 2.11
F2 1C cDNA:5 Actin2 27.40 28.76 2.11
F3 1C cDNA:5 Actin2 31.19 28.76 2.11
F4 2C cDNA:5 Actin2 27.53 27.25 0.28
F5 2C cDNA:5 Actin2 27.24 27.25 0.28
F6 2C cDNA:5 Actin2 26.98 27.25 0.28
F7 3C cDNA:5 Actin2 26.98 26.78 0.25
F8 3C cDNA:5 Actin2 26.50 26.78 0.25
F9 3C cDNA:5 Actin2 26.88 26.78 0.25
F10 4C cDNA:5 Actin2 26.37 26.41 0.03
F11 4C cDNA:5 Actin2 26.43 26.41 0.03
F12 4C cDNA:5 Actin2 26.43 26.41 0.03
G1 1E cDNA:5 DF1 E1A 21.82 21.56 0.28
G2 1E cDNA:5 DF1 E1A 21.60 21.56 0.28
G3 1E cDNA:5 DF1 E1A 21.26 21.56 0.28
G4 1E cDNA:5 DF10 E1A 24.72 24.47 0.28
G5 1E cDNA:5 DF10 E1A 24.53 24.47 0.28
G6 1E cDNA:5 DF10 E1A 24.17 24.47 0.28
G7 1E cDNA:5 DF100 E1A 27.69 27.57 0.11
G8 1E cDNA:5 DF100 E1A 27.55 27.57 0.11
G9 1E cDNA:5 DF100 E1A 27.47 27.57 0.11
G10 1E cDNA:5 DF1000 E1A 31.81 31.41 0.48
G11 1E cDNA:5 DF1000 E1A 31.55 31.41 0.48
G12 1E cDNA:5 DF1000 E1A 30.88 31.41 0.48
H1 1E cDNA:5 DF1 Hex 14.29 14.25 0.19
H2 1E cDNA:5 DF1 Hex 14.43 14.25 0.19
H3 1E cDNA:5 DF1 Hex 14.05 14.25 0.19
H4 1E cDNA:5 DF10 Hex 17.23 17.16 0.22
H5 1E cDNA:5 DF10 Hex 17.33 17.16 0.22
H6 1E cDNA:5 DF10 Hex 16.92 17.16 0.22
H7 1E cDNA:5 DF100 Hex 20.41 20.43 0.03
H8 1E cDNA:5 DF100 Hex 20.46 20.43 0.03
H9 1E cDNA:5 DF100 Hex 20.43 20.43 0.03
H10 1E cDNA:5 DF1000 Hex 23.39 23.39 0.03
H11 1E cDNA:5 DF1000 Hex 23.41 23.39 0.03
H12 1E cDNA:5 DF1000 Hex 23.35 23.39 0.03
Analysis Parameters
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Pos Name Ct SYBR Ct Mean SYBR Ct Dev. SYBR Expr. Level SYBR Range SYBR
A1 1D cDNA:5 E1A 21.43 21.54 0.17
A2 1D cDNA:5 E1A 21.74 21.54 0.17
A3 1D cDNA:5 E1A 21.46 21.54 0.17
A4 2D cDNA:5 E1A 25.63 25.46 0.22
A5 2D cDNA:5 E1A 25.55 25.46 0.22
A6 2D cDNA:5 E1A 25.21 25.46 0.22
A7 3D cDNA:5 E1A 28.27 28.42 0.16
A8 3D cDNA:5 E1A 28.41 28.42 0.16
A9 3D cDNA:5 E1A 28.58 28.42 0.16
A10 4D cDNA:5 E1A 29.95 30.18 0.36
A11 4D cDNA:5 E1A 30.59 30.18 0.36
A12 4D cDNA:5 E1A 29.99 30.18 0.36
B1 1D cDNA:5 Hex 16.67 16.41 0.42
B2 1D cDNA:5 Hex 16.64 16.41 0.42
B3 1D cDNA:5 Hex 15.93 16.41 0.42
B4 2D cDNA:5 Hex 20.68 20.58 0.09 3.400E-2X 3.07E-02 - 3.78E-02
B5 2D cDNA:5 Hex 20.51 20.58 0.09 3.400E-2X 3.07E-02 - 3.78E-02
B6 2D cDNA:5 Hex 20.54 20.58 0.09 3.400E-2X 3.07E-02 - 3.78E-02
B7 3D cDNA:5 Hex 24.20 24.16 0.20 1.630E-2X 8.38E-04 - 0.317
B8 3D cDNA:5 Hex 24.35 24.16 0.20 1.630E-2X 8.38E-04 - 0.317
B9 3D cDNA:5 Hex 23.94 24.16 0.20 1.630E-2X 8.38E-04 - 0.317
B10 4D cDNA:5 Hex 26.95 26.80 0.14 4.260E-4X 3.67E-04 - 4.95E-04
B11 4D cDNA:5 Hex 26.68 26.80 0.14 4.260E-4X 3.67E-04 - 4.95E-04
B12 4D cDNA:5 Hex 26.77 26.80 0.14 4.260E-4X 3.67E-04 - 4.95E-04
C1 1D cDNA:5 Actin2 28.37 28.15 0.24
C2 1D cDNA:5 Actin2 28.18 28.15 0.24
C3 1D cDNA:5 Actin2 27.90 28.15 0.24
C4 2D cDNA:5 Actin2 27.53 27.44 0.12
C5 2D cDNA:5 Actin2 27.30 27.44 0.12
C6 2D cDNA:5 Actin2 27.49 27.44 0.12
C7 3D cDNA:5 Actin2 27.42 29.96 4.28
C8 3D cDNA:5 Actin2 27.57 29.96 4.28
C9 3D cDNA:5 Actin2 34.90 29.96 4.28
C10 4D cDNA:5 Actin2 27.46 27.34 0.16
C11 4D cDNA:5 Actin2 27.42 27.34 0.16
C12 4D cDNA:5 Actin2 27.16 27.34 0.16
D1 1E cDNA:5 E1A 22.08 21.45 0.56
D2 1E cDNA:5 E1A 21.27 21.45 0.56
D3 1E cDNA:5 E1A 21.02 21.45 0.56
D4 2E cDNA:5 E1A 24.84 24.85 0.11
D5 2E cDNA:5 E1A 24.75 24.85 0.11
D6 2E cDNA:5 E1A 24.97 24.85 0.11
D7 3E cDNA:5 E1A 27.73 27.76 0.23
D8 3E cDNA:5 E1A 27.55 27.76 0.23
D9 3E cDNA:5 E1A 28.00 27.76 0.23
D10 4E cDNA:5 E1A 29.52 29.32 0.19
D11 4E cDNA:5 E1A 29.29 29.32 0.19
D12 4E cDNA:5 E1A 29.14 29.32 0.19
E1 1E cDNA:5 Hex 14.67 14.46 0.20 7.03 5.34 - 9.26
E2 1E cDNA:5 Hex 14.41 14.46 0.20 7.03 5.34 - 9.26
E3 1E cDNA:5 Hex 14.29 14.46 0.20 7.03 5.34 - 9.26
E4 2E cDNA:5 Hex 18.07 17.94 0.14 0.301 0.237 - 0.383
E5 2E cDNA:5 Hex 17.80 17.94 0.14 0.301 0.237 - 0.383
E6 2E cDNA:5 Hex 17.95 17.94 0.14 0.301 0.237 - 0.383
E7 3E cDNA:5 Hex 20.86 20.89 0.06 3.850E-2X 3.68E-02 - 4.03E-02
E8 3E cDNA:5 Hex 20.85 20.89 0.06 3.850E-2X 3.68E-02 - 4.03E-02
E9 3E cDNA:5 Hex 20.96 20.89 0.06 3.850E-2X 3.68E-02 - 4.03E-02
E10 4E cDNA:5 Hex 22.81 22.91 0.12 6.400E-3X 5.67E-03 - 7.23E-03
E11 4E cDNA:5 Hex 22.88 22.91 0.12 6.400E-3X 5.67E-03 - 7.23E-03
E12 4E cDNA:5 Hex 23.05 22.91 0.12 6.400E-3X 5.67E-03 - 7.23E-03
F1 1E cDNA:5 Actin2 29.40 29.01 0.34
F2 1E cDNA:5 Actin2 28.77 29.01 0.34
F3 1E cDNA:5 Actin2 28.86 29.01 0.34
F4 2E cDNA:5 Actin2 28.31 27.95 0.32
F5 2E cDNA:5 Actin2 27.78 27.95 0.32
F6 2E cDNA:5 Actin2 27.75 27.95 0.32
F7 3E cDNA:5 Actin2 27.91 27.93 0.03
F8 3E cDNA:5 Actin2 27.93 27.93 0.03
F9 3E cDNA:5 Actin2 27.96 27.93 0.03
F10 4E cDNA:5 Actin2 27.49 27.37 0.12
F11 4E cDNA:5 Actin2 27.24 27.37 0.12
F12 4E cDNA:5 Actin2 27.38 27.37 0.12
G1 1E cDNA:5 DF1 E1A 22.02 21.67 0.31
G2 1E cDNA:5 DF1 E1A 21.54 21.67 0.31
G3 1E cDNA:5 DF1 E1A 21.44 21.67 0.31
G4 1E cDNA:5 DF10 E1A 24.82 24.66 0.22
G5 1E cDNA:5 DF10 E1A 24.74 24.66 0.22
G6 1E cDNA:5 DF10 E1A 24.41 24.66 0.22
G7 1E cDNA:5 DF100 E1A 27.97 27.91 0.13
G8 1E cDNA:5 DF100 E1A 28.00 27.91 0.13
G9 1E cDNA:5 DF100 E1A 27.75 27.91 0.13
G10 1E cDNA:5 DF1000 E1A 30.67 31.55 0.77
G11 1E cDNA:5 DF1000 E1A 31.89 31.55 0.77
G12 1E cDNA:5 DF1000 E1A 32.08 31.55 0.77
H1 1E cDNA:5 DF1 Hex 14.53 14.49 0.14
H2 1E cDNA:5 DF1 Hex 14.59 14.49 0.14
H3 1E cDNA:5 DF1 Hex 14.33 14.49 0.14
H4 1E cDNA:5 DF10 Hex 17.43 17.43 0.08
H5 1E cDNA:5 DF10 Hex 17.51 17.43 0.08
H6 1E cDNA:5 DF10 Hex 17.35 17.43 0.08
H7 1E cDNA:5 DF100 Hex 20.51 20.65 0.14
H8 1E cDNA:5 DF100 Hex 20.66 20.65 0.14
H9 1E cDNA:5 DF100 Hex 20.79 20.65 0.14
H10 1E cDNA:5 DF1000 Hex 24.02 23.82 0.18
H11 1E cDNA:5 DF1000 Hex 23.67 23.82 0.18
H12 1E cDNA:5 DF1000 Hex 23.77 23.82 0.18
Analysis Parameters






Baseline range (from cycle no. ... to) n/a
Drift Correction OFF
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All RNA qPCR results 
 
  







E1A (copies) Hex (copies) N/No CT (mg/L * min)
1B 5 27.77 27.69 1 1528 0 1 0
2B 5 30.17 27.27 0.14161049 313 0 0.26580227 0.22511248
3B 5 27.93 0 0 0.00641815 0.44309995
4B 5 35.31 28.575 10 0 0.00181524 0.60031006
1B 5 28.75 27.67 1 800 0 1 0
2B 5 32.21 27.14 0.06293472 81 0 0.08448276 0.20298051
3B 5 37.09 26.62 3 0 0.00775862 0.37206716
4B 5 36.28 27.14 6 0 0.00362069 0.50409828
1B 5 27.73 27.55 1 1569 0 1 0
2B 5 30.87 27.42 0.10366494 197 0 0.14545455 0.19939758
3B 5 26.6 0 0 0.00081818 0.43975506
4B 5 26.89 0 0 2.5455E-05 0.65516935
1B 5 28.34 27.04 1 1049 0 1 0
2B 5 33.53 27.18 0.03018551 34 0 0.02121951 0.1877802
3B 5 27.2 0 0 0.00139024 0.41347751







E1A (copies) Hex (copies) N/No CT (mg/L * min)
12 hpi 1C 5 22.2 28.31 27.59 1 1 60625 2146 1 0
2C 5 25.47 31.96 27.19 0.07856334 0.06037102 6986 218 0.26580227 0.22511248
3C 5 30.9 26.92 0.00151129 193 0 0.00641815 0.44309995
4C 5 32.5 27.5 0.00074524 67 0 0.00181524 0.60031006
1C 5 22.38 25.95 27.545 1 1 53827 9404 1 0
2C 5 26.39 32.82 27.25 0.05059014 0.00696819 3804 127 0.08448276 0.20298051
3C 5 30.1 26.78 0.002791 328 0 0.00775862 0.37206716
4C 5 31.05 26.41 0.00111789 175 0 0.00362069 0.50409828
1C 5 22.65 28.78 27.53 1 1 45031 1599 1 0
2C 5 26.65 34.21 26.89 0.04010706 0.01488497 3203 53 0.14545455 0.19939758
3C 5 32.34 27.16 0.00093678 75 0 0.00081818 0.43975506
4C 5 26.99 0 0 2.5455E-05 0.65516935







E1A (copies) Hex (copies) N/No CT (mg/L * min)
24 hpi 1D 5 21 16.4 28.65 1 1 133975 3713845 1 0
2D 5 24.12 19.01 27.35 0.04671404 0.06652314 17047 724768 0.26580227 0.22511248
3D 5 29.73 25.75 27.72 0.00123609 0.00080429 419 10658 0.00641815 0.44309995
4D 5 29.92 26.15 27.04 0.00067632 0.00038045 369 8297 0.00181524 0.60031006
1D 5 21.54 16.41 28.15 1 1 93769 3690667 1 0
2D 5 25.46 20.58 27.44 0.04038603 0.03396046 7032 271229 0.08448276 0.20298051
3D 5 28.42 24.16 27.495 0.00539186 0.00295014 995 28839 0.00775862 0.37206716
4D 5 30.18 26.8 27.34 0.00142977 0.00042507 311 5523 0.00362069 0.50409828
1D 5 21.14 16.97 27.21 1 1 122137 2599251 1 0
2D 5 24.5 21.02 27.01 0.08478777 0.05255603 13262 205924 0.14545455 0.19939758
3D 5 31.98 28.37 26.67 0.00037521 0.00025451 95 2067 0.00081818 0.43975506
4D 5 33.24 31.3 26.96 0.00019155 4.083E-05 41 330 2.5455E-05 0.65516935







E1A (copies) Hex (copies) N/No CT (mg/L * min)
1E 5 20.72 14.4 27.83 1 1 161205 12989652 1 0
2E 5 23.38 17.32 27.97 0.17434296 0.1455917 27798 2087795 0.26580227 0.22511248
3E 5 28.4 22.24 26.53 0.00198039 0.0017725 1008 95941 0.00641815 0.44309995
4E 5 30.22 24.29 26.54 0.00056479 0.00043101 303 26585 0.00181524 0.60031006
1E 5 21.45 14.46 29.01 1 1 99514 12510778 1 0
2E 5 24.85 17.94 27.95 0.04543664 0.04298568 10524 1416178 0.08448276 0.20298051
3E 5 27.76 20.89 27.93 0.00596195 0.00548611 1538 223384 0.00775862 0.37206716
4E 5 29.32 22.91 27.37 0.00137153 0.0009175 549 63072 0.00362069 0.50409828
1D 5 20.44 14.39 26.46 1 1 193969 13071228 1 0
2D 5 25.8 20.08 25.67 0.01408204 0.01120278 5617 370920 0.02121951 0.1877802
3D 5 31.63 26.1 26.26 0.00037262 0.00025986 119 8561 0.00139024 0.41347751
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Pos Name Ct SYBR Ct Mean SYBR Ct Dev. SYBR Amount SYBR Target SYBR
A1 1G DF:10^2 PCR E1A 4.78 4.72 0.27 -
A2 1G DF:10^2 PCR E1A 4.95 4.72 0.27 -
A3 1G DF:10^2 PCR E1A 4.42 4.72 0.27 -
A4 1G DF:10^3 PCR E1A 7.39 7.31 0.07 -
A5 1G DF:10^3 PCR E1A 7.28 7.31 0.07 -
A6 1G DF:10^3 PCR E1A 7.27 7.31 0.07 -
A7 1G DF:10^4 PCR E1A 11.14 12.99 3.40 -
A8 1G DF:10^4 PCR E1A 16.91 12.99 3.40 -
A9 1G DF:10^4 PCR E1A 10.92 12.99 3.40 -
A10 1G DF:10^5 PCR E1A 13.85 14.15 0.51 -
A11 1G DF:10^5 PCR E1A 13.86 14.15 0.51 -
A12 1G DF:10^5 PCR E1A 14.73 14.15 0.51 -
B1 1G DF:10^6 PCR E1A 17.89 17.80 0.14 -
B2 1G DF:10^6 PCR E1A 17.88 17.80 0.14 -
B3 1G DF:10^6 PCR E1A 17.64 17.80 0.14 -
B4 1G DF:10^7 PCR E1A 21.26 21.27 0.22 -
B5 1G DF:10^7 PCR E1A 21.04 21.27 0.22 -
B6 1G DF:10^7 PCR E1A 21.49 21.27 0.22 -
B7 1G DF:10^8 PCR E1A 24.67 26.24 2.58 -
B8 1G DF:10^8 PCR E1A 29.22 26.24 2.58 -
B9 1G DF:10^8 PCR E1A 24.83 26.24 2.58 -
B10 1G DF:10^9 PCR E1A 28.18 28.19 0.15 -
B11 1G DF:10^9 PCR E1A 28.04 28.19 0.15 -
B12 1G DF:10^9 PCR E1A 28.34 28.19 0.15 -
C1 1G DNA DF:1 E1A 27.74 20.87 5.95 -
C2 1G DNA DF:1 E1A 17.56 20.87 5.95 -
C3 1G DNA DF:1 E1A 17.31 20.87 5.95 -
C4 1G DNA DF:10 E1A 20.61 20.56 0.17 -
C5 1G DNA DF:10 E1A 20.37 20.56 0.17 -
C6 1G DNA DF:10 E1A 20.70 20.56 0.17 -
C7 1G DNA DF:100 E1A 24.00 23.88 0.10 -
C8 1G DNA DF:100 E1A 23.82 23.88 0.10 -
C9 1G DNA DF:100 E1A 23.81 23.88 0.10 -
C10 1G DNA DF:1000 E1A 28.02 27.59 0.38 -
C11 1G DNA DF:1000 E1A 27.46 27.59 0.38 -
C12 1G DNA DF:1000 E1A 27.30 27.59 0.38 -
D1 1G DNA DF:10000 E1A 34.79 32.82 1.74 -
D2 1G DNA DF:10000 E1A 32.17 32.82 1.74 -
D3 1G DNA DF:10000 E1A 31.49 32.82 1.74 -
D4 1G DNA DF:100000  E1A -
D5 1G DNA DF:100000  E1A 33.88 -
D6 1G DNA DF:100000  E1A -
E1 1G DF:10^2 PCR Hex 4.83 4.64 0.17 -
E2 1G DF:10^2 PCR Hex 4.58 4.64 0.17 -
E3 1G DF:10^2 PCR Hex 4.51 4.64 0.17 -
E4 1G DF:10^3 PCR Hex 7.43 7.22 0.19 -
E5 1G DF:10^3 PCR Hex 7.04 7.22 0.19 -
E6 1G DF:10^3 PCR Hex 7.19 7.22 0.19 -
E7 1G DF:10^4 PCR Hex 10.65 10.71 0.08 -
E8 1G DF:10^4 PCR Hex 10.68 10.71 0.08 -
E9 1G DF:10^4 PCR Hex 10.81 10.71 0.08 -
E10 1G DF:10^5 PCR Hex 14.17 14.41 0.23 -
E11 1G DF:10^5 PCR Hex 14.44 14.41 0.23 -
E12 1G DF:10^5 PCR Hex 14.62 14.41 0.23 -
F1 1G DF:10^6 PCR Hex 18.29 18.16 0.15 -
F2 1G DF:10^6 PCR Hex 18.00 18.16 0.15 -
F3 1G DF:10^6 PCR Hex 18.20 18.16 0.15 -
F4 1G DF:10^7 PCR Hex 21.59 21.62 0.04 -
F5 1G DF:10^7 PCR Hex 21.66 21.62 0.04 -
F6 1G DF:10^7 PCR Hex 21.60 21.62 0.04 -
F7 1G DF:10^8 PCR Hex 25.29 25.30 0.06 -
F8 1G DF:10^8 PCR Hex 25.25 25.30 0.06 -
F9 1G DF:10^8 PCR Hex 25.37 25.30 0.06 -
F10 1G DF:10^9 PCR Hex 28.82 28.53 0.35 -
F11 1G DF:10^9 PCR Hex 28.14 28.53 0.35 -
F12 1G DF:10^9 PCR Hex 28.64 28.53 0.35 -
G1 1G DNA DF:1 Hex 18.10 17.79 0.33 -
G2 1G DNA DF:1 Hex 17.82 17.79 0.33 -
G3 1G DNA DF:1 Hex 17.44 17.79 0.33 -
G4 1G DNA DF:10 Hex 21.84 21.48 0.31 -
G5 1G DNA DF:10 Hex 21.32 21.48 0.31 -
G6 1G DNA DF:10 Hex 21.27 21.48 0.31 -
G7 1G DNA DF:100 Hex 24.71 24.83 0.11 -
G8 1G DNA DF:100 Hex 24.91 24.83 0.11 -
G9 1G DNA DF:100 Hex 24.87 24.83 0.11 -
G10 1G DNA DF:1000 Hex 28.45 28.55 0.17 -
G11 1G DNA DF:1000 Hex 28.45 28.55 0.17 -
G12 1G DNA DF:1000 Hex 28.74 28.55 0.17 -
H1 1G DNA DF:10000 Hex 33.35 32.84 0.71 -
H2 1G DNA DF:10000 Hex 32.84 0.71 -
H3 1G DNA DF:10000 Hex 32.34 32.84 0.71 -
H4 1G DNA DF:100000 Hex -
H5 1G DNA DF:100000 Hex -
H6 1G DNA DF:100000 Hex -
Analysis Parameters






Baseline range (from cycle no. ... to) n/a
Drift Correction OFF
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DNA2 
 
Pos Name Ct SYBR Ct Mean SYBR Ct Dev. SYBR Amount SYBR Target SYBR 6_20_14 Ad2 1.134 DNA Calibration
A1 Calib PCR DF10^4 E1A 13.16 12.10 0.92 -
A2 Calib PCR DF10^4 E1A 11.47 12.10 0.92 -
A3 Calib PCR DF10^4 E1A 11.67 12.10 0.92 -
A4 1G 5_5 DF1 E1A 17.39 17.11 0.28 -
A5 1G 5_5 DF1 E1A 17.10 17.11 0.28 -
A6 1G 5_5 DF1 E1A 16.82 17.11 0.28 -
A7 1G 4_30 DF1 E1A 17.70 17.77 0.08 -
A8 1G 4_30 DF1 E1A 17.86 17.77 0.08 -
A9 1G 4_30 DF1 E1A 17.76 17.77 0.08 -
B1 Calib PCR DF10^5 E1A 15.71 15.66 0.36 -
B2 Calib PCR DF10^5 E1A 15.27 15.66 0.36 -
B3 Calib PCR DF10^5 E1A 15.99 15.66 0.36 -
B4 1G 5_5 DF10 E1A 20.79 21.15 0.31 -
B5 1G 5_5 DF10 E1A 21.31 21.15 0.31 -
B6 1G 5_5 DF10 E1A 21.35 21.15 0.31 -
B7 1G 4_30 DF10 E1A 25.22 25.31 0.49 -
B8 1G 4_30 DF10 E1A 25.85 25.31 0.49 -
B9 1G 4_30 DF10 E1A 24.87 25.31 0.49 -
C1 Calib PCR DF10^6 E1A 18.94 19.28 0.64 -
C2 Calib PCR DF10^6 E1A 20.02 19.28 0.64 -
C3 Calib PCR DF10^6 E1A 18.88 19.28 0.64 -
C4 1G 5_5 DF100 E1A 24.70 24.51 0.21 -
C5 1G 5_5 DF100 E1A 24.28 24.51 0.21 -
C6 1G 5_5 DF100 E1A 24.56 24.51 0.21 -
C7 1G 4_30 DF100 E1A 20.75 20.80 0.08 -
C8 1G 4_30 DF100 E1A 20.90 20.80 0.08 -
C9 1G 4_30 DF100 E1A 20.76 20.80 0.08 -
D1 Calib PCR DF10^7 E1A 22.60 22.07 0.46 -
D2 Calib PCR DF10^7 E1A 21.78 22.07 0.46 -
D3 Calib PCR DF10^7 E1A 21.83 22.07 0.46 -
D4 1G 5_5 DF1000 E1A 27.88 27.03 0.76 -
D5 1G 5_5 DF1000 E1A 26.76 27.03 0.76 -
D6 1G 5_5 DF1000 E1A 26.44 27.03 0.76 -
D7 1G 4_30 DF1000 E1A 28.16 28.41 0.38 -
D8 1G 4_30 DF1000 E1A 28.21 28.41 0.38 -
D9 1G 4_30 DF1000 E1A 28.85 28.41 0.38 -
E1 Calib PCR DF10^8 E1A 26.60 26.08 0.45 -
E2 Calib PCR DF10^8 E1A 25.74 26.08 0.45 -
E3 Calib PCR DF10^8 E1A 25.91 26.08 0.45 -
E4 1G 5_6 DF1 E1A 17.79 17.12 0.59 -
E5 1G 5_6 DF1 E1A 16.77 17.12 0.59 -
E6 1G 5_6 DF1 E1A 16.79 17.12 0.59 -
E7 1G 4_18 DF1 E1A 16.64 16.93 0.25 -
E8 1G 4_18 DF1 E1A 17.07 16.93 0.25 -
E9 1G 4_18 DF1 E1A 17.07 16.93 0.25 -
F1 Calib PCR DF10^9 E1A 30.69 29.57 0.97 -
F2 Calib PCR DF10^9 E1A 28.96 29.57 0.97 -
F3 Calib PCR DF10^9 E1A 29.07 29.57 0.97 -
F4 1G 5_6 DF10 E1A 20.71 20.70 0.09 -
F5 1G 5_6 DF10 E1A 20.62 20.70 0.09 -
F6 1G 5_6 DF10 E1A 20.79 20.70 0.09 -
F7 1G 4_18 DF10 E1A 20.71 20.51 0.19 -
F8 1G 4_18 DF10 E1A 20.48 20.51 0.19 -
F9 1G 4_18 DF10 E1A 20.34 20.51 0.19 -
G1 Calib PCR DF10^10 E1A 31.22 32.92 2.08 -
G2 Calib PCR DF10^10 E1A 32.30 32.92 2.08 -
G3 Calib PCR DF10^10 E1A 35.23 32.92 2.08 -
G4 1G 5_6 DF100 E1A 24.75 24.50 0.47 -
G5 1G 5_6 DF100 E1A 24.79 24.50 0.47 -
G6 1G 5_6 DF100 E1A 23.96 24.50 0.47 -
G7 1G 4_18 DF100 E1A 24.09 22.84 2.11 -
G8 1G 4_18 DF100 E1A 24.03 22.84 2.11 -
G9 1G 4_18 DF100 E1A 20.40 22.84 2.11 -
H1 Calib PCR DF10^11 E1A 35.57 34.92 0.56 -
H2 Calib PCR DF10^11 E1A 34.63 34.92 0.56 -
H3 Calib PCR DF10^11 E1A 34.56 34.92 0.56 -
H4 1G 5_6 DF1000 E1A 28.26 27.99 0.42 -
H5 1G 5_6 DF1000 E1A 28.21 27.99 0.42 -
H6 1G 5_6 DF1000 E1A 27.51 27.99 0.42 -
H7 1G 4_18 DF1000 E1A 27.64 27.54 0.18 -
H8 1G 4_18 DF1000 E1A 27.65 27.54 0.18 -
H9 1G 4_18 DF1000 E1A 27.33 27.54 0.18 -
A10 Calib PCR DF10^1 Actin2 4.77 4.98 0.26 -
A11 Calib PCR DF10^1 Actin2 5.27 4.98 0.26 -
A12 Calib PCR DF10^1 Actin2 4.90 4.98 0.26 -
B10 Calib PCR DF10^2 Actin2 8.07 8.14 0.15 -
B11 Calib PCR DF10^2 Actin2 8.04 8.14 0.15 -
B12 Calib PCR DF10^2 Actin2 8.31 8.14 0.15 -
C10 Calib PCR DF10^3 Actin2 11.80 11.96 0.21 -
C11 Calib PCR DF10^3 Actin2 12.20 11.96 0.21 -
C12 Calib PCR DF10^3 Actin2 11.89 11.96 0.21 -
D10 Calib PCR DF10^4 Actin2 15.36 15.64 0.34 -
D11 Calib PCR DF10^4 Actin2 16.02 15.64 0.34 -
D12 Calib PCR DF10^4 Actin2 15.56 15.64 0.34 -
E10 Calib PCR DF10^5 Actin2 19.27 19.27 0.29 -
E11 Calib PCR DF10^5 Actin2 19.55 19.27 0.29 -
E12 Calib PCR DF10^5 Actin2 18.97 19.27 0.29 -
F10 Calib PCR DF10^6 Actin2 22.39 22.62 0.21 -
F11 Calib PCR DF10^6 Actin2 22.81 22.62 0.21 -
F12 Calib PCR DF10^6 Actin2 22.66 22.62 0.21 -
G10 Calib PCR DF10^7 Actin2 26.14 27.31 1.17 -
G11 Calib PCR DF10^7 Actin2 28.49 27.31 1.17 -
G12 Calib PCR DF10^7 Actin2 27.30 27.31 1.17 -
H10 No template Actin PCR 14.66 16.64 3.79 -
H11 No template Actin PCR 14.26 16.64 3.79 -
H12 No template Actin PCR 21.00 16.64 3.79 -
Subassay Subassay A1-H9 Analysis Parameters






Baseline range (from cycle no. ... to) n/a
Drift Correction OFF
Subassay Subassay A10-H12 Analysis Parameters






Baseline range (from cycle no. ... to) n/a
Drift Correction OFF
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DNA3 
 
Pos Name Ct SYBR Ct Mean SYBR Ct Dev. SYBR Amount SYBR Target SYBR 6_24_14 Ad2 4.134 DNA Calibration
A1 Calib PCR DF10^4 Hex 13.28 13.08 0.18 -
A2 Calib PCR DF10^4 Hex 12.93 13.08 0.18 -
A3 Calib PCR DF10^4 Hex 13.04 13.08 0.18 -
A4 1G 5_5 DF1 Hex 19.20 18.50 0.73 -
A5 1G 5_5 DF1 Hex 17.75 18.50 0.73 -
A6 1G 5_5 DF1 Hex 18.54 18.50 0.73 -
A7 1G 4_30 DF1 Hex 19.69 19.22 0.61 -
A8 1G 4_30 DF1 Hex 18.52 19.22 0.61 -
A9 1G 4_30 DF1 Hex 19.45 19.22 0.61 -
B1 Calib PCR DF10^5 Hex 15.09 15.41 0.31 -
B2 Calib PCR DF10^5 Hex 15.44 15.41 0.31 -
B3 Calib PCR DF10^5 Hex 15.71 15.41 0.31 -
B4 1G 5_5 DF10 Hex 22.80 22.78 0.02 -
B5 1G 5_5 DF10 Hex 22.79 22.78 0.02 -
B6 1G 5_5 DF10 Hex 22.76 22.78 0.02 -
B7 1G 4_30 DF10 Hex 22.38 22.69 0.28 -
B8 1G 4_30 DF10 Hex 22.80 22.69 0.28 -
B9 1G 4_30 DF10 Hex 22.90 22.69 0.28 -
C1 Calib PCR DF10^6 Hex 20.14 19.97 0.14 -
C2 Calib PCR DF10^6 Hex 19.91 19.97 0.14 -
C3 Calib PCR DF10^6 Hex 19.87 19.97 0.14 -
C4 1G 5_5 DF100 Hex 25.73 25.93 0.29 -
C5 1G 5_5 DF100 Hex 25.81 25.93 0.29 -
C6 1G 5_5 DF100 Hex 26.26 25.93 0.29 -
C7 1G 4_30 DF100 Hex 26.54 26.62 0.33 -
C8 1G 4_30 DF100 Hex 26.98 26.62 0.33 -
C9 1G 4_30 DF100 Hex 26.34 26.62 0.33 -
D1 Calib PCR DF10^7 Hex 25.32 24.61 0.79 -
D2 Calib PCR DF10^7 Hex 23.76 24.61 0.79 -
D3 Calib PCR DF10^7 Hex 24.73 24.61 0.79 -
D4 1G 5_5 DF1000 Hex 30.32 29.65 0.58 -
D5 1G 5_5 DF1000 Hex 29.26 29.65 0.58 -
D6 1G 5_5 DF1000 Hex 29.37 29.65 0.58 -
D7 1G 4_30 DF1000 Hex 29.83 29.69 0.19 -
D8 1G 4_30 DF1000 Hex 29.48 29.69 0.19 -
D9 1G 4_30 DF1000 Hex 29.77 29.69 0.19 -
E1 Calib PCR DF10^8 Hex 28.62 27.87 0.67 -
E2 Calib PCR DF10^8 Hex 27.37 27.87 0.67 -
E3 Calib PCR DF10^8 Hex 27.61 27.87 0.67 -
E4 1G 5_6 DF1 Hex 18.28 17.88 0.54 -
E5 1G 5_6 DF1 Hex 17.26 17.88 0.54 -
E6 1G 5_6 DF1 Hex 18.10 17.88 0.54 -
E7 1G 4_18 DF1 Hex 18.39 18.13 0.35 -
E8 1G 4_18 DF1 Hex 18.28 18.13 0.35 -
E9 1G 4_18 DF1 Hex 17.73 18.13 0.35 -
F1 Calib PCR DF10^9 Hex 30.12 30.18 0.27 -
F2 Calib PCR DF10^9 Hex 29.95 30.18 0.27 -
F3 Calib PCR DF10^9 Hex 30.48 30.18 0.27 -
F4 1G 5_6 DF10 Hex 21.80 21.66 0.22 -
F5 1G 5_6 DF10 Hex 21.77 21.66 0.22 -
F6 1G 5_6 DF10 Hex 21.41 21.66 0.22 -
F7 1G 4_18 DF10 Hex 22.07 21.79 0.38 -
F8 1G 4_18 DF10 Hex 21.36 21.79 0.38 -
F9 1G 4_18 DF10 Hex 21.95 21.79 0.38 -
G1 Calib PCR DF10^10 Hex 34.48 34.58 0.31 -
G2 Calib PCR DF10^10 Hex 34.93 34.58 0.31 -
G3 Calib PCR DF10^10 Hex 34.33 34.58 0.31 -
G4 1G 5_6 DF100 Hex 26.53 26.28 0.22 -
G5 1G 5_6 DF100 Hex 26.12 26.28 0.22 -
G6 1G 5_6 DF100 Hex 26.18 26.28 0.22 -
G7 1G 4_18 DF100 Hex 25.87 26.06 0.20 -
G8 1G 4_18 DF100 Hex 26.27 26.06 0.20 -
G9 1G 4_18 DF100 Hex 26.04 26.06 0.20 -
H1 Calib PCR DF10^11 Hex -
H2 Calib PCR DF10^11 Hex -
H3 Calib PCR DF10^11 Hex -
H4 1G 5_6 DF1000 Hex 30.50 30.43 0.08 -
H5 1G 5_6 DF1000 Hex 30.43 30.43 0.08 -
H6 1G 5_6 DF1000 Hex 30.34 30.43 0.08 -
H7 1G 4_18 DF1000 Hex 28.94 29.11 0.23 -
H8 1G 4_18 DF1000 Hex 29.02 29.11 0.23 -
H9 1G 4_18 DF1000 Hex 29.38 29.11 0.23 -
A10 Calib PCR DF10^3 Actin2 12.43 12.57 0.17 -
A11 Calib PCR DF10^3 Actin2 12.51 12.57 0.17 -
A12 Calib PCR DF10^3 Actin2 12.76 12.57 0.17 -
B10 Calib PCR DF10^4 Actin2 16.53 16.57 0.19 -
B11 Calib PCR DF10^4 Actin2 16.78 16.57 0.19 -
B12 Calib PCR DF10^4 Actin2 16.41 16.57 0.19 -
C10 Calib PCR DF10^5 Actin2 20.92 20.85 0.36 -
C11 Calib PCR DF10^5 Actin2 21.16 20.85 0.36 -
C12 Calib PCR DF10^5 Actin2 20.46 20.85 0.36 -
D10 Calib PCR DF10^6 Actin2 24.31 25.95 2.89 -
D11 Calib PCR DF10^6 Actin2 29.28 25.95 2.89 -
D12 Calib PCR DF10^6 Actin2 24.25 25.95 2.89 -
E10 Calib PCR DF10^7 Actin2 27.67 27.54 0.24 -
E11 Calib PCR DF10^7 Actin2 27.26 27.54 0.24 -
E12 Calib PCR DF10^7 Actin2 27.69 27.54 0.24 -
F10 Calib PCR DF10^8 Actin2 32.11 31.25 0.75 -
F11 Calib PCR DF10^8 Actin2 30.71 31.25 0.75 -
F12 Calib PCR DF10^8 Actin2 30.92 31.25 0.75 -
G10 Calib PCR DF10^9 Actin2 34.67 34.24 0.52 -
G11 Calib PCR DF10^9 Actin2 33.66 34.24 0.52 -
G12 Calib PCR DF10^9 Actin2 34.38 34.24 0.52 -
H10 No template Actin2 - -
H11 No template Actin2 - -
H12 No template Actin2 - -
Subassay Subassay A1-H9 Analysis Parameters






Baseline range (from cycle no. ... to) n/a
Drift Correction OFF
Subassay Subassay A10-H12 Analysis Parameters






Baseline range (from cycle no. ... to) n/a
Drift Correction OFF
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RNA1 
 
Pos Name Ct SYBR Ct Mean SYBR Ct Dev. SYBR Amount SYBR Target SYBR 6_24_14 Ad2 4.134 RNA1 Calibration
H12 No Template E1A - -
H11 No Template E1A - -
H10 No Template E1A - -
E7 1D 4_18 cDNA DF1 E1A 20.92 20.02 0.80 -
E8 1D 4_18 cDNA DF1 E1A 19.39 20.02 0.80 -
E9 1D 4_18 cDNA DF1 E1A 19.75 20.02 0.80 -
F7 1D 4_18 cDNA DF10 E1A 21.98 21.95 0.09 -
F8 1D 4_18 cDNA DF10 E1A 21.85 21.95 0.09 -
F9 1D 4_18 cDNA DF10 E1A 22.03 21.95 0.09 -
G7 1D 4_18 cDNA DF100 E1A 26.64 26.65 0.11 -
G8 1D 4_18 cDNA DF100 E1A 26.76 26.65 0.11 -
G9 1D 4_18 cDNA DF100 E1A 26.54 26.65 0.11 -
H7 1D 4_18 cDNA DF1000 E1A 31.22 31.02 0.29 -
H8 1D 4_18 cDNA DF1000 E1A 31.15 31.02 0.29 -
H9 1D 4_18 cDNA DF1000 E1A 30.68 31.02 0.29 -
A7 1D 4_30 cDNA DF1 E1A 21.01 20.92 0.12 -
A8 1D 4_30 cDNA DF1 E1A 20.78 20.92 0.12 -
A9 1D 4_30 cDNA DF1 E1A 20.97 20.92 0.12 -
B7 1D 4_30 cDNA DF10 E1A 22.40 22.57 0.38 -
B8 1D 4_30 cDNA DF10 E1A 23.01 22.57 0.38 -
B9 1D 4_30 cDNA DF10 E1A 22.31 22.57 0.38 -
C7 1D 4_30 cDNA DF100 E1A 26.99 27.30 0.60 -
C8 1D 4_30 cDNA DF100 E1A 27.99 27.30 0.60 -
C9 1D 4_30 cDNA DF100 E1A 26.92 27.30 0.60 -
D7 1D 4_30 cDNA DF1000 E1A 29.35 29.56 0.19 -
D8 1D 4_30 cDNA DF1000 E1A 29.62 29.56 0.19 -
D9 1D 4_30 cDNA DF1000 E1A 29.72 29.56 0.19 -
A4 1E 5_5 cDNA DF1 E1A 22.84 22.29 0.48 -
A5 1E 5_5 cDNA DF1 E1A 22.08 22.29 0.48 -
A6 1E 5_5 cDNA DF1 E1A 21.94 22.29 0.48 -
B4 1E 5_5 cDNA DF10 E1A 25.28 23.97 1.18 -
B5 1E 5_5 cDNA DF10 E1A 23.01 23.97 1.18 -
B6 1E 5_5 cDNA DF10 E1A 23.62 23.97 1.18 -
C4 1E 5_5 cDNA DF100 E1A 27.26 27.40 0.18 -
C5 1E 5_5 cDNA DF100 E1A 27.61 27.40 0.18 -
C6 1E 5_5 cDNA DF100 E1A 27.33 27.40 0.18 -
D4 1E 5_5 cDNA DF1000 E1A 31.28 31.42 0.13 -
D5 1E 5_5 cDNA DF1000 E1A 31.53 31.42 0.13 -
D6 1E 5_5 cDNA DF1000 E1A 31.44 31.42 0.13 -
E4 1E 5_6 cDNA DF1 E1A 21.09 20.56 0.81 -
E5 1E 5_6 cDNA DF1 E1A 20.97 20.56 0.81 -
E6 1E 5_6 cDNA DF1 E1A 19.63 20.56 0.81 -
F4 1E 5_6 cDNA DF10 E1A 22.78 23.39 0.57 -
F5 1E 5_6 cDNA DF10 E1A 23.47 23.39 0.57 -
F6 1E 5_6 cDNA DF10 E1A 23.91 23.39 0.57 -
G4 1E 5_6 cDNA DF100 E1A 29.68 28.71 0.84 -
G5 1E 5_6 cDNA DF100 E1A 28.13 28.71 0.84 -
G6 1E 5_6 cDNA DF100 E1A 28.31 28.71 0.84 -
H4 1E 5_6 cDNA DF1000 E1A 32.98 32.38 0.91 -
H5 1E 5_6 cDNA DF1000 E1A 32.82 32.38 0.91 -
H6 1E 5_6 cDNA DF1000 E1A 31.34 32.38 0.91 -
F1 Calib PCR DF10^10 E1A 33.49 0.47 -
F2 Calib PCR DF10^10 E1A 33.82 33.49 0.47 -
F3 Calib PCR DF10^10 E1A 33.16 33.49 0.47 -
G1 Calib PCR DF10^11 E1A -
G2 Calib PCR DF10^11 E1A -
G3 Calib PCR DF10^11 E1A -
H1 Calib PCR DF10^12 E1A -
H2 Calib PCR DF10^12 E1A -
H3 Calib PCR DF10^12 E1A -
A1 Calib PCR DF10^5 E1A 15.90 15.82 0.24 -
A2 Calib PCR DF10^5 E1A 16.00 15.82 0.24 -
A3 Calib PCR DF10^5 E1A 15.54 15.82 0.24 -
B1 Calib PCR DF10^6 E1A 21.00 20.93 0.38 -
B2 Calib PCR DF10^6 E1A 21.27 20.93 0.38 -
B3 Calib PCR DF10^6 E1A 20.52 20.93 0.38 -
C1 Calib PCR DF10^7 E1A 23.44 22.95 0.43 -
C2 Calib PCR DF10^7 E1A 22.62 22.95 0.43 -
C3 Calib PCR DF10^7 E1A 22.81 22.95 0.43 -
D1 Calib PCR DF10^8 E1A 26.35 26.03 0.28 -
D2 Calib PCR DF10^8 E1A 25.83 26.03 0.28 -
D3 Calib PCR DF10^8 E1A 25.91 26.03 0.28 -
E1 Calib PCR DF10^9 E1A 30.00 29.39 0.55 -
E2 Calib PCR DF10^9 E1A 28.92 29.39 0.55 -
E3 Calib PCR DF10^9 E1A 29.25 29.39 0.55 -
A10 Calib PCR DF10^3 Actin2 12.16 12.85 0.62 -
A11 Calib PCR DF10^3 Actin2 13.33 12.85 0.62 -
A12 Calib PCR DF10^3 Actin2 13.08 12.85 0.62 -
B10 Calib PCR DF10^4 Actin2 16.28 16.36 0.07 -
B11 Calib PCR DF10^4 Actin2 16.38 16.36 0.07 -
B12 Calib PCR DF10^4 Actin2 16.41 16.36 0.07 -
C12 Calib PCR DF10^5 Actin2 20.62 20.87 0.32 -
C11 Calib PCR DF10^5 Actin2 20.75 20.87 0.32 -
C10 Calib PCR DF10^5 Actin2 21.23 20.87 0.32 -
D10 Calib PCR DF10^6 Actin2 24.64 24.49 0.13 -
D11 Calib PCR DF10^6 Actin2 24.44 24.49 0.13 -
D12 Calib PCR DF10^6 Actin2 24.40 24.49 0.13 -
E10 Calib PCR DF10^7 Actin2 27.66 28.11 0.58 -
E11 Calib PCR DF10^7 Actin2 27.90 28.11 0.58 -
E12 Calib PCR DF10^7 Actin2 28.77 28.11 0.58 -
F10 Calib PCR DF10^8 Actin2 30.34 30.65 0.33 -
F11 Calib PCR DF10^8 Actin2 30.64 30.65 0.33 -
F12 Calib PCR DF10^8 Actin2 30.99 30.65 0.33 -
G10 Calib PCR DF10^9 Actin2 34.50 35.28 1.10 -
G11 Calib PCR DF10^9 Actin2 35.28 1.10 -
G12 Calib PCR DF10^9 Actin2 36.06 35.28 1.10 -
Main Assay Analysis Parameters






Baseline range (from cycle no. ... to) n/a
Drift Correction OFF
Subassay Subassay A1-H9 Analysis Parameters






Baseline range (from cycle no. ... to) n/a
Drift Correction OFF
Subassay Subassay A10-G12 Analysis Parameters






Baseline range (from cycle no. ... to) n/a
Drift Correction OFF
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RNA2 
 
Pos Name Ct SYBR Ct Mean SYBR Ct Dev. SYBR Amount SYBR Target SYBR 6_24_14 Ad2 4.134 RNA2 Calibration
H11 No template Hex - -
H12 No template Hex - -
A1 Calib PCR DF10^4 Hex 13.42 13.42 0.04 -
A2 Calib PCR DF10^4 Hex 13.46 13.42 0.04 -
A3 Calib PCR DF10^4 Hex 13.38 13.42 0.04 -
A4 1E 5_5 cDNA:5 DF1 Hex 16.61 15.89 0.64 -
A5 1E 5_5 cDNA:5 DF1 Hex 15.64 15.89 0.64 -
A6 1E 5_5 cDNA:5 DF1 Hex 15.42 15.89 0.64 -
A7 1D 4_30 cDNA:5 DF1 Hex 17.53 17.80 0.24 -
A8 1D 4_30 cDNA:5 DF1 Hex 17.98 17.80 0.24 -
A9 1D 4_30 cDNA:5 DF1 Hex 17.88 17.80 0.24 -
B1 Calib PCR DF10^5 Hex 17.49 17.02 0.49 -
B2 Calib PCR DF10^5 Hex 17.05 17.02 0.49 -
B3 Calib PCR DF10^5 Hex 16.52 17.02 0.49 -
B4 1E 5_5 cDNA:5 DF10 Hex 19.06 18.67 0.70 -
B5 1E 5_5 cDNA:5 DF10 Hex 17.85 18.67 0.70 -
B6 1E 5_5 cDNA:5 DF10 Hex 19.08 18.67 0.70 -
B7 1E 5_6 cDNA:5 DF10 Hex 18.37 18.71 0.31 -
B8 1E 5_6 cDNA:5 DF10 Hex 18.83 18.71 0.31 -
B9 1E 5_6 cDNA:5 DF10 Hex 18.95 18.71 0.31 -
C1 Calib PCR DF10^6 Hex 20.77 20.41 0.31 -
C2 Calib PCR DF10^6 Hex 20.23 20.41 0.31 -
C3 Calib PCR DF10^6 Hex 20.23 20.41 0.31 -
C4 1E 5_5 cDNA:5 DF100 Hex 22.56 22.41 0.17 -
C5 1E 5_5 cDNA:5 DF100 Hex 22.46 22.41 0.17 -
C6 1E 5_5 cDNA:5 DF100 Hex 22.22 22.41 0.17 -
C7 1E 5_6 cDNA:5 DF100 Hex 21.75 21.86 0.10 -
C8 1E 5_6 cDNA:5 DF100 Hex 21.92 21.86 0.10 -
C9 1E 5_6 cDNA:5 DF100 Hex 21.92 21.86 0.10 -
D1 Calib PCR DF10^7 Hex 25.16 24.87 0.33 -
D2 Calib PCR DF10^7 Hex 24.95 24.87 0.33 -
D3 Calib PCR DF10^7 Hex 24.51 24.87 0.33 -
D4 1E 5_5 cDNA:5 DF1000 Hex 27.06 26.30 0.67 -
D5 1E 5_5 cDNA:5 DF1000 Hex 26.01 26.30 0.67 -
D6 1E 5_5 cDNA:5 DF1000 Hex 25.81 26.30 0.67 -
D7 1E 5_6 cDNA:5 DF1000 Hex 25.92 25.85 0.08 -
D8 1E 5_6 cDNA:5 DF1000 Hex 25.86 25.85 0.08 -
D9 1E 5_6 cDNA:5 DF1000 Hex 25.76 25.85 0.08 -
E1 Calib PCR DF10^8 Hex 27.95 28.14 0.17 -
E2 Calib PCR DF10^8 Hex 28.26 28.14 0.17 -
E3 Calib PCR DF10^8 Hex 28.23 28.14 0.17 -
E4 1E 5_6 cDNA:5 DF1 Hex 14.79 14.69 0.21 -
E5 1E 5_6 cDNA:5 DF1 Hex 14.83 14.69 0.21 -
E6 1E 5_6 cDNA:5 DF1 Hex 14.45 14.69 0.21 -
E7 1D 4_18 cDNA:5 DF1 Hex 13.90 14.27 0.47 -
E8 1D 4_18 cDNA:5 DF1 Hex 14.12 14.27 0.47 -
E9 1D 4_18 cDNA:5 DF1 Hex 14.81 14.27 0.47 -
F1 Calib PCR DF10^9 Hex 30.88 30.91 0.02 -
F2 Calib PCR DF10^9 Hex 30.91 30.91 0.02 -
F3 Calib PCR DF10^9 Hex 30.92 30.91 0.02 -
F4 1D 4_30 cDNA:5 DF10 Hex 20.71 20.61 0.22 -
F5 1D 4_30 cDNA:5 DF10 Hex 20.76 20.61 0.22 -
F6 1D 4_30 cDNA:5 DF10 Hex 20.36 20.61 0.22 -
F7 1D 4_18 cDNA:5 DF10 Hex 17.46 17.39 0.53 -
F8 1D 4_18 cDNA:5 DF10 Hex 16.83 17.39 0.53 -
F9 1D 4_18 cDNA:5 DF10 Hex 17.88 17.39 0.53 -
G1 Calib PCR DF10^10 Hex 34.80 34.81 0.15 -
G2 Calib PCR DF10^10 Hex 34.66 34.81 0.15 -
G3 Calib PCR DF10^10 Hex 34.96 34.81 0.15 -
G4 1D 4_30 cDNA:5 DF100 Hex 24.61 24.28 0.30 -
G5 1D 4_30 cDNA:5 DF100 Hex 24.19 24.28 0.30 -
G6 1D 4_30 cDNA:5 DF100 Hex 24.03 24.28 0.30 -
G7 1D 4_18 cDNA:5 DF100 Hex 22.00 21.85 0.17 -
G8 1D 4_18 cDNA:5 DF100 Hex 21.67 21.85 0.17 -
G9 1D 4_18 cDNA:5 DF100 Hex 21.89 21.85 0.17 -
H1 Calib PCR DF10^11 Hex -
H2 Calib PCR DF10^11 Hex -
H3 Calib PCR DF10^11 Hex -
H4 1D 4_30 cDNA:5 DF1000 Hex 27.55 27.46 0.20 -
H5 1D 4_30 cDNA:5 DF1000 Hex 27.61 27.46 0.20 -
H6 1D 4_30 cDNA:5 DF1000 Hex 27.23 27.46 0.20 -
H7 1D 4_18 cDNA:5 DF1000 Hex 25.44 25.76 0.28 -
H8 1D 4_18 cDNA:5 DF1000 Hex 25.89 25.76 0.28 -
H9 1D 4_18 cDNA:5 DF1000 Hex 25.97 25.76 0.28 -
A10 Calib PCR DF10^3 Actin2 12.35 12.31 0.16 -
A11 Calib PCR DF10^3 Actin2 12.13 12.31 0.16 -
A12 Calib PCR DF10^3 Actin2 12.44 12.31 0.16 -
B10 Calib PCR DF10^4 Actin2 16.69 16.72 0.07 -
B11 Calib PCR DF10^4 Actin2 16.80 16.72 0.07 -
B12 Calib PCR DF10^4 Actin2 16.67 16.72 0.07 -
C10 Calib PCR DF10^5 Actin2 21.16 21.41 0.23 -
C11 Calib PCR DF10^5 Actin2 21.59 21.41 0.23 -
C12 Calib PCR DF10^5 Actin2 21.49 21.41 0.23 -
D10 Calib PCR DF10^6 Actin2 24.66 24.41 0.25 -
D11 Calib PCR DF10^6 Actin2 24.40 24.41 0.25 -
D12 Calib PCR DF10^6 Actin2 24.17 24.41 0.25 -
E10 Calib PCR DF10^7 Actin2 28.05 28.11 0.10 -
E11 Calib PCR DF10^7 Actin2 28.05 28.11 0.10 -
E12 Calib PCR DF10^7 Actin2 28.23 28.11 0.10 -
F10 Calib PCR DF10^8 Actin2 30.90 31.25 0.76 -
F11 Calib PCR DF10^8 Actin2 30.73 31.25 0.76 -
F12 Calib PCR DF10^8 Actin2 32.13 31.25 0.76 -
G10 Calib PCR DF10^9 Actin2 35.56 34.99 0.82 -
G11 Calib PCR DF10^9 Actin2 34.41 34.99 0.82 -
G12 Calib PCR DF10^9 Actin2 34.99 0.82 -
Main Assay Analysis Parameters






Baseline range (from cycle no. ... to) n/a
Drift Correction OFF
Subassay Subassay A1-H9 Analysis Parameters






Baseline range (from cycle no. ... to) n/a
Drift Correction OFF
Subassay Subassay A10-G12 Analysis Parameters






Baseline range (from cycle no. ... to) n/a
Drift Correction OFF





















































N (pfu/mL) N (pfu/uL) log-N (pfu/uL)
687500 687.5 2.8372727
5/5/14
N (pfu/mL) N (pfu/uL) log-N (pfu/uL)
385625 385.625 2.58616518
5/6/14











(PCR) DF Ct Copies/uL
Log 
Copies/uL DF Ct Copies/uL
Log 
Copies/uL DF Ct Copies/uL
Log-
copies/uL
1 ND 1.2527E+11 1 ND 1.2527E+11 11.097852 1 ND 1.2527E+11 0
100 4.72 1252714241 9.09785201 100 ND 0 0
1000 7.31 125271424 8.09785201 1000 ND 0 0
10000 11.03 12527142.4 7.09785201 10000 11.57 12527142.4 7.09785201
100000 14.15 1252714.24 6.09785201 100000 15.66 1252714.24 6.09785201 100000 15.82 1252714.24 6.09785201
1000000 17.8 125271.424 5.09785201 1000000 19.28 125271.424 5.09785201 1000000 20.93 125271.424 5.09785201
10000000 21.27 12527.1424 4.09785201 10000000 22.07 12527.1424 4.09785201 10000000 22.95 12527.1424 4.09785201
100000000 24.75 1252.71424 3.09785201 100000000 26.08 1252.71424 3.09785201 100000000 26.03 1252.71424 3.09785201
1000000000 28.19 125.271424 2.09785201 1000000000 29.015 125.271424 2.09785201 1000000000 29.39 125.271424 2.09785201
1E+10 31.76 12.5271424 1.09785201 1E+10 33.49 12.5271424 1.09785201
1E+11 34.92 1.25271424 0.09785201 1E+11 1.25271424 0.09785201
1E+12 0.12527142 -0.902148
No template 0 0 0
Hexon
Hex Calibrator 
(PCR) DF Ct Copies/uL
Log 
Copies/uL DF Ct Copies/uL
Log 
Copies/uL DF Ct Copies/uL
Log 
Copies/uL
0 1 ND 1.0058E+11 1 ND 1.0058E+11 1 ND 1.0058E+11
0 100 4.64 1005767636 9.00249766 100 ND
0 1000 7.22 100576764 8.00249766 1000 ND
0 10000 10.71 10057676.4 7.00249766 10000 13.08 10057676.4 7.00249766 10000 13.42 10057676.4 7.00249766
0 100000 14.41 1005767.64 6.00249766 100000 15.41 1005767.64 6.00249766 100000 17.02 1005767.64 6.00249766
0 1000000 18.16 100576.764 5.00249766 1000000 19.97 100576.764 5.00249766 1000000 20.41 100576.764 5.00249766
0 10000000 21.62 10057.6764 4.00249766 10000000 24.61 10057.6764 4.00249766 10000000 24.87 10057.6764 4.00249766
0 100000000 25.3 1005.76764 3.00249766 100000000 27.87 1005.76764 3.00249766 100000000 28.14 1005.76764 3.00249766
0 1000000000 28.53 100.576764 2.00249766 1000000000 30.18 100.576764 2.00249766 1000000000 30.91 100.576764 2.00249766
1E+10 34.58 10.0576764 1.00249766 1E+10 34.81 10.0576764 1.00249766
1E+11 1.00576764 0.00249766 1E+11 1.00576764 0.00249766
No template 0 0
Actin
Actin2 Calibrator 
(PCR) DF Ct Copies/uL
Log 
Copies/uL DF Ct Copies/uL
Log 
Copies/uL DF Ct Copies/uL
Log 
Copies/uL DF Ct Copies/uL Log Copies/uL
1 ND 8475240978 9.92815206 1 ND 8475240978 0 1 ND 8475240978 0 1 ND 8475240978 0
10 4.98 847524098 8.92815206 10 ND 0 0 10 ND 0 0
100 8.14 84752409.8 7.92815206 100 ND 0 0 100 ND 0 0
1000 11.96 8475240.98 6.92815206 1000 12.57 8475240.98 6.92815206 1000 12.85 8475240.98 0 1000 12.31 8475240.98 6.928152055
10000 15.64 847524.098 5.92815206 10000 16.57 847524.098 5.92815206 10000 16.36 847524.098 5.92815206 10000 16.72 847524.098 5.928152055
100000 19.27 84752.4098 4.92815206 100000 20.85 84752.4098 4.92815206 100000 20.87 84752.4098 4.92815206 100000 21.41 84752.4098 4.928152055
1000000 22.62 8475.24098 3.92815206 1000000 24.28 8475.24098 3.92815206 1000000 24.49 8475.24098 3.92815206 1000000 24.41 8475.24098 3.928152055
10000000 26.72 847.524098 2.92815206 10000000 27.54 847.524098 2.92815206 10000000 28.11 847.524098 2.92815206 10000000 28.11 847.524098 2.928152055
100000000 31.25 84.7524098 1.92815206 100000000 30.65 84.7524098 1.92815206 100000000 31.25 84.7524098 1.928152055
1000000000 34.24 8.47524098 0.92815206 1000000000 35.28 8.47524098 0.92815206 1000000000 34.99 8.47524098 0.928152055
E1A
E1A
Copies/uL Log-copies/uL MEAN Standard Deviation
1.25E+07 7.10 11.3 0.38183766
1.25E+06 6.10 15.21 0.92146622
1.25E+05 5.10 19.3366667 1.56576925
1.25E+04 4.10 22.0966667 0.8403174
1.25E+03 3.10 25.62 0.75385675
1.25E+02 2.10 28.865 0.61390146
1.25E+01 1.10 32.63 1.22
Hex
Copies/uL Log-copies/uL MEAN Standard Deviation
1.01E+07 7.00 12.40 1.4762904
1.01E+06 6.00 15.61 1.31682699
1.01E+05 5.00 19.51 1.19249039
1.01E+04 4.00 23.70 1.80601772
1.01E+03 3.00 27.10 1.56755648
1.01E+02 2.00 29.87 1.21927574
1.01E+01 1.00 34.70 0.16263456
Actin
Copies/uL Log-copies/uL MEAN Standard Deviation
8.48E+06 6.92815206 12.42 0.37906684
8.48E+05 5.92815206 16.32 0.47835656
8.48E+04 4.92815206 20.60 0.9238326
8.48E+03 3.92815206 23.95 0.89087972
8.48E+02 2.92815206 27.62 0.6574192
8.48E+01 1.92815206 31.05 0.34641016
8.48E+00 0.92815206 34.84 0.53668737
E1A
Slope B R^2 Efficiency
-3.4846 36.43 0.99801 93.63%
Hex
Slope B R^2
-3.678 37.993 0.99723 87.02%
Actin
Slope B R^2
-3.7042 38.379 0.99899 86.19%
Primer set Equation R^2
E1A y = -3.485x + 36.430.99801
Hexon y = -3.678x + 37.990.99723
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APPENDIX F:  RAW DATA FOR CHAPTER 4 	  





# Date pH 
Temp 
























1.127 4 7/17/10 9.20 1 9.24-9.21 - 1.15E+06 12/1/09 0.461 0.247 0.311 0.124 0.852 
1.157 12 8/13/10 9.60 1 9.62-9.65 - 4.28E+06 12/1/09 0.640 0.410 0.472 0.032 0.851 
1.159 13 8/14/10 9.60 1 9.56-9.45 - 3.72E+06 12/1/09 0.640 0.391 0.446 0.067 0.940 
1.175 19 9/15/10 9.00 1 9.05-9.05 - 9.50E+05 12/1/09 0.610 0.595 0.597 0.003 0.006 
1.179 21 9/20/10 9.00 1 9.01-9.10 - 1.45E+06 12/1/09 0.478 0.449 0.451 0.003 0.046 
1.183 22 9/22/10 9.20 1 9.24-9.20 - 1.06E+06 12/1/09 0.423 0.401 0.409 0.014 0.198 
1.185 23 9/24/10 8.70 1 8.72-8.70 - 5.75E+05 12/1/09 0.307 0.284 0.305 0.112 0.666 
1.189 24 9/27/10 9.60 1 9.60-9.55 - 7.00E+05 12/1/09 0.420 0.376 0.385 0.013 0.300 
1.191 25 10/4/10 10.00 1 10.02-9.99 - 4.63E+05 12/1/09 0.377 0.343 0.356 0.021 0.556 
1.193 26 10/4/10 9.80 1 9.83-9.86 - 5.25E+05 12/1/09 0.377 0.342 0.350 0.014 0.267 
1.199 29 10/7/10 9.80 1 9.83-9.89 - 1.13E+06 12/1/09 0.350 0.325 0.344 0.029 0.516 
1.201 30 10/14/10 10.00 1 9.99-9.83 - 8.13E+05 12/1/09 0.415 0.385 0.408 0.023 0.997 
1.203 31 10/14/10 9.20 1 9.24-9.21 - 1.28E+06 12/1/09 0.415 0.373 0.383 0.021 0.189 
1.207 33 10/19/10 10.00 1 9.97-10.00 - 8.50E+05 12/1/09 0.390 0.371 0.391 0.02 0.604 
1.211 34 10/21/10 9.00 1 8.99-9.01 - 1.56E+07 12/1/09 0.668 0.291 0.348 0.779 0.877 
1.221 35 10/28/10 9.60 14 9.59-9.59 - 9.63E+05 12/1/09 0.404 0.388 0.398 0.032 0.744 
1.225 36 11/1/10 9.60 14 9.59-9.54 - 1.51E+06 12/1/09 0.448 0.411 0.401 -0.0338 0.309 
1.227 37 11/1/10 9.20 14 9.20-9.17 - 1.70E+06 12/1/09 0.448 0.410 0.407 -0.0088 0.141 
1.239 39 3/21/11 9.20 14 9.18-9.10 - 1.33E+06 12/1/09 0.415 0.416 0.374 -0.0663 0.222 
1.253 43 3/28/11 9.60 30 9.62-9.55 - 4.00E+05 12/1/09 0.318 0.261 0.281 0.062 0.823 
3.17 48 11/8/11 9.20 14 9.22-9.21 14.3-14.2 8.13E+05 5/5/11 0.428 0.353 0.360 0.009 0.989 
3.18 49 11/8/11 10.00 14 9.95-9.89 14.0-14.0 5.63E+05 5/5/11 0.428 0.350 0.370 0.027 0.998 
3.20 51 11/9/11 8.70 14 8.74-8.73 13.9-14.1 6.88E+05 5/5/11 0.412 0.326 0.348 0.056 0.907 
3.21 52 12/4/11 8.70 14 8.66-8.67 14.0-14.0 1.20E+06 5/5/11 0.442 0.330 0.354 0.048 0.304 
3.22 53 12/4/11 10.00 14 10.00-9.99 14.4-14.5 1.28E+06 5/5/11 0.442 0.341 0.362 0.025 0.890 
3.23 54 12/11/11 9.20 30 9.18-9.16 30.3-30.7 1.31E+06 5/5/11 0.412 0.310 0.334 0.064 0.812 
3.27 55 1/3/12 10.00 14 9.98-9.97 14.1-14.3 9.88E+05 5/5/11 0.452 0.287 0.333 0.052 0.794 
3.28 56 1/3/12 9.80 14 9.77-9.70 13.7-14.3 7.75E+05 5/5/11 0.452 0.297 0.340 0.059 0.824 
3.29 57 1/4/12 9.20 30 9.19-9.18 29.6-29.5 8.88E+05 5/5/11 0.405 0.274 0.279 0.02 0.063 
3.31 58 1/6/12 9.60 30 9.64-9.62 30.2-29.9 1.14E+06 5/5/11 0.407 0.302 0.314 0.027 0.958 
3.33 59 1/7/12 9.80 14 9.79-9.78 14.1-14.2 1.46E+06 5/5/11 0.464 0.342 0.371 0.033 0.966 
3.35 60 1/9/12 9.60 30 9.61-9.61 29.1-29.1 1.00E+06 5/5/11 0.433 0.298 0.329 0.061 0.925 
3.36 61 1/9/12 10.00 30 9.98-9.96 30.0-30.5 1.41E+06 5/5/11 0.433 0.302 0.328 0.034 0.918 
3.59 63 10/25/12 10.00 30 9.98-9.98 30.2-29.9 2.04E+06 10/16/12 0.451 0.347 0.390 0.039 1.000 
3.61 64 11/4/12 9.60 30 9.58-9.55 29.8-29.6 8.88E+06 10/16/12 0.619 0.334 0.383 0.065 0.944 
3.63 65 11/4/12 10.00 30 9.98-9.93 29.7-29.8 6.38E+06 10/16/12 0.619 0.352 0.407 0.065 0.992 
3.67 67 1/7/13 10.00 30 10.02-10.00 29.9-29.7 6.00E+05 10/16/12 0.656 0.315 0.372 0.097 0.921 
3.69 68 1/8/13 9.60 14 9.63-9.63 13.5-13.6 3.56E+05 10/16/12 0.675 0.422 0.439 0.02 0.349 
3.71 69 1/8/13 10.00 14 10.01-10.01 14.2-14.3 2.71E+05 10/16/12 0.675 0.403 0.474 0.055 0.712 
3.101 70 5/16/13 9.20 30 9.18-9.17 29.5-29.6 1.16E+07 1/12/13 0.934 0.348 0.427 0.174 0.937 
3.183 71 11/5/13 9.20 30 9.20-9.14 29.6-29.6 1.11E+06 7/29/13 0.383 0.325 0.344 0.019 0.899 
3.187 72 11/11/13 9.20 30 9.18-9.07 29.6-29.7 1.64E+07 8/16/13 0.516 0.324 0.361 0.033 0.975 
3.189 73 11/11/13 9.60 30 9.60-9.55 30.3-30.0 1.86E+07 8/16/13 0.516 0.322 0.358 0.031 0.937 
3.193 74 11/24/13 9.20 30 9.21-9.19 29.6-29.8 1.46E+07 11/13/13 0.481 0.417 0.430 0.009 0.916 
3.195 75 11/24/13 9.60 30 9.60-9.57 29.8-29.5 1.70E+07 11/13/13 0.481 0.404 0.404 0 0.000 
3.197 76 12/16/13 9.20 30 9.21-9.17 30.3-30.2 1.81E+07 11/13/13 0.567 0.392 0.405 0.02 0.400 	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# Date pH 
Temp 
























3.201 77 1/3/14 9.60 30 9.61-9.55 29.6-29.6 3.01E+07 1/2/14 0.375 0.324 0.342 0.017 0.914 
3.203 78 1/3/14 10.00 30 10.02-9.98 29.7-29.9 3.20E+07 1/2/14 0.375 0.331 0.349 0.014 0.960 
3.207 80 1/8/14 10.00 30 10.01-9.96 30.1-29.8 8.00E+07 1/2/14 0.418 0.322 0.345 0.02 0.951 
3.209 81 1/10/14 9.20 14 9.20-9.10 14.4-14.4 7.63E+07 1/2/14 0.385 0.335 0.351 0.019 0.969 
3.211 82 1/10/14 10.00 14 10.01-9.96 13.9-14.0 4.63E+07 1/2/14 0.385 0.344 0.354 0.009 0.594 
3.213 83 1/14/14 8.70 14 8.74-8.55 13.9-14.2 8.50E+07 1/2/14 0.393 0.365 0.375 0.009 0.874 
3.215 84 1/17/14 9.20 1 9.21-9.05 1.5-1.7 6.38E+07 1/2/14 0.413 0.372 0.392 0.015 0.992 
3.217 85 1/21/14 8.70 1 8.73-8.57 1.7-2.2 4.88E+07 1/2/14 0.383 0.317 0.334 0.015 0.868 
3.219 86 1/21/14 9.80 1 9.80-9.69 1.2-1.6 2.60E+07 1/2/14 0.383 0.335 0.352 0.013 0.965 
3.221 87 2/5/14 10.00 1 10.03-9.90 1.8-2.3 3.61E+07 1/2/14 0.466 0.457 0.470 0.009 0.777 
3.233 FC1 1/21/15 9.20 14 9.21-9.11 13.8-13.9 8.88E+06 11/23/14 0.459 0.356 0.375 0.049 0.902 
3.237 FC2 1/27/15 9.20 14 9.21-9.18 13.8-13.9 7.38E+06 11/23/14 0.399 0.296 0.315 0.047 0.936 
3.241 FC3 1/30/15 9.20 14 9.23-9.17 14.0-14.1 8.75E+06 11/23/14 0.391 0.281 0.298 0.038 0.952 
3.235 FC4 2/16/15 9.20 14 9.23-9.15 14.1-14.1 4.88E+06 11/23/14 0.394 0.293 0.308 0.028 0.935 
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0.250 1 0.098 0.466
1.500 1 0.097 0.461








0.300 1 0.066 0.314
2.033 1 0.046 0.219













1 0.00 92 27 0 1150000 1 0 0
2 0.50 TNTC TNTC TNTC TNTC 58 11 0 725000 0.630434783 0.15058367 0.12351544
3 0.73 TNTC TNTC TNTC 63 4 0 78750 0.068478261 0.21772414 0.18115598
4 1.00 TNTC TNTC 20 1 0 0
5 1.97 58 5 0 0 72.5 6.30435EB05 0.54206687 0.4858274
















































	  	   203 
 















0.333 1 0.135 0.641
1.333 1 0.135 0.641











0.333 1 0.096 0.456 9.59 Co%(mg/L%as%Cl₂) 0.472
1.000 1 0.083 0.394 kd%(minY¹) 0.032











1 0.00 TNTC 304 38 4275000 1 0 0
2 0.33 TNTC TNTC 118 6 1475000 0.34502924 0.1564972 0.13671153
3 0.67 355 21 0 35312.5 0.00826023 0.31133396 0.27342307
4 1.00 23 2 1 0
5 1.50 5 3 0 0 0
6 2.00 4 0 0
































































0.333 1 0.136 0.646
1.500 1 0.134 0.637








0.500 1 0.092 0.437 Co%(mg/L%as%Cl₂) 0.446
2.167 1 0.079 0.375 kd%(minY¹) 0.067











1 0.00 TNTC 395 20 3718750 1 0 0
2 0.25 TNTC TNTC 144 10 1800000 0.48403361 0.11057138 0.09778306
3 0.67 TNTC 74 3 92500 0.02487395 0.29079066 0.26075482
4 0.83 TNTC 48 0 1 6000 0.00161345 0.36148141 0.32594352
5 1.17 39 2 0 0 487.5 0.00013109 0.50051665 0.45632093
6 1.50 73 21 0 0 0 91.25 2.4538EF05 0.63648119 0.58669834
7 1.87 4 2 0 0 0




































































0.333 1 0.130 0.618
1.250 1 0.128 0.608










0.333 1 0.131 0.622 Co%(mg/L%as%Cl₂) 0.5969
0.733 1 0.122 0.580 kd%(minX¹) 0.003
1.017 1 0.121 0.575 R² 0.00566









1 0.00 TNTC 76 1 950000 1 0
2 0.12 TNTC TNTC TNTC 31 387500 0.407894737 0.06941805
3 0.27 TNTC TNTC TNTC 77 9 96250 0.101315789 0.15866983
4 0.40 TNTC 255 23 5 0 3187.5 0.003355263 0.23800475
5 0.53 50 2 0 0 62.5 6.57895EB05 0.31733967
6 0.75 18 0 0 0
7 0.93 0 0 0 0
8 1.08 0 0 0 0
9 1.33333333 2 1 0






























































0.333 1 0.101 0.480
1.383 1 0.100 0.475











0.217 1 0.097 0.461 8.99
0.500 1 0.093 0.442
0.767 1 0.093 0.442 Co%(mg/L%as%Cl₂) 0.451
3.500 1 0.094 0.447 9.05 kd%(minY¹) 0.003









1 0.00 TNTC 116 18 1450000 1 0
2 0.12 TNTC 54 7 675000 0.46551724 0.05243072
3 0.22 TNTC 204 47 421250 0.29051724 0.09737134
4 0.35 TNTC TNTC TNTC 209 22 261250 0.18017241 0.15729216
5 0.47 TNTC TNTC TNTC 68 85000 0.05862069 0.20972288
6 0.62 TNTC TNTC 97 2 12125 0.00836207 0.27713381
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0.400 1 0.089 0.423
1.467 1 0.089 0.423











0.250 1 0.088 0.418 9.16
0.517 1 0.084 0.399
0.833 1 0.082 0.390 Co%(mg/L%as%Cl₂) 0.4092
2.667 1 0.083 0.394 9.08 kd%(minY¹) 0.014
1.567 1 0.088 0.418 R² 0.19779









1 0.00 TNTC 85 6 1062500 1 0
2 0.12 TNTC 53 2 662500 0.62352941 0.04683294
3 0.25 TNTC TNTC 43 537500 0.50588235 0.10035629
4 0.38 TNTC 135 10 168750 0.15882353 0.15387965
5 0.52 TNTC TNTC 308 28 5 36750 0.03458824 0.20740301
6 0.68 318 13 12 1 1
7 1.02 15 1 0 0
8 1.37 25 4 0 0
9 1.75 14 1 0 0
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0.250 1 0.066 0.314
1.250 1 0.064 0.304











0.267 1 0.064 0.304 8.66 Co%(mg/L%as%Cl₂) 0.3048
0.500 1 0.059 0.280 kd%(minY¹) 0.112
0.733 1 0.058 0.276 8.66 R² 0.66579











1 0.00 TNTC 46 1 575000 1 0 0
2 0.10 TNTC TNTC 460 27 456250 0.79347826 0.03030995 0.0283848
3 0.23 TNTC TNTC TNTC 39 5 48750 0.08478261 0.07019874 0.0662312
4 0.33 TNTC 512 19 5 4387.5 0.00763043 0.09972685 0.09461599
5 0.40 68 31 1 0 236.25 0.00041087 0.11922932 0.11353919
6 0.52 12 4 0
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0.250 1 0.089 0.423
1.250 1 0.088 0.418









0.300 1 0.083 0.394 9.55
0.650 1 0.079 0.375
1.000 1 0.078 0.371 Co%(mg/L%as%Cl₂) 0.3853
2.850 1 0.079 0.375 kd%(minY¹) 0.013
3.133 1 0.076 0.361 9.43?%pH%meter%was%responding%very%slowlyR² 0.29951
2.500 1 0.081 0.385









1 0.00 TNTC 56 1 700000 1 0
2 0.17 TNTC TNTC 63 787500 1.125 0.06266259
3 0.33 TNTC TNTC 52 650000 0.92857143 0.12532519
4 0.50 TNTC 268 20 335000 0.47857143 0.18798778
5 0.75 TNTC TNTC TNTC 77 9 96250 0.1375 0.28198168
6 1.02 TNTC TNTC 86 11 1 10750 0.01535714 0.38224183
7 1.25 46 57 8 0 385 0.00055 0.46996946
8 1.50 22 0 0 0
9 1.75 3 0 0
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0.367 1 0.080 0.380
1.333 1 0.079 0.375











0.300 1 0.076 0.361 9.95
0.667 1 0.071 0.337
1.767 1 0.072 0.342 Co%(mg/L%as%Cl₂) 0.356
3.017 1 0.072 0.342 kd%(minY¹) 0.021
3.300 1 0.070 0.333 9.48%(pH%meter%responding%slowlyR² 0.556
0.983 1 0.075 0.356










1 0.00 TNTC 37 2 462500 1 0 0
2 0.17 TNTC TNTC 35 437500 0.94594595 0.05922962 0.05712024
3 0.33 TNTC TNTC 32 400000 0.86486486 0.1182523 0.11424047
4 0.50 TNTC 522 27 495000 1.07027027 0.17706876 0.17136071
5 0.83 TNTC 297 36 410625 0.88783784 0.29408591 0.28560118
6 1.17 TNTC TNTC 272 24 340000 0.73513514 0.4102868 0.39984165
7 1.50 TNTC TNTC TNTC 42 19 52500 0.11351351 0.52567712 0.51408212
8 2.00 TNTC TNTC TNTC 99 123750 0.26756757 0.69725515 0.68544282
9 2.33333333 TNTC TNTC TNTC 6
10 2.66666667 TNTC TNTC 96 2 12000 0.02594595 0.92324132 0.91392376


































































0.367 1 0.080 0.380
1.333 1 0.079 0.375











0.267 1 0.076 0.361 9.84
0.633 1 0.070 0.333
0.983 1 0.070 0.333 Co%(mg/L%as%Cl₂) 0.3503
3.567 1 0.072 0.342 kd%(minY¹) 0.014
3.733 1 0.069 0.328 R² 0.26679
0.667 1 0.076 0.361









1 0.00 TNTC 42 2 525000 1 0
2 0.18 TNTC 39 3 487500 0.92857143 0.06270784
3 0.37 490 35 3 437500 0.83333333 0.12541568
4 0.50 TNTC 249 26 311250 0.59285714 0.17102138
5 0.80 TNTC TNTC 268 16 335000 0.63809524 0.2736342
6 1.00 TNTC TNTC 174 16 217500 0.41428571 0.34204276
7 1.23 TNTC TNTC TNTC 116 145000 0.27619048 0.42185273
8 1.50 TNTC TNTC 41 37 25687.5 0.04892857 0.51306413
9 1.8 TNTC TNTC 133 16625 0.03166667 0.61567696
10 2.01666667 TNTC TNTC 71 8875 0.01690476 0.68978622
































































0.417 1 0.074 0.352
1.417 1 0.073 0.347









0.183 1 0.075 0.356 9.77
0.950 1 0.069 0.328
1.767 1 0.068 0.323
2.667 1 0.067 0.318 Co%(mg/L%as%Cl₂) 0.344
3.717 1 0.067 0.318 9.61 kd%(minY¹) 0.029
0.667 1 0.072 0.342 R² 0.516
2.217 1 0.063 0.299











1 0.00 TNTC 90 5 1125000 1 0 0
2 0.15 TNTC 39 4 487500 0.43333333 0.05148793 0.04881235
3 0.30 TNTC 85 8 1062500 0.94444444 0.10275238 0.0976247
4 0.48 TNTC TNTC 70 875000 0.77777778 0.16510684 0.15728424
5 0.85 TNTC 285 34 390625 0.34722222 0.2888256 0.27660333
6 1.40 TNTC 95 8 118750 0.10555556 0.4719545 0.45558195
7 1.83 TNTC 73 10 9125 0.00811111 0.61419465 0.59659541
8 2.40 98 4 1 122.5 0.00010889 0.79752424 0.78099762
9 2.66666667 114 20 0 142.5 0.00012667 0.88276005 0.86777514


































































0.267 1 0.088 0.418
1.217 1 0.087 0.413











0.383 1 0.085 0.404 Co%(mg/L%as%Cl₂) 0.408
2.683 1 0.081 0.385 kd%(minY¹) 0.023









1 0.00 TNTC 65 1 812500 1 0 0
2 0.25 TNTC 95 13 1187500 1.46153846 0.10170731 0.096199525
3 0.53 TNTC TNTC 86 1075000 1.32307692 0.21627083 0.205225653
4 0.72 TNTC TNTC 81 1012500 1.24615385 0.29000332 0.275771971
5 1.70 TNTC 323 29 383125 0.47153846 0.68021514 0.65415677
6 1.95 TNTC 206 21 257500 0.31692308 0.77802243 0.750356295
7 2.45 220 78 13 62500 0.07692308 0.97195791 0.942755344
8 2.95 TNTC 195 19 24375 0.03 1.1636759 1.135154394
9 3.7 TNTC 80 11 0 1000 0.00123077 1.4471505 1.423752969
10 4.01666667 110 7 3 137.5 0.00016923 1.56537934 1.545605701
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0.267 1 0.088 0.418
1.217 1 0.087 0.413











0.183 1 0.083 0.394 9.20
0.400 1 0.075 0.356
1.500 1 0.078 0.371 Co%(mg/L%as%Cl₂) 0.3826
2.067 1 0.077 0.366 9.20 kd%(minY¹) 0.021
1.133 1 0.082 0.390 R² 0.1891









1 0.00 TNTC 102 12 1275000 1 0
2 0.15 TNTC 130 8 1625000 1.2745098 0.05593824
3 0.27 TNTC TNTC 49 612500 0.48039216 0.09944576
4 0.40 122 161 18 108250 0.08490196 0.14916865
5 0.52 TNTC 189 10 0 23625 0.01852941 0.19267617
6 0.67 TNTC 226 9 0 2825 0.00221569 0.24861441
7 0.82 4 46 0
8 1.00 16 0 0
9 1.28333333 24 3
10 1.41666667 13 0
11 1.51666667 43 0 53.75 4.2157EC05 0.56559778
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0.333 1 0.083 0.394
1.333 1 0.082 0.390








0.250 1 0.085 0.404
1.300 1 0.077 0.366 Co%(mg/L%as%Cl₂) 0.391
2.483 1 0.077 0.366 kd%(minY¹) 0.02
3.867 1 0.076 0.361 R² 0.604











1 0.00 TNTC 68 9 850000 1 0 0
2 0.43 472 27 463750 0.54558824 0.16870124 0.16098179
3 0.83 409 34 425000 0.5 0.32313308 0.30958036
4 1.55 TNTC 126 4 157500 0.18529412 0.59675255 0.57581948
5 2.13 196 8 0 24500 0.02882353 0.81658889 0.79252573
6 2.75 45 8 2 0 562.5 0.00066176 1.04621536 1.0216152
7 3.33 5 1 0
8 3.67 4 0 0
9 4.03333333 2 1 0
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0.333 1 0.140 0.665
1.383 1 0.141 0.670











0.133 1 0.076 0.361 8.82?
0.367 1 0.056 0.266 Co%(mg/L%as%Cl₂) 0.348
0.617 1 0.052 0.247 8.65? kd%(minZ¹) 0.779
1.117 1 0.045 Below%detection R² 0.877










1 0.00 TNTC 125 8 15625000 1 0 0
2 0.10 233 31 3393750 0.2172 0.03347906 0.02913698
3 0.23 139 12 1 173750 0.01112 0.0742478 0.06798628
4 0.33 TNTC 56 0 0 0 7000 0.000448 0.1021625 0.09712325
5 0.45 330 49 7 0 0 0 612.5 0.0000392 0.13209677 0.13111639
6 0.57 118 8 2 0 0 147.5 0.00000944 0.15943048 0.16510953
7 0.68 59 8 0 0 0 73.75 0.00000472 0.18438954 0.19910267
8 0.83 183 33 1 228.75 0.00001464 0.21332043 0.24280813
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0.367 1 0.085 0.404
1.283 1 0.085 0.404









0.200 1 0.085 0.404 9.50
0.433 1 0.082 0.390
0.733 1 0.081 0.385 Co%(mg/L%as%Cl₂) 0.398
0.767 1 0.081 0.385 kd%(minY¹) 0.032











1 0.00 TNTC 77 2 962500 1 0 0
2 0.13 TNTC TNTC TNTC 385 30 375000 0.38961039 0.05295362 0.05168646
3 0.25 TNTC TNTC TNTC 145 21 181250 0.18831169 0.09910306 0.09691211
4 0.38 TNTC TNTC 228 39 38625 0.04012987 0.15163474 0.14859857
5 0.50 TNTC 319 46 3 5750 0.00597403 0.19741646 0.19382423
6 0.97 4 0 0
7 1.18 0 0




















































	  	   218 
 
 















0.433 1 0.094 0.447
1.400 1 0.094 0.447











0.183 1 0.086 0.409 9.50
0.417 1 0.085 0.404 Co%(mg/L%as%Cl₂) 0.4011
0.767 1 0.084 0.399 kd%(minY¹) D0.0338
0.983 1 0.090 0.428 R² 0.30884









1 0.00 TNTC 121 11 1512500 1 0
2 0.12 TNTC TNTC 65 812500 0.53719008 0.04799683
3 0.23 TNTC TNTC 40 500000 0.33057851 0.09599367
4 0.35 TNTC TNTC 124 155000 0.10247934 0.1439905
5 0.48 TNTC TNTC TNTC 38 47500 0.03140496 0.19884402
6 0.62 TNTC 287 30 3668.75 0.00242562 0.25369755
7 0.73 338 6
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0.433 1 0.094 0.447
1.400 1 0.094 0.447









0.167 1 0.087 0.413 9.20
0.400 1 0.085 0.404 Co%(mg/L%as%Cl₂) 0.4067
0.717 1 0.085 0.404 kd%(minY¹) B0.0088
1.100 1 0.087 0.413 R² 0.14128









1 0.00 TNTC 136 20 1700000 1 0
2 0.10 TNTC TNTC TNTC 41 512500 0.30147059 0.04095012
3 0.23 TNTC TNTC TNTC 37 6 46250 0.02720588 0.09555028
4 0.35 TNTC 86 11 2 1075 0.00063235 0.14332542
5 0.47 1 0 0 0
6 0.60 0 0 0
7 0.72 0 0
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0.267 1 0.089 0.423
1.383 1 0.087 0.413









0.233 1 0.082 0.390 9.13
0.500 1 0.079 0.375 Co%(mg/L%as%Cl₂) 0.3738
0.933 1 0.078 0.371 9.10 kd%(minY¹) B0.0663
0.850 1 0.087 0.413 R² 0.22164









1 0.00 TNTC 106 12 1325000 1 0
2 0.12 TNTC TNTC 41 512500 0.38679245 0.04849565
3 0.23 TNTC 211 5 263750 0.1990566 0.09699129
4 0.33 TNTC TNTC 102 8 12750 0.00962264 0.13855899
5 0.47 TNTC 83 5 1037.5 0.00078302 0.19398258
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0.250 1 0.069 0.328
1.450 1 0.066 0.314









0.200 1 0.059 0.280 9.60
0.417 1 0.057 0.271 Co%(mg/L%as%Cl₂) 0.2811
0.767 1 0.057 0.271 kd%(minY¹) 0.062
0.933 1 0.055 0.261 R² 0.82265











1 0.00 TNTC 32 3 400000 1 0 0
2 0.10 TNTC 170 16 212500 0.53125 0.02802304 0.02612827
3 0.22 TNTC TNTC TNTC 66 82500 0.20625 0.06049775 0.05661124
4 0.33 TNTC TNTC 276 34500 0.08625 0.0927384 0.08709422
5 0.45 TNTC TNTC
6 0.57 TNTC 49 612.5 0.00153125 0.15652429 0.14806017
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0.433 1 0.090 0.428
1.617 1 0.090 0.428








0.967 1 0.075 0.356 Co%(mg/L%as%Cl₂) 0.3598
1.350 1 0.075 0.356 kd%(minZ¹) 0.009











1 0.00 TNTC 65 9 812500 1 0 0
2 0.12 TNTC TNTC 39 487500 0.6 0.04195464 0.04119821
3 0.22 TNTC 70 1 87500 0.10769231 0.07788071 0.07651095
4 0.32 TNTC TNTC 35 43750 0.05384615 0.11377446 0.1118237
5 0.43 TNTC TNTC 42 5250 0.00646154 0.1556097 0.15302191
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0.433 1 0.090 0.428
1.617 1 0.090 0.428








0.483 1 0.077 0.366 Co%(mg/L%as%Cl₂) 0.3704
2.350 1 0.073 0.347 kd%(minZ¹) 0.027











1 0.00 TNTC 45 7 562500 1 0 0
2 0.13 TNTC 35 5 437500 0.77777778 0.04929788 0.04666139
3 0.30 TNTC TNTC 39 487500 0.86666667 0.11067118 0.10498812
4 0.63 TNTC 223 7 278750 0.49555556 0.23259233 0.22164159
6 1.08 TNTC TNTC 240+BB 11
7 1.33 TNTC TNTC 114 142500 0.25333333 0.48508279 0.46661388
8 1.52 TNTC TNTC TNTC
9 1.81666667 TNTC TNTC
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1.350 1 0.086 0.409
2.600 1 0.087 0.413








0.733 1 0.070 0.333 Co%(mg/L%as%Cl₂) 0.3476
1.183 1 0.069 0.328 kd%(minZ¹) 0.056











1 0.00 TNTC 55 4 687500 1 0 0
2 0.10 TNTC 129 8 161250 0.23454545 0.03466285 0.03262074
3 0.20 TNTC 39 8 0 487.5 0.00070909 0.06913214 0.06524149
4 0.32 11 1 0
5 0.42 3 0 0
6 0.52 0 0
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0.133 1 0.094 0.447
1.367 1 0.093 0.442








0.633 1 0.070 0.333
0.783 1 0.069 0.328 Co%(mg/L%as%Cl₂) 0.354
0.150 1 0.078 0.371 kd%(minZ¹) 0.048
0.483 1 0.072 0.342 R² 0.30428









1 0.00 TNTC 96 11 1200000 1 0
2 0.10 TNTC 89 10 111250 0.09270833 0.03301663
3 0.20 TNTC 42 8 525 0.0004375 0.06603325
4 0.28 35 21 43.75 3.6458ED05 0.09354711
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0.133 1 0.094 0.447
1.367 1 0.093 0.442








0.333 1 0.077 0.366 Co%(mg/L%as%Cl₂) 0.362
1.133 1 0.073 0.347 kd%(minY¹) 0.025
3.200 1 0.069 0.328 R² 0.89017











1 0.00 TNTC 102 11 1275000 1 0 0
2 0.18 TNTC 53 3 662500 0.51960784 0.06621481 0.0624901
3 0.60 TNTC TNTC 83 1037500 0.81372549 0.21557911 0.20451306
4 0.97 TNTC TNTC 49 612500 0.48039216 0.34573883 0.32949327
5 1.37 TNTC TNTC 25
6 2.20 TNTC TNTC 96 120000 0.09411765 0.77489506 0.74988124
8 3.02 TNTC TNTC 118 14750 0.01156863 1.05187054 1.02824624
9 3.45 TNTC TNTC 39 4875 0.00382353 1.19655681 1.17595012
10 4.18333333 65 16 0 81.25 6.3725EC05 1.43786782 1.42591053
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1.467 1 0.087 0.413
2.867 1 0.087 0.413








0.667 1 0.066 0.314 Co%(mg/L%as%Cl₂) 0.3335
0.833 1 0.068 0.323 kd%(minZ¹) 0.064











1 0.00 TNTC 105 8 1312500 1 0 0
2 0.12 TNTC TNTC TNTC 425
3 0.25 TNTC TNTC TNTC 125 156250 0.11904762 0.08271154 0.07759303
4 0.35 TNTC TNTC 255 31875 0.02428571 0.11542739 0.10863025
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0.133 1 0.097 0.461
1.267 1 0.094 0.447
2.367 1 0.094 0.447








0.333 1 0.073 0.347 Co%(mg/L%as%Cl₂) 0.333
1.867 1 0.059 0.280 kd%(minZ¹) 0.052
4.250 1 0.055 0.261 R² 0.79429











1 0.00 TNTC 79 9 987500 1 0 0
2 0.18 TNTC 53 7 662500 0.67088608 0.06075992 0.052692
3 0.57 TNTC 39 0 487500 0.49367089 0.18594693 0.16286619
4 1.15 TNTC 182 18 227500 0.23037975 0.37172466 0.33052257
5 1.68 TNTC 187 14 233750 0.23670886 0.53671703 0.48380839
6 2.15 TNTC 85 4 106250 0.10759494 0.6773791 0.61793349
7 2.48 TNTC 40 3 50000 0.05063291 0.77578256 0.71373713
8 3.10 TNTC 123 7 15375 0.01556962 0.9533929 0.89097387
9 3.56666667 TNTC TNTC 67 8375 0.00848101 1.08406533 1.02509897
10 4.08333333 TNTC 98 6 1225 0.00124051 1.22508723 1.17359462
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0.133 1 0.097 0.461
1.267 1 0.094 0.447
2.367 1 0.094 0.447








0.333 1 0.073 0.347 Co%(mg/L%as%Cl₂) 0.34
1.783 1 0.061 0.290 kd%(minZ¹) 0.059
3.250 1 0.058 0.276 R² 0.8244











1 0.00 TNTC 62 3 775000 1 0 0
2 0.20 307 30 2 375000 0.48387097 0.06760037 0.05938242
3 0.58 TNTC 219 20 273750 0.35322581 0.19495917 0.17319873
4 1.17 TNTC TNTC 76 95000 0.12258065 0.38332264 0.34639747
5 1.53 TNTC TNTC 71 88750 0.11451613 0.49844701 0.45526524
6 1.98 TNTC TNTC 125 27 15625 0.02016129 0.63637416 0.58887569
7 2.60 TNTC 197 24 2462.5 0.00317742 0.8195352 0.7719715
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0.333 1 0.086 0.409
1.550 1 0.085 0.404








0.750 1 0.057 0.271 Co%(mg/L%as%Cl₂) 0.2792
0.883 1 0.059 0.280 kd%(minZ¹) 0.02









1 0.00 TNTC 71 9 887500 1 0
2 0.10 TNTC TNTC 32 1 400000 0.45070423 0.02739509
3 0.23 TNTC TNTC TNTC 152 190000 0.21408451 0.06392188
4 0.32 TNTC TNTC TNTC 38 47500 0.05352113 0.08675112
5 0.43 TNTC 251 19 3137.5 0.00353521 0.11871206
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0.417 1 0.087 0.413
1.617 1 0.085 0.404








1.067 1 0.064 0.304 Co%(mg/L%as%Cl₂) 0.3136
1.200 1 0.064 0.304 kd%(minZ¹) 0.027











1 0.00 TNTC 91 9 1137500 1 0 0
2 0.10 TNTC TNTC 51 637500 0.56043956 0.0313177 0.03024545
3 0.20 TNTC TNTC TNTC 57 712500 0.62637363 0.06255096 0.06049089
4 0.30 TNTC TNTC 147 183750 0.16153846 0.0937 0.09073634
5 0.42 TNTC TNTC TNTC 187 233750 0.20549451 0.12993442 0.1260227
6 0.53 TNTC TNTC TNTC
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0.417 1 0.098 0.466
1.667 1 0.097 0.461








0.267 1 0.078 0.371 Co%(mg/L%as%Cl₂) 0.3709
1.983 1 0.072 0.342 kd%(minZ¹) 0.033
3.667 1 0.069 0.328 R² 0.96579











1 0.00 TNTC 117 12 1462500 1 0 0
2 0.13 TNTC 77 5 962500 0.65811966 0.0493447 0.0456057
3 0.38 TNTC TNTC 32 400000 0.27350427 0.14128284 0.13111639
4 0.55 TNTC 260 15 325000 0.22222222 0.20215489 0.18812352
5 0.88 TNTC TNTC 297 19 371250 0.25384615 0.32289921 0.30213777
6 1.82 TNTC 147 11 18375 0.0125641 0.65400209 0.62137767
7 2.62 71 9 0 88.75 6.0684EC05 0.92979989 0.89501188
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0.183 1 0.093 0.442
1.417 1 0.091 0.432
2.617 1 0.091 0.432








0.500 1 0.068 0.323 Co%(mg/L%as%Cl₂) 0.3293
1.717 1 0.061 0.290 kd%(minZ¹) 0.061











1 0.00 TNTC 80 10 1000000 1 0 0
2 0.12 TNTC 45 10 562500 0.5625 0.03828195 0.03473212
3 0.23 TNTC TNTC 36 450000 0.45 0.07629243 0.06946424
4 0.33 TNTC TNTC 35 437500 0.4375 0.10865823 0.09923463
5 0.70 TNTC TNTC 44 55000 0.055 0.22565792 0.20839272
6 0.80 TNTC 196 30 31000 0.031 0.25711536 0.2381631
7 1.02 TNTC 290 55 5250 0.00525 0.32461842 0.30266561
8 1.17 262 48 2 463.75 0.00046375 0.37083142 0.34732119
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0.183 1 0.093 0.442
1.417 1 0.091 0.432
2.617 1 0.091 0.432








0.717 1 0.068 0.323 Co%(mg/L%as%Cl₂) 0.3284
2.617 1 0.062 0.295 kd%(minZ¹) 0.034











1 0.00 TNTC 113 7 1412500 1 0 0
2 0.10 TNTC 109 9 1362500 0.96460177 0.03278424 0.03024545
3 0.22 TNTC TNTC 77 962500 0.68141593 0.07089189 0.0655318
4 0.33 TNTC TNTC 73 912500 0.6460177 0.10884869 0.10081816
5 0.53 TNTC TNTC 43 537500 0.38053097 0.17356823 0.16130905
6 0.92 TNTC TNTC TNTC 37 462500 0.32743363 0.29639059 0.27724993
7 1.33 TNTC TNTC TNTC 110 137500 0.09734513 0.42808998 0.40327263
8 1.53 TNTC TNTC TNTC 55 68750 0.04867257 0.49064604 0.46376353
9 1.76666667 TNTC TNTC 279 34875 0.02469027 0.5630925 0.53433624
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0.200 1 0.097 0.461
1.383 1 0.095 0.451
2.633 1 0.094 0.447








0.183 1 0.068 0.323
1.183 1 0.063 0.299
2.350 1 0.061 0.290 Co%(mg/L%as%Cl₂) 0.3903
3.500 1 0.060 0.285 kd%(minZ¹) 0.039
0.350 1 0.081 0.385 R² 0.99994
3.367 1 0.072 0.342











1 0.00 163 16 0 2037500 1 0.000 0
2 0.15 98 13 0 1225000 0.60122699 0.058 0.052019
3 0.50 TNTC 38 9 475000 0.23312883 0.193 0.17339667
4 1.20 TNTC 65 15 81250 0.0398773 0.458 0.41615202
5 1.45 TNTC 256 34 2 37250 0.01828221 0.550 0.50285036
6 1.77 TNTC 248 17 3100 0.00152147 0.666 0.61266825
7 2.22 33 0 0 41.25 2.0245EE05 0.829 0.76872526
8 2.48 4 1 0
9 2.75 0 1 0
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0.217 1 0.131 0.622
1.400 1 0.130 0.618








0.200 1 0.069 0.328
1.317 1 0.061 0.290
2.650 1 0.056 0.266 Co%(mg/L%as%Cl₂) 0.3827
0.683 1 0.078 0.371 kd%(minZ¹) 0.065
2.217 1 0.068 0.323 R² 0.94356










1 0.00 TNTC 71 5 8875000 1 0.000 0.00
2 0.17 TNTC 38 1 4750000 0.53521127 0.063 0.06
3 0.33 TNTC 123 13 0 1537500 0.17323944 0.126 0.11
4 0.52 TNTC 84 2 0 105000 0.01183099 0.194 0.17
6 0.97 299 25 2 1 373.75 4.2113EE05 0.359 0.32
7 1.13 283 37 2 0 408.125 4.5986EE05 0.418 0.38
8 1.27 201 27 1 251.25 2.831EE05 0.465 0.42
9 1.47 178 12 5 222.5 2.507EE05 0.535 0.49




































































0.217 1 0.131 0.622
1.400 1 0.130 0.618








0.200 1 0.069 0.328
1.317 1 0.061 0.290
2.650 1 0.056 0.266 Co%(mg/L%as%Cl₂) 0.4073
0.483 1 0.083 0.394 kd%(minZ¹) 0.065
3.067 1 0.071 0.337 R² 0.99223











1 0.00 TNTC 51 6 6375000 1 0.000 0
2 0.15 TNTC 42 2 5250000 0.82352941 0.061 0.05273159
3 0.33 TNTC 217 10 2712500 0.4254902 0.134 0.11718131
4 0.72 TNTC 80 6 1000000 0.15686275 0.285 0.25193983
5 0.88 TNTC TNTC 47 1 587500 0.09215686 0.350 0.31053048
6 1.43 354 26 1 0 3837.5 0.00060196 0.557 0.50387965
7 1.60 218 16 2 2725 0.00042745 0.619 0.56247031
8 1.88 311 24 5 344.375 5.402EE05 0.722 0.66207443
9 2.18 267 24 0 333.75 5.2353EE05 0.829 0.76753761
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0.317 1 0.139 0.660
1.300 1 0.137 0.651








0.267 1 0.079 0.375 Co%(mg/L%as%Cl₂) 0.3716
1.250 1 0.066 0.314 kd%(minZ¹) 0.097
2.283 1 0.062 0.295 R² 0.92054











1 0.00 48 4 0 600000 1 0.000 0
2 0.17 24 0 1 300000 0.5 0.061 0.05245447
3 0.45 234 19 1 292500 0.4875 0.164 0.14162708
4 1.02 451 26 2 44437.5 0.0740625 0.360 0.31997229
5 1.48 TNTC 44 6 5500 0.00916667 0.513 0.46684481
6 2.03 113 5 0 141.25 0.00023542 0.686 0.63994458
7 2.20 47 1 0 58.75 9.7917EB05 0.736 0.69239905
8 2.47 2 0 0
9 2.77 1 0 0
10 2.98 6 0 0
11 3.12 7 0
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0.233 1 0.144 0.684
1.500 1 0.141 0.670








0.633 1 0.093 0.442 Co%(mg/L%as%Cl₂) 0.4393
1.117 1 0.089 0.423 kd%(minZ¹) 0.02
3.067 1 0.083 0.394 R² 0.34853











1 0.00 330 24 4 356250 1 0 0.000
2 0.20 99 18 2 123750 0.34736842 0.08432304 0.088
3 0.37 TNTC 71 5 88750 0.24912281 0.15459224 0.160
4 0.48 TNTC TNTC 55 68750 0.19298246 0.20378068 0.211
5 0.78 TNTC TNTC 277 34625 0.09719298 0.33026524 0.341
6 0.92 TNTC TNTC 41 5125 0.01438596 0.3864806 0.399
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0.233 1 0.144 0.684
1.500 1 0.141 0.670








0.517 1 0.107 0.508 Co%(mg/L%as%Cl₂) 0.4736
1.867 1 0.081 0.385 kd%(minZ¹) 0.055
3.700 1 0.078 0.371 R² 0.71249











1 0.00 217 26 1 271250 1 0.000 0
2 0.30 173 28 2 216250 0.79723502 0.141 0.12078385
3 1.45 TNTC 109 7 136250 0.50230415 0.660 0.5837886
4 2.15 TNTC 153 2 19125 0.07050691 0.960 0.86561758
5 3.12 TNTC 77 3 962.5 0.00354839 1.356 1.25480998
6 3.97 7 0 0
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0.283 1 0.198 0.941
1.783 1 0.195 0.926








0.417 1 0.086 0.409 Co%(mg/L%as%Cl₂) 0.4274
1.100 1 0.071 0.337 kd%(minY¹) 0.174











1 0.00 TNTC 93 11 11625000 1 0.000 0
2 0.13 TNTC 260 13 1 3250000 0.27956989 0.056 0.04645025
3 0.28 TNTC 69 6 1 2 8625 0.00074194 0.118 0.09870678
4 0.57 163 36 2 0 326.875 2.8118EE05 0.231 0.19741357
5 0.70 156 26 0 195 1.6774EE05 0.282 0.24386382
6 0.82 44 11 0 55 4.7312EE06 0.325 0.28450779
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0.250 1 0.082 0.390
1.333 1 0.081 0.385








0.667 1 0.072 0.342 Co%(mg/L%as%Cl₂) 0.344
2.667 1 0.068 0.323 kd%(minY¹) 0.019
3.650 1 0.067 0.318 R² 0.89856











1 0.00 89 8 0 1112500 1 0.000 0
2 0.15 175 5 1 0 218750 0.19662921 0.052 0.04881235
3 0.33 52 4 2 0 650 0.00058427 0.114 0.10847189
4 0.48 39 3 0 0 48.75 4.382EC05 0.166 0.15728424
5 0.92 2 0 0
6 1.08 4 1 0
7 1.28 4 3 0
8 1.55 0 0
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0.283 1 0.109 0.518
1.333 1 0.108 0.513








1.350 1 0.073 0.347 Co%(mg/L%as%Cl₂) 0.3609
2.883 1 0.069 0.328 kd%(minY¹) 0.033
3.983 1 0.066 0.314 R² 0.9748











1 0.00 TNTC 131 11 16375000 1 0.000 0
2 0.18 148 20 0 185000 0.01129771 0.066 0.05944181
3 0.35 16 0 0 0
4 0.50 2 0 2 0
5 0.67 14 3 0
6 0.90 5 1 0
7 1.08 0 0 0
8 1.50 6 0
9 1.65 1 1
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0.283 1 0.109 0.518
1.333 1 0.108 0.513








0.883 1 0.074 0.352 Co%(mg/L%as%Cl₂) 0.3579
3.367 1 0.067 0.318 kd%(minY¹) 0.031
4.467 1 0.065 0.309 R² 0.9368











1 0.00 TNTC 149 20 18625000 1 0.000 0
2 0.22 TNTC 30 9 3750000 0.20134228 0.077 0.06973476
3 0.42 57 2 0 71250 0.0038255 0.148 0.1341053
4 0.62 2 1 0
5 1.07 54 4 0 67.5 3.6242EC06 0.376 0.34330958
6 1.37 39 1 0 48.75 2.6174EC06 0.479 0.4398654
7 1.92 0 0 0
8 2.12 2 0
9 2.35 0 0
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0.200 1 0.103 0.489
1.233 1 0.101 0.480








2.000 1 0.089 0.423 Co%(mg/L%as%Cl₂) 0.4295
2.983 1 0.088 0.418 kd%(minY¹) 0.009
3.950 1 0.087 0.413 R² 0.91643











1 0.00 TNTC 117 17 14625000 1 0.000 0
2 0.17 201 11 1 2512500 0.17179487 0.072 0.06967538
3 0.33 87 6 0 0 1087.5 7.4359EC05 0.143 0.13935075
4 0.50 17 6 0 0
5 0.68 20 9 0
6 0.88 28 5 0
7 1.07 11 3 0
8 1.23 8 0










































	  	   246 
 















0.200 1 0.103 0.489
1.233 1 0.101 0.480








2.817 1 0.085 0.404 Co%(mg/L%as%Cl₂) 0.4038
3.767 1 0.085 0.404 kd%(minY¹) 0









1 0.00 TNTC 136 10 17000000 1 0
2 0.17 TNTC 74 6 9250000 0.54411765 0.06730008
3 0.38 TNTC TNTC 47 1 587500 0.03455882 0.15479018
4 0.57 312 24 3 0 3450 0.00020294 0.22882027
5 0.83 233 25 0 0 291.25 1.7132EE05 0.3365004
6 1.00 6 9 1
7 1.18 19 2 1
8 1.47 13 6 0
9 1.65 11 3 1
10 1.83 31 1 38.75 2.2794EE06 0.74030087
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0.217 1 0.120 0.570
1.450 1 0.119 0.565








0.583 1 0.086 0.409 Co%(mg/L%as%Cl₂) 0.4045
1.250 1 0.081 0.385 kd%(minY¹) 0.02
2.000 1 0.081 0.385 R² 0.39966











1 0.00 145 22 2 18125000 1 0 0.0000
2 0.17 123 9 3 1537500 0.08482759 0.06532067 0.0673
3 0.33 363 15 1 0 3206.25 0.0001769 0.13064133 0.1344
4 0.50 TNTC 49 2 0 612.5 3.3793EC05 0.195962 0.2012
5 0.65 221 16 2 276.25 1.5241EC05 0.25475059 0.2612
6 0.83 27 2 0
7 1.07 41 11 1 51.25 2.8276EC06 0.41805226 0.4269
8 1.40 18 2 0
9 1.65 35 5 1 43.75 2.4138EC06 0.64667458 0.6565
10 1.82 7 1
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0.450 1 0.080 0.380
1.433 1 0.079 0.375








1.083 1 0.071 0.337 Co%(mg/L%as%Cl₂) 0.3417
2.967 1 0.068 0.323 kd%(minY¹) 0.017
3.850 1 0.067 0.318 R² 0.91421











1 0.00 241 23 2 30125000 1 0.000 0
2 0.17 111 10 1 13875000 0.46058091 0.057 0.054038
3 0.35 TNTC 33 2 0 4125000 0.13692946 0.119 0.11347981
4 0.60 19 3 0 0
5 0.85 51 2 0 0 0 637.5 2.1162ED05 0.288 0.27559382
6 1.27 43 12 2 0 53.75 1.7842ED06 0.428 0.41068884
7 1.77 12 2 0
8 1.93 18 2 0
9 2.13 7 1 0
10 2.32 10 2
































































0.450 1 0.080 0.380
1.433 1 0.079 0.375








0.650 1 0.073 0.347 Co%(mg/L%as%Cl₂) 0.3488
3.867 1 0.069 0.328 kd%(minY¹) 0.014
4.767 1 0.069 0.328 R² 0.9599











1 0.00 256 27 1 32000000 1 0.000 0
2 0.30 97 11 0 12125000 0.37890625 0.104 0.09940618
3 0.48 TNTC 96 12 12000000 0.375 0.168 0.16015439
4 1.18 123 9 2 0 153750 0.00480469 0.409 0.39210214
5 1.60 97 7 1 0 1212.5 3.7891EC05 0.552 0.53016627
6 2.05 133 32 5 0 283.125 8.8477EC06 0.705 0.67927553
7 2.32 68 8 0 85 2.6563EC06 0.795 0.76763658
8 2.70 60 11 0 75 2.3438EC06 0.924 0.89465558
9 2.98 48 2 1 60 1.875EC06 1.019 0.98853919
10 3.25 21 2
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0.600 1 0.089 0.423
1.367 1 0.088 0.418








0.533 1 0.075 0.356 Co%(mg/L%as%Cl₂) 0.3572
2.483 1 0.072 0.342 kd%(minY¹) 0.013
3.500 1 0.072 0.342 R² 0.91301











1 0.00 TNTC 33 4 41250000 1 0.000 0
2 0.18 249 24 1 31125000 0.75454545 0.065 0.06314331
3 0.35 TNTC 53 5 6625000 0.16060606 0.125 0.12054632
4 0.70 98 17 7 2 1225 2.9697ED05 0.249 0.24109264
5 0.88 TNTC 98 4 0 1225 2.9697ED05 0.314 0.30423595
6 1.07 356 19 4 3 341.25 8.2727ED06 0.378 0.36737926
7 1.25 TNTC 61 4 1 762.5 1.8485ED05 0.443 0.43052257
8 1.45 170 35 3 325 7.8788ED06 0.513 0.49940618
9 1.67 88 20 3 110 2.6667ED06 0.589 0.57403009
10 1.83 61 21 3 76.25 1.8485ED06 0.647 0.6314331
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0.600 1 0.089 0.423
1.367 1 0.088 0.418








0.600 1 0.072 0.342 Co%(mg/L%as%Cl₂) 0.3446
3.567 1 0.067 0.318 kd%(minY¹) 0.02
4.450 1 0.066 0.314 R² 0.95104











1 0.00 TNTC 64 50 80000000 1 0.000 0
2 0.18 TNTC 43 5 53750000 0.671875 0.063 0.05900633
3 0.38 TNTC 238 25 29750000 0.371875 0.132 0.12337688
4 0.80 TNTC TNTC 39 4 4875000 0.0609375 0.273 0.25748219
5 1.37 TNTC 84 0 3 105000 0.0013125 0.465 0.4398654
6 1.60 TNTC 495 28 3 4843.75 6.0547EB05 0.543 0.51496437
7 1.90 216 53 3 0 466.25 5.8281EB06 0.642 0.61152019
9 2.45 90 12 4 112.5 1.4063EB06 0.824 0.78853919
10 2.78 122 36 7 301.25 3.7656EB06 0.933 0.89582344
11 3.00 113 9 141.25 1.7656EB06 1.003 0.96555819
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0.500 1 0.081 0.385
1.467 1 0.081 0.385








0.533 1 0.073 0.347 Co%(mg/L%as%Cl₂) 0.3513
2.317 1 0.071 0.337 kd%(minY¹) 0.019
3.233 1 0.070 0.333 R² 0.96868











1 0.00 TNTC 61 6 76250000 1 0.000 0
2 0.17 167 17 1 20875000 0.27377049 0.058 0.05581948
3 0.35 208 13 2 0 260000 0.00340984 0.123 0.1172209
4 0.72 404 23 2 0 3962.5 5.1967EC05 0.250 0.24002375
5 0.88 TNTC 62 3 1 775 1.0164EC05 0.308 0.29584323
6 1.07 54 2 0 67.5 8.8525EC07 0.371 0.35724466
7 1.27 111 7 1 138.75 1.8197EC06 0.440 0.42422803
8 1.45 280 10 5 350 4.5902EC06 0.502 0.48562945
9 1.62 72 2 90 1.1803EC06 0.559 0.54144893
10 1.78 13 2
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0.500 1 0.081 0.385
1.467 1 0.081 0.385








0.533 1 0.076 0.361 Co%(mg/L%as%Cl₂) 0.3544
1.733 1 0.072 0.342 kd%(minY¹) 0.009
4.217 1 0.071 0.337 R² 0.59441











1 0.00 TNTC 37 3 46250000 1 0.000 0
2 0.28 126 16 1 15750000 0.34054054 0.100 0.09758511
3 1.32 19 3 0
4 2.10 0 0 0
5 3.35 1 0 0 0
6 4.02 7 0 0
7 4.42 84 22 0 105 2.2703EB06 1.535 1.52117973
8 5.17 64 2 0 80 1.7297EB06 1.789 1.77949327
9 5.75 26 1 0
10 6.35 19 4
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0.433 1 0.084 0.399
1.600 1 0.082 0.390








1.600 1 0.078 0.371 Co%(mg/L%as%Cl₂) 0.375
2.550 1 0.077 0.366 kd%(minY¹) 0.009
3.483 1 0.076 0.361 R² 0.87441











1 0.00 TNTC 68 3 85000000 1 0.000 0
2 0.17 TNTC 72 4 1 90000 0.00105882 0.062 0.06076801
3 0.37 92 1 0 0 1150 1.3529EC05 0.137 0.13368963
4 0.55 162 8 3 202.5 2.3824EC06 0.206 0.20053444
5 0.75 240 27 4 300 3.5294EC06 0.280 0.27345606
6 1.02 71 8 88.75 1.0441EC06 0.380 0.37068488
Large%plates%(0.8%mL%sample)
4 0.55 186 22 232.5 2.7353EC06 0.206 0.20118765
5 0.75 260 27 325 3.8235EC06 0.280 0.27434679
6 1.02 112 15 140 1.6471EC06 0.380 0.37189232
Large%plates%(0.4mL%sample)
4 0.55 171 15 427.5 5.0294EC06 0.206 0.20118765
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0.417 1 0.089 0.423
1.567 1 0.087 0.413
2.583 1 0.086 0.409








0.583 1 0.082 0.390 Co%(mg/L%as%Cl₂) 0.3922
3.533 1 0.078 0.371 kd%(minY¹) 0.015
4.667 1 0.077 0.366 R² 0.99157











1 0.00 TNTC 51 5 63750000 1 0.000 0
2 0.20 252 29 1 31500000 0.49411765 0.078 0.07434679
3 0.42 TNTC TNTC 35 4 4375000 0.06862745 0.163 0.15488915
4 0.75 TNTC 113 14 141250 0.00221569 0.293 0.27880048
5 1.33 258 27 4 3225 5.0588EC05 0.518 0.49564529
6 1.62 TNTC 82 9 0 1025 1.6078EC05 0.626 0.60096991
7 1.87 265 10 2 331.25 5.1961EC06 0.722 0.6939034
8 2.17 TNTC 38 5 475 7.451EC06 0.836 0.80542359
9 2.37 TNTC 42 8 525 8.2353EC06 0.912 0.87977039
10 2.60 272 19 340 5.3333EC06 1.000 0.96650831














































	  	   256 
 
 















0.400 1 0.081 0.385
1.683 1 0.081 0.385








2.083 1 0.068 0.323 Co%(mg/L%as%Cl₂) 0.334
3.017 1 0.067 0.318 kd%(minY¹) 0.015
3.850 1 0.067 0.318 R² 0.8676











1 0.00 TNTC 39 2 48750000 1 0.000 0
2 0.20 42 7 1 525000 0.01076923 0.067 0.06342043
3 0.40 345 19 1 0 3343.75 6.859ED05 0.133 0.12684086
4 0.75 27 3 0 0
5 0.97 65 25 1 81.25 1.6667ED06 0.321 0.30653207
6 1.17 26 24 2
















































	  	   257 
 
 















0.400 1 0.081 0.385
1.683 1 0.081 0.385








0.667 1 0.074 0.352 Co%(mg/L%as%Cl₂) 0.3524
2.550 1 0.071 0.337 kd%(minY¹) 0.013
5.633 1 0.069 0.328 R² 0.9646











1 0.00 208 26 2 26000000 1 0.000 0
2 0.25 198 10 0 24750000 0.95192308 0.088 0.08372922
3 0.88 TNTC 60 4 7500000 0.28846154 0.310 0.29584323
4 1.73 TNTC 133 14 1662500 0.06394231 0.604 0.58052257
5 dropped
6 3.32 165 36 1 3281.25 0.0001262 1.144 1.1108076
7 3.73 TNTC 30 2 0 375 1.4423EC05 1.284 1.25035629
8 4.08 TNTC 61 5 1 762.5 2.9327EC05 1.400 1.36646081
9 4.40 199 20 0 248.75 9.5673EC06 1.507 1.4736342
10 4.63 232 14 0 290 1.1154EC05 1.585 1.55178147
11 4.95 114 15 142.5 5.4808EC06 1.689 1.65783848
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0.400 1 0.099 0.470
1.283 1 0.098 0.466








0.400 1 0.100 0.475 Co%(mg/L%as%Cl₂) 0.4702
1.833 1 0.096 0.456 kd%(minY¹) 0.009
3.767 1 0.095 0.451 R² 0.77696











1 0.00 289 28 3 36125000 1 0.000 0
2 0.20 214 20 2 26750000 0.74048443 0.094 0.09144893
3 0.63 TNTC 111 13 13875000 0.38408304 0.297 0.28958828
4 1.22 TNTC 288 10 3600000 0.09965398 0.569 0.55631433
5 1.62 TNTC TNTC 120 10 1500000 0.04152249 0.755 0.73921219
6 2.05 TNTC 295 29 368750 0.01020761 0.955 0.93735154
7 2.73 TNTC 185 6 23125 0.00064014 1.270 1.24980206
8 3.37 TNTC 251 3 0 3137.5 8.6851ED05 1.559 1.53939034
9 4.02 87 54 5 391.875 1.0848ED05 1.855 1.83659937
10 4.87 221 20 1 276.25 7.6471ED06 2.239 2.22525732
11 5.55 108 11 2 135 3.737ED06 2.546 2.53770784
































































0.200 1 0.098 0.466
1.300 1 0.096 0.456








0.550 1 0.076 0.361 Co%(mg/L%as%Cl₂) 0.3748
0.733 1 0.077 0.366 kd%(minW¹) 0.049











1 0.00 TNTC 71 8 0 8875000 1 0.000 0
2 0.18 TNTC 111 7 0 1387500 0.15633803 0.068 0.06532067






























































0.583 1 0.085 0.404
1.583 1 0.084 0.399








0.533 1 0.064 0.304 Co%(mg/L%as%Cl₂) 0.3154
0.767 1 0.065 0.309 kd%(minW¹) 0.047
1.700 1 0.061 0.290 R² 0.93615











1 0.00 TNTc 59 11 7375000 1 0.000 0
2 0.15 TNTC 39 3 4875000 0.66101695 0.047 0.04435867
3 0.27 TNTC 178 12 2225000 0.30169492 0.084 0.07885986






























































0.433 1 0.084 0.399
1.433 1 0.082 0.390








0.667 1 0.061 0.290 Co%(mg/L%as%Cl₂) 0.2975
0.850 1 0.061 0.290 kd%(minW¹) 0.038
1.733 1 0.058 0.276 R² 0.95164











1 0.00 TNTC 70 10 8750000 1 0.000 0
2 0.20 TNTC 122 8 1525000 0.17428571 0.059 0.05629454
3 0.33 TNTC 157 9 2 196250 0.02242857 0.099 0.09382423





























































2.400 1 0.083 0.394
3.567 1 0.083 0.394








0.683 1 0.063 0.299 Co%(mg/L%as%Cl₂) 0.3075
0.850 1 0.064 0.304 kd%(minW¹) 0.028
1.933 1 0.061 0.290 R² 0.93524











1 0.00 TNTC 39 2 4875000 1 0.000 0
2 0.17 TNTC 105 10 1 1312500 0.26923077 0.051 0.04889153
3 0.32 455 26 2 0 44687.5 0.00916667 0.097 0.0928939
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Pos Name Ct SYBR Ct Mean SYBR Ct Dev. SYBR Amount SYBR Target SYBR
A1 1E DNA:1 P3 27.80 27.80 0.02 -
A2 1E DNA:1 P3 27.82 27.80 0.02 -
A3 1E DNA:1 P3 27.79 27.80 0.02 -
A4 1F DNA:1 P3 27.19 26.87 0.29 -
A5 1F DNA:1 P3 26.83 26.87 0.29 -
A6 1F DNA:1 P3 26.61 26.87 0.29 -
A7 3E DNA:1 P3 26.88 26.50 0.44 -
A8 3E DNA:1 P3 26.02 26.50 0.44 -
A9 3E DNA:1 P3 26.60 26.50 0.44 -
A10 3F DNA:1 P3 26.44 26.16 0.25 -
A11 3F DNA:1 P3 26.06 26.16 0.25 -
A12 3F DNA:1 P3 25.98 26.16 0.25 -
B1 1E DNA:1 P12 28.98 28.89 0.32 -
B2 1E DNA:1 P12 29.14 28.89 0.32 -
B3 1E DNA:1 P12 28.53 28.89 0.32 -
B4 1F DNA:1 P12 27.46 27.64 0.28 -
B5 1F DNA:1 P12 27.96 27.64 0.28 -
B6 1F DNA:1 P12 27.51 27.64 0.28 -
B7 3E DNA:1 P12 27.57 27.89 0.35 -
B8 3E DNA:1 P12 27.84 27.89 0.35 -
B9 3E DNA:1 P12 28.26 27.89 0.35 -
B10 3F DNA:1 P12 27.23 26.71 0.46 -
B11 3F DNA:1 P12 26.34 26.71 0.46 -
B12 3F DNA:1 P12 26.56 26.71 0.46 -
C1 1E DNA:1 rpoD2 17.50 17.15 0.34 -
C2 1E DNA:1 rpoD2 17.12 17.15 0.34 -
C3 1E DNA:1 rpoD2 16.83 17.15 0.34 -
C4 1F DNA:1 rpoD2 17.00 16.86 0.14 -
C5 1F DNA:1 rpoD2 16.71 16.86 0.14 -
C6 1F DNA:1 rpoD2 16.87 16.86 0.14 -
C7 3E DNA:1 rpoD2 17.11 16.85 0.23 -
C8 3E DNA:1 rpoD2 16.78 16.85 0.23 -
C9 3E DNA:1 rpoD2 16.66 16.85 0.23 -
C10 3F DNA:1 rpoD2 16.93 16.83 0.25 -
C11 3F DNA:1 rpoD2 16.55 16.83 0.25 -
C12 3F DNA:1 rpoD2 17.02 16.83 0.25 -
D1 1V DNA:1 P3 20.50 20.16 0.66 -
D2 1V DNA:1 P3 20.58 20.16 0.66 -
D3 1V DNA:1 P3 19.41 20.16 0.66 -
D4 2V DNA:1 P3 19.48 19.58 0.14 -
D5 2V DNA:1 P3 19.52 19.58 0.14 -
D6 2V DNA:1 P3 19.73 19.58 0.14 -
D7 3V DNA:1 P3 19.32 19.49 0.18 -
D8 3V DNA:1 P3 19.68 19.49 0.18 -
D9 3V DNA:1 P3 19.49 19.49 0.18 -
E1 1V DNA:1 P12 22.54 21.93 0.57 -
E2 1V DNA:1 P12 21.40 21.93 0.57 -
E3 1V DNA:1 P12 21.84 21.93 0.57 -
E4 2V DNA:1 P12 21.09 20.60 0.42 -
E5 2V DNA:1 P12 20.42 20.60 0.42 -
E6 2V DNA:1 P12 20.30 20.60 0.42 -
E7 3V DNA:1 P12 20.18 20.32 0.41 -
E8 3V DNA:1 P12 20.00 20.32 0.41 -
E9 3V DNA:1 P12 20.77 20.32 0.41 -
F1 1V DNA:1 rpoD2 28.67 28.50 0.22 -
F2 1V DNA:1 rpoD2 28.58 28.50 0.22 -
F3 1V DNA:1 rpoD2 28.26 28.50 0.22 -
F4 2V DNA:1 rpoD2 27.35 27.50 0.19 -
F5 2V DNA:1 rpoD2 27.43 27.50 0.19 -
F6 2V DNA:1 rpoD2 27.71 27.50 0.19 -
F7 3V DNA:1 rpoD2 28.14 28.02 0.10 -
F8 3V DNA:1 rpoD2 27.97 28.02 0.10 -
F9 3V DNA:1 rpoD2 27.95 28.02 0.10 -
G1 1V DNA:10 P3 24.14 24.07 0.20 -
G2 1V DNA:10 P3 24.23 24.07 0.20 -
G3 1V DNA:10 P3 23.85 24.07 0.20 -
G4 1V DNA:100 P3 27.40 27.36 0.05 -
G5 1V DNA:100 P3 27.38 27.36 0.05 -
G6 1V DNA:100 P3 27.31 27.36 0.05 -
G7 1V DNA:1000 P3 30.48 30.82 0.31 -
G8 1V DNA:1000 P3 30.88 30.82 0.31 -
G9 1V DNA:1000 P3 31.11 30.82 0.31 -
G10 1V DNA:10000 P3 33.82 34.84 2.16 -
G11 1V DNA:10000 P3 37.32 34.84 2.16 -
G12 1V DNA:10000 P3 33.38 34.84 2.16 -
H1 1V DNA:10 P12 25.69 25.46 0.28 -
H2 1V DNA:10 P12 25.56 25.46 0.28 -
H3 1V DNA:10 P12 25.14 25.46 0.28 -
H4 1V DNA:100 P12 28.70 28.65 0.13 -
H5 1V DNA:100 P12 28.74 28.65 0.13 -
H6 1V DNA:100 P12 28.50 28.65 0.13 -
H7 1V DNA:1000 P12 32.07 32.06 0.45 -
H8 1V DNA:1000 P12 32.50 32.06 0.45 -
H9 1V DNA:1000 P12 31.60 32.06 0.45 -
H10 1V DNA:10000 P12 36.68 35.75 0.88 -
H11 1V DNA:10000 P12 35.66 35.75 0.88 -
H12 1V DNA:10000 P12 34.92 35.75 0.88 -
Analysis Parameters






Baseline range (from cycle no. ... to) n/a
Drift Correction OFF




Level (12) P3 copies P12 copies rpoD2 copies
1E 1 27.80 28.89 17.15 1 1 82 103 74119
1F 1 26.87 27.64 16.86 1.55832916 1.94530989 154 233 89784
3E 1 26.50 27.89 16.85 2 1.62450479 198 198 90379
3F 1 26.16 26.71 16.83 2.4966611 3.63007662 250 427 91582
1V 1 20.16 21.93 28.50 1 1 15092 9623 41
2V 1 19.58 20.60 27.50 0.74742462 1.25701337 22432 22890 79
3V 1 19.49 20.32 28.02 1.14076372 2.1885874 23855 27471 56
1V 10 24.07 25.46 10435 9648
1V 100 27.36 28.65 11020 12072
1V 1000 30.82 32.06 10362 13088
1V 10000 33.60 35.75 15506 11823




Pos Name Ct SYBR Ct Mean SYBR Ct Dev. SYBR Amount SYBR Target SYBR
A1 1A DNA:1 P3 23.44 23.55 0.21 -
A2 1A DNA:1 P3 23.79 23.55 0.21 -
A3 1A DNA:1 P3 23.42 23.55 0.21 -
A4 2A DNA:1 P3 23.77 23.30 0.47 -
A5 2A DNA:1 P3 22.83 23.30 0.47 -
A6 2A DNA:1 P3 23.31 23.30 0.47 -
A7 3A DNA:1 P3 23.49 23.40 0.13 -
A8 3A DNA:1 P3 23.47 23.40 0.13 -
A9 3A DNA:1 P3 23.25 23.40 0.13 -
A10 P3 - -
A11 P3 - -
A12 P3 - -
B1 1A DNA:1 P12 25.05 24.74 0.33 -
B2 1A DNA:1 P12 24.79 24.74 0.33 -
B3 1A DNA:1 P12 24.39 24.74 0.33 -
B4 2A DNA:1 P12 24.67 24.47 0.40 -
B5 2A DNA:1 P12 24.74 24.47 0.40 -
B6 2A DNA:1 P12 24.01 24.47 0.40 -
B7 3A DNA:1 P12 24.77 24.68 0.20 -
B8 3A DNA:1 P12 24.81 24.68 0.20 -
B9 3A DNA:1 P12 24.45 24.68 0.20 -
B10 P12 - -
B11 P12 - -
B12 P12 - -
C1 1A DNA:1 rpoD2 18.14 18.07 0.10 -
C2 1A DNA:1 rpoD2 18.11 18.07 0.10 -
C3 1A DNA:1 rpoD2 17.96 18.07 0.10 -
C4 2A DNA:1 rpoD2 17.74 17.26 0.46 -
C5 2A DNA:1 rpoD2 17.20 17.26 0.46 -
C6 2A DNA:1 rpoD2 16.83 17.26 0.46 -
C7 3A DNA:1 rpoD2 17.78 17.79 0.13 -
C8 3A DNA:1 rpoD2 17.92 17.79 0.13 -
C9 3A DNA:1 rpoD2 17.67 17.79 0.13 -
C10 rpoD2 - -
C11 rpoD2 - -
C12 rpoD2 - -
D1 1B DNA:1 P3 20.70 20.29 0.38 -
D2 1B DNA:1 P3 20.20 20.29 0.38 -
D3 1B DNA:1 P3 19.96 20.29 0.38 -
D4 2B DNA:1 P3 21.95 21.90 0.13 -
D5 2B DNA:1 P3 21.75 21.90 0.13 -
D6 2B DNA:1 P3 22.00 21.90 0.13 -
D7 3B DNA:1 P3 23.51 23.29 0.33 -
D8 3B DNA:1 P3 23.46 23.29 0.33 -
D9 3B DNA:1 P3 22.91 23.29 0.33 -
E1 1B DNA:1 P12 21.07 20.93 0.14 -
E2 1B DNA:1 P12 20.92 20.93 0.14 -
E3 1B DNA:1 P12 20.78 20.93 0.14 -
E4 2B DNA:1 P12 23.02 22.73 0.28 -
E5 2B DNA:1 P12 22.47 22.73 0.28 -
E6 2B DNA:1 P12 22.68 22.73 0.28 -
E7 3B DNA:1 P12 23.69 24.09 0.42 -
E8 3B DNA:1 P12 24.05 24.09 0.42 -
E9 3B DNA:1 P12 24.53 24.09 0.42 -
F1 1B DNA:1 rpoD2 16.98 16.90 0.08 -
F2 1B DNA:1 rpoD2 16.82 16.90 0.08 -
F3 1B DNA:1 rpoD2 16.92 16.90 0.08 -
F4 2B DNA:1 rpoD2 16.09 15.83 0.24 -
F5 2B DNA:1 rpoD2 15.60 15.83 0.24 -
F6 2B DNA:1 rpoD2 15.80 15.83 0.24 -
F7 3B DNA:1 rpoD2 16.97 16.72 0.22 -
F8 3B DNA:1 rpoD2 16.58 16.72 0.22 -
F9 3B DNA:1 rpoD2 16.62 16.72 0.22 -
G1 1V DNA:1 P3 21.57 21.52 0.28 -
G2 1V DNA:1 P3 21.77 21.52 0.28 -
G3 1V DNA:1 P3 21.21 21.52 0.28 -
G4 1V DNA:10 P3 24.77 24.18 0.63 -
G5 1V DNA:10 P3 23.51 24.18 0.63 -
G6 1V DNA:10 P3 24.25 24.18 0.63 -
G7 1V DNA:100 P3 27.50 27.37 0.11 -
G8 1V DNA:100 P3 27.31 27.37 0.11 -
G9 1V DNA:100 P3 27.30 27.37 0.11 -
G10 1V DNA:1000 P3 31.34 32.93 2.31 -
G11 1V DNA:1000 P3 35.58 32.93 2.31 -
G12 1V DNA:1000 P3 31.88 32.93 2.31 -
H1 1V DNA:1 P12 22.11 22.37 0.26 -
H2 1V DNA:1 P12 22.63 22.37 0.26 -
H3 1V DNA:1 P12 22.38 22.37 0.26 -
H4 1V DNA:10 P12 26.19 26.07 0.35 -
H5 1V DNA:10 P12 26.35 26.07 0.35 -
H6 1V DNA:10 P12 25.68 26.07 0.35 -
H7 1V DNA:100 P12 28.95 28.97 0.12 -
H8 1V DNA:100 P12 29.09 28.97 0.12 -
H9 1V DNA:100 P12 28.86 28.97 0.12 -
H10 1V DNA:1000 P12 32.51 32.83 0.29 -
H11 1V DNA:1000 P12 33.05 32.83 0.29 -
H12 1V DNA:1000 P12 32.94 32.83 0.29 -
Analysis Parameters






Baseline range (from cycle no. ... to) n/a
Drift Correction OFF




Level (12) P3 copies P12 copies rpoD2 copies
1A 1 23.55 24.74 18.07 1 1 1489 1542 40344
2A 1 23.30 24.47 17.26 0.67830216 0.68777091 1766 1839 68921
3A 1 23.40 24.68 17.79 0.91383145 0.85856544 1649 1604 48548
1B 1 20.29 20.93 16.90 1 1 13810 18462 87441
2B 1 21.90 22.73 15.83 0.15604132 0.13678671 4596 5714 177393
3B 1 23.29 24.09 16.72 0.11033787 0.09875516 1778 2356 98491
1V 1 21.52 22.37 5959 7224
1V 10 24.18 26.07 9679 6484
1V 100 27.37 28.97 10945 9800
1V 1000 31.61 32.83 6040 7925




Pos Name Ct SYBR Ct Mean SYBR Ct Dev. SYBR Expr. Level SYBR Range SYBR
A1 1C DNA:1 P3 18.80 18.72 0.19
A2 1C DNA:1 P3 18.86 18.72 0.19
A3 1C DNA:1 P3 18.51 18.72 0.19
A4 2C DNA:1 P3 21.61 21.48 0.12
A5 2C DNA:1 P3 21.40 21.48 0.12
A6 2C DNA:1 P3 21.42 21.48 0.12
A7 3C DNA:1 P3 23.49 23.82 0.29
A8 3C DNA:1 P3 24.04 23.82 0.29
A9 3C DNA:1 P3 23.93 23.82 0.29
B1 1C DNA:1 P12 20.62 19.99 0.54
B2 1C DNA:1 P12 19.68 19.99 0.54
B3 1C DNA:1 P12 19.68 19.99 0.54
B4 2C DNA:1 P12 22.50 22.60 0.18 0.172 0.122 - 0.244
B5 2C DNA:1 P12 22.49 22.60 0.18 0.172 0.122 - 0.244
B6 2C DNA:1 P12 22.81 22.60 0.18 0.172 0.122 - 0.244
B7 3C DNA:1 P12 25.41 25.30 0.26 2.370E-2X 1.89E-02 - 2.98E-02
B8 3C DNA:1 P12 25.49 25.30 0.26 2.370E-2X 1.89E-02 - 2.98E-02
B9 3C DNA:1 P12 25.00 25.30 0.26 2.370E-2X 1.89E-02 - 2.98E-02
C1 1C DNA:1 rpoD2 17.19 16.72 0.42
C2 1C DNA:1 rpoD2 16.63 16.72 0.42
C3 1C DNA:1 rpoD2 16.36 16.72 0.42
C4 2C DNA:1 rpoD2 17.25 16.79 0.47
C5 2C DNA:1 rpoD2 16.81 16.79 0.47
C6 2C DNA:1 rpoD2 16.31 16.79 0.47
C7 3C DNA:1 rpoD2 16.50 16.64 0.19
C8 3C DNA:1 rpoD2 16.56 16.64 0.19
C9 3C DNA:1 rpoD2 16.86 16.64 0.19
D1 1D DNA:1 P3 18.43 17.85 0.51
D2 1D DNA:1 P3 17.44 17.85 0.51
D3 1D DNA:1 P3 17.68 17.85 0.51
D4 2D DNA:1 P3 20.35 20.23 0.11
D5 2D DNA:1 P3 20.14 20.23 0.11
D6 2D DNA:1 P3 20.20 20.23 0.11
D7 3D DNA:1 P3 22.96 23.19 0.20
D8 3D DNA:1 P3 23.33 23.19 0.20
D9 3D DNA:1 P3 23.28 23.19 0.20
E1 1D DNA:1 P12 19.49 18.91 0.54
E2 1D DNA:1 P12 18.41 18.91 0.54
E3 1D DNA:1 P12 18.85 18.91 0.54
E4 2D DNA:1 P12 21.13 20.78 0.31
E5 2D DNA:1 P12 20.54 20.78 0.31
E6 2D DNA:1 P12 20.69 20.78 0.31
E7 3D DNA:1 P12 24.31 24.24 0.34
E8 3D DNA:1 P12 23.87 24.24 0.34
E9 3D DNA:1 P12 24.55 24.24 0.34
F1 1D DNA:1 rpoD2 17.18 16.63 0.51
F2 1D DNA:1 rpoD2 16.51 16.63 0.51
F3 1D DNA:1 rpoD2 16.19 16.63 0.51
F4 2D DNA:1 rpoD2 15.09 15.22 0.17
F5 2D DNA:1 rpoD2 15.41 15.22 0.17
F6 2D DNA:1 rpoD2 15.15 15.22 0.17
F7 3D DNA:1 rpoD2 15.90 15.59 0.28
F8 3D DNA:1 rpoD2 15.35 15.59 0.28
F9 3D DNA:1 rpoD2 15.51 15.59 0.28
G1 1V DNA:1 P3 20.98 21.10 0.19
G2 1V DNA:1 P3 21.32 21.10 0.19
G3 1V DNA:1 P3 20.99 21.10 0.19
G4 1V DNA:10 P3 23.90 23.88 0.02
G5 1V DNA:10 P3 23.86 23.88 0.02
G6 1V DNA:10 P3 23.88 23.88 0.02
G7 1V DNA:100 P3 27.78 27.63 0.14
G8 1V DNA:100 P3 27.59 27.63 0.14
G9 1V DNA:100 P3 27.51 27.63 0.14
G10 1V DNA:1000 P3 31.40 32.70 2.39
G11 1V DNA:1000 P3 35.46 32.70 2.39
G12 1V DNA:1000 P3 31.24 32.70 2.39
H1 1V DNA:1 P12 21.96 22.04 0.26
H2 1V DNA:1 P12 21.82 22.04 0.26
H3 1V DNA:1 P12 22.33 22.04 0.26
H4 1V DNA:10 P12 25.99 25.76 0.27
H5 1V DNA:10 P12 25.83 25.76 0.27
H6 1V DNA:10 P12 25.45 25.76 0.27
H7 1V DNA:100 P12 28.81 28.90 0.08
H8 1V DNA:100 P12 28.97 28.90 0.08
H9 1V DNA:100 P12 28.93 28.90 0.08
H10 1V DNA:1000 P12 31.94 32.00 0.22
H11 1V DNA:1000 P12 32.24 32.00 0.22
H12 1V DNA:1000 P12 31.81 32.00 0.22
Analysis Parameters






Baseline range (from cycle no. ... to) n/a
Drift Correction OFF




Level (12) P3 copies P12 copies rpoD2 copies N/No CT (mg*min/L)
1C 1 18.72 19.99 16.72 1 1 40371 34061 98491 1 0
2C 1 21.48 22.60 16.79 0.15496346 0.17194273 6124 6219 94037 0.15633803 0.068405618
3C 1 23.82 25.30 16.64 0.02758447 0.0238478 1238 1071 103840 0.00297183 0.136199478
1D 1 17.85 18.91 16.63 1 1 73154 68843 104529
2D 1 20.23 20.78 15.22 0.07229301 0.10294888 14388 20357 265512
3D 1 23.19 24.24 15.59 0.01200684 0.01209035 1904 2136 207897
1V 1 21.10 22.04 7940 8957
1V 10 23.88 25.76 11881 7935
1V 100 27.63 28.90 9164 10257
1V 1000 31.32 32.00 7364 13610





Pos Name Ct SYBR Ct Mean SYBR Ct Dev. SYBR Expr. Level SYBR Range SYBR
A1 1A cDNA:5 P3 32.73 33.50 1.11
A2 1A cDNA:5 P3 32.99 33.50 1.11
A3 1A cDNA:5 P3 34.78 33.50 1.11
A4 2A cDNA:5 P3
A5 2A cDNA:5 P3
A6 2A cDNA:5 P3 35.99
A7 3A cDNA:5 P3
A8 3A cDNA:5 P3
A9 3A cDNA:5 P3
B1 1A cDNA:5 P12 29.92 29.80 0.16
B2 1A cDNA:5 P12 29.86 29.80 0.16
B3 1A cDNA:5 P12 29.63 29.80 0.16
B4 2A cDNA:5 P12 32.77 33.06 0.65
B5 2A cDNA:5 P12 33.80 33.06 0.65
B6 2A cDNA:5 P12 32.60 33.06 0.65
B7 3A cDNA:5 P12
B8 3A cDNA:5 P12
B9 3A cDNA:5 P12
C1 1A cDNA:5 rpoD2 22.98 22.65 0.29
C2 1A cDNA:5 rpoD2 22.47 22.65 0.29
C3 1A cDNA:5 rpoD2 22.49 22.65 0.29
C4 2A cDNA:5 rpoD2 22.76 22.62 0.13
C5 2A cDNA:5 rpoD2 22.51 22.62 0.13
C6 2A cDNA:5 rpoD2 22.60 22.62 0.13
C7 3A cDNA:5 rpoD2 22.39 22.09 0.26
C8 3A cDNA:5 rpoD2 21.97 22.09 0.26
C9 3A cDNA:5 rpoD2 21.92 22.09 0.26
D1 1B cDNA:5 P3 27.93 27.56 0.34
D2 1B cDNA:5 P3 27.26 27.56 0.34
D3 1B cDNA:5 P3 27.49 27.56 0.34
D4 2B cDNA:5 P3 29.88 29.95 0.08 0.150 0.139 - 0.162
D5 2B cDNA:5 P3 30.04 29.95 0.08 0.150 0.139 - 0.162
D6 2B cDNA:5 P3 29.95 29.95 0.08 0.150 0.139 - 0.162
D7 3B cDNA:5 P3 33.30 33.08 0.54 2.050E-2X 1.38E-02 - 3.03E-02
D8 3B cDNA:5 P3 32.46 33.08 0.54 2.050E-2X 1.38E-02 - 3.03E-02
D9 3B cDNA:5 P3 33.48 33.08 0.54 2.050E-2X 1.38E-02 - 3.03E-02
E1 1B cDNA:5 P12 26.39 25.98 0.37
E2 1B cDNA:5 P12 25.87 25.98 0.37
E3 1B cDNA:5 P12 25.67 25.98 0.37
E4 2B cDNA:5 P12 28.85 28.60 0.23
E5 2B cDNA:5 P12 28.51 28.60 0.23
E6 2B cDNA:5 P12 28.43 28.60 0.23
E7 3B cDNA:5 P12 34.00 34.23 0.53
E8 3B cDNA:5 P12 33.85 34.23 0.53
E9 3B cDNA:5 P12 34.84 34.23 0.53
F1 1B cDNA:5 rpoD2 22.54 22.08 0.41
F2 1B cDNA:5 rpoD2 21.91 22.08 0.41
F3 1B cDNA:5 rpoD2 21.77 22.08 0.41
F4 2B cDNA:5 rpoD2 21.70 21.73 0.07
F5 2B cDNA:5 rpoD2 21.69 21.73 0.07
F6 2B cDNA:5 rpoD2 21.82 21.73 0.07
F7 3B cDNA:5 rpoD2 22.16 21.99 0.16
F8 3B cDNA:5 rpoD2 21.96 21.99 0.16
F9 3B cDNA:5 rpoD2 21.85 21.99 0.16
G1 1D cDNA:5 DF1 P3 25.15 24.91 0.21
G2 1D cDNA:5 DF1 P3 24.82 24.91 0.21
G3 1D cDNA:5 DF1 P3 24.76 24.91 0.21
G4 1D cDNA:5 DF10 P3 28.10 27.84 0.30
G5 1D cDNA:5 DF10 P3 27.90 27.84 0.30
G6 1D cDNA:5 DF10 P3 27.51 27.84 0.30
G7 1D cDNA:5 DF100 P3 31.45 31.46 0.46
G8 1D cDNA:5 DF100 P3 31.01 31.46 0.46
G9 1D cDNA:5 DF100 P3 31.93 31.46 0.46
G10 1D cDNA:5 DF1000 P3 34.91 36.22 2.76
G11 1D cDNA:5 DF1000 P3 39.40 36.22 2.76
G12 1D cDNA:5 DF1000 P3 34.36 36.22 2.76
H1 1D cDNA:5 DF1 P12 25.42 25.48 0.06
H2 1D cDNA:5 DF1 P12 25.53 25.48 0.06
H3 1D cDNA:5 DF1 P12 25.48 25.48 0.06
H4 1D cDNA:5 DF10 P12 29.04 28.89 0.13
H5 1D cDNA:5 DF10 P12 28.82 28.89 0.13
H6 1D cDNA:5 DF10 P12 28.80 28.89 0.13
H7 1D cDNA:5 DF100 P12 32.85 32.30 0.53
H8 1D cDNA:5 DF100 P12 32.25 32.30 0.53
H9 1D cDNA:5 DF100 P12 31.80 32.30 0.53
H10 1D cDNA:5 DF1000 P12 34.28 34.22 0.23
H11 1D cDNA:5 DF1000 P12 33.96 34.22 0.23
H12 1D cDNA:5 DF1000 P12 34.40 34.22 0.23
Analysis Parameters






Baseline range (from cycle no. ... to) n/a
Drift Correction OFF




Level (12) P3 copies P12 copies rpoD2 copies
1A 5 32.86 29.80 22.65 1 1 13 285 9766
2A 5 33.06 22.62 0.102237757 34 9962
3A 5 22.09 14142
1B 5 27.56 25.98 22.08 1 1 481 3438 14236
2B 5 29.95 28.60 21.73 0.14968484 0.127626516 94 624 17942
3B 5 33.08 34.23 21.99 0.0204749 0.003086099 11 16 15108
1D 5 24.91 25.48 2939 4762
1D 50 27.84 28.89 3969 5162
1D 500 31.46 32.30 3346 5597
1D 5000 34.64 34.22 3823 16019




Pos Name Ct SYBR Ct Mean SYBR Ct Dev. SYBR Expr. Level SYBR Range SYBR
A1 1C cDNA:5 P3 25.87 25.87 0.17
A2 1C cDNA:5 P3 26.03 25.87 0.17
A3 1C cDNA:5 P3 25.70 25.87 0.17
A4 2C cDNA:5 P3 28.92 28.81 0.10
A5 2C cDNA:5 P3 28.71 28.81 0.10
A6 2C cDNA:5 P3 28.81 28.81 0.10
A7 3C cDNA:5 P3 33.86 34.01 0.51
A8 3C cDNA:5 P3 34.59 34.01 0.51
A9 3C cDNA:5 P3 33.59 34.01 0.51
A10 1C-RT cDNA:5 P3
A11 1C-RT cDNA:5 P3
A12 1C-RT cDNA:5 P3
B1 1C cDNA:5 P12 26.74 26.51 0.26
B2 1C cDNA:5 P12 26.56 26.51 0.26
B3 1C cDNA:5 P12 26.23 26.51 0.26
B4 2C cDNA:5 P12 29.20 29.18 0.18
B5 2C cDNA:5 P12 29.36 29.18 0.18
B6 2C cDNA:5 P12 28.99 29.18 0.18
B7 3C cDNA:5 P12 34.31 34.51 0.25
B8 3C cDNA:5 P12 34.79 34.51 0.25
B9 3C cDNA:5 P12 34.43 34.51 0.25
B10 1C-RT cDNA:5 P12
B11 1C-RT cDNA:5 P12
B12 1C-RT cDNA:5 P12
C1 1C cDNA:5 rpoD2 22.55 22.19 0.33
C2 1C cDNA:5 rpoD2 22.10 22.19 0.33
C3 1C cDNA:5 rpoD2 21.92 22.19 0.33
C4 2C cDNA:5 rpoD2 22.45 22.15 0.29
C5 2C cDNA:5 rpoD2 21.86 22.15 0.29
C6 2C cDNA:5 rpoD2 22.14 22.15 0.29
C7 3C cDNA:5 rpoD2 21.43 21.10 0.28
C8 3C cDNA:5 rpoD2 20.92 21.10 0.28
C9 3C cDNA:5 rpoD2 20.95 21.10 0.28
C10 1C-RT cDNA:5 rpoD2
C11 1C-RT cDNA:5 rpoD2 35.51 36.33 1.17
C12 1C-RT cDNA:5 rpoD2 37.16 36.33 1.17
D1 1D cDNA:5 P3 25.65 25.17 0.42
D2 1D cDNA:5 P3 24.88 25.17 0.42
D3 1D cDNA:5 P3 24.97 25.17 0.42
D4 2D cDNA:5 P3 27.35 27.38 0.07 0.156 0.133 - 0.183
D5 2D cDNA:5 P3 27.34 27.38 0.07 0.156 0.133 - 0.183
D6 2D cDNA:5 P3 27.46 27.38 0.07 0.156 0.133 - 0.183
D7 3D cDNA:5 P3 34.36 33.50 1.39 2.430E-3X 9.28E-04 - 6.38E-03
D8 3D cDNA:5 P3 31.90 33.50 1.39 2.430E-3X 9.28E-04 - 6.38E-03
D9 3D cDNA:5 P3 34.24 33.50 1.39 2.430E-3X 9.28E-04 - 6.38E-03
D10 1D-RT cDNA:5 P3
D11 1D-RT cDNA:5 P3
D12 1D-RT cDNA:5 P3
E1 1D cDNA:5 P12 25.85 25.36 0.44
E2 1D cDNA:5 P12 25.25 25.36 0.44
E3 1D cDNA:5 P12 24.98 25.36 0.44
E4 2D cDNA:5 P12 27.71 27.49 0.19
E5 2D cDNA:5 P12 27.35 27.49 0.19
E6 2D cDNA:5 P12 27.41 27.49 0.19
E7 3D cDNA:5 P12 33.14 33.26 0.14
E8 3D cDNA:5 P12 33.23 33.26 0.14
E9 3D cDNA:5 P12 33.42 33.26 0.14
E10 1D-RT cDNA:5 P12
E11 1D-RT cDNA:5 P12
E12 1D-RT cDNA:5 P12
F1 1D cDNA:5 rpoD2 22.39 22.14 0.22
F2 1D cDNA:5 rpoD2 22.04 22.14 0.22
F3 1D cDNA:5 rpoD2 21.98 22.14 0.22
F4 2D cDNA:5 rpoD2 21.83 21.68 0.22
F5 2D cDNA:5 rpoD2 21.42 21.68 0.22
F6 2D cDNA:5 rpoD2 21.78 21.68 0.22
F7 3D cDNA:5 rpoD2 21.90 21.79 0.11
F8 3D cDNA:5 rpoD2 21.67 21.79 0.11
F9 3D cDNA:5 rpoD2 21.81 21.79 0.11
F10 1D-RT cDNA:5 rpoD2
F11 1D-RT cDNA:5 rpoD2
F12 1D-RT cDNA:5 rpoD2
G1 1D cDNA:5 DF10 P3 27.94 27.87 0.11
G2 1D cDNA:5 DF10 P3 27.93 27.87 0.11
G3 1D cDNA:5 DF10 P3 27.74 27.87 0.11
G4 1D cDNA:5 DF100 P3 31.74 31.65 0.23
G5 1D cDNA:5 DF100 P3 31.82 31.65 0.23
G6 1D cDNA:5 DF100 P3 31.39 31.65 0.23
G7 1D cDNA:5 DF1000 P3 35.19 34.64 0.94
G8 1D cDNA:5 DF1000 P3 35.18 34.64 0.94
G9 1D cDNA:5 DF1000 P3 33.55 34.64 0.94
G10 1D cDNA:5 DF10000 P3
G11 1D cDNA:5 DF10000 P3
G12 1D cDNA:5 DF10000 P3
H1 1D cDNA:5 DF10 P12 29.10 28.97 0.21
H2 1D cDNA:5 DF10 P12 29.07 28.97 0.21
H3 1D cDNA:5 DF10 P12 28.73 28.97 0.21
H4 1D cDNA:5 DF100 P12 32.64 32.40 0.20
H5 1D cDNA:5 DF100 P12 32.30 32.40 0.20
H6 1D cDNA:5 DF100 P12 32.27 32.40 0.20
H7 1D cDNA:5 DF1000 P12 34.79 35.20 0.35
H8 1D cDNA:5 DF1000 P12 35.38 35.20 0.35
H9 1D cDNA:5 DF1000 P12 35.41 35.20 0.35
H10 1D cDNA:5 DF10000 P12
H11 1D cDNA:5 DF10000 P12
H12 1D cDNA:5 DF10000 P12
Analysis Parameters






Baseline range (from cycle no. ... to) n/a
Drift Correction OFF




Level (12) P3 copies P12 copies rpoD2 copies
1C 5 25.87 26.51 22.19 1 1 1525 2434 13237
2C 5 28.81 29.18 22.15 0.12674493 0.15283003 205 427 13592
3C 5 34.01 34.51 21.10 0.0016653 0.00183501 6 13 27212
1D 5 25.17 25.36 22.14 1 1 2461 5149 13682
2D 5 27.38 27.49 21.68 0.15712667 0.16608573 544 1285 18545
3D 5 34.30 33.26 21.79 0.00140035 0.00328475 5 30 17244
1D 50 27.87 28.97 3889 4900
1D 500 31.65 32.40 2939 5244
1D 5000 34.64 35.20 3809 8459
1D 50000 - -
1C-RT - - 36.33 0
1D-RT - - -




Pos Name Ct SYBR Ct Mean SYBR Ct Dev. SYBR Expr. Level SYBR Range SYBR
A1 1X DNA:10 P3 28.88 28.91 0.04
A2 1X DNA:10 P3 28.90 28.91 0.04
A3 1X DNA:10 P3 28.96 28.91 0.04
A4 2X DNA:10 P3 30.09 29.82 0.29
A5 2X DNA:10 P3 29.86 29.82 0.29
A6 2X DNA:10 P3 29.51 29.82 0.29
A7 3X DNA:10 P3 29.71 29.73 0.06
A8 3X DNA:10 P3 29.79 29.73 0.06
A9 3X DNA:10 P3 29.68 29.73 0.06
A10 4X DNA:10 P3 28.95 29.39 0.44
A11 4X DNA:10 P3 29.37 29.39 0.44
A12 4X DNA:10 P3 29.84 29.39 0.44
B1 1X DNA:10 P12 31.32 30.86 0.43
B2 1X DNA:10 P12 30.48 30.86 0.43
B3 1X DNA:10 P12 30.77 30.86 0.43
B4 2X DNA:10 P12 32.28 31.86 0.40 0.350 0.258 - 0.475
B5 2X DNA:10 P12 31.79 31.86 0.40 0.350 0.258 - 0.475
B6 2X DNA:10 P12 31.50 31.86 0.40 0.350 0.258 - 0.475
B7 3X DNA:10 P12 32.19 32.09 0.12 0.278 0.248 - 0.312
B8 3X DNA:10 P12 32.13 32.09 0.12 0.278 0.248 - 0.312
B9 3X DNA:10 P12 31.96 32.09 0.12 0.278 0.248 - 0.312
B10 4X DNA:10 P12 31.42 30.78 0.56 0.876 0.589 - 1.30
B11 4X DNA:10 P12 30.38 30.78 0.56 0.876 0.589 - 1.30
B12 4X DNA:10 P12 30.55 30.78 0.56 0.876 0.589 - 1.30
C1 1X DNA:10 rpoD2 17.98 17.59 0.36
C2 1X DNA:10 rpoD2 17.52 17.59 0.36
C3 1X DNA:10 rpoD2 17.27 17.59 0.36
C4 2X DNA:10 rpoD2 17.23 17.07 0.19
C5 2X DNA:10 rpoD2 16.87 17.07 0.19
C6 2X DNA:10 rpoD2 17.11 17.07 0.19
C7 3X DNA:10 rpoD2 17.05 16.98 0.12
C8 3X DNA:10 rpoD2 16.84 16.98 0.12
C9 3X DNA:10 rpoD2 17.04 16.98 0.12
C10 4X DNA:10 rpoD2 17.44 17.32 0.12
C11 4X DNA:10 rpoD2 17.20 17.32 0.12
C12 4X DNA:10 rpoD2 17.32 17.32 0.12
D1 1E DNA:1 P3 17.46 16.98 0.47
D2 1E DNA:1 P3 16.52 16.98 0.47
D3 1E DNA:1 P3 16.95 16.98 0.47
D4 2E DNA:1 P3 17.93 17.76 0.18
D5 2E DNA:1 P3 17.57 17.76 0.18
D6 2E DNA:1 P3 17.77 17.76 0.18
D7 3E DNA:1 P3 19.18 19.30 0.10
D8 3E DNA:1 P3 19.34 19.30 0.10
D9 3E DNA:1 P3 19.38 19.30 0.10
D10 4E DNA:1 P3 21.05 21.05 0.15
D11 4E DNA:1 P3 20.89 21.05 0.15
D12 4E DNA:1 P3 21.20 21.05 0.15
E1 1E DNA:1 P12 18.79 18.17 0.55
E2 1E DNA:1 P12 17.92 18.17 0.55
E3 1E DNA:1 P12 17.80 18.17 0.55
E4 2E DNA:1 P12 19.07 18.82 0.22
E5 2E DNA:1 P12 18.65 18.82 0.22
E6 2E DNA:1 P12 18.75 18.82 0.22
E7 3E DNA:1 P12 20.27 20.30 0.13
E8 3E DNA:1 P12 20.19 20.30 0.13
E9 3E DNA:1 P12 20.44 20.30 0.13
E10 4E DNA:1 P12 21.96 22.13 0.20
E11 4E DNA:1 P12 22.08 22.13 0.20
E12 4E DNA:1 P12 22.35 22.13 0.20
F1 1E DNA:1 rpoD2 16.60 16.24 0.31
F2 1E DNA:1 rpoD2 16.09 16.24 0.31
F3 1E DNA:1 rpoD2 16.03 16.24 0.31
F4 2E DNA:1 rpoD2 15.50 15.38 0.12
F5 2E DNA:1 rpoD2 15.26 15.38 0.12
F6 2E DNA:1 rpoD2 15.39 15.38 0.12
F7 3E DNA:1 rpoD2 15.05 14.92 0.22
F8 3E DNA:1 rpoD2 14.66 14.92 0.22
F9 3E DNA:1 rpoD2 15.04 14.92 0.22
F10 4E DNA:1 rpoD2 15.00 15.10 0.11
F11 4E DNA:1 rpoD2 15.11 15.10 0.11
F12 4E DNA:1 rpoD2 15.21 15.10 0.11
G1 1V DNA:1 P3 19.75 19.46 0.34
G2 1V DNA:1 P3 19.55 19.46 0.34
G3 1V DNA:1 P3 19.08 19.46 0.34
G4 2V DNA:1 P3 19.58 18.97 0.58
G5 2V DNA:1 P3 18.90 18.97 0.58
G6 2V DNA:1 P3 18.42 18.97 0.58
G7 3V DNA:1 P3 18.93 18.92 0.17
G8 3V DNA:1 P3 19.09 18.92 0.17
G9 3V DNA:1 P3 18.76 18.92 0.17
G10 4V DNA:1 P3 18.69 20.47 3.19
G11 4V DNA:1 P3 24.16 20.47 3.19
G12 4V DNA:1 P3 18.57 20.47 3.19
H1 1V DNA:1 P12 21.32 21.14 0.26
H2 1V DNA:1 P12 21.25 21.14 0.26
H3 1V DNA:1 P12 20.85 21.14 0.26
H4 2V DNA:1 P12 21.25 21.14 0.17
H5 2V DNA:1 P12 21.23 21.14 0.17
H6 2V DNA:1 P12 20.94 21.14 0.17
H7 3V DNA:1 P12 20.42 20.41 0.01
H8 3V DNA:1 P12 20.40 20.41 0.01
H9 3V DNA:1 P12 20.41 20.41 0.01
H10 4V DNA:1 P12 19.57 19.68 0.30
H11 4V DNA:1 P12 20.02 19.68 0.30
H12 4V DNA:1 P12 19.45 19.68 0.30
Analysis Parameters






Baseline range (from cycle no. ... to) n/a
Drift Correction OFF




Level (12) P3 copies P12 copies
rpoD2 
copies
1X 10 28.91 30.86 17.59 1 1 382 286 554111
2X 10 29.82 31.86 17.07 0.37113089 0.34868592 205 149 781452
3X 10 29.73 32.09 16.98 0.37113089 0.27932178 218 128 829361
4X 10 29.39 30.78 17.32 0.59460356 0.87660572 275 301 662401
1E 1 16.98 18.17 16.24 1 1 132558 111495 135275
2E 1 17.76 18.82 15.38 0.32085647 0.35111122 77794 73001 238860
3E 1 19.30 20.30 14.92 0.08021412 0.09150536 27162 27832 323759
4E 1 21.05 22.13 15.10 0.02701679 0.02915728 8216 8447 287435
1V 1 19.46 21.14 1 1 24349 16101
2V 1 18.97 21.14 1.39767085 1 34032 16101
3V 1 18.92 20.41 1.44624591 1.60903244 35215 25907
4V 1 18.63 19.68 1.76318592 2.58898538 42932 41685




Pos Name Ct SYBR Ct Mean SYBR Ct Dev. SYBR Expr. Level SYBR Range SYBR
A1 1A DNA:1 P3 23.52 23.60 0.08
A2 1A DNA:1 P3 23.69 23.60 0.08
A3 1A DNA:1 P3 23.60 23.60 0.08
A4 2A DNA:1 P3 23.64 24.87 2.54
A5 2A DNA:1 P3 27.79 24.87 2.54
A6 2A DNA:1 P3 23.17 24.87 2.54
A7 3A DNA:1 P3 23.54 23.15 0.35
A8 3A DNA:1 P3 22.86 23.15 0.35
A9 3A DNA:1 P3 23.05 23.15 0.35
A10 4A DNA:1 P3 23.05 22.94 0.35
A11 4A DNA:1 P3 23.22 22.94 0.35
A12 4A DNA:1 P3 22.56 22.94 0.35
B1 1A DNA:1 P12 25.41 24.80 0.61
B2 1A DNA:1 P12 24.79 24.80 0.61
B3 1A DNA:1 P12 24.19 24.80 0.61
B4 2A DNA:1 P12 24.29 24.80 0.44
B5 2A DNA:1 P12 25.05 24.80 0.44
B6 2A DNA:1 P12 25.06 24.80 0.44
B7 3A DNA:1 P12 25.14 24.78 0.45
B8 3A DNA:1 P12 24.93 24.78 0.45
B9 3A DNA:1 P12 24.28 24.78 0.45
B10 4A DNA:1 P12 24.50 24.08 0.96
B11 4A DNA:1 P12 22.97 24.08 0.96
B12 4A DNA:1 P12 24.75 24.08 0.96
C1 1A DNA:1 rpoD2 17.65 17.49 0.26
C2 1A DNA:1 rpoD2 17.63 17.49 0.26
C3 1A DNA:1 rpoD2 17.19 17.49 0.26
C4 2A DNA:1 rpoD2 17.35 17.37 0.06
C5 2A DNA:1 rpoD2 17.33 17.37 0.06
C6 2A DNA:1 rpoD2 17.43 17.37 0.06
C7 3A DNA:1 rpoD2 17.21 17.28 0.38
C8 3A DNA:1 rpoD2 16.94 17.28 0.38
C9 3A DNA:1 rpoD2 17.68 17.28 0.38
C10 4A DNA:1 rpoD2 17.15 17.05 0.19
C11 4A DNA:1 rpoD2 16.84 17.05 0.19
C12 4A DNA:1 rpoD2 17.17 17.05 0.19
D1 1B DNA:1 P3 20.35 19.51 0.75
D2 1B DNA:1 P3 19.29 19.51 0.75
D3 1B DNA:1 P3 18.91 19.51 0.75
D4 2B DNA:1 P3 21.00 21.20 0.18
D5 2B DNA:1 P3 21.34 21.20 0.18
D6 2B DNA:1 P3 21.27 21.20 0.18
D7 3B DNA:1 P3 21.87 21.89 0.06
D8 3B DNA:1 P3 21.84 21.89 0.06
D9 3B DNA:1 P3 21.95 21.89 0.06
D10 4B DNA:1 P3 22.29 22.57 0.31
D11 4B DNA:1 P3 22.51 22.57 0.31
D12 4B DNA:1 P3 22.90 22.57 0.31
E1 1B DNA:1 P12 21.69 20.76 0.87
E2 1B DNA:1 P12 19.96 20.76 0.87
E3 1B DNA:1 P12 20.63 20.76 0.87
E4 2B DNA:1 P12 22.21 21.95 0.23 0.385 0.324 - 0.457
E5 2B DNA:1 P12 21.83 21.95 0.23 0.385 0.324 - 0.457
E6 2B DNA:1 P12 21.80 21.95 0.23 0.385 0.324 - 0.457
E7 3B DNA:1 P12 22.57 22.62 0.15 0.206 0.184 - 0.230
E8 3B DNA:1 P12 22.49 22.62 0.15 0.206 0.184 - 0.230
E9 3B DNA:1 P12 22.79 22.62 0.15 0.206 0.184 - 0.230
E10 4B DNA:1 P12 23.88 23.67 0.19 9.820E-2X 6.46E-02 - 0.149
E11 4B DNA:1 P12 23.50 23.67 0.19 9.820E-2X 6.46E-02 - 0.149
E12 4B DNA:1 P12 23.64 23.67 0.19 9.820E-2X 6.46E-02 - 0.149
F1 1B DNA:1 rpoD2 16.66 16.43 0.20
F2 1B DNA:1 rpoD2 16.35 16.43 0.20
F3 1B DNA:1 rpoD2 16.28 16.43 0.20
F4 2B DNA:1 rpoD2 16.13 16.24 0.10
F5 2B DNA:1 rpoD2 16.29 16.24 0.10
F6 2B DNA:1 rpoD2 16.31 16.24 0.10
F7 3B DNA:1 rpoD2 16.05 16.01 0.04
F8 3B DNA:1 rpoD2 15.99 16.01 0.04
F9 3B DNA:1 rpoD2 15.98 16.01 0.04
F10 4B DNA:1 rpoD2 15.39 15.99 0.57
F11 4B DNA:1 rpoD2 16.07 15.99 0.57
F12 4B DNA:1 rpoD2 16.52 15.99 0.57
G1 1V DNA:1 P3 19.58 19.50 0.14
G2 1V DNA:1 P3 19.59 19.50 0.14
G3 1V DNA:1 P3 19.34 19.50 0.14
G4 1V DNA:10 P3 22.63 22.62 0.10
G5 1V DNA:10 P3 22.53 22.62 0.10
G6 1V DNA:10 P3 22.72 22.62 0.10
G7 1V DNA:100 P3 25.95 26.05 0.10
G8 1V DNA:100 P3 26.16 26.05 0.10
G9 1V DNA:100 P3 26.05 26.05 0.10
G10 1V DNA:1000 P3 28.93 30.95 3.20
G11 1V DNA:1000 P3 34.63 30.95 3.20
G12 1V DNA:1000 P3 29.27 30.95 3.20
H1 1V DNA:1 P12 21.01 20.96 0.11
H2 1V DNA:1 P12 21.04 20.96 0.11
H3 1V DNA:1 P12 20.84 20.96 0.11
H4 1V DNA:10 P12 24.35 24.20 0.19
H5 1V DNA:10 P12 24.25 24.20 0.19
H6 1V DNA:10 P12 23.99 24.20 0.19
H7 1V DNA:100 P12 27.33 27.47 0.13
H8 1V DNA:100 P12 27.58 27.47 0.13
H9 1V DNA:100 P12 27.49 27.47 0.13
H10 1V DNA:1000 P12 30.41 30.40 0.22
H11 1V DNA:1000 P12 30.61 30.40 0.22
H12 1V DNA:1000 P12 30.18 30.40 0.22
Analysis Parameters






Baseline range (from cycle no. ... to) n/a
Drift Correction OFF




Level (12) P3 copies P12 copies rpoD2 copies N/No CT (mg*min/L)
1A 1 23.60 24.80 17.49 1 1 1439 1483 59198 1 0
2A 1 23.41 24.80 17.37 1.05336104 0.92018765 1644 1483 64086 0.66101695 0.047143623
3A 1 23.15 24.78 17.28 1.18099266 0.87660572 1957 1503 68015 0.30169492 0.083581793
4A 1 22.94 24.08 17.05 1.16473359 1.21419488 2258 2371 79185 0.04364407 0.124981493
1B 1 19.51 20.76 16.43 1 1 23531 20624 119306
2B 1 21.20 21.95 16.24 0.27168372 0.3842188 7416 9498 135275
3B 1 21.89 22.62 16.01 0.14358729 0.20589775 4628 6138 157491
4B 1 22.57 23.67 15.99 0.08838835 0.09807301 2908 3097 159587
1V 1 19.50 20.96 23692 18104
1V 10 22.62 24.20 28104 21927
1V 100 26.05 27.47 26973 26042
1V 1000 29.10 30.40 33563 38600




Pos Name Ct SYBR Ct Mean SYBR Ct Dev. SYBR Expr. Level SYBR Range SYBR
A1 1C DNA:1 P3 18.49 18.71 0.21
A2 1C DNA:1 P3 18.90 18.71 0.21
A3 1C DNA:1 P3 18.73 18.71 0.21
A4 2C DNA:1 P3 19.00 19.51 0.45
A5 2C DNA:1 P3 19.84 19.51 0.45
A6 2C DNA:1 P3 19.70 19.51 0.45
A7 3C DNA:1 P3 20.58 20.56 0.24
A8 3C DNA:1 P3 20.80 20.56 0.24
A9 3C DNA:1 P3 20.32 20.56 0.24
A10 4C DNA:1 P3 22.22 22.89 1.04
A11 4C DNA:1 P3 22.37 22.89 1.04
A12 4C DNA:1 P3 24.09 22.89 1.04
B1 1C DNA:1 P12 20.35 19.58 0.68
B2 1C DNA:1 P12 19.06 19.58 0.68
B3 1C DNA:1 P12 19.34 19.58 0.68
B4 2C DNA:1 P12 21.27 20.43 0.76
B5 2C DNA:1 P12 20.19 20.43 0.76
B6 2C DNA:1 P12 19.82 20.43 0.76
B7 3C DNA:1 P12 21.92 21.63 0.25
B8 3C DNA:1 P12 21.48 21.63 0.25
B9 3C DNA:1 P12 21.49 21.63 0.25
B10 4C DNA:1 P12 23.38 23.44 0.05
B11 4C DNA:1 P12 23.46 23.44 0.05
B12 4C DNA:1 P12 23.47 23.44 0.05
C1 1C DNA:1 rpoD2 16.95 16.56 0.39
C2 1C DNA:1 rpoD2 16.56 16.56 0.39
C3 1C DNA:1 rpoD2 16.16 16.56 0.39
C4 2C DNA:1 rpoD2 16.29 16.07 0.29
C5 2C DNA:1 rpoD2 15.74 16.07 0.29
C6 2C DNA:1 rpoD2 16.17 16.07 0.29
C7 3C DNA:1 rpoD2 16.05 16.03 0.25
C8 3C DNA:1 rpoD2 16.27 16.03 0.25
C9 3C DNA:1 rpoD2 15.77 16.03 0.25
C10 4C DNA:1 rpoD2 15.91 15.92 0.11
C11 4C DNA:1 rpoD2 16.03 15.92 0.11
C12 4C DNA:1 rpoD2 15.81 15.92 0.11
D1 1D DNA:1 P3 17.80 17.29 0.51
D2 1D DNA:1 P3 16.78 17.29 0.51
D3 1D DNA:1 P3 17.29 17.29 0.51
D4 2D DNA:1 P3 18.34 18.28 0.16
D5 2D DNA:1 P3 18.40 18.28 0.16
D6 2D DNA:1 P3 18.10 18.28 0.16
D7 3D DNA:1 P3 19.49 19.63 0.17
D8 3D DNA:1 P3 19.58 19.63 0.17
D9 3D DNA:1 P3 19.82 19.63 0.17
D10 4D DNA:1 P3 21.54 22.13 1.04
D11 4D DNA:1 P3 21.53 22.13 1.04
D12 4D DNA:1 P3 23.33 22.13 1.04
E1 1D DNA:1 P12 21.03 19.06 1.72
E2 1D DNA:1 P12 18.26 19.06 1.72
E3 1D DNA:1 P12 17.89 19.06 1.72
E4 2D DNA:1 P12 19.34 18.90 0.39 1.12 0.725 - 1.72
E5 2D DNA:1 P12 18.79 18.90 0.39 1.12 0.725 - 1.72
E6 2D DNA:1 P12 18.59 18.90 0.39 1.12 0.725 - 1.72
E7 3D DNA:1 P12 20.39 20.21 0.32 0.361 0.244 - 0.535
E8 3D DNA:1 P12 19.83 20.21 0.32 0.361 0.244 - 0.535
E9 3D DNA:1 P12 20.40 20.21 0.32 0.361 0.244 - 0.535
E10 4D DNA:1 P12 22.27 22.30 0.03 9.360E-2X 7.84E-02 - 0.112
E11 4D DNA:1 P12 22.32 22.30 0.03 9.360E-2X 7.84E-02 - 0.112
E12 4D DNA:1 P12 22.33 22.30 0.03 9.360E-2X 7.84E-02 - 0.112
F1 1D DNA:1 rpoD2 15.46 15.93 0.54
F2 1D DNA:1 rpoD2 16.52 15.93 0.54
F3 1D DNA:1 rpoD2 15.82 15.93 0.54
F4 2D DNA:1 rpoD2 15.68 15.94 0.49
F5 2D DNA:1 rpoD2 15.63 15.94 0.49
F6 2D DNA:1 rpoD2 16.50 15.94 0.49
F7 3D DNA:1 rpoD2 16.15 15.61 0.47
F8 3D DNA:1 rpoD2 15.34 15.61 0.47
F9 3D DNA:1 rpoD2 15.34 15.61 0.47
F10 4D DNA:1 rpoD2 15.58 15.76 0.25
F11 4D DNA:1 rpoD2 16.05 15.76 0.25
F12 4D DNA:1 rpoD2 15.65 15.76 0.25
G1 1V DNA:1 P3 19.95 19.75 0.18
G2 1V DNA:1 P3 19.69 19.75 0.18
G3 1V DNA:1 P3 19.61 19.75 0.18
G4 1V DNA:10 P3 22.82 22.84 0.04
G5 1V DNA:10 P3 22.88 22.84 0.04
G6 1V DNA:10 P3 22.82 22.84 0.04
G7 1V DNA:100 P3 26.36 26.11 0.23
G8 1V DNA:100 P3 25.92 26.11 0.23
G9 1V DNA:100 P3 26.06 26.11 0.23
G10 1V DNA:1000 P3 29.20 31.62 3.97
G11 1V DNA:1000 P3 36.20 31.62 3.97
G12 1V DNA:1000 P3 29.45 31.62 3.97
H1 1V DNA:1 P12 21.19 21.07 0.18
H2 1V DNA:1 P12 21.15 21.07 0.18
H3 1V DNA:1 P12 20.87 21.07 0.18
H4 1V DNA:10 P12 24.56 24.34 0.26
H5 1V DNA:10 P12 24.39 24.34 0.26
H6 1V DNA:10 P12 24.05 24.34 0.26
H7 1V DNA:100 P12 27.60 27.64 0.07
H8 1V DNA:100 P12 27.71 27.64 0.07
H9 1V DNA:100 P12 27.61 27.64 0.07
H10 1V DNA:1000 P12 30.51 30.60 0.15
H11 1V DNA:1000 P12 30.77 30.60 0.15
H12 1V DNA:1000 P12 30.53 30.60 0.15
Analysis Parameters






Baseline range (from cycle no. ... to) n/a
Drift Correction OFF




Level (12) P3 copies P12 copies rpoD2 copies
1C 1 18.71 19.58 16.56 1 1 40648 44491 109480
2C 1 19.51 20.43 16.07 0.40895103 0.39502066 23531 25571 151366
3C 1 20.56 21.63 16.03 0.1921094 0.16724094 11483 11700 155422
4C 1 22.30 23.44 15.92 0.05347469 0.04419417 3509 3598 167146
1D 1 17.29 18.08 15.93 1 1 107255 118614 166045
2D 1 18.28 18.90 15.94 0.50697974 0.56840849 54530 69293 164951
3D 1 19.63 20.21 15.61 0.15821957 0.18237754 21679 29512 205166
4D 1 21.54 22.30 15.76 0.04687622 0.04753059 5898 7561 185796
1V 1 19.75 21.07 19972 16852
1V 10 22.84 24.34 24181 20015
1V 100 26.11 27.64 25890 23312
1V 1000 29.33 30.60 28780 33884




Pos Name Ct SYBR Ct Mean SYBR Ct Dev. SYBR Expr. Level SYBR Range SYBR
A1 1A cDNA:5 DF1 P3 34.23 34.37 0.53
A2 1A cDNA:5 DF1 P3 33.92 34.37 0.53
A3 1A cDNA:5 DF1 P3 34.95 34.37 0.53
A4 2A cDNA:5 DF1 P3 34.80 35.03 0.34
A5 2A cDNA:5 DF1 P3 35.27 35.03 0.34
A6 2A cDNA:5 DF1 P3
A7 3A cDNA:5 DF1 P3 36.53
A8 3A cDNA:5 DF1 P3
A9 3A cDNA:5 DF1 P3
A10 4A cDNA:5 DF1 P3
A11 4A cDNA:5 DF1 P3
A12 4A cDNA:5 DF1 P3
B1 1A cDNA:5 DF1 P12 30.03 29.66 0.40
B2 1A cDNA:5 DF1 P12 29.70 29.66 0.40
B3 1A cDNA:5 DF1 P12 29.24 29.66 0.40
B4 2A cDNA:5 DF1 P12 31.33 31.00 0.29
B5 2A cDNA:5 DF1 P12 30.86 31.00 0.29
B6 2A cDNA:5 DF1 P12 30.80 31.00 0.29
B7 3A cDNA:5 DF1 P12 32.51 32.78 0.24
B8 3A cDNA:5 DF1 P12 32.97 32.78 0.24
B9 3A cDNA:5 DF1 P12 32.85 32.78 0.24
B10 4A cDNA:5 DF1 P12 35.55 34.85 0.80
B11 4A cDNA:5 DF1 P12 33.97 34.85 0.80
B12 4A cDNA:5 DF1 P12 35.03 34.85 0.80
C1 1A cDNA:5 DF1 rpoD2 23.29 22.91 0.35
C2 1A cDNA:5 DF1 rpoD2 22.86 22.91 0.35
C3 1A cDNA:5 DF1 rpoD2 22.60 22.91 0.35
C4 2A cDNA:5 DF1 rpoD2 22.83 22.59 0.21
C5 2A cDNA:5 DF1 rpoD2 22.42 22.59 0.21
C6 2A cDNA:5 DF1 rpoD2 22.52 22.59 0.21
C7 3A cDNA:5 DF1 rpoD2 22.32 22.24 0.10
C8 3A cDNA:5 DF1 rpoD2 22.27 22.24 0.10
C9 3A cDNA:5 DF1 rpoD2 22.14 22.24 0.10
C10 4A cDNA:5 DF1 rpoD2 21.96 21.99 0.06
C11 4A cDNA:5 DF1 rpoD2 21.96 21.99 0.06
C12 4A cDNA:5 DF1 rpoD2 22.06 21.99 0.06
D1 1B cDNA:5 DF1 P3 28.18 27.71 0.40
D2 1B cDNA:5 DF1 P3 27.47 27.71 0.40
D3 1B cDNA:5 DF1 P3 27.48 27.71 0.40
D4 NoTemp cDNA:5 DF1 P3
D5 NoTemp cDNA:5 DF1 P3
D6 NoTemp cDNA:5 DF1 P3
D7 3B cDNA:5 DF1 P3 30.75 30.69 0.06
D8 3B cDNA:5 DF1 P3 30.65 30.69 0.06
D9 3B cDNA:5 DF1 P3 30.66 30.69 0.06
D10 4B cDNA:5 DF1 P3 36.97 34.59 2.07
D11 4B cDNA:5 DF1 P3 33.56 34.59 2.07
D12 4B cDNA:5 DF1 P3 33.24 34.59 2.07
E1 1B cDNA:5 DF1 P12 26.24 25.70 0.46
E2 1B cDNA:5 DF1 P12 25.41 25.70 0.46
E3 1B cDNA:5 DF1 P12 25.46 25.70 0.46
E4 NoTemp cDNA:5 DF1 P12
E5 NoTemp cDNA:5 DF1 P12
E6 NoTemp cDNA:5 DF1 P12
E7 3B cDNA:5 DF1 P12 29.01 29.27 0.25 8.050E-2X 6.62E-02 - 9.78E-02
E8 3B cDNA:5 DF1 P12 29.28 29.27 0.25 8.050E-2X 6.62E-02 - 9.78E-02
E9 3B cDNA:5 DF1 P12 29.51 29.27 0.25 8.050E-2X 6.62E-02 - 9.78E-02
E10 4B cDNA:5 DF1 P12 30.84 30.63 0.21 1.650E-2X 1.37E-02 - 1.98E-02
E11 4B cDNA:5 DF1 P12 30.61 30.63 0.21 1.650E-2X 1.37E-02 - 1.98E-02
E12 4B cDNA:5 DF1 P12 30.44 30.63 0.21 1.650E-2X 1.37E-02 - 1.98E-02
F1 1B cDNA:5 DF1 rpoD2 22.64 22.42 0.19
F2 1B cDNA:5 DF1 rpoD2 22.36 22.42 0.19
F3 1B cDNA:5 DF1 rpoD2 22.28 22.42 0.19
F4 NoTemp cDNA:5 DF1 rpoD2
F5 NoTemp cDNA:5 DF1 rpoD2
F6 NoTemp cDNA:5 DF1 rpoD2
F7 3B cDNA:5 DF1 rpoD2 22.42 22.35 0.13
F8 3B cDNA:5 DF1 rpoD2 22.21 22.35 0.13
F9 3B cDNA:5 DF1 rpoD2 22.43 22.35 0.13
F10 4B cDNA:5 DF1 rpoD2 21.29 21.43 0.17
F11 4B cDNA:5 DF1 rpoD2 21.62 21.43 0.17
F12 4B cDNA:5 DF1 rpoD2 21.37 21.43 0.17
G1 1D cDNA:5 DF1 P3 24.66 24.50 0.18
G2 1D cDNA:5 DF1 P3 24.54 24.50 0.18
G3 1D cDNA:5 DF1 P3 24.31 24.50 0.18
G4 1D cDNA:5 DF10 P3 27.44 27.36 0.08
G5 1D cDNA:5 DF10 P3 27.36 27.36 0.08
G6 1D cDNA:5 DF10 P3 27.27 27.36 0.08
G7 1D cDNA:5 DF100 P3 31.15 30.49 0.66
G8 1D cDNA:5 DF100 P3 30.49 30.49 0.66




H1 1D cDNA:5 DF1 P12 25.03 24.89 0.27
H2 1D cDNA:5 DF1 P12 25.07 24.89 0.27
H3 1D cDNA:5 DF1 P12 24.58 24.89 0.27
H4 1D cDNA:5 DF10 P12 28.19 27.99 0.33
H5 1D cDNA:5 DF10 P12 28.17 27.99 0.33
H6 1D cDNA:5 DF10 P12 27.61 27.99 0.33
H7 1D cDNA:5 DF100 P12 31.66 31.52 0.25
H8 1D cDNA:5 DF100 P12 31.67 31.52 0.25











Baseline range (from cycle no. ... to) n/a
Drift Correction OFF




Level (12) P3 copies P12 copies rpoD2 copies
1A 5 34.37 29.66 22.91 1 1 5 313 8224
2A 5 35.03 31.00 22.59 0.31643915 131 10161
3A 5 32.78 22.24 0.07229301 41 12807
4A 5 34.85 21.99 0.01447794 11 15108
1B 5 27.71 25.70 22.42 1 1 434 4126 11370
No template 5
3B 5 30.69 29.27 22.35 0.12074204 0.08021412 57 403 11908
4B 5 33.40 30.63 21.43 0.00975258 0.01651591 9 166 21878
1D 5 24.50 24.89 3889 6994
1D 50 27.36 27.99 5510 9279
1D 500 30.49 31.52 6492 9303
No template




Pos Name Ct SYBR Ct Mean SYBR Ct Dev. SYBR Amount SYBR Target SYBR
A1 1C cDNA:5 DF1 P3 26.37 26.42 0.18 -
A2 1C cDNA:5 DF1 P3 26.63 26.42 0.18 -
A3 1C cDNA:5 DF1 P3 26.27 26.42 0.18 -
A4 2C cDNA:5 DF1 P3 27.16 27.05 0.10 -
A5 2C cDNA:5 DF1 P3 27.01 27.05 0.10 -
A6 2C cDNA:5 DF1 P3 26.97 27.05 0.10 -
A7 3C cDNA:5 DF1 P3 28.09 28.12 0.04 -
A8 3C cDNA:5 DF1 P3 28.11 28.12 0.04 -
A9 3C cDNA:5 DF1 P3 28.17 28.12 0.04 -
A10 4C cDNA:5 DF1 P3 30.05 30.22 0.38 -
A11 4C cDNA:5 DF1 P3 29.95 30.22 0.38 -
A12 4C cDNA:5 DF1 P3 30.66 30.22 0.38 -
B1 1C cDNA:5 DF1 P12 27.17 26.89 0.28 -
B2 1C cDNA:5 DF1 P12 26.88 26.89 0.28 -
B3 1C cDNA:5 DF1 P12 26.60 26.89 0.28 -
B4 2C cDNA:5 DF1 P12 26.98 26.90 0.08 -
B5 2C cDNA:5 DF1 P12 26.83 26.90 0.08 -
B6 2C cDNA:5 DF1 P12 26.88 26.90 0.08 -
B7 3C cDNA:5 DF1 P12 28.12 27.98 0.14 -
B8 3C cDNA:5 DF1 P12 27.98 27.98 0.14 -
B9 3C cDNA:5 DF1 P12 27.85 27.98 0.14 -
B10 4C cDNA:5 DF1 P12 30.13 29.81 0.29 -
B11 4C cDNA:5 DF1 P12 29.55 29.81 0.29 -
B12 4C cDNA:5 DF1 P12 29.75 29.81 0.29 -
C1 1C cDNA:5 DF1 rpoD2 23.57 23.17 0.36 -
C2 1C cDNA:5 DF1 rpoD2 23.06 23.17 0.36 -
C3 1C cDNA:5 DF1 rpoD2 22.88 23.17 0.36 -
C4 2C cDNA:5 DF1 rpoD2 22.18 22.00 0.17 -
C5 2C cDNA:5 DF1 rpoD2 21.83 22.00 0.17 -
C6 2C cDNA:5 DF1 rpoD2 21.97 22.00 0.17 -
C7 3C cDNA:5 DF1 rpoD2 21.64 21.54 0.12 -
C8 3C cDNA:5 DF1 rpoD2 21.58 21.54 0.12 -
C9 3C cDNA:5 DF1 rpoD2 21.40 21.54 0.12 -
C10 4C cDNA:5 DF1 rpoD2 21.46 21.37 0.11 -
C11 4C cDNA:5 DF1 rpoD2 21.39 21.37 0.11 -
C12 4C cDNA:5 DF1 rpoD2 21.25 21.37 0.11 -
D1 1D cDNA:5 DF1 P3 25.02 24.63 0.34 -
D2 1D cDNA:5 DF1 P3 24.39 24.63 0.34 -
D3 1D cDNA:5 DF1 P3 24.48 24.63 0.34 -
D4 2D cDNA:5 DF1 P3 25.65 25.67 0.02 -
D5 2D cDNA:5 DF1 P3 25.69 25.67 0.02 -
D6 2D cDNA:5 DF1 P3 25.66 25.67 0.02 -
D7 3D cDNA:5 DF1 P3 27.20 27.21 0.27 -
D8 3D cDNA:5 DF1 P3 26.94 27.21 0.27 -
D9 3D cDNA:5 DF1 P3 27.48 27.21 0.27 -
D10 4D cDNA:5 DF1 P3 29.65 29.74 0.30 -
D11 4D cDNA:5 DF1 P3 29.48 29.74 0.30 -
D12 4D cDNA:5 DF1 P3 30.07 29.74 0.30 -
E1 1D cDNA:5 DF1 P12 24.99 24.61 0.33 -
E2 1D cDNA:5 DF1 P12 24.43 24.61 0.33 -
E3 1D cDNA:5 DF1 P12 24.41 24.61 0.33 -
E4 2D cDNA:5 DF1 P12 25.63 25.47 0.18 -
E5 2D cDNA:5 DF1 P12 25.28 25.47 0.18 -
E6 2D cDNA:5 DF1 P12 25.49 25.47 0.18 -
E7 3D cDNA:5 DF1 P12 26.94 27.00 0.07 -
E8 3D cDNA:5 DF1 P12 27.08 27.00 0.07 -
E9 3D cDNA:5 DF1 P12 26.98 27.00 0.07 -
E10 4D cDNA:5 DF1 P12 28.89 29.06 0.22 -
E11 4D cDNA:5 DF1 P12 28.98 29.06 0.22 -
E12 4D cDNA:5 DF1 P12 29.30 29.06 0.22 -
F1 1D cDNA:5 DF1 rpoD2 22.19 21.84 0.30 -
F2 1D cDNA:5 DF1 rpoD2 21.68 21.84 0.30 -
F3 1D cDNA:5 DF1 rpoD2 21.65 21.84 0.30 -
F4 2D cDNA:5 DF1 rpoD2 21.48 21.54 0.06 -
F5 2D cDNA:5 DF1 rpoD2 21.60 21.54 0.06 -
F6 2D cDNA:5 DF1 rpoD2 21.55 21.54 0.06 -
F7 3D cDNA:5 DF1 rpoD2 22.50 21.96 0.47 -
F8 3D cDNA:5 DF1 rpoD2 21.68 21.96 0.47 -
F9 3D cDNA:5 DF1 rpoD2 21.70 21.96 0.47 -
F10 4D cDNA:5 DF1 rpoD2 21.74 21.76 0.02 -
F11 4D cDNA:5 DF1 rpoD2 21.77 21.76 0.02 -
F12 4D cDNA:5 DF1 rpoD2 21.76 21.76 0.02 -
G1 1D cDNA:5 DF10 P3 28.14 27.75 0.34 -
G2 1D cDNA:5 DF10 P3 27.59 27.75 0.34 -
G3 1D cDNA:5 DF10 P3 27.51 27.75 0.34 -
G4 1D cDNA:5 DF100 P3 30.76 30.90 0.17 -
G5 1D cDNA:5 DF100 P3 31.09 30.90 0.17 -
G6 1D cDNA:5 DF100 P3 30.84 30.90 0.17 -
G7 1C-RT cDNA:5 DF1 P3 33.90 34.18 0.29 -
G8 1C-RT cDNA:5 DF1 P3 34.48 34.18 0.29 -
G9 1C-RT cDNA:5 DF1 P3 34.14 34.18 0.29 -
G10 1D-RT cDNA:5 DF1 P3 -
G11 1D-RT cDNA:5 DF1 P3 -
G12 1D-RT cDNA:5 DF1 P3 -
H1 1D cDNA:5 DF10 P12 28.32 28.17 0.18 -
H2 1D cDNA:5 DF10 P12 28.23 28.17 0.18 -
H3 1D cDNA:5 DF10 P12 27.97 28.17 0.18 -
H4 1D cDNA:5 DF100 P12 31.26 31.50 0.49 -
H5 1D cDNA:5 DF100 P12 32.07 31.50 0.49 -
H6 1D cDNA:5 DF100 P12 31.19 31.50 0.49 -
H7 1C-RT cDNA:5 DF1 P12 36.23 -
H8 1C-RT cDNA:5 DF1 P12 -
H9 1C-RT cDNA:5 DF1 P12 -
H10 1D-RT cDNA:5 DF1 P12 -
H11 1D-RT cDNA:5 DF1 P12 -
H12 1D-RT cDNA:5 DF1 P12 -
Analysis Parameters






Baseline range (from cycle no. ... to) n/a
Drift Correction OFF




Level (12) P3 copies P12 copies rpoD2 copies
1C 5 26.42 26.89 23.17 1 1 1047 1900 6925
2C 5 27.05 26.90 22.00 0.28717459 0.4413515 681 1888 15009
3C 5 28.12 27.98 21.54 0.09944206 0.15177436 328 934 20343
4C 5 30.22 29.81 21.37 0.02061731 0.03794359 78 283 22763
1D 5 24.63 24.61 21.84 1 1 3559 8393 16683
2D 5 25.67 25.47 21.54 0.39502066 0.44751254 1749 4793 20343
3D 5 27.21 27.00 21.96 0.18174656 0.20732989 610 1769 15411
4D 5 29.74 29.06 21.76 0.02739393 0.04328467 108 462 17590
1D 50 27.75 28.17 4221 8252
1D 500 30.90 31.50 4906 9425
1C-RT 5 34.18 5
1D-RT 5




Pos Name Ct SYBR Ct Mean SYBR Ct Dev. SYBR Expr. Level SYBR Range SYBR
A1 1B cDNA:5 FC2 P3 28.45 28.38 0.07
A2 1B cDNA:5 FC2 P3 28.30 28.38 0.07
A3 1B cDNA:5 FC2 P3 28.40 28.38 0.07
A4 2B cDNA:5 FC2 P3 29.27 29.10 0.15
A5 2B cDNA:5 FC2 P3 29.06 29.10 0.15
A6 2B cDNA:5 FC2 P3 28.98 29.10 0.15
A7 3B cDNA:5 FC2 P3 31.66 31.83 0.44
A8 3B cDNA:5 FC2 P3 31.49 31.83 0.44
A9 3B cDNA:5 FC2 P3 32.33 31.83 0.44
A10 4B cDNA:5 FC2 P3 34.05 33.88 0.81
A11 4B cDNA:5 FC2 P3 34.59 33.88 0.81
A12 4B cDNA:5 FC2 P3 33.01 33.88 0.81
B1 1B cDNA:5 FC2 P12 26.94 26.59 0.41
B2 1B cDNA:5 FC2 P12 26.68 26.59 0.41
B3 1B cDNA:5 FC2 P12 26.13 26.59 0.41
B4 2B cDNA:5 FC2 P12 27.83 27.81 0.04 0.219 0.193 - 0.249
B5 2B cDNA:5 FC2 P12 27.84 27.81 0.04 0.219 0.193 - 0.249
B6 2B cDNA:5 FC2 P12 27.77 27.81 0.04 0.219 0.193 - 0.249
B7 3B cDNA:5 FC2 P12 29.68 29.99 0.27 8.800E-2X 7.22E-02 - 0.107
B8 3B cDNA:5 FC2 P12 30.09 29.99 0.27 8.800E-2X 7.22E-02 - 0.107
B9 3B cDNA:5 FC2 P12 30.19 29.99 0.27 8.800E-2X 7.22E-02 - 0.107
B10 4B cDNA:5 FC2 P12 31.40 31.10 0.27 2.430E-2X 2.01E-02 - 2.93E-02
B11 4B cDNA:5 FC2 P12 30.99 31.10 0.27 2.430E-2X 2.01E-02 - 2.93E-02
B12 4B cDNA:5 FC2 P12 30.90 31.10 0.27 2.430E-2X 2.01E-02 - 2.93E-02
C1 1B cDNA:5 FC2 rpoD 23.56 23.13 0.39
C2 1B cDNA:5 FC2 rpoD 23.02 23.13 0.39
C3 1B cDNA:5 FC2 rpoD 22.82 23.13 0.39
C4 2B cDNA:5 FC2 rpoD 22.38 22.17 0.18
C5 2B cDNA:5 FC2 rpoD 22.04 22.17 0.18
C6 2B cDNA:5 FC2 rpoD 22.10 22.17 0.18
C7 3B cDNA:5 FC2 rpoD 23.08 23.03 0.09
C8 3B cDNA:5 FC2 rpoD 23.08 23.03 0.09
C9 3B cDNA:5 FC2 rpoD 22.92 23.03 0.09
C10 4B cDNA:5 FC2 rpoD 22.28 22.28 0.03
C11 4B cDNA:5 FC2 rpoD 22.31 22.28 0.03
C12 4B cDNA:5 FC2 rpoD 22.25 22.28 0.03
D1 1D cDNA:5 DF1 FC2 P3 24.87 24.43 0.39
D2 1D cDNA:5 DF1 FC2 P3 24.32 24.43 0.39
D3 1D cDNA:5 DF1 FC2 P3 24.11 24.43 0.39
D4 1D cDNA:5 DF10 FC2 P3 27.26 27.12 0.20
D5 1D cDNA:5 DF10 FC2 P3 27.20 27.12 0.20
D6 1D cDNA:5 DF10 FC2 P3 26.90 27.12 0.20
D7 1D cDNA:5 DF100 FC2 P3 31.42 31.38 0.11
D8 1D cDNA:5 DF100 FC2 P3 31.25 31.38 0.11
D9 1D cDNA:5 DF100 FC2 P3 31.46 31.38 0.11
D10 No Template P3
D11 No Template P3
D12 No Template P3
E1 1D cDNA:5 DF1 FC2 P12 24.82 24.41 0.37
E2 1D cDNA:5 DF1 FC2 P12 24.12 24.41 0.37
E3 1D cDNA:5 DF1 FC2 P12 24.30 24.41 0.37
E4 1D cDNA:5 DF10 FC2 P12 28.25 27.36 0.77
E5 1D cDNA:5 DF10 FC2 P12 26.92 27.36 0.77
E6 1D cDNA:5 DF10 FC2 P12 26.90 27.36 0.77
E7 1D cDNA:5 DF100 FC2 P12 31.42 31.58 0.16
E8 1D cDNA:5 DF100 FC2 P12 31.74 31.58 0.16
E9 1D cDNA:5 DF100 FC2 P12 31.56 31.58 0.16
E10 No Template P12
E11 No Template P12
E12 No Template P12
F1 Calib STD P3 DF10^7 22.16 22.29 0.13
F2 Calib STD P3 DF10^7 22.32 22.29 0.13
F3 Calib STD P3 DF10^7 22.40 22.29 0.13
F4 Calib STD P3 DF10^8 25.91 25.57 0.31
F5 Calib STD P3 DF10^8 25.49 25.57 0.31
F6 Calib STD P3 DF10^8 25.31 25.57 0.31
F7 Calib STD P3 DF10^9 28.98 28.93 0.05
F8 Calib STD P3 DF10^9 28.88 28.93 0.05
F9 Calib STD P3 DF10^9 28.92 28.93 0.05
F10 Calib STD P3 DF10^10 32.08 31.95 0.43
F11 Calib STD P3 DF10^10 31.47 31.95 0.43
F12 Calib STD P3 DF10^10 32.29 31.95 0.43
G1 Calib STD P12 DF10^7 23.96 23.71 0.22
G2 Calib STD P12 DF10^7 23.57 23.71 0.22
G3 Calib STD P12 DF10^7 23.60 23.71 0.22
G4 Calib STD P12 DF10^8 26.36 26.28 0.08
G5 Calib STD P12 DF10^8 26.19 26.28 0.08
G6 Calib STD P12 DF10^8 26.29 26.28 0.08
G7 Calib STD P12 DF10^9 30.19 29.95 0.22
G8 Calib STD P12 DF10^9 29.88 29.95 0.22
G9 Calib STD P12 DF10^9 29.77 29.95 0.22
G10 Calib STD P12 DF10^10 34.19 33.34 1.21
G11 Calib STD P12 DF10^10
G12 Calib STD P12 DF10^10 32.49 33.34 1.21
H1 Calib STD rpoD DF10^7 22.97 22.73 0.28
H2 Calib STD rpoD DF10^7 22.80 22.73 0.28
H3 Calib STD rpoD DF10^7 22.42 22.73 0.28
H4 Calib STD rpoD DF10^8 26.35 26.41 0.09
H5 Calib STD rpoD DF10^8 26.37 26.41 0.09
H6 Calib STD rpoD DF10^8 26.51 26.41 0.09
H7 Calib STD rpoD DF10^9 31.83 30.55 1.14
H8 Calib STD rpoD DF10^9 29.64 30.55 1.14
H9 Calib STD rpoD DF10^9 30.19 30.55 1.14
H10 Calib STD rpoD DF10^10 32.83 33.52 1.06
H11 Calib STD rpoD DF10^10 34.73 33.52 1.06
H12 Calib STD rpoD DF10^10 32.99 33.52 1.06
Analysis Parameters






Baseline range (from cycle no. ... to) n/a
Drift Correction OFF




Level (12) P3 copies P12 copies
rpoD2 
copies
1B 5 28.38 26.59 23.13 1 1 274 2310 7110
2B 5 29.10 27.81 22.17 0.31208264 0.22067575 168 1043 13413
3B 5 31.83 29.99 23.03 0.08537752 0.08838835 26 252 7596
4B 5 33.88 31.10 22.28 0.01225913 0.02434889 6 122 12472
1D 5 24.43 24.41 4080 9561
1D 50 27.12 27.36 6492 13989
1D 500 31.38 31.58 3534 8947
No temp `




Pos Name Ct SYBR Ct Mean SYBR Ct Dev. SYBR Expr. Level SYBR Range SYBR
A1 1X DNA:10 P3 30.04 30.14 0.09
A2 1X DNA:10 P3 30.14 30.14 0.09
A3 1X DNA:10 P3 30.22 30.14 0.09
A4 2X DNA:10 P3 29.96 29.89 0.19
A5 2X DNA:10 P3 29.68 29.89 0.19
A6 2X DNA:10 P3 30.04 29.89 0.19
A7 3X DNA:10 P3 30.67 30.53 0.14
A8 3X DNA:10 P3 30.38 30.53 0.14
A9 3X DNA:10 P3 30.52 30.53 0.14
A10 4X DNA:10 P3 30.89 30.53 0.33
A11 4X DNA:10 P3 30.45 30.53 0.33
A12 4X DNA:10 P3 30.25 30.53 0.33
B1 1X DNA:10 P12 31.94 31.60 0.30
B2 1X DNA:10 P12 31.51 31.60 0.30
B3 1X DNA:10 P12 31.35 31.60 0.30
B4 2X DNA:10 P12 32.12 31.73 0.39 0.449 0.329 - 0.612
B5 2X DNA:10 P12 31.72 31.73 0.39 0.449 0.329 - 0.612
B6 2X DNA:10 P12 31.35 31.73 0.39 0.449 0.329 - 0.612
B7 3X DNA:10 P12 32.36 32.04 0.29 0.382 0.305 - 0.480
B8 3X DNA:10 P12 31.79 32.04 0.29 0.382 0.305 - 0.480
B9 3X DNA:10 P12 31.98 32.04 0.29 0.382 0.305 - 0.480
B10 4X DNA:10 P12 31.92 31.53 0.38 0.615 0.470 - 0.805
B11 4X DNA:10 P12 31.52 31.53 0.38 0.615 0.470 - 0.805
B12 4X DNA:10 P12 31.15 31.53 0.38 0.615 0.470 - 0.805
C1 1X DNA:10 rpoD2 18.33 17.89 0.40
C2 1X DNA:10 rpoD2 17.78 17.89 0.40
C3 1X DNA:10 rpoD2 17.56 17.89 0.40
C4 2X DNA:10 rpoD2 17.11 16.86 0.22
C5 2X DNA:10 rpoD2 16.80 16.86 0.22
C6 2X DNA:10 rpoD2 16.67 16.86 0.22
C7 3X DNA:10 rpoD2 17.11 16.94 0.15
C8 3X DNA:10 rpoD2 16.82 16.94 0.15
C9 3X DNA:10 rpoD2 16.90 16.94 0.15
C10 4X DNA:10 rpoD2 17.05 17.12 0.05
C11 4X DNA:10 rpoD2 17.15 17.12 0.05
C12 4X DNA:10 rpoD2 17.15 17.12 0.05
D1 1V DNA:1 P3 19.77 19.46 0.34
D2 1V DNA:1 P3 19.53 19.46 0.34
D3 1V DNA:1 P3 19.09 19.46 0.34
D4 2V DNA:1 P3 19.66 19.57 0.12
D5 2V DNA:1 P3 19.49 19.57 0.12
D6 2V DNA:1 P3
D7 3V DNA:1 P3 19.37 19.13 0.23
D8 3V DNA:1 P3 19.13 19.13 0.23
D9 3V DNA:1 P3 18.90 19.13 0.23
D10 4V DNA:1 P3 19.47 19.13 0.30
D11 4V DNA:1 P3 18.99 19.13 0.30
D12 4V DNA:1 P3 18.92 19.13 0.30
E1 1V DNA:1 P12 21.05 20.59 0.39
E2 1V DNA:1 P12 20.34 20.59 0.39
E3 1V DNA:1 P12 20.40 20.59 0.39
E4 2V DNA:1 P12 20.67 20.35 0.34
E5 2V DNA:1 P12 20.39 20.35 0.34
E6 2V DNA:1 P12 20.00 20.35 0.34
E7 3V DNA:1 P12 19.00 19.86 0.76
E8 3V DNA:1 P12 20.42 19.86 0.76
E9 3V DNA:1 P12 20.16 19.86 0.76
E10 4V DNA:1 P12 19.63 20.03 0.37
E11 4V DNA:1 P12 20.13 20.03 0.37
E12 4V DNA:1 P12 20.34 20.03 0.37
F1 1V DNA:1 rpoD2 28.12 27.80 0.28
F2 1V DNA:1 rpoD2 27.68 27.80 0.28
F3 1V DNA:1 rpoD2 27.60 27.80 0.28
F4 2V DNA:1 rpoD2 27.53 27.29 0.35
F5 2V DNA:1 rpoD2 26.89 27.29 0.35
F6 2V DNA:1 rpoD2 27.44 27.29 0.35
F7 3V DNA:1 rpoD2 26.66 27.02 0.31
F8 3V DNA:1 rpoD2 27.23 27.02 0.31
F9 3V DNA:1 rpoD2 27.15 27.02 0.31
F10 4V DNA:1 rpoD2 26.84 27.13 0.36
F11 4V DNA:1 rpoD2 27.02 27.13 0.36
F12 4V DNA:1 rpoD2 27.54 27.13 0.36
G1 1V DNA:10 P3 23.92 23.63 0.26
G2 1V DNA:10 P3 23.57 23.63 0.26
G3 1V DNA:10 P3 23.41 23.63 0.26
G4 1V DNA:100 P3 26.81 26.57 0.21
G5 1V DNA:100 P3 26.51 26.57 0.21
G6 1V DNA:100 P3 26.40 26.57 0.21
G7 1V DNA:1000 P3 30.00 30.04 0.15
G8 1V DNA:1000 P3 30.20 30.04 0.15
G9 1V DNA:1000 P3 29.91 30.04 0.15
G10 No temp P3
G11 No temp P3
G12 No temp P3
H1 1V DNA:10 P12 24.88 24.87 0.20
H2 1V DNA:10 P12 25.06 24.87 0.20
H3 1V DNA:10 P12 24.66 24.87 0.20
H4 1V DNA:100 P12 28.24 28.09 0.22
H5 1V DNA:100 P12 28.19 28.09 0.22
H6 1V DNA:100 P12 27.84 28.09 0.22
H7 1V DNA:1000 P12 31.70 31.57 0.30
H8 1V DNA:1000 P12 31.79 31.57 0.30
H9 1V DNA:1000 P12 31.23 31.57 0.30
H10 No temp P12
H11 No temp P12
H12 No temp P12
Analysis Parameters






Baseline range (from cycle no. ... to) n/a
Drift Correction OFF




Level (12) P3 copies P12 copies rpoD2 copies
1X 10 30.14 31.60 17.89 1 1 165 177 454422
2X 10 29.89 31.73 16.86 0.58236679 0.44751254 196 162 897839
3X 10 30.53 32.04 16.94 0.39502066 0.3815648 126 133 851586
4X 10 30.53 31.53 17.12 0.44751254 0.61557221 126 185 756042
1V 1 19.46 20.59 27.80 1 1 24349 23040 65
2V 1 19.57 20.35 27.29 0.65067093 0.82931955 22586 26940 91
3V 1 19.13 19.86 27.02 0.73204285 0.96593633 30507 37072 109
4V 1 19.13 20.03 27.13 0.79004131 0.92658806 30507 33185 101
1V 10 23.63 24.87 14095 14171
1V 100 26.57 28.09 18907 17388
1V 1000 30.04 31.57 17657 18010
No template 1




Pos Name Ct SYBR Ct Mean SYBR Ct Dev. SYBR Expr. Level SYBR Range SYBR
A1 1A DNA:1 P3 23.53 23.45 0.16
A2 1A DNA:1 P3 23.56 23.45 0.16
A3 1A DNA:1 P3 23.26 23.45 0.16
A4 2A DNA:1 P3 22.94 22.84 0.11
A5 2A DNA:1 P3 22.85 22.84 0.11
A6 2A DNA:1 P3 22.73 22.84 0.11
A7 3A DNA:1 P3 23.02 22.98 0.03
A8 3A DNA:1 P3 22.97 22.98 0.03
A9 3A DNA:1 P3 22.95 22.98 0.03
A10 4A DNA:1 P3 22.97 22.84 0.11
A11 4A DNA:1 P3 22.81 22.84 0.11
A12 4A DNA:1 P3 22.76 22.84 0.11
B1 1A DNA:1 P12 25.05 24.98 0.25
B2 1A DNA:1 P12 25.18 24.98 0.25
B3 1A DNA:1 P12 24.70 24.98 0.25
B4 2A DNA:1 P12 24.19 24.46 0.76
B5 2A DNA:1 P12 23.87 24.46 0.76
B6 2A DNA:1 P12 25.32 24.46 0.76
B7 3A DNA:1 P12 24.47 24.52 0.06
B8 3A DNA:1 P12 24.58 24.52 0.06
B9 3A DNA:1 P12 24.49 24.52 0.06
B10 4A DNA:1 P12 24.15 24.13 0.01
B11 4A DNA:1 P12 24.13 24.13 0.01
B12 4A DNA:1 P12 24.13 24.13 0.01
C1 1A DNA:1 rpoD2 18.03 17.49 0.52
C2 1A DNA:1 rpoD2 17.45 17.49 0.52
C3 1A DNA:1 rpoD2 16.99 17.49 0.52
C4 2A DNA:1 rpoD2 17.66 17.60 0.06
C5 2A DNA:1 rpoD2 17.55 17.60 0.06
C6 2A DNA:1 rpoD2 17.58 17.60 0.06
C7 3A DNA:1 rpoD2 17.16 16.86 0.59
C8 3A DNA:1 rpoD2 17.23 16.86 0.59
C9 3A DNA:1 rpoD2 16.18 16.86 0.59
C10 4A DNA:1 rpoD2 17.02 17.06 0.09
C11 4A DNA:1 rpoD2 17.01 17.06 0.09
C12 4A DNA:1 rpoD2 17.16 17.06 0.09
D1 1B DNA:1 P3 19.88 19.29 0.56
D2 1B DNA:1 P3 18.77 19.29 0.56
D3 1B DNA:1 P3 19.21 19.29 0.56
D4 2B DNA:1 P3 21.81 21.66 0.26
D5 2B DNA:1 P3 21.81 21.66 0.26
D6 2B DNA:1 P3 21.37 21.66 0.26
D7 3B DNA:1 P3 23.23 22.92 0.29
D8 3B DNA:1 P3 22.88 22.92 0.29
D9 3B DNA:1 P3 22.66 22.92 0.29
D10 4B DNA:1 P3 23.10 23.13 0.26
D11 4B DNA:1 P3 22.88 23.13 0.26
D12 4B DNA:1 P3 23.39 23.13 0.26
E1 1B DNA:1 P12 20.92 20.29 0.54
E2 1B DNA:1 P12 19.97 20.29 0.54
E3 1B DNA:1 P12 19.98 20.29 0.54
E4 2B DNA:1 P12 22.57 22.25 0.33 0.182 0.144 - 0.232
E5 2B DNA:1 P12 21.91 22.25 0.33 0.182 0.144 - 0.232
E6 2B DNA:1 P12 22.27 22.25 0.33 0.182 0.144 - 0.232
E7 3B DNA:1 P12 24.13 24.00 0.18 5.190E-2X 4.39E-02 - 6.13E-02
E8 3B DNA:1 P12 24.07 24.00 0.18 5.190E-2X 4.39E-02 - 6.13E-02
E9 3B DNA:1 P12 23.79 24.00 0.18 5.190E-2X 4.39E-02 - 6.13E-02
E10 4B DNA:1 P12 23.93 24.09 0.24 2.530E-2X 1.51E-02 - 4.26E-02
E11 4B DNA:1 P12 23.98 24.09 0.24 2.530E-2X 1.51E-02 - 4.26E-02
E12 4B DNA:1 P12 24.36 24.09 0.24 2.530E-2X 1.51E-02 - 4.26E-02
F1 1B DNA:1 rpoD2 16.81 16.88 0.07
F2 1B DNA:1 rpoD2 16.94 16.88 0.07
F3 1B DNA:1 rpoD2 16.90 16.88 0.07
F4 2B DNA:1 rpoD2 16.33 16.38 0.10
F5 2B DNA:1 rpoD2 16.32 16.38 0.10
F6 2B DNA:1 rpoD2 16.50 16.38 0.10
F7 3B DNA:1 rpoD2 16.29 16.32 0.16
F8 3B DNA:1 rpoD2 16.18 16.32 0.16
F9 3B DNA:1 rpoD2 16.49 16.32 0.16
F10 4B DNA:1 rpoD2 15.13 15.38 0.71
F11 4B DNA:1 rpoD2 14.83 15.38 0.71
F12 4B DNA:1 rpoD2 16.18 15.38 0.71
G1 1V DNA:1 P3 19.99 19.47 0.45
G2 1V DNA:1 P3 19.16 19.47 0.45
G3 1V DNA:1 P3 19.27 19.47 0.45
G4 1V DNA:10 P3 23.37 23.28 0.09
G5 1V DNA:10 P3 23.20 23.28 0.09
G6 1V DNA:10 P3 23.25 23.28 0.09
G7 1V DNA:100 P3 26.62 26.55 0.17
G8 1V DNA:100 P3 26.68 26.55 0.17
G9 1V DNA:100 P3 26.36 26.55 0.17
G10 1V DNA:1000 P3 30.28 32.05 3.33
G11 1V DNA:1000 P3 35.90 32.05 3.33
G12 1V DNA:1000 P3 29.99 32.05 3.33
H1 1V DNA:1 P12 21.16 20.83 0.32
H2 1V DNA:1 P12 20.80 20.83 0.32
H3 1V DNA:1 P12 20.53 20.83 0.32
H4 1V DNA:10 P12 24.92 24.70 0.23
H5 1V DNA:10 P12 24.72 24.70 0.23
H6 1V DNA:10 P12 24.46 24.70 0.23
H7 1V DNA:100 P12 28.04 28.05 0.09
H8 1V DNA:100 P12 28.15 28.05 0.09
H9 1V DNA:100 P12 27.96 28.05 0.09
H10 1V DNA:1000 P12 31.56 31.19 0.33
H11 1V DNA:1000 P12 30.93 31.19 0.33
H12 1V DNA:1000 P12 31.09 31.19 0.33
Analysis Parameters






Baseline range (from cycle no. ... to) n/a
Drift Correction OFF




Level (12) P3 copies P12 copies rpoD2 copies
1A 1 23.45 24.98 17.49 1 1 1594 1319 59198
2A 1 22.84 24.46 17.60 1.64718203 1.54756499 2418 1851 55046
3A 1 22.98 24.52 16.86 0.89502507 0.88884268 2198 1780 89784
4A 1 22.84 24.13 17.06 1.13288389 1.33792755 2418 2295 78664
1B 1 19.29 20.29 16.88 1 1 27348 28014 88605
2B 1 21.66 22.25 16.38 0.13678671 0.18174656 5416 7812 123316
3B 1 22.92 24.00 16.32 0.05478786 0.05183247 2290 2498 128306
4B 1 23.13 24.09 15.38 0.02468879 0.02538289 1983 2356 238860
1V 1 19.47 20.83 24183 19705
1V 10 23.28 24.70 17903 15830
1V 100 26.55 28.05 19167 17847
1V 1000 30.14 31.19 16547 23070




Pos Name Ct SYBR Ct Mean SYBR Ct Dev. SYBR Expr. Level SYBR Range SYBR
A1 1C DNA:1 P3 18.12 18.25 0.14
A2 1C DNA:1 P3 18.24 18.25 0.14
A3 1C DNA:1 P3 18.39 18.25 0.14
A4 2C DNA:1 P3 20.72 20.32 0.35
A5 2C DNA:1 P3 20.06 20.32 0.35
A6 2C DNA:1 P3 20.20 20.32 0.35
A7 3C DNA:1 P3 23.26 23.11 0.19
A8 3C DNA:1 P3 23.17 23.11 0.19
A9 3C DNA:1 P3 22.90 23.11 0.19
A10 4C DNA:1 P3 23.62 23.39 0.20
A11 4C DNA:1 P3 23.27 23.39 0.20
A12 4C DNA:1 P3 23.26 23.39 0.20
B1 1C DNA:1 P12 19.48 19.16 0.31
B2 1C DNA:1 P12 18.88 19.16 0.31
B3 1C DNA:1 P12 19.10 19.16 0.31
B4 2C DNA:1 P12 21.71 21.35 0.39
B5 2C DNA:1 P12 20.94 21.35 0.39
B6 2C DNA:1 P12 21.40 21.35 0.39
B7 3C DNA:1 P12 24.11 24.44 0.31
B8 3C DNA:1 P12 24.72 24.44 0.31
B9 3C DNA:1 P12 24.49 24.44 0.31
B10 4C DNA:1 P12 24.97 24.81 0.16
B11 4C DNA:1 P12 24.65 24.81 0.16
B12 4C DNA:1 P12 24.81 24.81 0.16
C1 1C DNA:1 rpoD2 16.96 16.63 0.30
C2 1C DNA:1 rpoD2 16.53 16.63 0.30
C3 1C DNA:1 rpoD2 16.40 16.63 0.30
C4 2C DNA:1 rpoD2 16.23 16.16 0.15
C5 2C DNA:1 rpoD2 15.98 16.16 0.15
C6 2C DNA:1 rpoD2 16.25 16.16 0.15
C7 3C DNA:1 rpoD2 16.27 15.83 0.38
C8 3C DNA:1 rpoD2 15.66 15.83 0.38
C9 3C DNA:1 rpoD2 15.58 15.83 0.38
C10 4C DNA:1 rpoD2 15.88 15.59 0.28
C11 4C DNA:1 rpoD2 15.32 15.59 0.28
C12 4C DNA:1 rpoD2 15.56 15.59 0.28
D1 1D DNA:1 P3 17.31 17.06 0.23
D2 1D DNA:1 P3 16.99 17.06 0.23
D3 1D DNA:1 P3 16.88 17.06 0.23
D4 2D DNA:1 P3 18.78 18.43 0.71
D5 2D DNA:1 P3 17.61 18.43 0.71
D6 2D DNA:1 P3 18.89 18.43 0.71
D7 3D DNA:1 P3 22.35 22.28 0.49
D8 3D DNA:1 P3 21.77 22.28 0.49
D9 3D DNA:1 P3 22.73 22.28 0.49
D10 4D DNA:1 P3 24.09 23.75 0.36
D11 4D DNA:1 P3 23.38 23.75 0.36
D12 4D DNA:1 P3 23.79 23.75 0.36
E1 1D DNA:1 P12 18.46 18.02 0.48
E2 1D DNA:1 P12 17.50 18.02 0.48
E3 1D DNA:1 P12 18.10 18.02 0.48
E4 2D DNA:1 P12 19.66 19.71 0.62 0.189 9.98E-02 - 0.359
E5 2D DNA:1 P12 19.12 19.71 0.62 0.189 9.98E-02 - 0.359
E6 2D DNA:1 P12 20.36 19.71 0.62 0.189 9.98E-02 - 0.359
E7 3D DNA:1 P12 22.38 23.18 0.71 2.020E-2X 8.67E-03 - 4.71E-02
E8 3D DNA:1 P12 23.47 23.18 0.71 2.020E-2X 8.67E-03 - 4.71E-02
E9 3D DNA:1 P12 23.71 23.18 0.71 2.020E-2X 8.67E-03 - 4.71E-02
E10 4D DNA:1 P12 24.02 24.33 0.30 1.460E-2X 1.13E-02 - 1.87E-02
E11 4D DNA:1 P12 24.37 24.33 0.30 1.460E-2X 1.13E-02 - 1.87E-02
E12 4D DNA:1 P12 24.61 24.33 0.30 1.460E-2X 1.13E-02 - 1.87E-02
F1 1D DNA:1 rpoD2 16.02 15.42 0.61
F2 1D DNA:1 rpoD2 15.44 15.42 0.61
F3 1D DNA:1 rpoD2 14.80 15.42 0.61
F4 2D DNA:1 rpoD2 14.93 14.71 0.69
F5 2D DNA:1 rpoD2 15.26 14.71 0.69
F6 2D DNA:1 rpoD2 13.94 14.71 0.69
F7 3D DNA:1 rpoD2 15.63 14.95 0.99
F8 3D DNA:1 rpoD2 13.81 14.95 0.99
F9 3D DNA:1 rpoD2 15.41 14.95 0.99
F10 4D DNA:1 rpoD2 15.56 15.63 0.21
F11 4D DNA:1 rpoD2 15.86 15.63 0.21
F12 4D DNA:1 rpoD2 15.46 15.63 0.21
G1 1V DNA:1 P3 18.99 19.34 0.30
G2 1V DNA:1 P3 19.58 19.34 0.30
G3 1V DNA:1 P3 19.44 19.34 0.30
G4 1V DNA:10 P3 23.65 23.59 0.08
G5 1V DNA:10 P3 23.62 23.59 0.08
G6 1V DNA:10 P3 23.50 23.59 0.08
G7 1V DNA:100 P3 26.87 26.79 0.13
G8 1V DNA:100 P3 26.86 26.79 0.13
G9 1V DNA:100 P3 26.64 26.79 0.13
G10 1V DNA:1000 P3 30.17 32.04 3.51
G11 1V DNA:1000 P3 36.10 32.04 3.51
G12 1V DNA:1000 P3 29.86 32.04 3.51
H1 1V DNA:1 P12 20.71 20.68 0.36
H2 1V DNA:1 P12 21.03 20.68 0.36
H3 1V DNA:1 P12 20.31 20.68 0.36
H4 1V DNA:10 P12 24.98 24.84 0.13
H5 1V DNA:10 P12 24.80 24.84 0.13
H6 1V DNA:10 P12 24.74 24.84 0.13
H7 1V DNA:100 P12 28.14 28.14 0.06
H8 1V DNA:100 P12 28.21 28.14 0.06
H9 1V DNA:100 P12 28.08 28.14 0.06
H10 1V DNA:1000 P12 31.37 31.45 0.12
H11 1V DNA:1000 P12 31.39 31.45 0.12
H12 1V DNA:1000 P12 31.60 31.45 0.12
Analysis Parameters






Baseline range (from cycle no. ... to) n/a
Drift Correction OFF




Level (12) P3 copies P12 copies rpoD2 copies N/No CT (mg*min/L)
1C 1 18.25 19.16 16.63 1 1 55660 58495 104529 1 0
2C 1 20.32 21.35 16.16 0.17194273 0.15821957 13529 14042 142622 0.17428571 0.059274472
3C 1 23.11 24.44 15.83 0.01977745 0.01478215 2011 1875 177393 0.02242857 0.098541255
4C 1 23.39 24.81 15.59 0.01379223 0.00968522 1661 1474 207897 0.00042357 0.137609589
1D 1 17.06 18.02 15.42 1 1 125507 122942 232626
2D 1 18.43 19.71 14.71 0.23651441 0.18946457 49218 40878 371979
3D 1 22.28 23.18 15.52 0.02875586 0.029977 3545 4262 217744
4D 1 23.75 24.33 15.63 0.01120278 0.01457864 1299 2015 202471
1V 1 19.34 20.68 26430 21728
1V 10 23.59 24.84 14485 14450
1V 100 26.79 28.14 16268 16830
1V 1000 30.02 31.45 17961 19475




Pos Name Ct SYBR Ct Mean SYBR Ct Dev. SYBR Expr. Level SYBR Range SYBR
A1 1A cDNA:5 DF1 P3 33.95 33.55 0.36
A2 1A cDNA:5 DF1 P3 33.31 33.55 0.36
A3 1A cDNA:5 DF1 P3 33.37 33.55 0.36
A4 2A cDNA:5 DF1 P3
A5 2A cDNA:5 DF1 P3 35.33 35.13 0.28
A6 2A cDNA:5 DF1 P3 34.93 35.13 0.28
A7 3A cDNA:5 DF1 P3
A8 3A cDNA:5 DF1 P3
A9 3A cDNA:5 DF1 P3
A10 4A cDNA:5 DF1 P3 35.50
A11 4A cDNA:5 DF1 P3
A12 4A cDNA:5 DF1 P3
B1 1A cDNA:5 DF1 P12 28.77 28.49 0.33
B2 1A cDNA:5 DF1 P12 28.58 28.49 0.33
B3 1A cDNA:5 DF1 P12 28.13 28.49 0.33
B4 2A cDNA:5 DF1 P12 30.98 30.98 0.09
B5 2A cDNA:5 DF1 P12 31.07 30.98 0.09
B6 2A cDNA:5 DF1 P12 30.89 30.98 0.09
B7 3A cDNA:5 DF1 P12 35.62 34.97 0.58
B8 3A cDNA:5 DF1 P12 34.51 34.97 0.58
B9 3A cDNA:5 DF1 P12 34.78 34.97 0.58
B10 4A cDNA:5 DF1 P12
B11 4A cDNA:5 DF1 P12 35.95
B12 4A cDNA:5 DF1 P12
C1 1A cDNA:5 DF1 rpoD2 22.68 22.15 0.48
C2 1A cDNA:5 DF1 rpoD2 22.00 22.15 0.48
C3 1A cDNA:5 DF1 rpoD2 21.76 22.15 0.48
C4 2A cDNA:5 DF1 rpoD2 21.86 21.74 0.15
C5 2A cDNA:5 DF1 rpoD2 21.78 21.74 0.15
C6 2A cDNA:5 DF1 rpoD2 21.57 21.74 0.15
C7 3A cDNA:5 DF1 rpoD2 21.01 20.95 0.08
C8 3A cDNA:5 DF1 rpoD2 20.86 20.95 0.08
C9 3A cDNA:5 DF1 rpoD2 20.98 20.95 0.08
C10 4A cDNA:5 DF1 rpoD2 21.58 21.58 0.02
C11 4A cDNA:5 DF1 rpoD2 21.60 21.58 0.02
C12 4A cDNA:5 DF1 rpoD2 21.56 21.58 0.02
D1 1B cDNA:5 DF1 P3 26.73 26.29 0.43
D2 1B cDNA:5 DF1 P3 26.25 26.29 0.43
D3 1B cDNA:5 DF1 P3 25.88 26.29 0.43
D4 2B cDNA:5 DF1 P3 28.13 28.34 0.21
D5 2B cDNA:5 DF1 P3 28.56 28.34 0.21
D6 2B cDNA:5 DF1 P3 28.32 28.34 0.21
D7 3B cDNA:5 DF1 P3 32.58 32.67 0.55
D8 3B cDNA:5 DF1 P3 33.26 32.67 0.55
D9 3B cDNA:5 DF1 P3 32.17 32.67 0.55
D10 4B cDNA:5 DF1 P3
D11 4B cDNA:5 DF1 P3
D12 4B cDNA:5 DF1 P3
E1 1B cDNA:5 DF1 P12 24.26 23.77 0.44
E2 1B cDNA:5 DF1 P12 23.60 23.77 0.44
E3 1B cDNA:5 DF1 P12 23.44 23.77 0.44
E4 2B cDNA:5 DF1 P12 26.06 25.85 0.22 0.155 0.133 - 0.181
E5 2B cDNA:5 DF1 P12 25.86 25.85 0.22 0.155 0.133 - 0.181
E6 2B cDNA:5 DF1 P12 25.63 25.85 0.22 0.155 0.133 - 0.181
E7 3B cDNA:5 DF1 P12 29.76 29.69 0.10 7.560E-3X 7.02E-03 - 8.15E-03
E8 3B cDNA:5 DF1 P12 29.58 29.69 0.10 7.560E-3X 7.02E-03 - 8.15E-03
E9 3B cDNA:5 DF1 P12 29.71 29.69 0.10 7.560E-3X 7.02E-03 - 8.15E-03
E10 4B cDNA:5 DF1 P12 1.360E-4X 1.07E-04 - 1.74E-04
E11 4B cDNA:5 DF1 P12 35.47 35.70 0.32 1.360E-4X 1.07E-04 - 1.74E-04
E12 4B cDNA:5 DF1 P12 35.93 35.70 0.32 1.360E-4X 1.07E-04 - 1.74E-04
F1 1B cDNA:5 DF1 rpoD2 21.33 21.07 0.23
F2 1B cDNA:5 DF1 rpoD2 21.00 21.07 0.23
F3 1B cDNA:5 DF1 rpoD2 20.88 21.07 0.23
F4 2B cDNA:5 DF1 rpoD2 20.49 20.46 0.03
F5 2B cDNA:5 DF1 rpoD2 20.44 20.46 0.03
F6 2B cDNA:5 DF1 rpoD2 20.46 20.46 0.03
F7 3B cDNA:5 DF1 rpoD2 19.96 19.94 0.05
F8 3B cDNA:5 DF1 rpoD2 19.89 19.94 0.05
F9 3B cDNA:5 DF1 rpoD2 19.98 19.94 0.05
F10 4B cDNA:5 DF1 rpoD2 20.17 20.16 0.13
F11 4B cDNA:5 DF1 rpoD2 20.02 20.16 0.13
F12 4B cDNA:5 DF1 rpoD2 20.28 20.16 0.13
G1 1D cDNA:5 DF1 P3 23.66 23.36 0.28
G2 1D cDNA:5 DF1 P3 23.30 23.36 0.28
G3 1D cDNA:5 DF1 P3 23.11 23.36 0.28
G4 1D cDNA:5 DF10 P3 26.70 26.38 0.28
G5 1D cDNA:5 DF10 P3 26.20 26.38 0.28
G6 1D cDNA:5 DF10 P3 26.23 26.38 0.28
G7 1D cDNA:5 DF100 P3 29.80 29.52 0.28
G8 1D cDNA:5 DF100 P3 29.54 29.52 0.28
G9 1D cDNA:5 DF100 P3 29.23 29.52 0.28
G10 1X cDNA:5 DF1 P3 31.62 34.04 3.42
G11 1X cDNA:5 DF1 P3 37.95 34.04 3.42
G12 1X cDNA:5 DF1 P3 32.56 34.04 3.42
H1 1D cDNA:5 DF1 P12 24.17 23.95 0.23
H2 1D cDNA:5 DF1 P12 23.97 23.95 0.23
H3 1D cDNA:5 DF1 P12 23.72 23.95 0.23
H4 1D cDNA:5 DF10 P12 26.91 26.80 0.18
H5 1D cDNA:5 DF10 P12 26.90 26.80 0.18
H6 1D cDNA:5 DF10 P12 26.59 26.80 0.18
H7 1D cDNA:5 DF100 P12 30.00 30.12 0.12
H8 1D cDNA:5 DF100 P12 30.23 30.12 0.12
H9 1D cDNA:5 DF100 P12 30.13 30.12 0.12
H10 1X cDNA:5 DF1 P12 27.85 27.68 0.25
H11 1X cDNA:5 DF1 P12 27.79 27.68 0.25
H12 1X cDNA:5 DF1 P12 27.39 27.68 0.25
Analysis Parameters






Baseline range (from cycle no. ... to) n/a
Drift Correction OFF




Level (12) P3 copies P12 copies rpoD2 copies
1A 5 33.55 28.49 22.15 1 1 8 670 13592
2A 5 35.13 30.98 21.74 0.13397168 132 17824
3A 5 34.97 20.95 0.00487629 10 30049
4A 5 21.58 19812
1B 5 26.29 23.77 21.07 1 1 1145 14508 27757
2B 5 28.34 25.85 20.46 0.15821957 0.15496346 282 3742 41545
3B 5 32.67 29.69 19.94 0.00548611 0.00754638 15 307 58590
4B 5 35.70 20.16 0.00013639 6 50659
1D 5 23.36 23.95 8475 12903
1D 50 26.38 26.80 10764 20148
1D 500 29.52 30.12 12595 23163
1X 5 32.09 27.68 22 1136
Bacteria P3 copies P12 copies
Normal 10057 9219
Chloramphenicol 49 1706




Pos Name Ct SYBR Ct Mean SYBR Ct Dev. SYBR Expr. Level SYBR Range SYBR
A1 1C cDNA:5 DF1 P3 24.57 24.63 0.15
A2 1C cDNA:5 DF1 P3 24.80 24.63 0.15
A3 1C cDNA:5 DF1 P3 24.52 24.63 0.15
A4 2C cDNA:5 DF1 P3 27.81 27.50 0.32
A5 2C cDNA:5 DF1 P3 27.53 27.50 0.32
A6 2C cDNA:5 DF1 P3 27.16 27.50 0.32
A7 3C cDNA:5 DF1 P3 31.35 31.01 0.30
A8 3C cDNA:5 DF1 P3 30.85 31.01 0.30
A9 3C cDNA:5 DF1 P3 30.83 31.01 0.30
A10 4C cDNA:5 DF1 P3 35.05 34.80 0.24
A11 4C cDNA:5 DF1 P3 34.58 34.80 0.24
A12 4C cDNA:5 DF1 P3 34.77 34.80 0.24
B1 1C cDNA:5 DF1 P12 25.38 25.13 0.31
B2 1C cDNA:5 DF1 P12 25.24 25.13 0.31
B3 1C cDNA:5 DF1 P12 24.79 25.13 0.31
B4 2C cDNA:5 DF1 P12 28.38 28.30 0.07
B5 2C cDNA:5 DF1 P12 28.27 28.30 0.07
B6 2C cDNA:5 DF1 P12 28.25 28.30 0.07
B7 3C cDNA:5 DF1 P12 31.43 31.52 0.18
B8 3C cDNA:5 DF1 P12 31.73 31.52 0.18
B9 3C cDNA:5 DF1 P12 31.41 31.52 0.18
B10 4C cDNA:5 DF1 P12 36.21 36.64 1.35
B11 4C cDNA:5 DF1 P12 35.56 36.64 1.35
B12 4C cDNA:5 DF1 P12 38.16 36.64 1.35
C1 1C cDNA:5 DF1 rpoD2 22.11 21.67 0.41
C2 1C cDNA:5 DF1 rpoD2 21.61 21.67 0.41
C3 1C cDNA:5 DF1 rpoD2 21.29 21.67 0.41
C4 2C cDNA:5 DF1 rpoD2 22.28 21.98 0.29
C5 2C cDNA:5 DF1 rpoD2 21.69 21.98 0.29
C6 2C cDNA:5 DF1 rpoD2 21.98 21.98 0.29
C7 3C cDNA:5 DF1 rpoD2 21.30 21.35 0.10
C8 3C cDNA:5 DF1 rpoD2 21.46 21.35 0.10
C9 3C cDNA:5 DF1 rpoD2 21.29 21.35 0.10
C10 4C cDNA:5 DF1 rpoD2 20.94 20.98 0.05
C11 4C cDNA:5 DF1 rpoD2
C12 4C cDNA:5 DF1 rpoD2 21.01 20.98 0.05
D1 1D cDNA:5 DF1 P3 23.89 23.54 0.31
D2 1D cDNA:5 DF1 P3 23.42 23.54 0.31
D3 1D cDNA:5 DF1 P3 23.30 23.54 0.31
D4 2D cDNA:5 DF1 P3 25.68 25.49 0.16
D5 2D cDNA:5 DF1 P3 25.39 25.49 0.16
D6 2D cDNA:5 DF1 P3 25.42 25.49 0.16
D7 3D cDNA:5 DF1 P3 29.33 29.45 0.10
D8 3D cDNA:5 DF1 P3 29.50 29.45 0.10
D9 3D cDNA:5 DF1 P3 29.52 29.45 0.10
D10 4D cDNA:5 DF1 P3
D11 4D cDNA:5 DF1 P3
D12 4D cDNA:5 DF1 P3
E1 1D cDNA:5 DF1 P12 24.72 24.26 0.41
E2 1D cDNA:5 DF1 P12 23.97 24.26 0.41
E3 1D cDNA:5 DF1 P12 24.09 24.26 0.41
E4 2D cDNA:5 DF1 P12 26.55 26.23 0.32 0.183 0.145 - 0.230
E5 2D cDNA:5 DF1 P12 25.91 26.23 0.32 0.183 0.145 - 0.230
E6 2D cDNA:5 DF1 P12 26.24 26.23 0.32 0.183 0.145 - 0.230
E7 3D cDNA:5 DF1 P12 29.98 30.22 0.21 1.260E-2X 8.06E-03 - 1.96E-02
E8 3D cDNA:5 DF1 P12 30.36 30.22 0.21 1.260E-2X 8.06E-03 - 1.96E-02
E9 3D cDNA:5 DF1 P12 30.31 30.22 0.21 1.260E-2X 8.06E-03 - 1.96E-02
E10 4D cDNA:5 DF1 P12 38.22 36.72 1.32 1.160E-4X 4.63E-05 - 2.89E-04
E11 4D cDNA:5 DF1 P12 36.19 36.72 1.32 1.160E-4X 4.63E-05 - 2.89E-04
E12 4D cDNA:5 DF1 P12 35.74 36.72 1.32 1.160E-4X 4.63E-05 - 2.89E-04
F1 1D cDNA:5 DF1 rpoD2 21.49 21.14 0.33
F2 1D cDNA:5 DF1 rpoD2 21.06 21.14 0.33
F3 1D cDNA:5 DF1 rpoD2 20.86 21.14 0.33
F4 2D cDNA:5 DF1 rpoD2 20.66 20.66 0.08
F5 2D cDNA:5 DF1 rpoD2 20.58 20.66 0.08
F6 2D cDNA:5 DF1 rpoD2 20.74 20.66 0.08
F7 3D cDNA:5 DF1 rpoD2 21.45 20.78 0.61
F8 3D cDNA:5 DF1 rpoD2 20.29 20.78 0.61
F9 3D cDNA:5 DF1 rpoD2 20.59 20.78 0.61
F10 4D cDNA:5 DF1 rpoD2 20.52 20.52 0.04
F11 4D cDNA:5 DF1 rpoD2 20.47 20.52 0.04
F12 4D cDNA:5 DF1 rpoD2 20.55 20.52 0.04
G1 1D cDNA:5 DF10 P3 26.97 26.51 0.42
G2 1D cDNA:5 DF10 P3 26.41 26.51 0.42
G3 1D cDNA:5 DF10 P3 26.14 26.51 0.42
G4 1D cDNA:5 DF100 P3 29.72 29.88 0.16
G5 1D cDNA:5 DF100 P3 30.04 29.88 0.16
G6 1D cDNA:5 DF100 P3 29.87 29.88 0.16
G7 1C-RT cDNA:5 DF1 P3
G8 1C-RT cDNA:5 DF1 P3
G9 1C-RT cDNA:5 DF1 P3
G10 1D-RT cDNA:5 DF1 P3
G11 1D-RT cDNA:5 DF1 P3
G12 1D-RT cDNA:5 DF1 P3
H1 1D cDNA:5 DF10 P12 28.03 27.95 0.09
H2 1D cDNA:5 DF10 P12 27.97 27.95 0.09
H3 1D cDNA:5 DF10 P12 27.85 27.95 0.09
H4 1D cDNA:5 DF100 P12 31.41 31.26 0.17
H5 1D cDNA:5 DF100 P12 31.28 31.26 0.17
H6 1D cDNA:5 DF100 P12 31.08 31.26 0.17
H7 1C-RT cDNA:5 DF1 P12
H8 1C-RT cDNA:5 DF1 P12
H9 1C-RT cDNA:5 DF1 P12
H10 1D-RT cDNA:5 DF1 P12
H11 1D-RT cDNA:5 DF1 P12 36.09
H12 1D-RT cDNA:5 DF1 P12
Analysis Parameters






Baseline range (from cycle no. ... to) n/a
Drift Correction OFF




Level (12) P3 copies P12 copies rpoD2 copies
1C 5 24.63 25.13 21.67 1 1 3559 5981 18668
2C 5 27.50 28.30 21.98 0.16957554 0.13773814 501 758 15209
3C 5 31.01 31.52 21.35 0.00961832 0.00955188 46 93 23066
4C 5 34.80 36.64 20.98 29459
1D 5 23.54 24.26 21.14 1 1 7494 10543 26502
2D 5 25.49 26.23 20.66 0.18556545 0.18301071 1977 2921 36399
3D 5 29.45 30.22 20.78 0.01295812 0.01251672 132 217 33623
4D 5 36.72 20.52 39929
1D 50 26.51 27.95 9849 9524
1D 500 29.88 31.26 9849 11021
1C-RT 5
1D-RT 5
	  	   279 




Pos Name Ct SYBR Ct Mean SYBR Ct Dev. SYBR Expr. Level SYBR Range SYBR
A1 1X DNA:10 FC4 P3 31.35 31.21 0.15
A2 1X DNA:10 FC4 P3 31.06 31.21 0.15
A3 1X DNA:10 FC4 P3 31.20 31.21 0.15
A4 2X DNA:10 FC4 P3 30.26 30.53 0.24
A5 2X DNA:10 FC4 P3 30.70 30.53 0.24
A6 2X DNA:10 FC4 P3 30.64 30.53 0.24
A7 3X DNA:10 FC4 P3 31.80 31.42 0.34
A8 3X DNA:10 FC4 P3 31.34 31.42 0.34
A9 3X DNA:10 FC4 P3 31.14 31.42 0.34
A10 4X DNA:10 FC4 P3 31.65 31.75 0.38
A11 4X DNA:10 FC4 P3 32.17 31.75 0.38
A12 4X DNA:10 FC4 P3 31.43 31.75 0.38
B1 1X DNA:10 FC4 P12 33.36 32.75 0.64
B2 1X DNA:10 FC4 P12 32.81 32.75 0.64
B3 1X DNA:10 FC4 P12 32.09 32.75 0.64
B4 2X DNA:10 FC4 P12 32.28 32.00 0.24 0.985 0.802 - 1.21
B5 2X DNA:10 FC4 P12 31.90 32.00 0.24 0.985 0.802 - 1.21
B6 2X DNA:10 FC4 P12 31.82 32.00 0.24 0.985 0.802 - 1.21
B7 3X DNA:10 FC4 P12 32.66 32.97 0.30 0.345 0.265 - 0.449
B8 3X DNA:10 FC4 P12 32.98 32.97 0.30 0.345 0.265 - 0.449
B9 3X DNA:10 FC4 P12 33.27 32.97 0.30 0.345 0.265 - 0.449
B10 4X DNA:10 FC4 P12 32.51 32.84 0.40 0.653 0.484 - 0.882
B11 4X DNA:10 FC4 P12 33.28 32.84 0.40 0.653 0.484 - 0.882
B12 4X DNA:10 FC4 P12 32.72 32.84 0.40 0.653 0.484 - 0.882
C1 1X DNA:10 FC4 rpoD 19.79 19.52 0.28
C2 1X DNA:10 FC4 rpoD 19.54 19.52 0.28
C3 1X DNA:10 FC4 rpoD 19.22 19.52 0.28
C4 2X DNA:10 FC4 rpoD 18.87 18.74 0.17
C5 2X DNA:10 FC4 rpoD 18.55 18.74 0.17
C6 2X DNA:10 FC4 rpoD 18.81 18.74 0.17
C7 3X DNA:10 FC4 rpoD 17.94 18.20 0.23
C8 3X DNA:10 FC4 rpoD 18.29 18.20 0.23
C9 3X DNA:10 FC4 rpoD 18.36 18.20 0.23
C10 4X DNA:10 FC4 rpoD 19.03 18.99 0.17
C11 4X DNA:10 FC4 rpoD 19.13 18.99 0.17
C12 4X DNA:10 FC4 rpoD 18.80 18.99 0.17
D1 1V DNA:1 FC2 P3 20.50 19.98 0.50
D2 1V DNA:1 FC2 P3 19.97 19.98 0.50
D3 1V DNA:1 FC2 P3 19.49 19.98 0.50
D4 2V DNA:1 FC2 P3 19.88 18.91 1.28
D5 2V DNA:1 FC2 P3 19.39 18.91 1.28
D6 2V DNA:1 FC2 P3 17.46 18.91 1.28
D7 3V DNA:1 FC2 P3 19.09 19.41 0.42
D8 3V DNA:1 FC2 P3 19.88 19.41 0.42
D9 3V DNA:1 FC2 P3 19.25 19.41 0.42
D10 4V DNA:1 FC2 P3 19.72 19.30 0.37
D11 4V DNA:1 FC2 P3 19.04 19.30 0.37
D12 4V DNA:1 FC2 P3 19.13 19.30 0.37
E1 1V DNA:1 FC2 P12 21.22 20.80 0.37
E2 1V DNA:1 FC2 P12 20.52 20.80 0.37
E3 1V DNA:1 FC2 P12 20.65 20.80 0.37
E4 2V DNA:1 FC2 P12 19.76 19.67 0.84
E5 2V DNA:1 FC2 P12 18.78 19.67 0.84
E6 2V DNA:1 FC2 P12 20.46 19.67 0.84
E7 3V DNA:1 FC2 P12 20.37 20.35 0.24
E8 3V DNA:1 FC2 P12 20.10 20.35 0.24
E9 3V DNA:1 FC2 P12 20.58 20.35 0.24
E10 4V DNA:1 FC2 P12 19.85 19.95 0.10
E11 4V DNA:1 FC2 P12 19.97 19.95 0.10
E12 4V DNA:1 FC2 P12 20.04 19.95 0.10
F1 1V DNA:1 FC2 rpoD 28.40 28.06 0.29
F2 1V DNA:1 FC2 rpoD 27.88 28.06 0.29
F3 1V DNA:1 FC2 rpoD 27.90 28.06 0.29
F4 2V DNA:1 FC2 rpoD 27.14 27.32 0.47
F5 2V DNA:1 FC2 rpoD 26.96 27.32 0.47
F6 2V DNA:1 FC2 rpoD 27.86 27.32 0.47
F7 3V DNA:1 FC2 rpoD 27.87 27.65 0.20
F8 3V DNA:1 FC2 rpoD 27.49 27.65 0.20
F9 3V DNA:1 FC2 rpoD 27.57 27.65 0.20
F10 4V DNA:1 FC2 rpoD 27.61 27.24 0.32
F11 4V DNA:1 FC2 rpoD 27.11 27.24 0.32
F12 4V DNA:1 FC2 rpoD 27.01 27.24 0.32
G1 1V DNA:10 FC2 P3 23.83 23.63 0.37
G2 1V DNA:10 FC2 P3 23.84 23.63 0.37
G3 1V DNA:10 FC2 P3 23.20 23.63 0.37
G4 1V DNA:100 FC2 P3 26.93 26.85 0.17
G5 1V DNA:100 FC2 P3 26.97 26.85 0.17
G6 1V DNA:100 FC2 P3 26.65 26.85 0.17
G7 1V DNA:1000 FC2 P3 30.65 30.20 0.39
G8 1V DNA:1000 FC2 P3 30.02 30.20 0.39
G9 1V DNA:1000 FC2 P3 29.92 30.20 0.39
G10 No template P3
G11 No template P3
G12 No template P3
H1 1V DNA:10 FC2 P12 25.15 24.84 0.30
H2 1V DNA:10 FC2 P12 24.82 24.84 0.30
H3 1V DNA:10 FC2 P12 24.55 24.84 0.30
H4 1V DNA:100 FC2 P12 28.36 28.18 0.15
H5 1V DNA:100 FC2 P12 28.10 28.18 0.15
H6 1V DNA:100 FC2 P12 28.09 28.18 0.15
H7 1V DNA:1000 FC2 P12 31.78 31.56 0.27
H8 1V DNA:1000 FC2 P12 31.26 31.56 0.27
H9 1V DNA:1000 FC2 P12 31.63 31.56 0.27
H10 No template P12
H11 No template P12
H12 No template P12
Analysis Parameters






Baseline range (from cycle no. ... to) n/a
Drift Correction OFF




Level (12) P3 copies P12 copies
rpoD2 
copies
1X 10 31.21 32.75 19.52 1 1 79 83 154684
2X 10 30.53 32.00 18.74 0.93303299 0.9794203 126 136 259062
3X 10 31.42 32.97 18.20 0.34627737 0.34388545 69 72 370212
4X 10 31.75 32.84 18.99 0.476319 0.65067093 55 79 219595
1V 1 19.98 20.80 28.06 1 1 17068 20094 55
2V 1 19.64 19.67 27.32 0.76048938 1.3103934 21605 41957 89
3V 1 19.41 20.35 27.65 1.11728714 1.02811383 25195 26940 72
4V 1 19.30 19.95 27.24 0.90751916 1.02101213 27162 34960 94
1V 10 23.63 24.84 14095 14450
1V 100 26.85 28.18 15615 16397
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Standard Curve Generation for PR772 system 
 
Pos Name Ct SYBR Ct Mean SYBR Ct Dev. SYBR Amount SYBR Target SYBR
A1 PCR:10^2 P3 4.18 4.04 0.12 -
A2 PCR:10^2 P3 3.99 4.04 0.12 -
A3 PCR:10^2 P3 3.95 4.04 0.12 - P3 Calibrator PCR
A4 PCR:10^2 P12 4.72 4.49 0.21 - DF Ct Copies/uL Log copies/uL
A5 PCR:10^2 P12 4.46 4.49 0.21 - 0.00 1 ND 1.16789E+11 11.067403
A6 PCR:10^2 P12 4.30 4.49 0.21 - 1.00 10 ND 11678928192 10.067403
A7 PCR:10^3 rpoD 6.45 6.42 0.04 - 2.00 100 4.04 1167892819 9.06740299
A8 PCR:10^3 rpoD 6.42 6.42 0.04 - 3.00 1000 6.52 116789281.9 8.06740299
A9 PCR:10^3 rpoD 6.38 6.42 0.04 - 4.00 10000 9.71 11678928.19 7.06740299
A10 PCR:10^10 P3 29.31 29.54 0.24 - 5.00 100000 12.63 1167892.819 6.06740299
A11 PCR:10^10 P3 29.54 29.54 0.24 - 6.00 1000000 16.31 116789.2819 5.06740299
A12 PCR:10^10 P3 29.78 29.54 0.24 - 7.00 10000000 19.51 11678.92819 4.06740299
B1 PCR:10^3 P3 6.71 6.52 0.35 - 8.00 100000000 23.02 1167.892819 3.06740299
B2 PCR:10^3 P3 6.74 6.52 0.35 - 9.00 1000000000 26.83 116.7892819 2.06740299
B3 PCR:10^3 P3 6.12 6.52 0.35 - 10.00 10000000000 29.54 11.67892819 1.06740299
B4 PCR:10^3 P12 6.99 6.90 0.10 - 11.00 100000000000 32.65 1.167892819 0.06740299
B5 PCR:10^3 P12 6.79 6.90 0.10 - 12.00 1000000000000
B6 PCR:10^3 P12 6.93 6.90 0.10 -
B7 PCR:10^4 rpoD 9.19 9.05 0.20 - P12 Calibrator PCR
B8 PCR:10^4 rpoD 8.82 9.05 0.20 - DF Ct Copies/uL Log copies/uL
B9 PCR:10^4 rpoD 9.14 9.05 0.20 - 0.00 1 ND 1.18438E+11 11.0734902
B10 PCR:10^11 P3 34.44 33.25 1.06 - 1.00 10 ND 11843776883 10.0734902
B11 PCR:10^11 P3 32.84 33.25 1.06 - 2.00 100 4.49 1184377688 9.07349022
B12 PCR:10^11 P3 32.45 33.25 1.06 - 3.00 1000 6.90 118437768.8 8.07349022
C1 PCR:10^4 P3 9.87 9.71 0.18 - 4.00 10000 10.42 11843776.88 7.07349022
C2 PCR:10^4 P3 9.75 9.71 0.18 - 5.00 100000 13.59 1184377.688 6.07349022
C3 PCR:10^4 P3 9.52 9.71 0.18 - 6.00 1000000 17.06 118437.7688 5.07349022
C4 PCR:10^4 P12 10.50 10.42 0.14 - 7.00 10000000 20.66 11843.77688 4.07349022
C5 PCR:10^4 P12 10.26 10.42 0.14 - 8.00 100000000 24.06 1184.377688 3.07349022
C6 PCR:10^4 P12 10.51 10.42 0.14 - 9.00 1000000000 27.67 118.4377688 2.07349022
C7 PCR:10^5 rpoD 12.73 12.55 0.15 - 10.00 10000000000 31.04 11.84377688 1.07349022
C8 PCR:10^5 rpoD 12.48 12.55 0.15 - 11.00 100000000000 34.05 1.184377688 0.07349022
C9 PCR:10^5 rpoD 12.44 12.55 0.15 - 12.00 1000000000000 #NUM!
C10 PCR:10^12 P3 -
C11 PCR:10^12 P3 - rpoD Calibrator PCR
C12 PCR:10^12 P3 - DF Ct Copies/uL Log copies/uL
D1 PCR:10^5 P3 12.76 12.63 0.12 - 0.00 1 ND 1.08669E+11 11.0361073
D2 PCR:10^5 P3 12.52 12.63 0.12 - 1.00 10 ND 10866940543 10.0361073
D3 PCR:10^5 P3 12.60 12.63 0.12 - 2.00 100 ND 1086694054 9.03610729
D4 PCR:10^5 P12 13.72 13.59 0.11 - 3.00 1000 6.42 108669405.4 8.03610729
D5 PCR:10^5 P12 13.52 13.59 0.11 - 4.00 10000 9.05 10866940.54 7.03610729
D6 PCR:10^5 P12 13.54 13.59 0.11 - 5.00 100000 12.55 1086694.054 6.03610729
D7 PCR:10^6 rpoD 15.86 15.58 0.43 - 6.00 1000000 15.58 108669.4054 5.03610729
D8 PCR:10^6 rpoD 15.08 15.58 0.43 - 7.00 10000000 19.28 10866.94054 4.03610729
D9 PCR:10^6 rpoD 15.79 15.58 0.43 - 8.00 100000000 22.65 1086.694054 3.03610729
D10 PCR:10^10 P12 31.06 31.04 0.07 - 9.00 1000000000 26.23 108.6694054 2.03610729
D11 PCR:10^10 P12 31.10 31.04 0.07 - 10.00 10000000000 29.59 10.86694054 1.03610729
D12 PCR:10^10 P12 30.97 31.04 0.07 - 11.00 100000000000 33.05 1.086694054 0.03610729
E1 PCR:10^6 P3 16.68 16.31 0.40 - 12.00 1000000000000
E2 PCR:10^6 P3 15.89 16.31 0.40 -
E3 PCR:10^6 P3 16.37 16.31 0.40 -
E4 PCR:10^6 P12 17.24 17.06 0.16 -
E5 PCR:10^6 P12 16.99 17.06 0.16 -
E6 PCR:10^6 P12 16.94 17.06 0.16 -
E7 PCR:10^7 rpoD 19.28 19.28 0.33 -
E8 PCR:10^7 rpoD 18.96 19.28 0.33 -
E9 PCR:10^7 rpoD 19.62 19.28 0.33 -
E10 PCR:10^11 P12 37.06 35.05 1.74 -
E11 PCR:10^11 P12 34.16 35.05 1.74 -
E12 PCR:10^11 P12 33.94 35.05 1.74 -
F1 PCR:10^7 P3 19.71 19.51 0.18 -
F2 PCR:10^7 P3 19.35 19.51 0.18 -
F3 PCR:10^7 P3 19.48 19.51 0.18 -
F4 PCR:10^7 P12 20.70 20.66 0.10 -
F5 PCR:10^7 P12 20.55 20.66 0.10 -
F6 PCR:10^7 P12 20.73 20.66 0.10 -
F7 PCR:10^8 rpoD 22.85 22.65 0.18 -
F8 PCR:10^8 rpoD 22.51 22.65 0.18 -
F9 PCR:10^8 rpoD 22.58 22.65 0.18 -
F10 PCR:10^12 P12 -
F11 PCR:10^12 P12 -
F12 PCR:10^12 P12 -
G1 PCR:10^8 P3 23.24 23.02 0.23 -
G2 PCR:10^8 P3 23.03 23.02 0.23 -
G3 PCR:10^8 P3 22.78 23.02 0.23 -
G4 PCR:10^8 P12 24.22 24.06 0.15 -
G5 PCR:10^8 P12 23.92 24.06 0.15 -
G6 PCR:10^8 P12 24.05 24.06 0.15 -
G7 PCR:10^9 rpoD 26.12 26.23 0.12 -
G8 PCR:10^9 rpoD 26.23 26.23 0.12 -
G9 PCR:10^9 rpoD 26.35 26.23 0.12 -
G10 PCR:10^11 rpoD 32.32 33.05 1.04 -
G11 PCR:10^11 rpoD 33.05 1.04 -
G12 PCR:10^11 rpoD 33.79 33.05 1.04 -
H1 PCR:10^9 P3 27.05 26.83 0.25 -
H2 PCR:10^9 P3 26.89 26.83 0.25 -
H3 PCR:10^9 P3 26.55 26.83 0.25 -
H4 PCR:10^9 P12 30.64 28.65 1.73 -
H5 PCR:10^9 P12 27.80 28.65 1.73 -
H6 PCR:10^9 P12 27.53 28.65 1.73 -
H7 PCR:10^10 rpoD 29.55 29.59 0.37 -
H8 PCR:10^10 rpoD 29.99 29.59 0.37 -
H9 PCR:10^10 rpoD 29.24 29.59 0.37 -
H10 PCR:10^12 rpoD -
H11 PCR:10^12 rpoD -
H12 PCR:10^12 rpoD -
Analysis Parameters






Baseline range (from cycle no. ... to) n/a
Drift Correction OFF




Pos Name Ct SYBR Ct Mean SYBR Ct Dev. SYBR Amount SYBR Target SYBR
A1 PCR:10^3 P3 7.41 7.24 0.20 -
A2 PCR:10^3 P3 7.30 7.24 0.20 -
A3 PCR:10^3 P3 7.02 7.24 0.20 - P3 Calibrator PCR
A4 PCR:10^4 P3 10.72 10.65 0.16 - DF Ct Copies/uL Log copies/uL
A5 PCR:10^4 P3 10.76 10.65 0.16 - 0.00 1 ND 1.16789E+11 11.067403
A6 PCR:10^4 P3 10.47 10.65 0.16 - 1.00 10 ND 11678928192 10.067403
A7 PCR:10^5 P3 13.80 14.00 0.20 - 2.00 100 ND 1167892819 9.06740299
A8 PCR:10^5 P3 14.20 14.00 0.20 - 3.00 1000 7.24 116789281.9 8.06740299
A9 PCR:10^5 P3 14.01 14.00 0.20 - 4.00 10000 10.65 11678928.19 7.06740299
A10 PCR:10^6 P3 17.93 18.07 0.32 - 5.00 100000 14.00 1167892.819 6.06740299
A11 PCR:10^6 P3 17.85 18.07 0.32 - 6.00 1000000 18.07 116789.2819 5.06740299
A12 PCR:10^6 P3 18.43 18.07 0.32 - 7.00 10000000 20.75 11678.92819 4.06740299
B1 PCR:10^7 P3 20.66 20.75 0.08 - 8.00 100000000 24.11 1167.892819 3.06740299
B2 PCR:10^7 P3 20.82 20.75 0.08 - 9.00 1000000000 27.84 116.7892819 2.06740299
B3 PCR:10^7 P3 20.76 20.75 0.08 - 10.00 10000000000 31.54 11.67892819 1.06740299
B4 PCR:10^8 P3 24.40 24.11 0.36 - 11.00 100000000000 34.47 1.167892819 0.06740299
B5 PCR:10^8 P3 23.71 24.11 0.36 - 11.50 1000000000000
B6 PCR:10^8 P3 24.22 24.11 0.36 -
B7 PCR:10^9 P3 27.90 27.84 0.09 - P12 Calibrator PCR
B8 PCR:10^9 P3 27.88 27.84 0.09 - DF Ct Copies/uL Log copies/uL
B9 PCR:10^9 P3 27.73 27.84 0.09 - 0.00 1 ND 1.18438E+11 11.0734902
B10 PCR:10^10 P3 32.26 31.54 0.81 - 1.00 10 ND 11843776883 10.0734902
B11 PCR:10^10 P3 30.66 31.54 0.81 - 2.00 100 ND 1184377688 9.07349022
B12 PCR:10^10 P3 31.71 31.54 0.81 - 3.00 1000 7.78 118437768.8 8.07349022
C1 PCR:10^3 P12 7.97 7.78 0.26 - 4.00 10000 11.44 11843776.88 7.07349022
C2 PCR:10^3 P12 7.88 7.78 0.26 - 5.00 100000 13.76 1184377.688 6.07349022
C3 PCR:10^3 P12 7.49 7.78 0.26 - 6.00 1000000 18.54 118437.7688 5.07349022
C4 PCR:10^4 P12 11.92 11.44 0.45 - 7.00 10000000 22.51 11843.77688 4.07349022
C5 PCR:10^4 P12 11.02 11.44 0.45 - 8.00 100000000 24.77 1184.377688 3.07349022
C6 PCR:10^4 P12 11.37 11.44 0.45 - 9.00 1000000000 29.62 118.4377688 2.07349022
C7 PCR:10^5 P12 13.76 13.76 0.04 - 10.00 10000000000 33.26 11.84377688 1.07349022
C8 PCR:10^5 P12 13.79 13.76 0.04 - 11.00 100000000000 35.53 1.184377688 0.07349022
C9 PCR:10^5 P12 13.72 13.76 0.04 - 11.50 1000000000000
C10 PCR:10^6 P12 18.42 18.54 0.14 -
C11 PCR:10^6 P12 18.70 18.54 0.14 - rpoD Calibrator PCR
C12 PCR:10^6 P12 18.51 18.54 0.14 - DF Ct Copies/uL Log copies/uL
D1 PCR:10^7 P12 22.75 22.51 0.27 - 0.00 1 ND 1.08669E+11 11.0361073
D2 PCR:10^7 P12 22.22 22.51 0.27 - 1.00 10 ND 10866940543 10.0361073
D3 PCR:10^7 P12 22.57 22.51 0.27 - 2.00 100 ND 1086694054 9.03610729
D4 PCR:10^8 P12 24.67 24.77 0.46 - 3.00 1000 6.87 108669405.4 8.03610729
D5 PCR:10^8 P12 24.37 24.77 0.46 - 4.00 10000 9.65 10866940.54 7.03610729
D6 PCR:10^8 P12 25.27 24.77 0.46 - 5.00 100000 11.79 1086694.054 6.03610729
D7 PCR:10^9 P12 30.04 29.62 0.59 - 6.00 1000000 15.51 108669.4054 5.03610729
D8 PCR:10^9 P12 28.94 29.62 0.59 - 7.00 10000000 20.76 10866.94054 4.03610729
D9 PCR:10^9 P12 29.87 29.62 0.59 - 8.00 100000000 24.99 1086.694054 3.03610729
D10 PCR:10^10 P12 34.18 33.26 0.87 - 9.00 1000000000 27.60 108.6694054 2.03610729
D11 PCR:10^10 P12 32.44 33.26 0.87 - 10.00 10000000000 31.85 10.86694054 1.03610729
D12 PCR:10^10 P12 33.17 33.26 0.87 - 11.00 100000000000 33.98 1.086694054 0.03610729
E1 PCR:10^3 rpoD 7.02 6.87 0.16 - 11.50 1000000000000
E2 PCR:10^3 rpoD 6.90 6.87 0.16 -
E3 PCR:10^3 rpoD 6.70 6.87 0.16 -
E4 PCR:10^4 rpoD 9.77 9.65 0.11 -
E5 PCR:10^4 rpoD 9.64 9.65 0.11 -
E6 PCR:10^4 rpoD 9.55 9.65 0.11 -
E7 PCR:10^5 rpoD 11.95 12.48 1.20 -
E8 PCR:10^5 rpoD 11.63 12.48 1.20 -
E9 PCR:10^5 rpoD 13.85 12.48 1.20 -
E10 PCR:10^6 rpoD 14.88 15.51 0.62 -
E11 PCR:10^6 rpoD 15.56 15.51 0.62 -
E12 PCR:10^6 rpoD 16.11 15.51 0.62 -
F1 PCR:10^7 rpoD 21.01 20.76 0.22 -
F2 PCR:10^7 rpoD 20.59 20.76 0.22 -
F3 PCR:10^7 rpoD 20.67 20.76 0.22 -
F4 PCR:10^8 rpoD 25.58 24.99 0.52 -
F5 PCR:10^8 rpoD 24.78 24.99 0.52 -
F6 PCR:10^8 rpoD 24.60 24.99 0.52 -
F7 PCR:10^9 rpoD 27.62 27.60 0.38 -
F8 PCR:10^9 rpoD 27.21 27.60 0.38 -
F9 PCR:10^9 rpoD 27.97 27.60 0.38 -
F10 PCR:10^10 rpoD 31.71 31.85 0.48 -
F11 PCR:10^10 rpoD 32.38 31.85 0.48 -
F12 PCR:10^10 rpoD 31.45 31.85 0.48 -
G1 PCR:10^11 rpoD 33.91 33.98 0.09 -
G2 PCR:10^11 rpoD 33.98 0.09 -
G3 PCR:10^11 rpoD 34.04 33.98 0.09 -
G4 PCR:10^11.5 rpoD -
G5 PCR:10^11.5 rpoD -
G6 PCR:10^11.5 rpoD -
H1 PCR:10^11 P3 34.68 34.47 0.30 -
H2 PCR:10^11 P3 34.47 0.30 -
H3 PCR:10^11 P3 34.25 34.47 0.30 -
H4 PCR:10^11.5 P3 -
H5 PCR:10^11.5 P3 -
H6 PCR:10^11.5 P3 -
H7 PCR:10^11 P12 35.53 0.02 -
H8 PCR:10^11 P12 35.54 35.53 0.02 -
H9 PCR:10^11 P12 35.52 35.53 0.02 -
H10 PCR:10^11.5 P12 -
H11 PCR:10^11.5 P12 -
H12 PCR:10^11.5 P12 -
Analysis Parameters






Baseline range (from cycle no. ... to) n/a
Drift Correction OFF
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Pos Name Ct SYBR Ct Mean SYBR Ct Dev. SYBR Amount SYBR Target SYBR
A1 PCR:10^3 P3 7.37 7.24 0.12 -
A2 PCR:10^3 P3 7.13 7.24 0.12 -
A3 PCR:10^3 P3 7.21 7.24 0.12 - P3 Calibrator PCR
A4 PCR:10^4 P3 10.65 10.53 0.22 - DF Ct Copies/uL Log copies/uL
A5 PCR:10^4 P3 10.28 10.53 0.22 - 0.00 1 ND 1.16789E+11 11.067403
A6 PCR:10^4 P3 10.66 10.53 0.22 - 1.00 10 ND 11678928192 10.067403
A7 PCR:10^5 P3 13.23 13.44 0.23 - 2.00 100 3.78 1167892819 9.06740299
A8 PCR:10^5 P3 13.40 13.44 0.23 - 3.00 1000 7.24 116789281.9 8.06740299
A9 PCR:10^5 P3 13.69 13.44 0.23 - 4.00 10000 10.53 11678928.19 7.06740299
A10 PCR:10^6 P3 18.30 17.80 0.45 - 5.00 100000 13.44 1167892.819 6.06740299
A11 PCR:10^6 P3 17.42 17.80 0.45 - 6.00 1000000 17.80 116789.2819 5.06740299
A12 PCR:10^6 P3 17.69 17.80 0.45 - 7.00 10000000 21.55 11678.92819 4.06740299
B1 PCR:10^7 P3 22.07 21.55 0.50 - 8.00 100000000 24.36 1167.892819 3.06740299
B2 PCR:10^7 P3 21.49 21.55 0.50 - 9.00 1000000000 27.58 116.7892819 2.06740299
B3 PCR:10^7 P3 21.08 21.55 0.50 - 10.00 10000000000 32.34 11.67892819 1.06740299
B4 PCR:10^8 P3 24.24 24.36 0.11 - 11.00 100000000000 1.167892819 0.06740299
B5 PCR:10^8 P3 24.44 24.36 0.11 -
B6 PCR:10^8 P3 24.39 24.36 0.11 -
B7 PCR:10^9 P3 27.82 27.58 0.22 - P12 Calibrator PCR
B8 PCR:10^9 P3 27.51 27.58 0.22 - DF Ct Copies/uL Log copies/uL
B9 PCR:10^9 P3 27.41 27.58 0.22 - 0.00 1 ND 1.18438E+11 11.0734902
B10 PCR:10^10 P3 32.46 32.34 0.58 - 1.00 10 ND 11843776883 10.0734902
B11 PCR:10^10 P3 31.71 32.34 0.58 - 2.00 100 3.95 1184377688 9.07349022
B12 PCR:10^10 P3 32.86 32.34 0.58 - 3.00 1000 7.67 118437768.8 8.07349022
C1 PCR:10^3 P12 7.95 7.67 0.25 - 4.00 10000 11.42 11843776.88 7.07349022
C2 PCR:10^3 P12 7.52 7.67 0.25 - 5.00 100000 13.98 1184377.688 6.07349022
C3 PCR:10^3 P12 7.53 7.67 0.25 - 6.00 1000000 18.62 118437.7688 5.07349022
C4 PCR:10^4 P12 11.65 11.42 0.21 - 7.00 10000000 22.72 11843.77688 4.07349022
C5 PCR:10^4 P12 11.24 11.42 0.21 - 8.00 100000000 25.50 1184.377688 3.07349022
C6 PCR:10^4 P12 11.38 11.42 0.21 - 9.00 1000000000 30.12 118.4377688 2.07349022
C7 PCR:10^5 P12 13.72 13.98 0.24 - 10.00 10000000000 33.81 11.84377688 1.07349022
C8 PCR:10^5 P12 14.19 13.98 0.24 - 11.00 100000000000 36.16 1.184377688 0.07349022
C9 PCR:10^5 P12 14.02 13.98 0.24 -
C10 PCR:10^6 P12 18.70 18.62 0.46 -
C11 PCR:10^6 P12 18.13 18.62 0.46 - rpoD Calibrator PCR
C12 PCR:10^6 P12 19.04 18.62 0.46 - DF Ct Copies/uL Log copies/uL
D1 PCR:10^7 P12 23.44 22.72 0.74 - 0.00 1 ND 1.08669E+11 11.0361073
D2 PCR:10^7 P12 22.75 22.72 0.74 - 1.00 10 ND 10866940543 10.0361073
D3 PCR:10^7 P12 21.96 22.72 0.74 - 2.00 100 3.99 1086694054 9.03610729
D4 PCR:10^8 P12 25.76 25.50 0.22 - 3.00 1000 6.66 108669405.4 8.03610729
D5 PCR:10^8 P12 25.37 25.50 0.22 - 4.00 10000 9.87 10866940.54 7.03610729
D6 PCR:10^8 P12 25.37 25.50 0.22 - 5.00 100000 12.97 1086694.054 6.03610729
D7 PCR:10^9 P12 30.72 30.12 0.58 - 6.00 1000000 16.69 108669.4054 5.03610729
D8 PCR:10^9 P12 29.57 30.12 0.58 - 7.00 10000000 20.77 10866.94054 4.03610729
D9 PCR:10^9 P12 30.07 30.12 0.58 - 8.00 100000000 25.10 1086.694054 3.03610729
D10 PCR:10^10 P12 35.67 33.81 1.87 - 9.00 1000000000 27.59 108.6694054 2.03610729
D11 PCR:10^10 P12 31.94 33.81 1.87 - 10.00 10000000000 30.91 10.86694054 1.03610729
D12 PCR:10^10 P12 33.83 33.81 1.87 - 11.00 100000000000 1.086694054 0.03610729
E1 PCR:10^3 rpoD 7.00 6.66 0.31 -
E2 PCR:10^3 rpoD 6.59 6.66 0.31 -
E3 PCR:10^3 rpoD 6.39 6.66 0.31 -
E4 PCR:10^4 rpoD 9.53 9.87 0.32 -
E5 PCR:10^4 rpoD 10.16 9.87 0.32 -
E6 PCR:10^4 rpoD 9.92 9.87 0.32 -
E7 PCR:10^5 rpoD 12.99 12.97 0.07 -
E8 PCR:10^5 rpoD 12.89 12.97 0.07 -
E9 PCR:10^5 rpoD 13.03 12.97 0.07 -
E10 PCR:10^6 rpoD 16.51 16.69 0.42 -
E11 PCR:10^6 rpoD 16.39 16.69 0.42 -
E12 PCR:10^6 rpoD 17.17 16.69 0.42 -
F1 PCR:10^7 rpoD 21.26 20.77 0.52 -
F2 PCR:10^7 rpoD 20.22 20.77 0.52 -
F3 PCR:10^7 rpoD 20.83 20.77 0.52 -
F4 PCR:10^8 rpoD 25.82 25.10 0.64 -
F5 PCR:10^8 rpoD 24.93 25.10 0.64 -
F6 PCR:10^8 rpoD 24.56 25.10 0.64 -
F7 PCR:10^9 rpoD 27.84 27.59 0.49 -
F8 PCR:10^9 rpoD 27.03 27.59 0.49 -
F9 PCR:10^9 rpoD 27.92 27.59 0.49 -
F10 PCR:10^10 rpoD 30.82 30.91 0.13 -
F11 PCR:10^10 rpoD 30.85 30.91 0.13 -
F12 PCR:10^10 rpoD 31.06 30.91 0.13 -
G1 PCR:10^11 rpoD -
G2 PCR:10^11 rpoD 35.64 -
G3 PCR:10^11 rpoD -
G4 PCR:10^2 rpoD 4.08 3.99 0.08 -
G5 PCR:10^2 rpoD 3.93 3.99 0.08 -
G6 PCR:10^2 rpoD 3.97 3.99 0.08 -
H1 PCR:10^11 P3 33.93 -
H2 PCR:10^11 P3 -
H3 PCR:10^11 P3 -
H4 PCR:10^2 P3 3.95 3.78 0.15 -
H5 PCR:10^2 P3 3.64 3.78 0.15 -
H6 PCR:10^2 P3 3.76 3.78 0.15 -
H7 PCR:10^11 P12 36.16 0.47 -
H8 PCR:10^11 P12 36.49 36.16 0.47 -
H9 PCR:10^11 P12 35.83 36.16 0.47 -
H10 PCR:10^2 P12 3.94 3.95 0.04 -
H11 PCR:10^2 P12 4.00 3.95 0.04 -
H12 PCR:10^2 P12 3.92 3.95 0.04 -
Analysis Parameters






Baseline range (from cycle no. ... to) n/a
Drift Correction OFF














1 12300 12100 12200 12.2 62906.8 1.16789E+11
10 1430 1410 1400 14.1333333










1 13000 13200 13100 13.1 66607.3 1.18438E+11
10 1380 1370 1370 13.7333333










1 13000 12900 12500 12.8 70932.2 1.08669E+11
10 1220 1210 1210 12.1333333








Copies/uL Log copies/uL Ct 1 Ct 2 Ct 3 MEAN Standard Deviation
1.16789E+11 11.067403 ND ND ND #DIV/0! #DIV/0!
11678928192 10.067403 ND ND ND #DIV/0! #DIV/0!
1167892819 9.06740299 4.04 ND 3.78 3.91 0.18384776
116789281.9 8.06740299 6.52 7.24 7.24 7 0.41569219
11678928.19 7.06740299 9.71 10.65 10.53 10.2966667 0.5115988
1167892.819 6.06740299 12.63 14 13.44 13.3566667 0.68879121
116789.2819 5.06740299 16.31 18.07 17.8 17.3933333 0.94785723
11678.92819 4.06740299 19.51 20.75 21.55 20.6033333 1.02787807
1167.892819 3.06740299 23.02 24.11 24.36 23.83 0.7125307
116.7892819 2.06740299 26.83 27.84 27.58 27.4166667 0.52443621
11.67892819 1.06740299 29.54 31.54 32.34 31.14 1.44222051
1.167892819 0.06740299 32.645 34.47 33.5575 1.29046988
P12 Calibrator PCR
Copies/uL Log copies/uL Ct Ct Ct MEAN Standard Deviation
1.18438E+11 11.0734902 ND ND ND #DIV/0! #DIV/0!
11843776883 10.0734902 ND ND ND #DIV/0! #DIV/0!
1184377688 9.07349022 4.49 ND 3.95 4.22 0.38183766
118437768.8 8.07349022 6.9 7.78 7.67 7.45 0.47947888
11843776.88 7.07349022 10.42 11.44 11.42 11.0933333 0.58320951
1184377.688 6.07349022 13.59 13.76 13.98 13.7766667 0.19553346
118437.7688 5.07349022 17.06 18.54 18.62 18.0733333 0.87848354
11843.77688 4.07349022 20.66 22.51 22.72 21.9633333 1.13359311
1184.377688 3.07349022 24.06 24.77 25.5 24.7766667 0.72002315
118.4377688 2.07349022 27.665 29.62 30.12 29.135 1.29737234
11.84377688 1.07349022 31.04 33.26 33.81 32.7033333 1.46650378
1.184377688 0.07349022 34.05 35.53 36.16 35.2466667 1.08315896
rpoD Calibrator PCR Slope B R^2 Efficiency
Copies/uL Log copies/uL Ct Ct Ct MEAN Standard Deviation P3 -3.3699 34.242 0.99915 98.04%
1.08669E+11 11.0361073 ND ND ND #DIV/0! #DIV/0! P12 -3.534 36.007 0.99842 91.85%
10866940543 10.0361073 ND ND ND #DIV/0! #DIV/0! rpoD -3.4828 34.111 0.99727 93.70%
1086694054 9.03610729 ND ND 3.99 3.99 #DIV/0!
108669405.4 8.03610729 6.42 6.87 6.66 6.65 0.2251666
10866940.54 7.03610729 9.05 9.65 9.87 9.52333333 0.42442117
1086694.054 6.03610729 12.55 11.79 12.97 12.4366667 0.59810813
108669.4054 5.03610729 15.58 15.51 16.69 15.9266667 0.66199194
10866.94054 4.03610729 19.28 20.76 20.77 20.27 0.85737973
1086.694054 3.03610729 22.65 24.99 25.1 24.2466667 1.38384729
108.6694054 2.03610729 26.23 27.6 27.59 27.14 0.78809898
10.86694054 1.03610729 29.59 31.85 30.91 30.7833333 1.135312
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# Date pH 
Temp 
(°C) pH range 
Temp 















2.35 1 9/19/11 8 30 8.02-8.17  28.9-29.2 1 mM CBS 2.92 2.81 1.04E+06 3.5 Ad2-1 
2.35 2 9/19/11 8 30 8.00-8.16 29.4-29.8 1 mM CBS 3.06 2.97 7.75E+05 3.4 Ad2-1 
2.39 3 9/27/11 6 30 6.04-6.39* 29.6-29.0* 1 mM CBS 2.71 2.55 5.69E+05 3.8 Ad2-1 
2.41 4 9/29/11 7 30 6.94-7.23* 29.4-29.4* 1 mM CBS 2.71 2.61 8.25E+05 3.8 Ad2-1 
2.43 5 10/3/11 9 30 9.03-8.93* 29.6-29.4* 1 mM CBS 2.71 2.61 1.13E+06 3.8 Ad2-1 
2.45 6 10/5/11 10 30 9.99-9.91* 29.9-30.2* 1 mM CBS 3.09 2.85 5.38E+05 3.3 Ad2-1 
2.47 7 
10/7/11 to 
10/8/11 8 15 8.01-8.02* 15.9-15.0* 1 mM CBS 3.14 3.08 5.50E+05 3.3 Ad2-1 
2.53 8 5/23/12 8 30 8.04-8.00 29.5-29.7 1 mM CBS 4.96 4.77 7.88E+05 3.1 Ad2-1 
2.55 9 5/26/12 9 30 9.03-9.03 29.5-29.9 1 mM CBS 4.77 4.56 9.88E+05 3.2 Ad2-1 
2.57 10 5/27/12 10 30 10.05-10.05 29.7-30.1 1 mM CBS 5.23 4.95 1.01E+06 3.0 Ad2-1 
2.59 11 5/31/12 6 30 5.93-6.52 29.9-30.0 1 mM CBS 3.16 3.10 8.88E+05 3.3 Ad2-1 
2.61 12 6/2/12 8 15 8.07-7.82 14.8-14.6 1 mM CBS 8.61 8.61 6.38E+05 3.6 Ad2-1 
2.63 13 6/6/12 9 15 8.97-8.77* 14.5-14.9* 1 mM CBS 8.86 9.29 9.63E+05 3.5 Ad2-1 
2.65 14 6/11/12 10 15 9.98-9.78* 15.2-14.9* 1 mM CBS 9.87 9.87 7.88E+05 3.1 Ad2-1 
2.67 15 6/11/12 6 15 5.98-6.30 15.3-15.1 1 mM CBS 4.82 4.77 8.13E+05 3.2 Ad2-1 
2.73 18 6/18/12 6 5 6.05-6.33 6.0-6.2 1 mM CBS 10.40 10.30 7.63E+05 3.0 Ad2-1 
2.75 19 6/22/12 9 15 8.98-8.84* 14.9-15.0* 1 mM CBS 10.33 10.13 1.18E+06 3.0 Ad2-1 
2.77 20 6/22/12 8 15 7.98-8.15 14.7-15.1 1 mM CBS 10.40 10.13 1.06E+06 3.0 Ad2-1 
2.79 21 6/23/12 6 30 5.94-6.22 30.4-30.5 1 mM CBS 9.83 9.77 1.13E+06 3.1 Ad2-1 
2.81 22 6/23/12 7 30 6.98-7.25 29.4-29.5 1 mM CBS 9.87 9.52 1.63E+06 3.1 Ad2-1 
2.87 23 8/24/12 6 15 6.00-6.21 14.8-15.2 1 mM PBS 9.16 8.93 5.13E+05 6.7 Ad2-1 
2.89 24 8/24/12 7 15 7.03-7.44 15.2-15.0 1 mM PBS 9.37 9.27 8.75E+05 3.3 Ad2-1 
2.91 25 8/28/12 6 5 6.03-6.11 5.1-5.7 1 mM PBS 9.37 9.05 9.50E+05 3.3 Ad2-1 
2.93 26 8/28/12 8 5 8.05-8.13* 5.7-5.5* 1 mM CBS 9.66 9.54 1.03E+06 3.2 Ad2-1 
2.99 29 9/10/12 8 5 8.02-8.00* 5.3-5.2* 1 mM CBS 13.35 13.12 9.13E+05 2.3 Ad2-1 
2.101 30 9/10/12 7 5 7.02-7.23* 5.1-5.5* 1 mM PBS 12.11 12.04 1.06E+06 2.5 Ad2-1 
2.107 31 9/13/12 8 15 8.02-8.28 15.0-15.1 1 mM CBS 10.01 9.91 1.39E+06 3.1 Ad2-1 
2.109 32 9/13/12 7 15 7.03-7.03 15.1-15.3 1 mM PBS 9.90 9.69 2.31E+06 3.1 Ad2-1 
2.115 33 10/26/12 6 15 6.01-6.08 14.9-15.3 1 mM PBS 8.98 8.73 1.50E+06 3.4 Ad2-1 
2.117 34 10/26/12 7 15 6.96-7.00 14.9-15.0 1 mM PBS 9.30 9.18 1.34E+06 3.3 Ad2-1 
2.119 35 10/27/12 6 5 6.02-6.09 4.6-4.2 1 mM PBS 11.02 10.52 1.33E+06 2.8 Ad2-1 
2.121 36 10/27/12 7 5 7.02-7.13 5.0-5.0 1 mM PBS 12.21 11.79 1.04E+06 2.5 Ad2-1 
2.131 38 11/9/12 8 30 7.98-8.10 29.4-30.0 1 mM CBS 9.41 9.14 1.18E+06 3.3 Ad2-1 
2.157 48 3/21/13 8 15 7.96-8.01 15.1-15.2 1 mM CBS 11.78 11.80 1.70E+05 2.6 Ad2-1 
2.158 49 3/21/13 8 15 7.96-8.03 15.0-15.0 1 mM CBS 12.07 11.77 2.39E+04 2.6 Ad2-1 
3.79 51 3/26/13 8 15 8.00-8.17 15.0-14.8 1 mM CBS 5.11 5.00 1.38E+06 2.0 Ad2-1 
3.103 56 5/21/13 6 30 6.02-6.05 29.9-29.8 1 mM PBS 3.33 3.24 3.58E+06 3.1 Ad2-1 
3.105 57 5/23/13 6 15 6.02-6.11 15.1-14.9 1 mM PBS 10.12 9.83 2.81E+06 3.0 Ad2-1 
3.109 59 
5/26-
5/27/13 10 5 10.00-9.80* 4.3-4.4* 10 mM BBS 10.31 10.22 1.31E+06 3.0 Ad2-1 
3.111 60 
5/26-
5/27/13 9 5 9.08-8.93 4.5-5.3 10 mM BBS 10.83 10.59 1.81E+06 2.8 Ad2-1 
3.117 61 5/31/13 9 15 8.99-8.97* 14.9-15.3* 10 mM BBS 12.40 12.26 1.00E+06 2.5 Ad2-1 
3.119 62 5/31/13 10 15 10.03-9.92 14.8-14.9 10 mM BBS 12.19 12.16 9.00E+05 2.5 Ad2-1 
3.121 63 6/3/13 6 5 5.98-6.07 5.3-4.6 1 mM PBS 10.40 10.13 2.31E+06 3.0 Ad2-1 
3.123 64 6/3/13 6 30 6.02-6.06 29.5-30.0 1 mM PBS 3.09 2.97 1.81E+06 3.3 Ad2-1 
3.125 65 
6/5/13-
6/6/13 9 5 8.98-8.93* 5.4-5.5* 10 mM BBS 12.61 12.30 1.48E+06 2.4 Ad2-1 
3.127 66 
6/5/13-
6/7/13 10 5 10.01-9.76 4.4-5.2 10 mM BBS 11.90 12.23 1.59E+06 2.6 Ad2-1 
3.131 68 6/14/13 10 15 10.02-9.96 15.0-15.1 10 mM BBS 12.83 12.52 1.31E+06 2.4 Ad2-1 
3.133 69 
6/18/13-
6/19/13 10 15 10.04-9.91 15.0-15.0 10 mM BBS 8.88 8.71 1.41E+06 3.5 Ad2-1 
3.257 MC1 3/24/15 8 15 7.98-8.10 15.1-15.1 1 mM CBS 10.736 10.489 1025000 3.5 Ad2-2 
3.261 MC2 3/30/15 8 15 7.98-8.07 15.0-15.1 1 mM CBS 10.546 10.404 987500 3.4 Ad2-2 
3.265 MC3 4/6/15 8 15 7.96-8.10 15.1-15.1 1 mM CBS 10.356 10.214 762500 3.8 Ad2-2 
*More data points were taken for temp/pH.         






















0.00 5 0.123 2.922
0.92 5 0.121 2.874
3.30 5 0.126 2.993
9.58 5 0.122 2.898
14.65 5 0.121 2.874
104.00 5 0.116 2.755
144.00 5 0.114 2.708
166.00 5 0.113 2.684






Actual-Time 0 >1 >2 >3 >4 >5 N N/No
CT-
(mg*min/L)
R1 1 0.32 TNTC 83 9 1037500 1 0.9
2 1.07 TNTC TNTC 84 1050000 1.01204819 3.0
3 9.37 TNTC TNTC 71 887500 0.85542169 26.3
4 17.52 TNTC 301 36 450000 0.43373494 49.1
5 102.00 90 6 0 1125 0.00108434 286.2
6 147.35 283 10 0 353.75 0.00034096 413.4
7 168.683333 37 2 0 46.25 4.4578E>05 473.3


















































































0.48 5 0.129 3.064
3.37 5 0.130 3.088
8.17 5 0.128 3.040
97.00 5 0.123 2.922
138.00 5 0.121 2.874
159.00 5 0.122 2.898





Actual-Time 0 >1 >2 >3 >4 >5 N N/No CT-(mg*min/L)
R2 1 0.00 TNTC 62 5 775000 1 0.0
2 0.17 TNTC TNTC 45 562500 0.72580645 0.5
3 0.67 TNTC TNTC 51 637500 0.82258065 2.0
4 5.05 TNTC 289 25 361250 0.46612903 15.0
5 11.13 TNTC 165 21 206250 0.26612903 33.1
6 96.00 70 5 0 875 0.00112903 285.0
7 141.416667 175 1 0 218.75 0.00028226 419.9
8 160.333333 40 0 0 50 6.4516E>05 476.0
























































0.000 5 0.114 2.708
0.933 5 0.110 2.613
2.900 5 0.110 2.613
10.617 5 0.110 2.613
20.650 5 0.105 2.494
30.467 5 0.106 2.518





VIABILITY Actual/Time 0 @1 @2 @3 @4 @5 N N/No
CT/
(mg*min/L)
1 0 TNTC 46 6 575000
2 0.00 TNTC 45 8 562500
0.00 568750 1 0
3 0.38 TNTC 42 4 525000 0.92307692 0.97730272
4 2.15 TNTC 153 17 191250 0.33626374 5.48139351
5 4.98 TNTC TNTC 101 5 126250 0.22197802 12.7049353
6 9.98 TNTC 157 23 19625 0.03450549 25.4523621
7 15.00 TNTC TNTC 31 3875 0.00681319 38.2422803
8.00 19.9833333 TNTC 146 6 1825 0.00320879 50.9472156
9 29.5333333 252 3 0 pH/6:/no/dilution/rule













































































0.000 5 0.114 2.708
0.767 5 0.113 2.684
4.667 5 0.112 2.660
10.183 5 0.110 2.613
20.017 5 0.111 2.637
30.700 5 0.109 2.589
49.667 5 0.106 2.518





VIABILITY Actual.Time 0 @1 @2 @3 @4 @5 N N/No
CT.
(mg*min/L)
1 0 TNTC 56 9 700000
2 0.00 TNTC 65 9 812500
3 0.17 TNTC 66 7 825000 1 0.4354711
4 1.97 TNTC TNTC 60 750000 0.90909091 5.13855899
5 9.98 TNTC TNTC TNTC 203 28 253750 0.30757576 26.0847189
6 30.43 TNTC TNTC 92 10 11500 0.01393939 79.517023
7 49.97 TNTC 65 5 0 812.5 0.00098485 130.554236














































































0.000 5 0.114 2.708
0.917 5 0.114 2.708
2.817 5 0.113 2.684
8.867 5 0.113 2.684
30.167 5 0.113 2.684
60.767 5 0.110 2.613
117.000 5 0.108 2.565
180.617 5 0.104 2.470





VIABILITY Actual.Time 0 =1 =2 =3 =4 =5 N N/No
CT.
(mg*min/L)
1 0 TNTC 73 9 912500
2 0.00 TNTC 76 12 950000
3 0.18 TNTC 90 7 1125000 1 0.47792953
4 10.10 TNTC 69 8 862500 0.76666667 26.3295724
5 29.98 TNTC TNTC 94 8 1175000 1.04444444 78.1632027
6 60.22 TNTC TNTC 43 7 537500 0.47777778 156.978127
7 119.98 TNTC 109 14 136250 0.12111111 312.783155
8.00 179.95 TNTC 99 9 12375 0.011 469.109561




9.1 30.2 1h15min open.stirring
9.22 29.2 2h








































































0.000 5 0.130 3.088
0.850 5 0.129 3.064
2.367 5 0.129 3.064
29.717 5 0.126 2.993
60.133 5 0.125 2.969
158.000 5 0.122 2.898
211.000 5 0.116 2.755
243.000 5 0.117 2.779
298.500 5 0.115 2.732
372.850 5 0.111 2.637





VIABILITY Actual.Time 0 >1 >2 >3 >4 >5 N N/No
CT.
(mg*min/L)
R1 1 0 TNTC 43 4 537500
0.00 537500 1 0
2 0.18 TNTC 33 8 412500 0.76744186 0.52300079
3 29.98 214 35 C 352500 0.65581395 85.5344022
4 59.97 180 35 3 331250 0.61627907 171.068804
5 158.07 TNTC TNTC 51 2 63750 0.11860465 450.921774
6 210.77 TNTC 58 4 7250 0.01348837 601.260728
7.00 242.983333 144 28 1 1800 0.00334884 693.166231
8 299.983333 92 18 1 1 115 0.00021395 855.771932
















































































0.000 5 0.132 3.135
0.800 5 0.132 3.135
3.150 5 0.131 3.112
8.017 5 0.131 3.112
28.833 5 0.131 3.112
58.600 5 0.127 3.017
120.000 5 0.129 3.064
601.000 5 0.128 3.040
603.000 5 0.129 3.064
670.000 5 0.130 3.088






Actual%Time 0 >1 >2 >3 >4 >5 N N/No
CT%
(mg*min/L)
1 0.13 TNTC 44 2 550000 1 0.41076801
2 30.08 TNTC TNTC 41 0 512500 0.93181818 92.6795329
3 60.02 TNTC 184 17 0 230000 0.41818182 184.896952
4 120.03 TNTC 39 2 0 48750 0.08863636 369.793903
5 600.62 20 2 0 0 0
6.00 670.083333 21 1 0 0









































































0.00 5 0.209 4.964
0.33 5 0.203 4.822
3.53 5 0.202 4.798
5.62 5 0.201 4.774
17.78 5 0.202 4.798
41.43 5 0.201 4.774






Actual/Time 0 ?1 ?2 ?3 ?4 ?5 N N/No
CT/
(mg*min/L)
R1 1 0.13 TNTC 63 6 787500 1 0.6
2 1.00 TNTC 90 7 1125000 1.42857143 4.8
3 10.17 TNTC 41 4 512500 0.65079365 48.5
4 29.93 TNTC TNTC 92 115000 0.14603175 142.9
5 50.00 TNTC TNTC 135 16875 0.02142857 238.7
6 70.05 TNTC 202 2525 0.00320635 334.4









































































0.00 5 0.201 4.774
0.47 5 0.198 4.703
2.50 5 0.197 4.679
8.47 5 0.192 4.561
15.92 5 0.190 4.513
23.50 5 0.199 4.727
48.82 5 0.196 4.656
75.67 5 0.190 4.513
100.68 5 0.188 4.466
118.50 5 0.188 4.466
160.57 5 0.188 4.466






Actual/Time 0 ?1 ?2 ?3 ?4 ?5 N N/No
CT/
(mg*min/L)
R1 1 0.13 TNTC 79 5 987500 1 0.6
2 0.92 TNTC 72 8 900000 0.91139241 4.2
3 10.05 TNTC 71 10 887500 0.89873418 45.9
4 25.08 TNTC 39 6 487500 0.49367089 114.4
5 50.13 TNTC 178 26 222500 0.22531646 228.7
6 74.80 TNTC 133 19 166250 0.16835443 341.3
7 100 TNTC TNTC 39 48750 0.04936709 456.3
8 119.966667 TNTC TNTC 83 8 10375 0.01050633 547.4
9 140.033333 TNTC 211 23 2637.5 0.00267089 638.9
10 160 TNTC 49 1 612.5 0.00062025 730.0









































































0.00 5 0.220 5.226
0.47 5 0.210 4.988
2.37 5 0.209 4.964
6.37 5 0.210 4.988
45.30 5 0.206 4.893
80.50 5 0.211 5.012
128.00 5 0.207 4.917
158.00 5 0.210 4.988
191.00 5 0.209 4.964






Actual/Time 0 >1 >2 >3 >4 >5 N N/No
CT/
(mg*min/L)
R1 1 0.13 TNTC 81 7 1012500 1 0.7
2 1.65 TNTC 70 4 875000 0.86419753 8.2
3 10.42 TNTC 71 2 887500 0.87654321 51.5
4 45.03 TNTC 30 3 375000 0.37037037 222.8
5 59.95 165 23 1 206250 0.2037037 296.7
6 80.00 TNTC 34 6 42500 0.04197531 395.9
7 100.5 146 16 1 18250 0.01802469 497.3
8 123.533333 TNTC 43 6 5375 0.00530864 611.3
9 140.916667 131 10 0 1637.5 0.00161728 697.3
10 160.4 89 20 2 0 111.25 0.00010988 793.7
11 190.8 5 0 0
12 199.966667 0 0 0












































































0.00 5 0.133 3.159
0.58 5 0.132 3.135
2.30 5 0.132 3.135
7.40 5 0.132 3.135
15.22 5 0.127 3.017
21.30 5 0.132 3.135





VIABILITY Actual/Time 0 ?1 ?2 ?3 ?4 ?5 N N/No
CT/
(mg*min/L)
R1 1 0.00 TNTC 53 2 662500
2 0.00 TNTC 62 2 775000
R2 3 0.12 TNTC 71 10 887500 1 0.4
4 0.42 TNTC 68 2 850000 0.95774648 1.3
5 0.87 TNTC TNTC 42 525000 0.5915493 2.7
6 5.00 TNTC 197 27 2 24625 0.02774648 15.5
7 10 135 15 0 1687.5 0.00190141 31.0
8 15.0333333 TNTC 19 1 0
9 20.5 213 2* 0 pH/6:/no/dilution/rule
10 24.9333333 145 1 1








































































0.00 6 0.302 8.608
0.65 6 0.308 8.779
2.67 6 0.295 8.409
5.08 6 0.302 8.608
6.80 6 0.301 8.580
19.42 6 0.300 8.551
30.82 6 0.308 8.779
62.00 6 0.295 8.409
90.00 6 0.303 8.637
120.00 6 0.299 8.523
150.82 6 0.305 8.694
196.00 6 0.305 8.694






Actual.Time 0 ?1 ?2 ?3 ?4 ?5 N N/No
CT.
(mg*min/L)
R1 1 0.15 TNTC 51 4 637500 1 1.3
2 2.03 TNTC 68 0 850000 1.33333333 17.5
3 9.95 TNTC 60 3 750000 1.17647059 85.7
4 29.90 TNTC 196 21 245000 0.38431373 257.4
5 62.18 TNTC TNTC 69 86250 0.13529412 535.3
6 90.00 TNTC TNTC 119 13 14875 0.02333333 774.7
7 119.85 TNTC TNTC 73 9125 0.01431373 1031.7
8 150.183333 TNTC. 225 25 2812.5 0.00441176 1292.8
9 190.316667 TNTC 113 1412.5 0.00221569 1638.3














































































0.00 6.00 0.311 8.865
0.45 6.00 0.315 8.979
2.97 7.50 0.262 9.335
4.85 7.50 0.276 9.834
7.28 7.50 0.276 9.834
9.27 7.50 0.263 9.371
15.63 7.50 0.258 9.192
17.95 6.00 0.317 9.036
61.00 7.50 0.262 9.335
120.00 7.50 0.257 9.157
180.00 7.50 0.254 9.050
238.00 7.50 0.259 9.228
323.00 7.50 0.258 9.192






Actual.Time 0 @1 @2 @3 @4 @5 N N/No CT.(mg*min/L)
R1 1 0.23 TNTC 77 9 962500 1 2.2
2 5.08 TNTC 63 7 787500 0.81818182 47.2
3 15.00 TNTC 44 4 550000 0.57142857 139.4
4 59.90 TNTC TNTC 154 26 192500 0.2 556.6
5 119.98 TNTC 230 25 28750 0.02987013 1115.0
6 179.68 TNTC 64 1 8000 0.00831169 1669.7
7 239.95 TNTC 185 11 0 2312.5 0.0024026 2229.8
8 323.883333 TNTC 59 5 737.5 0.00076623 3009.8
9 381.4 TNTC 61 2 762.5 0.00079221 3544.2
pH Temp time
8.97 14.5 0:00:00
8.71 15.2 2:09:00 add.NaOH.0.03mL
8.8 15.4 2:17:00 add.NaOH.0.03mL








































































0.00 7.50 0.277 9.869
0.98 7.50 0.276 9.834
2.75 7.50 0.280 9.976
5.80 7.50 0.277 9.869
44.75 7.50 0.276 9.834
153.00 7.50 0.274 9.762
243.00 7.50 0.279 9.941
330.00 7.50 0.276 9.834
437.00 7.50 0.276 9.834
531.00 7.50 0.277 9.869
600.00 7.50 0.278 9.905






Actual.Time 0 @1 @2 @3 @4 @5 N N/No
CT.
(mg*min/L)
R1 1 0.28 TNTC 63 2 787500 1 2.8
2 4.95 TNTC 69 4 862500 1.0952381 48.8
3 60.02 TNTC 51 7 637500 0.80952381 592.1
4 151.37 132 13 0 165000 0.20952381 1493.4
5 241.47 TNTC 45 5 56250 0.07142857 2382.3
6 329.42 99 2 0 12375 0.01571429 3250.1
7 436.3 151 16 3 0 1887.5 0.00239683 4304.6
8 530.2 102 5 1 1275 0.00161905 5231.0
9 599.733333 TNTC 41 7 1 512.5 0.00065079 5917.0












































































0.00 5.00 0.203 4.822
0.42 5.00 0.199 4.727
2.38 5.00 0.197 4.679
5.35 5.00 0.202 4.798
11.27 5.00 0.202 4.798
17.65 5.00 0.202 4.798
32.28 5.00 0.203 4.822






Actual.Time 0 >1 >2 >3 >4 >5 N N/No CT.(mg*min/L)
R1 1 0.18 TNTC 65 4 812500 1 0.9
2 0.77 TNTC 50 9 625000 0.76923077 3.7
3 5.17 TNTC 208 21 260000 0.32 24.6
4 10.27 TNTC TNTC 114 142500 0.17538462 48.9
5 20.08 TNTC TNTC 129 15 16125 0.01984615 95.7
6 27.45 TNTC TNTC 85 10625 0.01307692 130.9










































































0.00 7.50 0.292 10.404
1.00 7.50 0.285 10.154
3.10 7.50 0.291 10.368
5.55 7.50 0.290 10.333
15.23 7.50 0.291 10.368






Actual/Time 0 >1 >2 >3 >4 >5 N N/No
CT/
(mg*min/L)
R2 0 0 TNTC 44 3
R1 1 0.22 TNTC 61 4 762500 1 2.2
2 0.73 TNTC TNTC 82 1025000 1.3442623 7.6
3 5.00 TNTC TNTC 304 29 371250 0.48688525 51.5
4 14.70 TNTC TNTC 98 122500 0.16065574 151.4










































































0.00 7.50 0.290 10.333
1.38 7.50 0.284 10.119
3.53 7.50 0.283 10.083
15.73 7.50 0.284 10.119
54.50 7.50 0.284 10.119
117.55 7.50 0.281 10.012
183.10 7.50 0.283 10.083
262.00 7.50 0.286 10.190
385.00 7.50 0.288 10.261






Actual.Time 0 >1 >2 >3 >4 >5 N N/No
CT.
(mg*min/L)
R1 1 0.32 TNTC 94 9 1175000 1 3.2
2 5.05 TNTC 53 8 662500 0.56382979 51.2
3 14.83 TNTC 70 7 875000 0.74468085 150.3
4 57.57 TNTC 233 20 291250 0.24787234 583.2
5 120.00 TNTC TNTC 69 86250 0.07340426 1215.7
6 181.85 TNTC 117 8 14625 0.01244681 1842.3
7 261.03 TNTC 243 22 3037.5 0.00258511 2644.4
8 302.53 TNTC 135 12 1687.5 0.00143617 3064.9
9 384.32 TNTC 70 3 875 0.00074468 3893.4
10 470.00 121 10 151.25 0.00012872 4761.4
pH Temp time
8.98 14.9 0
8.84 15 2h5min added.NaOH.0.017mL
8.9 14.9 2h12min added.NaOH.0.017mL











































































0.00 7.50 0.292 10.404
1.03 7.50 0.289 10.297
3.45 7.50 0.289 10.297
15.68 7.50 0.280 9.976
17.92 7.50 0.284 10.119
42.03 7.50 0.289 10.297
75.97 7.50 0.281 10.012
104.67 7.50 0.283 10.083
136.33 7.50 0.284 10.119
218.73 7.50 0.282 10.048






Actual.Time 0 @1 @2 @3 @4 @5 N N/No
CT.
(mg*min/L)
R1 1 0.38 TNTC 85 9 1062500 1 3.9
2 5.00 TNTC 58 2 725000 0.68235294 50.7
3 15.05 TNTC 38 0 475000 0.44705882 152.5
4 44.45 TNTC 69 8 86250 0.08117647 450.4
5 75.03 TNTC 75 8 9375 0.00882353 760.3
6 104.83 177 27 0 2212.5 0.00208235 1062.3
7 135.48 94 3 0 1175 0.00110588 1372.9
8 181.23 169 7 0 211.25 0.00019882 1836.4
9 224.02 17 2 0












































































0.00 7.50 0.276 9.834
0.77 7.50 0.277 9.869
2.78 7.50 0.282 10.048
4.50 7.50 0.268 9.549
6.62 7.50 0.276 9.834






Actual/Time 0 @1 @2 @3 @4 @5 N N/No
CT/
(mg*min/L)
R2 0 0 TNTC 66 10 0.0
R1 1 0.15 TNTC 90 12 1125000 1 1.5
2 0.47 TNTC 53 5 662500 0.58888889 4.6
3 1.03 TNTC 43 537500 0.47777778 10.1
4 1.93 TNTC TNTC 35 43750 0.03888889 18.9
5 4.00 TNTC TNTC 48 60000 0.05333333 39.1
6 5.92 TNTC 106 13250 0.01177778 57.8
7 7.65 TNTC TNTC 30 3750 0.00333333 74.7
8 8.82 TNTC 49 9 612.5 0.00054444 86.1











































































0.00 7.50 0.277 9.869
0.65 7.50 0.259 small/spill
2.73 7.50 0.262
4.70 7.50 0.269 9.584
8.63 7.50 0.268 9.549
13.48 7.50 0.264 9.406






Actual/Time 0 @1 @2 @3 @4 @5 N N/No
CT/
(mg*min/L)
R2 0 0 TNTC 66 10 0.0
R1 1 0.15 TNTC 130 13 1625000 1 1.4
2 0.48 TNTC 103 14 1287500 0.79230769 4.6
3 1.02 TNTC 84 11 1050000 0.64615385 9.7
4 1.75 TNTC 66 15 825000 0.50769231 16.7
5 2.30 TNTC TNTC 73 912500 0.56153846 21.9
6 5.00 TNTC 212 13 265000 0.16307692 47.6
7 8.00 TNTC TNTC 69 86250 0.05307692 76.2
8 12.93 TNTC TNTC 108 13500 0.00830769 123.2
9 17.95 TNTC 133 12 1662.5 0.00102308 170.9









































































0.00 7.50 0.257 9.157
0.83 7.50 0.249 8.872
2.73 7.50 0.254 9.050
6.25 7.50 0.248 8.836
10.60 7.50 0.250 8.907
20.33 7.50 0.253 9.014
31.58 7.50 0.251 8.943






Actual/Time 0 @1 @2 @3 @4 @5 N N/No
CT/
(mg*min/L)
R1 1 0.12 TNTC 41 4 512500 1 1.0
2 0.27 TNTC 54 3 675000 1.31707317 2.4
3 0.62 TNTC 72 6 900000 1.75609756 5.5
4 1.03 249 36 2 380625 0.74268293 9.2
5 2.55 TNTC 140 17 175000 0.34146341 22.8
6 4.92 TNTC 79 11 98750 0.19268293 43.9
7 9.92 TNTC 206 49 43500 0.08487805 88.6
8 15.03 TNTC 37 5 4625 0.00902439 134.3
9 20.05 TNTC 236 9 2950 0.0057561 179.1
10 25.00 TNTC 140 6 1750 0.00341463 223.3
11 31.98 TNTC 78 1 975 0.00190244 285.7
12 38.02 TNTC 42 525 0.00102439 339.6















































































0.00 7.50 0.263 9.371
0.97 7.50 0.257 9.157
2.82 7.50 0.262 9.335
9.83 7.50 0.257 9.157
20.45 7.50 0.260 9.264
43.63 7.50 0.263 9.371
80.45 7.50 0.264 9.406






Actual/Time 0 @1 @2 @3 @4 @5 N N/No
CT/
(mg*min/L)
R1 1 0.17 TNTC 70 1 875000 1 1.5
2 0.43 TNTC 68 3 850000 0.97142857 4.0
3 2.23 TNTC 46 4 575000 0.65714286 20.7
4 4.98 TNTC 183 17 228750 0.26142857 46.2
5 20.18 TNTC TNTC 50 3 62500 0.07142857 187.2
6 43.08 TNTC TNTC 35 2 4375 0.005 399.5
7 60.47 TNTC 83 12 0 1037.5 0.00118571 560.8
8 80.12 TNTC 49 3 612.5 0.0007 743.0
9 100.25 287 12 0 358.75 0.00041 929.7













































































0.00 7.50 0.263 9.371
1.22 7.50 0.245 8.729
3.68 7.50 0.249 8.872
6.42 7.50 0.262 9.335
32.43 7.50 0.257 9.157
61.45 7.50 0.254 9.050
87.63 7.50 0.256 9.121






Actual.Time 0 ?1 ?2 ?3 ?4 ?5 N N/No
CT.
(mg*min/L)
R1 1 0.37 TNTC 76 9 950000 1 3.3
2 1.40 TNTC 60 5 750000 0.78947368 12.7
3 5.05 TNTC TNTC 36 450000 0.47368421 45.7
4 15.03 TNTC 118 12 147500 0.15526316 136.1
5 30.63 TNTC 160 17 20000 0.02105263 277.4
6 43.20 TNTC 32 2 4000 0.00421053 391.2
7 59.83 TNTC 189 16 2362.5 0.00248684 541.8
8 74.88 TNTC 112 4 1400 0.00147368 678.1
9 89.80 TNTC 64 1 800 0.00084211 813.1














































































0.00 7.50 0.271 9.656
1.30 7.50 0.266 9.477
3.98 7.50 0.260 9.264
6.43 7.50 0.269 9.584
31.25 7.50 0.273 9.727
63.97 7.50 0.267 9.513
118.63 7.50 0.266 9.477
181.00 7.50 0.273 9.727
234.00 7.50 0.269 9.584






Actual.Time 0 >1 >2 >3 >4 >5 N N/No CT.(mg*min/L)
R1 1 0.32 TNTC 82 14 1025000 1 3.0
2 1.93 TNTC 81 10 1012500 0.98780488 18.5
3 30.25 TNTC 56 6 700000 0.68292683 288.7
4 60.83 TNTC 231 29 288750 0.28170732 580.6
5 120.20 TNTC 115 10 143750 0.1402439 1147.3
6 180.05 TNTC 224 22 2 28000 0.02731707 1718.5
7 235.83 TNTC TNTC 32 2 4000 0.00390244 2251.0
8 309.33 TNTC 122 12 0 1525 0.0014878 2952.5











































































0.00 10.00 0.281 13.349
0.43 10.00 0.282 13.397
3.00 10.00 0.289 13.729
50.67 10.00 0.260 12.352
56.00 10.00 0.261 12.399
58.00 10.00 0.280 13.302
89.00 10.00 0.278 13.207
174.75 10.00 0.280 13.302
278.00 10.00 0.274 13.017
316.00 10.00 0.282 13.397
405.00 10.00 0.270 12.827






Actual/Time 0 >1 >2 >3 >4 >5 N N/No CT/(mg*min/L)
R1 1 0.22 TNTC 73 10 912500 1 2.8
2 4.98 TNTC 71 10 887500 0.97260274 65.4
3 48.63 246 27 1 307500 0.3369863 638.1
4 90.32 TNTC 39 3 48750 0.05342466 1185.0
5 139.58 TNTC 53 4 6625 0.00726027 1831.4
6 177.22 TNTC 32 3 4000 0.00438356 2325.1
7 219.67 TNTC 180 25 2250 0.00246575 2882.1
8 275.03 117 67 9 491.875 0.00053904 3608.5
9 315.15 56 36 5 260 0.00028493 4134.9
10 345.40 15 22 7
11 375.03 4 19
12 403.35 2 7
pH Temp time
8.02 5.3 0h










































































0.00 10.00 0.255 12.114
0.00 10.00 0.257 12.209
0.62 10.00 0.256 12.162
2.43 10.00 0.252 11.971
27.83 10.00 0.251 11.924
96.00 10.00 0.254 12.067
199.42 10.00 0.253 12.019
237.00 10.00 0.253 12.019






Actual/Time 0 ?1 ?2 ?3 ?4 ?5 N N/No CT/(mg*min/L)
R1 1 0.38 TNTC 85 7 1062500 1 4.6
2 5.32 TNTC 71 10 887500 0.83529412 64.0
3 29.90 TNTC 180 15 225000 0.21176471 360.0
4 62.67 163 17 0 20375 0.01917647 754.5
5 95.23 TNTC 30 1 3750 0.00352941 1146.5
6 142.37 98 6 1 1225 0.00115294 1714.0
7 198.05 TNTC 19 4
8 235.80 37 16 46.25 0.0000435 2838.9
9 269.97 27 4
pH Temp time
7.02 5.1 0h









































































0.00 7.50 0.281 10.012
0.93 7.50 0.279 9.941
3.07 7.50 0.279 9.941
31.95 7.50 0.276 9.834
65.20 7.50 0.277 9.869
115.40 7.50 0.276 9.834
180.70 7.50 0.277 9.869






Actual/Time 0 ?1 ?2 ?3 ?4 ?5 N N/No CT/(mg*min/L)
R1 1 0.37 TNTC 111 12 1387500 1 3.6
2 2.30 TNTC 97 18 1212500 0.87387387 22.8
3 7.97 TNTC 133 9 1662500 1.1981982 79.0
4 30.08 TNTC TNTC 52 650000 0.46846847 298.1
5 60.07 TNTC TNTC 63 78750 0.05675676 595.3
6 90.75 TNTC 39 6 4875 0.00351351 899.3
7 119.93 TNTC 104 9 1300 0.00093694 1188.5
8 150.10 TNTC 32 3 400 0.00028829 1487.5
9 179.72 244 6 305 0.00021982 1781.0
10 194.45 93 6 116.25 8.3784E?05 1927.0









































































0.00 7.50 0.278 9.905
1.78 7.50 0.279 9.941
3.80 7.50 0.275 9.798
19.50 7.50 0.266 9.477
57.67 7.50 0.273 9.727
101.80 7.50 0.271 9.656
120.30 7.50 0.268 9.549






Actual/Time 0 ?1 ?2 ?3 ?4 ?5 N N/No CT/(mg*min/L)
R1 1 0.30 TNTC 185 15 2312500 1 2.9
2 0.68 TNTC 163 17 2037500 0.88108108 6.6
3 1.37 TNTC 162 14 2025000 0.87567568 13.2
4 5.25 TNTC TNTC 109 1362500 0.58918919 50.9
5 19.97 TNTC 138 16 172500 0.07459459 193.5
6 40.07 TNTC 127 8 15875 0.00686486 388.3
7 59.55 TNTC 122 15 1525 0.00065946 577.1
8 80.62 TNTC 18 3
9 100.77 80 4 0 100 4.3243E?05 976.6








































































0.00 7.50 0.252 8.979
1.68 7.50 0.247 8.800
3.60 7.50 0.250 8.907
9.55 7.50 0.246 8.765
29.55 7.50 0.244 8.694
42.60 7.50 0.241 8.587






Actual/Time 0 >1 >2 >3 >4 >5 N N/No CT/(mg*min/L)
R1 1 0.33 TNTC 120 8 1500000 1 2.9
2 0.67 TNTC 73 6 912500 0.60833333 5.8
3 1.00 TNTC 71 10 887500 0.59166667 8.7
4 2.95 TNTC 295 33 390625 0.26041667 25.8
5 8.10 TNTC TNTC 31 38750 0.02583333 70.7
6 13.08 TNTC 65 6 8125 0.00541667 114.2
7 20.03 TNTC TNTC 14
8 27.97 TNTC 91 2 1137.5 0.00075833 244.1
9 36.18 TNTC 32 400 0.00026667 315.9
10 44.27 TNTC 9
11 52.58 TNTC 2













































































0.00 7.50 0.261 9.299
1.25 7.50 0.246 8.765
3.00 7.50 0.263 9.371
4.75 7.50 0.261 9.299
22.58 7.50 0.260 9.264
66.00 7.50 0.256 9.121






Actual/Time 0 A1 A2 A3 A4 A5 N N/No CT/(mg*min/L)
R1 1 0.20 TNTC 107 13 1337500 1 1.8
2 1.13 TNTC 82 9 1025000 0.76635514 10.4
3 19.88 TNTC 72 6 90000 0.06728972 182.5
4 40.12 TNTC 48 3 6000 0.00448598 368.3
5 75.03 TNTC 66 4 825 0.00061682 688.8












































































0.00 10.00 0.232 11.021
1.57 10.00 0.220 10.451
3.53 10.00 0.222 10.546
10.57 10.00 0.224 10.641
21.02 10.00 0.221 10.499
61.68 10.00 0.222 10.546
105.03 10.00 0.218 10.356






Actual/Time 0 ?1 ?2 ?3 ?4 ?5 N N/No CT/(mg*min/L)
R1 1 0.30 TNTC 106 6 1325000 1 3.2
2 1.13 TNTC 78 6 975000 0.73584906 11.9
3 4.92 TNTC 55 3 687500 0.51886792 51.7
4 10.17 TNTC 246 18 307500 0.23207547 106.9
5 22.83 TNTC 251 20 31375 0.02367925 240.2
6 30.95 TNTC 69 7 8625 0.00650943 325.6
7 45.18 TNTC *dropped/plate 17
8 60.25 TNTC 106 7 1325 0.001 633.8
9 79.88 TNTC 30 1 375 0.00028302 840.3
10 103.23 TNTC 7 1
11 120.18 293 2 pH/6:/no/dilution/rule









































































0.00 10.00 0.257 12.209
2.55 10.00 0.245 11.639
4.98 10.00 0.244 11.591
23.52 10.00 0.249 11.829
61.20 10.00 0.250 11.876
124.28 10.00 0.251 11.924
181.68 10.00 0.248 11.781
241.67 10.00 0.249 11.829






Actual/Time 0 ?1 ?2 ?3 ?4 ?5 N N/No CT/(mg*min/L)
R1 1 0.25 TNTC 83 9 1037500 1 2.9
2 4.02 TNTC 75 7 937500 0.90361446 47.4
3 25.47 TNTC 255 33 365625 0.35240964 300.3
4 60.10 TNTC 226 41 39750 0.03831325 708.8
5 120.48 TNTC TNTC 26
6 180.82 TNTC 62 2 775 0.00074699 2132.4
7 213.12 TNTC 30 1 375 0.00036145 2513.4
8 240.50 274 12 342.5 0.00033012 2836.3









































































0.00 10.00 0.198 9.406
1.17 10.00 0.194 9.216
3.98 10.00 0.193 9.169
10.33 10.00 0.194 9.216
30.25 10.00 0.193 9.169
54.65 10.00 0.191 9.074






Actual.Time 0 ?1 ?2 ?3 ?4 ?5 N N/No CT.(mg*min/L)
R1 1 0.32 TNTC 94 6 1175000 1 2.9
2 0.93 TNTC 100 13 1250000 1.06382979 8.5
3 2.88 TNTC 56 5 700000 0.59574468 26.4
4 10.05 TNTC 86 13 107500 0.09148936 91.9
5 20.33 TNTC 106 5 13250 0.0112766 185.9
6 30.02 TNTC 132 11 1650 0.00140426 274.5
7 41.22 213 14 1 266.25 0.0002266 376.9
8 54.38 3 0 0
9 64.82 0 0 0
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3/21/13 No'Control Experiment'Number 48
T'(°C) 15
pH 8
















0.00 10.00 0.248 11.781
0.95 10.00 0.248 11.781
3.50 10.00 0.248 11.781
31.32 10.00 0.249 11.829
60.75 10.00 0.252 11.971
80.62 10.00 0.247 11.734






Actual'Time 0 C1 C2 C3 C4 C5 N N/No CT'(mg*min/L)
R1 1 0.25 TNTC 136 12 170000 1 2.9
2 2.40 TNTC 140 17 175000 1.02941176 28.3
3 30.50 180 20 2 22500 0.13235294 359.8
4 60.40 207 21 3 2587.5 0.01522059 712.6
5 80.37 TNTC 89 6 1112.5 0.00654412 948.1
6 101.78 TNTC 45 2 562.5 0.00330882 1200.8
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3/21/13 No'Control Experiment'Number 49
T'(°C) 15
pH 8
















0.00 10.00 0.254 12.067
2.20 10.00 0.249 11.829
5.33 10.00 0.250 11.876
22.07 10.00 0.244 11.591
41.07 10.00 0.248 11.781
60.42 10.00 0.248 11.781






Actual'Time 0 C1 C2 C3 C4 C5 N N/No CT'(mg*min/L)
R1 1 0.28 TNTC 191 19 23875 1 3.3
2 1.15 TNTC 170 13 21250 0.89005236 13.5
3 5.07 TNTC 131 15 16375 0.68586387 59.7
4 21.17 TNTC TNTC 50 6250 0.2617801 249.2
5 40.13 TNTC 77 10 962.5 0.04031414 472.5
6 60.75 207 28 2 258.75 0.0108377 715.2
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3/26/13 CT(Control Experiment(Number 51
T((°C) 15
pH 8
















0.00 5.00 0.215 5.107
0.98 5.00 0.213 5.059
3.10 5.00 0.214 5.083
10.62 5.00 0.213 5.059
46.20 5.00 0.211 5.012
107.30 5.00 0.210 4.988
170.45 5.00 0.211 5.012
241.27 5.00 0.210 4.988
303.22 5.00 0.208 4.941
386.17 5.00 0.209 4.964






Actual(Time 0 A1 A2 A3 A4 A5 N N/No CT((mg*min/L)
R1 1 0.25 TNTC 110 16 1375000 1 1.3
2 10.28 TNTC 71 11 887500 0.64545455 51.5
3 45.12 173 13 2 216250 0.15727273 225.8
4 106.13 144 12 1 18000 0.01309091 531.2
5 165.23 TNTC 60 2 7500 0.00545455 827.0
6 240.15 TNTC 113 2 1412.5 0.00102727 1201.9
7 301.48 290 31 8 375 0.00027273 1508.8
8 360.13 67 2 83.75 6.0909EA05 1802.4









































































0.00 5.00 0.140 3.325
1.52 5.00 0.138 3.278
3.82 5.00 0.138 3.278
7.75 5.00 0.137 3.254
13.77 5.00 0.136 3.230
16.20 5.00 0.136 3.230
19.45 5.00 0.136 3.230






Actual/Time 0 >1 >2 >3 >4 >5 N N/No CT/(mg*min/L)
R1 1 0.25 TNTC 286 24 3575000 1 0.8
2 0.57 TNTC 292 43 4512500 1.26223776 1.8
3 0.78 TNTC 280 26 3500000 0.97902098 2.5
4 3.12 TNTC TNTC 125 1562500 0.43706294 10.1
5 6.95 TNTC TNTC 143 178750 0.05 22.5
6 10.90 TNTC TNTC TNTC
7 15.38 TNTC TNTC 93 11625 0.00325175 49.9
8 18.88 TNTC TNTC 48 6000 0.00167832 61.2
9 22.03 TNTC 110 15 1375 0.00038462 71.4
10 25.00 TNTC 41 4 512.5 0.00014336 81.0
1/Normal 0.25 TNTC 121 10 1512500 1 0.8
4/Normal 3.12 TNTC 144 12 180000 0.11900826 10.1











































































0.00 10.00 0.213 10.119
1.38 10.00 0.208 9.881
3.80 10.00 0.208 9.881
11.20 10.00 0.209 9.929
26.30 10.00 0.207 9.834
41.43 10.00 0.208 9.881
72.82 10.00 0.205 9.739
85.97 10.00 0.206 9.786






Actual/Time 0 ?1 ?2 ?3 ?4 ?5 N N/No CT/(mg*min/L)
R1 1 0.27 TNTC 225 21 2812500 1 2.6
2 0.52 TNTC 204 26 2550000 0.90666667 5.1
3 2.92 TNTC TNTC 146 1825000 0.64888889 28.7
4 5.93 TNTC TNTC 101 1262500 0.44888889 58.3
5 9.98 TNTC TNTC 274 342500 0.12177778 98.2
6 15.07 TNTC TNTC 65 81250 0.02888889 148.2
7 25.08 TNTC TNTC 57 7125 0.00253333 246.7
8 40.53 TNTC 93 11 1162.5 0.00041333 398.6
9 55.70 130 7 1 162.5 5.7778E?05 547.7
10 70.48 17 5 0
11 85.00 3 0









































































0.00 10.00 0.217 10.309
3.32 10.00 0.216 10.261
10.77 10.00 0.215 10.214
60.87 10.00 0.215 10.214
123.78 10.00 0.217 10.309
173.22 10.00 0.216 10.261
347.43 10.00 0.215 10.214
975.97 10.00 0.215 10.214
1221.42 10.00 0.214 10.166






Actual2Time 0 %1 %2 %3 %4 %5 N N/No CT2(mg*min/L)
R1 1 0.50 TNTC 105 5 1312500 1 5.1
2 10.00 TNTC 94 11 1175000 0.8952381 102.2
4 122.07 TNTC 99 5 1237500 0.94285714 1248.1
5 179.97 TNTC TNTC 66 825000 0.62857143 1840.0
6 349.22 TNTC TNTC 69 862500 0.65714286 3570.5
7 968.30 TNTC TNTC TNTC 55 68750 0.05238095 9900.2
8 1215.43 TNTC TNTC 145 18125 0.01380952 12427.0
9 1392.13 TNTC TNTC 77 9625 0.00733333 14233.6










































































0.00 10.00 0.228 10.831
3.55 10.00 0.217 10.309
11.18 10.00 0.224 10.641
61.63 10.00 0.224 10.641
123.72 10.00 0.224 10.641
173.50 10.00 0.224 10.641
340.93 10.00 0.225 10.689
967.98 10.00 0.225 10.689
1217.37 10.00 0.222 10.546






Actual2Time 0 %1 %2 %3 %4 %5 N N/No CT2(mg*min/L)
R1 1 0.42 TNTC 145 8 1812500 1 4.4
2 10.50 TNTC 103 10 1287500 0.71034483 111.2
3 60.90 TNTC 98 9 1225000 0.67586207 644.8
4 120.52 TNTC 78 7 975000 0.53793103 1276.1
5 178.75 TNTC TNTC 48 600000 0.33103448 1892.7
6 347.77 TNTC 80 9 100000 0.05517241 3682.3
7 965.42 TNTC 64 13 1 800 0.00044138 10222.4
8 1213.98 125 15 3 156.25 8.6207E%05 12854.3
9 1390.85 71 7 0 88.75 4.8966E%05 14727.1







































































0.00 15.00 0.174 12.399
1.77 15.00 0.172 12.257
10.58 15.00 0.173 12.328
80.95 15.00 0.174 12.399
150.83 15.00 0.172 12.257
242.02 15.00 0.173 12.328
310.15 15.00 0.172 12.257
362.02 15.00 0.170 12.114
420.70 15.00 0.171 12.185






Actual.Time 0 >1 >2 >3 >4 >5 N N/No CT.(mg*min/L)
R1 1 0.28 TNTC 80 6 1000000 1 3.5
2 2.12 TNTC 64 9 800000 0.8 25.9
3 9.97 TNTC 70 5 875000 0.875 122.2
4 60.62 TNTC 186 22 232500 0.2325 743.0
5 149.98 TNTC 129 19 16125 0.016125 1838.3
6 241.05 TNTC 196 14 2450 0.00245 2954.4
7 309.00 TNTC 60 3 750 0.00075 3787.3
8 361.10 TNTC 36 450 0.00045 4425.8
9 392.02 166 16 207.5 0.0002075 4804.8
10 420.48 12 4
11 451.83 18 2










































































0.00 15.00 0.171 12.185
2.17 15.00 0.173 12.328
11.25 15.00 0.171 12.185
88.95 15.00 0.172 12.257
174.17 15.00 0.171 12.185
275.75 15.00 0.169 12.043
364.80 15.00 0.169 12.043
494.27 15.00 0.170 12.114






Actual.Time 0 >1 >2 >3 >4 >5 N N/No CT.(mg*min/L)
R1 1 0.33 TNTC 72 10 900000 1 4.1
2 1.92 TNTC 76 8 950000 1.05555556 23.3
3 10.62 TNTC 79 5 987500 1.09722222 129.1
4 90.92 TNTC TNTC 41 512500 0.56944444 1105.4
5 176.35 TNTC 212 24 265000 0.29444444 2144.2
6 274.20 TNTC TNTC 69 6 86250 0.09583333 3333.9
7 363.73 TNTC 172 22 21500 0.02388889 4422.5
8 490.85 TNTC TNTC 48 6000 0.00666667 5968.0











































































0.00 10.00 0.219 10.404
1.37 10.00 0.215 10.214
3.55 10.00 0.215 10.214
18.58 10.00 0.214 10.166
31.13 10.00 0.213 10.119
46.37 10.00 0.214 10.166
61.68 10.00 0.213 10.119
93.98 10.00 0.213 10.119
135.98 10.00 0.212 10.071






Actual.Time 0 >1 >2 >3 >4 >5 N N/No CT.(mg*min/L)
R1 1 0.32 TNTC 185 16 2312500 1 3.2
2 1.08 TNTC 186 22 2325000 1.00540541 11.0
3 14.88 TNTC TNTC 41 512500 0.22162162 150.8
4 30.23 TNTC TNTC 82 102500 0.04432432 306.4
5 45.45 TNTC TNTC 226 21 28250 0.01221622 460.6
6 60.50 TNTC TNTC 77 9625 0.00416216 613.1
7 85.87 TNTC 87 12 1087.5 0.00047027 870.2
8 104.95 TNTC 40 1 500 0.00021622 1063.6
9 134.98 101 9 126.25 5.4595E>05 1368.0









































































0.00 5.00 0.130 3.088
2.40 5.00 0.126 2.993
4.53 5.00 0.130 3.088
11.60 5.00 0.124 2.945
17.60 5.00 0.124 2.945
24.93 5.00 0.125 2.969
31.30 5.00 0.124 2.945






Actual.Time 0 >1 >2 >3 >4 >5 N N/No CT.(mg*min/L)
R1 1 0.23 TNTC 145 24 1812500 1 0.7
2 0.47 TNTC 192 30 3075000 1.69655172 1.4
3 1.97 TNTC 182 14 2275000 1.25517241 5.8
4 8.15 TNTC 91 7 113750 0.06275862 24.2
5 16.65 239 25 2 2987.5 0.00164828 49.4
6 23.32 223 20 2 278.75 0.00015379 69.2
7 26.52 51 12 0 63.75 3.5172E>05 78.7
8 30.13 22 1 0
9 33.12 6 0
10 35.87 6 0










































































0.00 15.00 0.177 12.613
1.15 15.00 0.164 11.686
15.08 15.00 0.172 12.257
135.15 15.00 0.172 12.257
350.25 15.00 0.173 12.328
532.05 15.00 0.177 12.613
689.02 15.00 0.173 12.328
1071.62 15.00 0.173 12.328
1153.33 15.00 0.175 12.470






Actual0Time 0 &1 &2 &3 &4 &5 N N/No CT0(mg*min/L)
R1 1 0.37 TNTC 118 16 1475000 1 4.5
2 14.12 TNTC 116 10 1450000 0.98305085 173.7
3 132.12 167 17 1 208750 0.14152542 1625.6
4 349.32 90 10 3 11250 0.00762712 4298.0
5 531.00 249 25 2 3112.5 0.00211017 6533.4
6 691.02 TNTC 79 9 1 987.5 0.00066949 8502.3
7 1069.97 59 0 0 73.75 0.00005 13164.9
8 1149.67 32 2 1 40 2.7119E&05 14145.5
9 1200.23 19 2 0










































































0.00 15.00 0.167 11.900
2.13 15.00 0.171 12.185
10.23 15.00 0.175 12.470
127.45 15.00 0.173 12.328
375.45 15.00 0.170 12.114
527.12 15.00 0.172 12.257
682.22 15.00 0.172 12.257
1064.02 15.00 0.170 12.114
1372.80 15.00 0.172 12.257
1605.77 15.00 0.172 12.257
1767.87 15.00 0.170 12.114
1934.75 15.00 0.171 12.185






Actual1Time 0 &1 &2 &3 &4 &5 N N/No CT1(mg*min/L)
R1 1 0.42 TNTC 127 7 1.59E+06 1 5.1
2 11.95 TNTC 93 3 1162500 0.732283465 146.2
3 122.68 TNTC 83 4 1037500 0.653543307 1500.8
4 377.50 TNTC 261 43 4 431875 0.272047244 4617.9
5 525.18 TNTC 181 32 313125 0.197244094 6424.5
6 684.20 TNTC 82 4 102500 0.064566929 8369.7
7 1060.47 TNTC 134 6 16750 0.010551181 12972.5
8 1332.62 TNTC 32 6 4000 0.002519685 16301.6
9 1585.10 TNTC 121 13 1512.5 0.000952756 19390.2
10 1766.32 TNTC 47 3 587.5 0.000370079 21607.0
11 1932.00 133 14 2 166.25 0.000104724 23633.7
12 1990.78 76 12 1 95 5.98425E&05 24352.8














































































0.00 15.00 0.180 12.827
1.43 15.00 0.177 12.613
6.15 15.00 0.175 12.470
64.28 15.00 0.177 12.613
149.02 15.00 0.176 12.542
241.77 15.00 0.176 12.542
377.33 15.00 0.177 12.613
564.30 15.00 0.175 12.470






Actual/Time 0 @1 @2 @3 @4 @5 N N/No CT/(mg*min/L)
R1 1 0.52 TNTC 105 11 1312500 1 6.5
2 3.05 TNTC 70 5 875000 0.66666667 38.2
3 60.63 TNTC 64 9 800000 0.60952381 759.4
4 150.70 TNTC TNTC 30 375000 0.28571429 1887.3
5 240.47 TNTC 139 10 173750 0.13238095 3011.5
6 379.42 TNTC 169 14 21125 0.01609524 4751.7
7 562.92 TNTC 103 11 1287.5 0.00098095 7049.8
8 616.65 TNTC 105 5 1312.5 0.001 7722.8









































































0.00 10.00 0.187 8.884
1.15 10.00 0.186 8.836
4.08 10.00 0.191 9.074
61.60 10.00 0.185 8.789
263.00 10.00 0.186 8.836
693.77 10.00 0.185 8.789
793.00 10.00 0.184 8.741
872.93 10.00 0.183 8.694
971.37 10.00 0.182 8.646
1152.10 10.00 0.181 8.599
1205.08 10.00 0.180 8.551
1239.17 10.00 0.179 8.504






Actual1Time 0 &1 &2 &3 &4 &5 N N/No CT1(mg*min/L)
R1 1 0.42 TNTC 113 14 1412500 1 3.6
2 3.02 TNTC 116 8 1450000 1.02654867 26.3
3 60.37 TNTC 73 4 912500 0.6460177 525.8
4 261.40 TNTC 39 487500 0.34513274 2276.6
5 692.12 162 19 6 2025 0.00143363 6027.9
6 792.07 TNTC 95 10 1187.5 0.00084071 6898.4
7 871.95 TNTC 44 2 550 0.00038938 7594.2
8 967.87 229 33 5 349.375 0.00024735 8429.6
9 1044.28 147 14 1 183.75 0.00013009 9095.1
10 1151.20 67 8 0 83.75 5.9292E&05 10026.3
11 1204.07 37 1 1 46.25 3.2743E&05 10486.7
12 1235.58 21 2
13 1268.12 13 0
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3/24/15 3.257 Experiment2Number MC1
T2(°C) 15
pH 8















0.00 10.00 0.226 10.736
1.68 10.00 0.223 10.594
3.57 10.00 0.222 10.546
11.37 10.00 0.220 10.451
60.72 10.00 0.218 10.356






Actual2Time 0 A1 A2 A3 A4 A5 N N/No CT2(mg*min/L)
R1 1 0.48 TNTC 82 9 1025000 1 5.1
2 9.88 TNTC TNTC 65 5 812500 0.79268293 103.7
3 59.52 TNTC 172 26 1 21500 0.02097561 624.3
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3/30/15 3.261 Experiment2Number MC2
T2(°C) 15
pH 8















0.00 10.00 0.222 10.546
1.75 10.00 0.221 10.499
6.08 10.00 0.218 10.356
9.15 10.00 0.219 10.404
31.10 10.00 0.219 10.404






Actual2Time 0 B1 B2 B3 B4 B5 N N/No CT2(mg*min/L)
R1 1 0.45 TNTC 79 2 987500 1 4.7
2 4.72 TNTC TNTC 65 6 812500 0.82278481 49.1
3 30.02 TNTC 75 9 0 93750 0.09493671 312.3



















































	  	   337 
 
 
4/6/15 3.265 Experiment2Number MC3
T2(°C) 15
pH 8















0.00 10.00 0.218 10.356
1.53 10.00 0.217 10.309
3.63 10.00 0.215 10.214
5.88 10.00 0.215 10.214
21.07 10.00 0.215 10.214
142.50 10.00 0.214 10.166






Actual2Time 0 B1 B2 B3 B4 B5 N N/No CT2(mg*min/L)
R1 1 0.53 TNTC 61 5 762500 1 5.4
2 20.00 TNTC 115 9 0 143750 0.18852459 204.3
3 141.05 TNTC 132 6 0 1650 0.00216393 1440.7























































Pos Name Ct SYBR Ct Mean SYBR Ct Dev. SYBR Expr. Level SYBR Range SYBR 3/30/15
A1 1A DNA:100 E1A 27.17 26.99 0.19
A2 1A DNA:100 E1A 27.01 26.99 0.19
A3 1A DNA:100 E1A 26.79 26.99 0.19
A4 2A DNA:100 E1A 26.27 26.22 0.05
A5 2A DNA:100 E1A 26.22 26.22 0.05
A6 2A DNA:100 E1A 26.17 26.22 0.05
A7 3A DNA:100 E1A 25.81 25.50 0.28
A8 3A DNA:100 E1A 25.43 25.50 0.28
A9 3A DNA:100 E1A 25.27 25.50 0.28
A10 4A DNA:100 E1A 26.12 26.16 0.13
A11 4A DNA:100 E1A 26.05 26.16 0.13
A12 4A DNA:100 E1A 26.30 26.16 0.13
B1 1A DNA:100 Hex 28.09 27.60 0.55
B2 1A DNA:100 Hex 27.70 27.60 0.55
B3 1A DNA:100 Hex 27.01 27.60 0.55
B4 2A DNA:100 Hex 27.16 27.05 0.11 0.770 0.675 - 0.877
B5 2A DNA:100 Hex 27.04 27.05 0.11 0.770 0.675 - 0.877
B6 2A DNA:100 Hex 26.95 27.05 0.11 0.770 0.675 - 0.877
B7 3A DNA:100 Hex 26.32 26.24 0.21 0.792 0.647 - 0.969
B8 3A DNA:100 Hex 26.41 26.24 0.21 0.792 0.647 - 0.969
B9 3A DNA:100 Hex 26.01 26.24 0.21 0.792 0.647 - 0.969
B10 4A DNA:100 Hex 27.04 27.04 0.21 0.970 0.838 - 1.12
B11 4A DNA:100 Hex 26.83 27.04 0.21 0.970 0.838 - 1.12
B12 4A DNA:100 Hex 27.24 27.04 0.21 0.970 0.838 - 1.12
C1 1A DNA:100 Actin2 29.85 29.18 0.61
C2 1A DNA:100 Actin2 29.03 29.18 0.61
C3 1A DNA:100 Actin2 28.66 29.18 0.61
C4 2A DNA:100 Actin2 28.43 28.25 0.16
C5 2A DNA:100 Actin2 28.20 28.25 0.16
C6 2A DNA:100 Actin2 28.13 28.25 0.16
C7 3A DNA:100 Actin2 27.72 27.49 0.20
C8 3A DNA:100 Actin2 27.39 27.49 0.20
C9 3A DNA:100 Actin2 27.35 27.49 0.20
C10 4A DNA:100 Actin2 28.52 28.58 0.05
C11 4A DNA:100 Actin2 28.60 28.58 0.05
C12 4A DNA:100 Actin2 28.61 28.58 0.05
D1 1V DNA:1 E1A 17.80 17.50 0.30
D2 1V DNA:1 E1A 17.48 17.50 0.30
D3 1V DNA:1 E1A 17.21 17.50 0.30
D4 2V DNA:1 E1A 17.98 17.63 0.31
D5 2V DNA:1 E1A 17.48 17.63 0.31
D6 2V DNA:1 E1A 17.42 17.63 0.31
D7 3V DNA:1 E1A 17.36 17.47 0.10
D8 3V DNA:1 E1A 17.51 17.47 0.10
D9 3V DNA:1 E1A 17.56 17.47 0.10
D10 4V DNA:1 E1A 17.58 17.40 0.16
D11 4V DNA:1 E1A 17.34 17.40 0.16
D12 4V DNA:1 E1A 17.29 17.40 0.16
E1 1V DNA:1 Hex 18.32 17.99 0.29
E2 1V DNA:1 Hex 17.84 17.99 0.29
E3 1V DNA:1 Hex 17.81 17.99 0.29
E4 2V DNA:1 Hex 18.19 17.68 0.48
E5 2V DNA:1 Hex 17.63 17.68 0.48
E6 2V DNA:1 Hex 17.22 17.68 0.48
E7 3V DNA:1 Hex 18.58 18.59 0.12
E8 3V DNA:1 Hex 18.71 18.59 0.12
E9 3V DNA:1 Hex 18.47 18.59 0.12
E10 4V DNA:1 Hex 18.17 18.34 0.23
E11 4V DNA:1 Hex 18.26 18.34 0.23
E12 4V DNA:1 Hex 18.60 18.34 0.23
F1 1V DNA:1 Actin2 35.89 35.43 0.66
F2 1V DNA:1 Actin2
F3 1V DNA:1 Actin2 34.97 35.43 0.66
F4 2V DNA:1 Actin2
F5 2V DNA:1 Actin2
F6 2V DNA:1 Actin2
F7 3V DNA:1 Actin2 34.79 34.86 0.11
F8 3V DNA:1 Actin2 34.94 34.86 0.11
F9 3V DNA:1 Actin2
F10 4V DNA:1 Actin2
F11 4V DNA:1 Actin2 35.48 34.78 1.00
F12 4V DNA:1 Actin2 34.07 34.78 1.00
G1 1V DNA:10 E1A 21.71 21.45 0.30
G2 1V DNA:10 E1A 21.53 21.45 0.30
G3 1V DNA:10 E1A 21.11 21.45 0.30
G4 1V DNA:100 E1A 24.30 24.12 0.16
G5 1V DNA:100 E1A 24.08 24.12 0.16
G6 1V DNA:100 E1A 23.98 24.12 0.16
G7 1V DNA:1000 E1A 27.57 27.40 0.20
G8 1V DNA:1000 E1A 27.18 27.40 0.20
G9 1V DNA:1000 E1A 27.44 27.40 0.20
G10 No template E1A
G11 No template E1A
G12 No template E1A
H1 1V DNA:10 Hex 22.42 22.27 0.14
H2 1V DNA:10 Hex 22.23 22.27 0.14
H3 1V DNA:10 Hex 22.15 22.27 0.14
H4 1V DNA:100 Hex 25.28 25.21 0.14
H5 1V DNA:100 Hex 25.30 25.21 0.14
H6 1V DNA:100 Hex 25.06 25.21 0.14
H7 1V DNA:1000 Hex 28.57 28.58 0.29
H8 1V DNA:1000 Hex 28.88 28.58 0.29
H9 1V DNA:1000 Hex 28.29 28.58 0.29
H10 No template Hex
H11 No template Hex
H12 No template Hex
Analysis Parameters






Baseline range (from cycle no. ... to) n/a
Drift Correction OFF



















1A 100 26.99 27.60 29.18 1 1 5.1E+04 6.7E+04 3.0E+04 1.68E+02 2.20E+02
2A 100 26.22 27.05 28.25 0.89502507 0.76843759 8.5E+04 9.4E+04 5.4E+04 1.57E+02 1.74E+02
3A 100 25.50 26.24 27.49 0.87055056 0.79553648 1.4E+05 1.6E+05 8.7E+04 1.57E+02 1.80E+02
4A 100 26.16 27.04 28.58 1.17283495 0.97265495 8.9E+04 9.5E+04 4.4E+04 2.00E+02 2.15E+02
1V 1 17.50 17.99 1.00 1.00 2.7E+05 2.7E+05
2V 1 17.63 17.68 0.92 1.21 2.5E+05 3.3E+05
3V 1 17.47 18.59 1.02 0.69 2.8E+05 1.9E+05
4V 1 17.40 18.34 1.07 0.80 2.9E+05 2.2E+05
1V 10 21.45 22.27 2.0E+05 1.9E+05
1V 100 24.12 25.21 3.4E+05 3.0E+05
1V 1000 27.40 28.58 3.9E+05 3.6E+05
No template 1




Pos Name Ct SYBR Ct Mean SYBR Ct Dev. SYBR Expr. Level SYBR Range SYBR
A1 1B DNA:100 E1A 28.61 28.41 0.42
A2 1B DNA:100 E1A 28.70 28.41 0.42
A3 1B DNA:100 E1A 27.92 28.41 0.42
A4 2B DNA:100 E1A 29.23 28.50 0.63
A5 2B DNA:100 E1A 28.14 28.50 0.63
A6 2B DNA:100 E1A 28.14 28.50 0.63
A7 3B DNA:100 E1A 28.40 28.47 0.14
A8 3B DNA:100 E1A 28.37 28.47 0.14
A9 3B DNA:100 E1A 28.63 28.47 0.14
A10 4B DNA:100 E1A 29.44 29.07 0.32
A11 4B DNA:100 E1A 28.94 29.07 0.32
A12 4B DNA:100 E1A 28.85 29.07 0.32
B1 1B DNA:100 Hex 28.98 28.75 0.42
B2 1B DNA:100 Hex 29.00 28.75 0.42
B3 1B DNA:100 Hex 28.27 28.75 0.42
B4 2B DNA:100 Hex 29.37 29.14 0.24
B5 2B DNA:100 Hex 28.88 29.14 0.24
B6 2B DNA:100 Hex 29.16 29.14 0.24
B7 3B DNA:100 Hex 29.22 29.27 0.05
B8 3B DNA:100 Hex 29.26 29.27 0.05
B9 3B DNA:100 Hex 29.33 29.27 0.05
B10 4B DNA:100 Hex 29.84 29.75 0.10
B11 4B DNA:100 Hex 29.64 29.75 0.10
B12 4B DNA:100 Hex 29.77 29.75 0.10
C1 1B DNA:100 Actin2 28.97 28.19 0.69
C2 1B DNA:100 Actin2 28.00 28.19 0.69
C3 1B DNA:100 Actin2 27.62 28.19 0.69
C4 2B DNA:100 Actin2 27.66 27.53 0.11
C5 2B DNA:100 Actin2 27.47 27.53 0.11
C6 2B DNA:100 Actin2 27.45 27.53 0.11
C7 3B DNA:100 Actin2 27.18 27.13 0.08
C8 3B DNA:100 Actin2 27.17 27.13 0.08
C9 3B DNA:100 Actin2 27.04 27.13 0.08
C10 4B DNA:100 Actin2 27.51 27.74 0.41
C11 4B DNA:100 Actin2 27.50 27.74 0.41
C12 4B DNA:100 Actin2 28.22 27.74 0.41
D1 1C DNA:100 E1A 26.62 26.15 0.41
D2 1C DNA:100 E1A 25.90 26.15 0.41
D3 1C DNA:100 E1A 25.94 26.15 0.41
D4 2C DNA:100 E1A 26.81 26.77 0.20
D5 2C DNA:100 E1A 26.56 26.77 0.20
D6 2C DNA:100 E1A 26.95 26.77 0.20
D7 3C DNA:100 E1A 29.62 29.49 0.15
D8 3C DNA:100 E1A 29.33 29.49 0.15
D9 3C DNA:100 E1A 29.50 29.49 0.15
D10 4C DNA:100 E1A 30.26 30.38 0.14
D11 4C DNA:100 E1A 30.35 30.38 0.14
D12 4C DNA:100 E1A 30.54 30.38 0.14
E1 1C DNA:100 Hex 27.42 26.91 0.44
E2 1C DNA:100 Hex 26.65 26.91 0.44
E3 1C DNA:100 Hex 26.67 26.91 0.44
E4 2C DNA:100 Hex 27.64 27.52 0.12 0.360 0.305 - 0.426
E5 2C DNA:100 Hex 27.40 27.52 0.12 0.360 0.305 - 0.426
E6 2C DNA:100 Hex 27.51 27.52 0.12 0.360 0.305 - 0.426
E7 3C DNA:100 Hex 30.04 30.20 0.15 4.700E-2X 3.98E-02 - 5.56E-02
E8 3C DNA:100 Hex 30.34 30.20 0.15 4.700E-2X 3.98E-02 - 5.56E-02
E9 3C DNA:100 Hex 30.22 30.20 0.15 4.700E-2X 3.98E-02 - 5.56E-02
E10 4C DNA:100 Hex 31.09 31.17 0.08 3.920E-2X 3.46E-02 - 4.44E-02
E11 4C DNA:100 Hex 31.16 31.17 0.08 3.920E-2X 3.46E-02 - 4.44E-02
E12 4C DNA:100 Hex 31.25 31.17 0.08 3.920E-2X 3.46E-02 - 4.44E-02
F1 1C DNA:100 Actin2 28.62 27.77 0.75
F2 1C DNA:100 Actin2 27.50 27.77 0.75
F3 1C DNA:100 Actin2 27.20 27.77 0.75
F4 2C DNA:100 Actin2 27.12 26.90 0.21
F5 2C DNA:100 Actin2 26.89 26.90 0.21
F6 2C DNA:100 Actin2 26.70 26.90 0.21
F7 3C DNA:100 Actin2 26.86 26.65 0.19
F8 3C DNA:100 Actin2 26.55 26.65 0.19
F9 3C DNA:100 Actin2 26.53 26.65 0.19
F10 4C DNA:100 Actin2 27.25 27.35 0.16
F11 4C DNA:100 Actin2 27.27 27.35 0.16
F12 4C DNA:100 Actin2 27.54 27.35 0.16
G1 1V DNA:1 E1A 17.48 17.42 0.15
G2 1V DNA:1 E1A 17.53 17.42 0.15
G3 1V DNA:1 E1A 17.25 17.42 0.15
G4 1V DNA:10 E1A 21.62 21.29 0.28
G5 1V DNA:10 E1A 21.10 21.29 0.28
G6 1V DNA:10 E1A 21.16 21.29 0.28
G7 1V DNA:100 E1A 24.68 24.53 0.17
G8 1V DNA:100 E1A 24.56 24.53 0.17
G9 1V DNA:100 E1A 24.35 24.53 0.17
G10 1V DNA:1000 E1A 27.53 27.59 0.08
G11 1V DNA:1000 E1A
G12 1V DNA:1000 E1A 27.65 27.59 0.08
H1 1V DNA:1 Hex 18.53 18.47 0.11
H2 1V DNA:1 Hex 18.54 18.47 0.11
H3 1V DNA:1 Hex 18.34 18.47 0.11
H4 1V DNA:10 Hex 22.55 22.32 0.39
H5 1V DNA:10 Hex 22.54 22.32 0.39
H6 1V DNA:10 Hex 21.88 22.32 0.39
H7 1V DNA:100 Hex 25.45 25.51 0.05
H8 1V DNA:100 Hex 25.52 25.51 0.05
H9 1V DNA:100 Hex 25.55 25.51 0.05
H10 1V DNA:1000 Hex 28.70 28.46 0.35
H11 1V DNA:1000 Hex 28.62 28.46 0.35
H12 1V DNA:1000 Hex 28.06 28.46 0.35
Analysis Parameters






Baseline range (from cycle no. ... to) n/a
Drift Correction OFF























1B 100 28.41 28.75 28.19 1 1 2.0E+04 3.3E+04 5.6E+04 3.56E+01 5.79E+01 4.67E+01
2B 100 28.50 29.14 27.53 0.59460356 0.48296816 1.9E+04 2.6E+04 8.5E+04 2.22E+01 3.01E+01 2.62E+01
3B 100 28.47 29.27 27.13 0.46009383 0.33448189 1.9E+04 2.4E+04 1.1E+05 1.77E+01 2.16E+01 1.97E+01
4B 100 29.07 29.75 27.74 0.46329403 0.36602142 1.3E+04 1.7E+04 7.4E+04 1.74E+01 2.34E+01 2.04E+01
1C 100 26.15 26.91 27.77 1 1 8.9E+04 1.0E+05 7.3E+04 1.22E+02 1.41E+02 1.31E+02
2C 100 26.77 27.52 26.90 0.35601255 0.35848881 5.9E+04 7.0E+04 1.3E+05 4.71E+01 5.60E+01 5.16E+01
3C 100 29.49 30.20 26.65 0.04543664 0.04703896 9.8E+03 1.3E+04 1.5E+05 6.69E+00 8.96E+00 7.82E+00
4C 100 30.38 31.17 27.35 0.03983002 0.03901033 5.4E+03 7.2E+03 9.5E+04 5.74E+00 7.54E+00 6.64E+00
1V 1 17.42 18.47 2.9E+05 2.0E+05
1V 10 21.29 22.32 2.2E+05 1.8E+05
1V 100 24.53 25.51 2.6E+05 2.5E+05
1V 1000 27.59 28.46 3.4E+05 3.9E+05




Pos Name Ct SYBR Ct Mean SYBR Ct Dev. SYBR Expr. Level SYBR Range SYBR
A1 1D DNA:100 E1A 16.02 15.79 0.23
A2 1D DNA:100 E1A 15.79 15.79 0.23
A3 1D DNA:100 E1A 15.57 15.79 0.23
A4 2D DNA:100 E1A 19.73 19.41 0.32
A5 2D DNA:100 E1A 19.39 19.41 0.32
A6 2D DNA:100 E1A 19.09 19.41 0.32
A7 3D DNA:100 E1A 24.47 24.57 0.10
A8 3D DNA:100 E1A 24.66 24.57 0.10
A9 3D DNA:100 E1A 24.59 24.57 0.10
A10 4D DNA:100 E1A 28.00 28.15 0.14
A11 4D DNA:100 E1A 28.19 28.15 0.14
A12 4D DNA:100 E1A 28.26 28.15 0.14
B1 1D DNA:100 Hex 16.56 16.20 0.41
B2 1D DNA:100 Hex 16.29 16.20 0.41
B3 1D DNA:100 Hex 15.75 16.20 0.41
B4 2D DNA:100 Hex 20.09 19.94 0.15
B5 2D DNA:100 Hex 19.94 19.94 0.15
B6 2D DNA:100 Hex 19.80 19.94 0.15
B7 3D DNA:100 Hex 25.51 25.50 0.10
B8 3D DNA:100 Hex 25.60 25.50 0.10
B9 3D DNA:100 Hex 25.40 25.50 0.10
B10 4D DNA:100 Hex 29.52 29.35 0.25
B11 4D DNA:100 Hex 29.07 29.35 0.25
B12 4D DNA:100 Hex 29.48 29.35 0.25
C1 1D DNA:100 Actin2 26.93 26.23 0.61
C2 1D DNA:100 Actin2 25.94 26.23 0.61
C3 1D DNA:100 Actin2 25.83 26.23 0.61
C4 2D DNA:100 Actin2 27.61 27.35 0.37
C5 2D DNA:100 Actin2 26.92 27.35 0.37
C6 2D DNA:100 Actin2 27.52 27.35 0.37
C7 3D DNA:100 Actin2 28.32 28.42 0.08
C8 3D DNA:100 Actin2 28.45 28.42 0.08
C9 3D DNA:100 Actin2 28.47 28.42 0.08
C10 4D DNA:100 Actin2 28.79 29.00 0.27
C11 4D DNA:100 Actin2 28.90 29.00 0.27
C12 4D DNA:100 Actin2 29.30 29.00 0.27
D1 1E DNA:100 E1A 14.46 13.36 0.97
D2 1E DNA:100 E1A 12.95 13.36 0.97
D3 1E DNA:100 E1A 12.67 13.36 0.97
D4 2E DNA:100 E1A 14.71 14.57 0.12
D5 2E DNA:100 E1A 14.49 14.57 0.12
D6 2E DNA:100 E1A 14.52 14.57 0.12
D7 3E DNA:100 E1A 21.50 21.53 0.17
D8 3E DNA:100 E1A 21.38 21.53 0.17
D9 3E DNA:100 E1A 21.71 21.53 0.17
D10 4E DNA:100 E1A 25.28 25.00 0.27
D11 4E DNA:100 E1A 24.74 25.00 0.27
D12 4E DNA:100 E1A 24.99 25.00 0.27
E1 1E DNA:100 Hex 13.94 13.50 0.40
E2 1E DNA:100 Hex 13.16 13.50 0.40
E3 1E DNA:100 Hex 13.39 13.50 0.40
E4 2E DNA:100 Hex 15.18 14.95 0.20 0.367 0.315 - 0.429
E5 2E DNA:100 Hex 14.81 14.95 0.20 0.367 0.315 - 0.429
E6 2E DNA:100 Hex 14.85 14.95 0.20 0.367 0.315 - 0.429
E7 3E DNA:100 Hex 22.06 22.19 0.19 5.500E-3X 4.68E-03 - 6.47E-03
E8 3E DNA:100 Hex 22.09 22.19 0.19 5.500E-3X 4.68E-03 - 6.47E-03
E9 3E DNA:100 Hex 22.40 22.19 0.19 5.500E-3X 4.68E-03 - 6.47E-03
E10 4E DNA:100 Hex 25.75 25.65 0.22 6.940E-4X 5.73E-04 - 8.41E-04
E11 4E DNA:100 Hex 25.40 25.65 0.22 6.940E-4X 5.73E-04 - 8.41E-04
E12 4E DNA:100 Hex 25.80 25.65 0.22 6.940E-4X 5.73E-04 - 8.41E-04
F1 1E DNA:100 Actin2 26.86 25.95 0.79
F2 1E DNA:100 Actin2 25.53 25.95 0.79
F3 1E DNA:100 Actin2 25.45 25.95 0.79
F4 2E DNA:100 Actin2 26.06 25.95 0.10
F5 2E DNA:100 Actin2 25.93 25.95 0.10
F6 2E DNA:100 Actin2 25.87 25.95 0.10
F7 3E DNA:100 Actin2 27.10 27.13 0.14
F8 3E DNA:100 Actin2 27.01 27.13 0.14
F9 3E DNA:100 Actin2 27.28 27.13 0.14
F10 4E DNA:100 Actin2 27.51 27.60 0.17
F11 4E DNA:100 Actin2 27.50 27.60 0.17
F12 4E DNA:100 Actin2 27.80 27.60 0.17
G1 1V DNA:1 E1A 17.91 17.45 0.44
G2 1V DNA:1 E1A 17.39 17.45 0.44
G3 1V DNA:1 E1A 17.04 17.45 0.44
G4 1V DNA:10 E1A 21.37 21.28 0.24
G5 1V DNA:10 E1A 21.01 21.28 0.24
G6 1V DNA:10 E1A 21.45 21.28 0.24
G7 1V DNA:100 E1A 24.81 24.50 0.29
G8 1V DNA:100 E1A 24.46 24.50 0.29
G9 1V DNA:100 E1A 24.24 24.50 0.29
G10 1V DNA:1000 E1A 28.17 28.19 0.03
G11 1V DNA:1000 E1A
G12 1V DNA:1000 E1A 28.22 28.19 0.03
H1 1V DNA:1 Hex 18.73 18.56 0.15
H2 1V DNA:1 Hex 18.47 18.56 0.15
H3 1V DNA:1 Hex 18.47 18.56 0.15
H4 1V DNA:10 Hex 22.73 22.28 0.42
H5 1V DNA:10 Hex 22.20 22.28 0.42
H6 1V DNA:10 Hex 21.90 22.28 0.42
H7 1V DNA:100 Hex 25.62 25.61 0.09
H8 1V DNA:100 Hex 25.69 25.61 0.09
H9 1V DNA:100 Hex 25.51 25.61 0.09
H10 1V DNA:1000 Hex 28.91 29.03 0.12
H11 1V DNA:1000 Hex 29.14 29.03 0.12
H12 1V DNA:1000 Hex 29.04 29.03 0.12
Analysis Parameters






Baseline range (from cycle no. ... to) n/a
Drift Correction OFF























1D 100 15.79 16.20 26.23 1 1 8.4E+07 8.4E+07 1.9E+05 4.40E+04 4.42E+04 4.41E+04
2D 100 19.41 19.94 27.35 0.1767767 0.16266773 7.7E+06 8.1E+06 9.5E+04 8.07E+03 8.53E+03 8.30E+03
3D 100 24.57 25.50 28.42 0.01038036 0.00723897 2.5E+05 2.5E+05 4.9E+04 5.19E+02 5.11E+02 5.15E+02
4D 100 28.15 29.35 29.00 0.00129754 0.00075043 2.4E+04 2.2E+04 3.4E+04 6.99E+01 6.58E+01 6.78E+01
1E 100 12.81 13.50 25.95 1 1 6.0E+08 4.6E+08 2.3E+05 2.65E+05 2.01E+05 2.33E+05
2E 100 14.57 14.95 25.95 0.29524817 0.36602142 1.9E+08 1.8E+08 2.3E+05 8.28E+04 8.12E+04 8.20E+04
3E 100 21.53 22.19 27.13 0.00537321 0.00548611 1.9E+06 2.0E+06 1.1E+05 1.73E+03 1.82E+03 1.78E+03
4E 100 25.00 25.65 27.60 0.00067165 0.00069053 1.9E+05 2.3E+05 8.1E+04 2.35E+02 2.79E+02 2.57E+02
1V 1 17.45 18.56 2.8E+05 1.9E+05
1V 10 21.28 22.28 2.2E+05 1.9E+05
1V 100 24.50 25.61 2.7E+05 2.3E+05
1V 1000 28.19 29.03 2.3E+05 2.7E+05




Pos Name Ct SYBR Ct Mean SYBR Ct Dev. SYBR Expr. Level SYBR Range SYBR
A1 1B cDNA:5 E1A 27.15 27.29 0.14
A2 1B cDNA:5 E1A 27.44 27.29 0.14
A3 1B cDNA:5 E1A 27.27 27.29 0.14
A4 2B cDNA:5 E1A 28.79 28.70 0.26
A5 2B cDNA:5 E1A 28.91 28.70 0.26
A6 2B cDNA:5 E1A 28.40 28.70 0.26
A7 3B cDNA:5 E1A 33.05 32.48 0.50
A8 3B cDNA:5 E1A 32.24 32.48 0.50
A9 3B cDNA:5 E1A 32.14 32.48 0.50
A10 4B cDNA:5 E1A
A11 4B cDNA:5 E1A
A12 4B cDNA:5 E1A 33.50
B1 1B cDNA:5 Hexon
B2 1B cDNA:5 Hexon 35.73 35.87 0.21
B3 1B cDNA:5 Hexon 36.02 35.87 0.21
B4 2B cDNA:5 Hexon
B5 2B cDNA:5 Hexon
B6 2B cDNA:5 Hexon
B7 3B cDNA:5 Hexon
B8 3B cDNA:5 Hexon
B9 3B cDNA:5 Hexon
B10 4B cDNA:5 Hexon
B11 4B cDNA:5 Hexon
B12 4B cDNA:5 Hexon
C1 1B cDNA:5 Actin2 27.57 27.32 0.24
C2 1B cDNA:5 Actin2 27.29 27.32 0.24
C3 1B cDNA:5 Actin2 27.09 27.32 0.24
C4 2B cDNA:5 Actin2 27.22 27.06 0.15
C5 2B cDNA:5 Actin2 27.03 27.06 0.15
C6 2B cDNA:5 Actin2 26.93 27.06 0.15
C7 3B cDNA:5 Actin2 26.50 26.50 0.04
C8 3B cDNA:5 Actin2 26.54 26.50 0.04
C9 3B cDNA:5 Actin2 26.46 26.50 0.04
C10 4B cDNA:5 Actin2 25.96 26.07 0.18
C11 4B cDNA:5 Actin2 25.97 26.07 0.18
C12 4B cDNA:5 Actin2 26.27 26.07 0.18
D1 1C cDNA:5 E1A 22.76 22.33 0.38
D2 1C cDNA:5 E1A 22.19 22.33 0.38
D3 1C cDNA:5 E1A 22.04 22.33 0.38
D4 2C cDNA:5 E1A 23.05 23.08 0.13
D5 2C cDNA:5 E1A 23.22 23.08 0.13
D6 2C cDNA:5 E1A 22.97 23.08 0.13
D7 3C cDNA:5 E1A 28.00 27.93 0.15
D8 3C cDNA:5 E1A 27.76 27.93 0.15
D9 3C cDNA:5 E1A 28.04 27.93 0.15
D10 4C cDNA:5 E1A 30.70 30.74 0.74
D11 4C cDNA:5 E1A 30.03 30.74 0.74
D12 4C cDNA:5 E1A 31.50 30.74 0.74
E1 1C cDNA:5 Hexon 28.63 28.33 0.32
E2 1C cDNA:5 Hexon 28.35 28.33 0.32
E3 1C cDNA:5 Hexon 28.00 28.33 0.32
E4 2C cDNA:5 Hexon 29.68 29.47 0.19 0.338 0.284 - 0.402
E5 2C cDNA:5 Hexon 29.42 29.47 0.19 0.338 0.284 - 0.402
E6 2C cDNA:5 Hexon 29.30 29.47 0.19 0.338 0.284 - 0.402
E7 3C cDNA:5 Hexon 34.22 34.34 0.17 9.970E-3X 8.61E-03 - 1.16E-02
E8 3C cDNA:5 Hexon 9.970E-3X 8.61E-03 - 1.16E-02
E9 3C cDNA:5 Hexon 34.46 34.34 0.17 9.970E-3X 8.61E-03 - 1.16E-02
E10 4C cDNA:5 Hexon 35.59 3.270E-3X 3.07E-03 - 3.48E-03
E11 4C cDNA:5 Hexon 3.270E-3X 3.07E-03 - 3.48E-03
E12 4C cDNA:5 Hexon 3.270E-3X 3.07E-03 - 3.48E-03
F1 1C cDNA:5 Actin2 27.02 26.69 0.30
F2 1C cDNA:5 Actin2 26.42 26.69 0.30
F3 1C cDNA:5 Actin2 26.64 26.69 0.30
F4 2C cDNA:5 Actin2 26.42 26.27 0.16
F5 2C cDNA:5 Actin2 26.28 26.27 0.16
F6 2C cDNA:5 Actin2 26.10 26.27 0.16
F7 3C cDNA:5 Actin2 25.93 26.06 0.13
F8 3C cDNA:5 Actin2 26.06 26.06 0.13
F9 3C cDNA:5 Actin2 26.19 26.06 0.13
F10 4C cDNA:5 Actin2 25.64 25.70 0.09
F11 4C cDNA:5 Actin2 25.66 25.70 0.09
F12 4C cDNA:5 Actin2 25.80 25.70 0.09
G1 1E cDNA:5 DF:1 E1A 21.47 21.14 0.29
G2 1E cDNA:5 DF:1 E1A 21.03 21.14 0.29
G3 1E cDNA:5 DF:1 E1A 20.92 21.14 0.29
G4 1E cDNA:5 DF:10 E1A 24.34 24.06 0.28
G5 1E cDNA:5 DF:10 E1A 24.05 24.06 0.28
G6 1E cDNA:5 DF:10 E1A 23.77 24.06 0.28
G7 1E cDNA:5 DF:100 E1A 26.88 26.81 0.10
G8 1E cDNA:5 DF:100 E1A 26.84 26.81 0.10
G9 1E cDNA:5 DF:100 E1A 26.69 26.81 0.10
G10 No Template cDNA:5 E1A
G11 No Template cDNA:5 E1A
G12 No Template cDNA:5 E1A
H1 1E cDNA:5 DF:1 Hexon 14.69 14.52 0.21
H2 1E cDNA:5 DF:1 Hexon 14.59 14.52 0.21
H3 1E cDNA:5 DF:1 Hexon 14.29 14.52 0.21
H4 1E cDNA:5 DF:10 Hexon 17.35 17.25 0.19
H5 1E cDNA:5 DF:10 Hexon 17.36 17.25 0.19
H6 1E cDNA:5 DF:10 Hexon 17.04 17.25 0.19
H7 1E cDNA:5 DF:100 Hexon 20.71 20.67 0.05
H8 1E cDNA:5 DF:100 Hexon 20.62 20.67 0.05
H9 1E cDNA:5 DF:100 Hexon 20.70 20.67 0.05
H10 No Template cDNA:5 Hexon
H11 No Template cDNA:5 Hexon
H12 No Template cDNA:5 Hexon
Analysis Parameters






Baseline range (from cycle no. ... to) n/a
Drift Correction OFF











1B 5 27.29 27.32 1 #VALUE! 2.1E+03 #VALUE! 4.8E+03
2B 5 28.70 27.06 0.31425334 #VALUE! 8.3E+02 #VALUE! 5.7E+03
3B 5 32.48 26.50 0.01551707 #VALUE! 6.8E+01 #VALUE! 8.1E+03
4B 5 26.07 #VALUE! #VALUE! #VALUE! #VALUE! 1.1E+04
1C 5 22.33 28.33 26.69 1 1 5.6E+04 2.1E+03 7.2E+03
2C 5 23.08 29.47 26.27 0.44442134 0.33915108 3.4E+04 1.0E+03 9.3E+03
3C 5 27.93 34.34 26.06 0.01332242 0.01002676 1.4E+03 4.9E+01 1.1E+04
4C 5 30.74 25.70 0.00148019 #VALUE! 2.1E+02 #VALUE! 1.3E+04
1E 5 21.14 14.52 1.2E+05 1.2E+07
1E 50 24.06 17.25 1.8E+05 2.2E+07
1E 500 26.81 20.67 2.9E+05 2.6E+07
No template 5 #VALUE! #VALUE!




Pos Name Ct SYBR Ct Mean SYBR Ct Dev. SYBR Expr. Level SYBR Range SYBR
A1 1D cDNA:5 E1A 21.30 21.41 0.14
A2 1D cDNA:5 E1A 21.58 21.41 0.14
A3 1D cDNA:5 E1A 21.37 21.41 0.14
A4 2D cDNA:5 E1A 22.55 22.39 0.14
A5 2D cDNA:5 E1A 22.36 22.39 0.14
A6 2D cDNA:5 E1A 22.27 22.39 0.14
A7 3D cDNA:5 E1A 27.33 27.40 0.06
A8 3D cDNA:5 E1A 27.44 27.40 0.06
A9 3D cDNA:5 E1A 27.42 27.40 0.06
A10 4D cDNA:5 E1A 30.16 30.00 0.14
A11 4D cDNA:5 E1A 29.96 30.00 0.14
A12 4D cDNA:5 E1A 29.89 30.00 0.14
B1 1D cDNA:5 Hexon 16.60 16.33 0.28
B2 1D cDNA:5 Hexon 16.35 16.33 0.28
B3 1D cDNA:5 Hexon 16.04 16.33 0.28
B4 2D cDNA:5 Hexon 17.36 17.44 0.13
B5 2D cDNA:5 Hexon 17.59 17.44 0.13
B6 2D cDNA:5 Hexon 17.36 17.44 0.13
B7 3D cDNA:5 Hexon 23.02 22.98 0.05
B8 3D cDNA:5 Hexon 22.93 22.98 0.05
B9 3D cDNA:5 Hexon 23.00 22.98 0.05
B10 4D cDNA:5 Hexon 25.68 25.74 0.11
B11 4D cDNA:5 Hexon 25.67 25.74 0.11
B12 4D cDNA:5 Hexon 25.86 25.74 0.11
C1 1D cDNA:5 Actin2 27.63 27.28 0.36
C2 1D cDNA:5 Actin2 27.30 27.28 0.36
C3 1D cDNA:5 Actin2 26.91 27.28 0.36
C4 2D cDNA:5 Actin2 26.80 26.67 0.20
C5 2D cDNA:5 Actin2 26.44 26.67 0.20
C6 2D cDNA:5 Actin2 26.77 26.67 0.20
C7 3D cDNA:5 Actin2 26.49 26.51 0.03
C8 3D cDNA:5 Actin2 26.49 26.51 0.03
C9 3D cDNA:5 Actin2 26.55 26.51 0.03
C10 4D cDNA:5 Actin2 26.21 26.22 0.00
C11 4D cDNA:5 Actin2 26.22 26.22 0.00
C12 4D cDNA:5 Actin2 26.22 26.22 0.00
D1 1E cDNA:5 E1A 21.39 20.83 0.54
D2 1E cDNA:5 E1A 20.78 20.83 0.54
D3 1E cDNA:5 E1A 20.32 20.83 0.54
D4 2E cDNA:5 E1A 21.45 21.49 0.04
D5 2E cDNA:5 E1A 21.53 21.49 0.04
D6 2E cDNA:5 E1A 21.49 21.49 0.04
D7 3E cDNA:5 E1A 25.90 26.01 0.19
D8 3E cDNA:5 E1A 25.91 26.01 0.19
D9 3E cDNA:5 E1A 26.23 26.01 0.19
D10 4E cDNA:5 E1A 28.72 28.71 0.10
D11 4E cDNA:5 E1A 28.61 28.71 0.10
D12 4E cDNA:5 E1A 28.80 28.71 0.10
E1 1E cDNA:5 Hexon 14.15 13.92 0.21
E2 1E cDNA:5 Hexon 13.75 13.92 0.21
E3 1E cDNA:5 Hexon 13.84 13.92 0.21
E4 2E cDNA:5 Hexon 14.91 14.75 0.17 0.429 0.369 - 0.500
E5 2E cDNA:5 Hexon 14.57 14.75 0.17 0.429 0.369 - 0.500
E6 2E cDNA:5 Hexon 14.77 14.75 0.17 0.429 0.369 - 0.500
E7 3E cDNA:5 Hexon 19.57 19.64 0.07 1.110E-2X 1.00E-02 - 1.24E-02
E8 3E cDNA:5 Hexon 19.64 19.64 0.07 1.110E-2X 1.00E-02 - 1.24E-02
E9 3E cDNA:5 Hexon 19.72 19.64 0.07 1.110E-2X 1.00E-02 - 1.24E-02
E10 4E cDNA:5 Hexon 22.58 22.76 0.17 1.160E-3X 9.46E-04 - 1.43E-03
E11 4E cDNA:5 Hexon 22.90 22.76 0.17 1.160E-3X 9.46E-04 - 1.43E-03
E12 4E cDNA:5 Hexon 22.81 22.76 0.17 1.160E-3X 9.46E-04 - 1.43E-03
F1 1E cDNA:5 Actin2 26.81 26.51 0.29
F2 1E cDNA:5 Actin2 26.50 26.51 0.29
F3 1E cDNA:5 Actin2 26.23 26.51 0.29
F4 2E cDNA:5 Actin2 26.29 26.13 0.14
F5 2E cDNA:5 Actin2 26.03 26.13 0.14
F6 2E cDNA:5 Actin2 26.07 26.13 0.14
F7 3E cDNA:5 Actin2 25.91 25.75 0.14
F8 3E cDNA:5 Actin2 25.65 25.75 0.14
F9 3E cDNA:5 Actin2 25.70 25.75 0.14
F10 4E cDNA:5 Actin2 25.47 25.61 0.25
F11 4E cDNA:5 Actin2 25.47 25.61 0.25
F12 4E cDNA:5 Actin2 25.90 25.61 0.25
G1 1E cDNA:5 DF:10 E1A 24.14 24.00 0.28
G2 1E cDNA:5 DF:10 E1A 24.19 24.00 0.28
G3 1E cDNA:5 DF:10 E1A 23.68 24.00 0.28
G4 1E cDNA:5 DF:100 E1A 27.82 27.41 0.39
G5 1E cDNA:5 DF:100 E1A 27.38 27.41 0.39
G6 1E cDNA:5 DF:100 E1A 27.05 27.41 0.39
G7 1D-RT cDNA:5 E1A
G8 1D-RT cDNA:5 E1A
G9 1D-RT cDNA:5 E1A
G10 1E-RT cDNA:5 E1A 33.88 33.33 0.78
G11 1E-RT cDNA:5 E1A
G12 1E-RT cDNA:5 E1A 32.78 33.33 0.78
H1 1E cDNA:5 DF:10 Hexon 17.57 17.33 0.22
H2 1E cDNA:5 DF:10 Hexon 17.26 17.33 0.22
H3 1E cDNA:5 DF:10 Hexon 17.14 17.33 0.22
H4 1E cDNA:5 DF:100 Hexon 20.32 20.38 0.07
H5 1E cDNA:5 DF:100 Hexon 20.45 20.38 0.07
H6 1E cDNA:5 DF:100 Hexon 20.37 20.38 0.07
H7 1D-RT cDNA:5 Hexon
H8 1D-RT cDNA:5 Hexon
H9 1D-RT cDNA:5 Hexon
H10 1E-RT cDNA:5 Hexon 32.97 32.56 0.61
H11 1E-RT cDNA:5 Hexon 32.85 32.56 0.61
H12 1E-RT cDNA:5 Hexon 31.86 32.56 0.61
Analysis Parameters






Baseline range (from cycle no. ... to) n/a
Drift Correction OFF











1D 5 21.41 16.33 27.28 1 1 1.0E+05 3.9E+06 5.0E+03
2D 5 22.39 17.44 26.67 0.33217145 0.30354872 5.3E+04 1.9E+06 7.2E+03
3D 5 27.40 22.98 26.51 0.00922651 0.00583925 2.0E+03 6.0E+04 8.0E+03
4D 5 30.00 25.74 26.22 0.00124469 0.00070504 3.5E+02 1.1E+04 9.6E+03
1E 5 20.83 13.92 26.51 1 1 1.5E+05 1.8E+07 8.0E+03
2E 5 21.49 14.75 26.13 0.48632747 0.43226862 9.7E+04 1.0E+07 1.0E+04
3E 5 26.01 19.64 25.75 0.01628853 0.01120278 4.9E+03 4.9E+05 1.3E+04
4E 5 28.71 22.76 25.61 0.00227487 0.00116941 8.2E+02 6.9E+04 1.4E+04
1E 50 24.00 17.33 1.8E+05 2.1E+07
1E 500 27.41 20.38 1.9E+05 3.1E+07
1D-RT 5 #VALUE! #VALUE!
1E-RT 5 33.33 32.56 39 150




Pos Name Ct SYBR Ct Mean SYBR Ct Dev. SYBR Expr. Level SYBR Range SYBR
A1 1A DNA:100 E1A 27.58 26.97 0.54
A2 1A DNA:100 E1A 26.78 26.97 0.54
A3 1A DNA:100 E1A 26.54 26.97 0.54
A4 2A DNA:100 E1A 27.31 27.02 0.27
A5 2A DNA:100 E1A 26.97 27.02 0.27
A6 2A DNA:100 E1A 26.78 27.02 0.27
A7 3A DNA:100 E1A 26.12 25.84 0.26
A8 3A DNA:100 E1A 25.63 25.84 0.26
A9 3A DNA:100 E1A 25.76 25.84 0.26
A10 4A DNA:100 E1A 26.90 26.89 0.11
A11 4A DNA:100 E1A 27.00 26.89 0.11
A12 4A DNA:100 E1A 26.78 26.89 0.11
B1 1A DNA:100 Hex 28.20 27.97 0.21
B2 1A DNA:100 Hex 27.90 27.97 0.21
B3 1A DNA:100 Hex 27.80 27.97 0.21
B4 2A DNA:100 Hex 27.89 28.03 0.19 0.891 0.674 - 1.18
B5 2A DNA:100 Hex 28.25 28.03 0.19 0.891 0.674 - 1.18
B6 2A DNA:100 Hex 27.96 28.03 0.19 0.891 0.674 - 1.18
B7 3A DNA:100 Hex 27.11 26.94 0.19 1.10 0.755 - 1.60
B8 3A DNA:100 Hex 26.97 26.94 0.19 1.10 0.755 - 1.60
B9 3A DNA:100 Hex 26.73 26.94 0.19 1.10 0.755 - 1.60
B10 4A DNA:100 Hex 27.93 27.93 0.10 1.29 0.969 - 1.72
B11 4A DNA:100 Hex 27.83 27.93 0.10 1.29 0.969 - 1.72
B12 4A DNA:100 Hex 28.02 27.93 0.10 1.29 0.969 - 1.72
C1 1A DNA:100 Actin2 29.51 29.01 0.44
C2 1A DNA:100 Actin2 28.80 29.01 0.44
C3 1A DNA:100 Actin2 28.72 29.01 0.44
C4 2A DNA:100 Actin2 29.25 28.91 0.35
C5 2A DNA:100 Actin2 28.93 28.91 0.35
C6 2A DNA:100 Actin2 28.54 28.91 0.35
C7 3A DNA:100 Actin2 28.67 28.11 0.50
C8 3A DNA:100 Actin2 27.99 28.11 0.50
C9 3A DNA:100 Actin2 27.69 28.11 0.50
C10 4A DNA:100 Actin2 28.96 29.34 0.40
C11 4A DNA:100 Actin2 29.31 29.34 0.40
C12 4A DNA:100 Actin2 29.76 29.34 0.40
D1 1V DNA:1 E1A 17.78 17.33 0.41
D2 1V DNA:1 E1A 17.24 17.33 0.41
D3 1V DNA:1 E1A 16.97 17.33 0.41
D4 2V DNA:1 E1A 16.93 17.09 0.17
D5 2V DNA:1 E1A 17.07 17.09 0.17
D6 2V DNA:1 E1A 17.26 17.09 0.17
D7 3V DNA:1 E1A 17.00 17.14 0.15
D8 3V DNA:1 E1A 17.12 17.14 0.15
D9 3V DNA:1 E1A 17.30 17.14 0.15
D10 4V DNA:1 E1A 17.28 17.22 0.09
D11 4V DNA:1 E1A 17.26 17.22 0.09
D12 4V DNA:1 E1A 17.12 17.22 0.09
E1 1V DNA:1 Hex 18.73 18.47 0.24
E2 1V DNA:1 Hex 18.25 18.47 0.24
E3 1V DNA:1 Hex 18.44 18.47 0.24
E4 2V DNA:1 Hex 18.13 18.09 0.11
E5 2V DNA:1 Hex 18.17 18.09 0.11
E6 2V DNA:1 Hex 17.97 18.09 0.11
E7 3V DNA:1 Hex 18.16 17.79 0.33
E8 3V DNA:1 Hex 17.52 17.79 0.33
E9 3V DNA:1 Hex 17.69 17.79 0.33
E10 4V DNA:1 Hex 18.19 18.20 0.10
E11 4V DNA:1 Hex 18.30 18.20 0.10
E12 4V DNA:1 Hex 18.10 18.20 0.10
F1 1V DNA:1 Actin2
F2 1V DNA:1 Actin2 36.22
F3 1V DNA:1 Actin2
F4 2V DNA:1 Actin2
F5 2V DNA:1 Actin2
F6 2V DNA:1 Actin2
F7 3V DNA:1 Actin2
F8 3V DNA:1 Actin2 34.78
F9 3V DNA:1 Actin2
F10 4V DNA:1 Actin2 34.60
F11 4V DNA:1 Actin2
F12 4V DNA:1 Actin2
G1 1V DNA:10 E1A 21.15 20.77 0.34
G2 1V DNA:10 E1A 20.68 20.77 0.34
G3 1V DNA:10 E1A 20.49 20.77 0.34
G4 1V DNA:100 E1A 23.65 23.68 0.11
G5 1V DNA:100 E1A 23.81 23.68 0.11
G6 1V DNA:100 E1A 23.59 23.68 0.11
G7 1V DNA:1000 E1A 27.39 27.08 0.30
G8 1V DNA:1000 E1A 26.79 27.08 0.30
G9 1V DNA:1000 E1A 27.06 27.08 0.30
G10 No template E1A
G11 No template E1A
G12 No template E1A
H1 1V DNA:10 Hex 22.30 22.14 0.14
H2 1V DNA:10 Hex 22.09 22.14 0.14
H3 1V DNA:10 Hex 22.03 22.14 0.14
H4 1V DNA:100 Hex 25.47 25.44 0.05
H5 1V DNA:100 Hex 25.47 25.44 0.05
H6 1V DNA:100 Hex 25.38 25.44 0.05
H7 1V DNA:1000 Hex 28.54 28.71 0.31
H8 1V DNA:1000 Hex 28.51 28.71 0.31
H9 1V DNA:1000 Hex 29.06 28.71 0.31
H10 No template Hex
H11 No template Hex
H12 No template Hex
Analysis Parameters






Baseline range (from cycle no. ... to) n/a
Drift Correction OFF



















1A 100 26.97 27.97 29.01 1 1 5.2E+04 5.3E+04 3.4E+04 1.53E+02 1.57E+02
2A 100 27.02 28.03 28.91 0.90125046 0.89502507 5.0E+04 5.1E+04 3.6E+04 1.39E+02 1.42E+02
3A 100 25.84 26.94 28.11 1.17283495 1.0942937 1.1E+05 1.0E+05 5.9E+04 1.85E+02 1.71E+02
4A 100 26.89 27.93 29.34 1.32868581 1.29235283 5.5E+04 5.4E+04 2.8E+04 1.98E+02 1.98E+02
1V 1 17.33 18.47 1.00 1.00 3.0E+05 2.0E+05
2V 1 17.09 18.09 1.17 1.27 3.5E+05 2.6E+05
3V 1 17.14 17.79 1.13 1.53 3.4E+05 3.1E+05
4V 1 17.22 18.20 1.08 1.18 3.3E+05 2.4E+05
1V 10 20.77 22.14 3.1E+05 2.0E+05
1V 100 23.68 25.44 4.6E+05 2.6E+05
1V 1000 27.08 28.71 4.8E+05 3.3E+05
No template 1




Pos Name Ct SYBR Ct Mean SYBR Ct Dev. SYBR Expr. Level SYBR Range SYBR
A1 1B DNA:100 E1A 27.97 27.67 0.27
A2 1B DNA:100 E1A 27.57 27.67 0.27
A3 1B DNA:100 E1A 27.48 27.67 0.27
A4 2B DNA:100 E1A 27.97 27.86 0.22
A5 2B DNA:100 E1A 27.99 27.86 0.22
A6 2B DNA:100 E1A 27.60 27.86 0.22
A7 3B DNA:100 E1A 27.55 27.51 0.09
A8 3B DNA:100 E1A 27.40 27.51 0.09
A9 3B DNA:100 E1A 27.58 27.51 0.09
A10 4B DNA:100 E1A 28.81 28.70 0.09
A11 4B DNA:100 E1A 28.64 28.70 0.09
A12 4B DNA:100 E1A 28.66 28.70 0.09
B1 1B DNA:100 Hex 29.18 28.86 0.27
B2 1B DNA:100 Hex 28.74 28.86 0.27
B3 1B DNA:100 Hex 28.67 28.86 0.27
B4 2B DNA:100 Hex 29.32 29.21 0.19
B5 2B DNA:100 Hex 29.00 29.21 0.19
B6 2B DNA:100 Hex 29.32 29.21 0.19
B7 3B DNA:100 Hex 28.90 28.63 0.25
B8 3B DNA:100 Hex 28.60 28.63 0.25
B9 3B DNA:100 Hex 28.40 28.63 0.25
B10 4B DNA:100 Hex 29.56 29.64 0.10
B11 4B DNA:100 Hex 29.74 29.64 0.10
B12 4B DNA:100 Hex 29.61 29.64 0.10
C1 1B DNA:100 Actin2 28.81 28.22 0.53
C2 1B DNA:100 Actin2 28.06 28.22 0.53
C3 1B DNA:100 Actin2 27.79 28.22 0.53
C4 2B DNA:100 Actin2 28.69 28.35 0.30
C5 2B DNA:100 Actin2 28.15 28.35 0.30
C6 2B DNA:100 Actin2 28.21 28.35 0.30
C7 3B DNA:100 Actin2 28.06 27.99 0.11
C8 3B DNA:100 Actin2 28.05 27.99 0.11
C9 3B DNA:100 Actin2 27.87 27.99 0.11
C10 4B DNA:100 Actin2 28.64 28.57 0.46
C11 4B DNA:100 Actin2 28.08 28.57 0.46
C12 4B DNA:100 Actin2 29.00 28.57 0.46
D1 1C DNA:100 E1A 26.51 25.76 0.67
D2 1C DNA:100 E1A 25.22 25.76 0.67
D3 1C DNA:100 E1A 25.54 25.76 0.67
D4 2C DNA:100 E1A 26.35 26.14 0.28
D5 2C DNA:100 E1A 26.25 26.14 0.28
D6 2C DNA:100 E1A 25.83 26.14 0.28
D7 3C DNA:100 E1A 30.01 29.66 0.44
D8 3C DNA:100 E1A 29.81 29.66 0.44
D9 3C DNA:100 E1A 29.17 29.66 0.44
D10 4C DNA:100 E1A 29.86 30.13 0.35
D11 4C DNA:100 E1A 30.00 30.13 0.35
D12 4C DNA:100 E1A 30.52 30.13 0.35
E1 1C DNA:100 Hex 26.87 26.53 0.30
E2 1C DNA:100 Hex 26.40 26.53 0.30
E3 1C DNA:100 Hex 26.33 26.53 0.30
E4 2C DNA:100 Hex 27.21 26.73 0.48 1.00 0.706 - 1.42
E5 2C DNA:100 Hex 26.75 26.73 0.48 1.00 0.706 - 1.42
E6 2C DNA:100 Hex 26.24 26.73 0.48 1.00 0.706 - 1.42
E7 3C DNA:100 Hex 29.95 30.02 0.12 0.122 0.110 - 0.135
E8 3C DNA:100 Hex 29.95 30.02 0.12 0.122 0.110 - 0.135
E9 3C DNA:100 Hex 30.16 30.02 0.12 0.122 0.110 - 0.135
E10 4C DNA:100 Hex 30.56 30.95 0.59 3.740E-2X 2.42E-02 - 5.79E-02
E11 4C DNA:100 Hex 31.63 30.95 0.59 3.740E-2X 2.42E-02 - 5.79E-02
E12 4C DNA:100 Hex 30.67 30.95 0.59 3.740E-2X 2.42E-02 - 5.79E-02
F1 1C DNA:100 Actin2 28.80 28.30 0.46
F2 1C DNA:100 Actin2 28.19 28.30 0.46
F3 1C DNA:100 Actin2 27.90 28.30 0.46
F4 2C DNA:100 Actin2 28.48 28.49 0.13
F5 2C DNA:100 Actin2 28.37 28.49 0.13
F6 2C DNA:100 Actin2 28.63 28.49 0.13
F7 3C DNA:100 Actin2 28.83 28.75 0.08
F8 3C DNA:100 Actin2 28.75 28.75 0.08
F9 3C DNA:100 Actin2 28.67 28.75 0.08
F10 4C DNA:100 Actin2 27.96 27.98 0.23
F11 4C DNA:100 Actin2 27.75 27.98 0.23
F12 4C DNA:100 Actin2 28.22 27.98 0.23
G1 1V DNA:1 E1A 17.84 17.35 0.44
G2 1V DNA:1 E1A 17.21 17.35 0.44
G3 1V DNA:1 E1A 17.00 17.35 0.44
G4 1V DNA:10 E1A 20.81 20.55 0.23
G5 1V DNA:10 E1A 20.49 20.55 0.23
G6 1V DNA:10 E1A 20.35 20.55 0.23
G7 1V DNA:100 E1A 23.66 23.68 0.20
G8 1V DNA:100 E1A 23.50 23.68 0.20
G9 1V DNA:100 E1A 23.89 23.68 0.20
G10 1V DNA:1000 E1A 26.75 26.91 0.22
G11 1V DNA:1000 E1A
G12 1V DNA:1000 E1A 27.06 26.91 0.22
H1 1V DNA:1 Hex 18.66 18.22 0.43
H2 1V DNA:1 Hex 18.19 18.22 0.43
H3 1V DNA:1 Hex 17.80 18.22 0.43
H4 1V DNA:10 Hex 21.91 21.67 0.21
H5 1V DNA:10 Hex 21.61 21.67 0.21
H6 1V DNA:10 Hex 21.50 21.67 0.21
H7 1V DNA:100 Hex 24.73 24.81 0.10
H8 1V DNA:100 Hex 24.92 24.81 0.10
H9 1V DNA:100 Hex 24.79 24.81 0.10
H10 1V DNA:1000 Hex 27.89 28.01 0.13
H11 1V DNA:1000 Hex 27.98 28.01 0.13
H12 1V DNA:1000 Hex 28.14 28.01 0.13
Analysis Parameters






Baseline range (from cycle no. ... to) n/a
Drift Correction OFF























1B 100 27.67 28.86 28.22 1 1 3.3E+04 3.0E+04 5.5E+04 5.91E+01 5.50E+01 5.70E+01
2B 100 27.86 29.21 28.35 0.95926412 0.85856544 2.9E+04 2.4E+04 5.1E+04 5.65E+01 4.79E+01 5.22E+01
3B 100 27.51 28.63 27.99 0.952638 1 3.6E+04 3.5E+04 6.4E+04 5.69E+01 5.51E+01 5.60E+01
4B 100 28.70 29.64 28.57 0.62416527 0.74226179 1.7E+04 1.9E+04 4.4E+04 3.72E+01 4.20E+01 3.96E+01
1C 100 25.76 26.53 28.30 1 1 1.2E+05 1.3E+05 5.3E+04 2.19E+02 2.49E+02 2.34E+02
2C 100 26.14 26.73 28.49 0.87660572 0.9930925 9.0E+04 1.2E+05 4.7E+04 1.92E+02 2.47E+02 2.19E+02
3C 100 29.66 30.02 28.75 0.09150536 0.12158187 8.8E+03 1.5E+04 4.0E+04 2.20E+01 3.70E+01 2.95E+01
4C 100 30.13 30.95 27.98 0.03874087 0.03742121 6.4E+03 8.2E+03 6.4E+04 1.00E+01 1.28E+01 1.14E+01
1V 1 17.35 18.22 3.0E+05 2.4E+05
1V 10 20.55 21.67 3.6E+05 2.7E+05
1V 100 23.68 24.81 4.6E+05 3.8E+05
1V 1000 26.91 28.01 5.4E+05 5.2E+05




Pos Name Ct SYBR Ct Mean SYBR Ct Dev. SYBR Expr. Level SYBR Range SYBR
A1 1D DNA:100 E1A 29.22 20.58 7.48
A2 1D DNA:100 E1A 16.27 20.58 7.48
A3 1D DNA:100 E1A 16.24 20.58 7.48
A4 2D DNA:100 E1A 17.12 16.91 0.19
A5 2D DNA:100 E1A 16.83 16.91 0.19
A6 2D DNA:100 E1A 16.77 16.91 0.19
A7 3D DNA:100 E1A 22.10 22.07 0.04
A8 3D DNA:100 E1A 22.02 22.07 0.04
A9 3D DNA:100 E1A 22.09 22.07 0.04
A10 4D DNA:100 E1A 25.27 25.36 0.18
A11 4D DNA:100 E1A 25.24 25.36 0.18
A12 4D DNA:100 E1A 25.57 25.36 0.18
B1 1D DNA:100 Hex 16.91 16.65 0.45
B2 1D DNA:100 Hex 16.90 16.65 0.45
B3 1D DNA:100 Hex 16.13 16.65 0.45
B4 2D DNA:100 Hex 17.25 17.23 0.02
B5 2D DNA:100 Hex 17.22 17.23 0.02
B6 2D DNA:100 Hex 17.23 17.23 0.02
B7 3D DNA:100 Hex 22.87 22.64 0.23
B8 3D DNA:100 Hex 22.63 22.64 0.23
B9 3D DNA:100 Hex 22.41 22.64 0.23
B10 4D DNA:100 Hex 25.65 25.87 0.34
B11 4D DNA:100 Hex 25.69 25.87 0.34
B12 4D DNA:100 Hex 26.25 25.87 0.34
C1 1D DNA:100 Actin2 27.80 27.20 0.53
C2 1D DNA:100 Actin2 26.95 27.20 0.53
C3 1D DNA:100 Actin2 26.84 27.20 0.53
C4 2D DNA:100 Actin2 27.15 27.07 0.08
C5 2D DNA:100 Actin2 26.99 27.07 0.08
C6 2D DNA:100 Actin2 27.07 27.07 0.08
C7 3D DNA:100 Actin2 27.55 27.40 0.25
C8 3D DNA:100 Actin2 27.11 27.40 0.25
C9 3D DNA:100 Actin2 27.53 27.40 0.25
C10 4D DNA:100 Actin2 27.18 27.57 0.42
C11 4D DNA:100 Actin2 27.52 27.57 0.42
C12 4D DNA:100 Actin2 28.02 27.57 0.42
D1 1E DNA:100 E1A 15.53 15.07 0.42
D2 1E DNA:100 E1A 14.94 15.07 0.42
D3 1E DNA:100 E1A 14.73 15.07 0.42
D4 2E DNA:100 E1A 14.66 14.68 0.06
D5 2E DNA:100 E1A 14.74 14.68 0.06
D6 2E DNA:100 E1A 14.63 14.68 0.06
D7 3E DNA:100 E1A 19.52 19.50 0.11
D8 3E DNA:100 E1A 19.39 19.50 0.11
D9 3E DNA:100 E1A 19.61 19.50 0.11
D10 4E DNA:100 E1A 23.55 23.54 0.14
D11 4E DNA:100 E1A 23.39 23.54 0.14
D12 4E DNA:100 E1A 23.68 23.54 0.14
E1 1E DNA:100 Hex 15.82 15.41 0.35
E2 1E DNA:100 Hex 15.22 15.41 0.35
E3 1E DNA:100 Hex 15.21 15.41 0.35
E4 2E DNA:100 Hex 15.44 15.31 0.12 0.774 0.645 - 0.930
E5 2E DNA:100 Hex 15.20 15.31 0.12 0.774 0.645 - 0.930
E6 2E DNA:100 Hex 15.30 15.31 0.12 0.774 0.645 - 0.930
E7 3E DNA:100 Hex 20.09 20.12 0.19 5.640E-2X 4.87E-02 - 6.54E-02
E8 3E DNA:100 Hex 19.94 20.12 0.19 5.640E-2X 4.87E-02 - 6.54E-02
E9 3E DNA:100 Hex 20.32 20.12 0.19 5.640E-2X 4.87E-02 - 6.54E-02
E10 4E DNA:100 Hex 23.84 23.93 0.11 4.510E-3X 3.50E-03 - 5.82E-03
E11 4E DNA:100 Hex 23.90 23.93 0.11 4.510E-3X 3.50E-03 - 5.82E-03
E12 4E DNA:100 Hex 24.05 23.93 0.11 4.510E-3X 3.50E-03 - 5.82E-03
F1 1E DNA:100 Actin2 29.17 28.60 0.50
F2 1E DNA:100 Actin2 28.23 28.60 0.50
F3 1E DNA:100 Actin2 28.40 28.60 0.50
F4 2E DNA:100 Actin2 27.86 28.13 0.23
F5 2E DNA:100 Actin2 28.30 28.13 0.23
F6 2E DNA:100 Actin2 28.22 28.13 0.23
F7 3E DNA:100 Actin2 29.06 29.15 0.09
F8 3E DNA:100 Actin2 29.16 29.15 0.09
F9 3E DNA:100 Actin2 29.24 29.15 0.09
F10 4E DNA:100 Actin2 29.06 29.32 0.35
F11 4E DNA:100 Actin2 29.72 29.32 0.35
F12 4E DNA:100 Actin2 29.19 29.32 0.35
G1 1V DNA:1 E1A 17.64 17.07 0.63
G2 1V DNA:1 E1A 17.17 17.07 0.63
G3 1V DNA:1 E1A 16.39 17.07 0.63
G4 1V DNA:10 E1A 20.69 20.64 0.04
G5 1V DNA:10 E1A 20.63 20.64 0.04
G6 1V DNA:10 E1A 20.61 20.64 0.04
G7 1V DNA:100 E1A 23.73 23.67 0.06
G8 1V DNA:100 E1A 23.61 23.67 0.06
G9 1V DNA:100 E1A 23.66 23.67 0.06
G10 1V DNA:1000 E1A 27.13 27.12 0.01
G11 1V DNA:1000 E1A
G12 1V DNA:1000 E1A 27.11 27.12 0.01
H1 1V DNA:1 Hex 18.27 18.04 0.22
H2 1V DNA:1 Hex 17.85 18.04 0.22
H3 1V DNA:1 Hex 17.99 18.04 0.22
H4 1V DNA:10 Hex 21.64 21.50 0.19
H5 1V DNA:10 Hex 21.58 21.50 0.19
H6 1V DNA:10 Hex 21.28 21.50 0.19
H7 1V DNA:100 Hex 24.80 24.73 0.06
H8 1V DNA:100 Hex 24.69 24.73 0.06
H9 1V DNA:100 Hex 24.70 24.73 0.06
H10 1V DNA:1000 Hex 27.99 27.93 0.10
H11 1V DNA:1000 Hex 27.99 27.93 0.10
H12 1V DNA:1000 Hex 27.82 27.93 0.10
Analysis Parameters






Baseline range (from cycle no. ... to) n/a
Drift Correction OFF























1D 100 16.26 16.65 27.20 1 1 6.2E+07 6.4E+07 1.0E+05 5.91E+04 6.09E+04 6.00E+04
2D 100 16.91 17.23 27.07 0.58035196 0.61132014 4.0E+07 4.4E+07 1.1E+05 3.54E+04 3.91E+04 3.72E+04
3D 100 22.07 22.64 27.40 0.02040406 0.01807325 1.3E+06 1.5E+06 9.2E+04 1.44E+03 1.62E+03 1.53E+03
4D 100 25.36 25.87 27.57 0.00234695 0.00216713 1.5E+05 2.0E+05 8.3E+04 1.81E+02 2.39E+02 2.10E+02
1E 100 15.07 15.41 28.60 1 1 1.3E+08 1.4E+08 4.4E+04 3.09E+05 3.16E+05 3.13E+05
2E 100 14.68 15.31 28.13 0.94605765 0.7737825 1.7E+08 1.5E+08 5.8E+04 2.98E+05 2.51E+05 2.75E+05
3E 100 19.50 20.12 29.15 0.06792093 0.05593907 7.2E+06 7.2E+06 3.1E+04 2.33E+04 2.33E+04 2.33E+04
4E 100 23.54 23.93 29.32 0.00464534 0.0044871 5.0E+05 6.7E+05 2.8E+04 1.79E+03 2.39E+03 2.09E+03
1V 1 17.07 18.04 3.6E+05 2.7E+05
1V 10 20.64 21.50 3.4E+05 3.0E+05
1V 100 23.67 24.73 4.6E+05 4.0E+05
1V 1000 27.12 27.93 4.7E+05 5.4E+05




Pos Name Ct SYBR Ct Mean SYBR Ct Dev. SYBR Expr. Level SYBR Range SYBR
A1 1B cDNA:5 E1A 27.86 27.71 0.16
A2 1B cDNA:5 E1A 27.74 27.71 0.16
A3 1B cDNA:5 E1A 27.54 27.71 0.16
A4 2B cDNA:5 E1A 27.76 27.63 0.11
A5 2B cDNA:5 E1A 27.55 27.63 0.11
A6 2B cDNA:5 E1A 27.58 27.63 0.11
A7 3B cDNA:5 E1A 31.09 31.53 0.44
A8 3B cDNA:5 E1A 31.96 31.53 0.44
A9 3B cDNA:5 E1A 31.55 31.53 0.44
A10 4B cDNA:5 E1A 34.04 33.74 0.44
A11 4B cDNA:5 E1A 33.23 33.74 0.44
A12 4B cDNA:5 E1A 33.93 33.74 0.44
B1 1B cDNA:5 Hexon
B2 1B cDNA:5 Hexon
B3 1B cDNA:5 Hexon 35.58
B4 2B cDNA:5 Hexon
B5 2B cDNA:5 Hexon
B6 2B cDNA:5 Hexon
B7 3B cDNA:5 Hexon
B8 3B cDNA:5 Hexon
B9 3B cDNA:5 Hexon
B10 4B cDNA:5 Hexon
B11 4B cDNA:5 Hexon
B12 4B cDNA:5 Hexon
C1 1B cDNA:5 Actin2 27.71 27.18 0.49
C2 1B cDNA:5 Actin2 27.09 27.18 0.49
C3 1B cDNA:5 Actin2 26.75 27.18 0.49
C4 2B cDNA:5 Actin2 27.44 27.31 0.12
C5 2B cDNA:5 Actin2 27.20 27.31 0.12
C6 2B cDNA:5 Actin2 27.29 27.31 0.12
C7 3B cDNA:5 Actin2 26.44 26.35 0.20
C8 3B cDNA:5 Actin2 26.49 26.35 0.20
C9 3B cDNA:5 Actin2 26.12 26.35 0.20
C10 4B cDNA:5 Actin2 26.85 26.97 0.11
C11 4B cDNA:5 Actin2 27.06 26.97 0.11
C12 4B cDNA:5 Actin2 27.01 26.97 0.11
D1 1C cDNA:5 E1A 23.00 22.37 0.54
D2 1C cDNA:5 E1A 22.03 22.37 0.54
D3 1C cDNA:5 E1A 22.08 22.37 0.54
D4 2C cDNA:5 E1A 22.42 22.43 0.04
D5 2C cDNA:5 E1A 22.47 22.43 0.04
D6 2C cDNA:5 E1A 22.39 22.43 0.04
D7 3C cDNA:5 E1A 26.67 26.54 0.17
D8 3C cDNA:5 E1A 26.35 26.54 0.17
D9 3C cDNA:5 E1A 26.61 26.54 0.17
D10 4C cDNA:5 E1A 29.27 29.38 0.26
D11 4C cDNA:5 E1A 29.19 29.38 0.26
D12 4C cDNA:5 E1A 29.67 29.38 0.26
E1 1C cDNA:5 Hexon 29.00 28.65 0.30
E2 1C cDNA:5 Hexon 28.46 28.65 0.30
E3 1C cDNA:5 Hexon 28.49 28.65 0.30
E4 2C cDNA:5 Hexon 28.05 27.98 0.18 0.619 0.507 - 0.755
E5 2C cDNA:5 Hexon 28.11 27.98 0.18 0.619 0.507 - 0.755
E6 2C cDNA:5 Hexon 27.77 27.98 0.18 0.619 0.507 - 0.755
E7 3C cDNA:5 Hexon 33.30 33.33 0.41 1.420E-2X 1.04E-02 - 1.95E-02
E8 3C cDNA:5 Hexon 33.75 33.33 0.41 1.420E-2X 1.04E-02 - 1.95E-02
E9 3C cDNA:5 Hexon 32.93 33.33 0.41 1.420E-2X 1.04E-02 - 1.95E-02
E10 4C cDNA:5 Hexon 7.920E-3X 7.32E-03 - 8.56E-03
E11 4C cDNA:5 Hexon 7.920E-3X 7.32E-03 - 8.56E-03
E12 4C cDNA:5 Hexon 34.56 7.920E-3X 7.32E-03 - 8.56E-03
F1 1C cDNA:5 Actin2 27.54 27.16 0.35
F2 1C cDNA:5 Actin2 27.10 27.16 0.35
F3 1C cDNA:5 Actin2 26.85 27.16 0.35
F4 2C cDNA:5 Actin2 25.97 25.80 0.22
F5 2C cDNA:5 Actin2 25.88 25.80 0.22
F6 2C cDNA:5 Actin2 25.55 25.80 0.22
F7 3C cDNA:5 Actin2 25.92 25.71 0.18
F8 3C cDNA:5 Actin2 25.60 25.71 0.18
F9 3C cDNA:5 Actin2 25.61 25.71 0.18
F10 4C cDNA:5 Actin2 25.97 26.10 0.11
F11 4C cDNA:5 Actin2 26.16 26.10 0.11
F12 4C cDNA:5 Actin2 26.16 26.10 0.11
G1 1E cDNA:5 DF:1 E1A 21.37 21.09 0.35
G2 1E cDNA:5 DF:1 E1A 21.21 21.09 0.35
G3 1E cDNA:5 DF:1 E1A 20.70 21.09 0.35
G4 1E cDNA:5 DF:10 E1A 24.20 23.73 0.41
G5 1E cDNA:5 DF:10 E1A 23.45 23.73 0.41
G6 1E cDNA:5 DF:10 E1A 23.53 23.73 0.41
G7 1E cDNA:5 DF:100 E1A 26.91 26.80 0.17
G8 1E cDNA:5 DF:100 E1A 26.88 26.80 0.17
G9 1E cDNA:5 DF:100 E1A 26.61 26.80 0.17
G10 No Template cDNA:5 E1A
G11 No Template cDNA:5 E1A
G12 No Template cDNA:5 E1A
H1 1E cDNA:5 DF:1 Hexon 14.83 14.73 0.11
H2 1E cDNA:5 DF:1 Hexon 14.76 14.73 0.11
H3 1E cDNA:5 DF:1 Hexon 14.61 14.73 0.11
H4 1E cDNA:5 DF:10 Hexon 17.80 17.70 0.10
H5 1E cDNA:5 DF:10 Hexon 17.67 17.70 0.10
H6 1E cDNA:5 DF:10 Hexon 17.61 17.70 0.10
H7 1E cDNA:5 DF:100 Hexon 21.00 20.91 0.07
H8 1E cDNA:5 DF:100 Hexon 20.87 20.91 0.07
H9 1E cDNA:5 DF:100 Hexon 20.87 20.91 0.07
H10 No Template cDNA:5 Hexon
H11 No Template cDNA:5 Hexon
H12 No Template cDNA:5 Hexon
Analysis Parameters






Baseline range (from cycle no. ... to) n/a
Drift Correction OFF











1B 5 27.71 27.18 1 #VALUE! 1.6E+03 #VALUE! 5.3E+03
2B 5 27.63 27.31 1.15668818 #VALUE! 1.7E+03 #VALUE! 4.9E+03
3B 5 31.53 26.35 0.03983002 #VALUE! 1.3E+02 #VALUE! 8.8E+03
4B 5 33.74 26.97 0.0132304 #VALUE! 3.0E+01 #VALUE! 6.0E+03
1C 5 22.37 28.65 27.16 1 1 5.4E+04 1.7E+03 5.3E+03
2C 5 22.43 27.98 25.80 0.37371231 0.61985385 5.2E+04 2.6E+03 1.2E+04
3C 5 26.54 33.33 25.71 0.02033347 0.01427862 3.4E+03 9.3E+01 1.3E+04
4C 5 29.38 26.10 0.00372124 #VALUE! 5.3E+02 #VALUE! 1.0E+04
1E 5 21.09 14.73 1.3E+05 1.1E+07
1E 50 23.73 17.70 2.2E+05 1.6E+07
1E 500 26.80 20.91 2.9E+05 2.2E+07
No template 5 #VALUE! #VALUE!




Pos Name Ct SYBR Ct Mean SYBR Ct Dev. SYBR Expr. Level SYBR Range SYBR
A1 1D cDNA:5 E1A 21.77 21.67 0.15
A2 1D cDNA:5 E1A 21.74 21.67 0.15
A3 1D cDNA:5 E1A 21.50 21.67 0.15
A4 2D cDNA:5 E1A 21.85 21.61 0.21
A5 2D cDNA:5 E1A 21.51 21.61 0.21
A6 2D cDNA:5 E1A 21.47 21.61 0.21
A7 3D cDNA:5 E1A 25.78 25.93 0.20
A8 3D cDNA:5 E1A 25.85 25.93 0.20
A9 3D cDNA:5 E1A 26.15 25.93 0.20
A10 4D cDNA:5 E1A 28.57 28.66 0.19
A11 4D cDNA:5 E1A 28.52 28.66 0.19
A12 4D cDNA:5 E1A 28.87 28.66 0.19
B1 1D cDNA:5 Hexon 17.34 17.07 0.30
B2 1D cDNA:5 Hexon 17.12 17.07 0.30
B3 1D cDNA:5 Hexon 16.74 17.07 0.30
B4 2D cDNA:5 Hexon 16.54 16.58 0.10
B5 2D cDNA:5 Hexon 16.69 16.58 0.10
B6 2D cDNA:5 Hexon 16.50 16.58 0.10
B7 3D cDNA:5 Hexon 22.07 21.72 0.31
B8 3D cDNA:5 Hexon 21.64 21.72 0.31
B9 3D cDNA:5 Hexon 21.46 21.72 0.31
B10 4D cDNA:5 Hexon 25.33 25.40 0.10
B11 4D cDNA:5 Hexon 25.35 25.40 0.10
B12 4D cDNA:5 Hexon 25.51 25.40 0.10
C1 1D cDNA:5 Actin2 28.05 27.64 0.36
C2 1D cDNA:5 Actin2 27.38 27.64 0.36
C3 1D cDNA:5 Actin2 27.50 27.64 0.36
C4 2D cDNA:5 Actin2 27.54 27.21 0.34
C5 2D cDNA:5 Actin2 26.86 27.21 0.34
C6 2D cDNA:5 Actin2 27.24 27.21 0.34
C7 3D cDNA:5 Actin2 26.88 26.81 0.16
C8 3D cDNA:5 Actin2 26.92 26.81 0.16
C9 3D cDNA:5 Actin2 26.62 26.81 0.16
C10 4D cDNA:5 Actin2 26.82 26.63 0.18
C11 4D cDNA:5 Actin2 26.64 26.63 0.18
C12 4D cDNA:5 Actin2 26.45 26.63 0.18
D1 1E cDNA:5 E1A 21.45 21.04 0.36
D2 1E cDNA:5 E1A 20.87 21.04 0.36
D3 1E cDNA:5 E1A 20.80 21.04 0.36
D4 2E cDNA:5 E1A 20.95 20.92 0.05
D5 2E cDNA:5 E1A 20.86 20.92 0.05
D6 2E cDNA:5 E1A 20.95 20.92 0.05
D7 3E cDNA:5 E1A 24.80 24.71 0.24
D8 3E cDNA:5 E1A 24.44 24.71 0.24
D9 3E cDNA:5 E1A 24.89 24.71 0.24
D10 4E cDNA:5 E1A 28.28 28.16 0.21
D11 4E cDNA:5 E1A 27.93 28.16 0.21
D12 4E cDNA:5 E1A 28.29 28.16 0.21
E1 1E cDNA:5 Hexon 15.13 14.73 0.37
E2 1E cDNA:5 Hexon 14.66 14.73 0.37
E3 1E cDNA:5 Hexon 14.40 14.73 0.37
E4 2E cDNA:5 Hexon 14.36 14.09 0.24 1.15 0.924 - 1.43
E5 2E cDNA:5 Hexon 13.89 14.09 0.24 1.15 0.924 - 1.43
E6 2E cDNA:5 Hexon 14.01 14.09 0.24 1.15 0.924 - 1.43
E7 3E cDNA:5 Hexon 18.95 19.02 0.11 3.330E-2X 2.98E-02 - 3.72E-02
E8 3E cDNA:5 Hexon 18.98 19.02 0.11 3.330E-2X 2.98E-02 - 3.72E-02
E9 3E cDNA:5 Hexon 19.15 19.02 0.11 3.330E-2X 2.98E-02 - 3.72E-02
E10 4E cDNA:5 Hexon 22.53 22.45 0.08 1.840E-3X 1.74E-03 - 1.95E-03
E11 4E cDNA:5 Hexon 22.37 22.45 0.08 1.840E-3X 1.74E-03 - 1.95E-03
E12 4E cDNA:5 Hexon 22.45 22.45 0.08 1.840E-3X 1.74E-03 - 1.95E-03
F1 1E cDNA:5 Actin2 27.51 27.14 0.34
F2 1E cDNA:5 Actin2 26.85 27.14 0.34
F3 1E cDNA:5 Actin2 27.05 27.14 0.34
F4 2E cDNA:5 Actin2 26.85 26.70 0.20
F5 2E cDNA:5 Actin2 26.78 26.70 0.20
F6 2E cDNA:5 Actin2 26.47 26.70 0.20
F7 3E cDNA:5 Actin2 26.64 26.52 0.12
F8 3E cDNA:5 Actin2 26.40 26.52 0.12
F9 3E cDNA:5 Actin2 26.52 26.52 0.12
F10 4E cDNA:5 Actin2 25.77 25.77 0.00
F11 4E cDNA:5 Actin2 25.77 25.77 0.00
F12 4E cDNA:5 Actin2 25.77 25.77 0.00
G1 1E cDNA:5 DF:10 E1A 24.80 24.30 0.45
G2 1E cDNA:5 DF:10 E1A 24.19 24.30 0.45
G3 1E cDNA:5 DF:10 E1A 23.92 24.30 0.45
G4 1E cDNA:5 DF:100 E1A 27.20 27.24 0.26
G5 1E cDNA:5 DF:100 E1A 27.51 27.24 0.26
G6 1E cDNA:5 DF:100 E1A 27.00 27.24 0.26
G7 1D-RT cDNA:5 E1A
G8 1D-RT cDNA:5 E1A
G9 1D-RT cDNA:5 E1A 38.17
G10 1E-RT cDNA:5 E1A 28.46 28.59 0.18
G11 1E-RT cDNA:5 E1A
G12 1E-RT cDNA:5 E1A 28.72 28.59 0.18
H1 1E cDNA:5 DF:10 Hexon 18.13 17.81 0.28
H2 1E cDNA:5 DF:10 Hexon 17.69 17.81 0.28
H3 1E cDNA:5 DF:10 Hexon 17.61 17.81 0.28
H4 1E cDNA:5 DF:100 Hexon 21.29 21.09 0.22
H5 1E cDNA:5 DF:100 Hexon 21.13 21.09 0.22
H6 1E cDNA:5 DF:100 Hexon 20.86 21.09 0.22
H7 1D-RT cDNA:5 Hexon
H8 1D-RT cDNA:5 Hexon
H9 1D-RT cDNA:5 Hexon
H10 1E-RT cDNA:5 Hexon 28.16 28.09 0.19
H11 1E-RT cDNA:5 Hexon 28.24 28.09 0.19
H12 1E-RT cDNA:5 Hexon 27.88 28.09 0.19
Analysis Parameters






Baseline range (from cycle no. ... to) n/a
Drift Correction OFF











1D 5 21.67 17.07 27.64 1 1 8.6E+04 2.4E+06 4.0E+03
2D 5 21.61 16.58 27.21 0.7737825 1.04246576 9.0E+04 3.3E+06 5.2E+03
3D 5 25.93 21.72 26.81 0.02936009 0.02240555 5.2E+03 1.3E+05 6.6E+03
4D 5 28.66 25.40 26.63 0.00390625 0.00154305 8.5E+02 1.3E+04 7.4E+03
1E 5 21.04 14.73 27.14 1 1 1.3E+05 1.1E+07 5.4E+03
2E 5 20.92 14.09 26.70 0.80106988 1.14869835 1.4E+05 1.6E+07 7.1E+03
3E 5 24.71 19.02 26.52 0.05111888 0.03326157 1.2E+04 7.2E+05 8.0E+03
4E 5 28.16 22.45 25.77 0.00278135 0.00183501 1.2E+03 8.4E+04 1.3E+04
1E 50 24.30 17.81 1.5E+05 1.5E+07
1E 500 27.24 21.09 2.2E+05 2.0E+07
1D-RT 5 #VALUE! #VALUE!
1E-RT 5 28.59 28.09 889 2463




Pos Name Ct SYBR Ct Mean SYBR Ct Dev. SYBR Expr. Level SYBR Range SYBR
A1 1A DNA:100 E1A 26.72 26.75 0.09
A2 1A DNA:100 E1A 26.85 26.75 0.09
A3 1A DNA:100 E1A 26.67 26.75 0.09
A4 2A DNA:100 E1A 26.79 26.41 0.33
A5 2A DNA:100 E1A 26.26 26.41 0.33
A6 2A DNA:100 E1A 26.18 26.41 0.33
A7 3A DNA:100 E1A 25.96 26.03 0.09
A8 3A DNA:100 E1A 26.00 26.03 0.09
A9 3A DNA:100 E1A 26.14 26.03 0.09
A10 4A DNA:100 E1A 25.61 25.67 0.05
A11 4A DNA:100 E1A 25.71 25.67 0.05
A12 4A DNA:100 E1A 25.70 25.67 0.05
B1 1A DNA:100 Hex 28.07 27.84 0.26
B2 1A DNA:100 Hex 27.89 27.84 0.26
B3 1A DNA:100 Hex 27.57 27.84 0.26
B4 2A DNA:100 Hex 27.97 27.78 0.22 0.768 0.618 - 0.954
B5 2A DNA:100 Hex 27.83 27.78 0.22 0.768 0.618 - 0.954
B6 2A DNA:100 Hex 27.53 27.78 0.22 0.768 0.618 - 0.954
B7 3A DNA:100 Hex 27.32 27.27 0.05 0.624 0.495 - 0.787
B8 3A DNA:100 Hex 27.22 27.27 0.05 0.624 0.495 - 0.787
B9 3A DNA:100 Hex 27.27 27.27 0.05 0.624 0.495 - 0.787
B10 4A DNA:100 Hex 26.65 26.88 0.24 0.959 0.693 - 1.33
B11 4A DNA:100 Hex 26.86 26.88 0.24 0.959 0.693 - 1.33
B12 4A DNA:100 Hex 27.13 26.88 0.24 0.959 0.693 - 1.33
C1 1A DNA:100 Actin2 30.65 29.74 0.83
C2 1A DNA:100 Actin2 29.57 29.74 0.83
C3 1A DNA:100 Actin2 29.01 29.74 0.83
C4 2A DNA:100 Actin2 29.45 29.29 0.22
C5 2A DNA:100 Actin2 29.04 29.29 0.22
C6 2A DNA:100 Actin2 29.39 29.29 0.22
C7 3A DNA:100 Actin2 28.85 28.49 0.33
C8 3A DNA:100 Actin2 28.42 28.49 0.33
C9 3A DNA:100 Actin2 28.20 28.49 0.33
C10 4A DNA:100 Actin2 28.28 28.72 0.40
C11 4A DNA:100 Actin2 28.80 28.72 0.40
C12 4A DNA:100 Actin2 29.06 28.72 0.40
D1 1V DNA:1 E1A 17.67 17.17 0.44
D2 1V DNA:1 E1A 17.00 17.17 0.44
D3 1V DNA:1 E1A 16.85 17.17 0.44
D4 2V DNA:1 E1A 16.93 17.04 0.10
D5 2V DNA:1 E1A 17.11 17.04 0.10
D6 2V DNA:1 E1A 17.08 17.04 0.10
D7 3V DNA:1 E1A 17.64 17.48 0.16
D8 3V DNA:1 E1A 17.31 17.48 0.16
D9 3V DNA:1 E1A 17.48 17.48 0.16
D10 4V DNA:1 E1A 17.26 17.10 0.14
D11 4V DNA:1 E1A 16.99 17.10 0.14
D12 4V DNA:1 E1A 17.04 17.10 0.14
E1 1V DNA:1 Hex 18.64 18.24 0.35
E2 1V DNA:1 Hex 18.10 18.24 0.35
E3 1V DNA:1 Hex 17.98 18.24 0.35
E4 2V DNA:1 Hex 18.05 18.02 0.05
E5 2V DNA:1 Hex 17.96 18.02 0.05
E6 2V DNA:1 Hex 18.05 18.02 0.05
E7 3V DNA:1 Hex 18.07 17.97 0.30
E8 3V DNA:1 Hex 17.64 17.97 0.30
E9 3V DNA:1 Hex 18.21 17.97 0.30
E10 4V DNA:1 Hex 17.97 17.92 0.17
E11 4V DNA:1 Hex 17.74 17.92 0.17
E12 4V DNA:1 Hex 18.06 17.92 0.17
F1 1V DNA:1 Actin2
F2 1V DNA:1 Actin2
F3 1V DNA:1 Actin2
F4 2V DNA:1 Actin2
F5 2V DNA:1 Actin2 35.89 35.51 0.53
F6 2V DNA:1 Actin2 35.14 35.51 0.53
F7 3V DNA:1 Actin2 35.05 34.96 0.13
F8 3V DNA:1 Actin2 34.87 34.96 0.13
F9 3V DNA:1 Actin2
F10 4V DNA:1 Actin2 34.07 34.39 0.45
F11 4V DNA:1 Actin2 34.71 34.39 0.45
F12 4V DNA:1 Actin2
G1 1V DNA:10 E1A 21.02 20.84 0.17
G2 1V DNA:10 E1A 20.79 20.84 0.17
G3 1V DNA:10 E1A 20.70 20.84 0.17
G4 1V DNA:100 E1A 23.98 23.83 0.17
G5 1V DNA:100 E1A 23.84 23.83 0.17
G6 1V DNA:100 E1A 23.65 23.83 0.17
G7 1V DNA:1000 E1A 27.30 27.32 0.17
G8 1V DNA:1000 E1A 27.50 27.32 0.17
G9 1V DNA:1000 E1A 27.16 27.32 0.17
G10 No template E1A
G11 No template E1A
G12 No template E1A
H1 1V DNA:10 Hex 22.37 22.00 0.32
H2 1V DNA:10 Hex 21.80 22.00 0.32
H3 1V DNA:10 Hex 21.83 22.00 0.32
H4 1V DNA:100 Hex 25.37 25.24 0.16
H5 1V DNA:100 Hex 25.29 25.24 0.16
H6 1V DNA:100 Hex 25.06 25.24 0.16
H7 1V DNA:1000 Hex 28.46 28.38 0.08
H8 1V DNA:1000 Hex 28.38 28.38 0.08
H9 1V DNA:1000 Hex 28.30 28.38 0.08
H10 No template Hex
H11 No template Hex
H12 No template Hex
Analysis Parameters






Baseline range (from cycle no. ... to) n/a
Drift Correction OFF



















1A 100 26.75 27.84 29.74 1 1 6.0E+04 5.8E+04 2.1E+04 2.79E+02 2.68E+02
2A 100 26.41 27.78 29.29 0.92658806 0.7631296 7.5E+04 6.0E+04 2.8E+04 2.64E+02 2.10E+02
3A 100 26.03 27.27 28.49 0.69255473 0.62416527 9.7E+04 8.2E+04 4.7E+04 2.06E+02 1.76E+02
4A 100 25.67 26.88 28.72 1.04246576 0.95926412 1.2E+05 1.1E+05 4.1E+04 3.02E+02 2.59E+02
1V 1 17.17 18.24 1.00 1.00 3.4E+05 2.3E+05
2V 1 17.04 18.02 1.09 1.15 3.7E+05 2.7E+05
3V 1 17.48 17.97 0.81 1.18 2.7E+05 2.8E+05
4V 1 17.10 17.92 1.05 1.22 3.5E+05 2.9E+05
1V 10 20.84 22.00 3.0E+05 2.2E+05
1V 100 23.83 25.24 4.1E+05 2.9E+05
1V 1000 27.32 28.38 4.1E+05 4.1E+05
No template 1




Pos Name Ct SYBR Ct Mean SYBR Ct Dev. SYBR Expr. Level SYBR Range SYBR
A1 1B DNA:100 E1A 28.73 28.54 0.20
A2 1B DNA:100 E1A 28.56 28.54 0.20
A3 1B DNA:100 E1A 28.32 28.54 0.20
A4 2B DNA:100 E1A 28.70 28.35 0.31
A5 2B DNA:100 E1A 28.23 28.35 0.31
A6 2B DNA:100 E1A 28.13 28.35 0.31
A7 3B DNA:100 E1A 29.53 29.46 0.09
A8 3B DNA:100 E1A 29.37 29.46 0.09
A9 3B DNA:100 E1A 29.48 29.46 0.09
A10 4B DNA:100 E1A 29.37 29.13 0.31
A11 4B DNA:100 E1A 29.24 29.13 0.31
A12 4B DNA:100 E1A 28.77 29.13 0.31
B1 1B DNA:100 Hex 29.32 29.00 0.27
B2 1B DNA:100 Hex 28.86 29.00 0.27
B3 1B DNA:100 Hex 28.83 29.00 0.27
B4 2B DNA:100 Hex 29.42 29.41 0.03
B5 2B DNA:100 Hex 29.42 29.41 0.03
B6 2B DNA:100 Hex 29.38 29.41 0.03
B7 3B DNA:100 Hex 30.84 30.54 0.26
B8 3B DNA:100 Hex 30.38 30.54 0.26
B9 3B DNA:100 Hex 30.39 30.54 0.26
B10 4B DNA:100 Hex 30.23 30.12 0.24
B11 4B DNA:100 Hex 29.84 30.12 0.24
B12 4B DNA:100 Hex 30.28 30.12 0.24
C1 1B DNA:100 Actin2 28.95 28.31 0.56
C2 1B DNA:100 Actin2 28.11 28.31 0.56
C3 1B DNA:100 Actin2 27.88 28.31 0.56
C4 2B DNA:100 Actin2 28.47 28.15 0.27
C5 2B DNA:100 Actin2 28.00 28.15 0.27
C6 2B DNA:100 Actin2 27.98 28.15 0.27
C7 3B DNA:100 Actin2 28.83 28.73 0.13
C8 3B DNA:100 Actin2 28.59 28.73 0.13
C9 3B DNA:100 Actin2 28.78 28.73 0.13
C10 4B DNA:100 Actin2 28.55 28.41 0.21
C11 4B DNA:100 Actin2 28.17 28.41 0.21
C12 4B DNA:100 Actin2 28.51 28.41 0.21
D1 1C DNA:100 E1A 25.99 25.66 0.28
D2 1C DNA:100 E1A 25.51 25.66 0.28
D3 1C DNA:100 E1A 25.48 25.66 0.28
D4 2C DNA:100 E1A 28.37 28.42 0.04
D5 2C DNA:100 E1A 28.44 28.42 0.04
D6 2C DNA:100 E1A 28.45 28.42 0.04
D7 3C DNA:100 E1A 30.96 31.44 0.41
D8 3C DNA:100 E1A 31.70 31.44 0.41
D9 3C DNA:100 E1A 31.65 31.44 0.41
D10 4C DNA:100 E1A 31.70 30.84 0.76
D11 4C DNA:100 E1A 30.26 30.84 0.76
D12 4C DNA:100 E1A 30.58 30.84 0.76
E1 1C DNA:100 Hex 27.38 26.75 0.54
E2 1C DNA:100 Hex 26.42 26.75 0.54
E3 1C DNA:100 Hex 26.46 26.75 0.54
E4 2C DNA:100 Hex 29.37 29.49 0.10 0.130 0.117 - 0.145
E5 2C DNA:100 Hex 29.54 29.49 0.10 0.130 0.117 - 0.145
E6 2C DNA:100 Hex 29.56 29.49 0.10 0.130 0.117 - 0.145
E7 3C DNA:100 Hex 31.95 31.47 0.43 4.180E-2X 2.87E-02 - 6.10E-02
E8 3C DNA:100 Hex 31.35 31.47 0.43 4.180E-2X 2.87E-02 - 6.10E-02
E9 3C DNA:100 Hex 31.11 31.47 0.43 4.180E-2X 2.87E-02 - 6.10E-02
E10 4C DNA:100 Hex 32.43 31.67 0.68 3.180E-2X 1.95E-02 - 5.20E-02
E11 4C DNA:100 Hex 31.44 31.67 0.68 3.180E-2X 1.95E-02 - 5.20E-02
E12 4C DNA:100 Hex 31.13 31.67 0.68 3.180E-2X 1.95E-02 - 5.20E-02
F1 1C DNA:100 Actin2 28.92 28.45 0.41
F2 1C DNA:100 Actin2 28.18 28.45 0.41
F3 1C DNA:100 Actin2 28.25 28.45 0.41
F4 2C DNA:100 Actin2 28.35 28.25 0.11
F5 2C DNA:100 Actin2 28.26 28.25 0.11
F6 2C DNA:100 Actin2 28.13 28.25 0.11
F7 3C DNA:100 Actin2 28.71 28.59 0.34
F8 3C DNA:100 Actin2 28.85 28.59 0.34
F9 3C DNA:100 Actin2 28.21 28.59 0.34
F10 4C DNA:100 Actin2 28.21 28.39 0.20
F11 4C DNA:100 Actin2 28.35 28.39 0.20
F12 4C DNA:100 Actin2 28.60 28.39 0.20
G1 1V DNA:1 E1A 17.97 17.43 0.48
G2 1V DNA:1 E1A 17.26 17.43 0.48
G3 1V DNA:1 E1A 17.06 17.43 0.48
G4 1V DNA:10 E1A 20.54 20.46 0.15
G5 1V DNA:10 E1A 20.54 20.46 0.15
G6 1V DNA:10 E1A 20.29 20.46 0.15
G7 1V DNA:100 E1A 23.82 23.71 0.10
G8 1V DNA:100 E1A 23.69 23.71 0.10
G9 1V DNA:100 E1A 23.63 23.71 0.10
G10 1V DNA:1000 E1A 26.77 27.01 0.34
G11 1V DNA:1000 E1A
G12 1V DNA:1000 E1A 27.25 27.01 0.34
H1 1V DNA:1 Hex 18.85 18.64 0.28
H2 1V DNA:1 Hex 18.75 18.64 0.28
H3 1V DNA:1 Hex 18.32 18.64 0.28
H4 1V DNA:10 Hex 21.85 21.76 0.08
H5 1V DNA:10 Hex 21.73 21.76 0.08
H6 1V DNA:10 Hex 21.70 21.76 0.08
H7 1V DNA:100 Hex 25.04 24.91 0.19
H8 1V DNA:100 Hex 25.01 24.91 0.19
H9 1V DNA:100 Hex 24.69 24.91 0.19
H10 1V DNA:1000 Hex 28.01 28.14 0.15
H11 1V DNA:1000 Hex 28.30 28.14 0.15
H12 1V DNA:1000 Hex 28.11 28.14 0.15
Analysis Parameters






Baseline range (from cycle no. ... to) n/a
Drift Correction OFF























1B 100 28.54 29.00 28.31 1 1 1.8E+04 2.8E+04 5.2E+04 3.52E+01 5.33E+01 4.42E+01
2B 100 28.35 29.41 28.15 1.02101213 0.67361679 2.1E+04 2.2E+04 5.8E+04 3.61E+01 3.73E+01 3.67E+01
3B 100 29.46 30.54 28.73 0.70710678 0.46009383 1.0E+04 1.1E+04 4.0E+04 2.49E+01 2.64E+01 2.56E+01
4B 100 29.13 30.12 28.41 0.7120251 0.49311635 1.2E+04 1.4E+04 4.9E+04 2.53E+01 2.81E+01 2.67E+01
1C 100 25.66 26.75 28.45 1 1 1.2E+05 1.1E+05 4.8E+04 2.57E+02 2.38E+02 2.48E+02
2C 100 28.42 29.49 28.25 0.12851423 0.13030822 2.0E+04 2.1E+04 5.4E+04 3.67E+01 3.78E+01 3.72E+01
3C 100 31.44 31.47 28.59 0.02005353 0.04181024 2.7E+03 5.9E+03 4.4E+04 6.16E+00 1.35E+01 9.84E+00
4C 100 30.84 31.67 28.39 0.02646079 0.03168623 4.0E+03 5.2E+03 5.0E+04 8.08E+00 1.05E+01 9.31E+00
1V 1 17.43 18.64 2.8E+05 1.8E+05
1V 10 20.46 21.76 3.8E+05 2.6E+05
1V 100 23.71 24.91 4.5E+05 3.6E+05
1V 1000 27.01 28.14 5.1E+05 4.8E+05




Pos Name Ct SYBR Ct Mean SYBR Ct Dev. SYBR Expr. Level SYBR Range SYBR
A1 1D DNA:100 E1A 17.35 17.18 0.18
A2 1D DNA:100 E1A 17.20 17.18 0.18
A3 1D DNA:100 E1A 17.00 17.18 0.18
A4 2D DNA:100 E1A 21.45 21.44 0.10
A5 2D DNA:100 E1A 21.34 21.44 0.10
A6 2D DNA:100 E1A 21.54 21.44 0.10
A7 3D DNA:100 E1A 28.53 28.83 0.31
A8 3D DNA:100 E1A 29.15 28.83 0.31
A9 3D DNA:100 E1A 28.80 28.83 0.31
A10 4D DNA:100 E1A 30.56 30.34 0.34
A11 4D DNA:100 E1A 29.95 30.34 0.34
A12 4D DNA:100 E1A 30.52 30.34 0.34
B1 1D DNA:100 Hex 18.16 17.62 0.57
B2 1D DNA:100 Hex 17.69 17.62 0.57
B3 1D DNA:100 Hex 17.02 17.62 0.57
B4 2D DNA:100 Hex 21.96 21.98 0.03
B5 2D DNA:100 Hex 21.97 21.98 0.03
B6 2D DNA:100 Hex 22.02 21.98 0.03
B7 3D DNA:100 Hex 29.64 29.61 0.04
B8 3D DNA:100 Hex 29.63 29.61 0.04
B9 3D DNA:100 Hex 29.56 29.61 0.04
B10 4D DNA:100 Hex 31.38 31.23 0.34
B11 4D DNA:100 Hex 30.84 31.23 0.34
B12 4D DNA:100 Hex 31.46 31.23 0.34
C1 1D DNA:100 Actin2 28.62 27.68 0.82
C2 1D DNA:100 Actin2 27.27 27.68 0.82
C3 1D DNA:100 Actin2 27.14 27.68 0.82
C4 2D DNA:100 Actin2 27.98 28.14 0.15
C5 2D DNA:100 Actin2 28.15 28.14 0.15
C6 2D DNA:100 Actin2 28.29 28.14 0.15
C7 3D DNA:100 Actin2 27.88 27.99 0.22
C8 3D DNA:100 Actin2 28.25 27.99 0.22
C9 3D DNA:100 Actin2 27.85 27.99 0.22
C10 4D DNA:100 Actin2 27.94 27.80 0.13
C11 4D DNA:100 Actin2 27.77 27.80 0.13
C12 4D DNA:100 Actin2 27.69 27.80 0.13
D1 1E DNA:100 E1A 16.70 15.67 0.90
D2 1E DNA:100 E1A 15.30 15.67 0.90
D3 1E DNA:100 E1A 15.02 15.67 0.90
D4 2E DNA:100 E1A 18.30 18.24 0.07
D5 2E DNA:100 E1A 18.27 18.24 0.07
D6 2E DNA:100 E1A 18.16 18.24 0.07
D7 3E DNA:100 E1A 24.96 25.02 0.12
D8 3E DNA:100 E1A 24.95 25.02 0.12
D9 3E DNA:100 E1A 25.17 25.02 0.12
D10 4E DNA:100 E1A 27.38 27.40 0.07
D11 4E DNA:100 E1A 27.34 27.40 0.07
D12 4E DNA:100 E1A 27.48 27.40 0.07
E1 1E DNA:100 Hex 16.15 15.73 0.37
E2 1E DNA:100 Hex 15.54 15.73 0.37
E3 1E DNA:100 Hex 15.49 15.73 0.37
E4 2E DNA:100 Hex 18.82 18.61 0.19 9.110E-2X 7.96E-02 - 0.104
E5 2E DNA:100 Hex 18.45 18.61 0.19 9.110E-2X 7.96E-02 - 0.104
E6 2E DNA:100 Hex 18.57 18.61 0.19 9.110E-2X 7.96E-02 - 0.104
E7 3E DNA:100 Hex 25.58 25.57 0.23 7.350E-4X 6.24E-04 - 8.66E-04
E8 3E DNA:100 Hex 25.34 25.57 0.23 7.350E-4X 6.24E-04 - 8.66E-04
E9 3E DNA:100 Hex 25.80 25.57 0.23 7.350E-4X 6.24E-04 - 8.66E-04
E10 4E DNA:100 Hex 27.67 27.95 0.26 1.910E-4X 1.38E-04 - 2.62E-04
E11 4E DNA:100 Hex 28.01 27.95 0.26 1.910E-4X 1.38E-04 - 2.62E-04
E12 4E DNA:100 Hex 28.17 27.95 0.26 1.910E-4X 1.38E-04 - 2.62E-04
F1 1E DNA:100 Actin2 28.97 28.04 0.81
F2 1E DNA:100 Actin2 27.50 28.04 0.81
F3 1E DNA:100 Actin2 27.66 28.04 0.81
F4 2E DNA:100 Actin2 27.44 27.48 0.04
F5 2E DNA:100 Actin2 27.52 27.48 0.04
F6 2E DNA:100 Actin2 27.47 27.48 0.04
F7 3E DNA:100 Actin2 27.55 27.48 0.07
F8 3E DNA:100 Actin2 27.41 27.48 0.07
F9 3E DNA:100 Actin2 27.48 27.48 0.07
F10 4E DNA:100 Actin2 27.84 27.91 0.38
F11 4E DNA:100 Actin2 27.56 27.91 0.38
F12 4E DNA:100 Actin2 28.32 27.91 0.38
G1 1V DNA:1 E1A 18.28 17.70 0.62
G2 1V DNA:1 E1A 17.78 17.70 0.62
G3 1V DNA:1 E1A 17.04 17.70 0.62
G4 1V DNA:10 E1A 20.59 20.48 0.12
G5 1V DNA:10 E1A 20.36 20.48 0.12
G6 1V DNA:10 E1A 20.48 20.48 0.12
G7 1V DNA:100 E1A 23.88 23.80 0.12
G8 1V DNA:100 E1A 23.87 23.80 0.12
G9 1V DNA:100 E1A 23.66 23.80 0.12
G10 1V DNA:1000 E1A 27.37 27.29 0.11
G11 1V DNA:1000 E1A
G12 1V DNA:1000 E1A 27.21 27.29 0.11
H1 1V DNA:1 Hex 18.57 18.30 0.33
H2 1V DNA:1 Hex 18.40 18.30 0.33
H3 1V DNA:1 Hex 17.92 18.30 0.33
H4 1V DNA:10 Hex 21.37 21.48 0.09
H5 1V DNA:10 Hex 21.55 21.48 0.09
H6 1V DNA:10 Hex 21.52 21.48 0.09
H7 1V DNA:100 Hex 24.66 24.68 0.02
H8 1V DNA:100 Hex 24.68 24.68 0.02
H9 1V DNA:100 Hex 24.69 24.68 0.02
H10 1V DNA:1000 Hex 28.12 28.15 0.15
H11 1V DNA:1000 Hex 28.31 28.15 0.15
H12 1V DNA:1000 Hex 28.02 28.15 0.15
Analysis Parameters






Baseline range (from cycle no. ... to) n/a
Drift Correction OFF























1D 100 17.18 17.62 27.68 1 1 3.3E+07 3.5E+07 7.7E+04 4.32E+04 4.48E+04 4.40E+04
2D 100 21.44 21.98 28.14 0.07179365 0.06698584 2.0E+06 2.3E+06 5.8E+04 3.45E+03 3.89E+03 3.67E+03
3D 100 28.83 29.61 27.99 0.00038576 0.00030477 1.5E+04 1.9E+04 6.4E+04 2.38E+01 2.98E+01 2.68E+01
4D 100 30.34 31.23 27.80 0.00011873 8.6917E-05 5.6E+03 6.9E+03 7.2E+04 7.79E+00 9.61E+00 8.70E+00
1E 100 15.16 15.73 28.04 1 1 1.3E+08 1.1E+08 6.2E+04 2.06E+05 1.83E+05 1.94E+05
2E 100 18.24 18.61 27.48 0.08021412 0.09214183 1.7E+07 1.9E+07 8.8E+04 1.90E+04 2.13E+04 2.01E+04
3E 100 25.02 25.57 27.48 0.00072991 0.0007401 1.9E+05 2.4E+05 8.8E+04 2.15E+02 2.72E+02 2.44E+02
4E 100 27.40 27.95 27.91 0.00018891 0.00019155 3.9E+04 5.4E+04 6.7E+04 5.82E+01 8.02E+01 6.92E+01
1V 1 17.70 18.30 2.4E+05 2.3E+05
1V 10 20.48 21.48 3.8E+05 3.1E+05
1V 100 23.80 24.68 4.2E+05 4.2E+05
1V 1000 27.29 28.15 4.2E+05 4.7E+05




Pos Name Ct SYBR Ct Mean SYBR Ct Dev. SYBR Expr. Level SYBR Range SYBR
A1 1B cDNA:5 E1A 28.48 28.30 0.18
A2 1B cDNA:5 E1A 28.32 28.30 0.18
A3 1B cDNA:5 E1A 28.12 28.30 0.18
A4 2B cDNA:5 E1A 31.39 30.99 0.42
A5 2B cDNA:5 E1A 31.03 30.99 0.42
A6 2B cDNA:5 E1A 30.55 30.99 0.42
A7 3B cDNA:5 E1A 34.69
A8 3B cDNA:5 E1A
A9 3B cDNA:5 E1A
A10 4B cDNA:5 E1A 39.28 37.05 3.16
A11 4B cDNA:5 E1A 34.81 37.05 3.16
A12 4B cDNA:5 E1A
B1 1B cDNA:5 Hexon
B2 1B cDNA:5 Hexon
B3 1B cDNA:5 Hexon 36.22
B4 2B cDNA:5 Hexon
B5 2B cDNA:5 Hexon
B6 2B cDNA:5 Hexon
B7 3B cDNA:5 Hexon
B8 3B cDNA:5 Hexon
B9 3B cDNA:5 Hexon
B10 4B cDNA:5 Hexon
B11 4B cDNA:5 Hexon
B12 4B cDNA:5 Hexon
C1 1B cDNA:5 Actin2 27.44 26.96 0.43
C2 1B cDNA:5 Actin2 26.79 26.96 0.43
C3 1B cDNA:5 Actin2 26.63 26.96 0.43
C4 2B cDNA:5 Actin2 27.87 27.23 0.55
C5 2B cDNA:5 Actin2 26.96 27.23 0.55
C6 2B cDNA:5 Actin2 26.87 27.23 0.55
C7 3B cDNA:5 Actin2 26.99 26.90 0.11
C8 3B cDNA:5 Actin2 26.77 26.90 0.11
C9 3B cDNA:5 Actin2 26.92 26.90 0.11
C10 4B cDNA:5 Actin2 27.41 27.22 0.18
C11 4B cDNA:5 Actin2 27.20 27.22 0.18
C12 4B cDNA:5 Actin2 27.04 27.22 0.18
D1 1C cDNA:5 E1A 23.55 22.83 0.62
D2 1C cDNA:5 E1A 22.51 22.83 0.62
D3 1C cDNA:5 E1A 22.44 22.83 0.62
D4 2C cDNA:5 E1A 25.00 25.00 0.05
D5 2C cDNA:5 E1A 25.04 25.00 0.05
D6 2C cDNA:5 E1A 24.94 25.00 0.05
D7 3C cDNA:5 E1A 33.14 32.30 0.83
D8 3C cDNA:5 E1A 32.27 32.30 0.83
D9 3C cDNA:5 E1A 31.49 32.30 0.83
D10 4C cDNA:5 E1A 34.62 34.50 0.67
D11 4C cDNA:5 E1A 33.78 34.50 0.67
D12 4C cDNA:5 E1A 35.10 34.50 0.67
E1 1C cDNA:5 Hexon 29.31 28.81 0.43
E2 1C cDNA:5 Hexon 28.54 28.81 0.43
E3 1C cDNA:5 Hexon 28.58 28.81 0.43
E4 2C cDNA:5 Hexon 31.39 31.32 0.33 8.810E-2X 6.62E-02 - 0.117
E5 2C cDNA:5 Hexon 30.96 31.32 0.33 8.810E-2X 6.62E-02 - 0.117
E6 2C cDNA:5 Hexon 31.61 31.32 0.33 8.810E-2X 6.62E-02 - 0.117
E7 3C cDNA:5 Hexon <not calculated>
E8 3C cDNA:5 Hexon <not calculated>
E9 3C cDNA:5 Hexon <not calculated>
E10 4C cDNA:5 Hexon <not calculated>
E11 4C cDNA:5 Hexon <not calculated>
E12 4C cDNA:5 Hexon <not calculated>
F1 1C cDNA:5 Actin2 27.46 27.00 0.41
F2 1C cDNA:5 Actin2 26.87 27.00 0.41
F3 1C cDNA:5 Actin2 26.68 27.00 0.41
F4 2C cDNA:5 Actin2 26.04 26.00 0.25
F5 2C cDNA:5 Actin2 25.74 26.00 0.25
F6 2C cDNA:5 Actin2 26.23 26.00 0.25
F7 3C cDNA:5 Actin2 25.99 25.83 0.24
F8 3C cDNA:5 Actin2 25.55 25.83 0.24
F9 3C cDNA:5 Actin2 25.95 25.83 0.24
F10 4C cDNA:5 Actin2 25.98 25.92 0.05
F11 4C cDNA:5 Actin2 25.89 25.92 0.05
F12 4C cDNA:5 Actin2 25.89 25.92 0.05
G1 1E cDNA:5 DF:1 E1A 21.51 21.10 0.39
G2 1E cDNA:5 DF:1 E1A 21.07 21.10 0.39
G3 1E cDNA:5 DF:1 E1A 20.72 21.10 0.39
G4 1E cDNA:5 DF:10 E1A 24.10 23.74 0.35
G5 1E cDNA:5 DF:10 E1A 23.73 23.74 0.35
G6 1E cDNA:5 DF:10 E1A 23.40 23.74 0.35
G7 1E cDNA:5 DF:100 E1A 26.97 26.82 0.17
G8 1E cDNA:5 DF:100 E1A 26.63 26.82 0.17
G9 1E cDNA:5 DF:100 E1A 26.87 26.82 0.17
G10 No Template cDNA:5 E1A
G11 No Template cDNA:5 E1A
G12 No Template cDNA:5 E1A
H1 1E cDNA:5 DF:1 Hexon 14.70 14.51 0.24
H2 1E cDNA:5 DF:1 Hexon 14.58 14.51 0.24
H3 1E cDNA:5 DF:1 Hexon 14.24 14.51 0.24
H4 1E cDNA:5 DF:10 Hexon 17.57 17.28 0.26
H5 1E cDNA:5 DF:10 Hexon 17.17 17.28 0.26
H6 1E cDNA:5 DF:10 Hexon 17.09 17.28 0.26
H7 1E cDNA:5 DF:100 Hexon 20.57 20.58 0.06
H8 1E cDNA:5 DF:100 Hexon 20.65 20.58 0.06
H9 1E cDNA:5 DF:100 Hexon 20.52 20.58 0.06
H10 No Template cDNA:5 Hexon
H11 No Template cDNA:5 Hexon
H12 No Template cDNA:5 Hexon
Analysis Parameters






Baseline range (from cycle no. ... to) n/a
Drift Correction OFF











1B 5 28.30 26.96 1 #VALUE! 1.1E+03 #VALUE! 6.0E+03
2B 5 30.99 27.23 0.18685616 #VALUE! 1.8E+02 #VALUE! 5.1E+03
3B 5 26.90 #VALUE! #VALUE! #VALUE! #VALUE! 6.3E+03
4B 5 27.22 #VALUE! #VALUE! #VALUE! #VALUE! 5.1E+03
1C 5 22.83 28.81 27.00 1 1 4.0E+04 1.6E+03 5.9E+03
2C 5 25.00 31.32 26.00 0.11110534 0.0877778 9.5E+03 3.3E+02 1.1E+04
3C 5 32.30 25.83 0.00062667 #VALUE! 7.7E+01 #VALUE! 1.2E+04
4C 5 34.50 25.92 0.00014517 #VALUE! 1.8E+01 #VALUE! 1.2E+04
1E 5 21.10 14.51 1.3E+05 1.2E+07
1E 50 23.74 17.28 2.2E+05 2.1E+07
1E 500 26.82 20.58 2.9E+05 2.7E+07
No template 5 #VALUE! #VALUE!




Pos Name Ct SYBR Ct Mean SYBR Ct Dev. SYBR Expr. Level SYBR Range SYBR
A1 1D cDNA:5 E1A 21.70 21.55 0.17
A2 1D cDNA:5 E1A 21.57 21.55 0.17
A3 1D cDNA:5 E1A 21.36 21.55 0.17
A4 2D cDNA:5 E1A 24.53 24.16 0.36
A5 2D cDNA:5 E1A 24.13 24.16 0.36
A6 2D cDNA:5 E1A 23.82 24.16 0.36
A7 3D cDNA:5 E1A 31.15 31.33 0.44
A8 3D cDNA:5 E1A 31.00 31.33 0.44
A9 3D cDNA:5 E1A 31.83 31.33 0.44
A10 4D cDNA:5 E1A 32.89 32.33 0.59
A11 4D cDNA:5 E1A 32.39 32.33 0.59
A12 4D cDNA:5 E1A 31.71 32.33 0.59
B1 1D cDNA:5 Hexon 17.05 16.83 0.27
B2 1D cDNA:5 Hexon 16.91 16.83 0.27
B3 1D cDNA:5 Hexon 16.53 16.83 0.27
B4 2D cDNA:5 Hexon 19.84 19.81 0.09
B5 2D cDNA:5 Hexon 19.89 19.81 0.09
B6 2D cDNA:5 Hexon 19.72 19.81 0.09
B7 3D cDNA:5 Hexon 28.18 28.29 0.14
B8 3D cDNA:5 Hexon 28.23 28.29 0.14
B9 3D cDNA:5 Hexon 28.45 28.29 0.14
B10 4D cDNA:5 Hexon 30.91 30.70 0.18
B11 4D cDNA:5 Hexon 30.62 30.70 0.18
B12 4D cDNA:5 Hexon 30.57 30.70 0.18
C1 1D cDNA:5 Actin2 27.67 27.28 0.41
C2 1D cDNA:5 Actin2 27.30 27.28 0.41
C3 1D cDNA:5 Actin2 26.86 27.28 0.41
C4 2D cDNA:5 Actin2 26.12 25.80 0.29
C5 2D cDNA:5 Actin2 25.54 25.80 0.29
C6 2D cDNA:5 Actin2 25.76 25.80 0.29
C7 3D cDNA:5 Actin2 26.34 26.15 0.17
C8 3D cDNA:5 Actin2 26.09 26.15 0.17
C9 3D cDNA:5 Actin2 26.03 26.15 0.17
C10 4D cDNA:5 Actin2 26.07 25.99 0.13
C11 4D cDNA:5 Actin2 25.83 25.99 0.13
C12 4D cDNA:5 Actin2 26.05 25.99 0.13
D1 1E cDNA:5 E1A 21.49 20.87 0.54
D2 1E cDNA:5 E1A 20.52 20.87 0.54
D3 1E cDNA:5 E1A 20.60 20.87 0.54
D4 2E cDNA:5 E1A 23.56 23.53 0.08
D5 2E cDNA:5 E1A 23.59 23.53 0.08
D6 2E cDNA:5 E1A 23.44 23.53 0.08
D7 3E cDNA:5 E1A 31.09 30.40 0.60
D8 3E cDNA:5 E1A 30.01 30.40 0.60
D9 3E cDNA:5 E1A 30.09 30.40 0.60
D10 4E cDNA:5 E1A 31.89 31.49 0.41
D11 4E cDNA:5 E1A 31.07 31.49 0.41
D12 4E cDNA:5 E1A 31.50 31.49 0.41
E1 1E cDNA:5 Hexon 14.94 14.39 0.48
E2 1E cDNA:5 Hexon 14.13 14.39 0.48
E3 1E cDNA:5 Hexon 14.09 14.39 0.48
E4 2E cDNA:5 Hexon 17.71 17.54 0.16 6.550E-2X 5.84E-02 - 7.35E-02
E5 2E cDNA:5 Hexon 17.41 17.54 0.16 6.550E-2X 5.84E-02 - 7.35E-02
E6 2E cDNA:5 Hexon 17.49 17.54 0.16 6.550E-2X 5.84E-02 - 7.35E-02
E7 3E cDNA:5 Hexon 25.07 25.25 0.21 2.180E-4X 1.81E-04 - 2.63E-04
E8 3E cDNA:5 Hexon 25.19 25.25 0.21 2.180E-4X 1.81E-04 - 2.63E-04
E9 3E cDNA:5 Hexon 25.49 25.25 0.21 2.180E-4X 1.81E-04 - 2.63E-04
E10 4E cDNA:5 Hexon 26.17 26.11 0.10 9.620E-5X 8.81E-05 - 1.05E-04
E11 4E cDNA:5 Hexon 25.99 26.11 0.10 9.620E-5X 8.81E-05 - 1.05E-04
E12 4E cDNA:5 Hexon 26.17 26.11 0.10 9.620E-5X 8.81E-05 - 1.05E-04
F1 1E cDNA:5 Actin2 28.14 27.65 0.45
F2 1E cDNA:5 Actin2 27.27 27.65 0.45
F3 1E cDNA:5 Actin2 27.54 27.65 0.45
F4 2E cDNA:5 Actin2 26.90 26.87 0.05
F5 2E cDNA:5 Actin2 26.89 26.87 0.05
F6 2E cDNA:5 Actin2 26.81 26.87 0.05
F7 3E cDNA:5 Actin2 26.50 26.35 0.17
F8 3E cDNA:5 Actin2 26.17 26.35 0.17
F9 3E cDNA:5 Actin2 26.37 26.35 0.17
F10 4E cDNA:5 Actin2 25.97 26.03 0.07
F11 4E cDNA:5 Actin2 26.11 26.03 0.07
F12 4E cDNA:5 Actin2 26.00 26.03 0.07
G1 1E cDNA:5 DF:10 E1A 24.72 24.13 0.51
G2 1E cDNA:5 DF:10 E1A 23.92 24.13 0.51
G3 1E cDNA:5 DF:10 E1A 23.76 24.13 0.51
G4 1E cDNA:5 DF:100 E1A 27.18 27.17 0.27
G5 1E cDNA:5 DF:100 E1A 27.43 27.17 0.27
G6 1E cDNA:5 DF:100 E1A 26.89 27.17 0.27
G7 1D-RT cDNA:5 E1A 35.28 34.86 0.60
G8 1D-RT cDNA:5 E1A 34.44 34.86 0.60
G9 1D-RT cDNA:5 E1A
G10 1E-RT cDNA:5 E1A
G11 1E-RT cDNA:5 E1A
G12 1E-RT cDNA:5 E1A 35.07
H1 1E cDNA:5 DF:10 Hexon 17.83 17.62 0.24
H2 1E cDNA:5 DF:10 Hexon 17.67 17.62 0.24
H3 1E cDNA:5 DF:10 Hexon 17.35 17.62 0.24
H4 1E cDNA:5 DF:100 Hexon 20.80 20.74 0.16
H5 1E cDNA:5 DF:100 Hexon 20.86 20.74 0.16
H6 1E cDNA:5 DF:100 Hexon 20.56 20.74 0.16
H7 1D-RT cDNA:5 Hexon
H8 1D-RT cDNA:5 Hexon 37.40
H9 1D-RT cDNA:5 Hexon
H10 1E-RT cDNA:5 Hexon
H11 1E-RT cDNA:5 Hexon
H12 1E-RT cDNA:5 Hexon
Analysis Parameters






Baseline range (from cycle no. ... to) n/a
Drift Correction OFF











1D 5 21.55 16.83 27.28 1 1 9.3E+04 2.8E+06 5.0E+03
2D 5 24.16 19.81 25.80 0.05872017 0.04543664 1.7E+04 4.4E+05 1.2E+04
3D 5 31.33 28.29 26.15 0.00051971 0.00016219 1.5E+02 2.2E+03 1.0E+04
4D 5 32.33 30.70 25.99 0.00023258 2.7314E-05 7.5E+01 4.8E+02 1.1E+04
1E 5 20.87 14.39 27.65 1 1 1.5E+05 1.3E+07 3.9E+03
2E 5 23.53 17.54 26.87 0.09214183 0.06560729 2.5E+04 1.8E+06 6.4E+03
3E 5 30.40 25.25 26.35 0.00054934 0.00021851 2.7E+02 1.5E+04 8.8E+03
4E 5 31.49 26.11 26.03 0.00020672 9.6441E-05 1.3E+02 8.5E+03 1.1E+04
1E 50 24.13 17.62 1.7E+05 1.7E+07
1E 500 27.17 20.74 2.3E+05 2.5E+07
1D-RT 5 34.86 1.4E+01 #VALUE!
1E-RT 5 #VALUE! #VALUE!
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# Date pH 
Temp 





















J.31 1 10/22/11 8 30 8.00-8.02 29.6-29.8 1 mM CBS 2.80 2.78 7.81E+05 3.7 PR772-5/5/11 
J.33 2 10/30/11 9 30 8.99-9.04 29.9-30.2 1 mM CBS 2.68 2.60 1.05E+06 3.8 PR772-5/5/11 
J.35 3 12/4/11 8 15 7.99-8.21 15.0-15.1 1 mM CBS 2.68 2.69 7.75E+05 3.8 PR772-5/5/11 
J.37 4 12/15/11 9 15 8.97-8.74 15.3-15.5 1 mM CBS 3.25 3.37 1.53E+06 3.2 PR772-5/5/11 
J.39 5 1/23/12 10 30 9.98-10.16 30.0-29.8 1 mM CBS 2.87 2.87 1.53E+06 3.6 PR772-5/5/11 
J.41 6 2/1/12 10 15 10.00-10.25 14.6-13.5 1 mM CBS 2.97 2.90 1.66E+06 3.5 PR772-5/5/11 
J.43 7 5/21/12 8 30 8.05-8.12 30.1-29.4 1 mM CBS 2.95 2.82 1.19E+06 3.5 PR772-5/5/11 
J.45 8 5/23/12 9 30 8.99-9.04 29.9-29.4 1 mM CBS 2.90 2.89 1.21E+06 3.5 PR772-5/5/11 
J.47 9 5/28/12 10 30 10.06-10.06 29.9-29.6 1 mM CBS 2.78 2.67 1.26E+06 3.7 PR772-5/5/11 
J.49 10 5/29/12 6 15 6.03-6.07 15.3-15.2 1 mM CBS 2.99 2.95 9.06E+05 3.4 PR772-5/5/11 
J.51 11 6/4/12 8 15 8.08-8.12 15.1-15.3 1 mM CBS 2.33 2.25 1.34E+06 4.4 PR772-5/5/11 
J.53 12 6/7/12 9 15 9.01-8.90 15.0-15.4 1 mM CBS 2.85 2.49 1.65E+06 3.6 PR772-5/5/11 
J.55 13 6/20/12 10 15 9.97-9.96* 15.0-16.0* 1 mM CBS 2.68 2.68 1.41E+06 3.8 PR772-5/5/11 
J.57 14 6/23/12 7 15 7.03-7.00 15.6-15.6 1 mM CBS 3.09 3.02 1.68E+06 3.3 PR772-5/5/11 
J.59 15 6/25/12 7 30 7.04-7.20 27.3-30.0 1 mM CBS 1.27 1.24 1.45E+06 8.1 PR772-5/5/11 
J.64 17 7/2/12 7 30 6.95-7.07 29.5-29.6 1 mM CBS 1.24 1.21 7.00E+06 8.3 PR772-5/5/11 
J.69 18 8/6/12 9 30 8.97-8.88 29.9-30.0 1 mM CBS 3.04 2.93 9.00E+06 3.4 PR772-5/5/11 
J.71 19 8/7/12 6 30 6.01-6.12 29.6-29.8 1 mM CBS 1.25 1.20 3.88E+06 8.2 PR772-5/5/11 
J.73 20 8/8/12 6 15 5.99-6.03 15.3-15.4 1 mM CBS 1.30 1.25 5.75E+06 7.9 PR772-5/5/11 
J.77 22 8/16/12 7 15 6.99-7.23 15.1-15.0 1 mM CBS 1.24 1.23 5.75E+06 8.3 PR772-5/5/11 
J.79 23 8/21/12 6 30 6.01-6.11 29.7-30.8 1 mM CBS 1.25 1.19 3.88E+06 8.2 PR772-5/5/11 
J.81 24 8/23/12 7 5 7.04-7.22 5.3-5.5* 1 mM CBS 2.97 2.89 5.19E+05 3.5 PR772-5/5/11 
3.47 25 10/19/12 8 5 8.02-7.94 5.7-5.8 1 mM CBS 3.06 3.02 2.60E+06 3.4 PR772-5/5/11 
3.49 26 10/19/12 10 5 10.03-10.02 5.1-5.3 1 mM CBS 9.80 9.67 2.38E+06 3.1 PR772-5/5/11 
3.51 27 10/20/12 9 5 9.02-8.69 5.0-4.9 1 mM CBS 9.83 9.47 3.75E+06 3.1 PR772-5/5/11 
3.53 28 10/20/12 10 5 9.98-9.80 5.2-5.2 1 mM CBS 9.69 9.52 4.25E+06 3.2 PR772-5/5/11 
J.83 29 10/20/12 7 5 6.97-7.14 4.9-6.1 1 mM CBS 1.29 1.25 4.54E+06 8.0 PR772-5/5/11 
J.83 30 10/20/12 6 5 5.98-5.95 5.4-5.5 1 mM CBS 1.31 1.26 4.54E+06 7.8 PR772-5/5/11 
J.85 31 1/12/13 9 5 8.98-8.69 5.5-6.2 1 mM CBS 10.58 10.56 3.68E+06 2.9 PR772-5/5/11 
3.75 32 1/12/13 8 5 7.96-8.02 5.4-5.2 1 mM CBS 3.23 3.14 6.63E+06 3.2 PR772-5/5/11 
J.87 33 1/20/13 10 5 10.04-9.89 4.8-6.2 1 mM CBS 10.37 10.18 4.29E+06 3.0 PR772-5/5/11 
J.89 34 2/2/13 7 5 7.03-6.90* 5.2-5.4* 1 mM PBS 1.28 1.27 3.76E+06 24.1 PR772-5/5/11 
J.91 35 3/23/13 7 5 6.99-6.99 5.3-5.6 1 mM PBS 1.49 1.43 3.98E+06 20.7 PR772-5/5/11 
J.93 36 4/19/13 6 5 5.99-5.95 5.2-5.6 1 mM PBS 1.36 1.31 3.12E+06 22.7 PR772-5/5/11 
J.95 37 5/30/13 8 15 8.02-8.08 15.3-15.4 1 mM CBS 1.31 1.30 1.16E+06 7.8 PR772-5/5/11 
J.95 38 5/30/13 8 15 7.99-7.99 15.2-15.6 1 mM CBS 9.79 9.56 7.38E+05 3.2 PR772-5/5/11 
3.113 39 5/30/13 8 15 7.98-7.98 15.1-15.2 1 mM CBS 3.06 3.08 8.63E+04 3.4 PR772-5/5/11 
3.115 40 5/30/13 8 15 8.00-8.00 14.7-15.2 1 mM CBS 2.97 3.06 9.50E+03 3.5 PR772-5/5/11 
3.245 MC1 2/6/15 8 15 8.03-8.05 14.9-15.0 1 mM CBS 3.11 3.02 9.75E+06 3.3 PR772-11/24/14 
3.249 MC2 2/11/15 8 15 7.96-8.00 15.0-15.0 1 mM CBS 3.14 3.05 1.10E+07 3.3 PR772-11/24/14 
3.251 MC3 2/13/15 8 15 7.96-8.03 14.7-14.9 1 mM CBS 2.99 3.01 1.15E+07 3.4 PR772-11/24/14 
*More data points were taken for temp/pH 
  



























R2 0.000 5 0.118 2.80
0.517 5 0.120 2.85
2.367 5 0.118 2.80
4.900 5 0.115 2.73
6.433 5 0.116 2.76






Actual%Time%(mins) 0 I1 I2 I3 I4 I5 N N/No CT%(mg*min/L)
1 0.00 TNTC 65 2 812500
2 0.00 TNTC 60 1 750000
781250 1 0
3 0.23 TNTC 42 0 525000 0.672 0.648456057
4 1.03 TNTC 88 7 110000 0.1408 2.871733967
5 2.13 282 73 1 0 6325 0.008096 5.928741093
6 3.38 2 0 0 0
7 4.15 118 0 1 0 147.5 0.0001888 11.53325416
8 5.22 4 10 0
9 6.07 32 0 0 40 0.0000512 16.85985748
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R2 0.000 5 0.113 2.68
0.333 5 0.113 2.68
2.150 5 0.111 2.64
6.117 5 0.110 2.61
10.217 5 0.111 2.64
15.367 5 0.110 2.61
20.250 5 0.110 2.61
30.417 5 0.104 2.47






Actual%Time%(mins) 0 J1 J2 J3 J4 J5 N N/No CT%(mg*min/L)
1 0.00 TNTC 84 0 1050000
2 0.00 139 46 0 374375
1050000 1 0
3 0.30 370 27 7
4 0.98 TNTC TNTC 30 375000 0.357142857 2.55760095
5 1.95 TNTC TNTC 80 1000000 0.952380952 5.071852732
6 5.03 TNTC TNTC 375 7
7 9.85 TNTC TNTC TNTC 65 81250 0.077380952 25.61935867
8 15.05 TNTC 108 43 1 3362.5 0.003202381 39.14429929
9 19.98 249 120 2 905.625 0.0008625 51.97565321
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R2 0.000 5 0.113 2.68
0.500 5 0.112 2.66
2.267 5 0.112 2.66
5.683 5 0.113 2.68
10.400 5 0.114 2.71
16.200 5 0.114 2.71
30.433 5 0.114 2.71






Actual%Time%(mins) 0 K1 K2 K3 K4 K5 N N/No CT%(mg*min/L)
1 0.00 TNTC 45 1 562500
2 0.00 TNTC 54 7 675000
3 0.18 TNTC 62 2 775000 1 0.493326547
4 0.90 TNTC 252 18 315000 0.406451613 2.421784866
5 1.93 TNTC 85 7 106250 0.137096774 5.202352675
6 2.95 TNTC 84 4 0 10500 0.013548387 7.938072616
7 4.97 TNTC 193 38 0 3581.25 0.004620968 13.36466463
8 9.95 10 6 1
9 14.97 4 0 0
10 29.95 0 0
















































































R2 0.000 5 0.137 3.25
0.433 5 0.141 3.35
2.800 5 0.143 3.40
5.317 5 0.142 3.37
10.767 5 0.141 3.35
21.283 5 0.144 3.42






Actual%Time%(mins) 0 J1 J2 J3 J4 J5 N N/No CT%(mg*min/L)
1 0.00 TNTC 126 3 1575000
2 0.00 TNTC 119 6 1487500
1531250 1 0
3 0.18 TNTC 62 11 775000 0.506122449 0.618368963
4 0.98 TNTC 68 3 850000 0.555102041 3.316706255
5 2.05 TNTC TNTC 75 937500 0.612244898 6.914489311
6 4.97 TNTC TNTC 152 6 190000 0.124081633 16.75217736
7 10.05 TNTC TNTC 65 1 8125 0.005306122 33.89786223
8 15.05 TNTC 168 7 0 2100 0.001371429 50.76247031
9 20.18 TNTC 61 4 0 762.5 0.000497959 68.07680127
10 25.03 119 5 2 148.75 9.71429EJ05 84.4354711
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R2 0.000 5 0.121 2.87
1.150 5 0.121 2.87
3.367 5 0.122 2.90
6.067 5 0.121 2.87
11.467 5 0.121 2.87
30.583 5 0.120 2.85








Actual%Time%(mins) 0 K1 K2 K3 K4 K5 N N/No CT%(mg*min/L)
1 0.00 TNTC 94 5 1175000
2 0.00 TNTC 150 6 1875000
1525000 1 0
3 0.23 TNTC 120 11 1500000 0.983606557 0.668778042
4 0.92 TNTC 112 4 1400000 0.918032787 2.627342307
5 2.43 TNTC TNTC 143 1787500 1.172131148 6.974399578
6 4.97 TNTC TNTC 107 1337500 0.87704918 14.23541832
7 10.02 TNTC TNTC 43 537500 0.352459016 28.70968593
8 19.98 TNTC TNTC TNTC
9 29.98 TNTC TNTC TNTC 152 190000 0.124590164 85.93797836
10 39.97 TNTC TNTC 224 28000 0.018360656 114.5521246
11 49.98 TNTC 180 2250 0.00147541 143.2618105






















































































R2 1.200 5 0.125 2.97
3.350 5 0.123 2.92
5.717 5 0.123 2.92
8.150 5 0.122 2.90
10.700 5 0.122 2.90
12.833 5 0.122 2.90
20.700 5 0.123 2.92
45.217 5 0.122 2.90
75.600 5 0.120 2.85








Actual%Time%(mins) 0 I1 I2 I3 I4 I5 N N/No CT%(mg*min/L)
1 0.00 TNTC 83 4 1037500
2 0.00 TNTC 123 9 1537500
3 0.37 TNTC 133 11 1662500 1 1.061581772
4 0.95 TNTC 93 12 1162500 0.69924812 2.750461863
5 2.63 TNTC TNTC 97 5 1212500 0.729323308 7.62408727
6 9.93 TNTC TNTC 54 2 675000 0.406015038 28.75921527
7 19.97 TNTC TNTC 78 975000 0.586466165 57.80795285
8 29.90 TNTC TNTC TNTC 43 537500 0.323308271 86.56716812
9 44.95 TNTC TNTC TNTC 244 305000 0.183458647 130.1402745
10 59.98 TNTC TNTC TNTC 16
11 74.97 TNTC TNTC TNTC 48 60000 0.036090226 217.0452186














































































R2 0.000 5 0.124 2.95
0.367 5 0.118 2.80
2.367 5 0.119 2.83
4.550 5 0.120 2.85
6.467 5 0.118 2.80







Actual%Time%(mins) 0 J1 J2 J3 J4 J5 N N/No CT%(mg*min/L)
1 0.00 TNTC 92 2 1150000
2 0.00 TNTC 98 14 1225000
1187500 1 0
3 0.20 TNTC 84 5 1050000 0.884210526 0.563420428
4 1.07 TNTC 75 2 93750 0.078947368 3.004908947
5 2.02 289 30 3 3681 0.0031 5.681155978
6 3.00 74 0 1 93 7.78947EJ05 8.451306413
7 4.02 28 3 1
8 4.97 0 0 0
9 6.00 0 0















































































R2 0.000 5 0.122 2.90
0.350 5 0.123 2.92
2.300 5 0.121 2.87
4.400 5 0.122 2.90
15.417 5 0.121 2.87








Actual%Time%(mins) 0 K1 K2 K3 K4 K5 N N/No CT%(mg*min/L)
1 0.00 TNTC 86 2 1075000
2 0.00 TNTC 71 5 887500
3 0.17 TNTC 97 8 1212500 1 0.482185273
4 1.03 TNTC 58 3 725000 0.597938144 2.989548694
5 1.98 281 30 4 363125 0.299484536 5.738004751
6 5.03 TNTC 38 0 47500 0.039175258 14.56199525
7 10.07 15 3 0
8 15.03 52 14 0 0 65 5.36082EK05 43.49311164
9 20.05 0 0 0
















































































R2 0.550 5 0.117 2.78
3.183 5 0.113 2.68
4.667 5 0.112 2.66
6.467 5 0.115 2.73
8.417 5 0.114 2.71
10.600 5 0.113 2.68
12.733 5 0.112 2.66
20.117 5 0.113 2.68
40.150 5 0.113 2.68
60.250 5 0.109 2.59








Actual%Time%(mins) 0 L1 L2 L3 L4 L5 N N/No CT%(mg*min/L)
1 0.00 TNTC 74 6 925000
2 0.00 TNTC 120 2 1500000
3 0.43 TNTC 101 6 1262500 1 1.154869359
4 1.52 TNTC 101 7 1262500 1 4.042042755
5 9.92 TNTC 52 7 650000 0.514851485 26.42874109
6 19.88 265 14 1 331250 0.262376238 52.99073634
7 31.65 346 16 1
8 39.95 TNTC 135 4 16875 0.013366337 106.4700713
9 49.98 TNTC TNTC 35 4375 0.003465347 133.2097387
10 59.98 250 91 2 725 0.000574257 159.8605701
11 69.98 70 10 1 87.5 6.93069EL05 186.5114014
















































































R2 0.000 5 0.126 2.99
0.100 5 0.125 2.97








Actual%Time%(mins) 0 K1 K2 K3 K4 K5 N N/No CT%(mg*min/L)
1 0.00 TNTC 62 2 775000
2 0.00 TNTC 83 10 1037500
906250 1 0
3 0.08 TNTC TNTC TNTC 252 9 2 315000 0.347586207 0.245447348
4 0.22 TNTC TNTC 116 21 0 14500 0.016 0.638163104
5 0.35 TNTC 62 9 1 0 775 0.000855172 1.03087886
6 0.45 157 21 0 0 196 0.000216552 1.325415677























































	  	   364 
 
 




















R2 0.000 5 0.098 2.33
0.650 5 0.096 2.28
1.967 5 0.095 2.26
3.333 5 0.094 2.23
6.250 5 0.094 2.23








Actual%Time%(mins) 0 K1 K2 K3 K4 K5 N N/No CT%(mg*min/L)
1 0.00 TNTC 99 2 1237500
2 0.00 TNTC 115 7 1437500
1337500 1 0
3 0.15 TNTC 79 3 987500 0.738317757 0.337054632
4 0.35 TNTC TNTC 56 3 700000 0.523364486 0.786460808
5 0.73 TNTC 267 31 1 360625 0.269626168 1.647822644
6 0.97 TNTC 166 13 207500 0.155140187 2.17212985
7 2.95 TNTC 32 3 4000 0.002990654 6.628741093
8 4.95 195 6 2 244 0.000182243 11.12280285
9 6.98 32 0 0 40 2.99065EK05 15.69176564
10 7.98 44 3 55 4.11215EK05 17.93879652















































































R2 0.000 5 0.120 2.85
0.433 5 0.109 2.59
2.500 5 0.105 2.49
4.333 5 0.103 2.45
6.883 5 0.103 2.45
10.183 5 0.104 2.47
20.200 5 0.104 2.47







Actual%Time%(mins) 0 J1 J2 J3 J4 J5 N N/No CT%(mg*min/L)
1 0.00 TNTC 132 9 1650000
2 0.00 TNTC 116 11 1450000
3 0.17 TNTC 132 17 1650000 1 0.414545866
4 1.32 TNTC 114 13 1425000 0.863636364 3.27491234
5 2.20 TNTC 110 7 1375000 0.833333333 5.472005429
6 5.18 TNTC TNTC 47 587500 0.356060606 12.89237643
7 9.97 TNTC TNTC 53 66250 0.040151515 24.78984278
8 14.97 TNTC TNTC TNTC
9 19.98 TNTC TNTC 152 19000 0.011515152 49.70404932
10 24.98 TNTC 202 31 3200 0.001939394 62.14042529
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R2 0.000 5 0.113 2.68
0.850 5 0.114 2.71
2.217 5 0.113 2.68
4.117 5 0.113 2.68
15.150 5 0.112 2.66
45.217 5 0.112 2.66
91.117 5 0.114 2.71
180.233 5 0.113 2.68








Actual%Time%(mins) 0 K1 K2 K3 K4 K5 N N/No CT%(mg*min/L)
1 0.00 TNTC 85 6 1062500
2 0.00 TNTC 140 8 1750000
1406250 1 0
3 0.23 TNTC 108 7 1350000 0.96 0.625593824
4 5.08 TNTC 78 14 975000 0.693333333 13.62900831
5 14.93 TNTC 76 6 950000 0.675555556 40.03800475
6 29.97 TNTC 41 5 512500 0.364444444 80.34412114
7 45.00 TNTC TNTC 25
8 90.90 TNTC TNTC 56 70000 0.049777778 243.7134798
9 135.10 TNTC TNTC 49 0 6125 0.004355556 362.2188242
10 180.02 TNTC 69 10 1 863 0.000613333 482.6456354
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R2 0.000 5 0.130 3.09
0.267 5 0.128 3.04
1.967 5 0.127 3.02








Actual%Time%(mins) 0 K1 K2 K3 K4 K5 N N/No CT%(mg*min/L)
1 0.00 TNTC 98 6 1225000
2 0.00 TNTC 171 11 2137500
1681250 1 0
3 0.15 276 37 4 403750 0.240148699 0.45368171
4 0.43 133 2 0 0 16625 0.009888476 1.310636052
5 0.67 12 10 1 0
6 0.97 118 0 0 0 148 8.77323EK05 2.923726577
7 1.45 18 13 1 0
8 1.95 39 4 0 49 2.89963EK05 5.897862233
9 2.95 14 0 0





















































	  	   368 
	  




















R2 0.000 2 0.134 1.27
0.283 2 0.132 1.25
1.600 2 0.131 1.24








Actual%Time%(mins) 0 K1 K2 K3 K4 K5 N N/No CT%(mg*min/L)
1 0.00 TNTC 106 3 1325000
2 0.00 TNTC 126 5 1575000
1450000 1 0
3 0.17 TNTC TNTC 56 4 700000 0.482758621 0.206914753
4 0.38 TNTC TNTC TNTC 145 27 181250 0.125 0.475903932
5 0.58 TNTC TNTC 187 18 0 23375 0.01612069 0.724201636
6 0.82 TNTC TNTC 40 2 5000 0.003448276 1.013882291
7 1.02 154 172 14 1171 0.000807759 1.262179995
8 1.38 47 17 0 59 4.05172EK05 1.717392452
9 1.73 108 1 135 9.31034EK05 2.151913434
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R2 0.000 2 0.131 1.24
0.233 2 0.129 1.23
1.567 2 0.126 1.20








Actual%Time%(mins) 0 K1 K2 K3 K4 K5 K6 N N/No CT%(mg*min/L)
1 0.00 TNTC 41 3 5125000
2 0.00 TNTC 71 4 8875000
7000000 1 0
3 0.13 228 23 2 2850000 0.407142857 0.161309053
4 0.32 99 15 3 0 123750 0.017678571 0.383109
5 0.52 99 21 3 0 12375 0.001767857 0.625072579
6 0.72 9 0 0
7 1.00 TNTC 83 15 0 1038 0.000148214 1.209817894
8 1.33 147 47 4 0 386 5.50893EK05 1.613090525
9 1.72 35 7 10 44 0.00000625 2.076854051
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R2 0.000 5 0.128 3.04
0.433 5 0.124 2.95
2.467 5 0.125 2.97
4.100 5 0.121 2.87
6.300 5 0.121 2.87
8.150 5 0.126 2.99
14.167 5 0.125 2.97








Actual%Time%(mins) 0 K1 K2 K3 K4 K5 K6 N N/No CT%(mg*min/L)
1 0.00 141 39 5
2 0.00 TNTC 49 7 6125000
3 0.25 TNTC 72 0 9000000 1 0.732948761
4 1.53 TNTC 51 4 6375000 0.708333333 4.49541907
5 2.00 TNTC TNTC 18
6 5.12 TNTC 36 6 450000 0.05 15.00101798
7 7.95 40 3 0 50000 0.005555556 23.30777061
8 11.00 168 8 1 21000 0.002333333 32.2497455
9 13.97 TNTC 32 2 4000 0.000444444 40.94740414
10 17.02 TNTC 64 4 800 8.88889EK05 49.88937903
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R2 0.000 2 0.132 1.25
0.517 2 0.126 1.20
1.750 2 0.126 1.20








Actual%Time%(mins) 0 K1 K2 K3 K4 K5 K6 N N/No CT%(mg*min/L)
1 0.00 TNTC 25 0
2 0.00 TNTC 31 1 3875000
3875000 1 0
3 0.15 TNTC 73 2 912500 0.235483871 0.179572447
4 0.42 TNTC 196 59 0 4913 0.001267742 0.498812352
5 0.63 21 1 0 0
6 0.83 17 2 0
7 1.03 57 2 1 71 1.83871EK05 1.237054632
8 1.30 8 17 0
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R2 0.000 2 0.137 1.30
0.300 2 0.132 1.25








Actual%Time%(mins) 0 K1 K2 K3 K4 K5 K6 N N/No CT%(mg*min/L)
1 0.00 TNTC 47 6 5875000
2 0.00 TNTC 45 8 5625000
5750000 1 0
3 0.20 TNTC 142 13 1775000 0.308695652 0.250831354
4 0.40 TNTC 300 10 375000 0.065217391 0.501662708
5 0.58 TNTC 32 6 40000 0.006956522 0.731591449
6 0.80 209 24 1 2613 0.000454348 1.003325416
7 1.00 TNTC 70 3 875 0.000152174 1.25415677
8 1.28 TNTC 11 1
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R2 0.000 5 0.128 3.04
0.450 5 0.122 2.90
2.167 5 0.121 2.87
3.617 5 0.122 2.90
10.133 5 0.121 2.87
30.350 5 0.121 2.87








Actual%Time%(mins) 0 K1 K2 K3 K4 K5 K6 N N/No CT%(mg*min/L)
1 0.00 TNTC 30 1 3750000
2 0.00 TNTC 41 1 5125000
4437500 1 0
3 0.25 TNTC 29 4
4 1.97 TNTC 42 1 5250000 1.183098592 5.64462919
5 4.93 TNTC 200 24 2500000 0.563380282 14.15940881
6 9.92 TNTC TNTC 23
7 20.33 TNTC 180 23 0 22500 0.005070423 58.35972552
8 30.15 152 7 0 1900 0.000428169 86.53503563
9 40.07 2 0 0
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R2 0.000 2 0.131 1.24
0.283 2 0.130 1.24
1.817 2 0.129 1.23
3.367 2 0.130 1.24








Actual%Time%(mins) 0 J1 J2 J3 J4 J5 J6 N N/No CT%(mg*min/L)
1 0.00 TNTC 47 2 5875000
2 0.00 TNTC 45 2 5625000
5750000 1 0
3 0.17 TNTC 44 7 5500000 0.956521739 0.2050673
4 0.35 284 27 1 3550000 0.617391304 0.43064133
5 0.57 TNTC 118 14 1475000 0.256521739 0.69722882
6 0.80 TNTC TNTC 30 2 375000 0.065217391 0.98432304
7 1.00 TNTC 152 11 190000 0.033043478 1.2304038
8 1.43 TNTC TNTC 51 63750 0.011086957 1.763578781
9 2.23 TNTC TNTC 37 4625 0.000804348 2.747901821
10 3.50 279 22 0 349 6.06522EJ05 4.306413302
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R2 0.000 2 0.132 1.25
0.617 2 0.126 1.20
2.083 2 0.126 1.20








Actual%Time%(mins) 0 J1 J2 J3 J4 J5 J6 N N/No CT%(mg*min/L)
1 0.00 TNTC 16 3
2 0.00 TNTC 31 3 3875000
3875000 1 0
3 0.15 TNTC 55 2 687500 0.177419355 0.178147268
4 0.33 TNTC 36 2 1 4500 0.00116129 0.395882819
5 0.50 55 6 0 0 69 1.77419EJ05 0.593824228
6 0.68 4 0 0 0
7 0.87 4 2 0
8 1.30 39 0 0 49 1.25806EJ05 1.543942993
9 1.48 11 0 0
10 1.98 9 0 0
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R2 0.000 5 0.125 2.97
0.333 5 0.124 2.95
2.933 5 0.122 2.90
4.183 5 0.118 2.80








Actual%Time%(mins) 0 K1 K2 K3 K4 K5 N N/No CT%(mg*min/L)
1 0.00 TNTC 34 4 425000
2 0.00 TNTC 49 3 612500
518750 1 0
3 0.20 145 9 1 181250 0.34939759 0.57719715
4 0.42 TNTC 22 2
5 0.68 236 46 1 4350 0.008385542 1.972090261
6 0.98 11 2 0
7 2.00 4 0 0
8 2.98 0 0 0
9 4.02 1 0 0
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R2 0.000 5 0.129 3.06
1.183 5 0.127 3.02
3.300 5 0.127 3.02
9.033 5 0.127 3.02
14.650 5 0.127 3.02








Actual%Time%(mins) 0 J1 J2 J3 J4 J5 J6 N N/No CT%(mg*min/L)
1 0.25 208 20 3 2600000 1 0.75415677
2 1.00 84 6 0 1050000 0.403846154 3.016627078
3 2.32 252 9 2 315000 0.121153846 6.988519398
4 3.10 TNTC 87 10 2 108750 0.041826923 9.351543943
5 5.12 TNTC 170 7 1 21250 0.008173077 15.43507522
6 8.22 63 2 1 0 787.5 0.000302885 24.78661916
7 10.98 121 5 3 1 151.25 5.81731EJ05 33.13262074
8 14.12 42 5 1 52.5 2.01923EJ05 42.58471892
9 16.96666667 41 1 0 51.25 1.97115EJ05 51.1821061
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R2 0.000 7.5 0.275 9.80
1.000 7.5 0.268 9.55
2.950 7.5 0.273 9.73
28.150 7.5 0.275 9.80
60.917 7.5 0.273 9.73
90.250 7.5 0.273 9.73








Actual%Time%(mins) 0 K1 K2 K3 K4 K5 K6 N N/No CT%(mg*min/L)
1 0.27 190 15 4 2375000 1 2.579572447
2 3.13 148 19 1 1850000 0.778947368 30.30997625
3 15.00 31 6 0 387500 0.163157895 145.1009501
4 30.08 99 7 0 123750 0.052105263 291.0080166
5 46.32 TNTC 39 3 0 48750 0.020526316 448.0394893
6 59.90 TNTC 132 44 0 35750 0.015052632 579.4364608
7 75.17 TNTC 296 8 0 3700 0.001557895 727.1169834
8 90.00 TNTC 72 15 900 0.000378947 870.6057007
9 104.9666667 TNTC%(313) 18 0
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R2 0.000 7.5 0.276 9.83
0.917 7.5 0.267 9.51
3.750 7.5 0.255 9.09
10.233 7.5 0.268 9.55
21.017 7.5 0.270 9.62
30.817 7.5 0.268 9.55








Actual%Time%(mins) 0 I1 I2 I3 I4 I5 I6 N N/No CT%(mg*min/L)
1 0.28 TNTC 30 2 3750000 1 2.681908155
2 1.13 TNTC 183 20 2287500 0.61 10.72763262
3 5.05 63 1 0 78750 0.021 47.80106888
4 10.00 0 1 0
5 14.93 136 4 1 0 1700 0.000453333 141.3523357
6 20.22 36 4 0 0 450 0.00012 191.3620348
7 25.22 TNTC 35 1 1 438 0.000116667 238.6898258
8 30.00 64 10 0 80 2.13333EI05 283.9667458
9 35.3 32 6 0 40 1.06667EI05 334.1342043
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R2 0.000 7.5 0.272 9.69
1.333 7.5 0.259 9.23
3.133 7.5 0.268 9.55
12.650 7.5 0.265 9.44
50.033 7.5 0.266 9.48
91.483 7.5 0.269 9.58
131.217 7.5 0.276 9.83








Actual%Time%(mins) 0 J1 J2 J3 J4 J5 J6 N N/No CT%(mg*min/L)
1 0.33 TNTC 34 3 4250000 1 3.172718018
2 1.03 177 14 0 2212500 0.520588235 9.835425857
3 10.17 62 5 0 775000 0.182352941 96.76789956
4 20.12 173 19 0 216250 0.050882353 191.4735324
5 44.65 61 4 0 7625 0.001794118 424.9855786
6 69.92 74 2 0 0 925 0.000217647 665.4776043
7 90.33 0 0 0
8 110.32 3 0 1
9 130.1666667 0 0 0
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R2 0.000 2 0.136 1.29
0.633 2 0.133 1.26
2.500 2 0.131 1.24








Actual%Time%(mins) 0 J1 J2 J3 J4 J5 J6 N N/No CT%(mg*min/L)
1 0.00 186 23 1 2325000
2 0.00 TNTC 54 8 6750000
4537500 1 0
3 0.17 TNTC 35 4 4375000 0.964187328 0.209026128
4 0.38 TNTC 280 39 4187500 0.922865014 0.480760095
5 0.68 TNTC 140 14 1750000 0.385674931 0.857007126
6 0.98 TNTC 95 5 1187500 0.261707989 1.233254157
7 1.33 TNTC 158 27 197500 0.043526171 1.672209026
8 1.70 TNTC 63 4 78750 0.017355372 2.132066508
9 2.02 TNTC TNTC 62 6 77500 0.01707989 2.529216152
10 2.62 TNTC TNTC 77 14 9625 0.002121212 3.281710214
11 3.00 TNTC 212 6 2650 0.000584022 3.762470309
12 3.50 TNTC TNTC 40 5000 0.001101928 4.389548694
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R2 0.000 2 0.138 1.31
0.350 2 0.133 1.26
1.817 2 0.133 1.26








Actual%Time%(mins) 0 L1 L2 L3 L4 L5 L6 N N/No CT%(mg*min/L)
1 0.00 186 23 1 2325000
2 0.00 TNTC 54 8 6750000
4537500 1 0
15 0.17 139 15 2 1737500 0.38292011 0.210081816
16 0.42 134 9 2 167500 0.036914601 0.525204539
17 0.67 TNTC 66 5 0 82500 0.018181818 0.840327263
18 0.98 TNTC 188 28 2 23500 0.005179063 1.239482713
19 1.33 205 32 1 0 3281 0.00072314 1.680654526
20 1.65 26 1 0
21 2.00 62 3 0 0 77.5 1.70799EL05 2.520981789
22 2.33 TNTC 9 0
23 2.67 60 21 0 75 1.65289EL05 3.361309053
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R2 0.000 7.5 0.297 10.58
0.450 7.5 0.299 10.65
2.367 7.5 0.297 10.58
3.967 7.5 0.296 10.55
6.083 7.5 0.295 10.51
10.150 7.5 0.297 10.58
17.233 7.5 0.296 10.55
25.233 7.5 0.296 10.55








Actual%Time%(mins) 0 J1 J2 J3 J4 J5 J6 N N/No CT%(mg*min/L)
1 0.00 TNTC 28 2
2 0.00 294 13 0 3675000
3675000 1 0
3 0.25 149 21 1 1862500 0.506802721 2.641033254
4 1.53 TNTC 52 5 650000 0.176870748 16.19833729
5 5.22 296 30 0 37250 0.010136054 55.10956057
6 9.93 95 2 0 1188 0.000323129 104.9370546
7 13.00 173 6 2 216 5.88435EJ05 137.3337292
8 17.02 129 17 1 161.25 4.38776EJ05 179.7663302
9 21.00 120 2 0 150 4.08163EJ05 221.8467933
10 25.00 72 4 0 90 2.44898EJ05 264.1033254
11 29.02 32 1 0 40 1.08844EJ05 306.5359264
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R2 0.000 5 0.136 3.23
1.200 5 0.130 3.09
4.167 5 0.133 3.16
6.383 5 0.132 3.14
11.317 5 0.133 3.16
14.567 5 0.133 3.16








Actual%Time%(mins) 0 K1 K2 K3 K4 K5 K6 N N/No CT%(mg*min/L)
1 0.00 TNTC 28 2
2 0.00 294 13 0 3675000 0
1 0.18 TNTC 53 1 6625000 1 0.575547638
2 0.47 TNTC 39 4 4875000 0.735849057 1.465030351
3 1.52 TNTC 83 8 1037500 0.156603774 4.761348641
4 2.97 TNTC 60 6 75000 0.011320755 9.313407231
5 5.58 TNTC 88 2 11000 0.001660377 17.5280417
6 8.13 TNTC 240 13 3000 0.00045283 25.53338612
7 11.05 TNTC 38 5 475 7.16981EK05 34.68982581
8 14.32 TNTC 37 2 462.5 6.98113EK05 44.94503827
9 16.17 54 13 2 67.5 1.01887EK05 50.75283716
10 16.97 110 10 2 137.5 2.07547EK05 53.26431776
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R2 0.000 7.5 0.291 10.37
0.433 7.5 0.279 9.94
2.117 7.5 0.286 10.19
3.683 7.5 0.286 10.19
5.817 7.5 0.288 10.26
25.183 7.5 0.286 10.19
50.200 7.5 0.286 10.19
65.217 7.5 0.286 10.19








Actual%Time%(mins) 0 J1 J2 J3 J4 J5 J6 N N/No CT%(mg*min/L)
1 0.00 TNTC 26 3
2 0.00 TNTC 34 6 4250000
3 0.23 287 40 3 4293750 1 2.375593824
4 1.93 TNTC 233 28 2912500 0.678311499 19.68349169
5 9.92 TNTC 132 8 1650000 0.384279476 100.9627375
6 24.98 TNTC 222 19 277500 0.064628821 254.3582245
7 40.02 TNTC 236 14 1 29500 0.006870451 407.4143409
8 50.00 TNTC 64 6 0 8000 0.001863173 509.0558195
9 55.00 TNTC 86 3 10750 0.002503639 559.9614014
10 65.00 TNTC 236 10 2950 0.000687045 661.7725653
11 80.02 159 20 2 198.75 4.62882EJ05 814.6589964
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R2 0.000 2 0.135 1.28
0.300 2 0.136 1.29
2.633 2 0.133 1.26
4.317 2 0.131 1.24








Actual%Time%(mins) 0 J1 J2 J3 J4 J5 J6 N N/No CT%(mg*min/L)
1 0.00 383 24 3 3893750
2 0.00 310 27 1 3625000
3759375 1 0
3 0.17 157 14 1 1962500 0.522028263 0.211005542
4 0.83 273 41 2 426875 0.11354946 1.055027712
5 0.98 139 18 0 173750 0.046217789 1.2449327
6 1.17 110 8 0 137500 0.036575229 1.477038797
7 1.80 TNTC 225 35 1 35938 0.009559435 2.278859857
8 2.07 TNTC 137 11 1 17125 0.004555278 2.616468725
9 3.40 TNTC 180 1 0 2250 0.000598504 4.304513064
10 4.12 TNTC 97 14 1212.5 0.000322527 5.211836896
11 4.50 TNTC 54 675 0.000179551 5.697149644
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R2 0.000 2 0.157 1.49
0.317 2 0.152 1.44
2.300 2 0.150 1.43
4.100 2 0.151 1.43








Actual%Time%(mins) 0 J1 J2 J3 J4 J5 J6 N N/No CT%(mg*min/L)
1 0.00 244 31 0 3462500
2 0.00 TNTC 36 4 4500000
3981250 1 0
3 0.13 TNTC 31 0 3875000 0.973312402 0.190973872
4 0.42 TNTC 157 13 1962500 0.492935636 0.596793349
5 0.73 TNTC TNTC 93 8 1162500 0.291993721 1.050356295
6 1.02 TNTC TNTC 48 600000 0.150706436 1.456175772
7 1.53 TNTC TNTC 67 4 83750 0.021036107 2.196199525
8 2.02 TNTC 295 59 55312.5 0.01389325 2.88847981
9 3.02 TNTC TNTC 59 8 7375 0.001852433 4.320783848
10 3.98 TNTC 189 8 2362.5 0.000593407 5.705344418
11 4.25 TNTC 53 7 662.5 0.000166405 6.087292162
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R2 0.000 2 0.143 1.36
0.333 2 0.139 1.32
1.867 2 0.138 1.31








Actual%Time%(mins) 0 K1 K2 K3 K4 K5 K6 N N/No CT%(mg*min/L)
1 0.00 289 13 2 3612500
2 0.00 210 21 2 2625000
3118750 1 0
3 0.13 TNTC TNTC 161 11 2012500 0.645290581 0.174821853
4 0.45 TNTC 248 33 361250 0.115831663 0.590023753
5 0.73 TNTC TNTC 28 3
6 1.13 TNTC TNTC 51 3 6375 0.002044088 1.485985748
7 1.33 TNTC TNTC 100 12500 0.004008016 1.748218527
8 1.53 TNTC 76 3 950 0.000304609 2.010451306
9 2.03 121 33 281.875 9.03808EK05 2.666033254
10 2.50 69 49 349.375 0.000112024 3.277909739
11 2.73 111 8 138.75 4.4489EK05 3.583847981
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R2 0.000 2 0.138 1.31
0.550 2 0.137 1.30
2.550 2 0.134 1.27
4.183 2 0.133 1.26
5.767 2 0.138 1.31
9.183 2 0.137 1.30








Actual%Time%(mins) 0 J1 J2 J3 J4 J5 J6 N N/No CT%(mg*min/L)
1 0.00 TNTC 39 2 487500
2 0.00 TNTC 47 4 587500
3 0.18 TNTC 93 9 1162500 1 0.238928477
4 0.35 TNTC 96 8 1200000 1.032258065 0.456136184
5 1.75 TNTC TNTC 48 600000 0.516129032 2.280680918
6 3.98 TNTC TNTC 11
7 6.60 TNTC TNTC 81 10125 0.008709677 8.601425178
8 8.98 TNTC TNTC 37 4625 0.003978495 11.70749538
9 11.98 234 83 10 665 0.000572043 15.6172341
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R2 0.000 10 0.206 9.79
0.533 10 0.204 9.69
2.200 10 0.200 9.50








Actual%Time%(mins) 0 K1 K2 K3 K4 K5 K6 N N/No CT%(mg*min/L)
1 0.00 TNTC 39 2 487500
2 0.00 TNTC 47 4 587500
3 0.10 TNTC 59 5 737500 1 0.95645289
4 0.25 TNTC 77 0 96250 0.130508475 2.391132225
5 0.45 TNTC 183 9 22875 0.031016949 4.304038005
6 0.73 TNTC 278 2 3475 0.004711864 7.01398786
7 0.98 TNTC 14 2
8 1.47 39 0 0 48.75 6.61017EK05 14.02797572
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R2 0.000 5 0.129 3.06
0.383 5 0.129 3.06
1.817 5 0.129 3.06








Actual%Time%(mins) 0 K1 K2 K3 K4 K5 K6 N N/No CT%(mg*min/L)
1 0.00 TNTC 79 7 98750
2 0.00 TNTC 57 7 71250
3 0.18 TNTC 69 6 86250 1 0.56466086
4 0.33 TNTC 71 6 88750 1.028985507 1.02665611
5 0.97 TNTC 70 9 8750 0.101449275 2.977302718
6 1.73 TNTC 102 4 1275 0.014782609 5.338611771
7 2.50 142 15 1 178 0.002057971 7.699920823
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R2 0.000 5 0.125 2.97
0.317 5 0.131 3.11
1.683 5 0.129 3.06








Actual%Time%(mins) 0 K1 K2 K3 K4 K5 K6 N N/No CT%(mg*min/L)
1 0.00 TNTC 79 7 9875
2 0.00 TNTC 57 7 7125
3 0.22 TNTC 76 4 9500 1 0.663895487
4 0.38 TNTC 64 2 8000 0.842105263 1.174584323
5 0.57 TNTC TNTC 41 5125 0.539473684 1.736342043
6 1.03 TNTC 153 9 1913 0.201315789 3.166270784
7 1.48 TNTC 35 2 438 0.046052632 4.545130641

































































Actual%Time 0 ?1 ?2 ?3 ?4 N N/No
R1 1 0.58333333 TNTC 74 10 92500 1
2 67.6666667 TNTC 92 11 115000 1.24324324












Actual%Time 0 ?1 ?2 ?3 ?4 N N/No
R2: 4 0.6 TNTC 56 6 70000 1
5 1.58333333 TNTC 55 3 68750 0.98214286












Actual%Time 0 ?1 ?2 ?3 ?4 N N/No
R3 7 1.9 TNTC 97 9 121250 1
8 37.5333333 TNTC 94 6 117500 0.96907216












Actual%Time 0 ?1 ?2 ?3 ?4 N N/No
R4: 10 0.7 TNTC 81 8 101250 1
11 2.45 TNTC 94 11 117500 1.16049383
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R2 0.000 5 0.131 3.11
1.233 5 0.128 3.04
2.950 5 0.127 3.02








Actual%Time%(mins) 0 L1 L2 L3 L4 L5 L6 N N/No CT%(mg*min/L)
R1 1 0.00 TNTC 78 9 9750000 1 0
2 0.47 TNTC 37 2 4625000 0.474358974 1.41145421
3 0.98 TNTC 149 6 1862500 0.191025641 2.974135656
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R2 0.000 5 0.132 3.14
0.517 5 0.129 3.06
3.417 5 0.128 3.04








Actual%Time%(mins) 0 L1 L2 L3 L4 L5 L6 N N/No CT%(mg*min/L)
R1 1 0.00 TNTC 88 3 11000000 1 0
2 0.82 TNTC TNTC 39 4875000 0.443181818 2.489443125
3 1.82 TNTC TNTC 108 10 1350000 0.122727273 5.537740829
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R2 0.000 5 0.126 2.99
1.983 5 0.127 3.02
4.250 5 0.126 2.99








Actual%Time%(mins) 0 K1 K2 K3 K4 K5 K6 N N/No CT%(mg*min/L)
R1 1 0.00 TNTC 92 5 11500000 1 0
2 0.45 226 27 0 2825000 0.245652174 1.35391924
3 1.33 TNTC 38 5 475000 0.041304348 4.011612563
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A1 1X DNA:10 P3 31.60 31.69 0.59
A2 1X DNA:10 P3 31.16 31.69 0.59
A3 1X DNA:10 P3 32.32 31.69 0.59
A4 2X DNA:10 P3 31.25 30.95 0.25
A5 2X DNA:10 P3 30.85 30.95 0.25
A6 2X DNA:10 P3 30.77 30.95 0.25
A7 3X DNA:10 P3 31.12 31.17 0.11
A8 3X DNA:10 P3 31.29 31.17 0.11
A9 3X DNA:10 P3 31.09 31.17 0.11
A10 4X DNA:10 P3 30.74 30.40 0.30
A11 4X DNA:10 P3 30.16 30.40 0.30
A12 4X DNA:10 P3 30.31 30.40 0.30
B1 1X DNA:10 P12 33.22 32.88 0.48
B2 1X DNA:10 P12 33.09 32.88 0.48
B3 1X DNA:10 P12 32.34 32.88 0.48
B4 2X DNA:10 P12 31.91 32.25 0.33 1.01 0.768 - 1.32
B5 2X DNA:10 P12 32.56 32.25 0.33 1.01 0.768 - 1.32
B6 2X DNA:10 P12 32.28 32.25 0.33 1.01 0.768 - 1.32
B7 3X DNA:10 P12 33.38 33.06 0.28 0.612 0.490 - 0.765
B8 3X DNA:10 P12 32.85 33.06 0.28 0.612 0.490 - 0.765
B9 3X DNA:10 P12 32.96 33.06 0.28 0.612 0.490 - 0.765
B10 4X DNA:10 P12 32.51 31.90 0.53 1.18 0.813 - 1.73
B11 4X DNA:10 P12 31.66 31.90 0.53 1.18 0.813 - 1.73
B12 4X DNA:10 P12 31.53 31.90 0.53 1.18 0.813 - 1.73
C1 1X DNA:10 rpoD 18.84 18.51 0.29
C2 1X DNA:10 rpoD 18.39 18.51 0.29
C3 1X DNA:10 rpoD 18.30 18.51 0.29
C4 2X DNA:10 rpoD 18.11 17.89 0.21
C5 2X DNA:10 rpoD 17.69 17.89 0.21
C6 2X DNA:10 rpoD 17.86 17.89 0.21
C7 3X DNA:10 rpoD 18.15 17.99 0.15
C8 3X DNA:10 rpoD 17.95 17.99 0.15
C9 3X DNA:10 rpoD 17.86 17.99 0.15
C10 4X DNA:10 rpoD 17.89 17.77 0.10
C11 4X DNA:10 rpoD 17.71 17.77 0.10
C12 4X DNA:10 rpoD 17.72 17.77 0.10
D1 1V DNA:1 P3 19.57 19.28 0.29
D2 1V DNA:1 P3 19.28 19.28 0.29
D3 1V DNA:1 P3 18.99 19.28 0.29
D4 2V DNA:1 P3 19.07 18.82 0.50
D5 2V DNA:1 P3 18.25 18.82 0.50
D6 2V DNA:1 P3 19.15 18.82 0.50
D7 3V DNA:1 P3 18.85 18.91 0.19
D8 3V DNA:1 P3 18.76 18.91 0.19
D9 3V DNA:1 P3 19.12 18.91 0.19
D10 4V DNA:1 P3 19.09 19.08 0.11
D11 4V DNA:1 P3 18.97 19.08 0.11
D12 4V DNA:1 P3 19.18 19.08 0.11
E1 1V DNA:1 P12 21.03 20.20 0.73
E2 1V DNA:1 P12 19.71 20.20 0.73
E3 1V DNA:1 P12 19.86 20.20 0.73
E4 2V DNA:1 P12 20.32 19.84 0.56
E5 2V DNA:1 P12 19.97 19.84 0.56
E6 2V DNA:1 P12 19.23 19.84 0.56
E7 3V DNA:1 P12 19.57 19.34 0.54
E8 3V DNA:1 P12 18.72 19.34 0.54
E9 3V DNA:1 P12 19.72 19.34 0.54
E10 4V DNA:1 P12 19.83 19.92 0.13
E11 4V DNA:1 P12 19.84 19.92 0.13
E12 4V DNA:1 P12 20.07 19.92 0.13
F1 1V DNA:1 rpoD 28.03 27.53 0.53
F2 1V DNA:1 rpoD 27.59 27.53 0.53
F3 1V DNA:1 rpoD 26.98 27.53 0.53
F4 2V DNA:1 rpoD 27.09 27.05 0.23
F5 2V DNA:1 rpoD 26.79 27.05 0.23
F6 2V DNA:1 rpoD 27.25 27.05 0.23
F7 3V DNA:1 rpoD 27.10 26.82 0.28
F8 3V DNA:1 rpoD 26.54 26.82 0.28
F9 3V DNA:1 rpoD 26.82 26.82 0.28
F10 4V DNA:1 rpoD 27.14 27.05 0.30
F11 4V DNA:1 rpoD 26.71 27.05 0.30
F12 4V DNA:1 rpoD 27.29 27.05 0.30
G1 1V DNA:10 P3 23.31 23.21 0.10
G2 1V DNA:10 P3 23.10 23.21 0.10
G3 1V DNA:10 P3 23.20 23.21 0.10
G4 1V DNA:100 P3 26.28 26.18 0.10
G5 1V DNA:100 P3 26.17 26.18 0.10
G6 1V DNA:100 P3 26.09 26.18 0.10
G7 1V DNA:1000 P3 29.76 29.57 0.24
G8 1V DNA:1000 P3 29.30 29.57 0.24
G9 1V DNA:1000 P3 29.65 29.57 0.24
G10 No template P3
G11 No template P3
G12 No template P3
H1 1V DNA:10 P12 24.85 24.61 0.28
H2 1V DNA:10 P12 24.67 24.61 0.28
H3 1V DNA:10 P12 24.30 24.61 0.28
H4 1V DNA:100 P12 27.98 27.79 0.24
H5 1V DNA:100 P12 27.87 27.79 0.24
H6 1V DNA:100 P12 27.52 27.79 0.24
H7 1V DNA:1000 P12 30.64 30.97 0.28
H8 1V DNA:1000 P12 31.10 30.97 0.28
H9 1V DNA:1000 P12 31.16 30.97 0.28
H10 No template P12
H11 No template P12
H12 No template P12
Analysis Parameters






Baseline range (from cycle no. ... to)n/a
Drift CorrectionOFF




Level (12) P3 copies P12 copies rpoD2 copies
1X 10 31.69 32.88 18.51 1 1 57 77 301607
2X 10 30.95 32.25 17.89 1.08673486 1.00695555 95 116 454422
3X 10 31.17 33.06 17.99 1 0.61557221 82 68 425351
4X 10 30.40 31.90 17.77 1.4640857 1.18099266 138 145 491943
1V 1 19.28 20.20 27.53 1 1 27536 29705 78
2V 1 18.82 19.84 27.05 0.9862327 0.92018765 37705 37558 107
3V 1 18.91 19.34 26.82 0.79004131 1.10956947 35456 52022 124
4V 1 19.08 19.92 27.05 0.82359102 0.87055056 31568 35651 107
1V 10 23.21 24.61 18780 16786
1V 100 26.18 27.79 24681 21141
1V 1000 29.57 30.97 24344 26625
No template 1












A1 1A DNA:1 P3 24.28 24.13 0.19 -
A2 1A DNA:1 P3 24.18 24.13 0.19 -
A3 1A DNA:1 P3 23.92 24.13 0.19 -
A4 2A DNA:1 P3 23.95 23.63 0.28 -
A5 2A DNA:1 P3 23.46 23.63 0.28 -
A6 2A DNA:1 P3 23.47 23.63 0.28 -
A7 3A DNA:1 P3 23.10 23.22 0.11 -
A8 3A DNA:1 P3 23.24 23.22 0.11 -
A9 3A DNA:1 P3 23.31 23.22 0.11 -
A10 4A DNA:1 P3 23.17 22.95 0.19 -
A11 4A DNA:1 P3 22.87 22.95 0.19 -
A12 4A DNA:1 P3 22.82 22.95 0.19 -
B1 1A DNA:1 P12 25.05 24.75 0.29 -
B2 1A DNA:1 P12 24.73 24.75 0.29 -
B3 1A DNA:1 P12 24.46 24.75 0.29 -
B4 2A DNA:1 P12 24.41 24.35 0.06 -
B5 2A DNA:1 P12 24.34 24.35 0.06 -
B6 2A DNA:1 P12 24.29 24.35 0.06 -
B7 3A DNA:1 P21 24.18 24.12 0.06 -
B8 3A DNA:1 P21 24.12 24.12 0.06 -
B9 3A DNA:1 P21 24.05 24.12 0.06 -
B10 4A DNA:1 P12 24.00 24.26 0.24 -
B11 4A DNA:1 P12 24.31 24.26 0.24 -
B12 4A DNA:1 P12 24.47 24.26 0.24 -
C1 1A DNA:1 rpoD 18.34 18.09 0.22 -
C2 1A DNA:1 rpoD 17.99 18.09 0.22 -
C3 1A DNA:1 rpoD 17.95 18.09 0.22 -
C4 2A DNA:1 rpoD 17.70 17.58 0.11 -
C5 2A DNA:1 rpoD 17.50 17.58 0.11 -
C6 2A DNA:1 rpoD 17.53 17.58 0.11 -
C7 3A DNA:1 rpoD 17.35 17.34 0.09 -
C8 3A DNA:1 rpoD 17.25 17.34 0.09 -
C9 3A DNA:1 rpoD 17.43 17.34 0.09 -
C10 4A DNA:1 rpoD 16.53 16.97 0.43 -
C11 4A DNA:1 rpoD 16.97 16.97 0.43 -
C12 4A DNA:1 rpoD 17.40 16.97 0.43 -
D1 1B DNA:1 P3 22.48 21.58 1.15 -
D2 1B DNA:1 P3 21.98 21.58 1.15 -
D3 1B DNA:1 P3 20.29 21.58 1.15 -
D4 2B DNA:1 P3 21.94 21.89 0.12 -
D5 2B DNA:1 P3 21.75 21.89 0.12 -
D6 2B DNA:1 P3 21.99 21.89 0.12 -
D7 3B DNA:1 P3 22.83 22.87 0.04 -
D8 3B DNA:1 P3 22.89 22.87 0.04 -
D9 3B DNA:1 P3 22.88 22.87 0.04 -
D10 4B DNA:1 P3 23.92 23.86 0.14 -
D11 4B DNA:1 P3 23.70 23.86 0.14 -
D12 4B DNA:1 P3 23.96 23.86 0.14 -
E1 1B DNA:1 P12 21.82 21.47 0.64 -
E2 1B DNA:1 P12 21.85 21.47 0.64 -
E3 1B DNA:1 P12 20.73 21.47 0.64 -
E4 2B DNA:1 P12 22.55 22.43 0.10 -
E5 2B DNA:1 P12 22.37 22.43 0.10 -
E6 2B DNA:1 P12 22.39 22.43 0.10 -
E7 3B DNA:1 P21 22.97 23.06 0.08 -
E8 3B DNA:1 P21 23.13 23.06 0.08 -
E9 3B DNA:1 P21 23.09 23.06 0.08 -
E10 4B DNA:1 P12 23.21 23.10 0.11 -
E11 4B DNA:1 P12 22.99 23.10 0.11 -
E12 4B DNA:1 P12 23.11 23.10 0.11 -
F1 1B DNA:1 rpoD 16.81 16.82 0.50 -
F2 1B DNA:1 rpoD 17.32 16.82 0.50 -
F3 1B DNA:1 rpoD 16.33 16.82 0.50 -
F4 2B DNA:1 rpoD 16.78 16.81 0.07 -
F5 2B DNA:1 rpoD 16.76 16.81 0.07 -
F6 2B DNA:1 rpoD 16.89 16.81 0.07 -
F7 3B DNA:1 rpoD 16.79 16.60 0.19 -
F8 3B DNA:1 rpoD 16.59 16.60 0.19 -
F9 3B DNA:1 rpoD 16.41 16.60 0.19 -
F10 4B DNA:1 rpoD 16.16 16.16 0.18 -
F11 4B DNA:1 rpoD 15.98 16.16 0.18 -
F12 4B DNA:1 rpoD 16.33 16.16 0.18 -
G1 1V DNA:1 P3 19.88 19.98 0.09 -
G2 1V DNA:1 P3 20.04 19.98 0.09 -
G3 1V DNA:1 P3 20.01 19.98 0.09 -
G4 1V DNA:10 P3 23.04 23.07 0.03 -
G5 1V DNA:10 P3 23.09 23.07 0.03 -
G6 1V DNA:10 P3 23.09 23.07 0.03 -
G7 1V DNA:100 P3 26.62 26.38 0.21 -
G8 1V DNA:100 P3 26.27 26.38 0.21 -
G9 1V DNA:100 P3 26.24 26.38 0.21 -
G10 1V DNA:1000 P3 29.37 32.05 4.20 -
G11 1V DNA:1000 P3 36.89 32.05 4.20 -
G12 1V DNA:1000 P3 29.89 32.05 4.20 -
H1 1V DNA:1 P12 20.95 21.00 0.07 -
H2 1V DNA:1 P12 20.98 21.00 0.07 -
H3 1V DNA:1 P12 21.07 21.00 0.07 -
H4 1V DNA:10 P12 24.48 24.29 0.22 -
H5 1V DNA:10 P12 24.34 24.29 0.22 -
H6 1V DNA:10 P12 24.06 24.29 0.22 -
H7 1V DNA:100 P12 27.66 27.56 0.20 -
H8 1V DNA:100 P12 27.34 27.56 0.20 -
H9 1V DNA:100 P12 27.70 27.56 0.20 -
H10 1V DNA:1000 P12 30.08 30.63 0.56 -
H11 1V DNA:1000 P12 31.19 30.63 0.56 -








Baseline range (from cycle no. ... to)n/a
Drift CorrectionOFF




Level (12) P3 copies P12 copies
rpoD2 
copies
1A 1 24.13 24.75 18.09 1 1 1002 1532 39814
2A 1 23.63 24.35 17.58 0.9930925 0.92658806 1409 1989 55779
3A 1 23.22 24.12 17.34 1.11728714 0.92018765 1865 2310 65370
4A 1 22.95 24.26 16.97 1.04246576 0.64617642 2243 2109 83486
1B 1 21.58 21.47 16.82 1 1 5720 12986 92190
2B 1 21.89 22.43 16.81 0.80106988 0.51050606 4628 6947 92801
3B 1 22.87 23.06 16.60 0.35111122 0.28519093 2369 4608 106623
4B 1 23.86 23.10 16.16 0.13030822 0.20447551 1204 4490 142622
1V 1 19.98 21.00 17068 17639
1V 10 23.07 24.29 20665 20678
1V 100 26.38 27.56 21528 24559
1V 1000 29.63 30.63 23366 33228










A1 1C DNA:1 P3 18.87 18.59 0.26
A2 1C DNA:1 P3 18.38 18.59 0.26
A3 1C DNA:1 P3 18.50 18.59 0.26
A4 2C DNA:1 P3 19.90 19.64 0.23
A5 2C DNA:1 P3 19.50 19.64 0.23
A6 2C DNA:1 P3 19.52 19.64 0.23
A7 3C DNA:1 P3 20.78 20.78 0.18
A8 3C DNA:1 P3 20.95 20.78 0.18
A9 3C DNA:1 P3 20.60 20.78 0.18
A10 4C DNA:1 P3 22.75 22.31 0.73
A11 4C DNA:1 P3 22.72 22.31 0.73
A12 4C DNA:1 P3 21.46 22.31 0.73
B1 1C DNA:1 P12 20.06 19.60 0.41
B2 1C DNA:1 P12 19.28 19.60 0.41
B3 1C DNA:1 P12 19.46 19.60 0.41
B4 2C DNA:1 P12 19.94 20.30 0.80
B5 2C DNA:1 P12 21.21 20.30 0.80
B6 2C DNA:1 P12 19.74 20.30 0.80
B7 3C DNA:1 P12 22.23 21.83 0.36
B8 3C DNA:1 P12 21.56 21.83 0.36
B9 3C DNA:1 P12 21.69 21.83 0.36
B10 4C DNA:1 P12 23.48 23.52 0.29
B11 4C DNA:1 P12 23.25 23.52 0.29
B12 4C DNA:1 P12 23.82 23.52 0.29
C1 1C DNA:1 rpoD 16.71 16.47 0.21
C2 1C DNA:1 rpoD 16.30 16.47 0.21
C3 1C DNA:1 rpoD 16.39 16.47 0.21
C4 2C DNA:1 rpoD 16.45 16.50 0.23
C5 2C DNA:1 rpoD 16.31 16.50 0.23
C6 2C DNA:1 rpoD 16.75 16.50 0.23
C7 3C DNA:1 rpoD 16.48 16.01 0.54
C8 3C DNA:1 rpoD 15.42 16.01 0.54
C9 3C DNA:1 rpoD 16.13 16.01 0.54
C10 4C DNA:1 rpoD 16.73 16.69 0.24
C11 4C DNA:1 rpoD 16.43 16.69 0.24
C12 4C DNA:1 rpoD 16.91 16.69 0.24
D1 1D DNA:1 P3 18.32 18.00 0.28
D2 1D DNA:1 P3 17.91 18.00 0.28
D3 1D DNA:1 P3 17.77 18.00 0.28
D4 2D DNA:1 P3 18.28 18.16 0.10
D5 2D DNA:1 P3 18.10 18.16 0.10
D6 2D DNA:1 P3 18.11 18.16 0.10
D7 3D DNA:1 P3 19.82 19.77 0.07
D8 3D DNA:1 P3 19.69 19.77 0.07
D9 3D DNA:1 P3 19.80 19.77 0.07
D10 4D DNA:1 P3 21.58 21.37 0.19
D11 4D DNA:1 P3 21.23 21.37 0.19
D12 4D DNA:1 P3 21.29 21.37 0.19
E1 1D DNA:1 P12 18.68 18.57 0.16
E2 1D DNA:1 P12 18.39 18.57 0.16
E3 1D DNA:1 P12 18.63 18.57 0.16
E4 2D DNA:1 P12 19.38 18.99 0.66 0.593 0.376 - 0.937
E5 2D DNA:1 P12 18.24 18.99 0.66 0.593 0.376 - 0.937
E6 2D DNA:1 P12 19.37 18.99 0.66 0.593 0.376 - 0.937
E7 3D DNA:1 P12 20.93 20.68 0.21 0.239 0.202 - 0.282
E8 3D DNA:1 P12 20.58 20.68 0.21 0.239 0.202 - 0.282
E9 3D DNA:1 P12 20.54 20.68 0.21 0.239 0.202 - 0.282
E10 4D DNA:1 P12 21.64 21.92 0.24 7.230E-2X 6.02E-02 - 8.69E-02
E11 4D DNA:1 P12 22.01 21.92 0.24 7.230E-2X 6.02E-02 - 8.69E-02
E12 4D DNA:1 P12 22.09 21.92 0.24 7.230E-2X 6.02E-02 - 8.69E-02
F1 1D DNA:1 rpoD 16.50 15.83 0.97
F2 1D DNA:1 rpoD 16.29 15.83 0.97
F3 1D DNA:1 rpoD 14.72 15.83 0.97
F4 2D DNA:1 rpoD 15.49 15.51 0.07
F5 2D DNA:1 rpoD 15.45 15.51 0.07
F6 2D DNA:1 rpoD 15.58 15.51 0.07
F7 3D DNA:1 rpoD 15.97 15.88 0.11
F8 3D DNA:1 rpoD 15.76 15.88 0.11
F9 3D DNA:1 rpoD 15.92 15.88 0.11
F10 4D DNA:1 rpoD 15.51 15.39 0.10
F11 4D DNA:1 rpoD 15.30 15.39 0.10
F12 4D DNA:1 rpoD 15.37 15.39 0.10
G1 1V DNA:1 P3 19.74 19.11 0.97
G2 1V DNA:1 P3 19.61 19.11 0.97
G3 1V DNA:1 P3 17.99 19.11 0.97
G4 1V DNA:10 P3 22.86 22.89 0.07
G5 1V DNA:10 P3 22.85 22.89 0.07
G6 1V DNA:10 P3 22.97 22.89 0.07
G7 1V DNA:100 P3 26.06 26.02 0.07
G8 1V DNA:100 P3 26.06 26.02 0.07
G9 1V DNA:100 P3 25.94 26.02 0.07
G10 1V DNA:1000 P3 29.76 32.15 3.73
G11 1V DNA:1000 P3 36.45 32.15 3.73
G12 1V DNA:1000 P3 30.25 32.15 3.73
H1 1V DNA:1 P12 21.07 21.03 0.06
H2 1V DNA:1 P12 21.06 21.03 0.06
H3 1V DNA:1 P12 20.96 21.03 0.06
H4 1V DNA:10 P12 24.60 24.45 0.29
H5 1V DNA:10 P12 24.62 24.45 0.29
H6 1V DNA:10 P12 24.12 24.45 0.29
H7 1V DNA:100 P12 27.68 27.64 0.10
H8 1V DNA:100 P12 27.72 27.64 0.10
H9 1V DNA:100 P12 27.53 27.64 0.10
H10 1V DNA:1000 P12 31.33 30.59 0.80
H11 1V DNA:1000 P12 30.72 30.59 0.80
H12 1V DNA:1000 P12 29.74 30.59 0.80
Analysis Parameters






Baseline range (from cycle no. ... to)n/a
Drift Correction OFF




Level (12) P3 copies P12 copies
rpoD2 
copies N/No CT (mg*min/L)
1C 1 18.59 19.60 16.47 1 1 44121 43915 116192 1 0
2C 1 19.64 20.30 16.50 0.49311635 0.62850669 21531 27832 113910 0.47435897 1.41145421
3C 1 20.78 21.83 16.01 0.15932008 0.15496346 9880 10271 157491 0.19102564 2.97413566
4C 1 22.31 23.52 16.69 0.08838835 0.07694653 3473 3415 100464 0.08589744 4.73845342
1D 1 18.00 18.57 15.83 1 1 66028 85915 177393
2D 1 18.16 18.99 15.51 0.71697762 0.59873935 59190 65347 219188
3D 1 19.77 20.68 15.88 0.30354872 0.23981603 19701 21728 171625
4D 1 21.37 21.92 15.39 0.07129773 0.07229301 6602 9686 237286
1V 1 19.11 21.03 30927 17297
1V 10 22.89 24.45 23369 18631
1V 100 26.02 27.64 27532 23312
1V 1000 30.01 30.59 18085 34105










A1 1A cDNA:5 P3 33.27 33.49 0.47
A2 1A cDNA:5 P3 33.16 33.49 0.47
A3 1A cDNA:5 P3 34.03 33.49 0.47
A4 2A cDNA:5 P3
A5 2A cDNA:5 P3 35.09 34.96 0.19
A6 2A cDNA:5 P3 34.83 34.96 0.19
A7 3A cDNA:5 P3 34.95 35.44 0.43
A8 3A cDNA:5 P3 35.60 35.44 0.43
A9 3A cDNA:5 P3 35.77 35.44 0.43
A10 4A cDNA:5 P3
A11 4A cDNA:5 P3
A12 4A cDNA:5 P3
B1 1A cDNA:5 P12 29.70 29.55 0.24
B2 1A cDNA:5 P12 29.67 29.55 0.24
B3 1A cDNA:5 P12 29.28 29.55 0.24
B4 2A cDNA:5 P12 31.56 31.58 0.06
B5 2A cDNA:5 P12 31.53 31.58 0.06
B6 2A cDNA:5 P12 31.65 31.58 0.06
B7 3A cDNA:5 P12 31.95 31.91 0.05
B8 3A cDNA:5 P12 31.85 31.91 0.05
B9 3A cDNA:5 P12 31.91 31.91 0.05
B10 4A cDNA:5 P12 34.55 34.62 0.43
B11 4A cDNA:5 P12 35.08 34.62 0.43
B12 4A cDNA:5 P12 34.22 34.62 0.43
C1 1A cDNA:5 rpoD 21.76 21.44 0.29
C2 1A cDNA:5 rpoD 21.35 21.44 0.29
C3 1A cDNA:5 rpoD 21.20 21.44 0.29
C4 2A cDNA:5 rpoD 22.16 22.08 0.07
C5 2A cDNA:5 rpoD 22.04 22.08 0.07
C6 2A cDNA:5 rpoD 22.03 22.08 0.07
C7 3A cDNA:5 rpoD 20.69 20.65 0.04
C8 3A cDNA:5 rpoD 20.64 20.65 0.04
C9 3A cDNA:5 rpoD 20.62 20.65 0.04
C10 4A cDNA:5 rpoD 21.32 21.07 0.22
C11 4A cDNA:5 rpoD 20.97 21.07 0.22
C12 4A cDNA:5 rpoD 20.91 21.07 0.22
D1 1B cDNA:5 P3 28.25 27.97 0.26
D2 1B cDNA:5 P3 27.94 27.97 0.26
D3 1B cDNA:5 P3 27.73 27.97 0.26
D4 2B cDNA:5 P3 28.48 28.43 0.09
D5 2B cDNA:5 P3 28.33 28.43 0.09
D6 2B cDNA:5 P3 28.49 28.43 0.09
D7 3B cDNA:5 P3 30.57 30.45 0.23
D8 3B cDNA:5 P3 30.60 30.45 0.23
D9 3B cDNA:5 P3 30.18 30.45 0.23
D10 4B cDNA:5 P3 34.14 32.94 1.05
D11 4B cDNA:5 P3 32.49 32.94 1.05
D12 4B cDNA:5 P3 32.18 32.94 1.05
E1 1B cDNA:5 P12 26.26 25.85 0.39
E2 1B cDNA:5 P12 25.49 25.85 0.39
E3 1B cDNA:5 P12 25.80 25.85 0.39
E4 2B cDNA:5 P12 26.72 26.46 0.24 0.448 0.377 - 0.532
E5 2B cDNA:5 P12 26.42 26.46 0.24 0.448 0.377 - 0.532
E6 2B cDNA:5 P12 26.24 26.46 0.24 0.448 0.377 - 0.532
E7 3B cDNA:5 P12 27.86 28.03 0.15 0.157 0.134 - 0.184
E8 3B cDNA:5 P12 28.09 28.03 0.15 0.157 0.134 - 0.184
E9 3B cDNA:5 P12 28.13 28.03 0.15 0.157 0.134 - 0.184
E10 4B cDNA:5 P12 29.72 29.89 0.15 3.880E-2X 3.41E-02 - 4.41E-02
E11 4B cDNA:5 P12 29.98 29.89 0.15 3.880E-2X 3.41E-02 - 4.41E-02
E12 4B cDNA:5 P12 29.98 29.89 0.15 3.880E-2X 3.41E-02 - 4.41E-02
F1 1B cDNA:5 rpoD 21.40 21.12 0.24
F2 1B cDNA:5 rpoD 20.98 21.12 0.24
F3 1B cDNA:5 rpoD 20.98 21.12 0.24
F4 2B cDNA:5 rpoD 20.60 20.58 0.05
F5 2B cDNA:5 rpoD 20.52 20.58 0.05
F6 2B cDNA:5 rpoD 20.62 20.58 0.05
F7 3B cDNA:5 rpoD 20.67 20.63 0.18
F8 3B cDNA:5 rpoD 20.43 20.63 0.18
F9 3B cDNA:5 rpoD 20.78 20.63 0.18
F10 4B cDNA:5 rpoD 20.46 20.48 0.11
F11 4B cDNA:5 rpoD 20.38 20.48 0.11
F12 4B cDNA:5 rpoD 20.60 20.48 0.11
G1 1D cDNA:5 DF1 P3 24.48 24.36 0.19
G2 1D cDNA:5 DF1 P3 24.46 24.36 0.19
G3 1D cDNA:5 DF1 P3 24.14 24.36 0.19
G4 1D cDNA:5 DF10 P3 27.31 27.27 0.17
G5 1D cDNA:5 DF10 P3 27.42 27.27 0.17
G6 1D cDNA:5 DF10 P3 27.08 27.27 0.17
G7 1D cDNA:5 DF100 P3 30.63 30.33 0.27
G8 1D cDNA:5 DF100 P3 30.09 30.33 0.27
G9 1D cDNA:5 DF100 P3 30.29 30.33 0.27
G10 No RNA template P3
G11 No RNA template P3
G12 No RNA template P3
H1 1D cDNA:5 DF1 P12 25.56 25.29 0.26
H2 1D cDNA:5 DF1 P12 25.26 25.29 0.26
H3 1D cDNA:5 DF1 P12 25.05 25.29 0.26
H4 1D cDNA:5 DF10 P12 28.65 28.68 0.04
H5 1D cDNA:5 DF10 P12 28.72 28.68 0.04
H6 1D cDNA:5 DF10 P12 28.67 28.68 0.04
H7 1D cDNA:5 DF100 P12 32.56 32.32 0.23
H8 1D cDNA:5 DF100 P12 32.31 32.32 0.23
H9 1D cDNA:5 DF100 P12 32.09 32.32 0.23
H10 No RNA template P12
H11 No RNA template P12
H12 No RNA template P12
Analysis Parameters






Baseline range (from cycle no. ... to)n/a
Drift Correction OFF




Level (12) P3 copies P12 copies rpoD2 copies
1A 5 33.49 29.55 21.44 1 1 8 336 21734
2A 5 34.96 31.58 22.08 0.3815648 89 14236
3A 5 35.44 31.91 20.65 0.11265631 72 36641
4A 5 34.62 21.07 0.02303546 12 27757
1B 5 27.97 25.85 21.12 1 1 363 3742 26854
2B 5 28.43 26.46 20.58 0.5 0.45062523 265 2514 38376
3B 5 30.45 28.03 20.63 0.12762652 0.15712667 67 904 37128
4B 5 32.34 29.89 20.48 0.03114188 0.03901033 18 269 40999
1D 5 24.36 25.29 4280 5389
1D 50 27.27 28.68 5860 5919
1D 500 30.33 32.32 7242 5524
No template 5










A1 1C cDNA:5 P3 25.77 25.82 0.12 -
A2 1C cDNA:5 P3 25.96 25.82 0.12 -
A3 1C cDNA:5 P3 25.74 25.82 0.12 -
A4 2C cDNA:5 P3 26.73 26.61 0.15 -
A5 2C cDNA:5 P3 26.65 26.61 0.15 -
A6 2C cDNA:5 P3 26.45 26.61 0.15 -
A7 3C cDNA:5 P3 28.28 28.50 0.20 -
A8 3C cDNA:5 P3 28.66 28.50 0.20 -
A9 3C cDNA:5 P3 28.55 28.50 0.20 -
A10 4C cDNA:5 P3 29.79 29.80 0.25 -
A11 4C cDNA:5 P3 30.05 29.80 0.25 -
A12 4C cDNA:5 P3 29.55 29.80 0.25 -
B1 1C cDNA:5 P12 25.89 25.67 0.30 -
B2 1C cDNA:5 P12 25.79 25.67 0.30 -
B3 1C cDNA:5 P12 25.33 25.67 0.30 -
B4 2C cDNA:5 P12 26.33 26.24 0.11 -
B5 2C cDNA:5 P12 26.28 26.24 0.11 -
B6 2C cDNA:5 P12 26.12 26.24 0.11 -
B7 3C cDNA:5 P12 27.92 28.02 0.21 -
B8 3C cDNA:5 P12 28.26 28.02 0.21 -
B9 3C cDNA:5 P12 27.88 28.02 0.21 -
B10 4C cDNA:5 P12 29.23 29.01 0.24 -
B11 4C cDNA:5 P12 29.07 29.01 0.24 -
B12 4C cDNA:5 P12 28.75 29.01 0.24 -
C1 1C cDNA:5 rpoD 21.87 21.55 0.29 -
C2 1C cDNA:5 rpoD 21.49 21.55 0.29 -
C3 1C cDNA:5 rpoD 21.30 21.55 0.29 -
C4 2C cDNA:5 rpoD 21.42 21.16 0.22 -
C5 2C cDNA:5 rpoD 21.00 21.16 0.22 -
C6 2C cDNA:5 rpoD 21.06 21.16 0.22 -
C7 3C cDNA:5 rpoD 21.21 21.36 0.14 -
C8 3C cDNA:5 rpoD 21.36 21.36 0.14 -
C9 3C cDNA:5 rpoD 21.50 21.36 0.14 -
C10 4C cDNA:5 rpoD 20.96 20.94 0.03 -
C11 4C cDNA:5 rpoD 20.95 20.94 0.03 -
C12 4C cDNA:5 rpoD 20.90 20.94 0.03 -
D1 1D cDNA:5 P3 24.74 24.39 0.31 -
D2 1D cDNA:5 P3 24.20 24.39 0.31 -
D3 1D cDNA:5 P3 24.22 24.39 0.31 -
D4 2D cDNA:5 P3 24.61 24.62 0.05 -
D5 2D cDNA:5 P3 24.67 24.62 0.05 -
D6 2D cDNA:5 P3 24.57 24.62 0.05 -
D7 3D cDNA:5 P3 25.56 25.70 0.23 -
D8 3D cDNA:5 P3 25.57 25.70 0.23 -
D9 3D cDNA:5 P3 25.96 25.70 0.23 -
D10 4D cDNA:5 P3 27.66 27.58 0.09 -
D11 4D cDNA:5 P3 27.59 27.58 0.09 -
D12 4D cDNA:5 P3 27.49 27.58 0.09 -
E1 1D cDNA:5 P12 25.05 24.81 0.21 -
E2 1D cDNA:5 P12 24.63 24.81 0.21 -
E3 1D cDNA:5 P12 24.75 24.81 0.21 -
E4 2D cDNA:5 P12 24.94 24.72 0.20 -
E5 2D cDNA:5 P12 24.67 24.72 0.20 -
E6 2D cDNA:5 P12 24.54 24.72 0.20 -
E7 3D cDNA:5 P12 25.72 25.84 0.15 -
E8 3D cDNA:5 P12 25.78 25.84 0.15 -
E9 3D cDNA:5 P12 26.01 25.84 0.15 -
E10 4D cDNA:5 P12 27.55 27.43 0.12 -
E11 4D cDNA:5 P12 27.32 27.43 0.12 -
E12 4D cDNA:5 P12 27.43 27.43 0.12 -
F1 1D cDNA:5 rpoD 21.46 21.14 0.28 -
F2 1D cDNA:5 rpoD 20.94 21.14 0.28 -
F3 1D cDNA:5 rpoD 21.03 21.14 0.28 -
F4 2D cDNA:5 rpoD 20.25 20.20 0.09 -
F5 2D cDNA:5 rpoD 20.26 20.20 0.09 -
F6 2D cDNA:5 rpoD 20.10 20.20 0.09 -
F7 3D cDNA:5 rpoD 20.17 20.11 0.12 -
F8 3D cDNA:5 rpoD 20.20 20.11 0.12 -
F9 3D cDNA:5 rpoD 19.98 20.11 0.12 -
F10 4D cDNA:5 rpoD 19.95 20.09 0.12 -
F11 4D cDNA:5 rpoD 20.12 20.09 0.12 -
F12 4D cDNA:5 rpoD 20.19 20.09 0.12 -
G1 1D cDNA:5 DF10 P3 27.89 27.57 0.33 -
G2 1D cDNA:5 DF10 P3 27.60 27.57 0.33 -
G3 1D cDNA:5 DF10 P3 27.23 27.57 0.33 -
G4 1D cDNA:5 DF100 P3 30.54 30.27 0.27 -
G5 1D cDNA:5 DF100 P3 30.28 30.27 0.27 -
G6 1D cDNA:5 DF100 P3 30.00 30.27 0.27 -
G7 1C-RT cDNA:5 P3 -
G8 1C-RT cDNA:5 P3 -
G9 1C-RT cDNA:5 P3 -
G10 1D-RT cDNA:5 P3 -
G11 1D-RT cDNA:5 P3 -
G12 1D-RT cDNA:5 P3 -
H1 1D cDNA:5 DF10 P12 28.37 28.33 0.09 -
H2 1D cDNA:5 DF10 P12 28.39 28.33 0.09 -
H3 1D cDNA:5 DF10 P12 28.22 28.33 0.09 -
H4 1D cDNA:5 DF100 P12 31.93 31.67 0.31 -
H5 1D cDNA:5 DF100 P12 31.75 31.67 0.31 -
H6 1D cDNA:5 DF100 P12 31.33 31.67 0.31 -
H7 1C-RT cDNA:5 P12 -
H8 1C-RT cDNA:5 P12 -
H9 1C-RT cDNA:5 P12 -
H10 1D-RT cDNA:5 P12 -
H11 1D-RT cDNA:5 P12 -
H12 1D-RT cDNA:5 P12 -
Analysis Parameters






Baseline range (from cycle no. ... to)n/a
Drift Correction OFF




Level (12) P3 copies P12 copies
rpoD2 
copies
1C 5 25.82 25.67 21.55 1 1 1578 4207 20209
2C 5 26.61 26.24 21.16 0.4413515 0.51405691 920 2902 26153
3C 5 28.50 28.02 21.36 0.13678671 0.17194273 253 910 22914
4C 5 29.80 29.01 20.94 0.04152143 0.06470406 104 477 30248
1D 5 24.39 24.81 21.14 1 1 4193 7368 26502
2D 5 24.62 24.72 20.20 0.44442134 0.55478474 3583 7813 49337
3D 5 25.70 25.84 20.11 0.19751033 0.23981603 1713 3766 52361
4D 5 27.58 27.43 20.09 0.05292158 0.07856334 474 1336 53058
1D 50 27.57 28.33 4774 7435
1D 500 30.27 31.67 7545 8437
1C-RT 5
1D-RT 5











A1 1X DNA:10 P3 30.39 30.57 0.26
A2 1X DNA:10 P3 30.87 30.57 0.26
A3 1X DNA:10 P3 30.45 30.57 0.26
A4 2X DNA:10 P3 31.52 31.15 0.41
A5 2X DNA:10 P3 31.23 31.15 0.41
A6 2X DNA:10 P3 30.71 31.15 0.41
A7 3X DNA:10 P3 31.34 31.18 0.36
A8 3X DNA:10 P3 30.77 31.18 0.36
A9 3X DNA:10 P3 31.42 31.18 0.36
A10 4X DNA:10 P3 30.53 30.76 0.27
A11 4X DNA:10 P3 31.05 30.76 0.27
A12 4X DNA:10 P3 30.69 30.76 0.27
B1 1X DNA:10 P12 32.12 31.86 0.37
B2 1X DNA:10 P12 32.02 31.86 0.37
B3 1X DNA:10 P12 31.43 31.86 0.37
B4 2X DNA:10 P12 32.46 32.61 0.32 0.545 0.433 - 0.687
B5 2X DNA:10 P12 32.98 32.61 0.32 0.545 0.433 - 0.687
B6 2X DNA:10 P12 32.40 32.61 0.32 0.545 0.433 - 0.687
B7 3X DNA:10 P12 32.63 32.26 0.52 0.526 0.366 - 0.755
B8 3X DNA:10 P12 31.67 32.26 0.52 0.526 0.366 - 0.755
B9 3X DNA:10 P12 32.48 32.26 0.52 0.526 0.366 - 0.755
B10 4X DNA:10 P12 31.29 31.74 0.54 0.666 0.456 - 0.972
B11 4X DNA:10 P12 32.34 31.74 0.54 0.666 0.456 - 0.972
B12 4X DNA:10 P12 31.60 31.74 0.54 0.666 0.456 - 0.972
C1 1X DNA:10 rpoD 18.23 17.98 0.23
C2 1X DNA:10 rpoD 17.95 17.98 0.23
C3 1X DNA:10 rpoD 17.77 17.98 0.23
C4 2X DNA:10 rpoD 17.88 17.86 0.10
C5 2X DNA:10 rpoD 17.76 17.86 0.10
C6 2X DNA:10 rpoD 17.95 17.86 0.10
C7 3X DNA:10 rpoD 17.53 17.46 0.08
C8 3X DNA:10 rpoD 17.45 17.46 0.08
C9 3X DNA:10 rpoD 17.38 17.46 0.08
C10 4X DNA:10 rpoD 17.30 17.28 0.07
C11 4X DNA:10 rpoD 17.34 17.28 0.07
C12 4X DNA:10 rpoD 17.21 17.28 0.07
D1 1V DNA:1 P3 19.26 18.93 0.58
D2 1V DNA:1 P3 18.25 18.93 0.58
D3 1V DNA:1 P3 19.26 18.93 0.58
D4 2V DNA:1 P3 19.65 19.41 0.22
D5 2V DNA:1 P3 19.36 19.41 0.22
D6 2V DNA:1 P3 19.22 19.41 0.22
D7 3V DNA:1 P3 19.90 19.30 0.53
D8 3V DNA:1 P3 19.08 19.30 0.53
D9 3V DNA:1 P3 18.91 19.30 0.53
D10 4V DNA:1 P3 19.16 19.35 0.24
D11 4V DNA:1 P3 19.26 19.35 0.24
D12 4V DNA:1 P3 19.61 19.35 0.24
E1 1V DNA:1 P12 21.04 20.76 0.27
E2 1V DNA:1 P12 20.76 20.76 0.27
E3 1V DNA:1 P12 20.49 20.76 0.27
E4 2V DNA:1 P12 19.68 19.96 0.40
E5 2V DNA:1 P12 19.77 19.96 0.40
E6 2V DNA:1 P12 20.41 19.96 0.40
E7 3V DNA:1 P12 19.70 19.88 0.20
E8 3V DNA:1 P12 19.85 19.88 0.20
E9 3V DNA:1 P12 20.10 19.88 0.20
E10 4V DNA:1 P12 20.11 20.05 0.07
E11 4V DNA:1 P12 20.06 20.05 0.07
E12 4V DNA:1 P12 19.97 20.05 0.07
F1 1V DNA:1 rpoD 27.84 27.76 0.09
F2 1V DNA:1 rpoD 27.78 27.76 0.09
F3 1V DNA:1 rpoD 27.67 27.76 0.09
F4 2V DNA:1 rpoD 27.19 27.27 0.25
F5 2V DNA:1 rpoD 27.08 27.27 0.25
F6 2V DNA:1 rpoD 27.55 27.27 0.25
F7 3V DNA:1 rpoD 26.73 26.92 0.21
F8 3V DNA:1 rpoD 26.89 26.92 0.21
F9 3V DNA:1 rpoD 27.14 26.92 0.21
F10 4V DNA:1 rpoD 27.16 26.96 0.23
F11 4V DNA:1 rpoD 26.72 26.96 0.23
F12 4V DNA:1 rpoD 27.02 26.96 0.23
G1 1V DNA:10 P3 23.29 22.99 0.26
G2 1V DNA:10 P3 22.89 22.99 0.26
G3 1V DNA:10 P3 22.79 22.99 0.26
G4 1V DNA:100 P3 26.11 25.94 0.16
G5 1V DNA:100 P3 25.93 25.94 0.16
G6 1V DNA:100 P3 25.79 25.94 0.16
G7 1V DNA:1000 P3 29.05 29.32 0.53
G8 1V DNA:1000 P3 29.93 29.32 0.53
G9 1V DNA:1000 P3 28.98 29.32 0.53
G10 No template P3
G11 No template P3
G12 No template P3
H1 1V DNA:10 P12 24.65 24.52 0.12
H2 1V DNA:10 P12 24.49 24.52 0.12
H3 1V DNA:10 P12 24.42 24.52 0.12
H4 1V DNA:100 P12 27.62 27.71 0.19
H5 1V DNA:100 P12 27.93 27.71 0.19
H6 1V DNA:100 P12 27.58 27.71 0.19
H7 1V DNA:1000 P12 31.06 31.15 0.36
H8 1V DNA:1000 P12 31.55 31.15 0.36
H9 1V DNA:1000 P12 30.84 31.15 0.36
H10 No template P12
H11 No template P12
H12 No template P12
Analysis Parameters






Baseline range (from cycle no. ... to)n/a
Drift Correction OFF




Level (12) P3 copies P12 copies rpoD2 copies
1X 10 30.57 31.86 17.98 1 1 123 149 428172
2X 10 31.15 32.61 17.86 0.61557221 0.54714685 83 91 463525
3X 10 31.18 32.26 17.46 0.45691573 0.52850902 81 115 603842
4X 10 30.76 31.74 17.28 0.53961412 0.66896378 108 161 680152
1V 1 18.93 20.76 27.76 1 1 34975 20624 67
2V 1 19.41 19.96 27.27 0.51050606 1.2397077 25195 34733 92
3V 1 19.30 19.88 26.92 0.43226862 1.02811383 27162 36592 116
4V 1 19.35 20.05 26.96 0.42928272 0.93952275 26250 32755 113
1V 10 22.99 24.52 21826 17800
1V 100 25.94 27.71 29079 22272
1V 1000 29.32 31.15 28879 23679
No template 1












A1 1A DNA:1 P3 23.83 23.55 0.43
A2 1A DNA:1 P3 23.78 23.55 0.43
A3 1A DNA:1 P3 23.05 23.55 0.43
A4 2A DNA:1 P3 23.70 23.58 0.11
A5 2A DNA:1 P3 23.53 23.58 0.11
A6 2A DNA:1 P3 23.50 23.58 0.11
A7 3A DNA:1 P3 23.11 22.94 0.25
A8 3A DNA:1 P3 22.64 22.94 0.25
A9 3A DNA:1 P3 23.06 22.94 0.25
A10 4A DNA:1 P3 23.48 22.94 0.48
A11 4A DNA:1 P3 22.79 22.94 0.48
A12 4A DNA:1 P3 22.55 22.94 0.48
B1 1A DNA:1 P12 24.75 24.61 0.36
B2 1A DNA:1 P12 24.20 24.61 0.36
B3 1A DNA:1 P12 24.89 24.61 0.36
B4 2A DNA:1 P12 24.68 24.76 0.32
B5 2A DNA:1 P12 25.11 24.76 0.32
B6 2A DNA:1 P12 24.49 24.76 0.32
B7 3A DNA:1 P12 24.55 24.64 0.13
B8 3A DNA:1 P12 24.59 24.64 0.13
B9 3A DNA:1 P12 24.79 24.64 0.13
B10 4A DNA:1 P12 23.88 24.03 0.25
B11 4A DNA:1 P12 24.32 24.03 0.25
B12 4A DNA:1 P12 23.90 24.03 0.25
C1 1A DNA:1 rpoD 18.39 17.97 0.36
C2 1A DNA:1 rpoD 17.74 17.97 0.36
C3 1A DNA:1 rpoD 17.78 17.97 0.36
C4 2A DNA:1 rpoD 17.74 17.71 0.19
C5 2A DNA:1 rpoD 17.50 17.71 0.19
C6 2A DNA:1 rpoD 17.88 17.71 0.19
C7 3A DNA:1 rpoD 17.78 17.61 0.15
C8 3A DNA:1 rpoD 17.50 17.61 0.15
C9 3A DNA:1 rpoD 17.56 17.61 0.15
C10 4A DNA:1 rpoD 16.95 16.95 0.13
C11 4A DNA:1 rpoD 17.08 16.95 0.13
C12 4A DNA:1 rpoD 16.81 16.95 0.13
D1 1B DNA:1 P3 21.16 20.27 0.77
D2 1B DNA:1 P3 19.78 20.27 0.77
D3 1B DNA:1 P3 19.88 20.27 0.77
D4 2B DNA:1 P3 21.23 21.31 0.09
D5 2B DNA:1 P3 21.29 21.31 0.09
D6 2B DNA:1 P3 21.41 21.31 0.09
D7 3B DNA:1 P3 22.95 22.90 0.07
D8 3B DNA:1 P3 22.93 22.90 0.07
D9 3B DNA:1 P3 22.81 22.90 0.07
D10 4B DNA:1 P3 23.96 23.59 0.48
D11 4B DNA:1 P3 23.76 23.59 0.48
D12 4B DNA:1 P3 23.05 23.59 0.48
E1 1B DNA:1 P12 21.93 21.25 0.60
E2 1B DNA:1 P12 20.93 21.25 0.60
E3 1B DNA:1 P12 20.88 21.25 0.60
E4 2B DNA:1 P12 22.39 22.20 0.21 0.331 0.282 - 0.388
E5 2B DNA:1 P12 21.98 22.20 0.21 0.331 0.282 - 0.388
E6 2B DNA:1 P12 22.23 22.20 0.21 0.331 0.282 - 0.388
E7 3B DNA:1 P12 23.26 23.36 0.27 0.143 0.110 - 0.187
E8 3B DNA:1 P12 23.15 23.36 0.27 0.143 0.110 - 0.187
E9 3B DNA:1 P12 23.67 23.36 0.27 0.143 0.110 - 0.187
E10 4B DNA:1 P12 24.33 24.49 0.14 4.320E-2X 3.52E-02 - 5.29E-02
E11 4B DNA:1 P12 24.59 24.49 0.14 4.320E-2X 3.52E-02 - 5.29E-02
E12 4B DNA:1 P12 24.54 24.49 0.14 4.320E-2X 3.52E-02 - 5.29E-02
F1 1B DNA:1 rpoD 17.42 17.44 0.27
F2 1B DNA:1 rpoD 17.72 17.44 0.27
F3 1B DNA:1 rpoD 17.18 17.44 0.27
F4 2B DNA:1 rpoD 16.86 16.80 0.10
F5 2B DNA:1 rpoD 16.85 16.80 0.10
F6 2B DNA:1 rpoD 16.69 16.80 0.10
F7 3B DNA:1 rpoD 16.44 16.75 0.27
F8 3B DNA:1 rpoD 16.94 16.75 0.27
F9 3B DNA:1 rpoD 16.88 16.75 0.27
F10 4B DNA:1 rpoD 15.87 16.15 0.26
F11 4B DNA:1 rpoD 16.18 16.15 0.26
F12 4B DNA:1 rpoD 16.39 16.15 0.26
G1 1V DNA:1 P3 19.85 19.44 0.44
G2 1V DNA:1 P3 19.51 19.44 0.44
G3 1V DNA:1 P3 18.98 19.44 0.44
G4 1V DNA:10 P3 22.61 22.73 0.17
G5 1V DNA:10 P3 22.92 22.73 0.17
G6 1V DNA:10 P3 22.65 22.73 0.17
G7 1V DNA:100 P3 25.69 25.76 0.08
G8 1V DNA:100 P3 25.85 25.76 0.08
G9 1V DNA:100 P3 25.75 25.76 0.08
G10 1V DNA:1000 P3 28.71 28.95 0.34
G11 1V DNA:1000 P3
G12 1V DNA:1000 P3 29.19 28.95 0.34
H1 1V DNA:1 P12 20.96 20.73 0.24
H2 1V DNA:1 P12 20.75 20.73 0.24
H3 1V DNA:1 P12 20.48 20.73 0.24
H4 1V DNA:10 P12 24.27 24.10 0.21
H5 1V DNA:10 P12 24.17 24.10 0.21
H6 1V DNA:10 P12 23.86 24.10 0.21
H7 1V DNA:100 P12 27.41 27.54 0.26
H8 1V DNA:100 P12 27.84 27.54 0.26
H9 1V DNA:100 P12 27.36 27.54 0.26
H10 1V DNA:1000 P12 30.68 30.69 0.20
H11 1V DNA:1000 P12 30.50 30.69 0.20
H12 1V DNA:1000 P12 30.90 30.69 0.20
Analysis Parameters






Baseline range (from cycle no. ... to)n/a
Drift Correction OFF




Level (12) P3 copies P12 copies rpoD2 copies
1A 1 23.55 24.61 17.97 1 1 1489 1679 43101
2A 1 23.58 24.76 17.71 0.81790206 0.75262337 1458 1522 51185
3A 1 22.94 24.64 17.61 1.18920712 0.7631296 2258 1646 54683
4A 1 22.94 24.03 16.95 0.75262337 0.73713461 2258 2450 84597
1B 1 20.27 21.25 17.44 1 1 14000 14987 61188
2B 1 21.31 22.20 16.80 0.31208264 0.33217145 6879 8071 93417
3B 1 22.90 23.36 16.75 0.10013373 0.14358729 2321 3790 96557
4B 1 23.59 24.49 16.15 0.04094979 0.04328467 1449 1815 143568
1V 1 19.44 20.73 24684 21031
1V 10 22.73 24.10 26069 23403
1V 100 25.76 27.54 32884 24881
1V 1000 28.95 30.69 37185 31954












A1 1C DNA:1 P3 18.54 18.54 0.14
A2 1C DNA:1 P3 18.68 18.54 0.14
A3 1C DNA:1 P3 18.39 18.54 0.14
A4 2C DNA:1 P3 19.78 19.63 0.20
A5 2C DNA:1 P3 19.70 19.63 0.20
A6 2C DNA:1 P3 19.41 19.63 0.20
A7 3C DNA:1 P3 21.57 21.50 0.08
A8 3C DNA:1 P3 21.53 21.50 0.08
A9 3C DNA:1 P3 21.41 21.50 0.08
A10 4C DNA:1 P3 22.91 22.88 0.14
A11 4C DNA:1 P3 23.00 22.88 0.14
A12 4C DNA:1 P3 22.73 22.88 0.14
B1 1C DNA:1 P12 20.01 19.79 0.28
B2 1C DNA:1 P12 19.89 19.79 0.28
B3 1C DNA:1 P12 19.48 19.79 0.28
B4 2C DNA:1 P12 20.90 20.44 0.49
B5 2C DNA:1 P12 20.50 20.44 0.49
B6 2C DNA:1 P12 19.92 20.44 0.49
B7 3C DNA:1 P12 22.68 22.75 0.06
B8 3C DNA:1 P12 22.78 22.75 0.06
B9 3C DNA:1 P12 22.78 22.75 0.06
B10 4C DNA:1 P12 23.89 24.10 0.28
B11 4C DNA:1 P12 24.01 24.10 0.28
B12 4C DNA:1 P12 24.42 24.10 0.28
C1 1C DNA:1 rpoD 17.12 16.87 0.21
C2 1C DNA:1 rpoD 16.75 16.87 0.21
C3 1C DNA:1 rpoD 16.76 16.87 0.21
C4 2C DNA:1 rpoD 16.96 16.75 0.25
C5 2C DNA:1 rpoD 16.47 16.75 0.25
C6 2C DNA:1 rpoD 16.81 16.75 0.25
C7 3C DNA:1 rpoD 16.59 16.37 0.28
C8 3C DNA:1 rpoD 16.45 16.37 0.28
C9 3C DNA:1 rpoD 16.05 16.37 0.28
C10 4C DNA:1 rpoD 16.42 16.39 0.05
C11 4C DNA:1 rpoD 16.42 16.39 0.05
C12 4C DNA:1 rpoD 16.34 16.39 0.05
D1 1D DNA:1 P3 17.29 17.58 0.26
D2 1D DNA:1 P3 17.78 17.58 0.26
D3 1D DNA:1 P3 17.68 17.58 0.26
D4 2D DNA:1 P3 18.78 18.76 0.63
D5 2D DNA:1 P3 19.38 18.76 0.63
D6 2D DNA:1 P3 18.12 18.76 0.63
D7 3D DNA:1 P3 20.63 20.73 0.22
D8 3D DNA:1 P3 20.58 20.73 0.22
D9 3D DNA:1 P3 20.99 20.73 0.22
D10 4D DNA:1 P3 22.36 22.43 0.31
D11 4D DNA:1 P3 22.16 22.43 0.31
D12 4D DNA:1 P3 22.77 22.43 0.31
E1 1D DNA:1 P12 18.84 18.35 0.51
E2 1D DNA:1 P12 18.40 18.35 0.51
E3 1D DNA:1 P12 17.82 18.35 0.51
E4 2D DNA:1 P12 20.02 19.69 0.32 0.340 0.271 - 0.425
E5 2D DNA:1 P12 19.38 19.69 0.32 0.340 0.271 - 0.425
E6 2D DNA:1 P12 19.66 19.69 0.32 0.340 0.271 - 0.425
E7 3D DNA:1 P12 21.52 21.59 0.18 7.200E-2X 5.94E-02 - 8.74E-02
E8 3D DNA:1 P12 21.45 21.59 0.18 7.200E-2X 5.94E-02 - 8.74E-02
E9 3D DNA:1 P12 21.79 21.59 0.18 7.200E-2X 5.94E-02 - 8.74E-02
E10 4D DNA:1 P12 23.12 23.22 0.29 1.960E-2X 1.35E-02 - 2.85E-02
E11 4D DNA:1 P12 23.00 23.22 0.29 1.960E-2X 1.35E-02 - 2.85E-02
E12 4D DNA:1 P12 23.54 23.22 0.29 1.960E-2X 1.35E-02 - 2.85E-02
F1 1D DNA:1 rpoD 16.55 16.06 0.42
F2 1D DNA:1 rpoD 15.79 16.06 0.42
F3 1D DNA:1 rpoD 15.85 16.06 0.42
F4 2D DNA:1 rpoD 15.79 15.84 0.04
F5 2D DNA:1 rpoD 15.87 15.84 0.04
F6 2D DNA:1 rpoD 15.85 15.84 0.04
F7 3D DNA:1 rpoD 15.71 15.51 0.21
F8 3D DNA:1 rpoD 15.29 15.51 0.21
F9 3D DNA:1 rpoD 15.52 15.51 0.21
F10 4D DNA:1 rpoD 14.83 15.26 0.46
F11 4D DNA:1 rpoD 15.21 15.26 0.46
F12 4D DNA:1 rpoD 15.74 15.26 0.46
G1 1V DNA:1 P3 19.92 19.63 0.45
G2 1V DNA:1 P3 19.86 19.63 0.45
G3 1V DNA:1 P3 19.12 19.63 0.45
G4 1V DNA:10 P3 23.39 23.10 0.25
G5 1V DNA:10 P3 22.96 23.10 0.25
G6 1V DNA:10 P3 22.95 23.10 0.25
G7 1V DNA:100 P3 26.37 26.33 0.04
G8 1V DNA:100 P3 26.33 26.33 0.04
G9 1V DNA:100 P3 26.29 26.33 0.04
G10 1V DNA:1000 P3 29.64 29.45 0.27
G11 1V DNA:1000 P3
G12 1V DNA:1000 P3 29.26 29.45 0.27
H1 1V DNA:1 P12 21.29 21.05 0.26
H2 1V DNA:1 P12 21.08 21.05 0.26
H3 1V DNA:1 P12 20.77 21.05 0.26
H4 1V DNA:10 P12 24.44 24.34 0.19
H5 1V DNA:10 P12 24.45 24.34 0.19
H6 1V DNA:10 P12 24.12 24.34 0.19
H7 1V DNA:100 P12 27.56 27.44 0.11
H8 1V DNA:100 P12 27.42 27.44 0.11
H9 1V DNA:100 P12 27.35 27.44 0.11
H10 1V DNA:1000 P12 30.56 30.81 0.41
H11 1V DNA:1000 P12 31.28 30.81 0.41
H12 1V DNA:1000 P12 30.59 30.81 0.41
Analysis Parameters






Baseline range (from cycle no. ... to)n/a
Drift Correction OFF




Level (12) P3 copies P12 copies
rpoD2 
copies N/No CT (mg*min/L)
1C 1 18.54 19.79 16.87 1 1 45655 38802 89192 1 0
2C 1 19.63 20.44 16.75 0.43226862 0.58641747 21679 25405 96557 0.44318182 2.48944312
3C 1 21.50 22.75 16.37 0.09087328 0.09087328 6041 5640 124134 0.12272727 5.53774083
4C 1 22.88 24.10 16.39 0.03540262 0.03614651 2353 2340 122503 0.04090909 8.33201372
1D 1 17.58 18.35 16.06 1 1 87975 99157 152370
2D 1 18.76 19.69 15.84 0.37892914 0.33915108 39283 41414 176225
3D 1 20.73 21.59 15.51 0.07694653 0.07229301 10224 12009 219188
4D 1 22.43 23.22 15.26 0.01991501 0.01964083 3200 4152 258582
1V 1 19.63 21.05 21679 17073
1V 10 23.10 24.34 20246 20015
1V 100 26.33 27.44 22276 26556
1V 1000 29.45 30.81 26424 29551











A1 1A cDNA:5 P3 35.01 35.13 0.24
A2 1A cDNA:5 P3 34.97 35.13 0.24
A3 1A cDNA:5 P3 35.41 35.13 0.24
A4 2A cDNA:5 P3 35.22 34.85 0.53
A5 2A cDNA:5 P3
A6 2A cDNA:5 P3 34.47 34.85 0.53
A7 3A cDNA:5 P3
A8 3A cDNA:5 P3
A9 3A cDNA:5 P3
A10 4A cDNA:5 P3
A11 4A cDNA:5 P3
A12 4A cDNA:5 P3
B1 1A cDNA:5 P12 31.23 31.04 0.28
B2 1A cDNA:5 P12 30.72 31.04 0.28
B3 1A cDNA:5 P12 31.18 31.04 0.28
B4 2A cDNA:5 P12 32.86 32.57 0.39
B5 2A cDNA:5 P12 32.73 32.57 0.39
B6 2A cDNA:5 P12 32.12 32.57 0.39
B7 3A cDNA:5 P12 33.93 34.21 0.38
B8 3A cDNA:5 P12 34.64 34.21 0.38
B9 3A cDNA:5 P12 34.06 34.21 0.38
B10 4A cDNA:5 P12
B11 4A cDNA:5 P12 35.49
B12 4A cDNA:5 P12
C1 1A cDNA:5 rpoD 23.67 23.39 0.30
C2 1A cDNA:5 rpoD 23.43 23.39 0.30
C3 1A cDNA:5 rpoD 23.08 23.39 0.30
C4 2A cDNA:5 rpoD 23.26 23.06 0.19
C5 2A cDNA:5 rpoD 22.88 23.06 0.19
C6 2A cDNA:5 rpoD 23.02 23.06 0.19
C7 3A cDNA:5 rpoD 22.20 22.22 0.02
C8 3A cDNA:5 rpoD 22.22 22.22 0.02
C9 3A cDNA:5 rpoD 22.23 22.22 0.02
C10 4A cDNA:5 rpoD 22.37 22.31 0.12
C11 4A cDNA:5 rpoD 22.17 22.31 0.12
C12 4A cDNA:5 rpoD 22.39 22.31 0.12
D1 1B cDNA:5 P3 29.29 28.85 0.41
D2 1B cDNA:5 P3 28.77 28.85 0.41
D3 1B cDNA:5 P3 28.48 28.85 0.41
D4 2B cDNA:5 P3 31.07 30.73 0.34
D5 2B cDNA:5 P3 30.72 30.73 0.34
D6 2B cDNA:5 P3 30.39 30.73 0.34
D7 3B cDNA:5 P3 33.38 33.02 0.47
D8 3B cDNA:5 P3 33.20 33.02 0.47
D9 3B cDNA:5 P3 32.49 33.02 0.47
D10 4B cDNA:5 P3
D11 4B cDNA:5 P3 34.29 34.73 0.62
D12 4B cDNA:5 P3 35.16 34.73 0.62
E1 1B cDNA:5 P12 26.60 26.16 0.38
E2 1B cDNA:5 P12 25.87 26.16 0.38
E3 1B cDNA:5 P12 26.02 26.16 0.38
E4 2B cDNA:5 P12 28.56 28.21 0.32 0.258 0.196 - 0.339
E5 2B cDNA:5 P12 27.94 28.21 0.32 0.258 0.196 - 0.339
E6 2B cDNA:5 P12 28.12 28.21 0.32 0.258 0.196 - 0.339
E7 3B cDNA:5 P12 29.76 29.68 0.10 6.590E-2X 5.91E-02 - 7.35E-02
E8 3B cDNA:5 P12 29.71 29.68 0.10 6.590E-2X 5.91E-02 - 7.35E-02
E9 3B cDNA:5 P12 29.56 29.68 0.10 6.590E-2X 5.91E-02 - 7.35E-02
E10 4B cDNA:5 P12 32.07 32.06 0.01 1.310E-2X 1.18E-02 - 1.46E-02
E11 4B cDNA:5 P12 32.05 32.06 0.01 1.310E-2X 1.18E-02 - 1.46E-02
E12 4B cDNA:5 P12 32.06 32.06 0.01 1.310E-2X 1.18E-02 - 1.46E-02
F1 1B cDNA:5 rpoD 22.26 21.99 0.23
F2 1B cDNA:5 rpoD 21.84 21.99 0.23
F3 1B cDNA:5 rpoD 21.87 21.99 0.23
F4 2B cDNA:5 rpoD 22.32 22.08 0.23
F5 2B cDNA:5 rpoD 22.05 22.08 0.23
F6 2B cDNA:5 rpoD 21.87 22.08 0.23
F7 3B cDNA:5 rpoD 21.49 21.58 0.12
F8 3B cDNA:5 rpoD 21.54 21.58 0.12
F9 3B cDNA:5 rpoD 21.72 21.58 0.12
F10 4B cDNA:5 rpoD 21.54 21.64 0.16
F11 4B cDNA:5 rpoD 21.56 21.64 0.16
F12 4B cDNA:5 rpoD 21.82 21.64 0.16
G1 1D cDNA:5 DF1 P3 24.98 24.88 0.13
G2 1D cDNA:5 DF1 P3 24.93 24.88 0.13
G3 1D cDNA:5 DF1 P3 24.74 24.88 0.13
G4 1D cDNA:5 DF10 P3 27.84 27.67 0.28
G5 1D cDNA:5 DF10 P3 27.83 27.67 0.28
G6 1D cDNA:5 DF10 P3 27.35 27.67 0.28
G7 1D cDNA:5 DF100 P3 30.65 31.84 1.59
G8 1D cDNA:5 DF100 P3 33.64 31.84 1.59
G9 1D cDNA:5 DF100 P3 31.22 31.84 1.59
G10 No Template P3
G11 No Template P3
G12 No Template P3
H1 1D cDNA:5 DF1 P12 25.85 25.66 0.17
H2 1D cDNA:5 DF1 P12 25.59 25.66 0.17
H3 1D cDNA:5 DF1 P12 25.52 25.66 0.17
H4 1D cDNA:5 DF10 P12 28.53 28.65 0.22
H5 1D cDNA:5 DF10 P12 28.91 28.65 0.22
H6 1D cDNA:5 DF10 P12 28.52 28.65 0.22
H7 1D cDNA:5 DF100 P12 32.20 32.09 0.12
H8 1D cDNA:5 DF100 P12 32.10 32.09 0.12
H9 1D cDNA:5 DF100 P12 31.97 32.09 0.12
H10 No Template P12
H11 No Template P12
H12 No Template P12
Analysis Parameters






Baseline range (from cycle no. ... to)n/a
Drift Correction OFF




Level (12) P3 copies P12 copies
rpoD2 
copies
1A 5 35.13 31.04 23.39 1 127 5987
2A 5 34.85 32.57 23.06 0.27547628 47 7447
3A 5 34.21 22.22 0.04937758 16 12977
4A 5 22.31 #VALUE! #VALUE! 12227
1B 5 28.85 26.16 21.99 1 1 199 3057 15108
2B 5 30.73 28.21 22.08 0.28917205 0.25702846 55 804 14236
3B 5 33.02 29.68 21.58 0.04181024 0.06560729 12 309 19812
4B 5 34.73 32.06 21.64 0.01313901 65 19042
1D 5 24.88 25.66 3000 4235
1D 50 27.67 28.65 4458 6036
1D 500 30.94 32.09 4790 6417
No template 5 #VALUE! #VALUE!











A1 1C cDNA:5 P3 26.28 26.28 0.06
A2 1C cDNA:5 P3 26.33 26.28 0.06
A3 1C cDNA:5 P3 26.22 26.28 0.06
A4 2C cDNA:5 P3 27.97 27.78 0.18
A5 2C cDNA:5 P3 27.76 27.78 0.18
A6 2C cDNA:5 P3 27.62 27.78 0.18
A7 3C cDNA:5 P3 29.43 29.57 0.13
A8 3C cDNA:5 P3 29.68 29.57 0.13
A9 3C cDNA:5 P3 29.59 29.57 0.13
A10 4C cDNA:5 P3 31.91 31.94 0.09
A11 4C cDNA:5 P3 31.87 31.94 0.09
A12 4C cDNA:5 P3 32.04 31.94 0.09
B1 1C cDNA:5 P12 26.58 26.29 0.36
B2 1C cDNA:5 P12 26.39 26.29 0.36
B3 1C cDNA:5 P12 25.89 26.29 0.36
B4 2C cDNA:5 P12 27.14 27.29 0.16
B5 2C cDNA:5 P12 27.47 27.29 0.16
B6 2C cDNA:5 P12 27.25 27.29 0.16
B7 3C cDNA:5 P12 29.05 28.97 0.08
B8 3C cDNA:5 P12 28.88 28.97 0.08
B9 3C cDNA:5 P12 28.98 28.97 0.08
B10 4C cDNA:5 P12 31.47 31.61 0.22
B11 4C cDNA:5 P12 31.48 31.61 0.22
B12 4C cDNA:5 P12 31.86 31.61 0.22
C1 1C cDNA:5 rpoD 22.87 22.51 0.34
C2 1C cDNA:5 rpoD 22.48 22.51 0.34
C3 1C cDNA:5 rpoD 22.19 22.51 0.34
C4 2C cDNA:5 rpoD 22.58 22.33 0.24
C5 2C cDNA:5 rpoD 22.28 22.33 0.24
C6 2C cDNA:5 rpoD 22.11 22.33 0.24
C7 3C cDNA:5 rpoD 21.76 21.76 0.01
C8 3C cDNA:5 rpoD 21.77 21.76 0.01
C9 3C cDNA:5 rpoD 21.75 21.76 0.01
C10 4C cDNA:5 rpoD 22.30 22.35 0.10
C11 4C cDNA:5 rpoD 22.28 22.35 0.10
C12 4C cDNA:5 rpoD 22.46 22.35 0.10
D1 1D cDNA:5 P3 25.47 25.05 0.38
D2 1D cDNA:5 P3 24.90 25.05 0.38
D3 1D cDNA:5 P3 24.77 25.05 0.38
D4 2D cDNA:5 P3 25.87 25.63 0.22
D5 2D cDNA:5 P3 25.45 25.63 0.22
D6 2D cDNA:5 P3 25.58 25.63 0.22
D7 3D cDNA:5 P3 27.54 27.58 0.14
D8 3D cDNA:5 P3 27.46 27.58 0.14
D9 3D cDNA:5 P3 27.74 27.58 0.14
D10 4D cDNA:5 P3 30.33 29.92 0.46
D11 4D cDNA:5 P3 29.99 29.92 0.46
D12 4D cDNA:5 P3 29.43 29.92 0.46
E1 1D cDNA:5 P12 25.93 25.56 0.33
E2 1D cDNA:5 P12 25.30 25.56 0.33
E3 1D cDNA:5 P12 25.45 25.56 0.33
E4 2D cDNA:5 P12 26.21 25.98 0.27 0.374 0.306 - 0.456
E5 2D cDNA:5 P12 25.69 25.98 0.27 0.374 0.306 - 0.456
E6 2D cDNA:5 P12 26.04 25.98 0.27 0.374 0.306 - 0.456
E7 3D cDNA:5 P12 27.50 27.67 0.15 9.050E-2X 8.13E-02 - 0.101
E8 3D cDNA:5 P12 27.74 27.67 0.15 9.050E-2X 8.13E-02 - 0.101
E9 3D cDNA:5 P12 27.77 27.67 0.15 9.050E-2X 8.13E-02 - 0.101
E10 4D cDNA:5 P12 29.99 29.97 0.07 2.660E-2X 2.37E-02 - 2.98E-02
E11 4D cDNA:5 P12 29.89 29.97 0.07 2.660E-2X 2.37E-02 - 2.98E-02
E12 4D cDNA:5 P12 30.02 29.97 0.07 2.660E-2X 2.37E-02 - 2.98E-02
F1 1D cDNA:5 rpoD 22.47 22.21 0.24
F2 1D cDNA:5 rpoD 22.15 22.21 0.24
F3 1D cDNA:5 rpoD 22.00 22.21 0.24
F4 2D cDNA:5 rpoD 21.24 21.21 0.11
F5 2D cDNA:5 rpoD 21.30 21.21 0.11
F6 2D cDNA:5 rpoD 21.08 21.21 0.11
F7 3D cDNA:5 rpoD 20.82 20.85 0.04
F8 3D cDNA:5 rpoD 20.85 20.85 0.04
F9 3D cDNA:5 rpoD 20.90 20.85 0.04
F10 4D cDNA:5 rpoD 21.22 21.39 0.15
F11 4D cDNA:5 rpoD 21.42 21.39 0.15
F12 4D cDNA:5 rpoD 21.51 21.39 0.15
G1 1D cDNA:5 DF10 P3 28.27 28.04 0.25
G2 1D cDNA:5 DF10 P3 28.10 28.04 0.25
G3 1D cDNA:5 DF10 P3 27.77 28.04 0.25
G4 1D cDNA:5 DF100 P3 31.82 31.28 0.50
G5 1D cDNA:5 DF100 P3 31.16 31.28 0.50
G6 1D cDNA:5 DF100 P3 30.86 31.28 0.50
G7 1C-RT cDNA:5 P3
G8 1C-RT cDNA:5 P3
G9 1C-RT cDNA:5 P3
G10 1D-RT cDNA:5 P3
G11 1D-RT cDNA:5 P3
G12 1D-RT cDNA:5 P3
H1 1D cDNA:5 DF10 P12 29.08 28.97 0.11
H2 1D cDNA:5 DF10 P12 28.98 28.97 0.11
H3 1D cDNA:5 DF10 P12 28.85 28.97 0.11
H4 1D cDNA:5 DF100 P12 32.19 32.24 0.19
H5 1D cDNA:5 DF100 P12 32.08 32.24 0.19
H6 1D cDNA:5 DF100 P12 32.46 32.24 0.19
H7 1C-RT cDNA:5 P12
H8 1C-RT cDNA:5 P12
H9 1C-RT cDNA:5 P12
H10 1D-RT cDNA:5 P12
H11 1D-RT cDNA:5 P12
H12 1D-RT cDNA:5 P12
Analysis Parameters






Baseline range (from cycle no. ... to)n/a
Drift Correction OFF




Level (12) P3 copies P12 copies
rpoD2 
copies
1C 5 26.28 26.29 22.51 1 1 1153 2809 10713
2C 5 27.78 27.29 22.33 0.31208264 0.4413515 414 1464 12067
3C 5 29.57 28.97 21.76 0.06079093 0.09278272 122 490 17590
4C 5 31.94 31.61 22.35 0.01770131 0.02240555 24 88 11908
1D 5 25.05 25.56 22.21 1 1 2671 4520 13063
2D 5 25.63 25.98 21.21 0.33448189 0.37371231 1797 3438 25303
3D 5 27.58 27.67 20.85 0.06745176 0.09024557 474 1143 32102
4D 5 29.92 29.97 21.39 0.01937043 0.02664484 96 255 22464
1D 50 28.04 28.97 3462 4900
1D 500 31.28 32.24 3784 5820
1C-RT 5 #VALUE! #VALUE!
1D-RT 5 #VALUE! #VALUE!












A1 1X DNA:10 P3 30.65 31.03 0.42
A2 1X DNA:10 P3 31.48 31.03 0.42
A3 1X DNA:10 P3 30.95 31.03 0.42
A4 2X DNA:10 P3 30.77 30.63 0.12
A5 2X DNA:10 P3 30.56 30.63 0.12
A6 2X DNA:10 P3 30.57 30.63 0.12
A7 3X DNA:10 P3 30.76 30.60 0.33
A8 3X DNA:10 P3 30.83 30.60 0.33
A9 3X DNA:10 P3 30.22 30.60 0.33
A10 4X DNA:10 P3 31.16 30.71 0.41
A11 4X DNA:10 P3 30.63 30.71 0.41
A12 4X DNA:10 P3 30.35 30.71 0.41
B1 1X DNA:10 P12 32.10 31.87 0.43
B2 1X DNA:10 P12 32.14 31.87 0.43
B3 1X DNA:10 P12 31.37 31.87 0.43
B4 2X DNA:10 P12 31.36 31.27 0.19 1.08 0.761 - 1.52
B5 2X DNA:10 P12 31.40 31.27 0.19 1.08 0.761 - 1.52
B6 2X DNA:10 P12 31.05 31.27 0.19 1.08 0.761 - 1.52
B7 3X DNA:10 P12 32.24 32.23 0.29 0.680 0.542 - 0.851
B8 3X DNA:10 P12 31.93 32.23 0.29 0.680 0.542 - 0.851
B9 3X DNA:10 P12 32.52 32.23 0.29 0.680 0.542 - 0.851
B10 4X DNA:10 P12 31.25 31.63 0.42 0.537 0.399 - 0.724
B11 4X DNA:10 P12 31.55 31.63 0.42 0.537 0.399 - 0.724
B12 4X DNA:10 P12 32.08 31.63 0.42 0.537 0.399 - 0.724
C1 1X DNA:10 rpoD 18.59 18.23 0.35
C2 1X DNA:10 rpoD 18.21 18.23 0.35
C3 1X DNA:10 rpoD 17.90 18.23 0.35
C4 2X DNA:10 rpoD 18.27 17.73 0.46
C5 2X DNA:10 rpoD 17.49 17.73 0.46
C6 2X DNA:10 rpoD 17.45 17.73 0.46
C7 3X DNA:10 rpoD 18.18 18.03 0.14
C8 3X DNA:10 rpoD 18.00 18.03 0.14
C9 3X DNA:10 rpoD 17.91 18.03 0.14
C10 4X DNA:10 rpoD 17.18 17.09 0.08
C11 4X DNA:10 rpoD 17.05 17.09 0.08
C12 4X DNA:10 rpoD 17.03 17.09 0.08
D1 1V DNA:1 P3 20.15 19.32 0.72
D2 1V DNA:1 P3 18.99 19.32 0.72
D3 1V DNA:1 P3 18.84 19.32 0.72
D4 2V DNA:1 P3 18.69 18.90 0.20
D5 2V DNA:1 P3 19.09 18.90 0.20
D6 2V DNA:1 P3 18.92 18.90 0.20
D7 3V DNA:1 P3 19.70 19.35 0.33
D8 3V DNA:1 P3 19.05 19.35 0.33
D9 3V DNA:1 P3 19.28 19.35 0.33
D10 4V DNA:1 P3 19.59 18.71 1.08
D11 4V DNA:1 P3 19.03 18.71 1.08
D12 4V DNA:1 P3 17.50 18.71 1.08
E1 1V DNA:1 P12 20.85 20.37 0.56
E2 1V DNA:1 P12 20.52 20.37 0.56
E3 1V DNA:1 P12 19.76 20.37 0.56
E4 2V DNA:1 P12 19.95 19.69 0.41
E5 2V DNA:1 P12 19.89 19.69 0.41
E6 2V DNA:1 P12 19.22 19.69 0.41
E7 3V DNA:1 P12 19.94 20.21 0.25
E8 3V DNA:1 P12 20.41 20.21 0.25
E9 3V DNA:1 P12 20.30 20.21 0.25
E10 4V DNA:1 P12 19.72 19.83 0.10
E11 4V DNA:1 P12 19.85 19.83 0.10
E12 4V DNA:1 P12 19.93 19.83 0.10
F1 1V DNA:1 rpoD 27.92 27.43 0.62
F2 1V DNA:1 rpoD 27.64 27.43 0.62
F3 1V DNA:1 rpoD 26.72 27.43 0.62
F4 2V DNA:1 rpoD 27.23 26.90 0.38
F5 2V DNA:1 rpoD 26.49 26.90 0.38
F6 2V DNA:1 rpoD 26.98 26.90 0.38
F7 3V DNA:1 rpoD 26.77 26.92 0.87
F8 3V DNA:1 rpoD 26.13 26.92 0.87
F9 3V DNA:1 rpoD 27.86 26.92 0.87
F10 4V DNA:1 rpoD 27.34 27.58 0.27
F11 4V DNA:1 rpoD 27.87 27.58 0.27
F12 4V DNA:1 rpoD 27.52 27.58 0.27
G1 1V DNA:10 P3 23.56 23.03 0.50
G2 1V DNA:10 P3 22.95 23.03 0.50
G3 1V DNA:10 P3 22.57 23.03 0.50
G4 1V DNA:100 P3 26.10 26.00 0.09
G5 1V DNA:100 P3 25.92 26.00 0.09
G6 1V DNA:100 P3 25.98 26.00 0.09
G7 1V DNA:1000 P3 29.67 29.57 0.09
G8 1V DNA:1000 P3 29.50 29.57 0.09
G9 1V DNA:1000 P3 29.56 29.57 0.09
G10 No template P3
G11 No template P3
G12 No template P3
H1 1V DNA:10 P12 24.37 24.30 0.13
H2 1V DNA:10 P12 24.15 24.30 0.13
H3 1V DNA:10 P12 24.37 24.30 0.13
H4 1V DNA:100 P12 27.78 27.55 0.20
H5 1V DNA:100 P12 27.46 27.55 0.20
H6 1V DNA:100 P12 27.41 27.55 0.20
H7 1V DNA:1000 P12 30.68 30.81 0.13
H8 1V DNA:1000 P12 30.94 30.81 0.13
H9 1V DNA:1000 P12 30.80 30.81 0.13
H10 No template P12
H11 No template P12
H12 No template P12
Analysis Parameters






Baseline range (from cycle no. ... to)n/a
Drift Correction OFF




Level (12) P3 copies P12 copies
rpoD2 
copies
1X 10 31.03 31.87 18.23 1 1 90 148 362942
2X 10 30.63 31.27 17.73 0.93303299 1.07177346 118 219 505126
3X 10 30.60 32.23 18.03 1.17283495 0.67830216 120 117 414249
4X 10 30.71 31.63 17.09 0.56644194 0.53588673 112 173 771187
1V 1 19.32 20.37 27.43 1 1 26793 26591 83
2V 1 18.90 19.69 26.90 0.92658806 1.10956947 35699 41414 118
3V 1 19.35 20.21 26.92 0.68777091 0.7845841 26250 29512 116
4V 1 19.31 19.83 27.58 1.11728714 1.61328352 26977 37804 75
1V 10 23.03 24.30 21237 20544
1V 100 26.00 27.55 27911 24719
1V 1000 29.57 30.81 24344 29551
No template 1 #VALUE! #VALUE!
	  	   408 











A1 1A DNA:1 P3 22.65 22.66 0.04
A2 1A DNA:1 P3 22.62 22.66 0.04
A3 1A DNA:1 P3 22.70 22.66 0.04
A4 2A DNA:1 P3 22.93 22.62 0.27
A5 2A DNA:1 P3 22.42 22.62 0.27
A6 2A DNA:1 P3 22.52 22.62 0.27
A7 3A DNA:1 P3 22.35 22.27 0.14
A8 3A DNA:1 P3 22.12 22.27 0.14
A9 3A DNA:1 P3 22.35 22.27 0.14
A10 4A DNA:1 P3 22.35 22.27 0.23
A11 4A DNA:1 P3 22.44 22.27 0.23
A12 4A DNA:1 P3 22.00 22.27 0.23
B1 1A DNA:1 P12 24.15 23.86 0.52
B2 1A DNA:1 P12 24.17 23.86 0.52
B3 1A DNA:1 P12 23.26 23.86 0.52
B4 2A DNA:1 P12 23.92 23.76 0.18
B5 2A DNA:1 P12 23.55 23.76 0.18
B6 2A DNA:1 P12 23.80 23.76 0.18
B7 3A DNA:1 P12 23.54 23.41 0.32
B8 3A DNA:1 P12 23.64 23.41 0.32
B9 3A DNA:1 P12 23.04 23.41 0.32
B10 4A DNA:1 P12 23.30 23.25 0.05
B11 4A DNA:1 P12 23.23 23.25 0.05
B12 4A DNA:1 P12 23.21 23.25 0.05
C1 1A DNA:1 rpoD 18.05 17.78 0.27
C2 1A DNA:1 rpoD 17.78 17.78 0.27
C3 1A DNA:1 rpoD 17.51 17.78 0.27
C4 2A DNA:1 rpoD 17.21 17.06 0.18
C5 2A DNA:1 rpoD 17.10 17.06 0.18
C6 2A DNA:1 rpoD 16.86 17.06 0.18
C7 3A DNA:1 rpoD 17.44 17.14 0.31
C8 3A DNA:1 rpoD 17.16 17.14 0.31
C9 3A DNA:1 rpoD 16.82 17.14 0.31
C10 4A DNA:1 rpoD 16.53 16.67 0.17
C11 4A DNA:1 rpoD 16.61 16.67 0.17
C12 4A DNA:1 rpoD 16.86 16.67 0.17
D1 1B DNA:1 P3 19.72 19.43 0.25
D2 1B DNA:1 P3 19.23 19.43 0.25
D3 1B DNA:1 P3 19.36 19.43 0.25
D4 2B DNA:1 P3 20.51 20.46 0.12
D5 2B DNA:1 P3 20.54 20.46 0.12
D6 2B DNA:1 P3 20.32 20.46 0.12
D7 3B DNA:1 P3 22.91 23.10 0.17
D8 3B DNA:1 P3 23.21 23.10 0.17
D9 3B DNA:1 P3 23.19 23.10 0.17
D10 4B DNA:1 P3 23.72 23.80 0.11
D11 4B DNA:1 P3 23.75 23.80 0.11
D12 4B DNA:1 P3 23.92 23.80 0.11
E1 1B DNA:1 P12 20.20 20.09 0.20
E2 1B DNA:1 P12 19.85 20.09 0.20
E3 1B DNA:1 P12 20.20 20.09 0.20
E4 2B DNA:1 P12 21.49 21.31 0.29 0.380 0.299 - 0.482
E5 2B DNA:1 P12 20.98 21.31 0.29 0.380 0.299 - 0.482
E6 2B DNA:1 P12 21.45 21.31 0.29 0.380 0.299 - 0.482
E7 3B DNA:1 P12 24.06 24.17 0.13 4.290E-2X 3.90E-02 - 4.72E-02
E8 3B DNA:1 P12 24.12 24.17 0.13 4.290E-2X 3.90E-02 - 4.72E-02
E9 3B DNA:1 P12 24.31 24.17 0.13 4.290E-2X 3.90E-02 - 4.72E-02
E10 4B DNA:1 P12 24.46 24.57 0.14 3.480E-2X 2.61E-02 - 4.65E-02
E11 4B DNA:1 P12 24.53 24.57 0.14 3.480E-2X 2.61E-02 - 4.65E-02
E12 4B DNA:1 P12 24.73 24.57 0.14 3.480E-2X 2.61E-02 - 4.65E-02
F1 1B DNA:1 rpoD 16.73 16.52 0.41
F2 1B DNA:1 rpoD 16.77 16.52 0.41
F3 1B DNA:1 rpoD 16.04 16.52 0.41
F4 2B DNA:1 rpoD 16.51 16.34 0.19
F5 2B DNA:1 rpoD 16.13 16.34 0.19
F6 2B DNA:1 rpoD 16.39 16.34 0.19
F7 3B DNA:1 rpoD 16.03 16.05 0.04
F8 3B DNA:1 rpoD 16.10 16.05 0.04
F9 3B DNA:1 rpoD 16.04 16.05 0.04
F10 4B DNA:1 rpoD 16.59 16.16 0.39
F11 4B DNA:1 rpoD 15.81 16.16 0.39
F12 4B DNA:1 rpoD 16.07 16.16 0.39
G1 1V DNA:1 P3 19.25 18.92 0.82
G2 1V DNA:1 P3 19.52 18.92 0.82
G3 1V DNA:1 P3 17.99 18.92 0.82
G4 1V DNA:10 P3 22.80 22.59 0.20
G5 1V DNA:10 P3 22.57 22.59 0.20
G6 1V DNA:10 P3 22.40 22.59 0.20
G7 1V DNA:100 P3 25.69 25.69 0.12
G8 1V DNA:100 P3 25.82 25.69 0.12
G9 1V DNA:100 P3 25.57 25.69 0.12
G10 1V DNA:1000 P3 29.30 29.06 0.33
G11 1V DNA:1000 P3
G12 1V DNA:1000 P3 28.83 29.06 0.33
H1 1V DNA:1 P12 20.07 20.12 0.30
H2 1V DNA:1 P12 20.44 20.12 0.30
H3 1V DNA:1 P12 19.84 20.12 0.30
H4 1V DNA:10 P12 24.04 23.88 0.17
H5 1V DNA:10 P12 23.90 23.88 0.17
H6 1V DNA:10 P12 23.70 23.88 0.17
H7 1V DNA:100 P12 27.31 27.37 0.10
H8 1V DNA:100 P12 27.48 27.37 0.10
H9 1V DNA:100 P12 27.31 27.37 0.10
H10 1V DNA:1000 P12 30.56 30.09 0.41
H11 1V DNA:1000 P12 29.93 30.09 0.41
H12 1V DNA:1000 P12 29.78 30.09 0.41
Analysis Parameters






Baseline range (from cycle no. ... to)n/a
Drift Correction OFF




Level (12) P3 copies P12 copies
rpoD2 
copies
1A 1 22.66 23.86 17.78 1 1 2735 2736 48870
2A 1 22.62 23.76 17.06 0.62416527 0.65067093 2810 2921 78664
3A 1 22.27 23.41 17.14 0.84089642 0.87660572 3570 3669 74611
4A 1 22.27 23.25 16.67 0.60709744 0.70710678 3570 4072 101801
1B 1 19.43 20.09 16.52 1 1 24853 31913 112414
2B 1 20.46 21.31 16.34 0.43226862 0.37892914 12295 14413 126620
3B 1 23.10 24.17 16.05 0.05671995 0.04268876 2025 2236 153380
4B 1 23.80 24.57 16.16 0.03768149 0.03491522 1255 1723 142622
1V 1 18.92 20.12 35215 31295
1V 10 22.59 23.88 28686 27010
1V 100 25.69 27.37 34495 27795
1V 1000 29.07 30.09 34375 47240












A1 1C DNA:1 P3 17.68 17.77 0.16
A2 1C DNA:1 P3 17.67 17.77 0.16
A3 1C DNA:1 P3 17.96 17.77 0.16
A4 2C DNA:1 P3 19.18 19.29 0.12
A5 2C DNA:1 P3 19.42 19.29 0.12
A6 2C DNA:1 P3 19.27 19.29 0.12
A7 3C DNA:1 P3 22.87 22.82 0.12
A8 3C DNA:1 P3 22.91 22.82 0.12
A9 3C DNA:1 P3 22.68 22.82 0.12
A10 4C DNA:1 P3 24.72 24.58 0.32
A11 4C DNA:1 P3 24.81 24.58 0.32
A12 4C DNA:1 P3 24.22 24.58 0.32
B1 1C DNA:1 P12 19.25 18.82 0.39
B2 1C DNA:1 P12 18.50 18.82 0.39
B3 1C DNA:1 P12 18.71 18.82 0.39
B4 2C DNA:1 P12 20.71 20.65 0.17
B5 2C DNA:1 P12 20.77 20.65 0.17
B6 2C DNA:1 P12 20.46 20.65 0.17
B7 3C DNA:1 P12 24.11 24.12 0.05
B8 3C DNA:1 P12 24.17 24.12 0.05
B9 3C DNA:1 P12 24.07 24.12 0.05
B10 4C DNA:1 P12 27.74 26.28 1.28
B11 4C DNA:1 P12 25.36 26.28 1.28
B12 4C DNA:1 P12 25.73 26.28 1.28
C1 1C DNA:1 rpoD 16.07 16.17 0.24
C2 1C DNA:1 rpoD 16.44 16.17 0.24
C3 1C DNA:1 rpoD 16.01 16.17 0.24
C4 2C DNA:1 rpoD 16.52 16.00 0.44
C5 2C DNA:1 rpoD 15.74 16.00 0.44
C6 2C DNA:1 rpoD 15.75 16.00 0.44
C7 3C DNA:1 rpoD 16.25 15.91 0.30
C8 3C DNA:1 rpoD 15.70 15.91 0.30
C9 3C DNA:1 rpoD 15.77 15.91 0.30
C10 4C DNA:1 rpoD 15.74 15.72 0.12
C11 4C DNA:1 rpoD 15.59 15.72 0.12
C12 4C DNA:1 rpoD 15.82 15.72 0.12
D1 1D DNA:1 P3 17.19 16.85 0.38
D2 1D DNA:1 P3 16.93 16.85 0.38
D3 1D DNA:1 P3 16.44 16.85 0.38
D4 2D DNA:1 P3 18.12 18.07 0.09
D5 2D DNA:1 P3 18.12 18.07 0.09
D6 2D DNA:1 P3 17.96 18.07 0.09
D7 3D DNA:1 P3 21.91 21.95 0.03
D8 3D DNA:1 P3 21.98 21.95 0.03
D9 3D DNA:1 P3 21.94 21.95 0.03
D10 4D DNA:1 P3 24.29 24.45 0.16
D11 4D DNA:1 P3 24.61 24.45 0.16
D12 4D DNA:1 P3 24.44 24.45 0.16
E1 1D DNA:1 P12 18.09 17.72 0.46
E2 1D DNA:1 P12 17.20 17.72 0.46
E3 1D DNA:1 P12 17.85 17.72 0.46
E4 2D DNA:1 P12 19.35 19.20 0.18 0.308 0.263 - 0.360
E5 2D DNA:1 P12 19.25 19.20 0.18 0.308 0.263 - 0.360
E6 2D DNA:1 P12 19.01 19.20 0.18 0.308 0.263 - 0.360
E7 3D DNA:1 P12 22.92 23.11 0.17 1.160E-2X 7.80E-03 - 1.74E-02
E8 3D DNA:1 P12 23.20 23.11 0.17 1.160E-2X 7.80E-03 - 1.74E-02
E9 3D DNA:1 P12 23.22 23.11 0.17 1.160E-2X 7.80E-03 - 1.74E-02
E10 4D DNA:1 P12 24.85 25.10 0.32 4.770E-3X 3.78E-03 - 6.02E-03
E11 4D DNA:1 P12 24.97 25.10 0.32 4.770E-3X 3.78E-03 - 6.02E-03
E12 4D DNA:1 P12 25.46 25.10 0.32 4.770E-3X 3.78E-03 - 6.02E-03
F1 1D DNA:1 rpoD 16.09 15.94 0.13
F2 1D DNA:1 rpoD 15.84 15.94 0.13
F3 1D DNA:1 rpoD 15.88 15.94 0.13
F4 2D DNA:1 rpoD 15.63 15.72 0.14
F5 2D DNA:1 rpoD 15.88 15.72 0.14
F6 2D DNA:1 rpoD 15.66 15.72 0.14
F7 3D DNA:1 rpoD 15.54 14.91 0.55
F8 3D DNA:1 rpoD 14.68 14.91 0.55
F9 3D DNA:1 rpoD 14.50 14.91 0.55
F10 4D DNA:1 rpoD 15.58 15.60 0.09
F11 4D DNA:1 rpoD 15.53 15.60 0.09
F12 4D DNA:1 rpoD 15.70 15.60 0.09
G1 1V DNA:1 P3 19.67 19.23 0.39
G2 1V DNA:1 P3 19.10 19.23 0.39
G3 1V DNA:1 P3 18.93 19.23 0.39
G4 1V DNA:10 P3 22.82 22.71 0.11
G5 1V DNA:10 P3 22.72 22.71 0.11
G6 1V DNA:10 P3 22.59 22.71 0.11
G7 1V DNA:100 P3 25.88 25.94 0.09
G8 1V DNA:100 P3 26.04 25.94 0.09
G9 1V DNA:100 P3 25.91 25.94 0.09
G10 1V DNA:1000 P3 28.96 28.79 0.24
G11 1V DNA:1000 P3
G12 1V DNA:1000 P3 28.62 28.79 0.24
H1 1V DNA:1 P12 20.35 20.40 0.05
H2 1V DNA:1 P12 20.44 20.40 0.05
H3 1V DNA:1 P12 20.40 20.40 0.05
H4 1V DNA:10 P12 24.17 23.95 0.26
H5 1V DNA:10 P12 24.03 23.95 0.26
H6 1V DNA:10 P12 23.66 23.95 0.26
H7 1V DNA:100 P12 27.35 27.27 0.13
H8 1V DNA:100 P12 27.34 27.27 0.13
H9 1V DNA:100 P12 27.12 27.27 0.13
H10 1V DNA:1000 P12 30.53 30.21 0.31
H11 1V DNA:1000 P12 30.17 30.21 0.31
H12 1V DNA:1000 P12 29.93 30.21 0.31
Analysis Parameters






Baseline range (from cycle no. ... to)n/a
Drift Correction OFF




Level (12) P3 copies P12 copies
rpoD2 
copies N/No CT (mg*min/L)
1C 1 17.77 18.82 16.17 1 1 77264 73001 141682 1 0
2C 1 19.29 20.65 16.00 0.30992692 0.25 27348 22156 158535 0.24565217 1.35391924
3C 1 22.82 24.12 15.91 0.02520755 0.02119694 2451 2310 168255 0.04130435 4.01161256
4C 1 24.58 25.55 15.72 0.00652412 0.00692006 736 913 190775 0.0003587 11.2325152
1D 1 16.85 17.72 15.94 1 1 144872 149482 164951
2D 1 18.07 19.20 15.72 0.3685673 0.3077861 62944 56990 190775
3D 1 21.95 23.11 14.91 0.01427862 0.01167851 4442 4461 325906
4D 1 24.45 25.10 15.60 0.00407213 0.00474295 805 1220 206527
1V 1 19.23 20.40 28493 26076
1V 10 22.71 23.95 26428 25806
1V 100 25.94 27.27 29079 29667
1V 1000 28.79 30.21 41481 43687











A1 1A cDNA:5 P3 33.15 33.78 0.90
A2 1A cDNA:5 P3 33.39 33.78 0.90
A3 1A cDNA:5 P3 34.81 33.78 0.90
A4 2A cDNA:5 P3
A5 2A cDNA:5 P3 36.92 35.90 1.45
A6 2A cDNA:5 P3 34.87 35.90 1.45
A7 3A cDNA:5 P3
A8 3A cDNA:5 P3
A9 3A cDNA:5 P3
A10 4A cDNA:5 P3
A11 4A cDNA:5 P3 35.29 35.42 0.20
A12 4A cDNA:5 P3 35.56 35.42 0.20
B1 1A cDNA:5 P12 29.92 29.81 0.19
B2 1A cDNA:5 P12 29.93 29.81 0.19
B3 1A cDNA:5 P12 29.59 29.81 0.19
B4 2A cDNA:5 P12 32.12 31.94 0.31
B5 2A cDNA:5 P12 32.11 31.94 0.31
B6 2A cDNA:5 P12 31.58 31.94 0.31
B7 3A cDNA:5 P12 35.58 36.55 1.37
B8 3A cDNA:5 P12
B9 3A cDNA:5 P12 37.52 36.55 1.37
B10 4A cDNA:5 P12 38.49
B11 4A cDNA:5 P12
B12 4A cDNA:5 P12
C1 1A cDNA:5 rpoD 23.49 23.13 0.31
C2 1A cDNA:5 rpoD 23.02 23.13 0.31
C3 1A cDNA:5 rpoD 22.89 23.13 0.31
C4 2A cDNA:5 rpoD 23.18 23.05 0.12
C5 2A cDNA:5 rpoD 23.01 23.05 0.12
C6 2A cDNA:5 rpoD 22.95 23.05 0.12
C7 3A cDNA:5 rpoD 22.75 22.48 0.24
C8 3A cDNA:5 rpoD 22.39 22.48 0.24
C9 3A cDNA:5 rpoD 22.29 22.48 0.24
C10 4A cDNA:5 rpoD 22.10 22.03 0.07
C11 4A cDNA:5 rpoD 21.99 22.03 0.07
C12 4A cDNA:5 rpoD 21.99 22.03 0.07
D1 1B cDNA:5 P3 27.67 27.37 0.28
D2 1B cDNA:5 P3 27.31 27.37 0.28
D3 1B cDNA:5 P3 27.12 27.37 0.28
D4 2B cDNA:5 P3 29.01 28.92 0.13
D5 2B cDNA:5 P3 28.97 28.92 0.13
D6 2B cDNA:5 P3 28.77 28.92 0.13
D7 3B cDNA:5 P3 35.83 34.05 1.59
D8 3B cDNA:5 P3 33.53 34.05 1.59
D9 3B cDNA:5 P3 32.78 34.05 1.59
D10 4B cDNA:5 P3
D11 4B cDNA:5 P3
D12 4B cDNA:5 P3
E1 1B cDNA:5 P12 26.04 25.51 0.47
E2 1B cDNA:5 P12 25.15 25.51 0.47
E3 1B cDNA:5 P12 25.34 25.51 0.47
E4 2B cDNA:5 P12 26.80 26.57 0.20 0.292 0.249 - 0.343
E5 2B cDNA:5 P12 26.48 26.57 0.20 0.292 0.249 - 0.343
E6 2B cDNA:5 P12 26.44 26.57 0.20 0.292 0.249 - 0.343
E7 3B cDNA:5 P12 30.75 30.79 0.13 1.520E-2X 1.38E-02 - 1.68E-02
E8 3B cDNA:5 P12 30.68 30.79 0.13 1.520E-2X 1.38E-02 - 1.68E-02
E9 3B cDNA:5 P12 30.93 30.79 0.13 1.520E-2X 1.38E-02 - 1.68E-02
E10 4B cDNA:5 P12 <not calculated>
E11 4B cDNA:5 P12 <not calculated>
E12 4B cDNA:5 P12 <not calculated>
F1 1B cDNA:5 rpoD 22.56 22.22 0.31
F2 1B cDNA:5 rpoD 22.16 22.22 0.31
F3 1B cDNA:5 rpoD 21.95 22.22 0.31
F4 2B cDNA:5 rpoD 21.64 21.51 0.12
F5 2B cDNA:5 rpoD 21.50 21.51 0.12
F6 2B cDNA:5 rpoD 21.40 21.51 0.12
F7 3B cDNA:5 rpoD 21.53 21.46 0.06
F8 3B cDNA:5 rpoD 21.45 21.46 0.06
F9 3B cDNA:5 rpoD 21.41 21.46 0.06
F10 4B cDNA:5 rpoD 21.56 21.64 0.07
F11 4B cDNA:5 rpoD 21.69 21.64 0.07
F12 4B cDNA:5 rpoD 21.66 21.64 0.07
G1 1D cDNA:5 DF1 P3 24.38 24.20 0.21
G2 1D cDNA:5 DF1 P3 24.26 24.20 0.21
G3 1D cDNA:5 DF1 P3 23.97 24.20 0.21
G4 1D cDNA:5 DF10 P3 27.39 27.04 0.32
G5 1D cDNA:5 DF10 P3 26.97 27.04 0.32
G6 1D cDNA:5 DF10 P3 26.76 27.04 0.32
G7 1D cDNA:5 DF100 P3 30.80 30.53 0.29
G8 1D cDNA:5 DF100 P3 30.58 30.53 0.29
G9 1D cDNA:5 DF100 P3 30.22 30.53 0.29
G10 No template P3
G11 No template P3
G12 No template P3
H1 1D cDNA:5 DF1 P12 25.00 24.89 0.12
H2 1D cDNA:5 DF1 P12 24.90 24.89 0.12
H3 1D cDNA:5 DF1 P12 24.76 24.89 0.12
H4 1D cDNA:5 DF10 P12 28.32 28.13 0.23
H5 1D cDNA:5 DF10 P12 28.20 28.13 0.23
H6 1D cDNA:5 DF10 P12 27.87 28.13 0.23
H7 1D cDNA:5 DF100 P12 31.77 31.50 0.24
H8 1D cDNA:5 DF100 P12 31.35 31.50 0.24
H9 1D cDNA:5 DF100 P12 31.37 31.50 0.24
H10 No template P12
H11 No template P12
H12 No template P12
Analysis Parameters






Baseline range (from cycle no. ... to)n/a
Drift Correction OFF




Level (12) P3 copies P12 copies
rpoD2 
copies
1A 5 33.78 29.81 23.13 1 1 7 283 7110
2A 5 35.90 31.94 23.05 0.21613431 71 7497
3A 5 36.55 22.48 10928
4A 5 35.42 22.03 14714
1B 5 27.37 25.51 22.22 1 1 547 4669 12977
2B 5 28.92 26.57 21.51 0.20877198 0.29320874 190 2341 20751
3B 5 34.05 30.79 21.46 0.00575886 0.01519773 6 150 21448
4B 5 21.64 #VALUE! #VALUE! #VALUE! #VALUE! 19042
1D 5 24.20 24.89 4774 6994
1D 50 27.04 28.13 6857 8470
1D 500 30.53 31.50 6317 9425
No template 5 #VALUE! #VALUE!












A1 1C cDNA:5 P3 25.47 25.53 0.07
A2 1C cDNA:5 P3 25.61 25.53 0.07
A3 1C cDNA:5 P3 25.50 25.53 0.07
A4 2C cDNA:5 P3 26.98 26.79 0.17
A5 2C cDNA:5 P3 26.72 26.79 0.17
A6 2C cDNA:5 P3 26.66 26.79 0.17
A7 3C cDNA:5 P3 31.22 31.14 0.08
A8 3C cDNA:5 P3 31.07 31.14 0.08
A9 3C cDNA:5 P3 31.13 31.14 0.08
A10 4C cDNA:5 P3
A11 4C cDNA:5 P3
A12 4C cDNA:5 P3
B1 1C cDNA:5 P12 26.44 26.26 0.18
B2 1C cDNA:5 P12 26.26 26.26 0.18
B3 1C cDNA:5 P12 26.07 26.26 0.18
B4 2C cDNA:5 P12 27.35 27.22 0.13
B5 2C cDNA:5 P12 27.23 27.22 0.13
B6 2C cDNA:5 P12 27.09 27.22 0.13
B7 3C cDNA:5 P12 31.46 31.34 0.32
B8 3C cDNA:5 P12 31.59 31.34 0.32
B9 3C cDNA:5 P12 30.98 31.34 0.32
B10 4C cDNA:5 P12
B11 4C cDNA:5 P12
B12 4C cDNA:5 P12
C1 1C cDNA:5 rpoD 22.65 22.32 0.29
C2 1C cDNA:5 rpoD 22.22 22.32 0.29
C3 1C cDNA:5 rpoD 22.10 22.32 0.29
C4 2C cDNA:5 rpoD 21.96 21.90 0.11
C5 2C cDNA:5 rpoD 21.78 21.90 0.11
C6 2C cDNA:5 rpoD 21.97 21.90 0.11
C7 3C cDNA:5 rpoD 21.92 21.78 0.13
C8 3C cDNA:5 rpoD 21.76 21.78 0.13
C9 3C cDNA:5 rpoD 21.67 21.78 0.13
C10 4C cDNA:5 rpoD 21.42 21.39 0.05
C11 4C cDNA:5 rpoD 21.33 21.39 0.05
C12 4C cDNA:5 rpoD 21.41 21.39 0.05
D1 1D cDNA:5 P3 24.75 24.33 0.36
D2 1D cDNA:5 P3 24.07 24.33 0.36
D3 1D cDNA:5 P3 24.18 24.33 0.36
D4 2D cDNA:5 P3 25.15 25.04 0.21
D5 2D cDNA:5 P3 24.80 25.04 0.21
D6 2D cDNA:5 P3 25.17 25.04 0.21
D7 3D cDNA:5 P3 29.18 29.34 0.14
D8 3D cDNA:5 P3 29.41 29.34 0.14
D9 3D cDNA:5 P3 29.45 29.34 0.14
D10 4D cDNA:5 P3
D11 4D cDNA:5 P3
D12 4D cDNA:5 P3
E1 1D cDNA:5 P12 25.39 24.99 0.35
E2 1D cDNA:5 P12 24.86 24.99 0.35
E3 1D cDNA:5 P12 24.72 24.99 0.35
E4 2D cDNA:5 P12 25.98 25.81 0.18 0.360 0.312 - 0.416
E5 2D cDNA:5 P12 25.62 25.81 0.18 0.360 0.312 - 0.416
E6 2D cDNA:5 P12 25.83 25.81 0.18 0.360 0.312 - 0.416
E7 3D cDNA:5 P12 30.00 30.10 0.09 1.960E-2X 1.73E-02 - 2.24E-02
E8 3D cDNA:5 P12 30.19 30.10 0.09 1.960E-2X 1.73E-02 - 2.24E-02
E9 3D cDNA:5 P12 30.12 30.10 0.09 1.960E-2X 1.73E-02 - 2.24E-02
E10 4D cDNA:5 P12 <not calculated>
E11 4D cDNA:5 P12 <not calculated>
E12 4D cDNA:5 P12 <not calculated>
F1 1D cDNA:5 rpoD 21.88 21.66 0.20
F2 1D cDNA:5 rpoD 21.59 21.66 0.20
F3 1D cDNA:5 rpoD 21.51 21.66 0.20
F4 2D cDNA:5 rpoD 20.92 21.01 0.10
F5 2D cDNA:5 rpoD 21.12 21.01 0.10
F6 2D cDNA:5 rpoD 20.99 21.01 0.10
F7 3D cDNA:5 rpoD 21.12 21.10 0.16
F8 3D cDNA:5 rpoD 20.94 21.10 0.16
F9 3D cDNA:5 rpoD 21.26 21.10 0.16
F10 4D cDNA:5 rpoD 21.18 21.24 0.06
F11 4D cDNA:5 rpoD 21.29 21.24 0.06
F12 4D cDNA:5 rpoD 21.25 21.24 0.06
G1 1D cDNA:5 DF10 P3 27.24 27.11 0.12
G2 1D cDNA:5 DF10 P3 27.02 27.11 0.12
G3 1D cDNA:5 DF10 P3 27.06 27.11 0.12
G4 1D cDNA:5 DF100 P3 31.25 30.72 0.46
G5 1D cDNA:5 DF100 P3 30.53 30.72 0.46
G6 1D cDNA:5 DF100 P3 30.39 30.72 0.46
G7 1C-RT cDNA:5 P3
G8 1C-RT cDNA:5 P3
G9 1C-RT cDNA:5 P3
G10 1D-RT cDNA:5 P3 34.55 34.00 0.78
G11 1D-RT cDNA:5 P3
G12 1D-RT cDNA:5 P3 33.45 34.00 0.78
H1 1D cDNA:5 DF10 P12 28.30 28.29 0.03
H2 1D cDNA:5 DF10 P12 28.31 28.29 0.03
H3 1D cDNA:5 DF10 P12 28.25 28.29 0.03
H4 1D cDNA:5 DF100 P12 31.82 31.78 0.04
H5 1D cDNA:5 DF100 P12 31.74 31.78 0.04
H6 1D cDNA:5 DF100 P12 31.76 31.78 0.04
H7 1C-RT cDNA:5 P12
H8 1C-RT cDNA:5 P12
H9 1C-RT cDNA:5 P12
H10 1D-RT cDNA:5 P12
H11 1D-RT cDNA:5 P12 37.72 35.93 2.53
H12 1D-RT cDNA:5 P12 34.14 35.93 2.53
Analysis Parameters






Baseline range (from cycle no. ... to)n/a
Drift Correction OFF




Level (12) P3 copies P12 copies
rpoD2 
copies
1C 5 25.53 26.26 22.32 1 1 1924 2864 12147
2C 5 26.79 27.22 21.90 0.31208264 0.3842188 813 1532 16035
3C 5 31.14 31.34 21.78 0.01408204 0.02033347 42 105 17358
4C 5 21.39 #VALUE! #VALUE! #VALUE! #VALUE! 22464
1D 5 24.33 24.99 21.66 1 1 4368 6552 18792
2D 5 25.04 25.81 21.01 0.38958229 0.3609823 2689 3840 28880
3D 5 29.34 30.10 21.10 0.02105052 0.01964083 142 235 27212
4D 5 21.24 #VALUE! #VALUE! #VALUE! #VALUE! 24806
1D 50 27.11 28.29 6537 7632
1D 500 30.72 31.78 5548 7854
1C-RT 5 #VALUE! #VALUE!
1D-RT 5 34.00 35.93 6 5
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APPENDIX I.  ADDITIONAL INACTIVATION KINETICS STUDIES  
I.1  Low Pressure Ultraviolet Light 
I.1.1  Introduction 
HAdV is known to be the most resistant viral pathogen to low pressure ultraviolet (UV) light, 
and the mechanism of HAdV resistance remains unknown.  As described previously, 
bacteriophage PR772 has highly similar morphology, double stranded DNA genome, and 
replication cycle steps compared to HAdV.  Our aim of this study was to therefore determine if 
PR772 is a good surrogate for HAdV inactivation by UV.   
 
I.1.2  Materials and Methods 
Bacteriophage PR772 (BAA-769-B1) was propagated using bacterial hosts Escherichia coli K12 
J53-1 R15 (BAA-769) and Salmonella typhimurium LT2 (19585) obtained from the American 
Type Culture Collection (Manassas, VA).  PR772 propagation and viability assessment was 
performed as described previously.1  The PR772 stock propagated from S. typhimurium was used 
only for ultraviolet light (UV) experiments.  The virus titers ranged from 1.1 × 109 to 6.5 × 1010 
plaque-forming units (PFU)/mL for PR772 propagated with E. coli and 4 × 106 PFU/mL for 
PR772 propagated with S. typhimurium.  Viability was assessed using the double agar layer 
plaque technique using E. coli as host cells for both viruses.     
 
Viruses were exposed to low pressure ultraviolet (UV) light using a collimated beam system 
(Calgon Carbon Corporation, Pittsburg, PA) containing a low-pressure Hg lamp.  The incident 
light emits a narrow emission spectra centered at 254 nm.  Light intensity was measured using a 
radiometer and the intensity was approximately I = 0.046 mW/cm².  UV fluences were 
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determined by radiometry.2  A 6 cm diameter dish containing 15 mL of continuously mixed 1 
mM CBS was placed under the collimated beam.  Viruses were added to the reactor and samples 
were taken at increasing UV doses at room temperature.   	  
I.1.3  Inactivation Kinetics by Low Pressure Ultraviolet Light 
To assess if the phage exhibits similar inactivation kinetics to HAdV, the inactivation kinetics of 
bacteriophage PR772 were determined after exposure to low-pressure ultraviolet light.  PR772 
was propagated in E. coli K-12 J53 and S. typhimurium LT2 and both viruses were enumerated 
using a plaque assay with E. coli host cells.  The viruses with internal lipids derived from E. coli 
and S. typhimurium reached 4-log inactivation by 40.8 and 43.5 mJ/cm2, respectively (Figure 
I.1).  Similarly, previous studies utilizing another tectivirus, PRD1, with S. typhimurium as the 
host for propagation and enumeration, show 4-log inactivation at 31.6 mJ/cm2 and 35 mJ/cm2, 
and after exposure to a photoreactivating light, the dose required increased to 103 mJ/cm2.3, 4  
The USEPA requires a dose of 186 mJ/cm2 to achieve 4-log reduction of viruses by low pressure 
UV based on HAdV resistance, which is more than 4 times the dose required to inactivate 
PR772.5  When host cell lines lacking DNA repair mechanisms are used for HAdV, less than 57 
mJ/cm2 is required for 4-log inactivation, which is more similar to the dose required for PR772 
inactivation.6  Although HAdV and PR772 have highly similar structures, the internal lipid 
membrane of PR772 and less complex capsid protein structure may result in greater 
susceptibility of PR772 to LPUV as well as increased resistance for HAdV due to the DNA 
repair mechanisms in eukaryotic host cells.         
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Figure I.1.  Low pressure ultraviolet light inactivation of PR772 propagated in E. coli and S. 
typhimurium.  Viruses were quantified using a plaque assay with E. coli host cells.   
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I.1.5 Raw Data:  Inactivation of PR772 by LPUV 	  











Time%(mins) 0 C1 C2 C3 C4 C5 C6 C7 Dose%(mJ/cm^2) PFU/mL N/No
0 TNTC 137 22 0 0 2.23E+07 1
4:30 TNTC TNTC TNTC TNTC 87 12 0 0 10.8 1.09E+06 0.048739496
9:01 TNTC TNTC TNTC TNTC 25 2 0 1 20 3.13E+05 0.014005602





Time%(mins) Dose%(mJ/cm^2) 0 F1 F2 F3 F4 F5 F6 PFU/mL N/No
0 0 TNTC 74 19 9250000 1
4.3166667 10 TNTC 121 17 1512500 0.163514
8.6333333 20 TNTC 169 16 211250 0.022838
12.95 30 TNTC 173 15 21625 0.002338
17.266667 40 TNTC 99 8 1237.5 0.000134





Time%(mins) Dose%(mJ/cm^2) 0 G1 G2 G3 G4 G5 PFU/mL N/No
0 0 TNTC 129 12 1612500 1
2.15 5 TNTC TNTC 47 587500 0.364341
6.4666667 15 TNTC TNTC 62 7 77500 0.048062
10.783333 25 TNTC 56 4 7000 0.004341
15.2 35.2 335 77 4 962.5 0.000597
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Time-(mins) Dose-(mJ/cm^2) 0 H1 H2 H3 H4 H5 PFU/mL N/No
0 0 142 22 1 177500 1
4.25 10 TNTC TNTC 212 9 1 26500 0.149296
8.4833333 20 TNTC 241 26 0 0 3012.5 0.016972





Time-(mins) Dose-(mJ/cm^2) 0 H1 H2 H3 H4 H5 PFU/mL N/No
0.00 0 193 17 2 241250 1
2.17 5 TNTC 77 9 96250 0.398964
6.48 15 TNTC 70 11 8750 0.036269
10.80 25 TNTC 129 6 1612.5 0.006684
15.12 35 69 10 86.25 0.000358





Time-(mins) Dose-(mJ/cm^2) 0 I1 I2 I3 I4 I5 PFU/mL N/No
0.00 0 207 23 3 258750 1
4.32 10 237 23 2 29625 0.114493
8.63 20 389 20 1
12.95 30 334 46 2 575 0.002222
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I.2  Monochloramine with High Concentration  
I.2.1  Discussion 
HAdV is known to be resistant to monochloramine disinfection.  At high pH and low 
temperatures, HAdV required monochloramine exposures of nearly 2.5×104 mgCl2×min/L to 
achieve 4-log inactivation (Chapter 5).  The range of initial monochloramine concentration used 
in the kinetic study was 2-13 mg/L as Cl2.  This resulted in inactivation kinetic experiments 
lasting for long periods of time, sometimes in excess of 24 hours, in which pH was difficult to 
maintain.  As such, a higher initial monochloramine exposure was also investigated (C0 = 100 
mg/L as Cl2) to assess the CT concept.  Experiments were performed as previously described 
(Chapter 5 and 6) for pH 8-10 and 5, 15, and 30 °C for HAdV-2 and 5 °C for PR772.   
Experimental conditions are shown in Tables I.1 and I.2.     
 
Figures I.2 to I.4 show the inactivation of HAdV-2 by monochloramine, and Figure I.5 shows the 
inactivation of PR772.  PR772 was not affected by the high monochloramine concentration, and 
the model (Chapter 6) represented the data well.  Deviations from the model (Chapter 5) were 
observed for HAdV-2.  At pH 8 and 9 for all temperatures investigated, HAdV-2 required a 
higher CT to achieve the same inactivation characterized at lower initial monochloramine 
concentrations represented by the model.  Interestingly, no consistent trend was observed for pH 
10.  These deviations from the model predictions at high monochloramine concentrations could 
give insights into the mechanisms of HAdV-2 inactivation.  The inactivation of HAdV-2 by high 
monochloramine concentration does not obey the CT concept, and this may be caused by the 
reaction of monochloramine with capsid proteins becoming rate limiting. 
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Table I.1. Experimental conditions for HAdV-2 inactivation by monochloramine with initial 






# Date pH 
Temp 



















2.133 39 11/11/12 9 5 9.00-8.88 5.2-5.3 1 mM CBS 99.29 99.52 1.25E+06 3.5 Ad2-1 
2.137 40 1/16/13 9 5 8.99-8.79 5.2-5.6 1 mM CBS 100.24 98.13 6.88E+05 3.4 Ad2-1 
2.139 41 1/16/13 10 5 9.98-9.98 5.3-4.5 1 mM CBS 97.86 96.02 7.75E+05 3.8 Ad2-1 
2.141 42 1/18/13 10 15 10.01-10.02 14.5-14.4 1 mM CBS 97.86 95.01 1.79E+06 3.8 Ad2-1 
2.143 43 1/18/13 9 15 8.99-9.01 15.0-15.0 1 mM CBS 97.86 95.13 1.33E+06 3.8 Ad2-1 
2.149 44 3/13/13 10 15 10.01-10.01 14.5-15.0 1 mM CBS 107.36 104.75 9.63E+05 3.3 Ad2-1 
2.151 45 3/13/13 9 15 8.99-9.01 14.4-14.8 1 mM CBS 107.84 106.06 1.31E+06 3.3 Ad2-1 
2.153 46 3/18/13 10 5 9.99-9.96 5.3-5.2 1 mM CBS 111.64 105.38 1.16E+06 3.1 Ad2-1 
2.155 47 3/18/13 8 5 7.98-7.96 4.7-5.1 1 mM CBS 105.46 106.35 1.24E+06 3.2 Ad2-1 
2.159 50 3/21/13 8 15 7.96-7.96 15.1-15.1 1 mM CBS 96.91 97.47 9.63E+05 3.0 Ad2-1 
3.81 52 3/26/13 10 15 10.01-9.97 14.7-14.6 1 mM CBS 102.14 100.06 9.00E+05 3.3 Ad2-1 
3.85 53 4/2/13 10 5 10.00-9.97 5.1-5.2 1 mM CBS 102.61 101.70 1.18E+06 3.6 Ad2-1 
3.91 54 4/4/13 8 15 7.97-7.98 15.1-15.2 1 mM CBS 102.14 102.41 1.40E+06 3.5 Ad2-1 
3.97 55 4/19/13 8 15 8.01-7.99 15.2-15.2 1 mM CBS 100.24 99.58 1.50E+06 3.1 Ad2-1 
3.107 58 5/23/13 8 15 7.97-7.98 14.9-15.3 1 mM CBS 93.59 93.79 1.10E+05 3.2 Ad2-1 
3.129 67 6/11/13 8 5 7.95-7.98 5.0-5.2 1 mM CBS 98.34 96.86 1.66E+06 3.0 Ad2-1 
3.145 70 8/8/13 8 30 7.96-7.98 29.9-29.7 1 mM CBS 102.14 104.75 1.15E+06 3.0 Ad2-1 
3.149 71 8/11/13 9 30 8.98-8.96 29.7-29.6 1 mM CBS 102.14 101.28 1.18E+06 3.0 Ad2-1 
3.153 73 8/20/13 8 30 7.96-7.96 29.9-29.9 1 mM CBS 105.94 104.39 1.20E+06 3.1 Ad2-1 
3.155 74 8/23/13 10 30 10.00-9.98 30.2-30.1 1 mM CBS 106.89 103.56 1.29E+06 3.1 Ad2-1 
3.157 75 8/26/13 9 30 8.99-8.96 30.0-30.1 1 mM CBS 104.04 103.25 1.18E+06 6.7 Ad2-1 
3.161 76 9/5/13 10 30 10.02-9.99 29.5-29.7 1 mM CBS 104.51 101.43 4.00E+05 3.3 Ad2-1 




Table I.2.  Experimental conditions for PR772 inactivation by monochloramine with initial 






# Date pH 
Temp 





















3.137 41 6/26/13 8 5 7.96-7.98 5.2-5.1 1 mM CBS 98.81 95.13 1.11E+06 3.2 PR772-5/5/11 
3.169 42 9/27/13 9 5 8.98-8.94 5.2-5.3 1 mM CBS 101.19 102.14 1.11E+06 3.2 PR772-5/5/11 
3.171 43 9/27/13 10 5 9.99-9.96 4.8-5.2 1 mM CBS 99.76 100.87 1.11E+06 3.2 PR772-5/5/11 
3.177 44 10/2/13 9 5 8.98-8.93 5.5-5.4 1 mM CBS 98.81 96.32 3.58E+06 3.2 PR772-5/5/11 
3.179 45 10/2/13 8 5 7.98-8.01 5.5-5.4 1 mM CBS 98.81 97.27 3.58E+06 3.2 PR772-5/5/11 
3.180 46 10/2/13 10 5 9.99-9.98 5.1-5.1 1 mM CBS 98.81 97.03 3.58E+06 3.2 PR772-5/5/11 
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Figure I.2.  HAdV-2 inactivation by monochloramine with a high initial monochloramine 
concentration at 5 °C from pH 8-10 compared to the model (Chapter 5).    
 
 
Figure I.3.  HAdV-2 inactivation by monochloramine with a high initial monochloramine 
concentration at 15 °C from pH 8-10 compared to the model (Chapter 5).    
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Figure I.4.  HAdV-2 inactivation by monochloramine with a high initial monochloramine 




Figure I.5.  PR772 inactivation by monochloramine with a high initial monochloramine 
concentration at 5 °C from pH 8-10 compared to the model (Chapter 6).    
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0.00 100.00 0.209 99.287
0.98 100.00 0.212 100.713
4.07 100.00 0.208 98.812
20.58 100.00 0.208 98.812
68.27 100.00 0.211 100.238
127.45 100.00 0.216 102.613
155.75 100.00 0.209 99.287
212.15 100.00 0.200 95.012






Actual-Time 0 >1 >2 >3 >4 >5 N N/No CT-(mg*min/L)
R1 1 0.32 TNTC 100 10 1250000 1 31.5
2 6.03 TNTC 78 6 975000 0.78 600.5
3 20.08 TNTC 45 12 562500 0.45 1998.8
4 46.22 TNTC 61 7 76250 0.061 4599.7
5 67.23 236 27 2 29500 0.0236 6691.4
6 101.03 TNTC 39 4 4875 0.0039 10055.3
7 126.18 203 22 1 2537.5 0.00203 12558.4
8 154.48 TNTC 100 13 1 1250 0.001 15374.9
9 179.30 223 40 1 389.375 0.0003115 17844.8
10 211.90 109 11 1 136.25 0.000109 21089.3









































































0.00 100.00 0.211 100.238
0.97 100.00 0.206 97.862
5.67 100.00 0.202 95.962
11.33 100.00 0.208 98.812
69.75 100.00 0.216 102.613
107.50 100.00 0.208 98.812
131.63 100.00 0.209 99.287
196.50 100.00 0.204 96.912
228.33 100.00 0.201 95.487






Actual.Time 0 @1 @2 @3 @4 @5 N N/No CT.(mg*min/L)
R1 1 0.28 TNTC 55 8 687500 1 27.8
2 2.53 TNTC 69 8 862500 1.25454545 248.6
3 9.80 TNTC 50 10 625000 0.90909091 961.6
4 29.87 TNTC 166 20 207500 0.30181818 2930.7
5 70.10 TNTC 187 26 23375 0.034 6878.6
6 107.12 263 23 2 3287.5 0.00478182 10510.9
7 134.33 TNTC 88 8 1100 0.0016 13181.6
8 165.22 TNTC 22 6
9 195.58 176 10 3 220 0.00032 19191.8
10 226.18 49 4 61.25 8.9091E@05 22194.5












































































0.00 100.00 0.206 97.862
1.10 100.00 0.213 101.188
3.77 100.00 0.203 96.437
13.62 100.00 0.200 95.012
72.65 100.00 0.204 96.912
116.50 100.00 0.205 97.387
232.00 100.00 0.196 93.112
274.33 100.00 0.197 93.587






Actual.Time 0 @1 @2 @3 @4 @5 N N/No CT.(mg*min/L)
R1 1 0.48 TNTC 62 17 775000 1 46.4
2 5.40 TNTC 48 6 600000 0.77419355 518.5
3 9.97 TNTC 40 6 500000 0.64516129 957.0
4 29.97 TNTC 105 10 131250 0.16935484 2877.4
5 75.05 TNTC 25 4
6 118.47 38 4 1 475 0.0006129 11375.3
7 172.07 25 3 1
8 228.75 94 12 0 117.5 0.00015161 21964.9
9 272.22 58 11 0 72.5 9.3548E@05 26138.6






































































0.00 100.00 0.206 97.862
1.33 100.00 0.204 96.912
8.35 100.00 0.198 94.062
21.82 100.00 0.202 95.962
32.42 100.00 0.201 95.487
88.85 100.00 0.203 96.437
117.32 100.00 0.194 92.162






Actual.Time 0 ?1 ?2 ?3 ?4 ?5 N N/No CT.(mg*min/L)
R1 1 0.35 TNTC 143 10 1787500 1 33.3
2 3.15 TNTC 96 14 1200000 0.67132867 299.3
3 20.88 TNTC 138 19 172500 0.0965035 1984.2
4 31.08 TNTC 39 10 48750 0.02727273 2953.3
5 45.00 TNTC TNTC 95 118750 0.06643357 4275.5
6 71.05 TNTC TNTC 123 15375 0.0086014 6750.6
7 85.12 TNTC 263 27 3287.5 0.00183916 8087.1
8 103.18 132 58 15 445 0.00024895 9803.6
9 116.27 33 27 41.25 2.3077E?05 11046.7
10 125.67 37 18 46.25 2.5874E?05 11939.8









































































0.00 100.00 0.206 97.862
1.45 100.00 0.206 97.862
4.07 100.00 0.207 98.337
16.27 100.00 0.201 95.487
29.58 100.00 0.199 94.537
39.83 100.00 0.202 95.962
49.62 100.00 0.193 91.686
52.47 100.00 0.194 92.162






Actual.Time 0 >1 >2 >3 >4 >5 N N/No CT.(mg*min/L)
R1 1 0.35 TNTC 106 9 1325000 1 33.3
2 0.72 TNTC 106 7 1325000 1 68.2
3 0.97 TNTC 134 9 1675000 1.26415094 92.0
4 7.10 TNTC TNTC 55 687500 0.51886792 675.4
5 16.00 TNTC TNTC 228 285000 0.21509434 1522.1
6 29.88 TNTC TNTC 224 28000 0.02113208 2842.8
7 40.07 TNTC 287 39 4231.25 0.0031934 3811.6
8 45.20 TNTC 109 1362.5 0.0010283 4299.9
9 49.88 TNTC 87 1087.5 0.00082075 4745.4
10 55.12 231 23 288.75 0.00021792 5243.3










































































0.00 100.00 0.226 107.363
1.22 100.00 0.222 105.463
11.37 100.00 0.221 104.988
29.82 100.00 0.219 104.038
51.03 100.00 0.219 104.038
70.45 100.00 0.222 105.463
85.92 100.00 0.222 105.463
107.83 100.00 0.222 105.463






Actual-Time 0 =1 =2 =3 =4 =5 N N/No CT-(mg*min/L)
R1 1 0.28 TNTC 77 5 962500 1 29.7
2 0.95 TNTC 80 3 1000000 1.03896104 99.5
3 10.28 TNTC 256 26 320000 0.33246753 1077.2
4 30.05 TNTC 28 *cracked-flask
5 49.97 172 18 1 2150 0.00223377 5234.0
6 70.05 42 5 0 52.5 5.4545E=05 7337.8
7 85.05 4 0 0
8 94.48 1 2
9 106.90 0 0
10 109.97 0 0










































































0.00 100.00 0.227 107.838
1.48 100.00 0.224 106.413
6.07 100.00 0.214 101.663
15.90 100.00 0.222 105.463
26.10 100.00 0.229 108.789
35.97 100.00 0.218 103.563
45.32 100.00 0.226 107.363
55.00 100.00 0.227 107.838






Actual-Time 0 >1 >2 >3 >4 >5 N N/No CT-(mg*min/L)
R1 1 0.35 TNTC 105 9 1312500 1 37.1
2 1.05 TNTC 102 11 1275000 0.97142857 111.4
3 5.07 TNTC TNTC 59 737500 0.56190476 537.4
4 15.02 TNTC TNTC 148 185000 0.14095238 1592.6
5 25.03 TNTC 230 33 35000 0.02666667 2655.0
6 34.98 TNTC TNTC 57 7125 0.00542857 3710.2
7 40.85 TNTC 246 25 3075 0.00234286 4332.4
8 45.05 TNTC 96 8 1200 0.00091429 4777.9
9 50.52 TNTC 72 900 0.00068571 5357.6
10 54.82 100 24 125 9.5238E>05 5813.7









































































0.00 100.00 0.235 111.639
1.65 100.00 0.229 108.789
5.52 100.00 0.223 105.938
12.88 100.00 0.223 105.938
29.82 100.00 0.223 105.938
61.90 100.00 0.222 105.463
95.25 100.00 0.215 102.138
121.85 100.00 0.219 104.038
183.15 100.00 0.220 104.513
243.13 100.00 0.222 105.463
271.73 100.00 0.226 107.363






Actual.Time 0 @1 @2 @3 @4 @5 N N/No CT.(mg*min/L)
R1 1 0.87 TNTC 93 6 1162500 1 91.3
2 5.27 TNTC 53 8 662500 0.56989247 555.0
3 11.10 TNTC 40 4 500000 0.43010753 1169.7
4 30.13 TNTC 119 3 148750 0.12795699 3175.4
5 60.98 TNTC 85 12 10625 0.00913978 6426.2
6 90.00 TNTC 98 9 0 1225 0.00105376 9483.9
7 120.97 166 39 2 347.5 0.00029892 12747.1
8 149.98 40 18 0 50 4.3011E@05 15804.8
9 182.23 43 41 0 283.125 0.00024355 19203.2
10 210.17 7 0 0
11 242.15 4 1
12 270.55 1 1
13 285.016667 7 1











































































0.00 100.00 0.222 105.463
1.10 100.00 0.227 107.838
8.60 100.00 0.221 104.988
13.67 100.00 0.225 106.888
16.22 100.00 0.225 106.888
26.75 100.00 0.219 104.038
36.03 100.00 0.226 107.363






Actual.Time 0 ?1 ?2 ?3 ?4 ?5 N N/No CT.(mg*min/L)
R1 1 0.25 TNTC 99 4 1237500 1 26.6
2 0.67 TNTC 98 6 1225000 0.98989899 70.9
3 4.92 TNTC TNTC 73 912500 0.73737374 522.9
4 10.57 TNTC TNTC 45 562500 0.45454545 1123.7
5 15.23 TNTC TNTC 246 307500 0.24848485 1620.0
6 19.88 TNTC TNTC 180 225000 0.18181818 2114.5
7 24.95 TNTC TNTC TNTC
8 30.05 TNTC TNTC
9 35.03 TNTC TNTC
10 40.10 TNTC TNTC
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3/21/13 CT'Control Experiment'Number 50
T'(°C) 15
pH 8
















0.00 100.00 0.204 96.912
1.93 100.00 0.203 96.437
5.42 100.00 0.210 99.762
7.65 100.00 0.204 96.912
10.28 100.00 0.200 95.012
14.83 100.00 0.206 97.862






Actual'Time 0 C1 C2 C3 C4 C5 N N/No CT'(mg*min/L)
R1 1 0.67 TNTC 77 12 962500 1 65.0
2 1.02 TNTC 65 4 812500 0.84415584 99.1
3 5.22 TNTC 238 18 297500 0.30909091 508.4
4 9.40 TNTC TNTC 70 87500 0.09090909 916.2
5 13.97 TNTC TNTC 119 14875 0.01545455 1361.3
6 19.62 TNTC TNTC








































































0.00 100.00 0.215 102.138
1.52 100.00 0.212 100.713
4.35 100.00 0.211 100.238
14.22 100.00 0.210 99.762
20.48 100.00 0.207 98.337
31.15 100.00 0.212 100.713
53.52 100.00 0.210 99.762
76.78 100.00 0.211 100.238






Actual/Time 0 >1 >2 >3 >4 >5 N N/No CT/(mg*min/L)
R1 1 0.32 TNTC 72 8 900000 1 31.7
2 2.07 TNTC 59 7 737500 0.81944444 206.8
3 10.70 TNTC 276 42 435000 0.48333333 1070.6
4 20.12 TNTC 168 20 210000 0.23333333 2012.9
5 30.00 TNTC 56 10 70000 0.07777778 3001.8
6 39.95 TNTC 243 24 30375 0.03375 3997.4
7 50.00 TNTC TNTC 83 3 10375 0.01152778 5003.0
8 60.05 TNTC 185 19 2 2312.5 0.00256944 6008.6
9 75.58 33 25 4 41.25 4.5833E>05 7562.8
10 90.08 4 5 1








































































0.00 100.00 0.216 102.613
1.67 100.00 0.214 101.663
4.10 100.00 0.206 97.862
6.28 100.00 0.219 104.038
8.67 100.00 0.210 99.762
30.05 100.00 0.216 102.613
58.50 100.00 0.215 102.138
95.95 100.00 0.213 101.188
123.22 100.00 0.219 104.038
191.73 100.00 0.217 103.088
213.47 100.00 0.213 101.188
273.18 100.00 0.214 101.663






Actual/Time 0 >1 >2 >3 >4 >5 N N/No CT/(mg*min/L)
R1 1 0.28 TNTC 94 11 1175000 1 28.8
2 1.05 TNTC 97 5 1212500 1.03191489 106.8
3 8.38 TNTC 47 2 587500 0.5 852.6
4 29.75 TNTC 202 17 252500 0.21489362 3025.6
5 60.18 TNTC 218 27 27250 0.02319149 6120.8
6 93.38 TNTC 299 24 1 3737.5 0.00318085 9497.3
7 122.08 TNTC 66 7 0 825 0.00070213 12416.2
8 149.47 112 29 2 140 0.00011915 15201.1
9 172.18 38 28 3 47.5 4.0426E>05 17511.4
10 190.80 25 9 1
11 210.75 12 23 1
12 232.30 265 35 1 384.375 0.00032713 23625.4
13 249.92 TNTC 27
14 271.97 TNTC 30 375 0.00031915 27659.6









































































0.00 100.00 0.215 102.138
1.85 100.00 0.213 101.188
3.98 100.00 0.216 102.613
6.50 100.00 0.213 101.188
10.73 100.00 0.216 102.613
14.85 100.00 0.217 103.088
19.95 100.00 0.217 103.088






Actual.Time 0 ?1 ?2 ?3 ?4 ?5 N N/No CT.(mg*min/L)
R1 1 0.40 TNTC 112 9 1400000 1 41.0
2 0.87 TNTC 80 7 1000000 0.71428571 88.8
3 5.52 TNTC 189 14 236250 0.16875 565.0
4 9.05 TNTC TNTC 78 97500 0.06964286 926.8
5 12.90 TNTC TNTC 166 20 20750 0.01482143 1321.1
6 16.47 TNTC TNTC 113 11 14125 0.01008929 1686.3
7 18.97 TNTC TNTC 61 5 7625 0.00544643 1942.4
8 22.03 TNTC 270 37 4000 0.00285714 2256.4









































































0.00 100.00 0.211 100.238
1.43 100.00 0.205 97.387
3.25 100.00 0.212 100.713
5.75 100.00 0.208 98.812
9.67 100.00 0.209 99.287
13.95 100.00 0.210 99.762
19.45 100.00 0.213 101.188
22.68 100.00 0.208 98.812






Actual/Time 0 ?1 ?2 ?3 ?4 ?5 N N/No CT/(mg*min/L)
R1 1 0.27 TNTC 120 9 1500000 1 26.6
2 0.58 TNTC 107 7 1337500 0.89166667 58.1
3 5.07 TNTC 212 16 265000 0.17666667 504.6
4 9.00 TNTC TNTC 86 107500 0.07166667 896.3
5 13.03 TNTC TNTC 182 14 22750 0.01516667 1297.9
6 16.00 TNTC TNTC 77 8 9625 0.00641667 1593.3
7 19.22 TNTC TNTC 40 1 5000 0.00333333 1913.7
8 21.98 TNTC 220 16 2750 0.00183333 2189.2
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5/23/13 Co=100mg/L-with-No=1/10th-of-usual-experiment
T-(°C) 15 Experiment-Number 58
pH 8
















0.00 100.00 0.197 93.587
1.43 100.00 0.199 94.537
7.30 100.00 0.196 93.112
10.52 100.00 0.198 94.062
30.75 100.00 0.194 92.162
33.90 100.00 0.198 94.062
39.82 100.00 0.197 93.587






Actual-Time 0 H1 H2 H3 H4 H5 N N/No CT-(mg*min/L)
R1 1 0.38 TNTC 88 6 110000 1 36.0
2 0.65 TNTC 83 12 103750 0.94318182 61.0
3 6.17 TNTC 217 38 37312.5 0.33920455 578.4
4 12.10 208 17 3 2600 0.02363636 1134.9
5 19.82 186 20 2 232.5 0.00211364 1858.6
6 27.83 49 5 0 61.25 0.00055682 2610.5
7 33.07 24 2 0
8 38.98 7 0








































































0.00 100.00 0.207 98.337
1.42 100.00 0.204 96.912
5.90 100.00 0.206 97.862
11.03 100.00 0.202 95.962
27.62 100.00 0.207 98.337
42.35 100.00 0.201 95.487
55.22 100.00 0.205 97.387
72.88 100.00 0.205 97.387
94.62 100.00 0.203 96.437






Actual.Time 0 ?1 ?2 ?3 ?4 ?5 N N/No CT.(mg*min/L)
R1 1 0.33 TNTC 133 13 1662500 1 32.3
2 0.58 TNTC 86 9 1075000 0.64661654 56.5
3 5.10 TNTC 66 3 825000 0.4962406 494.0
4 10.15 TNTC 51 2 637500 0.38345865 983.1
5 26.70 TNTC 69 5 86250 0.0518797 2586.1
6 41.00 105 14 2 13125 0.00789474 3971.2
7 57.80 TNTC 37 1 4625 0.00278195 5598.5
8 71.95 TNTC 78 15 975 0.00058647 6969.0
9 87.00 TNTC 71 6 887.5 0.00053383 8426.8









































































0.00 100.00 0.215 102.138
0.57 100.00 0.222 105.463
3.33 100.00 0.214 101.663
6.22 100.00 0.224 106.413






Actual.Time 0 ?1 ?2 ?3 ?4 ?5 N N/No CT.(mg*min/L)
R1 1 0.22 TNTC 92 12 1150000 1 22.7
2 0.42 TNTC 48 10 600000 0.52173913 43.6
3 0.98 TNTC 31 3 387500 0.33695652 103.0
4 2.12 TNTC 92 2 115000 0.1 221.7
5 3.08 TNTC 70 7 1 8750 0.0076087 323.0
6 3.90 163 24 0 2037.5 0.00177174 408.5
7 5.13 126 16 0 1 157.5 0.00013696 537.7
8 5.95 29 0 1











































































0.00 100.00 0.215 102.138
1.52 100.00 0.213 101.188
3.80 100.00 0.213 101.188
7.12 100.00 0.212 100.713
9.23 100.00 0.214 101.663






Actual.Time 0 >1 >2 >3 >4 >5 N N/No CT.(mg*min/L)
R1 1 0.25 TNTC 94 7 1175000 1 25.3
2 0.48 TNTC 101 4 1262500 1.07446809 49.0
3 0.93 TNTC 70 10 875000 0.74468085 94.5
4 3.07 TNTC 137 22 171250 0.14574468 310.6
5 5.23 TNTC 84 17 3 10500 0.00893617 530.0
6 6.88 TNTC 38 6 1 475 0.00040426 697.2
7 9.07 8 1 0
8 10.62 0 0 0












































































0.00 100.00 0.223 105.938
1.18 100.00 0.220 104.513
5.82 100.00 0.216 102.613
7.48 100.00 0.223 105.938






Actual0Time 0 @1 @2 @3 @4 @5 N N/No CT0(mg*min/L)
R1 1 0.22 TNTC 96 11 1200000 1 22.6
2 0.42 TNTC 91 7 1137500 0.94791667 43.5
3 0.58 TNTC 74 10 925000 0.77083333 60.9
4 1.52 TNTC 235 22 293750 0.24479167 158.3
5 2.68 TNTC 33 2 41250 0.034375 280.1
6 3.45 TNTC 79 7 9875 0.00822917 360.2
7 3.90 TNTC 241 29 3012.5 0.00251042 407.1
8 4.48 TNTC 123 5 1537.5 0.00128125 468.0
9 4.98 TNTC 47 587.5 0.00048958 520.2










































































0.00 100.00 0.225 106.888
1.32 100.00 0.220 104.513
3.32 100.00 0.214 101.663
7.80 100.00 0.219 104.038






Actual/Time 0 ?1 ?2 ?3 ?4 ?5 N N/No CT/(mg*min/L)
R1 1 0.25 TNTC 103 6 1287500 1 25.9
2 0.43 TNTC TNTC 73 10 912500 0.70873786 44.9
3 1.08 TNTC TNTC 48 600000 0.46601942 112.2
4 2.43 TNTC 175 22 218750 0.16990291 252.0
5 3.10 TNTC TNTC 101 15 126250 0.09805825 321.0
6 4.40 TNTC TNTC 242 30250 0.02349515 455.7
7 5.32 TNTC TNTC 77 9625 0.00747573 550.6
8 6.00 TNTC TNTC 46 5750 0.00446602 621.4












































































0.00 100.00 0.219 104.038
1.67 100.00 0.217 103.088
5.55 100.00 0.218 103.563






Actual0Time 0 A1 A2 A3 A4 A5 N N/No CT0(mg*min/L)
R1 1 0.25 TNTC 94 9 1175000 1 25.8
2 0.65 TNTC 68 6 850000 0.72340426 67.1
3 1.47 TNTC TNTC 67 837500 0.71276596 151.4
4 2.20 TNTC TNTC 36 450000 0.38297872 227.1
5 3.63 TNTC TNTC 246 307500 0.26170213 375.1
6 4.98 TNTC TNTC 99 123750 0.10531915 514.5
7 6.82 TNTC TNTC 192 24000 0.02042553 703.8
8 7.40 TNTC TNTC 107 13375 0.01138298 764.0
9 7.92 TNTC TNTC 33 4125 0.00351064 817.4










































































0.00 100.00 0.220 104.513
1.38 100.00 0.214 101.663
4.60 100.00 0.215 102.138
7.27 100.00 0.210 99.762






Actual/Time 0 @1 @2 @3 @4 @5 N N/No CT/(mg*min/L)
R1 1 0.28 TNTC 32 3 400000 1 28.7
2 0.48 215 37 2 365625 0.9140625 49.0
3 0.73 216 29 5 270000 0.675 74.4
5 2.87 TNTC 55 5 68750 0.171875 290.8
6 4.57 TNTC 100 11 12500 0.03125 463.2
7 6.20 217 17 1 2712.5 0.00678125 628.8
8 7.58 115 28 2 143.75 0.00035938 769.1
9 9.07 23 6 1
10 10.47 8 3 0











































































0.00 100.00 0.206 97.862
1.58 100.00 0.205 97.387
4.17 100.00 0.203 96.437
10.32 100.00 0.201 95.487






Actual/Time 0 >1 >2 >3 >4 >5 N N/No CT/(mg*min/L)
R1 1 0.25 TNTC 83 9 1037500 1 24.2
2 0.50 TNTC 79 6 987500 0.95180723 48.3
3 0.92 TNTC 101 9 1262500 1.21686747 88.6
4 3.48 TNTC 279 20 348750 0.33614458 336.7
5 5.73 TNTC TNTC 53 66250 0.06385542 554.3
6 6.52 TNTC TNTC 193 24125 0.02325301 630.0
7 7.50 TNTC TNTC 89 11125 0.01072289 725.1
8 8.22 TNTC TNTC 33 4125 0.0039759 794.3
9 8.97 TNTC 135 4 1687.5 0.00162651 866.8























































	  	   444 
 
 

















R2 0.000 100 0.208 98.81
1.567 100 0.198 94.06
5.400 100 0.202 95.96
6.883 100 0.197 93.59








Actual%Time%(mins) 0 L1 L2 L3 L4 L5 L6 N N/No CT%(mg*min/L)
1 0.00 323 25 2 3581250
2 0.00 333 21 3 3393750
0
3487500 1 0
3 0.23 TNTC TNTC 254 32 2 35875 0.010286738 22.19714964
4 0.48 TNTC 76 2 0 0 950 0.000272401 45.97980998
5 0.65 117 8 1 0 146 4.19355EL05 61.83491686
6 0.92 30 3 1 38 1.07527EL05 87.20308789
7 1.13 3 0 0
8 1.40 2 0 0
9 1.90 2 0 0
10 2.783333333 0 0 0
11 3.233333333 0 0 0
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R2 0.000 100 0.213 101.19
4.283 100 0.216 102.61
5.950 100 0.215 102.14








Actual%Time%(mins) 0 K1 K2 K3 K4 K5 K6 N N/No CT%(mg*min/L)
1 0.00 TNTC 87 9 1087500
2 0.00 TNTC 90 8 1125000
1106250 1 0
3 0.25 TNTC 213 19 266250 0.240677966 25.53444181
4 0.57 TNTC 293 29 5 36625 0.033107345 57.87806809
5 0.93 TNTC 39 3 4875 0.00440678 95.32858274
6 1.52 148 3 0 185 0.000167232 154.908947
7 2.20 12 2 0
8 2.55 2 0 0
9 3.03 1 0 0
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R2 0.000 100 0.210 99.76
2.750 100 0.213 101.19
6.383 100 0.213 101.19








Actual%Time%(mins) 0 K1 K2 K3 K4 K5 K6 N N/No CT%(mg*min/L)
1 0.00 TNTC 87 9 1087500
2 0.00 TNTC 90 8 1125000
1106250 1 0
11 0.63 TNTC 47 1 587500 0.531073446 63.88493006
12 1.18 TNTC 289 21 361250 0.326553672 119.3639483
13 2.08 TNTC 109 6 136250 0.123163842 210.1477963
14 4.50 TNTC 47 2 0 5875 0.005310734 453.9192399
15 6.15 74 13 0 925 0.000836158 620.3562945
16 8.37 153 20 3 0 191.25 0.000172881 843.9535497
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R2 0.000 100 0.208 98.81
4.000 100 0.196 93.11
5.883 100 0.203 96.44
7.683 100 0.209 99.29








Actual%Time%(mins) 0 L1 L2 L3 L4 L5 L6 N N/No CT%(mg*min/L)
1 0.00 299 17 2 3737500
2 0.00 308 24 1 3425000
3581250 1 0
3 0.25 TNTC 53 11 662500 0.184991274 24.07957245
4 0.53 TNTC 202 5 252500 0.070506108 51.36975455
5 1.18 TNTC 124 15 15500 0.004328098 113.9766429
6 1.52 TNTC TNTC 38 4750 0.001326353 146.0827395
7 2.00 TNTC 55 4 688 0.000191972 192.6365796
8 2.48 244 13 0 305 8.51658EL05 239.1904196
9 2.95 47 3 58.75 1.64049EL05 284.1389549
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R3 0.000 100 0.208 98.81
1.900 100 0.206 97.86
3.700 100 0.204 96.91
5.667 100 0.203 96.44








Actual%Time%(mins) 0 L1 L2 L3 L4 L5 L6 N N/No CT%(mg*min/L)
1 0.00 299 17 2 3737500
2 0.00 308 24 1 3425000
3581250 1 0
11 0.18 TNTC 289 27 4 36125 0.01008726 17.83254157
12 0.33 TNTC 96 4 2 1200 0.000335079 32.42280285
13 0.62 47 7 1 59 1.64049EL05 59.98218527
14 0.78 13 1
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R3 0.000 100 0.208 98.81
2.067 100 0.204 96.91
5.350 100 0.204 96.91
7.800 100 0.204 96.91








Actual%Time%(mins) 0 L1 L2 L3 L4 L5 L6 N N/No CT%(mg*min/L)
1 0.00 299 17 2 3737500
2 0.00 308 24 1 3425000
3581250 1 0
16 0.25 221 24 6 2762500 0.771378709 24.25771971
17 0.63 194 17 2 2425000 0.677137871 61.45288994
18 1.47 TNTC 111 5 1387500 0.387434555 142.3119557
19 3.78 TNTC 93 10 116250 0.032460733 367.1001584
20 5.15 226 10 0 28250 0.007888307 499.7090261
21 7.02 TNTC TNTC 31 4 3875 0.001082024 680.8333333
22 9.17 TNTC 113 16 1412.5 0.000394415 889.4497229
23 10.92 TNTC 33 4 412.5 0.000115183 1059.253761
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I.3  Solar Disinfection 
I.3.1  Discussion 
Using a laboratory solar simulator, various filters were used to mimic sunlight conditions on a 
sunny day at equatorial latitudes.  A 1000 W Xenon arc lamp (Newport, Stratford, CT) was used 
to produce a collimated light beam that was then passed through filters before reaching the 
reactor.  Filters used included an Air Mass 0, Air Mass 1.5, a 25 % transmittance filter, and a 
>324 nm long pass filter.  A UV-vis radiant power meter (Newport, Irvine, CA) was used to 
measure the intensity of the incident light in mW/cm2.  Experiments were performed in a 100 mL 
water-jacketed batch reactor kept at constant temperature by a recirculating water bath.  The 
reactor contained 25 or 50 mL of 1 mM CBS and was continually mixed by magnetic stirring 
under the incident light.  The effect of temperature was also investigated from 10-40°C at a pH 
of approximately 8.3.  HAdV-2 or PR772 was added to the reactor, and samples were taken to 
assess virus viability as previously described.  Experimental conditions are shown in Table I.3.      
 
Both PR772 and HAdV-2 show similar resistance to solar disinfection (SODIS) as shown in 
Figures I.6 and I.7.  After exposure to 6 hours of sunlight, HAdV-2 and PR772 were inactivated 
by less than 1-log.  PR772 was also exposed to 48 hours of continuous simulated sunlight and 
still did not achieve 4-log inactivation.  Solar disinfection in buffered Milli-Q water is therefore 
not effective for both HAdV-2 and PR772 inactivation even at a relatively high temperature of 
40 °C.     
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1.029 1 7/16/09 8.32 25°C 107.0 1.00E+05 
2.025 2 8/25/11 8.28 25°C 136.5 6.13E+05 
2.027 3 8/30/11 8.28 40°C 130.9 4.25E+05 
PR772 
1.161 1 8/17/10 ~8.3 25°C 136.1 7.88E+06 
1.267 2 5/4/11 ~8.3 40°C 127.6 2.55E+06 
1.269 3 5/5/11 ~8.3 30°C 134.0 3.01E+06 
1.283 4 6/29/11 8.23 40°C 139.7 3.04E+06 
1.293 5 7/19/11 ~8.3 10°C 135.5 3.01E+06 
J.005 6 6/20/11 ~8.3 25°C 138.2 1.55E+06 





Figure I.6.  Inactivation of HAdV-2 after exposure to solar disinfection for 6 hours at a pH of 
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Figure I.7.  Inactivation of bacteriophage PR772 after exposure to solar disinfection at a pH of 
approximately 8.3 at temperatures ranging from 10-40 °C up to 6 hours (top) and 48 hours 
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Ad2 vs. SODIS 7/16/09
pH 8.32





Ad2 added: 0.10 mL
Temp 25°C
Intensity: 107
Time (hrs) 0 -1 -2 -3 -4 -5 -6 N N/No
1 0 8 0 0 100000 1
2 0.66666667 83 0 0 0 103750 1.0375
3 1.33333333 42 0 0 0 52500 0.525
4 2 TNTC 43 0 0 53750 0.5375
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Ad2 vs. SODIS 8/25/11
pH 8.2








Time (hrs) 0 -1 -2 -3 -4 -5 -6 N N/No
1 0 TNTC 49 2 0 612500 1
2 0.16666667 TNTC 39 2 487500 0.7959
3 1 TNTC TNTC 41 512500 0.8367
4 2 TNTC TNTC 54 675000 1.102
5 3 TNTC TNTC 46 575000 0.9388

















Ad2 vs. SODIS 8/30/11
pH 8.28





Ad2 added: 0.10 mL
Temp 40°C
Intensity: 130.9
Time (hrs) 0 -1 -2 -3 -4 -5 -6 N N/No
1 0 TNTC 34 5 425000 1
2 0.16666667 TNTC 59 6 737500 1.7353
3 0.78333333 TNTC TNTC TNTC 84 2 1E+06 2.4706
4 2.01666667 TNTC TNTC TNTC TNTC 36 3 450000 1.0588
5 4.31666667 TNTC TNTC TNTC TNTC 58 1 725000 1.7059
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PR772 vs. SODIS 8/17/10









Sample No. Time (hrs) 0 -1 -2 -3 -4 -5 -6 N N/No
1 0 TNTC 63 8 8E+06 1
2 1 TNTC 38 0 5E+06 0.6032
3 5 TNTC 147 16 1 2E+06 0.2333
4 15 TNTC TNTC TNTC TNTC 71 9 2 887500 0.1127
5 24 TNTC TNTC TNTC 189 15 4 0 236250 0.03
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PR772 vs. SODIS 5/4/11
Reactor 25mL 1mM CBS
Filters: AMO
AM1.5 plated 24 hours after time 0
25%T
>324nm
PR772 added: 0.05 mL
Temp 40°C
Intensity: 127.6
Sample No. Time (hrs) 0 -1 -2 -3 -4 -5 N N/No
1 0 TNTC 204 24 2550000 1
2 0.25 TNTC TNTC 129 15 1612500 0.632353
3 1 TNTC TNTC TNTC TNTC 68+
4 2 TNTC TNTC TNTC TNTC 114 1425000 0.558824
5 4 TNTC TNTC TNTC TNTC 102 1275000 0.5
6 6 TNTC TNTC TNTC TNTC
















PR772 vs. SODIS 5/5/11





PR772 added: 0.05 mL
Temp 30°C
Intensity: 134
Sample No. Time (hrs) 0 -1 -2 -3 -4 -5 N N/No
1 0 TNTC 241 23 3E+06 1
2 0.25 TNTC 179 30 2E+06 0.7427
3 1 TNTC TNTC TNTC 183 2E+06 0.7593
4 2 TNTC TNTC TNTC TNTC 104 1E+06 0.4315
5 4 TNTC TNTC TNTC TNTC 92 1E+06 0.3817
















PR772 vs. SODIS 6/29/11









Sample No. Time (hrs) 0 -1 -2 -3 -4 -5 N N/No
1 0 TNTC 243 14 3037500 1
2 0.083333333 TNTC TNTC 53 6625000 2.18107
3 0.583333333 TNTC TNTC 58 7250000 2.38683
4 1.083333333 TNTC TNTC 47 5875000 1.93416
5 2.883333333 TNTC TNTC 49 6125000 2.01646
6 4.5 TNTC TNTC TNTC 50 6250000 2.05761
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PR772 vs. SODIS 7/19/11









Sample No. Time (hrs) 0 -1 -2 -3 -4 -5 N N/No
1 0 TNTC 132 35 3012500 1
2 0.083333333 TNTC 106 3 1325000 0.43983
3 0.5 TNTC 175 24 2187500 0.72614
4 1.583333333 TNTC 107 11 1337500 0.44398
5 2 TNTC 129 11 1612500 0.53527
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PR772 vs. SODIS 6/20/11









Sample No. Time (hrs) 0 -1 -2 -3 -4 -5 N N/No
1 0 TNTC 124 5 1550000 1
2 0.083333333 TNTC 142 8 1775000 1.14516
3 0.5 TNTC TNTC 137 11 1712500 1.10484
4 1 TNTC TNTC 128 9 1600000 1.03226
5 2 TNTC TNTC 161 8 2012500 1.29839
6 4 TNTC TNTC 120 6 1500000 0.96774
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PR772 vs. SODIS 7/7/11









Sample No. Time (hrs) 0 -1 -2 -3 -4 -5 N N/No
1 0 TNTC 102 10 1275000 1
2 0.083333333 TNTC 136 8 1700000 1.33333
3 0.433333333 TNTC 115 8 1437500 1.12745
4 0.916666667 TNTC 86 16 1075000 0.84314
5 1.916666667 TNTC 136 6 1700000 1.33333
6 3.916666667 TNTC TNTC 119 12 1487500 1.16667
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I.4  Simultaneous Solar and Monochloramine Disinfection 
I.4.1  Discussion 
Both monochloramine and solar disinfection (SODIS) are not as effective for HAdV inactivation 
compared to other disinfectants like free chlorine.  In developing regions, the application of point 
of use disinfection is common.  If ammonia is present in drinking water and point of use 
chlorination is utilized, monochloramine can be formed and will be a less effective disinfectant 
than the intended free chlorine.  Previous research investigated the simultaneous application of 
monochloramine and solar disinfection and found a synergistic effect for bacteriophage MS2.1 
The aims of this research were to determine if HAdV-2 and PR772 also experienced a 
synergistic effect with SODIS in combination with monochloramine compared to 
monochloramine alone. Monochloramine disinfection experiments have been detailed previously 
(Chapter 5) and SODIS (Appendix I.3).          
 
HAdV-2 and PR772 were exposed to SODIS and monochloramine in 50 mL of 1 mM CBS 
Milli-Q water at a pH of approximately 8.3 with experimental conditions shown in Table I.4.  
Figure I.8 shows that there was no difference observed between monochloramine in combination 
with solar disinfection and monochloramine disinfection alone for HAdV-2 inactivation at 25°C.  
The same trend was observed for PR772 at 40 °C (Figure I.9), a common temperature achieved 
during SODIS.  At 25 °C and 10 °C SODIS may slightly enhance PR772 inactivation.  The 
synergic effect previously observed for MS2 inactivated by solar disinfection in combination 
with monochloramine disinfection was not as evident for HAdV-2 and PR772.        
	  	   464 
Table I.4. Experimental conditions for HAdV-2 and PR772 inactivation by simulated solar 














2.033 9/8/11 SODIS + Monochloramine 8.2 25 2.93 3.14E+05 
2.033 9/8/11 Monochloramine 8.2 25 2.92 3.14E+05 
PR772 
1.281 6/27/11 SODIS + Monochloramine 8.2 25 3.46 1.30E+06 
1.287 7/13/11 SODIS + Monochloramine 8.3 40 3.71 2.11E+06 
1.295 7/20/11 SODIS + Monochloramine 8.2 25 3.40 1.23E+06 
1.303 8/1/11 SODIS + Monochloramine 8.1 10 3.10 3.39E+06 
3.007 8/3/11 SODIS + Monochloramine 8.1 10 2.88 4.38E+05 
1.279 6/23/11 Monochloramine 8.3 25 3.22 1.39E+06 
1.285 7/11/11 Monochloramine 8.3 40 2.92 2.99E+06 
1.299 7/28/11 Monochloramine 8.3 10 3.05 1.74E+06 
3.009 8/4/11 Monochloramine 8.3 25 2.91 2.15E+06 
 
 
Figure I.8.  Inactivation of HAdV-2 after exposure to a combination of SODIS and 
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Figure I.9.  Inactivation of bacteriophage PR772 after exposure to a combination of SODIS and 
monochloramine or monochloramine alone at a pH of approximately 8.3 at temperatures ranging 
from 40 °C (top), 25°C (middle), and 10 °C (bottom).   
 
 
I.4.2  References 
1.  Page, M. A.  Kinetics and Mechanisms of Adenovirus Type 2 Inactivation with Chemical 
Oxidation, Irradiation, and Photocatalysis Processes.  Ph.D. Dissertation, University of Illinois at 
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0.000 5 0.129 3.064
1.833 5 0.125 2.969
3.917 5 0.125 2.969
10.933 5 0.123 2.922
30.200 5 0.123 2.922
58.367 5 0.123 2.922
122.217 5 0.119 2.827





Actual&Time 0 51 52 53 54 55 N N/No CT&(mg*min/L)
R1 1 0.00 251 26 1 313750 1 0
2 0.23 300 24 1 375000 1.19521912 0.6830958
3 9.90 TNTC TNTC 170 18 212500 0.67729084 28.9827791
4 29.62 TNTC TNTC TNTC 53 2 66250 0.21115538 86.7043745
5 59.97 TNTC TNTC 78 1 9750 0.0310757 175.555622
6 121.02 TNTC 117 8 1462.5 0.00466135 354.282759









































































0.000 5 0.129 3.064
1.233 5 0.125 2.969
3.233 5 0.124 2.945
21.583 5 0.119 2.827
30.867 5 0.121 2.874
61.450 5 0.121 2.874
122.833 5 0.122 2.898





Actual&Time 0 51 52 53 54 55 N N/No CT&(mg*min/L)
R1 1 0.00 251 26 1 313750 1 0
2 0.23 TNTC 41 2 512500 1.63346614 0.6830958
3 30.00 TNTC 73 4 91250 0.29083665 87.8266033
4 59.90 92 11 0 11500 0.03665339 175.360451
5 121.80 99 1 1 1237.5 0.00394422 356.57601




































































0.350 5 0.139 3.30
2.067 5 0.14 3.33










0.38333333 5 0.146 3.47
2.73333333 5 0.146 3.47
4.9 5 0.145 3.44
18.6166667 5 0.146 3.47
36.2166667 5 0.145 3.44





Actual%Time%(mins) 0 O1 O2 O3 O4 O5 N N/No CT%(mg*min/L)
1 0.00 TNTC 104 17 1300000 1 0
2 0.28 TNTC TNTC 49 612500 0.471153846 0.98033782
3 1.05 TNTC TNTC TNTC 67 7 83750 0.064423077 3.633016627
4 5.13 0 1 0 0
5 20.12 0 0 0
6 40.05 0 0 0































































0.817 5 0.137 3.25
2.883 5 0.138 3.28










0.46666667 5 0.156 3.71
0.81666667 5 0.163 3.87





Actual%Time%(mins) 0 S1 S2 S3 S4 S5 N N/No CT%(mg*min/L)
1 0.00 TNTC 169 18 2112500 1 0
2 0.15 TNTC TNTC TNTC TNTC 71 887500 0.42011834 0.555819477
3 0.35 TNTC TNTC TNTC TNTC 42 525000 0.24852071 1.296912114
4 0.53 TNTC TNTC TNTC 170 12 212500 0.10059172 1.976247031
5 0.92 TNTC TNTC TNTC 90 3 112500 0.05325444 3.396674584
6 1.12 TNTC TNTC 172 26 21500 0.01017751 4.137767221
7.000 1.966666667 TNTC 91 2 1137.5 0.00053846 7.287410926
































































0.833 5 0.138 3.28
2.817 5 0.138 3.28










0.33333333 5 0.145 3.44
2.01666667 5 0.143 3.40
3.73333333 5 0.144 3.42





Actual%Time%(mins) 0 O1 O2 O3 O4 O5 N N/No CT%(mg*min/L)
1 0.00 TNTC 98 8 1225000 1 0
2 0.22 TNTC TNTC 43 537500 0.43877551 0.737232779
3 0.98 TNTC TNTC 73 11 91250 0.074489796 3.345902613
4 1.97 TNTC 435 29 1 4531.25 0.00369898 6.691805226
5 3.02 TNTC 34 0 425 0.000346939 10.26454869































































1.500 5 0.128 3.04
4.733 5 0.13 3.09










0.33333333 5 0.134 3.18
2.28333333 5 0.132 3.14
3.83333333 5 0.132 3.14
5.56666667 5 0.131 3.11
17.1833333 5 0.131 3.11
27.2333333 5 0.128 3.04
31.0333333 5 0.13 3.09
37.0666667 5 0.129 3.06





Actual%Time%(mins) 0 M1 M2 M3 M4 M5 N N/No CT%(mg*min/L)
1 0.00 TNTC 232 31 3387500 1 0
2 0.20 TNTC TNTC 48 600000 0.177121771 0.62074426
3 1.03 TNTC TNTC 64 11 80000 0.023616236 3.207178675
4 5.00 74 33 5 0 412.5 0.000121771 15.51860649
5 14.97 0 1 0
6 25.02 0 1 0

































































0 5 0.123 2.92
0 5 0.122 2.90
1.71666667 5 0.122 2.90
3.7 5 0.119 2.83
5.56666667 5 0.121 2.87





Actual%Time%(mins) 0 O1 O2 O3 O4 O5 N N/No CT%(mg*min/L)
R1 1 0.00 TNTC 35 8 437500 1 0
2 0.23 TNTC 175 11 2187500 5 0.672472948
3 1.00 TNTC TNTC 56 700000 1.6 2.88202692
4 2.00 TNTC TNTC TNTC 115 143750 0.32857143 5.76405384
5 3.43 TNTC TNTC 244 30500 0.06971429 9.894959092
6 5.00 TNTC TNTC 33 4125 0.00942857 14.4101346
7 7 TNTC 98 1225 0.0028 20.17418844



































































0.350 5 0.132 3.14 3.21
1.667 5 0.137 3.25







0.483 5 0.135 3.21
3.383 5 0.136 3.23














0.26666667 5 0.138 3.28
2.68333333 5 0.136 3.23
4.71666667 5 0.132 3.14
10.2666667 5 0.14 3.33
15.4166667 5 0.137 3.25
45.55 5 0.136 3.23







Actual%Time%(mins) 0 N1 N2 N3 N4 N5 N N/No CT%(mg*min/L)
1 0.00 TNTC 111 5 1387500 1 0
2 0.45 TNTC TNTC TNTC TNTC 33 5 412500 0.2972973 1.450627757
3 1.97 TNTC TNTC TNTC 94 5 117500 0.08468468 6.339780568
4 15.23 1 0 0 0 0
5 45.37 90 0 1 0



























































0.267 5 0.126 2.99
1.250 5 0.125 2.97










0.48333333 5 0.132 3.14
3.15 5 0.125 2.97
5.38333333 5 0.12 2.85
7.96666667 5 0.118 2.80
15.6 5 0.124 2.95
18.3833333 5 0.125 2.97
25.2 5 0.123 2.92
36.2 5 0.123 2.92
45.9 5 0.121 2.87
54.5833333 5 0.12 2.85





Actual#Time#(mins) 0 K1 K2 K3 K4 K5 N N/No CT#(mg*min/L)
1 0.00 TNTC 168 31 2987500 1 0
2 0.20 TNTC TNTC TNTC TNTC 47 587500 0.19665272 0.583459296
3 0.98 TNTC TNTC TNTC 90 6 112500 0.0376569 2.868674872
4 2.98 102 8 0 0 127.5 4.2678EK05 8.703267833
5 8.12 0 0 0 0
6 18.20 0 0 0
7.000 35.78333333 0 0 0






























































Actual%Time%(mins) 0 ?1 ?2 ?3 ?4 ?5 N No N/No CT
0:00 TNTC 97 10 1212500 1350000 1 0





0 5 0.13 3.09
0.68333333 5 0.129 3.06
4.5 5 0.129 3.06
16.6666667 5 0.129 3.06
47 5 0.127 3.02





Actual%Time%(mins) 0 ?1 ?2 ?3 ?4 ?5 N N/No CT%(mg*min/L)
1 0.45 TNTC 139 9 1737500 1 1.373515439
2 1.88 TNTC TNTC TNTC 47 587500 0.3381295 5.748416469
3 15.00 TNTC 38 2 0 0 475 0.00027338 45.78384798
4 45.32 1 0 0 0
































































Actual%Time%(mins) 0 B1 B2 B3 B4 B5 N No N/No CT
0:00 TNTC 144 19 1800000 1887500 1 0





0 5 0.125 2.97
0.98333333 5 0.123 2.92
2.51666667 5 0.123 2.92
4.81666667 5 0.123 2.92
6.4 5 0.123 2.92
8.75 5 0.123 2.92
13.0333333 5 0.121 2.87
27 5 0.12 2.85





Actual%Time%(mins) 0 B1 B2 B3 B4 B5 N N/No CT%(mg*min/L)
3 0.23 TNTC 172 13 2150000 1 0.67801531
4 1.97 TNTC TNTC 34 425000 0.19767442 5.71470045
5 4.03 TNTC TNTC 32 40000 0.01860465 11.7199789
6 6.00 TNTC TNTC 40 4 5000 0.00232558 17.4346793
7 8.03 TNTC 30 6 0 375 0.00017442 23.3430984
8 12.03 0 1 0
9 25 0 0 0
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I.5  Silver Disinfection 
I.5.1  Discussion  
There has been increasing interest in understanding waterborne pathogen inactivation by metals.  
Virus inactivation by silver is important because of the use of embedded silver in ceramic filters 
and other applications of silver as a disinfectant for drinking water.  The inactivation of 
bacteriophage PR772 was investigated.  To determine the silver concentration, a DR4000 
spectrophotometer (Hach, Loveland, CO) was used with Hach Method 8120.  The colorimetric 
silver method measures a range of 0.02-0.70 m/L Ag.  Silver nitrate stocks were prepared fresh 
for each experiment at a concentration of 1.0g/L as Ag.  The quencher was sodium thiosulfate 
and sodium thioglycolate.  Experiments were conducted in a temperature controlled water bath 
with the reactors consisting of 400 mL of 1 mM CBS.  All glassware was acid washed prior to 
use.  Experimental conditions for bacteriophage PR772 are shown in Table I.5 with a pH range 
of 7-9.5 and initial silver concentrations from 0.2 to 2.4 mg/L Ag.  
 
Figures I.10 and I.11 show the inactivation of PR772 at 20 °C and 40 °C, respectively.  The 
higher the pH and temperature, the more effective silver was at inactivating PR772. PR772 
tended to become slightly inactivated (< 4-log), then not achieve any further inactivation with 
increasing silver exposure.  Repeatability between data sets was an issue, and further research is 
necessary to understand this disinfection phenomenon.  Overall, 4-log inactivation of PR772 by 
silver was not achieved under any pH or temperature condition investigated.          
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1.075 1 2/8/10 7.92 8 20 0.265 5.25E+06 1 mM CBS 
1.079 2 2/14/10 8.00 8 20 0.227 6.13E+06 1 mM CBS 
1.083 3 2/24/10 7.01 7 20 0.236 5.75E+06 1 mM CBS 
1.085 4 2/24/10 9.50 9.5 20 0.240 4.88E+06 1 mM CBS 
1.087 5 2/28/10 7.96 8 40 0.209 6.50E+06 1 mM CBS 
1.089 6 3/1/10 9.00 9 20 0.217 1.05E+07 1 mM CBS 
1.091 7 3/2/10 8.00 8 20 0.223 2.19E+06 1 mM CBS 
1.097 8 5/18/10 7.97 8 40 0.220 7.75E+05 1 mM CBS 
1.101 9 5/20/10 8.96 9 20 0.209 1.29E+06 1 mM CBS 
1.103 10 5/20/10 7.03 7 20 0.206 8.00E+05 1 mM CBS 
1.135 11 7/27/10 7.95 8 20 2.365 5.38E+05 1 mM CBS 
1.137 12 7/27/10 9.01 9 20 0.241 3.00E+05 1 mM CBS 
1.142 13 8/4/10 8.97 9 40 0.253 4.63E+05 1 mM CBS 
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Figure I.10.  (Left) Inactivation kinetics of PR772 by silver from pH 7-9.5 at 20 °C and (right) 





Figure I.11.  (Left) Inactivation kinetics of PR772 by silver at pH 8 and 9 at 40 °C and (right) 















































































	  	   480 










PR7721added1 1mL dilution:1ug/L 265.1167
Silver1stock1added 0.1mL mg/L 0.265117
Notes:11Added1PR772,1stirred,1took1No1sample.11At131mins,1took1a110mL1for1silver1concentration1sample.11
Notes:1temp1may1not1have1been1100%1correct.11pH1meter1also1not1working1correctly
Time1(mins) 0 W1 W2 W3 W4 W5 W6 W7 W8 N/No CT
0 T T 42 3 0 0 5250000 1 0
3 T T 78 4 0 1 975000 0.185714 0.79535
15 T T T 201 17 2 251250 0.047857 3.97675
30 T T T 91 14 1 113750 0.021667 7.9535




















Temp5(C5) 20 46.88 44.2
Reactor5size5(mL) 400 46.84 44.13
Buffer 1mM5CBS 46.8 44.13
Silver5nitrate5stock 1.05g/5L5as5Ag+ dilution:5ug/L 234.2 220.7667
PR7725added5 1mL mg/L 0.2342 0.220767




Time (mins) 0 -1 -2 -3 -4 -5 -6 pfu/mL N/No CT
0 T 49 1 6125000 1 0
2 T 225 22 2812500 0.459184 0.454967
13 T 54 3 675000 0.110204 2.957283
30 T 267 40 416875 0.068061 6.8245
60 T 158 24 197500 0.032245 13.649
120 T T T 207 11 258750 0.042245 27.298


















pH 7.01 Silver AT535MINS AFTER54H13MIN
Temp5(C5) 20 47.04 47.53
Reactor5size5(mL) 400 46.96 47.4
Buffer 1mM5CBS 46.88 47.37
Silver5nitrate5stock1.05g/5L5as5Ag+ dilution:5ug/L 234.8 237.1666667




Time5(mins) 0 V1 V2 V3 V4 V5 V6 PFU/mL N/No CT
0 T 46 4 5750000 1 0
2 T T 39 4875000 0.847826 0.471966667
13 T T 24 3000000 0.521739 3.067783333
30 T 289 18 3612500 0.628261 7.0795
61 T 189 19 2362500 0.41087 14.39498333
138 T T 98 1225000 0.213043 32.5657




























Time6(mins) 0 T1 T2 T3 T4 T5 T6 PFU/mL N/No CT
0 T 39 2 4875000 1 0
2.5 T T T 120 13 1500000 0.307692 0.601125
10 T T T 54 4 67500 0.013846 2.4045




















pH 7.96 Silver 11.5mins end
Temp;(C;) 40 43.84 39.85
Reactor;size;(mL) 400 43.73 39.93
Buffer 1mM;CBS 43.65 39.91
Silver;nitrate;stock1.0;g/;L;as;Ag+ dilution:;ug/L 218.7 199.4833





Time;(mins) 0 U1 U2 U3 U4 U5 U6 PFU/mL N/No CT
0 T 52 3 6500000 1 0
2.5 T T T 102 15 1275000 0.196154 0.522729
5 T T T T 81 15 1012500 0.155769 1.045458
10 T T T T 39 487500 0.075 2.090917
15 T T T T 58 725000 0.111538 3.136375
30 T T T 203 253750 0.039038 6.27275
60 T T T

















Date 3/1/10 Silver 4mins end
pH 9.00 Conc.::(ug/L) 45.3 41.6
Temp:(C:) 20 45.09 41.52
Reactor:size:(mL) 400 44.96 41.46
Buffer 1mM:CBS 44.9 41.76
Silver:nitrate:stock 1.0:g/:L:as:Ag+ dilution::ug/L 225.3125 207.925
PR772:added: 1mL mg/L 0.225313 0.207925




Time:(mins) 0 W1 W2 W3 W4 W5 W6 PFU/mL N/No CT
0 T 84 8 10500000 1 0
2 T T 43 5375000 0.511905 0.433238
14 T T 94 1175000 0.111905 3.032663
30 T T T
60 T T T T
















Date 3/2/10 Silver 16mins 6hrs440min 24hrs
pH 8.00 Conc.44(ug/L) 46.17 44.37 43.18
Temp4(C4) 20 46.16 44.38 43.14
Reactor4size4(mL) 400 46.04 44.3 43.07
Buffer 1mM4CBS 46.48 44.58 43.18
Silver4nitrate4stock 1.04g/4L4as4Ag+ dilution:4ug/L 231.0625 222.0375 215.7125
PR7724added4 1mL mg/L 0.231063 0.2220375 0.215713
Silver4stock4added 0.084mL C4(mg/L) 0.222938
Notes:44Added4PR772,4stirred,4took4No4sample.44
Took4a410mL4for4silver4concentration4sample4at4164mins,46hrs40mins,4and4at4the4end4of4experiment4at424hrs.
Time4(mins) 0 T1 T2 T3 T4 T5 T6 PFU/mL N/No CT
0 175 9 1 2187500 1 0
2 T 178 11 2225000 1.017143 0.445875
15 T 106 3 1325000 0.605714 3.3440625
60 T 303 18 301875 0.138 13.37625
190 T 113 11 141250 0.064571 42.358125
398 T T T 111 20 138750 0.063429 88.729125
752 T T T 137 6 171250 0.078286 167.649


















pH 7.97 Silver 16mins 8hrs 24hrs
Temp<(C<) 40 43.43 43.87 41.61
Reactor<size<(mL) 400 43.14 43.75 41.51
Buffer 1mM<CBS 43.07 53.65 41.43
Silver<nitrate<stock1.0<g/<L<as<Ag+ dilution:<ug/L 216.0667 235.45 207.5833




Time<(mins) 0 T1 T2 T3 T4 T5 T6 PFU/mL N/No CT
0 62 11 0 775000 1 0
2 T? 58 0 725000 0.935484 0.4394
8 51? 0? 0? #VALUE! #VALUE! 1.7576
15 42? 0? 0? #VALUE! #VALUE! 3.2955
30 T 44+C 3? #VALUE! #VALUE! 6.591
80 T? T? 2 #VALUE! #VALUE! 17.576
212 T T 158 25 0 25500 0.032903 46.5764
477 T T 193 8 0 24125 0.031129 104.7969


















pH 8.96 Silver 17mins 24:hrs
Temp:(C:) 20 43.8 39.84
Reactor:size:(mL) 400 43.71 39.58
Buffer 1mM:CBS 43.6 40.12
Silver:nitrate:stock1.0:g/:L:as:Ag+ dilution::ug/L 218.5167 199.2333





Time:(mins) 0 V1 V2 V3 V4 V5 V6 PFU/mL N/No CT
0 103 9? 1 1287500 1 0
2 T 77 2 962500 0.747573 0.41775
15 * 11 0 3.133125
60 9 0 3 12.5325
240 * 18 4 50.13
749 T T * 22 1 156.4474


















pH 7.03 Silver 17mins 248hrs
Temp8(C8) 20 42.25 40.33
Reactor8size8(mL) 400 42.17 40.11
Buffer 1mM8CBS 42.08 40.26
Silver8nitrate8stock 1.08g/8L8as8Ag+ dilution:8ug/L 210.8333 201.1667
PR7728added8 1mL mg/L 0.210833 0.201167
Silver8stock8added 0.088mL C8(mg/L) 0.206
Notes:88Added8PR772,8stirred,8took8No8sample.88
Took8a810mL8for8silver8concentration8sample8at817mins88and8at8the8end8of8experiment
Time8(mins) 0 S1 S2 S3 S4 S5 S6 PFU/mL N/No CT
0 64 0 0 800000 1 0
15 T 59 3 737500 0.921875 3.09
60 T 54 9 675000 0.84375 12.36
240 T 30 2 375000 0.46875 49.44
749 T T T 182 18 0 227500 0.284375 154.294

















Date 7/27/10 Time 30 10h16m 26h40m
pH 7.95 before=virus=added Sample=size 10mL 10mL 10mL
Temp=(C=) 20 471.76 470.64 476.32
Reactor=size=(mL) 400 471.6 470.72 476.81
Buffer 1mM=CBS 471.25 470.74 476.94
Silver=nitrate=stock 1.0=g/=L=as=Ag+ 471.38 470.72 476.94
PR772=added= 1mL dilution:=ug/L 2357.488 2353.525 2383.763
Silver=stock=added 1.0mL mg/L 2.357488 2.353525 2.383763
C=(mg/L) 2.364925
Notes:==Added=PR772,=stirred,=took=No=sample.==
Time=(mins) 0 T1 T2 T3 T4 T5 T6 PFU/mL N/No CT
0 43 13 1 537500 1 0
2 TNTC 50 11 625000 1.162791 4.72985
15 44 2 1 0 5500 0.010233 35.47388
60 342 36 1 0 4500 0.008372 141.8955
126 420 10 3 0 1 325 0.000605 297.9806
308 68 5 0 0 0 85 0.000158 728.3969
610 51 1 1 0 0 63.75 0.000119 1442.604






















Date 7/27/10 Time 12 10h11m 26h40m
pH 9.01 before;virus;added Sample;size 10mL 10mL 10mL
Temp;(C;) 20 51.36 48.17 45.6
Reactor;size;(mL) 400 51.18 47.89 45.56
Buffer 1mM;CBS 51.32 47.62 45.42
Silver;nitrate;stock 1.0;g/;L;as;Ag+ 51.13 47.64 45.38
PR772;added; 1mL dilution:;ug/L 256.2375 239.15 227.45
Silver;stock;added 0.1mL mg/L 0.256238 0.23915 0.22745
C;(mg/L) 0.240946
Notes:;;Added;PR772,;stirred,;took;No;sample.;;
Time;(mins) 0 T1 T2 T3 T4 T5 T6 PFU/mL N/No CT
0 24 12 2 300000 1 0
2 TNTC 59 3 737500 2.458333 0.481892
15 6 0 0 3.614188
60 1 0 0 14.45675
121 6 1 0 0 29.15445
304 239 57 3 0 0 505.625 0.001685 73.24753
607 TNTC 45 4 0 0 562.5 0.001875 146.2541
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13 Silver
Date 8/4/10 Time 12 12h3m 24h30m
pH 8.97 before<virus<added Sample<size 10mL 10mL 10mL
Temp<(C<) 40 36.91 49.86 51.61
Reactor<size<(mL) 400 36.88 49.65 51.55
Buffer 1mM<CBS 36.73 49.89 51.44
Silver<nitrate<stock 1.0<g/<L<as<Ag+ 36.62 49.63 51.43
PR772<added< 1mL dilution:<ug/L 183.925 248.7875 257.5375
Silver<stock<added 0.1mL mg/L 0.183925 0.248788 0.257538
C<(mg/L) 0.253163
Notes:<<Added<PR772,<stirred,<took<No<sample.<< *not<counting<the<12m<sample
Time<(mins) 0 U1 U2 U3 U4 U5 U6 PFU/mL N/No CT
0 TNTC 37 5 2 462500 1 0
2 TNTC 190 6 0 0 23750 0.051351 0.506325
10 TNTC 339 31 1 0 0 3875 0.008378 2.531625
30 183 17 0 0 0 0 228.75 0.000495 7.594875
60 336 43 6 0 0 537.5 0.001162 15.18975
124 129 17 1 0 0 161.25 0.000349 31.39215
720 0 0 0 0 0
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